01283000000000469000450099100020000070000020000270600020000470100020000609100090
00081300033000171510019000500350010000694800067000790300020001469300007001661170
00800173085000500181935001000186031000300196032000200199036000600201042000200207
20000020020906500090021112200030022004800140022304800140023704800240025104900350
02750490035003100490040003450490036003850490033004210490030004540490035004840490
03700519049003300556049003800589043006200627043006200689043006200751#1#0#i#1#201
10331#Jornal Brasileiro de Psiquiatria#J. bras. psiquiatr#0047-2085#Instituto de
 Psiquiatria da Universidade Federal do Rio de Janeiro#J. bras. psiquiatr.#JBPSI
Q#vancouv#decs#0047-2085#60#1#20111#1#1#20110000#14#^les^hSumario#^lpt^hSumário#
^len^hTable of Contents#^lpt^cJBPSIQ010^tArtigos originais#^len^cJBPSIQ010^tOrig
inal articles#^lpt^cJBPSIQ220^tRevisões de Literatura#^len^cJBPSIQ220^tLiteratur
e Reviews#^lpt^cJBPSIQ240^tRelatos de Caso#^len^cJBPSIQ240^tCase Reports#^lpt^cJ
BPSIQ250^tComunicação Breve#^len^cJBPSIQ250^tBrief Communication#^lpt^cJBPSIQ270
^tCarta ao Editor#^len^cJBPSIQ270^tLetter to the Editor#^les^tJ. bras. psiquiatr
.^vvol.60^nno.1^cRio de Janeiro^a2011#^lpt^tJ. bras. psiquiatr.^vvol.60^nno.1^cR
io de Janeiro^a2011#^len^tJ. bras. psiquiatr.^vvol.60^nno.1^cRio de Janeiro^a201
1##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#o#1#1#article
#1#20110331#101341#v60n1a01.htm#154##
04172000000000685000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400070015003500100015701201100
01670120126002770100042004030100038004450100041004830100035005240100038005590700
09600597070009600693070009900789070005400888070006600942083107101008085001002079
08500240208908500160211308500160212908500320214508311470217708500100332408500270
33340850016033610850016033770850031033931170008034240720003034321120009034351110
01003444114000903454113001003463002001303473#v60n1#V:\SciELO\serial\jbpsiq\v60n1
\markup\v60n1a01.htm#S#h#2#1#article#1#oa#en#br1.1#1#4.0#ILUS#TAB#1#JBPSIQ010#nd
#J. bras. psiquiatr.#60#1#20110000#^f1^l6#0047-2085#Cerebral perfusion and autom
ated individual analysis using SPECT among an obsessive-compulsive population^le
n#Perfusão cerebral e análise individual automatizada utilizando SPECT em uma po
pulação com transtorno obsessivo-compulsivo^lpt#^rND^1A01 A02^nEuclides Timóteo 
da^sRocha#^rND^1A03^nCarlos Alberto^sBuchpiguel#^rND^1A04^nEuripedes Constantino
^sMiguel#^rND^1A05^nStela Verzinhase^sPeres#^rND^1A03 A04^nGeraldo^sBusatto Filh
o#Fundação Pio XII^iA01^1Hospital de Câncer^2Department of Nuclear Medicine^cBar
retos^sSP^pBrazil#São Paulo State University^iA02^1Medical School^2Blood Transfu
sion Center^cBotucatu^sSP^pBrazil#University of São Paulo^iA03^1School of Medici
ne^2Department of Radiology Nuclear Medicine Service#USP^iA04^1School of Medicin
e^2Institute of Psychiatry#Fundação Pio XII^iA05^1Hospital de Câncer^2Research S
upport Group#^len^aOBJECTIVE: To make individual assessments using automated qua
ntification methodology in order to screen for perfusion abnormalities in cerebr
al SPECT examinations among a sample of subjects with OCD. METHODS: Statistical 
parametric mapping (SPM) was used to compare 26 brain SPECT images from patients
 with OCD individually with an image bank of 32 normal subjects, using the stati
stical threshold of p < 0.05 (corrected for multiple comparisons at the level of
 individual voxels or clusters). The maps were analyzed, and regions presenting 
voxels that remained above this threshold were sought. RESULTS: Six patients fro
m a sample of 26 OCD images showed abnormalities at cluster or voxel level, cons
idering the criteria described above, which represented 23.07%. However, seven i
mages from the normal group of 32 were also indicated as cases of perfusional ab
normality, representing 21.8% of the sample. CONCLUSION: The automated quantific
ation method was not considered to be a useful tool for clinical practice, for a
nalyses complementary to visual inspection.#^ddecs^i1#^tm^len^kBrain SPECT^i1#^t
m^len^kSPM^i1#^tm^len^kOCD^i1#^tm^len^kindividual analysis^i1#^lpt^aOBJETIVO: Av
aliar uma amostra de pacientes com transtorno obsessivo-compulsivo (TOC), indivi
dualmente, empregando uma metodologia de quantificação automatizada para rastrea
r anormalidades de perfusão em exames de SPECT cerebral. MÉTODOS: Foi utilizado 
o Statistical Parametric Mapping (SPM) para comparar 26 imagens de SPECT cerebra
l de pacientes com TOC, individualmente, com um banco de 32 imagens de voluntári
os normais, usando o limiar estatístico de p < 0,05 (corrigido para comparações 
múltiplas ao nível do voxel individual ou clusters). Os mapas foram analisados p
rocurando por regiões que apresentassem voxels acima desse limiar. RESULTADOS: S
eis pacientes da amostra de 26 imagens com TOC mostraram anormalidades ao nível 
do cluster ou voxel, considerando os critérios descritos acima, os quais represe
ntaram 23,07%. Contudo, sete imagens do grupo de 32 voluntários normais também f
oram apontadas com anormalidades de perfusão, que representou 21,8% da amostra. 
CONCLUSÃO: O método de quantificação automatizada não foi considerado como uma f
erramenta útil na prática clínica, como forma de análise complementar à inspeção
 visual.#^ddecs^i2#^tm^lpt^kSPECT cerebral^i2#^tm^lpt^kTOC^i2#^tm^lpt^kSPM^i2#^t
m^lpt^kanálise individual^i2#vancouv#24#20101207#7/12/2010#20101209#9/12/2010#v6
0n1a01.htm##
04248000000000685000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400070015003500100015701201170
01670120133002840100042004170100038004590100041004970100035005380100038005730700
09600611070009600707070009900803070005400902070006600956083110201022085001002124
08500240213408500160215808500160217408500320219008311780222208500100340008500270
34100850016034370850016034530850031034691170008035000720003035081120009035111110
01003520114000903530113001003539002001303549#v60n1#V:\SciELO\serial\jbpsiq\v60n1
\markup\v60n1a01.htm#S#f#3#1#article#1#oa#en#br1.1#1#4.0#ILUS#TAB#1#JBPSIQ010#nd
#J. bras. psiquiatr.#60#1#20110000#^f1^l6#0047-2085#<b>Cerebral perfusion and au
tomated individual analysis using SPECT among an obsessive-compulsive population
</b>^len#<b>Perfusão cerebral e análise individual automatizada utilizando SPECT
 em uma população com transtorno obsessivo-compulsivo</b>^lpt#^rND^1A01 A02^nEuc
lides Timóteo da^sRocha#^rND^1A03^nCarlos Alberto^sBuchpiguel#^rND^1A04^nEuriped
es Constantino^sMiguel#^rND^1A05^nStela Verzinhase^sPeres#^rND^1A03 A04^nGeraldo
^sBusatto Filho#Fundação Pio XII^iA01^1Hospital de Câncer^2Department of Nuclear
 Medicine^cBarretos^sSP^pBrazil#São Paulo State University^iA02^1Medical School^
2Blood Transfusion Center^cBotucatu^sSP^pBrazil#University of São Paulo^iA03^1Sc
hool of Medicine^2Department of Radiology Nuclear Medicine Service#USP^iA04^1Sch
ool of Medicine^2Institute of Psychiatry#Fundação Pio XII^iA05^1Hospital de Cânc
er^2Research Support Group#^len^a<b>OBJECTIVE:</b> To make individual assessment
s using automated quantification methodology in order to screen for perfusion ab
normalities in cerebral SPECT examinations among a sample of subjects with OCD. 
<b>METHODS:</b> Statistical parametric mapping (SPM) was used to compare 26 brai
n SPECT images from patients with OCD individually with an image bank of 32 norm
al subjects, using the statistical threshold of p &lt; 0.05 (corrected for multi
ple comparisons at the level of individual voxels or clusters). The maps were an
alyzed, and regions presenting voxels that remained above this threshold were so
ught. <b>RESULTS:</b> Six patients from a sample of 26 OCD images showed abnorma
lities at cluster or voxel level, considering the criteria described above, whic
h represented 23.07%. However, seven images from the normal group of 32 were als
o indicated as cases of perfusional abnormality, representing 21.8% of the sampl
e. <b>CONCLUSION:</b> The automated quantification method was not considered to 
be a useful tool for clinical practice, for analyses complementary to visual ins
pection.#^ddecs^i1#^tm^len^kBrain SPECT^i1#^tm^len^kSPM^i1#^tm^len^kOCD^i1#^tm^l
en^kindividual analysis^i1#^lpt^a<b>OBJETIVO:</b> Avaliar uma amostra de pacient
es com transtorno obsessivo-compulsivo (TOC), individualmente, empregando uma me
todologia de quantificação automatizada para rastrear anormalidades de perfusão 
em exames de SPECT cerebral. <b>MÉTODOS:</b> Foi utilizado o Statistical Paramet
ric Mapping (SPM) para comparar 26 imagens de SPECT cerebral de pacientes com TO
C, individualmente, com um banco de 32 imagens de voluntários normais, usando o 
limiar estatístico de p &lt; 0,05 (corrigido para comparações múltiplas ao nível
 do voxel individual ou clusters). Os mapas foram analisados procurando por regi
ões que apresentassem voxels acima desse limiar. <b>RESULTADOS:</b> Seis pacient
es da amostra de 26 imagens com TOC mostraram anormalidades ao nível do cluster 
ou voxel, considerando os critérios descritos acima, os quais representaram 23,0
7%. Contudo, sete imagens do grupo de 32 voluntários normais também foram aponta
das com anormalidades de perfusão, que representou 21,8% da amostra. <b>CONCLUSÃ
O:</b> O método de quantificação automatizada não foi considerado como uma ferra
menta útil na prática clínica, como forma de análise complementar à inspeção vis
ual.#^ddecs^i2#^tm^lpt^kSPECT cerebral^i2#^tm^lpt^kTOC^i2#^tm^lpt^kSPM^i2#^tm^lp
t^kanálise individual^i2#vancouv#24#20101207#7/12/2010#20101209#9/12/2010#v60n1a
01.htm##
04355000000000709000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000200108049001000110
15800030012003000190012303100030014203200020014506500090014701400070015603500100
01630120110001730120126002830100042004090100038004510100041004890100035005300100
03800565070009800603070009800701070010100799070005600900070009000956083108501046
08500100213108500240214108500160216508500160218108500320219708311650222908500100
33940850027034040850016034310850016034470850031034631170008034940720003035021120
00903505111001003514114000903524113001003533002001303543008008903556#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#l#4#1#article#1#^a2011#oa#en#br1.
1#1#4.0#ilus#tab#1#JBPSIQ010#nd#J. bras. psiquiatr#60#1#20110000#^f1^l6#0047-208
5#Cerebral perfusion and automated individual analysis using SPECT among an obse
ssive-compulsive population^len#Perfusão cerebral e análise individual automatiz
ada utilizando SPECT em uma população com transtorno obsessivo-compulsivo^lpt#^r
ND^1A01 A02^nEuclides Timóteo da^sRocha#^rND^1A03^nCarlos Alberto^sBuchpiguel#^r
ND^1A04^nEuripedes Constantino^sMiguel#^rND^1A05^nStela Verzinhase^sPeres#^rND^1
A03 A04^nGeraldo^sBusatto Filho#^iA01^1Fundação Pio XII^2Hospital de Câncer^3Dep
artment of Nuclear Medicine^cBarretos^sSP^pBrazil#^iA02^1São Paulo State Univers
ity^2Medical School^3Blood Transfusion Center^cBotucatu^sSP^pBrazil#^iA03^1Unive
rsity of São Paulo^2School of Medicine^3Department of Radiology Nuclear Medicine
 Service#^iA04^1USP^2School of Medicine^3Institute of Psychiatry#^iA05^1Fundação
 Pio XII^2Hospital de Câncer^3Research Support Group^cBarretos^sSP^pBrazil#^len^
aOBJECTIVE: To make individual assessments using automated quantification method
ology in order to screen for perfusion abnormalities in cerebral SPECT examinati
ons among a sample of subjects with OCD. METHODS: Statistical parametric mapping
 (SPM) was used to compare 26 brain SPECT images from patients with OCD individu
ally with an image bank of 32 normal subjects, using the statistical threshold o
f p < 0.05 (corrected for multiple comparisons at the level of individual voxels
 or clusters). The maps were analyzed, and regions presenting voxels that remain
ed above this threshold were sought. RESULTS: Six patients from a sample of 26 O
CD images showed abnormalities at cluster or voxel level, considering the criter
ia described above, which represented 23.07 percent. However, seven images from 
the normal group of 32 were also indicated as cases of perfusional abnormality, 
representing 21.8 percent of the sample. CONCLUSION: The automated quantificatio
n method was not considered to be a useful tool for clinical practice, for analy
ses complementary to visual inspection.#^ddecs^i1#^tm^len^kBrain SPECT^i1#^tm^le
n^kSPM^i1#^tm^len^kOCD^i1#^tm^len^kindividual analysis^i1#^lpt^aOBJETIVO: Avalia
r uma amostra de pacientes com transtorno obsessivo-compulsivo (TOC), individual
mente, empregando uma metodologia de quantificação automatizada para rastrear an
ormalidades de perfusão em exames de SPECT cerebral. MÉTODOS: Foi utilizado o St
atistical Parametric Mapping (SPM) para comparar 26 imagens de SPECT cerebral de
 pacientes com TOC, individualmente, com um banco de 32 imagens de voluntários n
ormais, usando o limiar estatístico de p < 0,05 (corrigido para comparações múlt
iplas ao nível do voxel individual ou clusters). Os mapas foram analisados procu
rando por regiões que apresentassem voxels acima desse limiar. RESULTADOS: Seis 
pacientes da amostra de 26 imagens com TOC mostraram anormalidades ao nível do c
luster ou voxel, considerando os critérios descritos acima, os quais representar
am 23,07 por cento. Contudo, sete imagens do grupo de 32 voluntários normais tam
bém foram apontadas com anormalidades de perfusão, que representou 21,8 por cent
o da amostra. CONCLUSÃO: O método de quantificação automatizada não foi consider
ado como uma ferramenta útil na prática clínica, como forma de análise complemen
tar à inspeção visual.#^ddecs^i2#^tm^lpt^kSPECT cerebral^i2#^tm^lpt^kTOC^i2#^tm^
lpt^kSPM^i2#^tm^lpt^kanálise individual^i2#vancouv#24#20101207#7/12/2010#2010120
9#9/12/2010#v60n1a01.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_ar
ttext&pid=S0047-20852011000100001##
00354000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704011900076002001300195#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#5#1#article#126#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ARTIGO ORIGINAL</b>
</font></p>     ^cY#v60n1a01.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#6#2#article#126#<p>&nbsp;</p>     ^
cY#v60n1a01.htm##
00455000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704022000076002001300296#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#7#3#article#126#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Cerebral
 perfusion and automated individual analysis using SPECT among an obsessive-comp
ulsive population</b></font></p>     ^cY#v60n1a01.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#8#4#article#126#<p>&nbsp;</p>     ^
cY#v60n1a01.htm##
00474000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704023900076002001300315#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#9#5#article#126#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Perfus&atilde;o cerebral e an&aac
ute;lise individual automatizada utilizando SPECT em uma popula&ccedil;&atilde;o
 com transtorno obsessivo-compulsivo</b></font></p>     ^cY#v60n1a01.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#10#6#article#126#<p>&nbsp;</p>     
^cY#v60n1a01.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#11#7#article#126#<p>&nbsp;</p>     
^cY#v60n1a01.htm##
00526000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704029000077002001300367#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#12#8#article#126#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Euclides Tim&oacute;teo da Rocha
<sup>I</sup>; Carlos Alberto Buchpiguel<sup>II</sup>; Euripedes Constantino Migu
el<sup>III</sup>; Stela Verzinhase Peres<sup>IV</sup>; Geraldo Busatto Filho<sup
>V</sup></b></font></p>     ^cY#v60n1a01.htm##
00537000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704030100077002001300378#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#13#9#article#126#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Hospital de C&acirc;nce
r - Funda&ccedil;&atilde;o Pio XII, Department of Nuclear Medicine, Barretos, SP
, Brazil; S&atilde;o Paulo State University (Unesp), Medical School, Blood Trans
fusion Center, Botucatu, SP, Brazil    ^cY#v60n1a01.htm##
00370000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704013300078002001300211#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#14#10#article#126#<br> <sup>II</sup
>University of S&atilde;o Paulo (USP), School of Medicine, Department of Radiolo
gy, Nuclear Medicine Service    ^cY#v60n1a01.htm##
00312000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704007500078002001300153#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#15#11#article#126#<br> <sup>III</su
p>USP, School of Medicine, Institute of Psychiatry    ^cY#v60n1a01.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#16#12#article#126#<br> <sup>IV</sup
>Hospital de C&acirc;ncer - Funda&ccedil;&atilde;o Pio XII, Research Support Gro
up    ^cY#v60n1a01.htm##
00373000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704013600078002001300214#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#17#13#article#126#<br> <sup>V</sup>
USP, School of Medicine, Institute of Psychiatry; Department of Radiology, Nucle
ar Medicine Service</font></p>     ^cY#v60n1a01.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#18#14#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#19#15#article#126#<p>&nbsp;</p>    
 ^cY#v60n1a01.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#20#16#article#126#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a01.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#21#17#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a01.htm##
00514000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704027700078002001300355#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#22#18#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVE:</b> To make individu
al assessments using automated quantification methodology in order to screen for
 perfusion abnormalities in cerebral SPECT examinations among a sample of subjec
ts with OCD.    ^cY#v60n1a01.htm##
00656000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704041900078002001300497#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#23#19#article#126#<br>  <b>METHODS:
</b> Statistical parametric mapping (SPM) was used to compare 26 brain SPECT ima
ges from patients with OCD individually with an image bank of 32 normal subjects
, using the statistical threshold of p &lt; 0.05 (corrected for multiple compari
sons at the level of individual voxels or clusters). The maps were analyzed, and
 regions presenting voxels that remained above this threshold were sought.    ^c
Y#v60n1a01.htm##
00567000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704033000078002001300408#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#24#20#article#126#<br>  <b>RESULTS:
</b> Six patients from a sample of 26 OCD images showed abnormalities at cluster
 or voxel level, considering the criteria described above, which represented 23.
07%. However, seven images from the normal group of 32 were also indicated as ca
ses of perfusional abnormality, representing 21.8% of the sample.    ^cY#v60n1a0
1.htm##
00429000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704019200078002001300270#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#25#21#article#126#<br>   <b>CONCLUS
ION:</b> The automated quantification method was not considered to be a useful t
ool for clinical practice, for analyses complementary to visual inspection.</fon
t></p>     ^cY#v60n1a01.htm##
00402000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704016500078002001300243#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#26#22#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Brain SPECT, SPM,
 OCD, individual analysis.</font></p> <hr size="1" noshade>     ^cY#v60n1a01.htm
##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#27#23#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a01.htm##
00564000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704032700078002001300405#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#28#24#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVO:</b> Avaliar uma amost
ra de pacientes com transtorno obsessivo-compulsivo (TOC), individualmente, empr
egando uma metodologia de quantifica&ccedil;&atilde;o automatizada para rastrear
 anormalidades de perfus&atilde;o em exames de SPECT cerebral.    ^cY#v60n1a01.h
tm##
00726000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704048900078002001300567#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#29#25#article#126#<br>  <b>M&Eacute
;TODOS:</b> Foi utilizado o Statistical Parametric Mapping (SPM) para comparar 2
6 imagens de SPECT cerebral de pacientes com TOC, individualmente, com um banco 
de 32 imagens de volunt&aacute;rios normais, usando o limiar estat&iacute;stico 
de p &lt; 0,05 (corrigido para compara&ccedil;&otilde;es m&uacute;ltiplas ao n&i
acute;vel do voxel individual ou clusters). Os mapas foram analisados procurando
 por regi&otilde;es que apresentassem voxels acima desse limiar.    ^cY#v60n1a01
.htm##
00625000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704038800078002001300466#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#30#26#article#126#<br>  <b>RESULTAD
OS:</b> Seis pacientes da amostra de 26 imagens com TOC mostraram anormalidades 
ao n&iacute;vel do cluster ou voxel, considerando os crit&eacute;rios descritos 
acima, os quais representaram 23,07%. Contudo, sete imagens do grupo de 32 volun
t&aacute;rios normais tamb&eacute;m foram apontadas com anormalidades de perfus&
atilde;o, que representou 21,8% da amostra.    ^cY#v60n1a01.htm##
00522000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704028500078002001300363#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#31#27#article#126#<br>  <b>CONCLUS&
Atilde;O:</b> O m&eacute;todo de quantifica&ccedil;&atilde;o automatizada n&atil
de;o foi considerado como uma ferramenta &uacute;til na pr&aacute;tica cl&iacute
;nica, como forma de an&aacute;lise complementar &agrave; inspe&ccedil;&atilde;o
 visual.</font></p>     ^cY#v60n1a01.htm##
00418000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704018100078002001300259#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#32#28#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>SPECT cereb
ral, TOC, SPM, an&aacute;lise individual. </font></p> <hr size="1" noshade>     
^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#33#29#article#126#<p>&nbsp;</p>    
 ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#34#30#article#126#<p>&nbsp;</p>    
 ^cY#v60n1a01.htm##
00339000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010200078002001300180#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#35#31#article#126#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION</b></font></p>    
 ^cY#v60n1a01.htm##
01256000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704101900078002001301097#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#36#32#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The neurobiology of obsessive-comp
ulsive disorder (OCD) has been widely investigated over the past decades. Functi
onal neuroimaging studies using positron emission tomography (PET), single-photo
n emission computed tomography (SPECT) and functional magnetic resonance imaging
 (fMRI) have sought to investigate the pathophysiology of OCD, and these have ma
inly implicated circuits involving fronto-subcortical connections. A series of p
ublished papers has indicated functional brain abnormalities in group comparison
s of OCD patients relative to healthy controls, particularly involving the orbit
ofrontal cortex, anterior cingulate cortex, basal ganglia and thalamus<sup>1-4</
sup>. Cortical regions such as the orbitofrontal cortex and the cingulate gyrus 
have been recognized to be heterogeneous among humans, with evidence of the exis
tence of subregions that possibly perform specific roles in the pathophysiology 
of OCD<sup>5,6</sup>. </font></p>     ^cY#v60n1a01.htm##
01467000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704123000078002001301308#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#37#33#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Despite the great impact that neur
oimaging studies have had with regard to elucidating the pathophysiology of the 
so-called functional psychiatric disorders such as major depressive disorder, OC
D and psychoses, the results from such investigations have generally come from s
tatistical comparisons of means from cerebral measurements, between groups of pa
tients and normal controls. On the other hand, when brain functional images of a
ny type are inspected individually, abnormalities are only detected in a certain
 proportion of patients with psychiatric disorders, and with considerable variab
ility regarding the nature and cerebral location. In this respect, there has bee
n a scarcity of systematic studies which suggest that such neuroimaging examinat
ions could be useful for practical clinical diagnostic purposes in the individua
l evaluation of subjects with functional psychiatric disorders. This is in sharp
 contrast with the well-established practical applications for functional neuroi
maging methods in the differential diagnosis of neurological diseases that presu
mably present well-defined cerebral pathological findings<sup>7-9</sup>. </font>
</p>     ^cY#v60n1a01.htm##
01307000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704107000078002001301148#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#38#34#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">In recent years, automated image a
nalysis methods have been developed to allow voxelwise quantifications of findin
gs in PET, SPECT and MRI studies. Classically, these methods have been used to m
ake statistical comparisons of mean signal intensities in each voxel of the cere
bral volume between groups of patients and normal controls, or alternatively, to
 compare images from the same group under two different conditions<sup>10,11</su
p>. The possibility of using SPECT in association with some form of automated qu
antification for evaluating individual patients with functional psychiatric diso
rders is of great interest, but there have been few published papers using this 
approach. Nevertheless, automated voxel-based image analysis methods have been a
pplied in case-by-case evaluations for investigating epileptic foci<sup>12</sup>
, for comparative assessments with visual analysis among patients with Alzheimer
's disease, and even for assessments of normal subjects<sup>13,14</sup>. </font>
</p>     ^cY#v60n1a01.htm##
01359000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704112200078002001301200#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#39#35#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Conventional methods using regions
-of-interest to quantify brain perfusion abnormalities are not appropriate for s
tudying subregions within functionally heterogeneous brain structures of relevan
ce to the pathophysiology of OCD, such as the orbitofrontal and anterior cingula
te cortices. Thus, automated voxel-based quantification methods may afford a bet
ter strategy for assessing subtle and highly circumscribed changes in cerebral S
PECT examinations in individual OCD cases. Hence, the aim of the present study w
as to evaluate whether the voxel-based statistical parametric mapping (SPM) appr
oach might have a complementary role in investigating possible perfusional abnor
malities among a group of patients with OCD (n = 26) assessed individually with 
SPECT. We predicted that the SPM-based approach could enable the detection of su
btle brain perfusion abnormalities in a proportion of OCD patients, in a frequen
cy greater than that found in the group of healthy control subjects (n = 32) eva
luated with exactly the same imaging methods.</font></p>     ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#40#36#article#126#<p>&nbsp;</p>    
 ^cY#v60n1a01.htm##
00347000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011000078002001300188#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#41#37#article#126#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>MATERIAL AND METHODS</b></font>
</p>     ^cY#v60n1a01.htm##
01457000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704122000078002001301298#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#42#38#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A sample of 26 patients (15 males/
11 females, 23 right-handed) fulfilling DMS-IV criteria for OCD<sup>15</sup> was
 selected. Their mean age was 32.1 years (SD 7.8). Eleven of the patients had ne
ver previously undergone any kind of treatment. Four patients agreed to remain f
ree from medication for three weeks in order to undergo washout from previous tr
eatments. The remaining patients had taken medications in the past, but had been
 free from all OCD treatments over the four-year period preceding the start of t
his study. The patients were recruited at the Institute of Psychiatry of Hospita
l das Cl&iacute;nicas, School of Medicine of the University of S&atilde;o Paulo 
(IPq-HC-FMUSP). All of the patients underwent a structured clinical interview in
 accordance with DSM-IV- Patient Edition (SCID-I/P)<sup>16</sup>. This group of 
OCD patients was recruited for a controlled study on cerebral SPECT and structur
al MRI<sup>17</sup>. The intensity of obsessive-compulsive symptoms was measured
 moments before performing the cerebral SPECT examination, with the Yale-Brown-O
bsessive-Compulsive Scale<sup>18 </sup>(mean = 26.8; SD = 5.9).</font></p>     ^
cY#v60n1a01.htm##
01111000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704087400078002001300952#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#43#39#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A control group of 32 normal volun
teers, of mean age 32 years (SD = 9.6) and age range from 20 to 57 years, compos
ed of 15 men and 17 women, was recruited at IPQ HC-FMUSP but also from social co
ntacts. Before undergoing the SPECT examination, all the subjects in this contro
l group had undergone a detailed assessment, including general medical anamnesis
 and the structured clinical interview for the DSM-IV diagnosis of psychiatric d
isorders (SCID<sup>19</sup>), in order to rule out any presence of neurological 
and/or psychiatric disorders. Moreover, these individuals had no signs of gross 
brain abnormalities as assessed by structural magnetic resonance scans, visually
 inspected by two radiologists independently from each other. The study received
 institutional review board approval.</font></p>     ^cY#v60n1a01.htm##
00391000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015400078002001300232#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#44#40#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Protocol for acquisition and pr
ocessing of cerebral SPECT images</b></font></p>     ^cY#v60n1a01.htm##
00971000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704073400078002001300812#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#45#41#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The protocols used for acquisition
 and processing of cerebral SPECT data were the same for all subjects in the abo
ve groups. After venous puncture in a superficial vein of the arm, the individua
ls remained at rest for 20 minutes and then received a dose of 740 MBq of <sup>9
9m</sup>Tc-ECD. After a further 20 minutes, image acquisition was started. All t
he examinations were performed using a device with two detectors and high-resolu
tion collimators (OPTIMA NX, General Electric, Milwaukee, USA). The images were 
acquired using the step-and-shoot method. A matrix of 128 X 128 was used, and 12
8 projections were acquired (20 seconds per projection).s</font></p>     ^cY#v60
n1a01.htm##
00783000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704054600078002001300624#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#46#42#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The orbital-meatal line was used f
or reconstructing the SPECT images, which was done by using the filtered back-pr
ojection method with attenuation correction in accordance with Chang's algorithm
 (&#181; = 0.12 cm<sup>-1</sup>). All the images were reconstructed with pixels 
of 2.25 mm and a tenth-order Butterworth filter with Nyquist frequency of 0.57. 
Transverse sections through the reconstructed images were selected for the subse
quent stages of the analysis.</font></p>     ^cY#v60n1a01.htm##
00410000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017300078002001300251#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#47#43#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Generation of individualized st
atistical parametric maps showing rCBF abnormalities</b></font></p>     ^cY#v60n
1a01.htm##
02320000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704208300078002001302161#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#48#44#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Individualized statistical paramet
ric maps for each subject were produced using the SPM program, version 1999, exe
cuted in MATLAB 4.2. Firstly, SPECT images of all patients with OCD and controls
 were spatially normalized, with linear 12-point affine transformations, to an a
natomical <i>template </i>provided by the SPM program, which approximates the st
ereotaxic space of the Talairach-Tournoux atlas<sup>20</sup>. Subsequently, imag
es were re-sliced using bi-linear interpolation to a final voxel size of 2x2x2 m
m<sup>3</sup>, and smoothed with an isotropic Gaussian filter (12 mm full-width 
at half maximum) in order to improve the signal-to-noise ratio and to reduce err
ors attributed to inter-individual variations in gyral and sulcal anatomy. For e
ach of the subjects with obsessive-compulsive disorder (n = 26), a voxel-by-voxe
l t-test map was obtained by comparison against the pool of controls (n = 32). W
ith the purpose of accounting for inter-individual differences in overall cerebr
al blood flow, the regional <sup>99m</sup>Tc-ECD uptake was standardized to the 
mean overall uptake using proportional scaling. The measure of total brain radio
active uptake was obtained automatically by the SPM program, given by the mean c
ounts of all voxels included in the SPECT volume of each subject, after the spat
ial transformations described above. In order to reduce the number of statistica
l comparisons, only voxels with signal intensities above 50% of the mean overall
 value were entered in each analysis. The individualized SPM{t} maps for each su
bject were transformed to the unit's normal distribution (Z scores), thresholded
 at 3.09 (corresponding to &rho; &lt; 0.001, uncorrected for multiple comparison
s), and displayed as statistical parametric maps into standard space. The same p
rocedure was carried out to provide individualized statistical parametric maps o
f rCBF abnormalities for the control subjects, by comparing each control individ
ual against the remaining thirty-one subjects.</font></p>     ^cY#v60n1a01.htm##
00697000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704046000078002001300538#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#49#45#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Clusters of rCBF abnormalities in 
the individualized maps were then examined in terms of size (k) and peak height 
(u), and were considered significant only if retaining statistical significance 
after correction for multiple comparisons based on Gaussian random field theory 
(p &lt; 0.05), either at the level of individual voxel height or at the level of
 clusters<sup>21</sup>.</font></p>     ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#50#46#article#126#<p>&nbsp;</p>    
 ^cY#v60n1a01.htm##
00334000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009700078002001300175#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#51#47#article#126#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTS</b></font></p>     ^cY#
v60n1a01.htm##
01267000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704103000078002001301108#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#52#48#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="/img/revistas/jbpsiq/v60n
1/a01tab01.jpg">Table 1</a> shows the results from the SPM maps relating to the 
individual comparisons of each of the 26 patients with OCD against the pool of h
ealthy controls, with voxels that were screened at the significance threshold of
 p &lt; 0.05, corrected for multiple comparisons. Significant abnormalities due 
to hypoperfusion were found in one patient at voxel level and in another subject
 at the cluster level; with regard to hyperperfusion, there were three patients 
with significant findings at the voxel level and one subject at cluster level (<
a href="/img/revistas/jbpsiq/v60n1/a01fig01.jpg">Figure 1</a>). Thus among the 2
6 images analyzed, only six cases showed abnormalities, i.e. 23.07% of the full 
sample. Such abnormalities were considerably variable in their location, involvi
ng the frontal, temporal and occipital cortices (<a href="/img/revistas/jbpsiq/v
60n1/a01tab01.jpg">Table 1</a>). </font></p>     ^cY#v60n1a01.htm##
01198000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704096100078002001301039#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#53#49#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Among the 32 images from healthy c
ontrols analyzed for hypoperfusion, two abnormal examinations were found at voxe
l level and two at cluster level, of which one presented significance at both le
vels, i.e. three healthy subjects with abnormalities (<a href="/img/revistas/jbp
siq/v60n1/a01tab02.jpg">Table 2</a>). The abnormalities were located in the righ
t occipital cortex and right inferior frontal cortex (<a href="#fig02">Figure 2<
/a>). In evaluating the presence of hyperperfusion, two examinations with voxels
 above the threshold were found at voxel level, and four at cluster level. Howev
er, one examination at voxel level and another at cluster level had already been
 described with hypoperfusion contrast. Thus, four subjects were deemed to prese
nt perfusion abnormalities, thus total seven healthy subjects (21.8%) with abnor
mal examinations considering both contrasts.</font></p>     ^cY#v60n1a01.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#54#50#article#126#<p><a name="fig02
"></a></p>     ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#55#51#article#126#<p>&nbsp;</p>    
 ^cY#v60n1a01.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#56#52#article#126#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a01fig02.jpg"></p>     ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#57#53#article#126#<p>&nbsp;</p>    
 ^cY#v60n1a01.htm##
00686000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704044900078002001300527#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#58#54#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#tab03">Table 3</a> shows
 the severity of symptoms with measures of compulsion, obsession and Y-BOCS for 
the group of six OCD patients as described in <a href="/img/revistas/jbpsiq/v60n
1/a01tab01.jpg">table 1</a>. It can be noticed that in this sub-group the Y-BOCS
 scores ranged 25-34 (mean 28,7), compulsion 12-17 (mean 14) and obsession 1117 
(mean 14,7).</font></p>     ^cY#v60n1a01.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#59#55#article#126#<p><a name="tab03
"></a></p>     ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#60#56#article#126#<p>&nbsp;</p>    
 ^cY#v60n1a01.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#61#57#article#126#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a01tab03.jpg"></p>     ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#62#58#article#126#<p>&nbsp;</p>    
 ^cY#v60n1a01.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#63#59#article#126#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSSION</b></font></p>     ^
cY#v60n1a01.htm##
01126000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704088900078002001300967#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#64#60#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A group of patients with OCD was e
valuated with the aim of measuring the efficiency of automated, SPM-based quanti
fications for detecting brain perfusional abnormalities individually, as assesse
d with SPECT<sup>22</sup>. Even considering the examinations with abnormalities 
that reached statistical significance either at the voxel level or at the cluste
r level, the number of patients whose abnormalities were mapped out and correlat
ed with the diagnosis of OCD was very small. Moreover, contrary to our predictio
n, similar numbers of abnormal results were found in both the OCD and control gr
oups. These results indicate that the evaluation of threshold per-fusion changes
 using an automated voxelwise analysis method is not clinically useful and does 
not add anything to the routine clinical evaluation.</font></p>     ^cY#v60n1a01
.htm##
00813000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704057600078002001300654#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#65#61#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Despite this, it's important to no
te that OCD patients showed a wide spectrum of severity of symptoms with YBOCS m
ean 26,77 ± 5,89, ranging 16-36. The majority (53%) of patients diagnosed with O
CD were categorized as serious, while a smaller portion was identified as modera
te or extreme as to severity of symptoms. In this sample eight patients met DMS-
IV criteria for major depressive episode and 10 met criteria for other anxiety d
isorders such as phobias and generalized anxiety disorder. </font></p>     ^cY#v
60n1a01.htm##
00647000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704041000078002001300488#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#66#62#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Moreover, all the healthy subjects
 recruited to the control group had undergone an assessment, which included a ge
neral medical anamnesis and the structured clinical interview for the DSM-IV dia
gnosis of psychiatric disorders. They also underwent structural magnetic resonan
ce scan, that visually did not show any abnormality. </font></p>     ^cY#v60n1a0
1.htm##
00786000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704054900078002001300627#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#67#63#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">At this point it's important to ta
ke into account that single subject analysis is a very interesting tool for clin
ical practice and it has been successfully applied to neurological disorders cha
racterized by precise regional deficit in brain function<sup>14,20</sup>. On the
 contrary, OCD is a really heterogeneous psychiatric disease where functional ab
normalities are difficult to detect in resting condition and particularly at sin
gle subject level<sup>21</sup>. </font></p>     ^cY#v60n1a01.htm##
00744000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704050700078002001300585#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#68#64#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Based on these results, we conclud
ed that SPM-based analyses of individual cases could be a valuable complementary
 tool within routine clinical practice for the assessment of brain abnormalities
 in SPECT datasets of patients with neurological conditions. Our present results
, using exactly the same methods, indicate that the same clinical applicability 
cannot be reached for the diagnostic evaluation of patients with OCD. </font></p
>     ^cY#v60n1a01.htm##
00956000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704071900078002001300797#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#69#65#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">However, caution is warranted in t
he evaluation of the present negative results for a number of reasons. Firstly, 
the low anatomical resolution of SPECT has to be born in mind, along with inter-
individual differences in anatomy and metabolism and mood variations at the time
 of administering the radiopharmaceutical, thus leading to increased variability
 of brain perfusion patterns in both groups. Also, although the diagnoses of OCD
 were based on widely validate diagnostic criteria (DSM-IV), OCD is characterize
d by heterogeneity in its clinical presentation, and this may also add variabili
ty to rCBF patterns as assessed by SPECT. </font></p>     ^cY#v60n1a01.htm##
01600000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704136300078002001301441#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#70#66#article#126#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Finally, it should be noted that t
he construction of individual statistical maps using SPM is not the only methodo
logical strategy for using automated methods to analyze cerebral SPECT data in c
linical practice. For instance, alternative analysis methods have been developed
 to support the diagnosis of neuropsychiatric conditions, enabling fully automat
ed categorization of individual structural or functional brain images based on m
achine-learning techniques, such as support vector machines (SVMs)<sup>23,24</su
p>. Recent studies have demonstrated the reliability and validity of SVM-based t
echniques, as well as their good diagnostic performance in discriminating, for i
nstance, between Alzheimer's disease patients and healthy control individuals<su
p>24</sup>. Therefore, replication of the current negative results are warranted
 using SVM-based methods, with the aim of studying whether these more sophistica
ted forms of analysis might lead to similar results or, instead, show greater pr
omise for clinical applications for automated evaluations of rCBF SPECT data fro
m OCD subjects. For the time being, we conclude that automated, SPM-based voxelw
ise analysis methods have very limited applicability in clinical practice to aid
 in the diagnostic evaluation of OCD patients.</font></p>     ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#71#67#article#126#<p>&nbsp;</p>    
 ^cY#v60n1a01.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#72#68#article#126#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font></p>     ^
cY#v60n1a01.htm##
00530000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704027900080002001300359#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#73#69#article#126#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Jang JH, Kim JH, 
Jung WH, Choi JS, Jung MH, Lee JM, et al. Functional connectivity in fronto-subc
ortical circuitry during the resting state in obsessive-compulsive disorder. Neu
rosci Lett. 2010;474:158-62.    ^cY#v60n1a01.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#74#70#article#126#</font></p>     ^
cY#v60n1a01.htm##
00562000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704031100080002001300391#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#75#71#article#126#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Schilman EA, Klav
ir O, Winter C, Sohr R, Joel D. The role of the striatum in compulsive behavior 
in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the se
rotonergic system. Neuropsychopharmacology. 2010;35:1026-39.    ^cY#v60n1a01.htm
##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#76#72#article#126#</font></p>     ^
cY#v60n1a01.htm##
00538000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704028700080002001300367#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#77#73#article#126#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Pena-Garijo J, Ru
ip&eacute;rez-Rodr&iacute;guez MA, Barros-Loscertales A. The neurobiology of obs
essive-compulsive disorder: new findings from functional magnetic resonance imag
ing (I). Rev Neurol. 2010;50:477-85.    ^cY#v60n1a01.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#78#74#article#126#</font></p>     ^
cY#v60n1a01.htm##
00490000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704023900080002001300319#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#79#75#article#126#4#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Black DW, Shaw M,
 Blum N. Pathological gambling and compulsive buying: do they fall within an obs
essive-compulsive spectrum? Dialogues Clin Neurosci. 2010;12:175-85.    ^cY#v60n
1a01.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#80#76#article#126#</font></p>     ^
cY#v60n1a01.htm##
00577000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704032600080002001300406#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#81#77#article#126#5#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Rotge JY, Langbou
r N, Jaafari N, Guehl D, Bioulac B, Aouizerate B, et al. Anatomical alterations 
and symptom-related functional activity in obsessive-compulsive disorder are cor
related in the lateral orbitofrontal cortex. Biol Psychiatry. 2010;67:37-8.    ^
cY#v60n1a01.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#82#78#article#126#</font></p>     ^
cY#v60n1a01.htm##
00443000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704019200080002001300272#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#83#79#article#126#6#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. DeLong M, Wichman
n T. Changing views of basal ganglia circuits and circuit disorders. Clin EEG Ne
urosci. 2010;41:61-7.    ^cY#v60n1a01.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#84#80#article#126#</font></p>     ^
cY#v60n1a01.htm##
00630000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704037900080002001300459#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#85#81#article#126#7#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Aso K, Ogasawara 
K, Sasaki M, Kobayashi M, Suga Y, Chida K, et al. Preoperative cerebrovascular r
eactivity to acetazolamide measured by brain perfusion SPECT predicts developmen
t of cerebral ischemic lesions caused by microemboli during carotid endarterecto
my. Eur J Nucl Med Mol Imaging. 2009;36:294-301.    ^cY#v60n1a01.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#86#82#article#126#</font></p>     ^
cY#v60n1a01.htm##
00473000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704022200080002001300302#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#87#83#article#126#8#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Ayalon L, Peterso
n S. Functional central nervous system imaging in the investigation of obstructi
ve sleep apnea. Curr Opin Pulm Med. 2007;13:479-83.    ^cY#v60n1a01.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#88#84#article#126# </font></p>     
^cY#v60n1a01.htm##
00396000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704014500080002001300225#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#89#85#article#126#9#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Maehara T. Neuroi
maging of epilepsy. Neuropathology. 2007;27(6):585-93.    ^cY#v60n1a01.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#90#86#article#126#</font></p>     ^
cY#v60n1a01.htm##
00488000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704023600081002001300317#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#91#87#article#126#10#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Friston KJ, Fri
th CD, Liddle PF, Frackowiak RS. Comparing functional (PET) images: the assessme
nt of significant change. J Cereb Blood Flow Metab. 1991;11:690-9.    ^cY#v60n1a
01.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#92#88#article#126# </font></p>     
^cY#v60n1a01.htm##
00477000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704022500081002001300306#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#93#89#article#126#11#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Friston KJ, Pol
ine JB, Holmes AP, Price CJ, Frith CD. Detecting activations in PET and FMRI: le
vels of inference and power. Neuroimage, 1996;4:223-35.    ^cY#v60n1a01.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#94#90#article#126#</font></p>     ^
cY#v60n1a01.htm##
00505000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704025300081002001300334#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#95#91#article#126#12#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Lee JD, Kim HJ,
 Lee BI, Kim OJ, Jeon, TJ, Kim MJ. Evaluation of ictal brain SPECT using statist
ical parametric mapping in temporal lobe epilepsy. Eur J Nucl Med. 2000;27:1658-
65.    ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#96#92#article#126# </font></p>     
 ^cY#v60n1a01.htm##
00560000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704030800081002001300389#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#97#93#article#126#13#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Imran MB, Kawas
hima R, Sato K, Kinomura S, Ono S, Qureshy A, et al. Detection of CBF deficit in
 neuropsychiatric by an expert system: a 99mTc-HMPAO brain SPECT study using aut
omated image registration. Nucl Med Commun. 1999;20:25-32.    ^cY#v60n1a01.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#98#94#article#126# </font></p>     
^cY#v60n1a01.htm##
00665000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704041300081002001300494#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#99#95#article#126#14#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Rocha ET, Buchp
iguel CA, Nitrini R, Tazima S, Peres SV, Busatto Filho G. Diagnosis of regional 
cerebral blood flow abnormalities using spect: agreement between individualized 
statistical parametric maps and visual inspection by nuclear medicine physicians
 with different levels of expertise in nuclear neurology. Clinics. 2009;64:1145-
53.    ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002100079002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#100#96#article#126# </font></p>    
 ^cY#v60n1a01.htm##
00482000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704022900082002001300311#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#101#97#article#126#15#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. American Psych
iatric Association, 1994. DSM-IV: Diagnostic and Statistical Manual of Mental Di
sorders, 4th ed. American Psychiatric Press, Washington, DC.    ^cY#v60n1a01.htm
##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002100079002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#102#98#article#126# </font></p>    
 ^cY#v60n1a01.htm##
00493000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704024000082002001300322#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#103#99#article#126#16#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. First MB, Spit
zer RL, Willians JBW, Gibbons M. Structures Clinical Interview for DSM-IV - Pati
ents Edition (SCIDP). Washington, DC: American Psychiatric Press; 1995.    ^cY#v
60n1a01.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#104#100#article#126# </font></p>   
  ^cY#v60n1a01.htm##
00605000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704035100083002001300434#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#105#101#article#126#17#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Busatto GF, Z
amignani DR, Buchpiguel CA, Garrido GE, Glabus MF, Rocha ET, et al. A voxel-base
d investigation of regional cerebral blood flow abnormalities in obsessive-compu
lsive disorder using single photon emission computed tomography (SPECT). Psychia
try Res. 2000;99:15-27.    ^cY#v60n1a01.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#106#102#article#126# </font></p>   
  ^cY#v60n1a01.htm##
00522000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704026800083002001300351#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#107#103#article#126#18#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Goodman WK, P
rice LH, Rasmussen SA Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown O
bsessive-Compulsive scale I: development, use and reliability. Arch Gen Psychiat
ry. 1989;46:1006-11.    ^cY#v60n1a01.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#108#104#article#126# </font></p>   
  ^cY#v60n1a01.htm##
00433000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704017900083002001300262#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#109#105#article#126#19#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Talairach J, 
Tournoux P. Coplanar stereotaxic atlas of the human brain. New Y, NY: Thieme Med
ical; 1998.    ^cY#v60n1a01.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#110#106#article#126# </font></p>   
  ^cY#v60n1a01.htm##
00543000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704028900083002001300372#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#111#107#article#126#20#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Nishimiya M, 
Matsuda H, Imabayashi E, Kuji I, Sato N. Comparison of SPM and NEUROSTAT in voxe
lwise statistical analysis of brain SPECT and MRI at the early stage of Alzheime
r's disease. Ann Nucl Med. 2008;22:921-7.    ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#112#108#article#126#</font></p>    
 ^cY#v60n1a01.htm##
00517000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704026300083002001300346#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#113#109#article#126#21#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Dougall N, No
bili F, Ebmeier KP. Predicting the accuracy of a diagnosis of Alzheimer's diseas
e with 99mTc HMPAO single photon emission computed tomography. Psychiatry Res. 2
004;131:157-68.    ^cY#v60n1a01.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#114#110#article#126# </font></p>   
  ^cY#v60n1a01.htm##
00623000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704036900083002001300452#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#115#111#article#126#22#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Signorini M, 
Paulesu E, Friston K, Perani D, Colleluori A, Lucignani G, et al. Rapid assessme
nt of regional cerebral metabolic abnormalities in single subjects with quantita
tive and non-quantitative 18F-FDG PET: a clinical validation of statistical para
metric mapping. Neuroimage. 1999;9:63-80.    ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#116#112#article#126#</font></p>    
 ^cY#v60n1a01.htm##
00551000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704029700083002001300380#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#117#113#article#126#23#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. Kalatzis I, P
appas D, Piliouras N, Cayouras D. Support vector machines based analysis of brai
n SPECT images for determining cerebral abnormalities in asymptomatic diabetic p
atients. Med Inform Internet Med. 2003;28:221-30.    ^cY#v60n1a01.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#118#114#article#126#</font></p>    
 ^cY#v60n1a01.htm##
00524000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704027000083002001300353#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#119#115#article#126#24#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24. Glenn Fung, J
onathan Stoeckel. SVM feature selection for classification of SPECT images of Al
zheimer's disease using spatial information. Knowledge and Information Systems v
olume. 2007;11:243-58.    ^cY#v60n1a01.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#120#116#article#126# </font></p>   
  ^cY#v60n1a01.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#121#117#article#126#<p>&nbsp;</p>  
   ^cY#v60n1a01.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#122#118#article#126#<p>&nbsp;</p>  
   ^cY#v60n1a01.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704023200080002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#123#119#article#126#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="
/img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a> <a name="linkcorresp"></a><
b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a01.htm##
00287000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004800080002001300128#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#124#120#article#126#<br>    Euclide
s Tim&oacute;teo da Rocha    ^cY#v60n1a01.htm##
00346000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704010700080002001300187#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#125#121#article#126#<br>    Departa
mento de Medicina Nuclear, Hospital de C&acirc;ncer - Funda&ccedil;&atilde;o Pio
 XII    ^cY#v60n1a01.htm##
00310000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704007100080002001300151#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#126#122#article#126#<br>    Av. Ant
enor Duarte Vilela, 1331, Bairro Dr. Paulo Prata    ^cY#v60n1a01.htm##
00300000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006100080002001300141#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#127#123#article#126#<br>   14784-40
0 - Barretos, S&atilde;o Paulo, Brasil    ^cY#v60n1a01.htm##
00347000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704010800080002001300188#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#128#124#article#126#<br>  E-mail: <
a href="mailto:euclidestimoteo@uol.com.br">euclidestimoteo@uol.com.br</a></font>
</p>     ^cY#v60n1a01.htm##
00331000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009200080002001300172#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#129#125#article#126#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 7/12/2010    ^cY#v60
n1a01.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#p#130#126#article#126#<br>  Aprovado 
em 9/12/2010</font></p>     ^cY#v60n1a01.htm##
00714000000000337000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100015000790100014000940100
01500108010001500123010001500138010001400153810000600167012011800173030001400291
06500090030506400050031403100040031901400070032386500090033000200130033903500100
0352801001400362#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#131
#1#article#24#1#^rND^sJang^nJH#^rND^sKim^nJH#^rND^sJung^nWH#^rND^sChoi^nJS#^rND^
sJung^nMH#^rND^sLee^nJM#et al#Functional connectivity in fronto-subcortical circ
uitry during the resting state in obsessive-compulsive disorder^len#Neurosci Let
t#20100000#2010#474#158-62#20110000#v60n1a01.htm#0304-3940#Neurosci Lett##
00727000000000313000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100019000790100016000980100
01600114010001400130010001400144012015000158030002400308065000900332064000500341
031000300346014000800349865000900357002001300366035001000379801002400389#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#132#2#article#24#2#^rND^sSc
hilman^nEA#^rND^sKlavir^nO#^rND^sWinter^nC#^rND^sSohr^nR#^rND^sJoel^nD#The role 
of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesion
ed rats: possible involvement of the serotonergic system^len#Neuropsychopharmaco
logy#20100000#2010#35#1026-39#20110000#v60n1a01.htm#0893-133X#Neuropsychopharmac
ology##
00640000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100021000790100029001000100
02800129012011500157030001100272065000900283064000500292031000300297014000700300
865000900307002001300316035001000329801001100339#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a01.htm#S#c#133#3#article#24#3#^rND^sPena-Garijo^nJ#^rND^sRuipé
rez-Rodríguez^nMA#^rND^sBarros-Loscertales^nA#The neurobiology of obsessive-comp
ulsive disorder: new findings from functional magnetic resonance imaging (I)^len
#Rev Neurol#20100000#2010#50#477-85#20110000#v60n1a01.htm#0210-0010#Rev Neurol##
00576000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100014000950100
01400109012010300123030002400226710000200250065000900252064000500261031000300266
014000700269865000900276002001300285#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a01.htm#S#c#134#4#article#24#4#^rND^sBlack^nDW#^rND^sShaw^nM#^rND^sBlum^nN#
Pathological gambling and compulsive buying: do they fall within an obsessive-co
mpulsive spectrum?^len#Dialogues Clin Neurosci#2#20100000#2010#12#175-85#2011000
0#v60n1a01.htm##
00763000000000337000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100018000950100
01700113010001500130010001700145010002000162810000600182012015100188030001600339
06500090035506400050036403100030036901400050037286500090037700200130038603500100
0399801001600409#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#135
#5#article#24#5#^rND^sRotge^nJY#^rND^sLangbour^nN#^rND^sJaafari^nN#^rND^sGuehl^n
D#^rND^sBioulac^nB#^rND^sAouizerate^nB#et al#Anatomical alterations and symptom-
related functional activity in obsessive-compulsive disorder are correlated in t
he lateral orbitofrontal cortex^len#Biol Psychiatry#20100000#2010#67#37-8#201100
00#v60n1a01.htm#0006-3223#Biol Psychiatry##
00510000000000265000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100018000950120
06700113030001800180710000200198065000900200064000500209031000300214014000500217
865000900222002001300231#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm
#S#c#136#6#article#24#6#^rND^sDeLong^nM#^rND^sWichmann^nT#Changing views of basa
l ganglia circuits and circuit disorders^len#Clin EEG Neurosci#2#20100000#2010#4
1#61-7#20110000#v60n1a01.htm##
00780000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100013000790100019000920100
01600111010001900127010001400146010001500160810000600175012019700181030002700378
71000020040506500090040706400050041603100030042101400080042486500090043200200130
0441#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#137#7#article#2
4#7#^rND^sAso^nK#^rND^sOgasawara^nK#^rND^sSasaki^nM#^rND^sKobayashi^nM#^rND^sSug
a^nY#^rND^sChida^nK#et al#Preoperative cerebrovascular reactivity to acetazolami
de measured by brain perfusion SPECT predicts development of cerebral ischemic l
esions caused by microemboli during carotid endarterectomy^len#Eur J Nucl Med Mo
l Imaging#2#20090000#2009#36#294-301#20110000#v60n1a01.htm##
00579000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100018000950120
09400113030001900207065000900226064000500235031000300240014000700243865000900250
002001300259035001000272801001900282#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a01.htm#S#c#138#8#article#24#8#^rND^sAyalon^nL#^rND^sPeterson^nS#Functional
 central nervous system imaging in the investigation of obstructive sleep apnea^
len#Curr Opin Pulm Med#20070000#2007#13#479-83#20110000#v60n1a01.htm#1078-1641#C
urr Opin Pulm Med##
00491000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790120029000960300
01500125065000900140064000500149031000300154032000200157014000700159865000900166
002001300175035001000188801001500198#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a01.htm#S#c#139#9#article#24#9#^rND^sMaehara^nT#Neuroimaging of epilepsy^le
n#Neuropathology#20070000#2007#27#6#585-93#20110000#v60n1a01.htm#0919-6544#NEURO
PATHOLOGY##
00636000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100016000990100
01700115010002100132012007600153030002500229065000900254064000500263031000300268
014000600271865000900277002001300286035001000299801002500309#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#140#10#article#24#10#^rND^sFriston^nKJ#
^rND^sFrith^nCD#^rND^sLiddle^nPF#^rND^sFrackowiak^nRS#Comparing functional (PET)
 images: the assessment of significant change^len#J Cereb Blood Flow Metab#19910
000#1991#11#690-9#20110000#v60n1a01.htm#0271-678X#J Cereb Blood Flow Metab##
00599000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100017000990100
01700116010001600133010001600149012007300165030001200238710000200250065000900252
064000500261031000200266014000700268865000900275002001300284#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#141#11#article#24#11#^rND^sFriston^nKJ#
^rND^sPoline^nJB#^rND^sHolmes^nAP#^rND^sPrice^nCJ#^rND^sFrith^nCD#Detecting acti
vations in PET and FMRI: levels of inference and power^len#Neuroimage,#2#1996000
0#1996#4#223-35#20110000#v60n1a01.htm##
00695000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100014000810100014000950100
01400109010001400123010001100137010000900148010001400157012009900171030001500270
06500090028506400050029403100030029901400080030286500090031000200130031903500100
0332801001500342#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#142
#12#article#24#12#^rND^sLee^nJD#^rND^sKim^nHJ#^rND^sLee^nBI#^rND^sKim^nOJ#^rND^s
Jeon#^rND^sTJ#^rND^sKim^nMJ#Evaluation of ictal brain SPECT using statistical pa
rametric mapping in temporal lobe epilepsy^len#Eur J Nucl Med#20000000#2000#27#1
658-65#20110000#v60n1a01.htm#0340-6997#Eur J Nucl Med##
00746000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100019000970100
01400116010001800130010001300148010001700161810000600178012013700184030001600321
06500090033706400050034603100030035101400060035486500090036000200130036903500100
0382801001600392#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#143
#13#article#24#13#^rND^sImran^nMB#^rND^sKawashima^nR#^rND^sSato^nK#^rND^sKinomur
a^nS#^rND^sOno^nS#^rND^sQureshy^nA#et al#Detection of CBF deficit in neuropsychi
atric by an expert system: a 99mTc-HMPAO brain SPECT study using automated image
 registration^len#Nucl Med Commun#19990000#1999#20#25-32#20110000#v60n1a01.htm#0
143-3636#Nucl Med Commun##
00832000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100021000970100
01700118010001600135010001600151010002300167012024300190030000800433065000900441
06400050045003100030045501400080045886500090046600200130047503500100048880100080
0498#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#144#14#article#
24#14#^rND^sRocha^nET#^rND^sBuchpiguel^nCA#^rND^sNitrini^nR#^rND^sTazima^nS#^rND
^sPeres^nSV#^rND^sBusatto Filho^nG#Diagnosis of regional cerebral blood flow abn
ormalities using spect: agreement between individualized statistical parametric 
maps and visual inspection by nuclear medicine physicians with different levels 
of expertise in nuclear neurology^len#Clinics#20090000#2009#64#1145-53#20110000#
v60n1a01.htm#1807-5932#Clinics##
00502000000000241000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780170033000810650009001140640
00500123018006600128063000200194062002700196066001500223865000900238002001300247
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#145#15#article#24#1
5#American Psychiatric Association#19940000#1994#DSM-IV: Diagnostic and Statisti
cal Manual of Mental Disorders^len#4#American Psychiatric Press#Washington^eDC#2
0110000#v60n1a01.htm##
00568000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160016000810160018000970160
02000115016001700135018007200152066001500224062002700239065000900266064000500275
865000900280002001300289#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm
#S#c#146#16#article#24#16#^rND^sFirst^nMB#^rND^sSpitzer^nRL#^rND^sWillians^nJBW#
^rND^sGibbons^nM#Structures Clinical Interview for DSM-IV - Patients Edition (SC
IDP)^len#Washington^eDC#American Psychiatric Press#19950000#1995#20110000#v60n1a
01.htm##
00788000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100020000990100
02100119010001800140010001700158010001600175810000600191012016800197030001500365
06500090038006400050038903100030039401400060039786500090040300200130041203500100
0425801001500435#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#147
#17#article#24#17#^rND^sBusatto^nGF#^rND^sZamignani^nDR#^rND^sBuchpiguel^nCA#^rN
D^sGarrido^nGE#^rND^sGlabus^nMF#^rND^sRocha^nET#et al#A voxel-based investigatio
n of regional cerebral blood flow abnormalities in obsessive-compulsive disorder
 using single photon emission computed tomography (SPECT)^len#Psychiatry Res#200
00000#2000#99#15-27#20110000#v60n1a01.htm#0165-1781#Psychiatry res##
00711000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100016000990100
02000115010001600135010002200151010001500173810000600188012008200194030002000276
06500090029606400050030503100030031001400080031386500090032100200130033003500100
0343801002000353#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#148
#18#article#24#18#^rND^sGoodman^nWK#^rND^sPrice^nLH#^rND^sRasmussen^nSA#^rND^sMa
zure^nC#^rND^sFleischmann^nRL#^rND^sHill^nCL#et al#The Yale-Brown Obsessive-Comp
ulsive scale I: development, use and reliability^len#Arch Gen Psychiatry#1989000
0#1989#46#1006-11#20110000#v60n1a01.htm#0003-990X#Arch Gen Psychiatry##
00472000000000241000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160019000810160018001000180
05100118066001000169062001500179065000900194064000500203865000900208002001300217
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#149#19#article#24#1
9#^rND^sTalairach^nJ#^rND^sTournoux^nP#Coplanar stereotaxic atlas of the human b
rain.^len#New Y^eNY#Thieme Medical#19980000#1998#20110000#v60n1a01.htm##
00695000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100017001000100
02000117010001400137010001400151012013500165030001300300065000900313064000500322
031000300327014000600330865000900336002001300345035001000358801001300368#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#150#20#article#24#20#^rND^s
Nishimiya^nM#^rND^sMatsuda^nH#^rND^sImabayashi^nE#^rND^sKuji^nI#^rND^sSato^nN#Co
mparison of SPM and NEUROSTAT in voxelwise statistical analysis of brain SPECT a
nd MRI at the early stage of Alzheimer's disease^len#Ann Nucl Med#20080000#2008#
22#921-7#20110000#v60n1a01.htm#0914-7187#Ann Nucl Med##
00635000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100016000980100
01800114012012600132030001500258065000900273064000500282031000400287014000700291
865000900298002001300307035001000320801001500330#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a01.htm#S#c#151#21#article#24#21#^rND^sDougall^nN#^rND^sNobili^
nF#^rND^sEbmeier^nKP#Predicting the accuracy of a diagnosis of Alzheimer's disea
se with 99mTc HMPAO single photon emission computed tomography^len#Psychiatry Re
s#20040000#2004#131#157-68#20110000#v60n1a01.htm#0165-1781#Psychiatry res##
00802000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100017001000100
01700117010001600134010002000150010001900170810000600189012019300195030001100388
06500090039906400050040803100020041301400060041586500090042100200130043003500100
0443801001100453#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm#S#c#152
#22#article#24#22#^rND^sSignorini^nM#^rND^sPaulesu^nE#^rND^sFriston^nK#^rND^sPer
ani^nD#^rND^sColleluori^nA#^rND^sLucignani^nG#et al#Rapid assessment of regional
 cerebral metabolic abnormalities in single subjects with quantitative and non-q
uantitative 18F-FDG PET: a clinical validation of statistical parametric mapping
^len#Neuroimage#19990000#1999#9#63-80#20110000#v60n1a01.htm#1053-8119#NEUROIMAGE
##
00652000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100016000990100
01900115010001800134012013800152030002400290710000200314065000900316064000500325
031000300330014000700333865000900340002001300349#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a01.htm#S#c#153#23#article#24#23#^rND^sKalatzis^nI#^rND^sPappas
^nD#^rND^sPiliouras^nN#^rND^sCayouras^nD#Support vector machines based analysis 
of brain SPECT images for determining cerebral abnormalities in asymptomatic dia
betic patients^len#Med Inform Internet Med#2#20030000#2003#28#221-30#20110000#v6
0n1a01.htm##
00580000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100024000980120
11000122030003400232710000200266065000900268064000500277031000300282014000700285
865000900292002001300301#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a01.htm
#S#c#154#24#article#24#24#^rND^sGlenn Fung#^rND^sJonathan Stoeckel#SVM feature s
election for classification of SPECT images of Alzheimer's disease using spatial
 information^len#Knowledge and Information Systems#2#20070000#2007#11#243-58#201
10000#v60n1a01.htm##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#o#1#1#article
#1#20110331#101344#v60n1a02.htm#154##
03784000000000661000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400080015003500100015801200930
01680120101002610100033003620100031003950100046004260700086004720700032005580700
05400590083099500644085001001639085003401649085002501683085003201708085002301740
08310350176308500100279808500330280808500250284108500320286608500230289805800620
29210580078029831170008030610720003030691120009030721110009030811140009030901130
01003099002001303109#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#h
#2#1#article#1#oa#en#br1.1#1#4.0#ILUS#TAB#2#JBPSIQ010#nd#J. bras. psiquiatr.#60#
1#20110000#^f7^l10#0047-2085#Association study of the Ile349val polymorphism of 
the gene ADH1C and alcohol dependence^len#Estudo sobre a associação entre o poli
morfismo Ile349Val do gene ADH1C e a dependência alcoólica^lpt#^rND^1A01^nAndré 
Soares^sRebello#^rND^1A02^nRodrigo^sMoura-Neto#^rND^1A03^nMaria da Glória da Cos
ta^sCarvalho#Federal University of Rio de Janeiro^iA01^1Medical School^cRio de J
aneiro^sRJ^pBrazil#UFRJ^iA02^1Institute of Biology#UFRJ^iA03^1Institute of Bioph
ysic Carlos Chagas Filho#^len^aOBJECTIVE: The aim of this study was to investiga
te the polymorphism Ile349Val of the enzyme alcohol dehydrogenase ADH1C gene amo
ng individuals with alcohol dependence syndrome (ADS) attending Alcoholics Anony
mous (AA) meetings. METHODS: A total of 120 subjects residing in Rio de Janeiro 
city participated in this study. Subjects were divided into two groups: a group 
consisting of 54 individuals from the ADS group and 66 individuals that declared
 not having any alcohol dependence (control group). DNA was extracted from mouth
 epithelial cells by phenol-chloroform method and further submitted to amplifica
tion by polymerase chain reaction (PCR). RESULTS: Our results did not show diffe
rences between the genotypes of control individuals and ADS subjects. Neverthele
ss, we found increased rates of alcoholism in families of ADS subjects as compar
ed to controls. CONCLUSIONS: Our results did not show any genotype difference on
 the ADH1C gene when control and AA genotypes are compared.#^ddecs^i1#^tm^len^kA
lcohol dehydrogenase^i1#^tm^len^kpolymorphism^i1#^tm^len^kchemical dependence^i1
#^tm^len^kalcoholism^i1#^lpt^aOBJETIVO: Investigar o polimorfismo Ile349Val do g
ene ADH1C da enzima álcool desidrogenase e a dependência de álcool em indivíduos
 frequentadores dos Alcoólicos Anônimos (AA). MÉTODOS: Um total de 120 pessoas r
esidentes na cidade do Rio de Janeiro foi dividido em dois grupos: o primeiro fo
i formado por 54 pessoas com síndrome de dependência do álcool (SDA) pertencente
s ao grupo dos AA. O segundo, com 66 pessoas, foi formado por indivíduos que des
creveram não serem dependentes de álcool (grupo controle). O DNA foi extraído de
 células da mucosa oral utilizando-se a técnica do fenol-clorofórmio e posterior
mente amplificado pela reação em cadeia pela polimerase (PCR). RESULTADOS: Nosso
s resultados não mostraram diferenças entre o genótipo dos indivíduos controle e
 aqueles do grupo SDA. A análise, entretanto, demonstrou uma significativa relaç
ão entre o grupo SDA e o histórico familiar de alcoolismo. CONCLUSÕES: Em nossos
 resultados não encontramos diferenças quanto ao genótipo ADH1C em indivíduos co
m SDA e controles.#^ddecs^i2#^tm^lpt^kÁlcool desidrogenase^i2#^tm^lpt^kpolimorfi
smo^i2#^tm^lpt^kdependência química^i2#^tm^lpt^kalcoolismo^i2#Conselho Nacional 
de Desenvolvimento Científico e Tecnológico#Fundação Carlos Chagas Filho de Ampa
ro à Pesquisa do Estado do Rio de Janeiro#vancouv#21#20100709#9/7/2010#20100124#
24/1/2010#v60n1a02.htm##
03854000000000661000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400080015003500100015801201000
01680120108002680100033003760100031004090100046004400700086004860700032005720700
05400604083102300658085001001681085003401691085002501725085003201750085002301782
08310630180508500100286808500330287808500250291108500320293608500230296805800620
29910580078030531170008031310720003031391120009031421110009031511140009031601130
01003169002001303179#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#f
#3#1#article#1#oa#en#br1.1#1#4.0#ILUS#TAB#2#JBPSIQ010#nd#J. bras. psiquiatr.#60#
1#20110000#^f7^l10#0047-2085#<b>Association study of the Ile349val polymorphism 
of the gene ADH1C and alcohol dependence</b>^len#<b>Estudo sobre a associação en
tre o polimorfismo Ile349Val do gene ADH1C e a dependência alcoólica</b>^lpt#^rN
D^1A01^nAndré Soares^sRebello#^rND^1A02^nRodrigo^sMoura-Neto#^rND^1A03^nMaria da
 Glória da Costa^sCarvalho#Federal University of Rio de Janeiro^iA01^1Medical Sc
hool^cRio de Janeiro^sRJ^pBrazil#UFRJ^iA02^1Institute of Biology#UFRJ^iA03^1Inst
itute of Biophysic Carlos Chagas Filho#^len^a<b>OBJECTIVE:</b> The aim of this s
tudy was to investigate the polymorphism Ile349Val of the enzyme alcohol dehydro
genase ADH1C gene among individuals with alcohol dependence syndrome (ADS) atten
ding Alcoholics Anonymous (AA) meetings. <b>METHODS:</b> A total of 120 subjects
 residing in Rio de Janeiro city participated in this study. Subjects were divid
ed into two groups: a group consisting of 54 individuals from the ADS group and 
66 individuals that declared not having any alcohol dependence (control group). 
DNA was extracted from mouth epithelial cells by phenol-chloroform method and fu
rther submitted to amplification by polymerase chain reaction (PCR). <b>RESULTS:
 </b>Our results did not show differences between the genotypes of control indiv
iduals and ADS subjects. Nevertheless, we found increased rates of alcoholism in
 families of ADS subjects as compared to controls. <b>CONCLUSIONS: </b>Our resul
ts did not show any genotype difference on the ADH1C gene when control and AA ge
notypes are compared.#^ddecs^i1#^tm^len^kAlcohol dehydrogenase^i1#^tm^len^kpolym
orphism^i1#^tm^len^kchemical dependence^i1#^tm^len^kalcoholism^i1#^lpt^a<b>OBJET
IVO:</b> Investigar o polimorfismo Ile349Val do gene ADH1C da enzima álcool desi
drogenase e a dependência de álcool em indivíduos frequentadores dos Alcoólicos 
Anônimos (AA). <b>MÉTODOS:</b> Um total de 120 pessoas residentes na cidade do R
io de Janeiro foi dividido em dois grupos: o primeiro foi formado por 54 pessoas
 com síndrome de dependência do álcool (SDA) pertencentes ao grupo dos AA. O seg
undo, com 66 pessoas, foi formado por indivíduos que descreveram não serem depen
dentes de álcool (grupo controle). O DNA foi extraído de células da mucosa oral 
utilizando-se a técnica do fenol-clorofórmio e posteriormente amplificado pela r
eação em cadeia pela polimerase (PCR). <b>RESULTADOS:</b> Nossos resultados não 
mostraram diferenças entre o genótipo dos indivíduos controle e aqueles do grupo
 SDA. A análise, entretanto, demonstrou uma significativa relação entre o grupo 
SDA e o histórico familiar de alcoolismo. <b>CONCLUSÕES:</b> Em nossos resultado
s não encontramos diferenças quanto ao genótipo ADH1C em indivíduos com SDA e co
ntroles.#^ddecs^i2#^tm^lpt^kÁlcool desidrogenase^i2#^tm^lpt^kpolimorfismo^i2#^tm
^lpt^kdependência química^i2#^tm^lpt^kalcoolismo^i2#Conselho Nacional de Desenvo
lvimento Científico e Tecnológico#Fundação Carlos Chagas Filho de Amparo à Pesqu
isa do Estado do Rio de Janeiro#vancouv#21#20100709#9/7/2010#20100124#24/1/2010#
v60n1a02.htm##
03909000000000685000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000200108049001000110
15800030012003000190012303100030014203200020014506500090014701400080015603500100
01640120093001740120101002670100033003680100031004010100046004320700088004780700
03400566070005600600083099500656085001001651085003401661085002501695085003201720
08500230175208310350177508500100281008500330282008500250285308500320287808500230
29100580062029330580078029951170008030730720003030811120009030841110009030931140
00903102113001003111002001303121008008903134#v60n1#V:\SciELO\serial\jbpsiq\v60n1
\markup\v60n1a02.htm#S#l#4#1#article#1#^a2011#oa#en#br1.1#1#4.0#ilus#tab#2#JBPSI
Q010#nd#J. bras. psiquiatr#60#1#20110000#^f7^l10#0047-2085#Association study of 
the Ile349val polymorphism of the gene ADH1C and alcohol dependence^len#Estudo s
obre a associação entre o polimorfismo Ile349Val do gene ADH1C e a dependência a
lcoólica^lpt#^rND^1A01^nAndré Soares^sRebello#^rND^1A02^nRodrigo^sMoura-Neto#^rN
D^1A03^nMaria da Glória da Costa^sCarvalho#^iA01^1Federal University of Rio de J
aneiro^2Medical School^cRio de Janeiro^sRJ^pBrazil#^iA02^1UFRJ^2Institute of Bio
logy#^iA03^1UFRJ^2Institute of Biophysic Carlos Chagas Filho#^len^aOBJECTIVE: Th
e aim of this study was to investigate the polymorphism Ile349Val of the enzyme 
alcohol dehydrogenase ADH1C gene among individuals with alcohol dependence syndr
ome (ADS) attending Alcoholics Anonymous (AA) meetings. METHODS: A total of 120 
subjects residing in Rio de Janeiro city participated in this study. Subjects we
re divided into two groups: a group consisting of 54 individuals from the ADS gr
oup and 66 individuals that declared not having any alcohol dependence (control 
group). DNA was extracted from mouth epithelial cells by phenol-chloroform metho
d and further submitted to amplification by polymerase chain reaction (PCR). RES
ULTS: Our results did not show differences between the genotypes of control indi
viduals and ADS subjects. Nevertheless, we found increased rates of alcoholism i
n families of ADS subjects as compared to controls. CONCLUSIONS: Our results did
 not show any genotype difference on the ADH1C gene when control and AA genotype
s are compared.#^ddecs^i1#^tm^len^kAlcohol dehydrogenase^i1#^tm^len^kpolymorphis
m^i1#^tm^len^kchemical dependence^i1#^tm^len^kalcoholism^i1#^lpt^aOBJETIVO: Inve
stigar o polimorfismo Ile349Val do gene ADH1C da enzima álcool desidrogenase e a
 dependência de álcool em indivíduos frequentadores dos Alcoólicos Anônimos (AA)
. MÉTODOS: Um total de 120 pessoas residentes na cidade do Rio de Janeiro foi di
vidido em dois grupos: o primeiro foi formado por 54 pessoas com síndrome de dep
endência do álcool (SDA) pertencentes ao grupo dos AA. O segundo, com 66 pessoas
, foi formado por indivíduos que descreveram não serem dependentes de álcool (gr
upo controle). O DNA foi extraído de células da mucosa oral utilizando-se a técn
ica do fenol-clorofórmio e posteriormente amplificado pela reação em cadeia pela
 polimerase (PCR). RESULTADOS: Nossos resultados não mostraram diferenças entre 
o genótipo dos indivíduos controle e aqueles do grupo SDA. A análise, entretanto
, demonstrou uma significativa relação entre o grupo SDA e o histórico familiar 
de alcoolismo. CONCLUSÕES: Em nossos resultados não encontramos diferenças quant
o ao genótipo ADH1C em indivíduos com SDA e controles.#^ddecs^i2#^tm^lpt^kÁlcool
 desidrogenase^i2#^tm^lpt^kpolimorfismo^i2#^tm^lpt^kdependência química^i2#^tm^l
pt^kalcoolismo^i2#Conselho Nacional de Desenvolvimento Científico e Tecnológico#
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro#va
ncouv#21#20100709#9/7/2010#20100124#24/1/2010#v60n1a02.htm#Internet^ihttp://www.
scielo.br/scielo.php?script=sci_arttext&pid=S0047-20852011000100002##
00354000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704011900076002001300195#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#5#1#article#129#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ARTIGO ORIGINAL</b>
</font></p>     ^cY#v60n1a02.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#6#2#article#129#<p>&nbsp;</p>     ^
cY#v60n1a02.htm##
00438000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704020300076002001300279#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#7#3#article#129#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Associat
ion study of the Ile349val polymorphism of the gene ADH1C and alcohol dependence
</b></font></p>     ^cY#v60n1a02.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#8#4#article#129#<p>&nbsp;</p>     ^
cY#v60n1a02.htm##
00448000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704021300076002001300289#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#9#5#article#129#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Estudo sobre a associa&ccedil;&at
ilde;o entre o polimorfismo Ile349Val do gene ADH1C e a depend&ecirc;ncia alco&o
acute;lica</b></font></p>     ^cY#v60n1a02.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#10#6#article#129#<p>&nbsp;</p>     
^cY#v60n1a02.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#11#7#article#129#<p>&nbsp;</p>     
^cY#v60n1a02.htm##
00454000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704021800077002001300295#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#12#8#article#129#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Andr&eacute; Soares Rebello<sup>
I</sup>; Rodrigo Moura-Neto<sup>II</sup>; Maria da Gl&oacute;ria da Costa Carval
ho<sup>III</sup></b></font></p>     ^cY#v60n1a02.htm##
00430000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704019400077002001300271#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#13#9#article#129#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Federal University of R
io de Janeiro (UFRJ), Medical School, Post-Graduate Program, Rio de Janeiro (RJ)
, Brazil    ^cY#v60n1a02.htm##
00289000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704005200078002001300130#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#14#10#article#129#<br> <sup>II</sup
>Institute of Biology, UFRJ    ^cY#v60n1a02.htm##
00324000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008700078002001300165#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#15#11#article#129#<br> <sup>III</su
p>Institute of Biophysic Carlos Chagas Filho, UFRJ</font></p>     ^cY#v60n1a02.h
tm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#16#12#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#17#13#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#18#14#article#129#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a02.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#19#15#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a02.htm##
00543000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704030600078002001300384#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#20#16#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVE:</b> The aim of this 
study was to investigate the polymorphism Ile349Val of the enzyme alcohol dehydr
ogenase ADH1C gene among individuals with alcohol dependence syndrome (ADS) atte
nding Alcoholics Anonymous (AA) meetings.    ^cY#v60n1a02.htm##
00679000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704044200078002001300520#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#21#17#article#129#<br>  <b>METHODS:
</b> A total of 120 subjects residing in Rio de Janeiro city participated in thi
s study. Subjects were divided into two groups: a group consisting of 54 individ
uals from the ADS group and 66 individuals that declared not having any alcohol 
dependence (control group).  DNA was extracted from mouth epithelial cells by ph
enol-chloroform method and further submitted to amplification by polymerase chai
n reaction (PCR).    ^cY#v60n1a02.htm##
00472000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704023500078002001300313#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#22#18#article#129#<br>  <b>RESULTS:
 </b>Our results did not show differences between the genotypes of control indiv
iduals and ADS subjects. Nevertheless, we found increased rates of alcoholism in
 families of ADS subjects as compared to controls.    ^cY#v60n1a02.htm##
00394000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015700078002001300235#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#23#19#article#129#<br>  <b>CONCLUSI
ONS: </b>Our results did not show any genotype difference on the ADH1C gene when
 control and AA genotypes are compared. </font></p>     ^cY#v60n1a02.htm##
00429000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704019200078002001300270#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#24#20#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Alcohol dehydroge
nase, polymorphism, chemical dependence, alcoholism. </font></p> <hr size="1" no
shade>     ^cY#v60n1a02.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#25#21#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a02.htm##
00530000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704029300078002001300371#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#26#22#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVO:</b> Investigar o poli
morfismo Ile349Val do gene ADH1C da enzima &aacute;lcool desidrogenase e a depen
d&ecirc;ncia de &aacute;lcool em indiv&iacute;duos frequentadores dos Alco&oacut
e;licos An&ocirc;nimos (AA).    ^cY#v60n1a02.htm##
00843000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704060600078002001300684#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#27#23#article#129#<br> <b>M&Eacute;
TODOS:</b> Um total de 120 pessoas residentes na cidade do Rio de Janeiro foi di
vidido em dois grupos: o primeiro foi formado por 54 pessoas com s&iacute;ndrome
 de depend&ecirc;ncia do &aacute;lcool (SDA) pertencentes ao grupo dos AA. O seg
undo, com 66 pessoas, foi formado por indiv&iacute;duos que descreveram n&atilde
;o serem dependentes de &aacute;lcool (grupo controle). O DNA foi extra&iacute;d
o de c&eacute;lulas da mucosa oral utilizando-se a t&eacute;cnica do fenol-cloro
f&oacute;rmio e posteriormente amplificado pela rea&ccedil;&atilde;o em cadeia p
ela polimerase (PCR).    ^cY#v60n1a02.htm##
00549000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704031200078002001300390#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#28#24#article#129#<br>  <b>RESULTAD
OS:</b> Nossos resultados n&atilde;o mostraram diferen&ccedil;as entre o gen&oac
ute;tipo dos indiv&iacute;duos controle e aqueles do grupo SDA. A an&aacute;lise
, entretanto, demonstrou uma significativa rela&ccedil;&atilde;o entre o grupo S
DA e o hist&oacute;rico familiar de alcoolismo.    ^cY#v60n1a02.htm##
00424000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704018700078002001300265#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#29#25#article#129#<br>  <b>CONCLUS&
Otilde;ES:</b> Em nossos resultados n&atilde;o encontramos diferen&ccedil;as qua
nto ao gen&oacute;tipo ADH1C em indiv&iacute;duos com SDA e controles.</font></p
>     ^cY#v60n1a02.htm##
00454000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704021700078002001300295#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#30#26#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>&Aacute;lco
ol desidrogenase, polimorfismo, depend&ecirc;ncia qu&iacute;mica, alcoolismo. </
font></p> <hr size="1" noshade>     ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#31#27#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#32#28#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00339000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010200078002001300180#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#33#29#article#129#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION</b></font></p>    
 ^cY#v60n1a02.htm##
01124000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704088700078002001300965#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#34#30#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Alcoholism is a complex syndrome i
nvolving genetic, psychological and sociocultural factors<sup>1,2</sup>. Despite
 the genetic evidence associated with alcoholism, polymorphism studies with alco
hol metabolism genes are still inconclusive<sup>3,4</sup>. The metabolism of eth
anol occurs almost entirely in the liver and involves the oxidation to acetaldeh
yde by the enzyme alcohol dehydrogenase (ADH) and further to acetate by acetalde
hyde dehydrogenase (ALDH)<sup>5</sup>. The genes that encode these enzymes displ
ay polymorphism, which modulates individual differences in alcohol and acetaldeh
yde oxidizing capacity. Functional allelic variants of these genes result in enh
anced catalytic activity (Vmax), increasing blood levels of acetaldehyde and, po
ssibly, protection against alcoholism<sup>6</sup>.</font></p>     ^cY#v60n1a02.h
tm##
01581000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704134400078002001301422#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#35#31#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The acetaldehyde is extremely toxi
c and produces the syndrome of "flushing" which is characterized by rubor facial
e, tachycardia and somnolence, resulting in an aversion to alcohol and decreasin
g the risk of consumption<sup>7</sup>. The set of enzymes called alcohol dehydro
genase complex (ADH) is the main responsible for the alcohol metabolism in the b
ody, and have a very complex genetic and functional role. The various forms of t
he enzyme ADH are divided into five separate classes according to their subunits
 and also the composition of their isoenzimes. Genes for ADH are located on chro
mosome 4 and divided into 5 classes. The ADH1 class includes the genes ADH1A, AD
H1B and ADH1C<sup>8,9</sup>. The ADH1C gene has two isoforms: gamma1 and gamma2.
 The gamma1 isoform has an isoleucine at the codon 349 and an arginine at the co
don 279 while the gamma2 isoform has a valine and a glutamine respectively. The 
gamma1 isoform codes for an enzyme that is two and a half times faster than the 
gamma2 isoform in ethanol metabolism, which causes a greater acetaldehyde accumu
lation<sup>10,11</sup>. The genes of human alcohol metabolism provide a rare exa
mple of how allelic variation contributes to a complex disease through interveni
ng physiology and behavior.</font></p>     ^cY#v60n1a02.htm##
00948000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704071100078002001300789#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#36#32#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The occurrence of these alleles de
pends on the population studied<sup>12</sup>. In South America, including Brazil
, there are only a few published studies on the variation of the ADH1C gene. The
se studies involved the indigenous population ethnic groups Ticuna, Quechua and 
Suru&iacute;<sup>13</sup>. In Brazil, more specifically, Nishimoto <i>et al.</i>
<sup>14</sup> studied the Ile349Val (rs698) polymorphism. However, these authors
 did not correlate their data with alcoholism but with cancer of the head and ne
ck, since an association between the ADH1C gene polymorphism and aero digestive 
tract cancer was already reported.</font></p>     ^cY#v60n1a02.htm##
00490000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704025300078002001300331#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#37#33#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Our study aims at investigating th
e Ile349Val polymorphism (ref. SNP ID: rs698) of the gene ADH1C in individuals w
ith alcohol dependence from Rio de Janeiro city, Brazil.</font></p>     ^cY#v60n
1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#38#34#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00334000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009700078002001300175#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#39#35#article#129#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>METHODS</b></font></p>     ^cY#
v60n1a02.htm##
00334000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009700078002001300175#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#40#36#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Samples</b></font></p>     ^cY#
v60n1a02.htm##
00932000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704069500078002001300773#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#41#37#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A total of 120 subjects, aged &gt;
 50 years, participated in this study. Participants were divided into two groups
: a group consisting of 54 subjects with alcohol dependence syndrome (ADS), recr
uited<sup>15</sup> in Alcoholics Anonymous meetings in Rio de Janeiro city, and 
a control group of with 66 convenience subjects. The control group was selected 
among the staff the Federal University of Rio de Janeiro and reported no history
 of problems with alcohol consumption. We chose control individuals older than 5
0 years based on the fact that alcoholism is more frequent in individuals betwee
n ages 20 and 50. </font></p>     ^cY#v60n1a02.htm##
00761000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704052400078002001300602#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#42#38#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">We interviewed all participants us
ing a structured questionnaire to obtain detailed information on demographic cha
racteristics. Ethnicity was defined according to the information provided by the
 individuals. All participants signed an informed consent to participate in this
 study. This Project was approved by the medical ethical committee of the Federa
l University of Rio de Janeiro (protocol number: 069/07) in June 16<sup>th</sup>
, 2007.</font></p>     ^cY#v60n1a02.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#43#39#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Genotyping</b></font></p>     ^
cY#v60n1a02.htm##
00713000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704047600078002001300554#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#44#40#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Genomic DNA was obtained from exfo
liated cells. The brush containing the biological material was inserted into Epp
endorf tubes containing 10 mM TRIS-HCl buffer, pH 7.5 in the presence of 10 mM N
aCl, 2% SDS and 15&#181;l of proteinase (10 mg/ml). The material was incubated a
t 56ºC for 2h and DNA was extracted by phenol-clorophorm-isoamilic alcohol and r
esuspended in sterile distilled water. </font></p>     ^cY#v60n1a02.htm##
00805000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704056800078002001300646#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#45#41#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The genotyping for the polymorphis
m of ADH1C was carried out by polymerase chain reaction (PCR) in 25 &#181;l of r
eaction mixture containing about 100 ng of genomic DNA, 100 ng of each initiatio
ns, 200 mM of dNTP, 2mM MgCl<sub>2</sub>, 50 mM KCl, 10mM TRIS-HCl (pH 8.41 and 
0.5U of Taq DNA polymerase Applied Biosystems). The PCR amplification was perfor
med using the following primers: A3FXNFOR1(5'- TTG TTT ATC TGT GAT TTT TTT TGT-3
'); A3FXNREV3 (5'-CGT TAC TGT AGA ATA CAA AGC-3'). </font></p>     ^cY#v60n1a02.
htm##
00861000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704062400078002001300702#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#46#42#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The reactions were performed by in
cubating the mixture at 95ºC for 5 minutes followed by 40 cycles at 95ºC (1 seco
nd), 51ºC (15 seconds), 72ºC (75 seconds) and 72ºC (10 minutes). The PCR product
s were digested with 5 units of restriction enzyme Sspl in buffer recommended by
 the manufacturer (New England Corporation). Aliquots were subjected to electrop
horesis in 10% polyacrylamide gels, stained with 0.1% silver nitrate solution an
d photographed on a light box using Polaroid film as described by Rebello and Ca
rvalho, 2008<sup>16</sup>. </font></p>     ^cY#v60n1a02.htm##
00347000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011000078002001300188#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#47#43#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Statistical analysis</b></font>
</p>     ^cY#v60n1a02.htm##
00734000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704049700078002001300575#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#48#44#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Differences in the characteristics
 of groups analyzed were estimated with Fisher's test, Epi Info program, using c
hisquared statistics, considering 5% as a significant value. The Hardy-Weinberg 
equilibrium was estimated by Fisher's Exact Test, using Genetic Data analysis Pa
ckage, developed by Lewis and Zaykin<sup>17</sup>. Sampling sizing estimations w
ere done as described by Budowle <i>et al.</i><sup>18</sup>.</font></p>     ^cY#
v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#49#45#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00334000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009700078002001300175#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#50#46#article#129#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTS</b></font></p>     ^cY#
v60n1a02.htm##
00637000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704040000078002001300478#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#51#47#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#tab01">Table 1</a> shows
 the distribution of the number of subjects by gender, race and family history o
f alcoholism. The analysis of this data suggests the genetic nature of ADS, sinc
e the percentage of relatives with a history of alcoholism was significantly hig
her in ADS than in controls (p &lt; 0.001).</font></p>     ^cY#v60n1a02.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#52#48#article#129#<p><a name="tab01
"></a></p>     ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#53#49#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#54#50#article#129#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a02tab01.jpg"></p>     ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#55#51#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00917000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704068000078002001300758#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#56#52#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Next, we characterized the genotyp
e of subjects with respect to the Ile349Val polymorphism of the gene ADH1C (<a h
ref="#tab02a">Table 2A</a>). There were no statistically significant differences
 (p = 0.80) in the distribution of genotypes between the control and ADS group. 
When comparing this distribution, there was a low percentage of subjects with th
e genotype Val.Val in both groups. Also, we have counted the alleles and the fre
quency determined as depicted on <a href="#tab02b">table 2B</a>. No departure fr
om Hardy Weinberg Equilibrium were observed in both control and ADS groups (p = 
1).</font></p>     ^cY#v60n1a02.htm##
00274000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003700078002001300115#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#57#53#article#129#<p><a name="tab02
a"></a></p>     ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#58#54#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00315000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704007800078002001300156#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#59#55#article#129#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a02tab02a.jpg">    ^cY#v60n1a02.htm##
00328000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009100078002001300169#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#60#56#article#129#<br> <a name="tab
02b"></a><img src="/img/revistas/jbpsiq/v60n1/a02tab02b.jpg"></p>     ^cY#v60n1a
02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#61#57#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00715000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704047800078002001300556#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#62#58#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">We then analyzed the male/female d
istribution according to the family history of alcoholism for each genotype (<a 
href="#tab03">Table 3</a>). For the genotype Val.Val, the number of individuals 
becomes too low when separated by gender. For this reason, the genotype Ile.Val 
was added to this sample. There was a strong association between ADS individuals
 and a family history for male subjects. </font></p>     ^cY#v60n1a02.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#63#59#article#129#<p><a name="tab03
"></a></p>     ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#64#60#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#65#61#article#129#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a02tab03.jpg"></p>     ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#66#62#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#67#63#article#129#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSSION</b></font></p>     ^
cY#v60n1a02.htm##
00947000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704071000078002001300788#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#68#64#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">In this study, the allelic variati
on of the gene ADH1C Ile349Val in alcohol dependence was studied in a sample of 
the population of Rio de Janeiro city, Brazil. Admittedly, detailed clinical dat
a on alcohol use, both in controls and in ADS subjects, were not obtained throug
h a structured questionnaire. Therefore, the results of our study should be exam
ined with caution. The Ile349Val polymorphism was chosen because it is one of th
e least studied in the literature, particularly in South America, where such stu
dies are restricted to the indigenous tribes in the Amazon region Quechua, Suru&
iacute; and Ticuna<sup>13</sup>. </font></p>     ^cY#v60n1a02.htm##
00931000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704069400078002001300772#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#69#65#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Literature data suggest that the d
istribution of genetic markers in the case of alcoholism is population specific.
 In the world distribution, ADH1C* 1 (ile.Ile) has a frequency of 55% to 60% in 
Europeans descendants and 90% in the Chinese population<sup>19,20</sup>. In our 
study, we observed a small number of Val.Val individuals, and this is consistent
 with studies by Nishimoto <i>et al.</i> in a sample from Sao Paulo city. The au
thors, as already mentioned, studied the incidence of cancer of the upper aerodi
gestive tract, since the ADH1C gene is also associated with cancer of head and n
eck<sup>14</sup>.</font></p>     ^cY#v60n1a02.htm##
00990000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704075300078002001300831#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#70#66#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">When comparing ADS and control gro
ups with regard to ADH1C polymorphism, there was no difference between the two g
roups. This result was not surprising, since the Brazilian population is quite m
ixed and these relationships are strongly dependent on the population studied. T
he absence of ethnic differences in Brazilian population data confirms that ther
e is no evidence of differences in genetic background based on the melanin conce
ntration<sup>21</sup>. As noted, the number of subjects, though small, was consi
dered adequate, since only one gene and two alleles were analyzed. Therefore, th
e minimum frequency of alleles with confidence level alpha = 0.05 was 0.033.</fo
nt></p>     ^cY#v60n1a02.htm##
00693000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704045600078002001300534#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#71#67#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Franc&egrave;s <i>et al.</i><sup>1
1</sup>, studying the Spanish Mediterranean population, also found no difference
s between genotype and alcohol consumption. When these authors, however, divided
 the population by gender, they found markedly increased ethanol consumption for
 the genotype Val.Val among females. These results were not observed in our stud
y (data not shown).</font></p>     ^cY#v60n1a02.htm##
00803000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704056600078002001300644#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#72#68#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The fact that ADS subjects have si
gnificantly more family history of alcoholism is in agreement with published lit
erature<sup>1,2</sup>. Further, for each genotype, male patients with ADS exhibi
ted increased family history of alcoholism. However, as our sample is restricted
 to the Rio de Janeiro city, these findings need to be analyzed with a larger sa
mple, and also in populations from different regions of the country due to the s
trong racial mixture of the Brazilian population.</font></p>     ^cY#v60n1a02.ht
m##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#73#69#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00338000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010100078002001300179#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#74#70#article#129#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUSIONS</b></font></p>     
^cY#v60n1a02.htm##
00590000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704035300078002001300431#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#75#71#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Our results showed no difference b
etween the polymorphism rates of the enzyme alcohol dehydrogenase ADH1C gene of 
control and the ADS group. We also find that individuals in the ADS group have a
 significantly greater number of alcoholic relatives than the control group.</fo
nt></p>     ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#76#72#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#77#73#article#129#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ACKNOWLEDGEMENTS</b></font></p>
     ^cY#v60n1a02.htm##
00534000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704029700078002001300375#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#78#74#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">This study was supported by the Co
nselho Nacional de Desenvolvimento Cient&iacute;fico e Tecnol&oacute;gico and th
e Funda&ccedil;&atilde;o Carlos Chagas Filho de Amparo &agrave; Pesquisa do Esta
do do Rio de Janeiro</font></p>     ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#79#75#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00372000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704013500078002001300213#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#80#76#article#129#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCLOSURE OF POTENTIAL CONFLIC
TS OF INTEREST</b></font></p>     ^cY#v60n1a02.htm##
00370000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704013300078002001300211#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#81#77#article#129#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">No potential conflicts of interest
 were disclosed.</font></p>     ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#82#78#article#129#<p>&nbsp;</p>    
 ^cY#v60n1a02.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#83#79#article#129#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font></p>     ^
cY#v60n1a02.htm##
00569000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704031800080002001300398#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#84#80#article#129#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Heath AC, Bucholz
 KK, Madden PA, Dinwidde SH, Slutske WS, Bierut LJ, et al. Genetic and environme
ntal contributions to alcohol dependence risk in a national twin sample: consist
ency of findings in women and men. Psychol Med. 1997;27(6):1381-96.    ^cY#v60n1
a02.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#85#81#article#129#</font></p>     ^
cY#v60n1a02.htm##
00565000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704031400080002001300394#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#86#82#article#129#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Heath AC, Whitfie
ld JB, Madden PA, Bucholz KK, Dinwiddie SH, Slutske WS, et al. Towards a molecul
ar epidemiology of alcohol dependence: analyzing the interplay of genetic and en
vironmental risk factors. Br J Psychiatry Suppl. 2001;40:33-40.    ^cY#v60n1a02.
htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#87#83#article#129# </font></p>     
^cY#v60n1a02.htm##
00473000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704022200080002001300302#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#88#84#article#129#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Dick DM, Foroud T
. Candidate genes for alcohol dependence: a review of genetic evidence from huma
n studies. Alcohol Clin Exp Res. 2003:27(5):868-79.    ^cY#v60n1a02.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#89#85#article#129# </font></p>     
^cY#v60n1a02.htm##
00579000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704032800080002001300408#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#90#86#article#129#4#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Enoch MA, Goldman
 D. Molecular and cellular genetics of alcohol addiction. In: Davis KL, Charney 
D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: the fifth generation 
of progress. Philadelphia: Lippincott Williams and Wilkins; 2002, p. 1413-23.   
 ^cY#v60n1a02.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#91#87#article#129# </font></p>     
^cY#v60n1a02.htm##
00431000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704018000080002001300260#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#92#88#article#129#5#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Ramchandani VA, B
osron WF, Li TK. Research advances in ethanol metabolism. Pathol Biol. 2001;49(9
):676-82.    ^cY#v60n1a02.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#93#89#article#129# </font></p>     
^cY#v60n1a02.htm##
00558000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704030700080002001300387#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#94#90#article#129#6#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Mulligan CJ, Robi
n RW, Osier MV, Sambuughin N, Goldfarb LG, Kittles RA, et al. Allelic variation 
at alcohol metabolism genes (ADH1B, ADH1C, ALDH2) and alcohol dependence in a Am
erican Indian population. Hum Genet. 2003;113(4):325-36.    ^cY#v60n1a02.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#95#91#article#129# </font></p>     
^cY#v60n1a02.htm##
00505000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704025400080002001300334#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#96#92#article#129#7#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Harada S, Agarwal
 DP, Goedde HW, Tagaki S, Ishikawa B. Possible protective role against alcoholis
m for aldehyde dehydrogenase isozyme deficience in Japan. Lancet. 1982;2(8302):8
27.    ^cY#v60n1a02.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#97#93#article#129# </font></p>     
^cY#v60n1a02.htm##
00464000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704021300080002001300293#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#98#94#article#129#8#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Thomasson HR, Cra
bb DW, Edenberg HJ, Li TK. Alcohol and aldehyde dehydrogenase polymorphisms and 
alcoholism. Behav Genet. 1993;23(2):131-6.    ^cY#v60n1a02.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#99#95#article#129# </font></p>     
^cY#v60n1a02.htm##
00423000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000200079704017100081002001300252#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#100#96#article#129#9#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Agarwal DP. Gene
tic polymorphisms of alcohol metabolizing enzymes. Pathol Biol. 2001;49(9):703-9
.    ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002100079002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#101#97#article#129# </font></p>    
 ^cY#v60n1a02.htm##
00509000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704025600082002001300338#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#102#98#article#129#10#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Xu YL, Carr LG
, Bosron WF, Li TK, Edenberg HJ. Genotyping of human alcohol dehydrogenases at t
he ADH2 and ADH3 loci following DNA sequence amplification. Genomics. 1988;2(3):
209-14.    ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002100079002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#103#99#article#129# </font></p>    
 ^cY#v60n1a02.htm##
00546000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704029200083002001300375#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#104#100#article#129#11#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Franc&egrave;
s F, Sorl&iacute; JV, Castell&oacute; A, Verdu F, Corella D, Portol&eacute;s O. 
Genetic predisposition to alcohol consumption: the case of alcohol dehydrogenase
 1C. Cuad Med Forense. 2007;13(4849):157-64.    ^cY#v60n1a02.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#105#101#article#129# </font></p>   
  ^cY#v60n1a02.htm##
00557000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704030300083002001300386#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#106#102#article#129#12#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Osier MV, Pak
stis AJ, Soodyal H, Comas D, Goldman D, Odunsi A, et al. A global perspective on
 genetic variation on the ADH genes reveals unusual patterns of linkage disequil
ibrium and diversity. Am J Hum Genet. 2002;71(1):84-99.    ^cY#v60n1a02.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#107#103#article#129# </font></p>   
  ^cY#v60n1a02.htm##
00538000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704028400083002001300367#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#108#104#article#129#13#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. <a href="http
://alfred.med.yale.edu/alfred/recordinfo.asp?condition.sites=site uid=S1000669V"
 target="_blank">http://alfred.med.yale.edu/alfred/recordinfo.asp?condition.site
s=site uid=S1000669V</a></font></p>     ^cY#v60n1a02.htm##
00547000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704029300083002001300376#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#109#105#article#129#14#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Nishimoto IN,
 Pinheiro NA, Rogatto SR, Carvalho AL, Moura RP, Caballero OL, et al. Alcohol de
hydrogenase 3 genotype as a risk factor for upper aerodigestive tract cancers. A
rch Otolaryngol Neck Surg. 2004;130(1):78-82.    ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#110#106#article#129#</font></p>    
 ^cY#v60n1a02.htm##
00481000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704022700083002001300310#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#111#107#article#129#15#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Gigliotti A, 
Bessa MC. S&iacute;ndrome de depend&ecirc;ncia do &aacute;lcool: crit&eacute;rio
s diagn&oacute;sticos. Rev Bras Psiquiatr. 2004;26(1):11-3.    ^cY#v60n1a02.htm#
#
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#112#108#article#129#</font></p>    
 ^cY#v60n1a02.htm##
00491000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023700083002001300320#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#113#109#article#129#16#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Rebello AS, C
arvalho MGC. Metodologia para estudo do polimorfismo do gene da enzima &aacute;l
cool desidrogenase. Rev Ci&ecirc;nc M&eacute;d Biol. 2008;7(2):163-8.    ^cY#v60
n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#114#110#article#129#</font></p>    
 ^cY#v60n1a02.htm##
00559000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704030500083002001300388#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#115#111#article#129#17#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Lewis PO, Zay
kin D. Genetic data analysis: computer program for the analysis of allelic data;
 2001. Available on: <a href="http://alley.eeb.uconn.edu/gda" target="_blank">ht
tp://alley.eeb.uconn.edu/gda</a>. Access on: Jul 1, 2010.    ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#116#112#article#129#</font></p>    
 ^cY#v60n1a02.htm##
00495000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024100083002001300324#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#117#113#article#129#18#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Budowle B, Mo
nson KL, Chakraborty R. Estimating minimum allele frequencies for DNA profile fr
equency estimates for PCR-based loci. Int J Legal Med. 1966;108(4):173-6.    ^cY
#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#118#114#article#129#</font></p>    
 ^cY#v60n1a02.htm##
00527000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704027300083002001300356#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#119#115#article#129#19#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Agarwal DP, H
arada S, Goedde HW. Racial differences in biological sensitivity to ethanol: the
 role of alcohol dehydrogenase and aldehyde dehydrogenase isozymes. Alcohol Clin
 Exp Res. 1981;5(1):12-6.    ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#120#116#article#129#</font></p>    
 ^cY#v60n1a02.htm##
00566000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704031200083002001300395#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#121#117#article#129#20#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Xingguang L, 
Kranzler HR, Zuo L, Wang S, Schork NJ, Gelernter J. Diplotype trend regression a
nalyses of the ADH gene cluster and the ALDH2 gene: multiple significant associa
tion with alcohol dependence. Am J Hum Genet. 2006;78(6):973-87.    ^cY#v60n1a02
.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#122#118#article#129#</font></p>    
 ^cY#v60n1a02.htm##
00523000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704026900083002001300352#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#123#119#article#129#21#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Pimenta JR, Z
uccherato RW, Debes AA, Maselli L, Soares R, Moura-Neto RS, et al. Color and gen
omic ancestry in Brazilians: a study with forensic microsatellites. Human Heredi
ty. 2006;62(4):190-5.    ^cY#v60n1a02.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#124#120#article#129#</font></p>    
 ^cY#v60n1a02.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#125#121#article#129#<p>&nbsp;</p>  
   ^cY#v60n1a02.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#126#122#article#129#<p>&nbsp;</p>  
   ^cY#v60n1a02.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704023200080002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#127#123#article#129#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="
/img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <
b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a02.htm##
00293000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704005400080002001300134#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#128#124#article#129#<br>  Maria da 
Gl&oacute;ria da Costa Carvalho    ^cY#v60n1a02.htm##
00353000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704011400080002001300194#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#129#125#article#129#<br>  Instituto
 de Biof&iacute;sica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro
 (UFRJ) CCS    ^cY#v60n1a02.htm##
00279000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004000080002001300120#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#130#126#article#129#<br> Cidade Uni
versit&aacute;ria    ^cY#v60n1a02.htm##
00302000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006300080002001300143#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#131#127#article#129#<br> 21941-902 
- Rio de Janeiro, RJ, Brasil</font></p>     ^cY#v60n1a02.htm##
00330000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009100080002001300171#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#132#128#article#129#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 9/7/2010    ^cY#v60n
1a02.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#p#133#129#article#129#<br>  Aprovado 
em 24/1/2010</font></p>     ^cY#v60n1a02.htm##
00762000000000349000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100018000950100
01700113010001900130010001800149010001700167810000600184012013900190030001200329
06500090034106400050035003100030035503200020035801400080036086500090036800200130
0377035001000390801001200400#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02
.htm#S#c#134#1#article#21#1#^rND^sHeath^nAC#^rND^sBucholz^nKK#^rND^sMadden^nPA#^
rND^sDinwidde^nSH#^rND^sSlutske^nWS#^rND^sBierut^nLJ#et al#Genetic and environme
ntal contributions to alcohol dependence risk in a national twin sample: consist
ency of findings in women and men^len#Psychol Med#19970000#1997#27#6#1381-96#201
10000#v60n1a02.htm#0033-2917#Psychol Med##
00757000000000337000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100020000950100
01700115010001800132010002000150010001800170810000600188012012600194030002200320
06500090034206400050035103100030035601400060035986500090036500200130037403500100
0387801002200397#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#135
#2#article#21#2#^rND^sHeath^nAC#^rND^sWhitfield^nJB#^rND^sMadden^nPA#^rND^sBucho
lz^nKK#^rND^sDinwiddie^nSH#^rND^sSlutske^nWS#et al#Towards a molecular epidemiol
ogy of alcohol dependence: analyzing the interplay of genetic and environmental 
risk factors^len#Br J Psychiatry Suppl#20010000#2001#40#33-40#20110000#v60n1a02.
htm#0960-5371#Br J Psychiatry Suppl##
00592000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100015000790100016000940120
09200110030002100202065000900223064000500232031000300237032000200240014000700242
865000900249002001300258035001000271801002100281#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a02.htm#S#c#136#3#article#21#3#^rND^sDick^nDM#^rND^sForoud^nT#C
andidate genes for alcohol dependence: a review of genetic evidence from human s
tudies^len#Alcohol Clin Exp Res#20030000#2003#27#5#868-79#20110000#v60n1a02.htm#
0145-6008#Alcohol Clin Exp Res##
00701000000000313000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100017000950120
05700112016001600169016001700185016001600202016001800218018006200236066001300298
062003200311014000800343065000900351064000500360865000900365002001300374#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#137#4#article#21#4#^rND^sEn
och^nMA#^rND^sGoldman^nD#Molecular and cellular genetics of alcohol addiction^le
n#^rED^sDavis^nKL#^rED^sCharney^nD#^rED^sCoyle^nJT#^rED^sNemeroff^nC#Neuropsycho
pharmacology: the fifth generation of progress^len#Philadelphia#Lippincott Willi
ams and Wilkins#1413-23#20020000#2002#20110000#v60n1a02.htm##
00527000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100022000790100017001010100
01300118012004400131030001200175710000200187065000900189064000500198031000300203
032000200206014000700208865000900215002001300224#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a02.htm#S#c#138#5#article#21#5#^rND^sRamchandani^nVA#^rND^sBosr
on^nWF#^rND^sLi^nTK#Research advances in ethanol metabolism^len#Pathol Biol#2#20
010000#2001#49#9#676-82#20110000#v60n1a02.htm##
00749000000000349000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100019000790100016000980100
01600114010002000130010001900150010001800169810000600187012012700193030001000320
06500090033006400050033903100040034403200020034801400070035086500090035700200130
0366035001000379801001000389#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02
.htm#S#c#139#6#article#21#6#^rND^sMulligan^nCJ#^rND^sRobin^nRW#^rND^sOsier^nMV#^
rND^sSambuughin^nN#^rND^sGoldfarb^nLG#^rND^sKittles^nRA#et al#Allelic variation 
at alcohol metabolism genes (ADH1B, ADH1C, ALDH2) and alcohol dependence in a Am
erican Indian population^len#Hum Genet#20030000#2003#113#4#325-36#20110000#v60n1
a02.htm#0340-6717#Hum Genet##
00664000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100018000950100
01700113010001600130010001800146012010300164030000700267065000900274064000500283
03100020028803200050029001400040029586500090029900200130030803500100032180100070
0331#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#140#7#article#2
1#7#^rND^sHarada^nS#^rND^sAgarwal^nDP#^rND^sGoedde^nHW#^rND^sTagaki^nS#^rND^sIsh
ikawa^nB#Possible protective role against alcoholism for aldehyde dehydrogenase 
isozyme deficience in Japan^len#Lancet#19820000#1982#2#8302#827#20110000#v60n1a0
2.htm#0099-5355#Lancet##
00610000000000313000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100020000790100016000990100
01900115010001300134012006800147030001200215065000900227064000500236031000300241
032000200244014000600246865000900252002001300261035001000274801001200284#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#141#8#article#21#8#^rND^sTh
omasson^nHR#^rND^sCrabb^nDW#^rND^sEdenberg^nHJ#^rND^sLi^nTK#Alcohol and aldehyde
 dehydrogenase polymorphisms and alcoholism^len#Behav Genet#19930000#1993#23#2#1
31-6#20110000#v60n1a02.htm#0001-8244#Behav Genet##
00482000000000265000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790120058000970300
01200155710000200167065000900169064000500178031000300183032000200186014000600188
865000900194002001300203#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm
#S#c#142#9#article#21#9#^rND^sAgarwal^nDP#Genetic polymorphisms of alcohol metab
olizing enzymes^len#Pathol Biol#2#20010000#2001#49#9#703-9#20110000#v60n1a02.htm
##
00669000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100013000810100015000940100
01700109010001300126010001900139012011000158030000900268065000900277064000500286
03100020029103200020029301400070029586500090030200200130031103500100032480100090
0334#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#143#10#article#
21#10#^rND^sXu^nYL#^rND^sCarr^nLG#^rND^sBosron^nWF#^rND^sLi^nTK#^rND^sEdenberg^n
HJ#Genotyping of human alcohol dehydrogenases at the ADH2 and ADH3 loci followin
g DNA sequence amplification^len#Genomics#19880000#1988#2#3#209-14#20110000#v60n
1a02.htm#0888-7543#Genomics##
00666000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100016000980100
01800114010001500132010001700147010001800164012008800182030001700270710000200287
06500090028906400050029803100030030303200050030601400070031186500090031800200130
0327#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#144#11#article#
21#11#^rND^sFrancès^nF#^rND^sSorlí^nJV#^rND^sCastelló^nA#^rND^sVerdu^nF#^rND^sCo
rella^nD#^rND^sPortolés^nO#Genetic predisposition to alcohol consumption: the ca
se of alcohol dehydrogenase 1C^len#Cuad Med Forense#2#20070000#2007#13#4849#157-
64#20110000#v60n1a02.htm##
00751000000000349000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100018000970100
01700115010001500132010001700147010001600164810000600180012012800186030001500314
06500090032906400050033803100030034303200020034601400060034886500090035400200130
0363035001000376801001500386#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02
.htm#S#c#145#12#article#21#12#^rND^sOsier^nMV#^rND^sPakstis^nAJ#^rND^sSoodyal^nH
#^rND^sComas^nD#^rND^sGoldman^nD#^rND^sOdunsi^nA#et al#A global perspective on g
enetic variation on the ADH genes reveals unusual patterns of linkage disequilib
rium and diversity^len#Am J Hum Genet#20020000#2002#71#1#84-99#20110000#v60n1a02
.htm#0002-9297#Am J Hum Genet##
00357000000000169000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780370084000818650009001650020
01300174#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#146#13#arti
cle#21#13#http://alfred.med.yale.edu/alfred/recordinfo.asp?condition.sites=site 
uid=S1000669V#20110000#v60n1a02.htm##
00706000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100020000810100019001010100
01800120010001900138010001600157010002000173810000600193012009200199030002700291
71000020031806500090032006400050032903100040033403200020033801400060034086500090
0346002001300355#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#147
#14#article#21#14#^rND^sNishimoto^nIN#^rND^sPinheiro^nNA#^rND^sRogatto^nSR#^rND^
sCarvalho^nAL#^rND^sMoura^nRP#^rND^sCaballero^nOL#et al#Alcohol dehydrogenase 3 
genotype as a risk factor for upper aerodigestive tract cancers^len#Arch Otolary
ngol Neck Surg#2#20040000#2004#130#1#78-82#20110000#v60n1a02.htm##
00523000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100016001000120
06200116030001900178710000200197065000900199064000500208031000300213032000200216
014000500218865000900223002001300232#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a02.htm#S#c#148#15#article#21#15#^rND^sGigliotti^nA#^rND^sBessa^nMC#Síndrom
e de dependência do álcool: critérios diagnósticos^lpt#Rev Bras Psiquiatr#2#2004
0000#2004#26#1#11-3#20110000#v60n1a02.htm##
00547000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100020000990120
08300119030001900202710000200221065000900223064000500232031000200237032000200239
014000600241865000900247002001300256#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a02.htm#S#c#149#16#article#21#16#^rND^sRebello^nAS#^rND^sCarvalho^nMGC#Meto
dologia para estudo do polimorfismo do gene da enzima álcool desidrogenase^lpt#R
ev Ciênc Méd Biol#2#20080000#2008#7#2#163-8#20110000#v60n1a02.htm##
00532000000000253000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160016000810160016000970180
07700113065000900190064000500199037003100204110000900235109001200244865000900256
002001300265#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#150#17#
article#21#17#^rND^sLewis^nPO#^rND^sZaykin^nD#Genetic data analysis: computer pr
ogram for the analysis of allelic data^len#20010000#2001#http://alley.eeb.uconn.
edu/gda#20100701#Jul 1, 2010#20110000#v60n1a02.htm##
00625000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100017000980100
02100115012009700136030001600233065000900249064000500258031000400263032000200267
014000600269865000900275002001300284035001000297801001600307#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#151#18#article#21#18#^rND^sBudowle^nB#^
rND^sMonson^nKL#^rND^sChakraborty^nR#Estimating minimum allele frequencies for D
NA profile frequency estimates for PCR-based loci^len#Int J Legal Med#19660000#1
966#108#4#173-6#20110000#v60n1a02.htm#0937-9827#Int J Legal Med##
00662000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100016000990100
01700115012013100132030002100263065000900284064000500293031000200298032000200300
014000500302865000900307002001300316035001000329801002100339#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#152#19#article#21#19#^rND^sAgarwal^nDP#
^rND^sHarada^nS#^rND^sGoedde^nHW#Racial differences in biological sensitivity to
 ethanol: the role of alcohol dehydrogenase and aldehyde dehydrogenase isozymes^
len#Alcohol Clin Exp Res#19810000#1981#5#1#12-6#20110000#v60n1a02.htm#0145-6008#
Alcohol Clin Exp Res##
00749000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100019001000100
01300119010001400132010001700146010001900163012014100182030001500323065000900338
06400050034703100030035203200020035501400070035786500090036400200130037303500100
0386801001500396#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02.htm#S#c#153
#20#article#21#20#^rND^sXingguang^nL#^rND^sKranzler^nHR#^rND^sZuo^nL#^rND^sWang^
nS#^rND^sSchork^nNJ#^rND^sGelernter^nJ#Diplotype trend regression analyses of th
e ADH gene cluster and the ALDH2 gene: multiple significant association with alc
ohol dependence^len#Am J Hum Genet#20060000#2006#78#6#973-87#20110000#v60n1a02.h
tm#0002-9297#Am J Hum Genet##
00717000000000349000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100021000990100
01600120010001700136010001600153010002100169810000600190012008400196030001500280
06500090029506400050030403100030030903200020031201400060031486500090032000200130
0329035001000342801001500352#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a02
.htm#S#c#154#21#article#21#21#^rND^sPimenta^nJR#^rND^sZuccherato^nRW#^rND^sDebes
^nAA#^rND^sMaselli^nL#^rND^sSoares^nR#^rND^sMoura-Neto^nRS#et al#Color and genom
ic ancestry in Brazilians: a study with forensic microsatellites^len#Human Hered
ity#20060000#2006#62#4#190-5#20110000#v60n1a02.htm#0001-5652#Human heredity##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#o#1#1#article
#1#20110331#101347#v60n1a03.htm#157##
04222000000000649000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901200830
01690120078002520100038003300100035003680100026004030100037004290100037004660700
07900503070008200582083124500664085001001909085002501919085002101944085002901965
08500260199408313700202008500100339008500260340008500220342608500320344808500290
34801170008035090720003035171120009035201110011035291140009035401130010035490020
01303559#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#h#2#1#article
#1#oa#en#br1.1#1#4.0#ILUS#TAB#3#JBPSIQ010#nd#J. bras. psiquiatr.#60#1#20110000#^
f11^l15#0047-2085#Prevalence of mental disorders among sexual offenders and non-
sexual offenders^len#Prevalência de transtornos mentais entre agressores sexuais
 e não sexuais^lpt#^rND^1A01^nMaria Fernanda Faria^sAchá#^rND^1A02^nSérgio Paulo
^sRigonatti#^rND^1A02^nFabiana^sSaffi#^rND^1A02^nDaniel Martins de^sBarros#^rND^
1A02^nAntônio de Pádua^sSerafim#Universidade de São Paulo^iA01^1Faculdade de Med
icina^2Programa de Psiquiatria#USP^iA02^1Departamento de Psiquiatria^2Núcleo de 
Psiquiatria e Psicologia Forense#^len^aOBJECTIVE: To evaluate the prevalence of 
mental disorders in convicted sex offenders admitted to the Psychiatric Custody 
and Treatment Hospital (Forensic Psychiatric Facility). METHOD: 89 patient recor
ds of males admitted from March 2005 to August 2006 were analyzed. The analysis 
included evaluation of two study groups: Group I comprised subjects who had comm
itted sex offenses (sexual offenders) while Group II contained subjects convicte
d for other crimes (non-sexual offenders). Variables studied were: age bracket, 
years of schooling, marital status, skin color, place of birth, previous psychia
tric admissions and psychiatric diagnosis. RESULTS: Mental retardation and perso
nality disorders were the mainly diagnoses in Group I (sexual offenders) (61,76%
 and 29,41% respectively). In the other hand, schizophrenic subjects predominate
d in Group II (non-sexual offenders) (82,93%). CONCLUSION: Different from intern
ational data, we have found low prevalence of personality disorders among Brazil
ian forensic population and we believe that it's due to a distinguishing charact
eristic of the Brazilian legal system, which does not consider personality disor
der a mental disease, thus, not prompting these patients to civil commitment.#^d
decs^i1#^tm^len^kEpidemiology^i1#^tm^len^kviolence^i1#^tm^len^kmental disorders^
i1#^tm^len^ksex offenders^i1#^lpt^aOBJETIVO: Avaliar a prevalência de transtorno
s mentais em pacientes em cumprimento de medida de segurança por crimes de natur
eza sexual e não sexual. MÉTODO: Foram analisados 89 prontuários de pacientes do
 sexo masculino internados no período de março de 2005 a agosto de 2006. A análi
se consistiu na avaliação de dois grupos de estudo assim divididos: Grupo I, com
posto de sujeitos que cometeram crimes sexuais, e Grupo II, formado por sujeitos
 que foram condenados por outros crimes que não de natureza sexual. As variáveis
 analisadas foram: idade, grau de escolaridade, estado civil, cútis, naturalidad
e, internações psiquiátricas anteriores e diagnóstico psiquiátrico. RESULTADOS: 
Entre os sujeitos do Grupo I (condenados por crimes sexuais), observou-se maior 
prevalência de diagnóstico de retardo mental (61,76%) e transtorno de personalid
ade (29,41%). Já no Grupo II (condenados por crimes de outra natureza que não se
xual), houve predominância do diagnóstico de esquizofrenia (82,93%). CONCLUSÃO: 
Diferentemente do encontrado na literatura internacional, em nosso meio observou
-se baixo índice de transtorno de personalidade entre os sujeitos estudados, o q
ue pode ser justificado pelo fato de o sistema penal brasileiro considerar tal d
iagnóstico apenas como perturbação da saúde mental, não acarretando em medida de
 segurança ou internação psiquiátrica.#^ddecs^i2#^tm^lpt^kEpidemiologia^i2#^tm^l
pt^kviolência^i2#^tm^lpt^ktranstornos mentais^i2#^tm^lpt^kcriminoso sexual^i2#va
ncouv#23#20101117#17/11/2010#20110124#24/1/2011#v60n1a03.htm##
04292000000000649000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901200900
01690120085002590100038003440100035003820100026004170100037004430100037004800700
07900517070008200596083127300678085001001951085002501961085002101986085002902007
08500260203608313980206208500100346008500260347008500220349608500320351808500290
35501170008035790720003035871120009035901110011035991140009036101130010036190020
01303629#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#f#3#1#article
#1#oa#en#br1.1#1#4.0#ILUS#TAB#3#JBPSIQ010#nd#J. bras. psiquiatr.#60#1#20110000#^
f11^l15#0047-2085#<b>Prevalence of mental disorders among sexual offenders and n
on-sexual offenders</b>^len#<b>Prevalência de transtornos mentais entre agressor
es sexuais e não sexuais</b>^lpt#^rND^1A01^nMaria Fernanda Faria^sAchá#^rND^1A02
^nSérgio Paulo^sRigonatti#^rND^1A02^nFabiana^sSaffi#^rND^1A02^nDaniel Martins de
^sBarros#^rND^1A02^nAntônio de Pádua^sSerafim#Universidade de São Paulo^iA01^1Fa
culdade de Medicina^2Programa de Psiquiatria#USP^iA02^1Departamento de Psiquiatr
ia^2Núcleo de Psiquiatria e Psicologia Forense#^len^a<b>OBJECTIVE:</b> To evalua
te the prevalence of mental disorders in convicted sex offenders admitted to the
 Psychiatric Custody and Treatment Hospital (Forensic Psychiatric Facility). <b>
METHOD: </b>89 patient records of males admitted from March 2005 to August 2006 
were analyzed. The analysis included evaluation of two study groups: Group I com
prised subjects who had committed sex offenses (sexual offenders) while Group II
 contained subjects convicted for other crimes (non-sexual offenders). Variables
 studied were: age bracket, years of schooling, marital status, skin color, plac
e of birth, previous psychiatric admissions and psychiatric diagnosis. <b>RESULT
S: </b>Mental retardation and personality disorders were the mainly diagnoses in
 Group I (sexual offenders) (61,76% and 29,41% respectively). In the other hand,
 schizophrenic subjects predominated in Group II (non-sexual offenders) (82,93%)
. <b>CONCLUSION:</b> Different from international data, we have found low preval
ence of personality disorders among Brazilian forensic population and we believe
 that it's due to a distinguishing characteristic of the Brazilian legal system,
 which does not consider personality disorder a mental disease, thus, not prompt
ing these patients to civil commitment.#^ddecs^i1#^tm^len^kEpidemiology^i1#^tm^l
en^kviolence^i1#^tm^len^kmental disorders^i1#^tm^len^ksex offenders^i1#^lpt^a<b>
OBJETIVO:</b> Avaliar a prevalência de transtornos mentais em pacientes em cumpr
imento de medida de segurança por crimes de natureza sexual e não sexual. <b>MÉT
ODO: </b>Foram analisados 89 prontuários de pacientes do sexo masculino internad
os no período de março de 2005 a agosto de 2006. A análise consistiu na avaliaçã
o de dois grupos de estudo assim divididos: Grupo I, composto de sujeitos que co
meteram crimes sexuais, e Grupo II, formado por sujeitos que foram condenados po
r outros crimes que não de natureza sexual. As variáveis analisadas foram: idade
, grau de escolaridade, estado civil, cútis, naturalidade, internações psiquiátr
icas anteriores e diagnóstico psiquiátrico. <b>RESULTADOS: </b>Entre os sujeitos
 do Grupo I (condenados por crimes sexuais), observou-se maior prevalência de di
agnóstico de retardo mental (61,76%) e transtorno de personalidade (29,41%). Já 
no Grupo II (condenados por crimes de outra natureza que não sexual), houve pred
ominância do diagnóstico de esquizofrenia (82,93%). <b>CONCLUSÃO:</b> Diferentem
ente do encontrado na literatura internacional, em nosso meio observou-se baixo 
índice de transtorno de personalidade entre os sujeitos estudados, o que pode se
r justificado pelo fato de o sistema penal brasileiro considerar tal diagnóstico
 apenas como perturbação da saúde mental, não acarretando em medida de segurança
 ou internação psiquiátrica.#^ddecs^i2#^tm^lpt^kEpidemiologia^i2#^tm^lpt^kviolên
cia^i2#^tm^lpt^ktranstornos mentais^i2#^tm^lpt^kcriminoso sexual^i2#vancouv#23#2
0101117#17/11/2010#20110124#24/1/2011#v60n1a03.htm##
04393000000000673000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000200108049001000110
15800030012003000190012303100030014203200020014506500090014701400090015603500100
01650120083001750120078002580100038003360100035003740100026004090100037004350100
03700472070008100509070008400590083126600674085001001940085002501950085002101975
08500290199608500260202508313970205108500100344808500260345808500220348408500320
35060850029035381170008035670720003035751120009035781110011035871140009035981130
01003607002001303617008008903630#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n
1a03.htm#S#l#4#1#article#1#^a2011#oa#en#br1.1#1#4.0#ilus#tab#3#JBPSIQ010#nd#J. b
ras. psiquiatr#60#1#20110000#^f11^l15#0047-2085#Prevalence of mental disorders a
mong sexual offenders and non-sexual offenders^len#Prevalência de transtornos me
ntais entre agressores sexuais e não sexuais^lpt#^rND^1A01^nMaria Fernanda Faria
^sAchá#^rND^1A02^nSérgio Paulo^sRigonatti#^rND^1A02^nFabiana^sSaffi#^rND^1A02^nD
aniel Martins de^sBarros#^rND^1A02^nAntônio de Pádua^sSerafim#^iA01^1Universidad
e de São Paulo^2Faculdade de Medicina^3Programa de Psiquiatria#^iA02^1USP^2Depar
tamento de Psiquiatria^3Núcleo de Psiquiatria e Psicologia Forense#^len^aOBJECTI
VE: To evaluate the prevalence of mental disorders in convicted sex offenders ad
mitted to the Psychiatric Custody and Treatment Hospital (Forensic Psychiatric F
acility). METHOD: 89 patient records of males admitted from March 2005 to August
 2006 were analyzed. The analysis included evaluation of two study groups: Group
 I comprised subjects who had committed sex offenses (sexual offenders) while Gr
oup II contained subjects convicted for other crimes (non-sexual offenders). Var
iables studied were: age bracket, years of schooling, marital status, skin color
, place of birth, previous psychiatric admissions and psychiatric diagnosis. RES
ULTS: Mental retardation and personality disorders were the mainly diagnoses in 
Group I (sexual offenders) (61,76 percent and 29,41 percent respectively). In th
e other hand, schizophrenic subjects predominated in Group II (non-sexual offend
ers) (82,93 percent). CONCLUSION: Different from international data, we have fou
nd low prevalence of personality disorders among Brazilian forensic population a
nd we believe that it's due to a distinguishing characteristic of the Brazilian 
legal system, which does not consider personality disorder a mental disease, thu
s, not prompting these patients to civil commitment.#^ddecs^i1#^tm^len^kEpidemio
logy^i1#^tm^len^kviolence^i1#^tm^len^kmental disorders^i1#^tm^len^ksex offenders
^i1#^lpt^aOBJETIVO: Avaliar a prevalência de transtornos mentais em pacientes em
 cumprimento de medida de segurança por crimes de natureza sexual e não sexual. 
MÉTODO: Foram analisados 89 prontuários de pacientes do sexo masculino internado
s no período de março de 2005 a agosto de 2006. A análise consistiu na avaliação
 de dois grupos de estudo assim divididos: Grupo I, composto de sujeitos que com
eteram crimes sexuais, e Grupo II, formado por sujeitos que foram condenados por
 outros crimes que não de natureza sexual. As variáveis analisadas foram: idade,
 grau de escolaridade, estado civil, cútis, naturalidade, internações psiquiátri
cas anteriores e diagnóstico psiquiátrico. RESULTADOS: Entre os sujeitos do Grup
o I (condenados por crimes sexuais), observou-se maior prevalência de diagnóstic
o de retardo mental (61,76 por cento) e transtorno de personalidade (29,41 por c
ento). Já no Grupo II (condenados por crimes de outra natureza que não sexual), 
houve predominância do diagnóstico de esquizofrenia (82,93 por cento). CONCLUSÃO
: Diferentemente do encontrado na literatura internacional, em nosso meio observ
ou-se baixo índice de transtorno de personalidade entre os sujeitos estudados, o
 que pode ser justificado pelo fato de o sistema penal brasileiro considerar tal
 diagnóstico apenas como perturbação da saúde mental, não acarretando em medida 
de segurança ou internação psiquiátrica.#^ddecs^i2#^tm^lpt^kEpidemiologia^i2#^tm
^lpt^kviolência^i2#^tm^lpt^ktranstornos mentais^i2#^tm^lpt^kcriminoso sexual^i2#
vancouv#23#20101117#17/11/2010#20110124#24/1/2011#v60n1a03.htm#Internet^ihttp://
www.scielo.br/scielo.php?script=sci_arttext&pid=S0047-20852011000100003##
00354000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704011900076002001300195#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#5#1#article#130#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ARTIGO ORIGINAL</b>
</font></p>     ^cY#v60n1a03.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#6#2#article#130#<p>&nbsp;</p>     ^
cY#v60n1a03.htm##
00428000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704019300076002001300269#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#7#3#article#130#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Prevalen
ce of mental disorders among sexual offenders and non-sexual offenders</b></font
></p>     ^cY#v60n1a03.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#8#4#article#130#<p>&nbsp;</p>     ^
cY#v60n1a03.htm##
00411000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704017600076002001300252#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#9#5#article#130#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Preval&ecirc;ncia de transtornos 
mentais entre agressores sexuais e n&atilde;o sexuais</b></font></p>     ^cY#v60
n1a03.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#10#6#article#130#<p>&nbsp;</p>     
^cY#v60n1a03.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#11#7#article#130#<p>&nbsp;</p>     
^cY#v60n1a03.htm##
00533000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704029700077002001300374#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#12#8#article#130#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Maria Fernanda Faria Ach&aacute;
<sup>I</sup>; S&eacute;rgio Paulo Rigonatti<sup>II</sup>; Fabiana Saffi<sup>II</
sup>; Daniel Martins de Barros<sup>II</sup>; Ant&ocirc;nio de P&aacute;dua Seraf
im<sup>II</sup></b></font></p>     ^cY#v60n1a03.htm##
00407000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704017100077002001300248#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#13#9#article#130#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Universidade de S&atild
e;o Paulo, Faculdade de Medicina (FMUSP), Programa de Psiquiatria    ^cY#v60n1a0
3.htm##
00359000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012200078002001300200#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#14#10#article#130#<br> <sup>II</sup
>USP, Departamento de Psiquiatria, N&uacute;cleo de Psiquiatria e Psicologia For
ense </font></p>     ^cY#v60n1a03.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#15#11#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#16#12#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#17#13#article#130#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a03.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#18#14#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a03.htm##
00491000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704025400078002001300332#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#19#15#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVE:</b> To evaluate the 
prevalence of mental disorders in convicted sex offenders admitted to the Psychi
atric Custody and Treatment Hospital (Forensic Psychiatric Facility).    ^cY#v60
n1a03.htm##
00724000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704048700078002001300565#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#20#16#article#130#<br>  <b>METHOD: 
</b>89 patient records of males admitted from March 2005 to August 2006 were ana
lyzed. The analysis included evaluation of two study groups: Group I comprised s
ubjects who had committed sex offenses (sexual offenders) while Group II contain
ed subjects convicted for other crimes (non-sexual offenders). Variables studied
 were: age bracket, years of schooling, marital status, skin color, place of bir
th, previous psychiatric admissions and psychiatric diagnosis.    ^cY#v60n1a03.h
tm##
00502000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704026500078002001300343#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#21#17#article#130#<br>  <b>RESULTS:
 </b>Mental retardation and personality disorders were the mainly diagnoses in G
roup I (sexual offenders) (61,76% and 29,41% respectively). In the other hand, s
chizophrenic subjects predominated in Group II (non-sexual offenders) (82,93%). 
    ^cY#v60n1a03.htm##
00619000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704038200078002001300460#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#22#18#article#130#<br> <b>CONCLUSIO
N:</b> Different from international data, we have found low prevalence of person
ality disorders among Brazilian forensic population and we believe that it's due
 to a distinguishing characteristic of the Brazilian legal system, which does no
t consider personality disorder a mental disease, thus, not prompting these pati
ents to civil commitment.</font></p>     ^cY#v60n1a03.htm##
00415000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017800078002001300256#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#23#19#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Epidemiology, vio
lence, mental disorders, sex offenders.</font></p> <hr size="1" noshade>     ^cY
#v60n1a03.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#24#20#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a03.htm##
00484000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704024700078002001300325#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#25#21#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVO:</b> Avaliar a preval&
ecirc;ncia de transtornos mentais em pacientes em cumprimento de medida de segur
an&ccedil;a por crimes de natureza sexual e n&atilde;o sexual.    ^cY#v60n1a03.h
tm##
00885000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704064800078002001300726#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#26#22#article#130#<br>  <b>M&Eacute
;TODO: </b>Foram analisados 89 prontu&aacute;rios de pacientes do sexo masculino
 internados no per&iacute;odo de mar&ccedil;o de 2005 a agosto de 2006. A an&aac
ute;lise consistiu na avalia&ccedil;&atilde;o de dois grupos de estudo assim div
ididos: Grupo I, composto de sujeitos que cometeram crimes sexuais, e Grupo II, 
formado por sujeitos que foram condenados por outros crimes que n&atilde;o de na
tureza sexual. As vari&aacute;veis analisadas foram: idade, grau de escolaridade
, estado civil, c&uacute;tis, naturalidade, interna&ccedil;&otilde;es psiqui&aac
ute;tricas anteriores e diagn&oacute;stico psiqui&aacute;trico.    ^cY#v60n1a03.
htm##
00618000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704038100078002001300459#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#27#23#article#130#<br>  <b>RESULTAD
OS: </b>Entre os sujeitos do Grupo I (condenados por crimes sexuais), observou-s
e maior preval&ecirc;ncia de diagn&oacute;stico de retardo mental (61,76%) e tra
nstorno de personalidade (29,41%). J&aacute; no Grupo II (condenados por crimes 
de outra natureza que n&atilde;o sexual), houve predomin&acirc;ncia do diagn&oac
ute;stico de esquizofrenia (82,93%).    ^cY#v60n1a03.htm##
00716000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704047900078002001300557#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#28#24#article#130#<br>  <b>CONCLUS&
Atilde;O:</b> Diferentemente do encontrado na literatura internacional, em nosso
 meio observou-se baixo &iacute;ndice de transtorno de personalidade entre os su
jeitos estudados, o que pode ser justificado pelo fato de o sistema penal brasil
eiro considerar tal diagn&oacute;stico apenas como perturba&ccedil;&atilde;o da 
sa&uacute;de mental, n&atilde;o acarretando em medida de seguran&ccedil;a ou int
erna&ccedil;&atilde;o psiqui&aacute;trica.</font></p>     ^cY#v60n1a03.htm##
00435000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704019800078002001300276#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#29#25#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>Epidemiolog
ia, viol&ecirc;ncia, transtornos mentais, criminoso sexual.</font></p> <hr size=
"1" noshade>     ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#30#26#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#31#27#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00339000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010200078002001300180#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#32#28#article#130#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODUCTION</b></font></p>    
 ^cY#v60n1a03.htm##
00605000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704036800078002001300446#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#33#29#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The motivations for human criminal
 behavior have been the subject of extensive study in several countries<sup>1-3<
/sup>. Although in its infancy, the field of forensic epidemiologic investigatio
n has grown in importance, furthering our understanding of forensic phenomena<su
p>4</sup>. </font></p>     ^cY#v60n1a03.htm##
01157000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704092000078002001300998#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#34#30#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Gaining greater insight and knowle
dge on the risk or protective factors for violent behavior is valuable to guide 
intervention and prevention projects to reduce the incidence of crimes<sup>5</su
p>. Surveys are devised to gain a better understanding of the etiology of violen
t behavior, and address clinical, epidemiological and etiological issues thought
 to be associated with violent behavior<sup>6</sup>. In fact, numerous studies h
ave shown a highly complex association between mental diseases and violent behav
ior<sup>7-10</sup>. In some countries, the mentally ill who perpetrate crimes ar
e incarcerated and treated in special institutions following their conviction. I
n Brazil, these entities are called "Casa de Cust&oacute;dia" (Custody Hospitals
) and their remit is the isolation and treatment of the mentally ill<sup>11</sup
>. </font></p>     ^cY#v60n1a03.htm##
00963000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704072600078002001300804#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#35#31#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Two studies carried out in Germany
 have highlighted the incidence of mental disorders among convicts<sup>2,7</sup>
. The first of these studies investigated the prevalence of sexual offenders wit
h axis I mental disorders and personality disorders, according to Diagnostic and
 Statistical Manual of Psychiatric Disorders (DSM-IV) criteria. The authors repo
rted anxiety, mood, and drugs-related disorder as the most prominent axis I dist
urbances. With regard to personality disorders, the study identified anti-social
 personality, borderline and avoidant personality disorders as the most common d
iagnoses among the subjects studied<sup>7</sup>. </font></p>     ^cY#v60n1a03.ht
m##
00816000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704057900078002001300657#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#36#32#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A study conducted in Germany<sup>2
 </sup>compared the prevalence of mental disorders among sexual aggressors held 
at psychiatric institutions with that of sexual and non-sexual offenders. All th
ree groups were found to share the diagnosis of substance use, a condition which
 had the highest incidence among all in-patients. Sexual aggressors admitted for
 psychiatric conditions presented a higher percentage of personality disorders a
nd greater psychiatric comorbidity than did the other groups. </font></p>     ^c
Y#v60n1a03.htm##
00661000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704042400078002001300502#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#37#33#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Another study, conducted in Icelan
d, investigated differences and similarities between violent offenders and two t
ypes of sex offender: rapists and child molesters. Results showed that violent o
ffenders were more extroverted than the two groups of sex offenders and that chi
ld molesters tended to assault relatives and friends<sup>12</sup>. </font></p>  
   ^cY#v60n1a03.htm##
00663000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704042600078002001300504#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#38#34#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Using the Mini International Neuro
psychiatric Interview (MINI) on sex offenders in Germany, the authors<sup>13</su
p> found 39% of subjects to have mood disorders, 30% anxiety disorders, 19% anti
-social personality disorders, 18% psychotic disorders, while 10% had attention 
deficit disorder. Substance abuse was identified in 79% of subjects. </font></p>
     ^cY#v60n1a03.htm##
00945000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704070800078002001300786#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#39#35#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">There is no consistent body of for
ensic studies available in Brazil. One study in the area by the S&atilde;o Paulo
 Casa de Cust&oacute;dia compiled data from the medical charts of institutionali
zed patients regarding criminal aspects, clinical profiles and profiles of victi
ms. Based on the study population, a predominance of psychotic disorder was foun
d, with 44% of subjects presenting comorbidity with the use of drugs. Homicide w
as found to be the most frequently committed crime and the most strongly associa
ted with psychotic patients, while sexual crimes were associated with mentally r
etarded patients<sup>11</sup>. </font></p>     ^cY#v60n1a03.htm##
00594000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704035700078002001300435#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#40#36#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Rigonatti <i>et al.</i><sup>14</su
p> focused on the prevalence of personality disorder in criminals convicted for 
murder or rape who were serving sentences in a maximum security prison. The resu
lts pointed to a high incidence of personality disorder in both groups studied. 
</font></p>     ^cY#v60n1a03.htm##
00447000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704021000078002001300288#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#41#37#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The aim of the present study was t
o compare the prevalence of mental disorders among sexual offenders and non-sexu
al offenders.</font></p>     ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#42#38#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00334000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009700078002001300175#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#43#39#article#130#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>METHODS</b></font></p>     ^cY#
v60n1a03.htm##
00954000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704071700078002001300795#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#44#40#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The study was carried out at the C
ustody and Treatment Psychiatric Hospital "Prof. Andr&eacute; Teixeira Lima" (fo
rmerly "Judiciary Asylum") located in the state of Sao Paulo. Medical records of
 patients admitted to hospital between March 2005 and August 2006 were randomly 
assessed. Of the 97 files selected, 18 were lacking relevant data and were there
fore excluded from the sample, giving a total of 78 medical records. A draw was 
performed in order to form two groups: Group I comprised subjects who had commit
ted sex offenses (sexual offenders) while Group II contained subjects convicted 
for other crimes (non-sexual offenders).</font></p>     ^cY#v60n1a03.htm##
00963000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704072600078002001300804#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#45#41#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Information was collected from psy
chiatric and criminal records. Data on age, level of formal education, marital s
tatus, skin color, place of birth, previous psychiatric admissions and psychiatr
ic diagnosis were obtained from the records. Only psychiatric reports produced b
y forensic psychiatrists from the institution were included in the analysis. The
 research project was approved by the ethic board of our institution ("Comiss&at
ilde;o de &Eacute;tica para An&aacute;lise de Projetos de Pesquisas - CAPPesq da
 Diretoria Cl&iacute;nica do Hospital das Cl&iacute;nicas e da Faculdade de Medi
cina da Universidade de S&atilde;o Paulo - USP").</font></p>     ^cY#v60n1a03.ht
m##
00889000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704065200078002001300730#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#46#42#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Data analysis included absolute an
d percentile frequency. The Chi-square test was used to compare groups for respe
ctive rates of specific diagnoses including other mental disorders secondary to 
brain damage or dysfunction, and due to physical disease, drug-related disorders
, schizophrenia, mood disorders, mental retardation and epilepsy. In cases where
 the prerequisites for the chi-square test were not met, Fisher's exact test was
 employed. Significance level was </font>&#945;<font size="2" face="Verdana, Ari
al, Helvetica, sans-serif"> = 0.05 for all comparisons.</font></p>     ^cY#v60n1
a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#47#43#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00334000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009700078002001300175#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#48#44#article#130#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTS</b></font></p>     ^cY#
v60n1a03.htm##
00996000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704075900078002001300837#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#49#45#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#tab01">Table 1</a> depic
ts the demographics of both groups. The two groups analyzed showed no statistica
lly significant differences. According the frequency of prior psychiatric admiss
ions results showing that 76.7% of sexual offenders <i>versus</i> 86.1% of nonse
xual offenders had prior psychiatric admissions (p = 0.322). Comparison of speci
fic diagnoses between sexual offenders and non-sexual offenders revealed a highe
r rate of schizophrenia (82.9%) among non-sexual offenders (p = 0.000) and a hig
her prevalence of mental retardation among sexual offenders (59.5%, p = 0.000). 
All results from this variable analysis are shown in <a href="#tab02">table 2</a
>.</font></p>     ^cY#v60n1a03.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#50#46#article#130#<p><a name="tab01
"></a></p>     ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#51#47#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#52#48#article#130#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a03tab01.jpg"></p>     ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#53#49#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#54#50#article#130#<p><a name="tab02
"></a></p>     ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#55#51#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#56#52#article#130#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a03tab02.jpg"></p>     ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#57#53#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#58#54#article#130#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSSION</b></font></p>     ^
cY#v60n1a03.htm##
00852000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704061500078002001300693#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#59#55#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Our socio-demographic data corrobo
rate the findings in the  national and international literature in terms of the 
prevalence  of younger, single subjects and a low level of schooling  among conv
icts. International studies in the forensic area are  generally conducted in cou
ntries with a different reality to  that of developing countries like Brazil, wh
ich have high rates  of crime, alcohol or drugs use and school truancy. Accordin
g  to some authors, these features are risk factors for higher levels  of violen
ce<sup>5,15</sup>.</font></p>     ^cY#v60n1a03.htm##
00755000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704051800078002001300596#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#60#56#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Cognitive performance proved anoth
er important variable. Mental retardation, for example, was the most prevalent  
diagnosis among the sexual offenders group. This disorder  tends to evolve with 
educational difficulties. In Brazil, the natural  history of the disorder, assoc
iated with the lack of specific  programs catering to these patients' needs, ham
pers the  social and professional adaptation of this patient group<sup>1,7</sup>
.</font></p>     ^cY#v60n1a03.htm##
00891000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704065400078002001300732#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#61#57#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A relationship between intelligenc
e levels and crime has  been proposed in a number of national and international 
papers<sup>1,16</sup>. The severity of the medical condition, degree of clinical
  support and social conditions are all potential factors underlying  this relat
ionship. According to researchers, subjects  with less severe mental retardation
 are more likely to commit  the type of crimes that require greater planning. On
 the other  hand, individuals with more severe retardation tend to commit  sex o
ffenses or crimes that need less planning<sup>1,11</sup>.</font></p>     ^cY#v60
n1a03.htm##
01518000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704128100078002001301359#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#62#58#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">In terms of psychopathology, thoug
h many studies have  reported strong correlation between personality disorders  
and crime, this association requires broader and more indepth studies in order t
o be relevant<sup>14,17,18</sup>. The role of schizophrenia, per example, in vio
lent behavior is a point widely discussed in the forensic literature<sup>19,20</
sup>. Some authors believe that psychotic symptoms such as delusion of persecuti
on and auditory hallucinations, account for approximately 45% of cases of violen
ce perpetrated by this patient group<sup>17-20</sup>. However, it's important to
 consider that many of these studies have found that the rate of violent behavio
r between schizophrenic patients is much higher among those who use some kind of
 toxic substance, such as alcohol and drugs<sup>19,20</sup>. It is also importan
t to consider that this research could not be investigated among individuals who
 were part of the sample, which made use of psychoactive substance to the time o
f the offense. Cognitive impairment in atencional processes, executive functions
, memory, learning and language are also considered to contribute to violent beh
avior in schizophrenics<sup>15,17,18</sup>. </font></p>     ^cY#v60n1a03.htm##
01562000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704132500078002001301403#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#63#59#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">There is also cause for concern ov
er the application of specific laws in Brazil. Brazilians committing criminal ac
ts are considered to be legally accountable, unaccountable, or partially (semi) 
accountable for their actions. The legal definition of accountable covers person
s deemed capable of understanding the nature of their actions that are able to e
xercise self-control. By contrast, unaccountable individuals are those who, due 
to mental illness, incomplete mental development, mental retardation or other di
seases, are unable to comprehend the full meaning of their actions or exert self
-control. Finally, partially accountable individuals are those with mental disor
ders which at the time of the crime, could affect their self-control but do not 
alter the ability to understand their actions. Therefore individuals with person
ality disorders are frequently considered accountable or partially accountable, 
and thus enter the standard prison system as opposed to being placed into forens
ic custody and treatment facilities. The low prevalence of personality disorders
 among Brazilian forensic population compared to international rates is likely d
ue to this distinguishing characteristic of the Brazilian legal system<sup>21-23
</sup>. </font></p>     ^cY#v60n1a03.htm##
00740000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704050300078002001300581#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#64#60#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The findings of this study are per
tinent to all those who investigate the relationship between criminal behavior a
nd mental disorders. Nevertheless, a methodological limitation of the study must
 be considered, like the lack of supplementary diagnostic instruments besides th
e clinical interview and patient history employed. The use of diagnostic instrum
ents would have increased the reliability of the information used.</font></p>   
  ^cY#v60n1a03.htm##
00613000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704037600078002001300454#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#65#61#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">It is important to note that the p
resent study in no way suggests that individuals with mental disorders are crimi
nals. Our objective was to study and identify the patterns and prevalence of men
tal illness among civilly committed populations in order to better understand an
d treat this group.</font></p>     ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#66#62#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#67#63#article#130#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUSION</b></font></p>     ^
cY#v60n1a03.htm##
00438000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704020100078002001300279#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#68#64#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">This study sought to determine the
 prevalence of psychiatric diagnoses among subjects convicted of a range of crim
es.</font></p>      ^cY#v60n1a03.htm##
00818000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704058100078002001300659#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#69#65#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Socio-demographic profiles in both
 groups mirrored both national and international data. Regarding psychiatric dia
gnoses, a high prevalence of mental retardation and schizophrenia was found. The
 finding of low prevalence of personality disorders was an important discrepancy
 when compared our results with those of the international literature. This may 
be due to the nature of the Brazilian Penal Code, which determines that individu
als with personality disorder enter the standard prison system. </font></p>     
^cY#v60n1a03.htm##
01012000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704077500078002001300853#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#70#66#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Finally, we believe that the prese
nt study may encourage similar research in this area. Studies investigating the 
relationship between mental health and the justice system have attracted growing
 interest. This focus in countries like Brazil may stem from the increased level
 of urban violence which has prompted greater involvement of health professional
s in investigating the etiological and epidemiological factors underlying violen
ce. However, it should be emphasized that other lines of research such as bioeth
ics, infanticide, personality disorders and infant-juvenile violence should also
 be incorporated in the scope of forensic research both in the Brazilian and Int
ernational milieu.</font></p>     ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#71#67#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00342000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010500078002001300183#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#72#68#article#130#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ACKNOWLEDGMENTS</b></font></p> 
    ^cY#v60n1a03.htm##
00678000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704044100078002001300519#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#73#69#article#130#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">The authors extend their thanks to
 Carlos Tarifa Botta (Department Technical Director), Carlos Eduardo Garcia (Psy
chiatrist) and the whole team responsible for the records at the Psychiatric Cus
tody and Treatment Hospital Prof. Andr&eacute; Teixeira Lima (HCTP) in the city 
of Franco da Rocha - S&atilde;o Paulo State, for providing access to the study d
ata.</font></p>     ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#74#70#article#130#<p>&nbsp;</p>    
 ^cY#v60n1a03.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#75#71#article#130#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font></p>     ^
cY#v60n1a03.htm##
00504000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704025300080002001300333#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#76#72#article#130#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Fotiadou M, Livad
itis M, Manou I, Kaniotou E, Xenitidis K. Prevalence of mental disorders and del
iberate self-harm in Greek male prisoners. Int J Law Psychiatry. 2006;29(1):68-7
3.    ^cY#v60n1a03.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#77#73#article#130#</font></p>     ^
cY#v60n1a03.htm##
00507000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704025600080002001300336#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#78#74#article#130#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Harsch S, Bergk J
E, Steinert T, Keller F, Jockusch U. Prevalence of mental disorders among sexual
 offenders in forensic psychiatry and prison. Int J Law Psychiatry. 2006;29(5):4
43-9.    ^cY#v60n1a03.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#79#75#article#130#</font></p>     ^
cY#v60n1a03.htm##
00482000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704023100080002001300311#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#80#76#article#130#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Barros P, Silva F
BN. Origem e manuten&ccedil;&atilde;o do comportamento agressivo na inf&acirc;nc
ia e adolesc&ecirc;ncia. Rev Bras Ter Cogn. 2006;2(1):55-66.    ^cY#v60n1a03.htm
##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#81#77#article#130#</font></p>     ^
cY#v60n1a03.htm##
00444000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704019300080002001300273#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#82#78#article#130#4#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Arboleda-Fl&oacut
e;rez J. Forensic psychiatry and epidemiology: Introduction. Int J Law Psychiatr
y. 2001;24(4-5):335-7.    ^cY#v60n1a03.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#83#79#article#130#</font></p>     ^
cY#v60n1a03.htm##
00506000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704025500080002001300335#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#84#80#article#130#5#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Gallo AE, William
s LCA. Adolescentes em conflito com a lei: uma revis&atilde;o dos fatores de ris
co para a conduta infracional. Psicologia: Teoria e pr&aacute;tica. 2005;7(1):81
-95.    ^cY#v60n1a03.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#85#81#article#130#</font></p>     ^
cY#v60n1a03.htm##
00473000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704022200080002001300302#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#86#82#article#130#6#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Del Pino V, Werla
ng SG. Homic&iacute;dio e lobo frontal: uma revis&atilde;o da literatura. Intera
&ccedil;&atilde;o em Psicologia. 2006;10(1):127-37.    ^cY#v60n1a03.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#87#83#article#130#</font></p>     ^
cY#v60n1a03.htm##
00447000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704019600080002001300276#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#88#84#article#130#7#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Leue A, Borchard 
B, Hoyer J. Mental disorders in a forensic sample of sexual offenders. Eur Psych
iatry. 2004;19(3):123-30.    ^cY#v60n1a03.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#89#85#article#130# </font></p>     
^cY#v60n1a03.htm##
00489000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704023800080002001300318#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#90#86#article#130#8#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Hodgins S, Mednic
k SA, Brenann PA, Schulsinger F, Engberg M. Mental disorder and crime: evidence 
from a Danish birth cohort. Arch Gen Psychiatry. 1996;53(6):489-96.    ^cY#v60n1
a03.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#91#87#article#130#</font></p>     ^
cY#v60n1a03.htm##
00465000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704021400080002001300294#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#92#88#article#130#9#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Mullen PE, Burges
s P, Wallace C, Palmer S, Ruschena D. Community care and criminal offending in s
chizophrenia. Lancet. 2000;355(9204):614-7.    ^cY#v60n1a03.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#93#89#article#130#</font></p>     ^
cY#v60n1a03.htm##
00526000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704027400081002001300355#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#94#90#article#130#10#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Swanson JW, Hol
zer III CE, Ganju VK, Jono RT. Violence and psychiatric disorder in the communit
y: evidence from the epidemiologic catchment area surveys. Hosp Community Psychi
atry. 1990;41(7):761-70.    ^cY#v60n1a03.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#95#91#article#130# </font></p>     
^cY#v60n1a03.htm##
00567000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704031500081002001300396#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#96#92#article#130#11#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Teixeira EH, Da
lgalarrondo P. Crime, diagn&oacute;stico psiqui&aacute;trico e perfil da v&iacut
e;tima: um estudo com a popula&ccedil;&atilde;o de uma casa de cust&oacute;dia d
o estado de S&atilde;o Paulo. J Bras Psiquiatr. 2006;55(3):192-4.    ^cY#v60n1a0
3.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#97#93#article#130#</font></p>     ^
cY#v60n1a03.htm##
00467000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704021500081002001300296#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#98#94#article#130#12#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Gudjonsson GH, 
Sigurdsson JF. Differences and similarities between violent offenders and sex of
fenders. Child Abuse Negl. 2000;24(3):363-72.    ^cY#v60n1a03.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#99#95#article#130#</font></p>     ^
cY#v60n1a03.htm##
00539000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704028600082002001300368#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#100#96#article#130#13#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Black DW, Arnd
t S, Hale N, Rogerson R. Use of the mini international neuropsychiatric intervie
w (mini) as a screening tool in prisons: results of a preliminary study. J Am Ac
ad Psychiatry Law. 2004;32(2):158-62.    ^cY#v60n1a03.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#101#97#article#130#</font></p>     
^cY#v60n1a03.htm##
00544000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704029100082002001300373#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#102#98#article#130#14#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Rigonatti SP, 
P&aacute;dua Serafim A, Freitas Caires MA, Filho AHGV, Arboleda-Florez J. Person
ality disorders in rapists and murderers from a maximum security prison in Brazi
l. Int J Law Psychiatry. 2006;29(5):361-9.    ^cY#v60n1a03.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#103#99#article#130#</font></p>     
^cY#v60n1a03.htm##
00465000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704021100083002001300294#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#104#100#article#130#15#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Valen&ccedil;
a AM, Moraes TM. Rela&ccedil;&atilde;o entre homic&iacute;dio e transtornos ment
ais. Rev Bras Psiquiatr. 2006;28(II):S62-8.    ^cY#v60n1a03.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#105#101#article#130# </font></p>   
  ^cY#v60n1a03.htm##
00497000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024300083002001300326#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#106#102#article#130#16#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Coid J, Kahta
n N, Gault S, Cook A, Jarman B. Medium secure forensic psychiatry services: comp
arison of seven English health regions. Br J Psychiatry. 2000;178(1):68-73.    ^
cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#107#103#article#130#</font></p>    
 ^cY#v60n1a03.htm##
00457000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704020300083002001300286#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#108#104#article#130#17#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Junginger J. 
Psychosis and violence: the case for a content analysis of psychotic experience.
 Schizophr Bull. 1996;22(1):91-103.    ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#109#105#article#130#</font></p>    
 ^cY#v60n1a03.htm##
00517000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704026300083002001300346#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#110#106#article#130#18#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Monteiro LC, 
Louz&atilde; MR. Altera&ccedil;&otilde;es cognitivas na esquizofrenia: consequ&e
circ;ncias funcionais e abordagens terap&ecirc;uticas. Rev Psiq Cl&iacute;n. 200
7;34(2):179-83.    ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#111#107#article#130#</font></p>    
 ^cY#v60n1a03.htm##
00450000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019600083002001300279#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#112#108#article#130#19#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Elbongen EB, 
Johnson SC. The intricate link between violence and mental disorder. Arch Gen Ps
ychiatry. 2009;66(2):152-61.    ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#113#109#article#130#</font></p>    
 ^cY#v60n1a03.htm##
00483000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704022900083002001300312#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#114#110#article#130#20#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Fazel S, L&ar
ing;ngstr&ouml;m N, Hjern A, Grann M, Lichtenstein P. Schizophrenia, substance a
buse, and violent crime. J Am Med Assoc. 2009;301(19):2016-2.    ^cY#v60n1a03.ht
m##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#115#111#article#130#</font></p>    
 ^cY#v60n1a03.htm##
00450000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019600083002001300279#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#116#112#article#130#21#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Taborda JGV, 
Morana HCP, Cardoso RG. Forensic psychiatry in Brazil: an overview. Int J Law Ps
ychiatry. 2000;23(5):579-88.    ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#117#113#article#130#</font></p>    
 ^cY#v60n1a03.htm##
00447000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019300083002001300276#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#118#114#article#130#22#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Trindade J. M
anual de psicologia jur&iacute;dica para operadores do direito. Porto Alegre: Li
vraria do Advogado; 2004.    ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#119#115#article#130#</font></p>    
 ^cY#v60n1a03.htm##
00441000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704018700083002001300270#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#120#116#article#130#23#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. Constitui&cce
dil;&atilde;o da Rep&uacute;blica Federativa do Brasil Di&aacute;rio Oficial da 
Uni&atilde;o; 1988.    ^cY#v60n1a03.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#121#117#article#130#</font></p>    
 ^cY#v60n1a03.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#122#118#article#130#<p>&nbsp;</p>  
   ^cY#v60n1a03.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#123#119#article#130#<p>&nbsp;</p>  
   ^cY#v60n1a03.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704023200080002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#124#120#article#130#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="
/img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <
b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a03.htm##
00287000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004800080002001300128#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#125#121#article#130#<br>    Maria F
ernanda Faria Ach&aacute;    ^cY#v60n1a03.htm##
00321000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704008200080002001300162#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#126#122#article#130#<br>    Rua Dr.
 Ov&iacute;dio de Pires Campos, 785, Cerqueira C&eacute;sar    ^cY#v60n1a03.htm#
#
00290000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704005100080002001300131#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#127#123#article#130#<br>   01060-97
0 - S&atilde;o Paulo, SP        ^cY#v60n1a03.htm##
00278000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704003900080002001300119#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#128#124#article#130#<br>   Telefone
: (11) 3069-7929    ^cY#v60n1a03.htm##
00336000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009700080002001300177#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#129#125#article#130#<br>  E-mail: <
a href="mailto:mfernandaacha@usp.br">mfernandaacha@usp.br</a> </font></p>     ^c
Y#v60n1a03.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009400080002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#130#126#article#130#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 17/11/2010     ^cY#v
60n1a03.htm##
00285000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004600080002001300126#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#131#127#article#130#<br> Aprovado e
m 24/1/2011</font></p>     ^cY#v60n1a03.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#132#128#article#130#<p>&nbsp;</p>  
   ^cY#v60n1a03.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#133#129#article#130#<p>&nbsp;</p>  
   ^cY#v60n1a03.htm##
00482000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704024300080002001300323#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#p#134#130#article#130#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Institui&ccedil;&atilde;o em que
 o trabalho foi elaborado: Hospital de Cust&oacute;dia e Tratamento Psiqui&aacut
e;trico Prof. Andr&eacute; Teixeira Lima (HCTP).</font></p>     ^cY#v60n1a03.htm
##
00677000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790100019000970100
01500116010001800131010001900149012008400168030002100252065000900273064000500282
03100030028703200020029001400060029286500090029800200130030703500100032080100210
0330#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#135#1#article#2
3#1#^rND^sFotiadou^nM#^rND^sLivaditis^nM#^rND^sManou^nI#^rND^sKaniotou^nE#^rND^s
Xenitidis^nK#Prevalence of mental disorders and deliberate self-harm in Greek ma
le prisoners^len#Int J Law Psychiatry#20060000#2006#29#1#68-73#20110000#v60n1a03
.htm#0160-2527#Int J Law Psychiatry##
00680000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100016000950100
01800111010001600129010001800145012009200163030002100255065000900276064000500285
03100030029003200020029301400060029586500090030100200130031003500100032380100210
0333#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#136#2#article#2
3#2#^rND^sHarsch^nS#^rND^sBergk^nJE#^rND^sSteinert^nT#^rND^sKeller^nF#^rND^sJock
usch^nU#Prevalence of mental disorders among sexual offenders in forensic psychi
atry and prison^len#Int J Law Psychiatry#20060000#2006#29#5#443-9#20110000#v60n1
a03.htm#0160-2527#Int J Law Psychiatry##
00534000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100017000950120
07800112030001800190710000200208065000900210064000500219031000200224032000200226
014000600228865000900234002001300243#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a03.htm#S#c#137#3#article#23#3#^rND^sBarros^nP#^rND^sSilva^nFBN#Origem e ma
nutenção do comportamento agressivo na infância e adolescência^lpt#Rev Bras Ter 
Cogn#2#20060000#2006#2#1#55-66#20110000#v60n1a03.htm##
00538000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100025000790120055001040300
02100159065000900180064000500189031000300194032000400197014000600201865000900207
002001300216035001000229801002100239#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a03.htm#S#c#138#4#article#23#4#^rND^sArboleda-Flórez^nJ#Forensic psychiatry
 and epidemiology: Introduction^len#Int J Law Psychiatry#20010000#2001#24#4-5#33
5-7#20110000#v60n1a03.htm#0160-2527#Int J Law Psychiatry##
00570000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100020000950120
10000115030002900215710000200244065000900246064000500255031000200260032000200262
014000600264865000900270002001300279#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a03.htm#S#c#139#5#article#23#5#^rND^sGallo^nAE#^rND^sWilliams^nLCA#Adolesce
ntes em conflito com a lei: uma revisão dos fatores de risco para a conduta infr
acional^lpt#Psicologia: Teoria e prática#2#20050000#2005#7#1#81-95#20110000#v60n
1a03.htm##
00523000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790100018000970120
05600115030002400171710000200195065000900197064000500206031000300211032000200214
014000700216865000900223002001300232#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a03.htm#S#c#140#6#article#23#6#^rND^sDel Pino^nV#^rND^sWerlang^nSG#Homicídi
o e lobo frontal: uma revisão da literatura^lpt#Interação em Psicologia#2#200600
00#2006#10#1#127-37#20110000#v60n1a03.htm##
00543000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100014000790100018000930100
01500111012006200126030001500188710000200203065000900205064000500214031000300219
032000200222014000700224865000900231002001300240#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a03.htm#S#c#141#7#article#23#7#^rND^sLeue^nA#^rND^sBorchard^nB#
^rND^sHoyer^nJ#Mental disorders in a forensic sample of sexual offenders^len#Eur
 Psychiatry#2#20040000#2004#19#3#123-30#20110000#v60n1a03.htm##
00661000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790100018000960100
01800114010002100132010001700153012006700170030002000237065000900257064000500266
03100030027103200020027401400070027686500090028300200130029203500100030580100200
0315#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#142#8#article#2
3#8#^rND^sHodgins^nS#^rND^sMednick^nSA#^rND^sBrenann^nPA#^rND^sSchulsinger^nF#^r
ND^sEngberg^nM#Mental disorder and crime: evidence from a Danish birth cohort^le
n#Arch Gen Psychiatry#19960000#1996#53#6#489-96#20110000#v60n1a03.htm#0003-990X#
Arch Gen Psychiatry##
00624000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790100017000960100
01700113010001600130010001800146012005900164030000700223065000900230064000500239
03100040024403200050024801400060025386500090025900200130026803500100028180100070
0291#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#143#9#article#2
3#9#^rND^sMullen^nPE#^rND^sBurgess^nP#^rND^sWallace^nC#^rND^sPalmer^nS#^rND^sRus
chena^nD#Community care and criminal offending in schizophrenia^len#Lancet#20000
000#2000#355#9204#614-7#20110000#v60n1a03.htm#0099-5355#Lancet##
00686000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100021000990100
01600120010001500136012011100151030002600262065000900288064000500297031000300302
032000200305014000700307865000900314002001300323035001000336801002600346#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#144#10#article#23#10#^rND^s
Swanson^nJW#^rND^sHolzer III^nCE#^rND^sGanju^nVK#^rND^sJono^nRT#Violence and psy
chiatric disorder in the community: evidence from the epidemiologic catchment ar
ea surveys^len#Hosp Community Psychiatry#19900000#1990#41#7#761-70#20110000#v60n
1a03.htm#0022-1597#Hosp Community Psychiatry##
00633000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100023001000120
12900123030001700252065000900269064000500278031000300283032000200286014000600288
865000900294002001300303035001000316801001700326#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a03.htm#S#c#145#11#article#23#11#^rND^sTeixeira^nEH#^rND^sDalga
larrondo^nP#Crime, diagnóstico psiquiátrico e perfil da vítima: um estudo com a 
população de uma casa de custódia do estado de São Paulo^lpt#J Bras Psiquiatr#20
060000#2006#55#3#192-4#20110000#v60n1a03.htm#0047-2085#J Bras Psiquiatr##
00582000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100021000810100021001020120
07700123030001700200065000900217064000500226031000300231032000200234014000700236
865000900243002001300252035001000265801001700275#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a03.htm#S#c#146#12#article#23#12#^rND^sGudjonsson^nGH#^rND^sSig
urdsson^nJF#Differences and similarities between violent offenders and sex offen
ders^len#Child Abuse Negl#20000000#2000#24#3#363-72#20110000#v60n1a03.htm#0145-2
134#Child Abuse Negl##
00697000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100015000970100
01400112010001800126012013100144030002500275065000900300064000500309031000300314
032000200317014000700319865000900326002001300335035001000348801002500358#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#147#13#article#23#13#^rND^s
Black^nDW#^rND^sArndt^nS#^rND^sHale^nN#^rND^sRogerson^nR#Use of the mini interna
tional neuropsychiatric interview (mini) as a screening tool in prisons: results
 of a preliminary study^len#J Am Acad Psychiatry Law#20040000#2004#32#2#158-62#2
0110000#v60n1a03.htm#1093-6793#J Am Acad Psychiatry Law##
00709000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100020000810100023001010100
02500124010001800149010002500167012009200192030002100284065000900305064000500314
03100030031903200020032201400060032486500090033000200130033903500100035280100210
0362#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#148#14#article#
23#14#^rND^sRigonatti^nSP#^rND^sPádua Serafim^nA#^rND^sFreitas Caires^nMA#^rND^s
Filho^nAHGV#^rND^sArboleda-Florez^nJ#Personality disorders in rapists and murder
ers from a maximum security prison in Brazil^len#Int J Law Psychiatry#20060000#2
006#29#5#361-9#20110000#v60n1a03.htm#0160-2527#Int J Law Psychiatry##
00513000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100017000990120
05000116030001900166710000200185065000900187064000500196031000300201032000300204
014000600207865000900213002001300222#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a03.htm#S#c#149#15#article#23#15#^rND^sValença^nAM#^rND^sMoraes^nTM#Relação
 entre homicídio e transtornos mentais^lpt#Rev Bras Psiquiatr#2#20060000#2006#28
#II#S62-8#20110000#v60n1a03.htm##
00663000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100014000810100016000950100
01500111010001400126010001600140012009100156030001600247065000900263064000500272
03100040027703200020028101400060028386500090028900200130029803500100031180100160
0321#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#150#16#article#
23#16#^rND^sCoid^nJ#^rND^sKahtan^nN#^rND^sGault^nS#^rND^sCook^nA#^rND^sJarman^nB
#Medium secure forensic psychiatry services: comparison of seven English health 
regions^len#Br J Psychiatry#20000000#2000#178#1#68-73#20110000#v60n1a03.htm#0007
-1250#Br J Psychiatry##
00550000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810120084001000300
01500184065000900199064000500208031000300213032000200216014000700218865000900225
002001300234035001000247801001500257#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a03.htm#S#c#151#17#article#23#17#^rND^sJunginger^nJ#Psychosis and violence:
 the case for a content analysis of psychotic experience^len#Schizophr Bull#1996
0000#1996#22#1#91-103#20110000#v60n1a03.htm#0586-7614#Schizophr Bull##
00553000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100016001000120
09500116030001400211710000200225065000900227064000500236031000300241032000200244
014000700246865000900253002001300262#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a03.htm#S#c#152#18#article#23#18#^rND^sMonteiro^nLC#^rND^sLouzã^nMR#Alteraç
ões cognitivas na esquizofrenia: consequências funcionais e abordagens terapêuti
cas^lpt#Rev Psiq Clín#2#20070000#2007#34#2#179-83#20110000#v60n1a03.htm##
00566000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100018001000120
06000118030002000178065000900198064000500207031000300212032000200215014000700217
865000900224002001300233035001000246801002000256#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a03.htm#S#c#153#19#article#23#19#^rND^sElbongen^nEB#^rND^sJohns
on^nSC#The intricate link between violence and mental disorder^len#Arch Gen Psyc
hiatry#20090000#2009#66#2#152-61#20110000#v60n1a03.htm#0003-990X#Arch Gen Psychi
atry##
00602000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100019000960100
01500115010001500130010002200145012005400167030001500221710000200236065000900238
064000500247031000400252032000300256014000700259865000900266002001300275#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#154#20#article#23#20#^rND^s
Fazel^nS#^rND^sLångström^nN#^rND^sHjern^nA#^rND^sGrann^nM#^rND^sLichtenstein^nP#
Schizophrenia, substance abuse, and violent crime^len#J Am Med Assoc#2#20090000#
2009#301#19#2016-2#20110000#v60n1a03.htm##
00585000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100018001000100
01800118012004700136030002100183065000900204064000500213031000300218032000200221
014000700223865000900230002001300239035001000252801002100262#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#155#21#article#23#21#^rND^sTaborda^nJGV
#^rND^sMorana^nHCP#^rND^sCardoso^nRG#Forensic psychiatry in Brazil: an overview^
len#Int J Law Psychiatry#20000000#2000#23#5#579-88#20110000#v60n1a03.htm#0160-25
27#Int J Law Psychiatry##
00460000000000229000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160018000810180061000990660
01300160062002100173065000900194064000500203865000900208002001300217#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a03.htm#S#c#156#22#article#23#22#^rND^sTrin
dade^nJ#Manual de psicologia jurídica para operadores do direito^lpt#Porto Alegr
e#Livraria do Advogado#20040000#2004#20110000#v60n1a03.htm##
00398000000000205000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780180051000810620024001320650
00900156064000500165865000900170002001300179#v60n1#V:\SciELO\serial\jbpsiq\v60n1
\markup\v60n1a03.htm#S#c#157#23#article#23#23#Constituição da República Federati
va do Brasil^lpt#Diário Oficial da União#19880000#1988#20110000#v60n1a03.htm##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#o#1#1#article
#1#20110331#101351#v60n1a04.htm#178##
03854000000000625000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901200860
01690120070002550100028003250100038003530700120003910831220005110850010017310850
02301741085003201764085002501796085002501821083114301846085001002989085002402999
08500270302308500270305008500260307705800530310306000110315611700080316707200030
3175112000903178111000903187114000903196113001003205002001303215#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#ILU
S#TAB#4#JBPSIQ010#nd#J. bras. psiquiatr.#60#1#20110000#^f16^l22#0047-2085#Taxa d
e permanência hospitalar de pacientes reinternados em hospital psiquiátrico^lpt#
Length of stay of patients hospitalized at a psychiatric hospital^len#^rND^1A01^
nVanessa^sMachado#^rND^1A01^nManoel Antônio dos^sSantos#Universidade de São Paul
o^iA01^1Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto^2Departament
o de Psicologia#^lpt^aOBJETIVO: Analisar a relação entre características sociode
mográficas e taxa de permanência hospitalar, entendida como a razão entre a quan
tidade total de dias internado e o número total de internações, em 114 pacientes
 reinternantes em hospital psiquiátrico estadual. MÉTODOS: Os dados demográficos
 referentes a sexo, idade, estado civil, nível de instrução e cor foram levantad
os nos prontuários médicos dos pacientes. Já dados sobre os aspectos sociais ref
erentes a situação ocupacional, recebimento de benefício, residência, acompanhan
tes, visitas e telefonemas durante a internação foram colhidos por meio da aplic
ação de um questionário aos profissionais do hospital. RESULTADOS: A análise est
atística mostrou que os sujeitos que apresentaram maior taxa de permanência hosp
italar foram do sexo feminino, entre 40 e 49 anos, viúvos ou divorciados, negros
, que residiam com outras pessoas e que não recebiam visitas durante o período e
m que se encontravam internados. CONCLUSÃO: Esses achados apontam para a existên
cia de relação entre características sociodemográficas e taxa de permanência, su
gerindo a importância da rede de apoio social na reabilitação do pacientes com h
istória de internações recorrentes.#^ddecs^i1#^tm^lpt^kReadmissão^i1#^tm^lpt^kta
xa de permanência^i1#^tm^lpt^kapoio social^i1#^tm^lpt^ksaúde mental^i1#^len^aOBJ
ECTIVE: To analyze the relationship between socio-demographic characteristics an
d the permanence rate, i.e., the ratio between the total number of days in hospi
tal and the total number of admissions, among 114 patients readmitted to a publi
c psychiatric hospital. METHODS: Demographic data related to gender, age, marita
l status, instruction level and color were surveyed in the patients' medical rec
ords. Hospital professionals received a questionnaire, asking for data on social
 aspects related to the occupational situation, reception of financial aid, livi
ng with other persons, company when arriving for hospitalization, receiving visi
ts and phone calls during the hospitalization. RESULTS: Statistical analysis sho
wed that female individuals aged 40-49 years, divorced or widowed, black, living
 with other people and who did not receive any visits while hospitalized stayed 
longer in hospital. CONCLUSION: These findings suggest that socio-demographic ch
aracteristics are associated with length of stay, indicating the relevance of th
e social support network for the recovery of patients with a history of recurrin
g admissions.#^ddecs^i2#^tm^len^kReadmission^i2#^tm^len^klength of stay^i2#^tm^l
en^ksocial support^i2#^tm^len^kmental health^i2#Fundação de Amparo à Pesquisa do
 Estado de São Paulo#06/51736-6#vancouv#30#20100809#9/8/2010#20110119#19/1/2011#
v60n1a04.htm##
03983000000000625000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901200930
01690120077002620100028003390100038003670700120004050831248005250850010017730850
02301783085003201806085002501838085002501863083117101888085001003059085002403069
08500270309308500270312008500260314705800530317306000700322611700080329607200030
3304112000903307111000903316114000903325113001003334002001303344#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#ILU
S#TAB#4#JBPSIQ010#nd#J. bras. psiquiatr.#60#1#20110000#^f16^l22#0047-2085#<b>Tax
a de permanência hospitalar de pacientes reinternados em hospital psiquiátrico</
b>^lpt#<b>Length of stay of patients hospitalized at a psychiatric hospital</b>^
len#^rND^1A01^nVanessa^sMachado#^rND^1A01^nManoel Antônio dos^sSantos#Universida
de de São Paulo^iA01^1Faculdade de Filosofia, Ciências e Letras de Ribeirão Pret
o^2Departamento de Psicologia#^lpt^a<b>OBJETIVO:</b> Analisar a relação entre ca
racterísticas sociodemográficas e taxa de permanência hospitalar, entendida como
 a razão entre a quantidade total de dias internado e o número total de internaç
ões, em 114 pacientes reinternantes em hospital psiquiátrico estadual. <b>MÉTODO
S:</b> Os dados demográficos referentes a sexo, idade, estado civil, nível de in
strução e cor foram levantados nos prontuários médicos dos pacientes. Já dados s
obre os aspectos sociais referentes a situação ocupacional, recebimento de benef
ício, residência, acompanhantes, visitas e telefonemas durante a internação fora
m colhidos por meio da aplicação de um questionário aos profissionais do hospita
l. <b>RESULTADOS:</b> A análise estatística mostrou que os sujeitos que apresent
aram maior taxa de permanência hospitalar foram do sexo feminino, entre 40 e 49 
anos, viúvos ou divorciados, negros, que residiam com outras pessoas e que não r
ecebiam visitas durante o período em que se encontravam internados. <b>CONCLUSÃO
: </b>Esses achados apontam para a existência de relação entre características s
ociodemográficas e taxa de permanência, sugerindo a importância da rede de apoio
 social na reabilitação do pacientes com história de internações recorrentes.#^d
decs^i1#^tm^lpt^kReadmissão^i1#^tm^lpt^ktaxa de permanência^i1#^tm^lpt^kapoio so
cial^i1#^tm^lpt^ksaúde mental^i1#^len^a<b>OBJECTIVE:</b> To analyze the relation
ship between socio-demographic characteristics and the permanence rate, i.e., th
e ratio between the total number of days in hospital and the total number of adm
issions, among 114 patients readmitted to a public psychiatric hospital. <b>METH
ODS:</b> Demographic data related to gender, age, marital status, instruction le
vel and color were surveyed in the patients' medical records. Hospital professio
nals received a questionnaire, asking for data on social aspects related to the 
occupational situation, reception of financial aid, living with other persons, c
ompany when arriving for hospitalization, receiving visits and phone calls durin
g the hospitalization. <b>RESULTS:</b> Statistical analysis showed that female i
ndividuals aged 40-49 years, divorced or widowed, black, living with other peopl
e and who did not receive any visits while hospitalized stayed longer in hospita
l. <b>CONCLUSION:</b> These findings suggest that socio-demographic characterist
ics are associated with length of stay, indicating the relevance of the social s
upport network for the recovery of patients with a history of recurring admissio
ns.#^ddecs^i2#^tm^len^kReadmission^i2#^tm^len^klength of stay^i2#^tm^len^ksocial
 support^i2#^tm^len^kmental health^i2#Fundação de Amparo à Pesquisa do Estado de
 São Paulo#<span style='font-size:10.0pt;font-family: Verdana'>06/51736-6</span>
#vancouv#30#20100809#9/8/2010#20110119#19/1/2011#v60n1a04.htm##
03975000000000649000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000200108049001000110
15800030012003000190012303100030014203200020014506500090014701400090015603500100
01650120086001750120070002610100028003310100038003590700122003970831220005190850
01001739085002301749085003201772085002501804085002501829083114301854085001002997
08500240300708500270303108500270305808500260308505800530311106000110316411700080
31750720003031831120009031861110009031951140009032041130010032130020013032230080
08903236#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#l#4#1#article
#1#^a2011#oa#pt#br1.1#1#4.0#ilus#tab#4#JBPSIQ010#nd#J. bras. psiquiatr#60#1#2011
0000#^f16^l22#0047-2085#Taxa de permanência hospitalar de pacientes reinternados
 em hospital psiquiátrico^lpt#Length of stay of patients hospitalized at a psych
iatric hospital^len#^rND^1A01^nVanessa^sMachado#^rND^1A01^nManoel Antônio dos^sS
antos#^iA01^1Universidade de São Paulo^2Faculdade de Filosofia, Ciências e Letra
s de Ribeirão Preto^3Departamento de Psicologia#^lpt^aOBJETIVO: Analisar a relaç
ão entre características sociodemográficas e taxa de permanência hospitalar, ent
endida como a razão entre a quantidade total de dias internado e o número total 
de internações, em 114 pacientes reinternantes em hospital psiquiátrico estadual
. MÉTODOS: Os dados demográficos referentes a sexo, idade, estado civil, nível d
e instrução e cor foram levantados nos prontuários médicos dos pacientes. Já dad
os sobre os aspectos sociais referentes a situação ocupacional, recebimento de b
enefício, residência, acompanhantes, visitas e telefonemas durante a internação 
foram colhidos por meio da aplicação de um questionário aos profissionais do hos
pital. RESULTADOS: A análise estatística mostrou que os sujeitos que apresentara
m maior taxa de permanência hospitalar foram do sexo feminino, entre 40 e 49 ano
s, viúvos ou divorciados, negros, que residiam com outras pessoas e que não rece
biam visitas durante o período em que se encontravam internados. CONCLUSÃO: Esse
s achados apontam para a existência de relação entre características sociodemogr
áficas e taxa de permanência, sugerindo a importância da rede de apoio social na
 reabilitação do pacientes com história de internações recorrentes.#^ddecs^i1#^t
m^lpt^kReadmissão^i1#^tm^lpt^ktaxa de permanência^i1#^tm^lpt^kapoio social^i1#^t
m^lpt^ksaúde mental^i1#^len^aOBJECTIVE: To analyze the relationship between soci
o-demographic characteristics and the permanence rate, i.e., the ratio between t
he total number of days in hospital and the total number of admissions, among 11
4 patients readmitted to a public psychiatric hospital. METHODS: Demographic dat
a related to gender, age, marital status, instruction level and color were surve
yed in the patients' medical records. Hospital professionals received a question
naire, asking for data on social aspects related to the occupational situation, 
reception of financial aid, living with other persons, company when arriving for
 hospitalization, receiving visits and phone calls during the hospitalization. R
ESULTS: Statistical analysis showed that female individuals aged 40-49 years, di
vorced or widowed, black, living with other people and who did not receive any v
isits while hospitalized stayed longer in hospital. CONCLUSION: These findings s
uggest that socio-demographic characteristics are associated with length of stay
, indicating the relevance of the social support network for the recovery of pat
ients with a history of recurring admissions.#^ddecs^i2#^tm^len^kReadmission^i2#
^tm^len^klength of stay^i2#^tm^len^ksocial support^i2#^tm^len^kmental health^i2#
Fundação de Amparo à Pesquisa do Estado de São Paulo#06/51736-6#vancouv#30#20100
809#9/8/2010#20110119#19/1/2011#v60n1a04.htm#Internet^ihttp://www.scielo.br/scie
lo.php?script=sci_arttext&pid=S0047-20852011000100004##
00354000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704011900076002001300195#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#5#1#article#144#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ARTIGO ORIGINAL</b>
</font></p>     ^cY#v60n1a04.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#6#2#article#144#<p>&nbsp;</p>     ^
cY#v60n1a04.htm##
00444000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704020900076002001300285#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#7#3#article#144#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Taxa de 
perman&ecirc;ncia hospitalar de pacientes reinternados em hospital psiqui&aacute
;trico</b></font></p>     ^cY#v60n1a04.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#8#4#article#144#<p>&nbsp;</p>     ^
cY#v60n1a04.htm##
00390000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704015500076002001300231#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#9#5#article#144#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Length of stay of patients hospit
alized at a psychiatric hospital</b></font></p>     ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#10#6#article#144#<p>&nbsp;</p>     
^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#11#7#article#144#<p>&nbsp;</p>     
^cY#v60n1a04.htm##
00374000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704013800077002001300215#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#12#8#article#144#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Vanessa Machado; Manoel Ant&ocir
c;nio dos Santos</b></font></p>     ^cY#v60n1a04.htm##
00453000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704021700077002001300294#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#13#9#article#144#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Universidade de S&atilde;o Paulo, F
aculdade de Filosofia, Ci&ecirc;ncias e Letras de Ribeir&atilde;o Preto, Departa
mento de Psicologia</font></p>     ^cY#v60n1a04.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#14#10#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#15#11#article#144#<p>&nbsp;</p>    
 ^cY#v60n1a04.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#16#12#article#144#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a04.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#17#13#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a04.htm##
00651000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704041400078002001300492#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#18#14#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVO:</b> Analisar a rela&c
cedil;&atilde;o entre caracter&iacute;sticas sociodemogr&aacute;ficas e taxa de 
perman&ecirc;ncia hospitalar, entendida como a raz&atilde;o entre a quantidade t
otal de dias internado e o n&uacute;mero total de interna&ccedil;&otilde;es, em 
114 pacientes reinternantes em hospital psiqui&aacute;trico estadual.    ^cY#v60
n1a04.htm##
00780000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704054300078002001300621#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#19#15#article#144#<br>  <b>M&Eacute
;TODOS:</b> Os dados demogr&aacute;ficos referentes a sexo, idade, estado civil,
 n&iacute;vel de instru&ccedil;&atilde;o e cor foram levantados nos prontu&aacut
e;rios m&eacute;dicos dos pacientes. J&aacute; dados sobre os aspectos sociais r
eferentes a situa&ccedil;&atilde;o ocupacional, recebimento de benef&iacute;cio,
 resid&ecirc;ncia, acompanhantes, visitas e telefonemas durante a interna&ccedil
;&atilde;o foram colhidos por meio da aplica&ccedil;&atilde;o de um question&aac
ute;rio aos profissionais do hospital.    ^cY#v60n1a04.htm##
00597000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704036000078002001300438#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#20#16#article#144#<br>  <b>RESULTAD
OS:</b> A an&aacute;lise estat&iacute;stica mostrou que os sujeitos que apresent
aram maior taxa de perman&ecirc;ncia hospitalar foram do sexo feminino, entre 40
 e 49 anos, vi&uacute;vos ou divorciados, negros, que residiam com outras pessoa
s e que n&atilde;o recebiam visitas durante o per&iacute;odo em que se encontrav
am internados.     ^cY#v60n1a04.htm##
00600000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704036300078002001300441#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#21#17#article#144#<br> <b>CONCLUS&A
tilde;O: </b>Esses achados apontam para a exist&ecirc;ncia de rela&ccedil;&atild
e;o entre caracter&iacute;sticas sociodemogr&aacute;ficas e taxa de perman&ecirc
;ncia, sugerindo a import&acirc;ncia da rede de apoio social na reabilita&ccedil
;&atilde;o do pacientes com hist&oacute;ria de interna&ccedil;&otilde;es recorre
ntes. </font></p>     ^cY#v60n1a04.htm##
00445000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704020800078002001300286#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#22#18#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>Readmiss&at
ilde;o, taxa de perman&ecirc;ncia, apoio social, sa&uacute;de mental.</font></p>
 <hr size="1" noshade>     ^cY#v60n1a04.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#23#19#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a04.htm##
00581000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704034400078002001300422#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#24#20#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVE:</b> To analyze the r
elationship between socio-demographic characteristics and the permanence rate, i
.e., the ratio between the total number of days in hospital and the total number
 of admissions, among 114 patients readmitted to a public psychiatric hospital. 
   ^cY#v60n1a04.htm##
00680000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704044300078002001300521#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#25#21#article#144#<br>  <b>METHODS:
</b> Demographic data related to gender, age, marital status, instruction level 
and color were surveyed in the patients' medical records. Hospital professionals
 received a questionnaire, asking for data on social aspects related to the occu
pational situation, reception of financial aid, living with other persons, compa
ny when arriving for hospitalization, receiving visits and phone calls during th
e hospitalization.    ^cY#v60n1a04.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704023400078002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#26#22#article#144#<br>  <b>RESULTS:
</b> Statistical analysis showed that female individuals aged 40-49 years, divor
ced or widowed, black, living with other people and who did not receive any visi
ts while hospitalized stayed longer in hospital.     ^cY#v60n1a04.htm##
00503000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704026600078002001300344#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#27#23#article#144#<br> <b>CONCLUSIO
N:</b> These findings suggest that socio-demographic characteristics are associa
ted with length of stay, indicating the relevance of the social support network 
for the recovery of patients with a history of recurring admissions. </font></p>
     ^cY#v60n1a04.htm##
00419000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704018200078002001300260#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#28#24#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Readmission, leng
th of stay, social support, mental health. </font></p> <hr size="1" noshade>    
 ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#29#25#article#144#<p>&nbsp;</p>    
 ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#30#26#article#144#<p>&nbsp;</p>    
 ^cY#v60n1a04.htm##
00351000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011400078002001300192#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#31#27#article#144#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde;O</b></f
ont></p>     ^cY#v60n1a04.htm##
01054000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704081700078002001300895#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#32#28#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Ao se considerarem as mudan&ccedil
;as na abordagem da sa&uacute;de mental, que passou a priorizar o modelo de aten
&ccedil;&atilde;o comunit&aacute;ria em oposi&ccedil;&atilde;o ao modelo centrad
o no hospital, o tempo de perman&ecirc;ncia hospitalar, associado a outros indic
adores, tem sido acatado na avalia&ccedil;&atilde;o da qualidade da assist&ecirc
;ncia em sa&uacute;de mental. Na literatura norte-americana, os pacientes com hi
st&oacute;rico de interna&ccedil;&otilde;es por longo tempo de perman&ecirc;ncia
 s&atilde;o denominados <i>heavy users</i><sup>1,2</sup>. As caracter&iacute;sti
cas sociodemogr&aacute;ficas e cl&iacute;nicas desses indiv&iacute;duos t&ecirc;
m sido foco de interesse crescente nos &uacute;ltimos anos. </font></p>     ^cY#
v60n1a04.htm##
01068000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704083100078002001300909#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#33#29#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Estudos realizados nos Estados Uni
dos em unidades psiqui&aacute;tricas de hospitais gerais identificaram um tempo 
m&eacute;dio de interna&ccedil;&atilde;o de 23<sup>3</sup> a 21<sup>4</sup> dias
. Pesquisa realizada por Caton identificou que o tempo de interna&ccedil;&atilde
;o de 119 pacientes esquizofr&ecirc;nicos em seis institui&ccedil;&otilde;es urb
anas norte-americanas variou de 21 dias em unidades para pacientes agudos at&eac
ute; 70 dias em unidades estaduais de longa perman&ecirc;ncia e que a dura&ccedi
l;&atilde;o da hospitaliza&ccedil;&atilde;o n&atilde;o tinha qualquer rela&ccedi
l;&atilde;o com a interna&ccedil;&atilde;o posterior, ades&atilde;o ao tratament
o cl&iacute;nico ou com o funcionamento social na comunidade<sup>5</sup>. </font
></p>     ^cY#v60n1a04.htm##
01122000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704088500078002001300963#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#34#30#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">No cen&aacute;rio brasileiro, inve
stiga&ccedil;&otilde;es<sup>6</sup> realizadas entre dezembro de 1986 e novembro
 de 1988 identificaram que o tempo m&eacute;dio de perman&ecirc;ncia em uma unid
ade psiqui&aacute;trica de um hospital geral universit&aacute;rio era de 19,4 di
as, per&iacute;odo relativamente menor do que o observado em hospital psiqui&aac
ute;trico. Estudos realizados na d&eacute;cada de 1990 demonstraram que a m&eacu
te;dia nacional do tempo de perman&ecirc;ncia de interna&ccedil;&atilde;o psiqui
&aacute;trica era de 18,6 dias, e nos hospitais psiqui&aacute;tricos conveniados
 ao Sistema &Uacute;nico de Sa&uacute;de (SUS), essa m&eacute;dia era maior (24 
dias) do que as interna&ccedil;&otilde;es psiqui&aacute;tricas em hospitais gera
is universit&aacute;rios (14 dias)<sup>7</sup>. </font></p>     ^cY#v60n1a04.htm
##
01100000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704086300078002001300941#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#35#31#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Outras investiga&ccedil;&otilde;es
 identificaram ainda um tempo m&eacute;dio de interna&ccedil;&atilde;o em hospit
ais psiqui&aacute;tricos conveniados ao SUS de 31,85 dias<sup>8 </sup>e de 30 di
as<sup>9</sup>. Em censo nacional realizado por Botega e Schechtman<sup>10</sup>
, identificou-se que o tempo m&eacute;dio de interna&ccedil;&atilde;o em hospita
is psiqui&aacute;tricos era de cerca de 20 dias, significativamente superior ao 
tempo m&eacute;dio de interna&ccedil;&atilde;o em unidades psiqui&aacute;tricas 
de hospitais gerais integrados ao SUS, que era de cinco a sete dias. De acordo c
om os resultados desses estudos, portanto, o tempo de perman&ecirc;ncia hospital
ar parece ser maior quando a interna&ccedil;&atilde;o &eacute; realizada em hosp
ital psiqui&aacute;trico. </font></p>     ^cY#v60n1a04.htm##
00918000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704068100078002001300759#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#36#32#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Por outro lado, investiga&ccedil;&
atilde;o<sup>11 </sup>realizada no munic&iacute;pio de Ribeir&atilde;o Preto con
cluiu que na unidade de emerg&ecirc;ncia do hospital universit&aacute;rio preval
eceram interna&ccedil;&otilde;es que duraram menos de dois dias, no hospital psi
qui&aacute;trico estadual predominaram as inferiores a 20 dias e no hospital ger
al universit&aacute;rio prevaleceram interna&ccedil;&otilde;es por mais de 20 di
as. Essa diferen&ccedil;a, segundo o autor, possivelmente pode ser justificada p
ela gravidade e comorbidade dos casos atendidos pelo hospital universit&aacute;r
io. </font></p>     ^cY#v60n1a04.htm##
01162000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704092500078002001301003#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#37#33#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Reconhecido indicador de qualidade
 da assist&ecirc;ncia &agrave; sa&uacute;de mental, o fen&ocirc;meno da reintern
a&ccedil;&atilde;o psiqui&aacute;trica, expresso por meio da taxa de reinterna&c
cedil;&atilde;o, tem sido denominado de "porta girat&oacute;ria", ou "<i>revolvi
ng door</i>", por alguns autores<sup>12-14</sup>. Nos estudos norte-americanos, 
o paciente reinternante tem sido designado como "<i>frequent </i>users"<sup>1</s
up>. Esse fen&ocirc;meno explicita que, embora se tenha reduzido o tempo das int
erna&ccedil;&otilde;es, que em outros tempos era de longa perman&ecirc;ncia, a i
nstitucionaliza&ccedil;&atilde;o dos pacientes acontece por meio de interna&cced
il;&otilde;es relativamente breves, que passam a transitar por diferentes hospit
ais e, assim, caracterizar o uso frequente da interna&ccedil;&atilde;o<sup>15,16
</sup>. </font></p>     ^cY#v60n1a04.htm##
01322000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704108500078002001301163#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#38#34#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A reinterna&ccedil;&atilde;o &eacu
te; um fen&ocirc;meno de m&uacute;ltiplas determina&ccedil;&otilde;es, associado
 especialmente a diagn&oacute;stico<sup>1,17-19</sup>, caracter&iacute;sticas so
ciodemogr&aacute;ficas<sup>1,18,20</sup>, ades&atilde;o ao tratamento ambulatori
al<sup>21,22 </sup>e qualidade e modalidade do tratamento ambulatorial oferecido
 pela rede<sup>23,24</sup>. Em geral, a reinterna&ccedil;&atilde;o &eacute; defi
nida por um determinado n&uacute;mero de interna&ccedil;&otilde;es em um per&iac
ute;odo limitado, como duas ou mais interna&ccedil;&otilde;es em um ano<sup>18,1
9,25,26</sup>, tr&ecirc;s ou mais interna&ccedil;&otilde;es em um ano<sup>27</su
p>, tr&ecirc;s ou mais interna&ccedil;&otilde;es em um per&iacute;odo de um ano 
e meio<sup>28</sup>. Neste estudo, foram considerados pacientes reinternantes aq
ueles que, ao longo de sua vida, apresentaram mais de uma interna&ccedil;&atilde
;o no hospital psiqui&aacute;trico no qual se desenvolveu a investiga&ccedil;&at
ilde;o. </font></p>     ^cY#v60n1a04.htm##
00955000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704071800078002001300796#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#39#35#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Tendo em vista a import&acirc;ncia
 do tema no atual cen&aacute;rio da sa&uacute;de mental, assim como a aus&ecirc;
ncia de estudos que investiguem a associa&ccedil;&atilde;o entre taxa de perman&
ecirc;ncia e aspectos sociodemogr&aacute;ficos em pacientes reinternantes, delin
eou-se o presente estudo. Assim, este estudo teve por objetivo identificar os fa
tores sociodemogr&aacute;ficos associados &agrave; taxa de perman&ecirc;ncia hos
pitalar, entendida como a raz&atilde;o entre a quantidade total de dias internad
o e o n&uacute;mero total de interna&ccedil;&otilde;es, entre pacientes reintern
antes em um hospital psiqui&aacute;trico.</font></p>     ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#40#36#article#144#<p>&nbsp;</p>    
 ^cY#v60n1a04.htm##
00338000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010100078002001300179#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#41#37#article#144#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>METODOLOGIA</b></font></p>     
^cY#v60n1a04.htm##
00342000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010500078002001300183#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#42#38#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Local do estudo</b></font></p> 
    ^cY#v60n1a04.htm##
01600000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704136300078002001301441#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#43#39#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O estudo foi desenvolvido em um ho
spital psiqui&aacute;trico da Secretaria da Sa&uacute;de do Estado de S&atilde;o
 Paulo, refer&ecirc;ncia para o atendimento da popula&ccedil;&atilde;o de 26 mun
ic&iacute;pios, que totaliza 1.284.340 habitantes (IBGE, 2009). O hospital conta
 com dois tipos de atendimento: um destinado aos pacientes de longa perman&ecirc
;ncia hospitalar, remanescentes da antiga pol&iacute;tica de institucionaliza&cc
edil;&atilde;o, e outro setor que oferece assist&ecirc;ncia integral, por meio d
e interna&ccedil;&otilde;es chamadas breves, para pacientes em quadro agudo e de
pendentes qu&iacute;micos. No per&iacute;odo de coleta de dados da presente pesq
uisa, o setor de interna&ccedil;&atilde;o breve era subdividido da seguinte form
a: setor de interna&ccedil;&atilde;o para pacientes do sexo feminino (chamado "a
gudos feminino", com 30 leitos), para pacientes do sexo masculino (chamado "agud
os masculino", com 30 leitos) e para pacientes do sexo masculino com depend&ecir
c;ncia qu&iacute;mica (chamado "dependentes qu&iacute;micos", com 20 leitos). To
dos os setores contam com duas equipes multidisciplinares, nos per&iacute;odos d
e manh&atilde; e da tarde, bem como profissionais m&eacute;dicos e assist&ecirc;
ncia de enfermagem em per&iacute;odo integral.</font></p>     ^cY#v60n1a04.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#44#40#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Sujeitos</b></font></p>     ^cY
#v60n1a04.htm##
00961000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704072400078002001300802#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#45#41#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Definiram-se como crit&eacute;rios
 de inclus&atilde;o dos sujeitos na amostra: pacientes que haviam apresentado re
interna&ccedil;&atilde;o nos setores de interna&ccedil;&atilde;o breve no hospit
al psiqui&aacute;trico de interesse da pesquisa, no per&iacute;odo de julho a de
zembro de 2006; residentes no munic&iacute;pio de Ribeir&atilde;o Preto, interio
r do estado de S&atilde;o Paulo, onde a referida institui&ccedil;&atilde;o est&a
acute; localizada. Estabeleceram-se os seguintes crit&eacute;rios de exclus&atil
de;o: pacientes internados pela primeira vez no hospital; residentes em outros m
unic&iacute;pios que n&atilde;o o de interesse.</font></p>     ^cY#v60n1a04.htm#
#
01169000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704093200078002001301010#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#46#42#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Para a composi&ccedil;&atilde;o da
 amostra, foi realizado um levantamento por meio de uma pesquisa preliminar na r
ede de sistema de arquivo m&eacute;dico desse hospital. Em um primeiro momento, 
foram levantadas todas as admiss&otilde;es de pacientes na institui&ccedil;&atil
de;o hospitalar no per&iacute;odo de julho a dezembro de 2006, totalizando 547 a
dmiss&otilde;es. Em seguida, foram aplicados os crit&eacute;rios de inclus&atild
e;o/exclus&atilde;o, que resultaram em um total de 182 interna&ccedil;&otilde;es
 realizadas por 141 pacientes. Portanto, para a composi&ccedil;&atilde;o da amos
tra (N = 141) foi considerada a totalidade dos pacientes reinternados no per&iac
ute;odo definido pelo estudo nos tr&ecirc;s setores de interna&ccedil;&atilde;o 
breve do hospital psiqui&aacute;trico, residentes no munic&iacute;pio de Ribeir&
atilde;o Preto.</font></p>     ^cY#v60n1a04.htm##
00342000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010500078002001300183#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#47#43#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Coleta de dados</b></font></p> 
    ^cY#v60n1a04.htm##
01900000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704166300078002001301741#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#48#44#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Como instrumento, foi elaborado e 
previamente testado um formul&aacute;rio para caracteriza&ccedil;&atilde;o socio
demogr&aacute;fica, que se mostrou adequado para a coleta dos dados de interesse
. O formul&aacute;rio foi composto de duas partes: informa&ccedil;&otilde;es col
etadas a partir de dados secund&aacute;rios e informa&ccedil;&otilde;es coletada
s a partir de uma entrevista estruturada aplicada aos profissionais do hospital.
 Os dados secund&aacute;rios foram extra&iacute;dos de informa&ccedil;&otilde;es
 constantes dos prontu&aacute;rios m&eacute;dicos de cada um dos sujeitos (data 
de admiss&atilde;o e alta de todas as interna&ccedil;&otilde;es, sexo, idade, es
tado civil, n&iacute;vel de instru&ccedil;&atilde;o e cor). Os dados que diziam 
respeito aos aspectos sociais foram respondidos por profissionais t&eacute;cnico
s da institui&ccedil;&atilde;o, escolhidos entre aqueles que estivessem mais hab
ilitados a responder pelos cuidados prestados aos sujeitos durante suas interna&
ccedil;&otilde;es, aos quais foi aplicada uma entrevista estruturada que contemp
lou as seguintes quest&otilde;es: Qual a atual situa&ccedil;&atilde;o ocupaciona
l do paciente? (ativo, inativo); O paciente recebe algum tipo de benef&iacute;ci
o? (sim, n&atilde;o); O paciente reside com outras pessoas? (sim, n&atilde;o); O
 paciente geralmente chega acompanhado nas interna&ccedil;&otilde;es? (sim, n&at
ilde;o); O paciente geralmente recebe visita enquanto est&aacute; internado? (si
m, n&atilde;o); O paciente geralmente recebe telefonema enquanto est&aacute; int
ernado? (sim, n&atilde;o).</font></p>     ^cY#v60n1a04.htm##
00529000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704029200078002001300370#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#49#45#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Este estudo foi aprovado pelo Comi
t&ecirc; de &Eacute;tica em Pesquisa do Centro de Sa&uacute;de Escola da Faculda
de de Medicina de Ribeir&atilde;o Preto - Universidade de S&atilde;o Paulo (prot
ocolo nº 229). </font></p>     ^cY#v60n1a04.htm##
00350000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011300078002001300191#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#50#46#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>An&aacute;lise de dados</b></fo
nt></p>     ^cY#v60n1a04.htm##
00845000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704060800078002001300686#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#51#47#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Ao considerar que o tempo de obser
va&ccedil;&atilde;o de cada sujeito era variado, uma vez que as datas das primei
ras interna&ccedil;&otilde;es diferiam entre eles, optou-se por trabalhar com a 
taxa de perman&ecirc;ncia hospitalar, que representa a raz&atilde;o entre a quan
tidade total de dias internado e o n&uacute;mero total de interna&ccedil;&otilde
;es. Sendo assim, a taxa de perman&ecirc;ncia &eacute; uma vari&aacute;vel discr
eta, que indica a propor&ccedil;&atilde;o de tempo que cada sujeito permaneceu n
o sistema. </font></p>     ^cY#v60n1a04.htm##
01321000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704108400078002001301162#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#52#48#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Por haver apenas uma vari&aacute;v
el dependente (taxa de perman&ecirc;ncia), foi realizada uma an&aacute;lise univ
ariada. Tendo em vista a grande dispers&atilde;o da vari&aacute;vel dependente, 
ela foi ajustada por meio de um modelo de regress&atilde;o binomial negativa, em
 fun&ccedil;&atilde;o das vari&aacute;veis independentes: idade, estado civil, s
exo, entre outras. Como a vari&aacute;vel dependente &eacute; discreta e represe
nta uma raz&atilde;o, &eacute; plaus&iacute;vel utilizar esse modelo para an&aac
ute;lise dos dados, considerando, ainda, que se pode presumir a superdispers&ati
lde;o dos dados. Al&eacute;m disso, foi ajustado um modelo para cada uma das var
i&aacute;veis independentes, e a qualidade do ajuste, que foi avaliada via <i>sc
aled deviance</i>, n&atilde;o se afastou significativamente do valor 1. Consider
ando um n&iacute;vel de signific&acirc;ncia de 5%, o ajuste univariado do modelo
 apontou como sendo significantes as vari&aacute;veis que retornaram p-valor &lt
; 0,05.</font></p>     ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#53#49#article#144#<p>&nbsp;</p>    
 ^cY#v60n1a04.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#54#50#article#144#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font></p>     ^
cY#v60n1a04.htm##
00995000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704075800078002001300836#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#55#51#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A t&iacute;tulo de descri&ccedil;&
atilde;o da amostra, a taxa de perman&ecirc;ncia hospitalar foi de 33,5 dias par
a os pacientes internados nos setores agudos feminino e agudos masculino e de 14
,5 dias para os pacientes internados no setor de dependentes qu&iacute;micos. Os
 pacientes internados nos setores agudos feminino e agudos masculino apresentara
m um intervalo m&eacute;dio entre as interna&ccedil;&otilde;es de 323,5 dias e u
ma m&eacute;dia de 7,9 interna&ccedil;&otilde;es; os pacientes internados no set
or dependentes qu&iacute;micos apresentaram o intervalo m&eacute;dio de interna&
ccedil;&otilde;es de 556,8 dias e m&eacute;dia de 4,8 interna&ccedil;&otilde;es.
 </font></p>     ^cY#v60n1a04.htm##
01452000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704121500078002001301293#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#56#52#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A an&aacute;lise estat&iacute;stic
a apontou diferen&ccedil;as estaticamente significantes no que se refere &agrave
;s vari&aacute;veis independentes: sexo, faixa et&aacute;ria, estado civil e cor
. Os sujeitos do sexo feminino apresentaram uma taxa de perman&ecirc;ncia de 36 
dias, enquanto os sujeitos do sexo masculino, em m&eacute;dia, permaneceram no h
ospital por 17,3 dias. No que diz respeito &agrave; faixa et&aacute;ria, os suje
itos na faixa et&aacute;ria de 40 a 49 anos apresentaram a maior taxa de perman&
ecirc;ncia (36,4 dias), seguidos dos sujeitos com idade igual ou maior de 50 ano
s (23,5 dias), na faixa et&aacute;ria de 30 a 39 anos (18,4 dias) e 29 anos ou m
enos (17,7 dias). Quanto ao estado civil, os sujeitos vi&uacute;vos ou divorciad
os, em m&eacute;dia, permaneceram internados 25,1 dias, enquanto os solteiros pe
rmaneceram 20,2 dias e os casados, 17,7 dias. No que concerne &agrave; cor, os s
ujeitos de cor negra permaneceram, em m&eacute;dia, 71,8 dias internados, enquan
to os de cor parda permaneceram 20,3 dias e os de cor branca, 20,1 dias (<a href
="/img/revistas/jbpsiq/v60n1/a04tab01.jpg">Tabela 1</a>). </font></p>     ^cY#v6
0n1a04.htm##
01151000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704091400078002001300992#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#57#53#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">No que diz respeito aos aspectos s
ociais, a an&aacute;lise estat&iacute;stica mostrou diferen&ccedil;as estaticame
nte significantes no que concerne ao paciente residir com outras pessoas (p = 0,
009), bem como receber visitas enquanto se encontra internado (p &lt; 0,0001). O
s sujeitos que residem com outras pessoas apresentaram, em m&eacute;dia, um temp
o de perman&ecirc;ncia hospitalar  de 31,07 dias, enquanto aqueles que n&atilde;
o residem com outras  pessoas apresentaram uma taxa de perman&ecirc;ncia de 18,3
 dias.  Os sujeitos que recebem visitas de um membro da rede social  enquanto es
t&atilde;o internados apresentaram a taxa de perman&ecirc;ncia de 22,3 dias, enq
uanto os sujeitos que n&atilde;o recebem  essas visitas apresentaram uma taxa de
 26,4 dias (<a href="/img/revistas/jbpsiq/v60n1/a04tab02.jpg">Tabela 2</a>). </f
ont></p>     ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#58#54#article#144#<p>&nbsp;</p>    
 ^cY#v60n1a04.htm##
00397000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704016000078002001300238#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#59#55#article#144#<p align="center"
><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="/img/revis
tas/jbpsiq/v60n1/a04tab03.jpg">Tabela 3</a></font></p>     ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#60#56#article#144#<p>&nbsp;</p>    
 ^cY#v60n1a04.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#61#57#article#144#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p>
     ^cY#v60n1a04.htm##
01569000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704133200078002001301410#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#62#58#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Em termos de estimativa populacion
al para a popula&ccedil;&atilde;o do munic&iacute;pio de Ribeir&atilde;o Preto r
einternante no hospital investigado, verificou-se que algumas vari&aacute;veis d
emonstraram exercer efeito sobre a taxa de perman&ecirc;ncia hospitalar. Os dado
s permitem estimar que, considerando os limites dessa popula&ccedil;&atilde;o, o
s sujeitos do sexo feminino apresentam maior taxa de perman&ecirc;ncia hospitala
r. Esse dado n&atilde;o pode ser explicado por meio da associa&ccedil;&atilde;o 
com a vari&aacute;vel diagn&oacute;stico, como se poderia supor em exame prelimi
nar, j&aacute; que, em an&aacute;lise paralela, essa vari&aacute;vel n&atilde;o 
trouxe efeitos na taxa de perman&ecirc;ncia. Por outro lado, pode ser associado 
ao setor de interna&ccedil;&atilde;o, considerando que, na &eacute;poca do prese
nte estudo, homens e mulheres eram internados em setores separados, com equipes 
e gerenciamentos tamb&eacute;m distintos. Assim, esse achado permite inferir pos
s&iacute;veis diferen&ccedil;as sociais e cl&iacute;nicas inerentes ao g&ecirc;n
ero, mas tamb&eacute;m se deve considerar a influ&ecirc;ncia de diferen&ccedil;a
s na condu&ccedil;&atilde;o e manejo dos casos pelas diferentes equipes de sa&ua
cute;de mental.</font></p>     ^cY#v60n1a04.htm##
01088000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704085100078002001300929#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#63#59#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A equipe, ao discutir as possibili
dades de alta do paciente, al&eacute;m de levar em considera&ccedil;&atilde;o o 
estado cl&iacute;nico, tamb&eacute;m avalia o suporte social com que ele conta p
ara apoi&aacute;-lo naquele determinado momento, assim como as caracter&iacute;s
ticas do servi&ccedil;o ambulatorial respons&aacute;vel por seu acompanhamento e
xtra-hospitalar. Essa situa&ccedil;&atilde;o indica que s&atilde;o v&aacute;rios
 os aspectos, n&atilde;o s&oacute; cl&iacute;nicos, presentes na avalia&ccedil;&
atilde;o de uma poss&iacute;vel alta, o que deixa margem para diferentes avalia&
ccedil;&otilde;es e possibilidades de encaminhamentos dos casos, conforme as dis
cuss&otilde;es e negocia&ccedil;&otilde;es estabelecidas pelos profissionais de 
sa&uacute;de. </font></p>     ^cY#v60n1a04.htm##
01305000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704106800078002001301146#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#64#60#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Outro aspecto importante a ser pro
blematizado &eacute; a press&atilde;o da rede de assist&ecirc;ncia por mais vaga
s, especialmente nos &uacute;ltimos anos, o que pode favorecer que se acelere o 
processo de alta. Segundo levantamento no servi&ccedil;o de arquivo m&eacute;dic
o e estat&iacute;stico do hospital psiqui&aacute;trico investigado, a taxa de oc
upa&ccedil;&atilde;o relacionada a interna&ccedil;&otilde;es de pacientes do sex
o masculino foi sempre superior &agrave;s interna&ccedil;&otilde;es de pacientes
 do sexo feminino; s&oacute; nos &uacute;ltimos anos houve uma equipara&ccedil;&
atilde;o. Esse aspecto pode indicar que as poss&iacute;veis press&otilde;es da r
ede, que demanda vagas para interna&ccedil;&atilde;o, estejam interferindo em um
a alta mais breve no setor de interna&ccedil;&atilde;o para pacientes do sexo ma
sculino, implicando uma acentuada diferen&ccedil;a entre o tempo de perman&ecirc
;ncia desse setor e do setor de interna&ccedil;&atilde;o para mulheres.</font></
p>     ^cY#v60n1a04.htm##
01170000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704093300078002001301011#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#65#61#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">No que se refere &agrave; faixa et
&aacute;ria, a partir da an&aacute;lise estat&iacute;stica dos dados, pode-se es
timar que sujeitos na meia-idade (entre 40 e 49 anos) apresentam maior taxa de p
erman&ecirc;ncia, o que permite inferir que os mais jovens apresentam uma remiss
&atilde;o mais r&aacute;pida dos sintomas, que se mostra mais dificultada em suj
eitos de maior idade, tendo em vista a evolu&ccedil;&atilde;o cr&ocirc;nica do q
uadro. Estudos desenvolvidos com pacientes psiqui&aacute;tricos apontam que idad
e igual ou superior a 60 anos contribui para o aumento no tempo de perman&ecirc;
ncia<sup>29</sup>, contudo n&atilde;o se trata de uma popula&ccedil;&atilde;o ex
clusivamente de pacientes reinternantes, o que pode sugerir que relativamente a 
essa popula&ccedil;&atilde;o o tempo de perman&ecirc;ncia &eacute; aumentado mai
s precocemente. </font></p>     ^cY#v60n1a04.htm##
01050000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704081300078002001300891#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#66#62#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os sujeitos que tiveram o v&iacute
;nculo conjugal rompido, seja por separa&ccedil;&atilde;o (div&oacute;rcio) ou v
iuvez, apresentam maior taxa de perman&ecirc;ncia hospitalar em compara&ccedil;&
atilde;o com pacientes solteiros e casados. A partir desse dado, pode-se hipotet
izar que o c&ocirc;njuge desempenha um papel importante na n&atilde;o institucio
naliza&ccedil;&atilde;o prolongada do paciente. De forma semelhante, os sujeitos
 da cor negra apresentaram uma taxa de perman&ecirc;ncia hospitalar muito maior 
do que os demais. Esse achado vai ao encontro da hist&oacute;rica exclus&atilde;
o social, estigmatiza&ccedil;&atilde;o e consequente marginaliza&ccedil;&atilde;
o sofrida por esse segmento da popula&ccedil;&atilde;o. </font></p>     ^cY#v60n
1a04.htm##
01204000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704096700078002001301045#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#67#63#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Quanto a residir com outra pessoa,
 chama a aten&ccedil;&atilde;o o dado que mostra que os sujeitos que residem com
 outros apresentam maior taxa de perman&ecirc;ncia hospitalar. Pode-se pensar qu
e o fato de ter fam&iacute;lia ou residir com outra pessoa n&atilde;o assegura a
 qualidade dos relacionamentos interpessoais, tal como se pode encontrar nos v&i
acute;nculos permeados por demonstra&ccedil;&otilde;es de preocupa&ccedil;&atild
e;o ou cuidado. Corroborando tal interpreta&ccedil;&atilde;o, por meio dos dados
 analisados, estima-se que os sujeitos que recebem visitas enquanto est&atilde;o
 internados apresentam menor taxa de perman&ecirc;ncia hospitalar. Esse dado sug
ere que a manuten&ccedil;&atilde;o do contato com pessoas de sua rede social exe
rce contribui&ccedil;&atilde;o positiva &agrave; recupera&ccedil;&atilde;o do pa
ciente, corroborando outros estudos<sup>30</sup>. </font></p>     ^cY#v60n1a04.h
tm##
00871000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704063400078002001300712#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#68#64#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Este estudo apresenta algumas limi
ta&ccedil;&otilde;es. A delimita&ccedil;&atilde;o da popula&ccedil;&atilde;o do 
estudo (reinternantes em um &uacute;nico hospital, p&uacute;blico, que atende a 
uma &aacute;rea espec&iacute;fica do estado de S&atilde;o Paulo) n&atilde;o perm
ite a generaliza&ccedil;&atilde;o dos resultados para outros contextos. Ainda, c
onsiderando que foram entrevistados diferentes profissionais, n&atilde;o houve u
niformidade das respostas, uma vez que elas estavam sujeitas &agrave; compreens&
atilde;o subjetiva dos entrevistados.</font></p>     ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#69#65#article#144#<p>&nbsp;</p>    
 ^cY#v60n1a04.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#70#66#article#144#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUS&Atilde;O</b></font></p>
     ^cY#v60n1a04.htm##
01030000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704079300078002001300871#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#71#67#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A partir da an&aacute;lise estat&i
acute;stica, conclui-se que os pacientes psiqui&aacute;tricos reinternantes que 
apresentam maior taxa de perman&ecirc;ncia hospitalar s&atilde;o do sexo feminin
o, com idade entre 40 e 49 anos, vi&uacute;vos ou divorciados, negros, que resid
em com outras pessoas, n&atilde;o recebem visitas durante o per&iacute;odo em qu
e se encontram internados. Esses achados sugerem que caracter&iacute;sticas soci
odemogr&aacute;ficas interferem na taxa de perman&ecirc;ncia hospitalar, apontan
do para a concep&ccedil;&atilde;o da import&acirc;ncia dos aspectos sociais na r
eabilita&ccedil;&atilde;o psicossocial e na manuten&ccedil;&atilde;o da estabili
dade do quadro psiqui&aacute;trico. </font></p>     ^cY#v60n1a04.htm##
01211000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704097400078002001301052#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#72#68#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Assim, deve-se considerar que aspe
ctos n&atilde;o meramente cl&iacute;nicos interferem na decis&atilde;o sobre a a
lta hospitalar, e o quadro cl&iacute;nico n&atilde;o &eacute; balizador suficien
te para consubstanciar tal avalia&ccedil;&atilde;o. Geralmente, entram em quest&
atilde;o a aprecia&ccedil;&atilde;o da rede social e familiar de apoio e as cond
i&ccedil;&otilde;es de atendimento do servi&ccedil;o ambulatorial de contrarrefe
r&ecirc;ncia. Ainda, al&eacute;m das quest&otilde;es de cunho social e a disponi
bilidade e qualidade da rede de servi&ccedil;os de sa&uacute;de mental, existem 
as quest&otilde;es institucionais, como &eacute; o caso das interna&ccedil;&otil
de;es por determina&ccedil;&atilde;o judicial, que t&ecirc;m se tornado cada vez
 mais frequentes, sendo respons&aacute;veis por consider&aacute;veis aumentos no
 tempo de perman&ecirc;ncia na interna&ccedil;&atilde;o. </font></p>     ^cY#v60
n1a04.htm##
00770000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704053300078002001300611#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#73#69#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Em um momento no qual o processo d
e desinstitucionaliza&ccedil;&atilde;o encontra-se em curso, os indicadores taxa
 de perman&ecirc;ncia e taxa de reinterna&ccedil;&otilde;es psiqui&aacute;tricas
 oferecem recursos para a avalia&ccedil;&atilde;o do funcionamento da rede de se
rvi&ccedil;os &agrave; sa&uacute;de mental, nas suas dimens&otilde;es hospitalar
, extra-hospitalar e social, que n&atilde;o podem ser analisadas de forma isolad
a e fragmentada.</font></p>     ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#74#70#article#144#<p>&nbsp;</p>    
 ^cY#v60n1a04.htm##
00340000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010300078002001300181#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#75#71#article#144#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>AGRADECIMENTO</b></font></p>   
  ^cY#v60n1a04.htm##
00806000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704056900078002001300647#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#76#72#article#144#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Agradecemos pelo apoio recebido da
 Funda&ccedil;&atilde;o de Amparo &agrave; Pesquisa do Estado de S&atilde;o Paul
o (FAPESP) ao projeto de pesquisa do Programa de Pesquisa em Pol&iacute;ticas P&
uacute;blicas intitulado "Avalia&ccedil;&atilde;o de interna&ccedil;&otilde;es p
siqui&aacute;tricas na regi&atilde;o de Ribeir&atilde;o Preto - SP entre 1998-20
04 e suas rela&ccedil;&otilde;es com a rede extra-hospitalar de sa&uacute;de men
tal", processo nº 06/51736-6, que gerou este artigo.</font></p>     ^cY#v60n1a04
.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#77#73#article#144#<p>&nbsp;</p>    
 ^cY#v60n1a04.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#78#74#article#144#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b></font></p
>     ^cY#v60n1a04.htm##
00465000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704021400080002001300294#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#79#75#article#144#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Lay B, Lauber C, 
R&atilde;ssler W. Prediction of in-patient use in first-admitted patients with p
sychosis. Eur Psychiatry. 2006;21(6):401-9.    ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#80#76#article#144# </font></p>     
^cY#v60n1a04.htm##
00460000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704020900080002001300289#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#81#77#article#144#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Montgomery P, Kir
kpatrick H. Understanding those who seek frequent psychiatric hospitalizations. 
Arch Psychiatr Nurs. 2002;16(1):16-24.    ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#82#78#article#144# </font></p>     
^cY#v60n1a04.htm##
00503000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704025200080002001300332#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#83#79#article#144#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Lieberman PB, McP
hetres EB, Elliott B, Egerter E, Wiitala S. Dimensions and predictors of change 
during brief psychiatric hospitalization. Gen Hosp Psychiatry. 1993;15(5):316-24
.    ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#84#80#article#144# </font></p>     
^cY#v60n1a04.htm##
00454000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704020300080002001300283#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#85#81#article#144#4#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Hibbard T, Trimbo
li F. Correlates of successful short-term psychiatric hospitalization. Hosp Comm
unity Psychiatr. 1982;33:829-33.    ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#86#82#article#144# </font></p>     
^cY#v60n1a04.htm##
00439000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704018800080002001300268#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#87#83#article#144#5#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Caton CLM. Effect
 of length of inpatient treatment for chronic schizophrenia. Am J Psychiatry. 19
82;139(7):856-61.    ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#88#84#article#144# </font></p>     
^cY#v60n1a04.htm##
00544000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704029300080002001300373#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#89#85#article#144#6#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Dalgalarrondo P. 
Dura&ccedil;&atilde;o da interna&ccedil;&atilde;o em uma unidade psiqui&aacute;t
rica de hospital geral: a experi&ecirc;ncia do Hospital das Cl&iacute;nicas da U
NICAMP. J Bras Psiquiatr. 1993;42(1):15-7.    ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#90#86#article#144# </font></p>     
^cY#v60n1a04.htm##
00585000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704033400080002001300414#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#91#87#article#144#7#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Ribeiro MS, Siano
 AK, Proc&oacute;pio NA, Santos KHO, Alves MJM. Psychiatry in general hospital v
ersus psychiatric hospital: an initial study of evaluation of the assistance per
formed by the psychiatric residency of the HU-UF JF. HU Revista. 2000;25(3):167-
79.    ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#92#88#article#144# </font></p>     
^cY#v60n1a04.htm##
00512000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704026100080002001300341#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#93#89#article#144#8#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Souza JC, Souza N
, Caetano D. Tempo m&eacute;dio de hospitaliza&ccedil;&atilde;o em um hospital p
siqui&aacute;trico de Campo Grande, Mato Grosso do Sul. J Bras Psiquiatr. 2005;5
4(1):13-8.    ^cY#v60n1a04.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#94#90#article#144#</font></p>     ^
cY#v60n1a04.htm##
00524000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704027300080002001300353#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#95#91#article#144#9#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Brenner MK, Cardo
so VM, Oliveira RL, Fensterseifer, GP, Barraz, ACG, Boeira LB, et al. Mudan&cced
il;as na clientela de internados em hospital psiqui&aacute;trico. J Bras Psiquia
tr. 1999;48(9):415-20.    ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#96#92#article#144# </font></p>     
^cY#v60n1a04.htm##
00501000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704024900081002001300330#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#97#93#article#144#10#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Botega NJ, Sche
chtman A. Censo nacional de unidades de psiquiatria em hospitais gerais. I Situa
&ccedil;&atilde;o atual e tend&ecirc;ncias. Revista ABP-APAL. 1997;19(3):79-86. 
   ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#98#94#article#144# </font></p>     
^cY#v60n1a04.htm##
00685000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704043300081002001300514#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#99#95#article#144#11#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Barros RE. Cara
cteriza&ccedil;&atilde;o cl&iacute;nica-demogr&aacute;fica das interna&ccedil;&o
tilde;es psiqui&aacute;tricas na regi&atilde;o de Ribeir&atilde;o Preto-SP entre
 1998 e 2004 &#91;disserta&ccedil;&atilde;o&#93;. Ribeir&atilde;o Preto: Faculda
de de Medicina de Ribeir&atilde;o Preto, Universidade de S&atilde;o Paulo. Ribei
r&atilde;o Preto; 2008.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002100079002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#100#96#article#144# </font></p>    
 ^cY#v60n1a04.htm##
00428000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704017500082002001300257#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#101#97#article#144#12#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Geller MD. The
 "revolving door": a trap or a life style? Hosp Community Psychiatr. 1982;33(5):
388-9.    ^cY#v60n1a04.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#102#98#article#144#</font></p>     
^cY#v60n1a04.htm##
00436000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704018300082002001300265#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#103#99#article#144#13#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Rosenfeld AH. 
Closing the revolving door through family therapy. Hosp Community Psychiatr. 198
2;33(6):893-4.    ^cY#v60n1a04.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#104#100#article#144# </font></p>   
  ^cY#v60n1a04.htm##
00503000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024900083002001300332#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#105#101#article#144#14#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Bandeira M. D
esinstitucionaliza&ccedil;&atilde;o ou transinstitucionaliza&ccedil;&atilde;o: l
i&ccedil;&otilde;es de alguns pa&iacute;ses. J Bras Psiquiatr. 1991;40(7):335-60
.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#106#102#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00484000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023000083002001300313#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#107#103#article#144#15#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Dalgalarrondo
 P. Enfermarias de psiquiatria. In: Botega NJ, organizador. Servi&ccedil;os de s
a&uacute;de mental no hospital geral. Campinas: Papiros; 1995.    ^cY#v60n1a04.h
tm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#108#104#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00466000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704021200083002001300295#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#109#105#article#144#16#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Mello R, Fure
gato ARF. Interna&ccedil;&otilde;es psiqui&aacute;tricas no Rio de Janeiro de 19
96 a 2005. R Enferm UERJ. 2007;15(2):176-82.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#110#106#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00441000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704018700083002001300270#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#111#107#article#144#17#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Amaral MA. Sa
&uacute;de mental na rede b&aacute;sica: modelo assistencial. Rev Saude Publica.
 1997;31(3):288-95.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#112#108#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00553000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704029900083002001300382#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#113#109#article#144#18#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Parente CJS, 
Mendes LPF, Souza CNS, Silva DKM, Silva JC, Parente ACBV, et al. O fen&ocirc;men
o de revolving door em hospitais psiqui&aacute;tricos de uma capital do Nordeste
 brasileiro. REME Rev Min Enferm. 2007;11(4):381-6.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#114#110#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00570000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704031600083002001300399#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#115#111#article#144#19#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Saarento O, C
hristiansen L, Gostas G, Kakko H, Lonnerberg O, Muus S, et al. The Nordic compar
ative study on sectorised pscychiatry: repeated emergency admissions to inpatien
t care during a 1-year follow-up. Eur Psychiatry. 1998;13(8):385-91.    ^cY#v60n
1a04.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#116#112#article#144# </font></p>   
  ^cY#v60n1a04.htm##
00507000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704025300083002001300336#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#117#113#article#144#20#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Geller JL, Fi
sher WH, McDermeit M, Brown JM. The effects of public managed care on patterns o
f intensive use of inpatient psychiatric services. Psychiatr Serv. 1998;49(3):32
7-32.    ^cY#v60n1a04.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#118#114#article#144#</font></p>    
  ^cY#v60n1a04.htm##
00499000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024500083002001300328#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#119#115#article#144#21#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Swartz MS, Sw
anson JW, Hiday VA, Wagner HR, Burns BJ, Borum R. A randomized controlled trial 
of outpatient commitment in North Carolina. Psychiatr Serv. 2001;52(3):325-9.   
 ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#120#116#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00483000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704022900083002001300312#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#121#117#article#144#22#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Suzuki Y, Yas
umura S, Fukao A, Otani K. Associated factors of rehospitalization among schizop
hrenic patients. Psychiatry Clin Neurosci. 2003;57(6):555-61.    ^cY#v60n1a04.ht
m##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#122#118#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00511000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704025700083002001300340#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#123#119#article#144#23#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. Chinman MJ, W
eingarten R, Stayner D, Davidson L. Chronicity reconsidered: improving person-en
vironment fit through a consumer-run service. Community Ment Health J. 2001;37(3
):215-29.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#124#120#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00462000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704020800083002001300291#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#125#121#article#144#24#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24. Essock SM, Fr
isman LK, Kontos NJ. Cost-effectiveness of assertive community treatment teams. 
Am J Orthopsychiatry. 1998;68(2):179-90.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#126#122#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00625000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704037100083002001300454#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#127#123#article#144#25#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25. Sytema S, Phi
lip B, Tansella M. Does community care decrease length of stay and risk of rehos
pitalization in new patients with schizophrenia disorders? A comparative case re
gister study in Groningen, the Netherlands; Victoria, Australia; and South-Veron
a, Italy. Shizophr Bull. 2002;28(2):273-81.    ^cY#v60n1a04.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#128#124#article#144# </font></p>   
  ^cY#v60n1a04.htm##
00510000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704025600083002001300339#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#129#125#article#144#26#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26. Husted J, Jor
gens A. Best practices: population density as a factor in the rehospitalization 
of persons with serious and persistent mental illness. Psychiatr Serv. 2000;51(5
):603-5.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#130#126#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00555000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704030100083002001300384#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#131#127#article#144#27#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27. Korkeila JA, 
Lehtinen V, Tuori T, Helenius H. Patterns of psychiatric hospital service use in
 Finland: a national register study of hospital discharges in the early 1990s. S
oc Psychiatry Psychiatr Epidemiol. 1998;33(5):218-23.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#132#128#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00504000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704025000083002001300333#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#133#129#article#144#28#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">28. Kumar S, Robi
nson E, Kumar Sinha V. What leads to frequent re-hospitalisation when community 
care is not well developed? Soc Psychiatry Psychiatr Epidemiol. 2002;37(9):435-4
0.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#134#130#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00495000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024100083002001300324#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#135#131#article#144#29#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">29. Dalgalarrondo
 P, Botega NJ, Banzato CEM. Pacientes que se beneficiam de interna&ccedil;&atild
e;o psiqui&aacute;trica em hospital geral. Rev Saude Publica. 2010;37(5).    ^cY
#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#136#132#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00441000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704018700083002001300270#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#137#133#article#144#30#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">30. Mezzich JE, C
offman GA. Factors influencing length of hospital stay. Hosp Community Psychiatr
y. 1985;36:1262-70.    ^cY#v60n1a04.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#138#134#article#144#</font></p>    
 ^cY#v60n1a04.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#139#135#article#144#<p>&nbsp;</p>  
   ^cY#v60n1a04.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#140#136#article#144#<p>&nbsp;</p>  
   ^cY#v60n1a04.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704023200080002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#141#137#article#144#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="
/img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <
b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a04.htm##
00270000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704003100080002001300111#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#142#138#article#144#<br>    Vanessa
 Machado    ^cY#v60n1a04.htm##
00328000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704008900080002001300169#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#143#139#article#144#<br>    Rua Dom
 Lu&iacute;s do Amaral Mousinho, 2111, ap. 21, Parque Bandeirantes    ^cY#v60n1a
04.htm##
00295000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704005600080002001300136#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#144#140#article#144#<br>   14090-28
0 - Ribeir&atilde;o Preto, SP        ^cY#v60n1a04.htm##
00278000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704003900080002001300119#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#145#141#article#144#<br>   Telefone
: (16) 9609-0303    ^cY#v60n1a04.htm##
00342000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704010300080002001300183#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#146#142#article#144#<br>  E-mail: <
a href="mailto:vanesmachado@bol.com.br">vanesmachado@bol.com.br</a> </font></p> 
    ^cY#v60n1a04.htm##
00330000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009100080002001300171#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#147#143#article#144#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 9/8/2010    ^cY#v60n
1a04.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#p#148#144#article#144#<br>  Aprovado 
em 19/1/2011</font></p>     ^cY#v60n1a04.htm##
00554000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100013000790100016000920100
01700108012007500125030001500200710000200215065000900217064000500226031000300231
032000200234014000600236865000900242002001300251#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a04.htm#S#c#149#1#article#30#1#^rND^sLay^nB#^rND^sLauber^nC#^rN
D^sRãssler^nW#Prediction of in-patient use in first-admitted patients with psych
osis^len#Eur Psychiatry#2#20060000#2006#21#6#401-9#20110000#v60n1a04.htm##
00578000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100020000790100021000990120
07100120030002000191065000900211064000500220031000300225032000200228014000600230
865000900236002001300245035001000258801002000268#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a04.htm#S#c#150#2#article#30#2#^rND^sMontgomery^nP#^rND^sKirkpa
trick^nH#Understanding those who seek frequent psychiatric hospitalizations^len#
Arch Psychiatr Nurs#20020000#2002#16#1#16-24#20110000#v60n1a04.htm#0883-9417#Arc
h Psychiatr Nurs##
00675000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100020000790100020000990100
01700119010001700136010001700153012008100170030002000251065000900271064000500280
03100030028503200020028801400070029086500090029700200130030603500100031980100200
0329#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#151#3#article#3
0#3#^rND^sLieberman^nPB#^rND^sMcPhetres^nEB#^rND^sElliott^nB#^rND^sEgerter^nE#^r
ND^sWiitala^nS#Dimensions and predictors of change during brief psychiatric hosp
italization^len#Gen Hosp Psychiatry#19930000#1993#15#5#316-24#20110000#v60n1a04.
htm#0163-8343#Gen Hosp Psychiatry##
00521000000000265000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790100018000960120
06800114030002500182710000200207065000900209064000500218031000300223014000700226
865000900233002001300242#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm
#S#c#152#4#article#30#4#^rND^sHibbard^nT#^rND^sTrimboli^nF#Correlates of success
ful short-term psychiatric hospitalization^len#Hosp Community Psychiatr#2#198200
00#1982#33#829-33#20110000#v60n1a04.htm##
00535000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790120070000960300
01600166065000900182064000500191031000400196032000200200014000700202865000900209
002001300218035001000231801001600241#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a04.htm#S#c#153#5#article#30#5#^rND^sCaton^nCLM#Effect of length of inpatie
nt treatment for chronic schizophrenia^len#Am J Psychiatry#19820000#1982#139#7#8
56-61#20110000#v60n1a04.htm#0002-953X#Am J Psychiatry##
00593000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100023000790120123001020300
01700225065000900242064000500251031000300256032000200259014000500261865000900266
002001300275035001000288801001700298#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a04.htm#S#c#154#6#article#30#6#^rND^sDalgalarrondo^nP#Duração da internação
 em uma unidade psiquiátrica de hospital geral: a experiência do Hospital das Cl
ínicas da UNICAMP^lpt#J Bras Psiquiatr#19930000#1993#42#1#15-7#20110000#v60n1a04
.htm#0047-2085#J Bras Psiquiatr##
00741000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790100016000970100
01900113010001800132010001700150012016800167030001100335065000900346064000500355
03100030036003200020036301400070036586500090037200200130038103500100039480100110
0404#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#155#7#article#3
0#7#^rND^sRibeiro^nMS#^rND^sSiano^nAK#^rND^sProcópio^nNA#^rND^sSantos^nKHO#^rND^
sAlves^nMJM#Psychiatry in general hospital versus psychiatric hospital: an initi
al study of evaluation of the assistance performed by the psychiatric residency 
of the HU-UF JF^len#HU Revista#20000000#2000#25#3#167-79#20110000#v60n1a04.htm#0
103-3123#HU revista##
00617000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100015000950100
01700110012009800127030001700225065000900242064000500251031000300256032000200259
014000500261865000900266002001300275035001000288801001700298#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#156#8#article#30#8#^rND^sSouza^nJC#^rND
^sSouza^nN#^rND^sCaetano^nD#Tempo médio de hospitalização em um hospital psiquiá
trico de Campo Grande, Mato Grosso do Sul^lpt#J Bras Psiquiatr#20050000#2005#54#
1#13-8#20110000#v60n1a04.htm#0047-2085#J Bras Psiquiatr##
00740000000000373000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790100018000970100
01900115010002000134010000900154010001300163010001000176010001700186810000600203
01200650020903000170027406500090029106400050030003100030030503200020030801400070
0310865000900317002001300326035001000339801001700349#v60n1#V:\SciELO\serial\jbps
iq\v60n1\markup\v60n1a04.htm#S#c#157#9#article#30#9#^rND^sBrenner^nMK#^rND^sCard
oso^nVM#^rND^sOliveira^nRL#^rND^sFensterseifer#^rND^sGP#^rND^sBarraz#^rND^sACG#^
rND^sBoeira^nLB#et al#Mudanças na clientela de internados em hospital psiquiátri
co^lpt#J Bras Psiquiatr#19990000#1999#48#9#415-20#20110000#v60n1a04.htm#0047-208
5#J Bras Psiquiatr##
00596000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100020000980120
09700118030001700215065000900232064000500241031000300246032000200249014000600251
865000900257002001300266035001000279801001700289#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a04.htm#S#c#158#10#article#30#10#^rND^sBotega^nNJ#^rND^sSchecht
man^nA#Censo nacional de unidades de psiquiatria em hospitais gerais: I Situação
 atual e tendências^lpt#Revista ABP-APAL#19970000#1997#19#3#79-86#20110000#v60n1
a04.htm#0102-7646#Revista ABP-APAL##
00591000000000241000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160017000810180118000980460
01500216050006700231066001500298065000900313064000500322865000900327002001300336
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#159#11#article#30#1
1#^rND^sBarros^nRE#Caracterização clínica-demográfica das internações psiquiátri
cas na região de Ribeirão Preto-SP entre 1998 e 2004^lpt#Ribeirão Preto#Universi
dade de São Paulo^dFaculdade de Medicina de Ribeirão Preto#Ribeirão Preto#200800
00#2008#20110000#v60n1a04.htm##
00488000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810120050000980300
02500148710000200173065000900175064000500184031000300189032000200192014000600194
865000900200002001300209#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm
#S#c#160#12#article#30#12#^rND^sGeller^nMD#The "revolving door": a trap or a lif
e style?^len#Hosp Community Psychiatr#2#19820000#1982#33#5#388-9#20110000#v60n1a
04.htm##
00495000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100020000810120054001010300
02500155710000200180065000900182064000500191031000300196032000200199014000600201
865000900207002001300216#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm
#S#c#161#13#article#30#13#^rND^sRosenfeld^nAH#Closing the revolving door through
 family therapy^len#Hosp Community Psychiatr#2#19820000#1982#33#6#893-4#20110000
#v60n1a04.htm##
00549000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810120080000990300
01700179065000900196064000500205031000300210032000200213014000700215865000900222
002001300231035001000244801001700254#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a04.htm#S#c#162#14#article#30#14#^rND^sBandeira^nM#Desinstitucionalização o
u transinstitucionalização: lições de alguns países^lpt#J Bras Psiquiatr#1991000
0#1991#40#7#335-60#20110000#v60n1a04.htm#0047-2085#J Bras Psiquiatr##
00507000000000253000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100023000810120031001040160
01800135018004700153066000900200062000800209065000900217064000500226865000900231
002001300240#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#163#15#
article#30#15#^rND^sDalgalarrondo^nP#Enfermarias de psiquiatria^lpt#^rORG^sBoteg
a^nNJ#Serviços de saúde mental no hospital geral^lpt#Campinas#Papiros#19950000#1
995#20110000#v60n1a04.htm##
00521000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100020000960120
06300116030001400179710000200193065000900195064000500204031000300209032000200212
014000700214865000900221002001300230#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a04.htm#S#c#164#16#article#30#16#^rND^sMello^nR#^rND^sFuregato^nARF#Interna
ções psiquiátricas no Rio de Janeiro de 1996 a 2005^lpt#R Enferm UERJ#2#20070000
#2007#15#2#176-82#20110000#v60n1a04.htm##
00523000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810120053000980300
01800151065000900169064000500178031000300183032000200186014000700188865000900195
002001300204035001000217801001800227#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a04.htm#S#c#165#17#article#30#17#^rND^sAmaral^nMA#Saúde mental na rede bási
ca: modelo assistencial^lpt#Rev Saude Publica#19970000#1997#31#3#288-95#20110000
#v60n1a04.htm#0034-8910#Rev Saude Publica##
00699000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100018001000100
01700118010001700135010001600152010002000168810000600188012009800194030002000292
71000020031206500090031406400050032303100030032803200020033101400060033386500090
0339002001300348#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#166
#18#article#30#18#^rND^sParente^nCJS#^rND^sMendes^nLPF#^rND^sSouza^nCNS#^rND^sSi
lva^nDKM#^rND^sSilva^nJC#^rND^sParente^nACBV#et al#O fenômeno de revolving door 
em hospitais psiquiátricos de uma capital do Nordeste brasileiro^lpt#REME Rev Mi
n Enferm#2#20070000#2007#11#4#381-6#20110000#v60n1a04.htm##
00729000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100022000990100
01600121010001500137010002000152010001400172810000600186012013400192030001500326
71000020034106500090034306400050035203100030035703200020036001400070036286500090
0369002001300378#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#167
#19#article#30#19#^rND^sSaarento^nO#^rND^sChristiansen^nL#^rND^sGostas^nG#^rND^s
Kakko^nH#^rND^sLonnerberg^nO#^rND^sMuus^nS#et al#The Nordic comparative study on
 sectorised pscychiatry: repeated emergency admissions to inpatient care during 
a 1-year follow-up^len#Eur Psychiatry#2#19980000#1998#13#8#385-91#20110000#v60n1
a04.htm##
00654000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100017000980100
01900115010001600134012010200150030001500252065000900267064000500276031000300281
032000200284014000700286865000900293002001300302035001000315801001500325#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#168#20#article#30#20#^rND^s
Geller^nJL#^rND^sFisher^nWH#^rND^sMcDermeit^nM#^rND^sBrown^nJM#The effects of pu
blic managed care on patterns of intensive use of inpatient psychiatric services
^len#Psychiatr Serv#19980000#1998#49#3#327-32#20110000#v60n1a04.htm#1075-2730#Ps
ychiatr Serv##
00682000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100018000980100
01600116010001700132010001600149010001500165012007700180030001500257065000900272
06400050028103100030028603200020028901400060029186500090029700200130030603500100
0319801001500329#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#169
#21#article#30#21#^rND^sSwartz^nMS#^rND^sSwanson^nJW#^rND^sHiday^nVA#^rND^sWagne
r^nHR#^rND^sBurns^nBJ#^rND^sBorum^nR#A randomized controlled trial of outpatient
 commitment in North Carolina^len#Psychiatr Serv#20010000#2001#52#3#325-9#201100
00#v60n1a04.htm#1075-2730#Psychiatr Serv##
00640000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100018000970100
01500115010001500130012007300145030002500218065000900243064000500252031000300257
032000200260014000700262865000900269002001300278035001000291801002500301#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#170#22#article#30#22#^rND^s
Suzuki^nY#^rND^sYasumura^nS#^rND^sFukao^nA#^rND^sOtani^nK#Associated factors of 
rehospitalization among schizophrenic patients^len#Psychiatry Clin Neurosci#2003
0000#2003#57#6#555-61#20110000#v60n1a04.htm#1323-1316#Psychiatry Clin Neurosci##
00667000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100020000990100
01700119010001800136012009300154030002400247065000900271064000500280031000300285
032000200288014000700290865000900297002001300306035001000319801002400329#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#171#23#article#30#23#^rND^s
Chinman^nMJ#^rND^sWeingarten^nR#^rND^sStayner^nD#^rND^sDavidson^nL#Chronicity re
considered: improving person-environment fit through a consumer-run service^len#
Community Ment Health J#20010000#2001#37#3#215-29#20110000#v60n1a04.htm#0010-385
3#Community Ment Health J##
00597000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100018000980100
01700116012006200133030002100195065000900216064000500225031000300230032000200233
014000700235865000900242002001300251035001000264801002100274#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#172#24#article#30#24#^rND^sEssock^nSM#^
rND^sFrisman^nLK#^rND^sKontos^nNJ#Cost-effectiveness of assertive community trea
tment teams^len#Am J Orthopsychiatry#19980000#1998#68#2#179-90#20110000#v60n1a04
.htm#0002-9432#Am J Orthopsychiatry##
00719000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100016000970100
01800113012023400131030001400365710000200379065000900381064000500390031000300395
032000200398014000700400865000900407002001300416#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a04.htm#S#c#173#25#article#30#25#^rND^sSytema^nS#^rND^sPhilip^n
B#^rND^sTansella^nM#Does community care decrease length of stay and risk of reho
spitalization in new patients with schizophrenia disorders: A comparative case r
egister study in Groningen, the Netherlands; Victoria, Australia; and South-Vero
na, Italy^len#Shizophr Bull#2#20020000#2002#28#2#273-81#20110000#v60n1a04.htm##
00621000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100017000970120
13000114030001500244065000900259064000500268031000300273032000200276014000600278
865000900284002001300293035001000306801001500316#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a04.htm#S#c#174#26#article#30#26#^rND^sHusted^nJ#^rND^sJorgens^
nA#Best practices: population density as a factor in the rehospitalization of pe
rsons with serious and persistent mental illness^len#Psychiatr Serv#20000000#200
0#51#5#603-5#20110000#v60n1a04.htm#1075-2730#Psychiatr Serv##
00722000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100018001000100
01500118010001800133012012900151030003500280065000900315064000500324031000300329
032000200332014000700334865000900341002001300350035001000363801003500373#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#175#27#article#30#27#^rND^s
Korkeila^nJA#^rND^sLehtinen^nV#^rND^sTuori^nT#^rND^sHelenius^nH#Patterns of psyc
hiatric hospital service use in Finland: a national register study of hospital d
ischarges in the early 1990s^len#Soc Psychiatry Psychiatr Epidemiol#19980000#199
8#33#5#218-23#20110000#v60n1a04.htm#0933-7954#Soc Psychiatry Psychiatr Epidemiol
##
00653000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100018000960100
02100114012008800135030003500223065000900258064000500267031000300272032000200275
014000700277865000900284002001300293035001000306801003500316#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a04.htm#S#c#176#28#article#30#28#^rND^sKumar^nS#^rN
D^sRobinson^nE#^rND^sKumar Sinha^nV#What leads to frequent re-hospitalisation wh
en community care is not well developed^len#Soc Psychiatry Psychiatr Epidemiol#2
0020000#2002#37#9#435-40#20110000#v60n1a04.htm#0933-7954#Soc Psychiatry Psychiat
r Epidemiol##
00594000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100023000810100017001040100
01900121012007700140030001800217065000900235064000500244031000300249032000200252
865000900254002001300263035001000276801001800286#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a04.htm#S#c#177#29#article#30#29#^rND^sDalgalarrondo^nP#^rND^sB
otega^nNJ#^rND^sBanzato^nCEM#Pacientes que se beneficiam de internação psiquiátr
ica em hospital geral^lpt#Rev Saude Publica#20100000#2010#37#5#20110000#v60n1a04
.htm#0034-8910#Rev Saude Publica##
00552000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100018000990120
04800117030002600165065000900191064000500200031000300205014000800208865000900216
002001300225035001000238801002600248#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a04.htm#S#c#178#30#article#30#30#^rND^sMezzich^nJE#^rND^sCoffman^nGA#Factor
s influencing length of hospital stay^len#Hosp Community Psychiatry#19850000#198
5#36#1262-70#20110000#v60n1a04.htm#0022-1597#Hosp Community Psychiatry##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#o#1#1#article
#1#20110331#101353#v60n1a05.htm#144##
02626000000000613000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901200730
01690120054002420100038002960100036003340700039003700700037004090700055004460700
02900501083066400530085001001194085003001204085001801234085002801252083058401280
08500100186408500280187408500180190208500300192011700080195007200030195811200090
1961111001001970114000901980113001001989002001301999#v60n1#V:\SciELO\serial\jbps
iq\v60n1\markup\v60n1a05.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#ILUS#TAB#5#JBPS
IQ010#nd#J. bras. psiquiatr.#60#1#20110000#^f23^l27#0047-2085#Qualidade de vida 
de uma amostra de profissionais de educação física^lpt#Quality of life in a samp
le of physical educators^len#^rND^1A01 A02 A03^nJosé Carlos^sSouza#^rND^1A04^nDo
mingos Sávio da^sCosta#Universidade Estadual de Campinas^iA01#Faculdade de Medic
ina de Lisboa^iA02#Universidade Católica Dom Bosco^iA03^cCampo Grande^sMS#Univer
sidade Gama Filho^iA04#^lpt^aOBJETIVO: Avaliar a QV de professores de educação f
ísica. MÉTODO: Quantitativo e de corte transversal. Uma amostra de 200 professor
es preencheu voluntariamente o termo de consentimento, o questionário sociodemog
ráfico e o MOS (SF-36). Foi aplicado o teste não paramétrico da mediana de Mood,
 com 95% de confiabilidade. RESULTADOS: Os domínios que tiveram associação signi
ficativa com o sexo foram dor, capacidade funcional e saúde mental. As dimensões
 correlacionadas com a idade foram a capacidade funcional e os aspectos físicos.
 CONCLUSÃO: A presença de quadra na escola foi um fator positivo para a QV dos p
rofessores, ao contrário do tempo de docência.#^ddecs^i1#^tm^lpt^kQualidade de v
ida^i1#^tm^lpt^kSF-36^i1#^tm^lpt^keducador físico^i1#^len^aOBJECTIVE: To assess 
the QOL of physical educators. METHOD: A quantitative and cross-sectional study.
 A sample of 200 teachers completed the informed consent term, the sociodemograp
hic questionnaire and the MOS (SF-36). The Nonparametric Mood's Median Test was 
used, with a 95% reliability. RESULTS: The areas that were significantly associa
ted with sex were pain, functional capacity and mental health. The dimensions co
rrelated with age were the functional capacity and mental health. CONCLUSION: Th
e square presence was a positive and teaching time a negative QOL predictor.#^dd
ecs^i2#^tm^len^kQuality of life^i2#^tm^len^kSF-36^i2#^tm^len^kphysical educator^
i2#vancouv#19#20100730#30/7/2010#20110114#14/1/2011#v60n1a05.htm##
02703000000000613000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901200800
01690120061002490100038003100100036003480700039003840700037004230700055004600700
02900515083069900544085001001243085003001253085001801283085002801301083061201329
08500100194108500280195108500180197908500300199711700080202707200030203511200090
2038111001002047114000902057113001002066002001302076#v60n1#V:\SciELO\serial\jbps
iq\v60n1\markup\v60n1a05.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#ILUS#TAB#5#JBPS
IQ010#nd#J. bras. psiquiatr.#60#1#20110000#^f23^l27#0047-2085#<b>Qualidade de vi
da de uma amostra de profissionais de educação física</b>^lpt#<b>Quality of life
 in a sample of physical educators</b>^len#^rND^1A01 A02 A03^nJosé Carlos^sSouza
#^rND^1A04^nDomingos Sávio da^sCosta#Universidade Estadual de Campinas^iA01#Facu
ldade de Medicina de Lisboa^iA02#Universidade Católica Dom Bosco^iA03^cCampo Gra
nde^sMS#Universidade Gama Filho^iA04#^lpt^a<b>OBJETIVO:</b> Avaliar a QV de prof
essores de educação física. <b>MÉTODO:</b> Quantitativo e de corte transversal. 
Uma amostra de 200 professores preencheu voluntariamente o termo de consentiment
o, o questionário sociodemográfico e o MOS (SF-36). Foi aplicado o teste não par
amétrico da mediana de <i>Mood</i>, com 95% de confiabilidade. <b>RESULTADOS:</b
> Os domínios que tiveram associação significativa com o sexo foram dor, capacid
ade funcional e saúde mental. As dimensões correlacionadas com a idade foram a c
apacidade funcional e os aspectos físicos. <b>CONCLUSÃO:</b> A presença de quadr
a na escola foi um fator positivo para a QV dos professores, ao contrário do tem
po de docência.#^ddecs^i1#^tm^lpt^kQualidade de vida^i1#^tm^lpt^kSF-36^i1#^tm^lp
t^keducador físico^i1#^len^a<b>OBJECTIVE:</b> To assess the QOL of physical educ
ators. <b>METHOD:</b> A quantitative and cross-sectional study. A sample of 200 
teachers completed the informed consent term, the sociodemographic questionnaire
 and the MOS (SF-36). The Nonparametric Mood's Median Test was used, with a 95% 
reliability. <b>RESULTS:</b> The areas that were significantly associated with s
ex were pain, functional capacity and mental health. The dimensions correlated w
ith age were the functional capacity and mental health. <b>CONCLUSION:</b> The s
quare presence was a positive and teaching time a negative QOL predictor.#^ddecs
^i2#^tm^len^kQuality of life^i2#^tm^len^kSF-36^i2#^tm^len^kphysical educator^i2#
vancouv#19#20100730#30/7/2010#20110114#14/1/2011#v60n1a05.htm##
02769000000000637000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000200108049001000110
15800030012003000190012303100030014203200020014506500090014701400090015603500100
01650120073001750120054002480100038003020100036003400700041003760700039004170700
05700456070003100513083067300544085001001217085003001227085001801257085002801275
08305910130308500100189408500280190408500180193208500300195011700080198007200030
1988112000901991111001002000114000902010113001002019002001302029008008902042#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#l#4#1#article#1#^a2011#oa
#pt#br1.1#1#4.0#ilus#tab#5#JBPSIQ010#nd#J. bras. psiquiatr#60#1#20110000#^f23^l2
7#0047-2085#Qualidade de vida de uma amostra de profissionais de educação física
^lpt#Quality of life in a sample of physical educators^len#^rND^1A01 A02 A03^nJo
sé Carlos^sSouza#^rND^1A04^nDomingos Sávio da^sCosta#^iA01^1Universidade Estadua
l de Campinas#^iA02^1Faculdade de Medicina de Lisboa#^iA03^1Universidade Católic
a Dom Bosco^cCampo Grande^sMS#^iA04^1Universidade Gama Filho#^lpt^aOBJETIVO: Ava
liar a QV de professores de educação física. MÉTODO: Quantitativo e de corte tra
nsversal. Uma amostra de 200 professores preencheu voluntariamente o termo de co
nsentimento, o questionário sociodemográfico e o MOS (SF-36). Foi aplicado o tes
te não paramétrico da mediana de Mood, com 95 por cento de confiabilidade. RESUL
TADOS: Os domínios que tiveram associação significativa com o sexo foram dor, ca
pacidade funcional e saúde mental. As dimensões correlacionadas com a idade fora
m a capacidade funcional e os aspectos físicos. CONCLUSÃO: A presença de quadra 
na escola foi um fator positivo para a QV dos professores, ao contrário do tempo
 de docência.#^ddecs^i1#^tm^lpt^kQualidade de vida^i1#^tm^lpt^kSF-36^i1#^tm^lpt^
keducador físico^i1#^len^aOBJECTIVE: To assess the QOL of physical educators. ME
THOD: A quantitative and cross-sectional study. A sample of 200 teachers complet
ed the informed consent term, the sociodemographic questionnaire and the MOS (SF
-36). The Nonparametric Mood's Median Test was used, with a 95 percent reliabili
ty. RESULTS: The areas that were significantly associated with sex were pain, fu
nctional capacity and mental health. The dimensions correlated with age were the
 functional capacity and mental health. CONCLUSION: The square presence was a po
sitive and teaching time a negative QOL predictor.#^ddecs^i2#^tm^len^kQuality of
 life^i2#^tm^len^kSF-36^i2#^tm^len^kphysical educator^i2#vancouv#19#20100730#30/
7/2010#20110114#14/1/2011#v60n1a05.htm#Internet^ihttp://www.scielo.br/scielo.php
?script=sci_arttext&pid=S0047-20852011000100005##
00354000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704011900076002001300195#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#5#1#article#121#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ARTIGO ORIGINAL</b>
</font></p>     ^cY#v60n1a05.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#6#2#article#121#<p>&nbsp;</p>     ^
cY#v60n1a05.htm##
00439000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704020400076002001300280#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#7#3#article#121#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Qualidad
e de vida de uma amostra de profissionais de educa&ccedil;&atilde;o f&iacute;sic
a</b></font></p>     ^cY#v60n1a05.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#8#4#article#121#<p>&nbsp;</p>     ^
cY#v60n1a05.htm##
00374000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704013900076002001300215#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#9#5#article#121#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Quality of life in a sample of ph
ysical educators</b></font></p>     ^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#10#6#article#121#<p>&nbsp;</p>     
^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#11#7#article#121#<p>&nbsp;</p>     
^cY#v60n1a05.htm##
00407000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704017100077002001300248#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#12#8#article#121#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Jos&eacute; Carlos Souza<sup>I</
sup>; Domingos S&aacute;vio da Costa<sup>II</sup></b></font></p>     ^cY#v60n1a0
5.htm##
00460000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704022400077002001300301#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#13#9#article#121#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Universidade Estadual d
e Campinas (Unicamp), Faculdade de Medicina de Lisboa, Universidade Cat&oacute;l
ica Dom Bosco (UCDB), Campo Grande, MS    ^cY#v60n1a05.htm##
00304000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704006700078002001300145#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#14#10#article#121#<br> <sup>II</sup
>Universidade Gama Filho, UCDB</font></p>     ^cY#v60n1a05.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#15#11#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#16#12#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#17#13#article#121#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a05.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#18#14#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a05.htm##
00393000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015600078002001300234#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#19#15#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVO:</b> Avaliar a QV de p
rofessores de educa&ccedil;&atilde;o f&iacute;sica.    ^cY#v60n1a05.htm##
00560000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704032300078002001300401#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#20#16#article#121#<br>  <b>M&Eacute
;TODO:</b> Quantitativo e de corte transversal. Uma amostra de 200 professores p
reencheu voluntariamente o termo de consentimento, o question&aacute;rio sociode
mogr&aacute;fico e o MOS (SF-36). Foi aplicado o teste n&atilde;o param&eacute;t
rico da mediana de <i>Mood</i>, com 95% de confiabilidade.    ^cY#v60n1a05.htm##
00512000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704027500078002001300353#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#21#17#article#121#<br>  <b>RESULTAD
OS:</b> Os dom&iacute;nios que tiveram associa&ccedil;&atilde;o significativa co
m o sexo foram dor, capacidade funcional e sa&uacute;de mental. As dimens&otilde
;es correlacionadas com a idade foram a capacidade funcional e os aspectos f&iac
ute;sicos.    ^cY#v60n1a05.htm##
00423000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704018600078002001300264#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#22#18#article#121#<br>  <b>CONCLUS&
Atilde;O:</b> A presen&ccedil;a de quadra na escola foi um fator positivo para a
 QV dos professores, ao contr&aacute;rio do tempo de doc&ecirc;ncia. </font></p>
     ^cY#v60n1a05.htm##
00415000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017800078002001300256#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#23#19#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>Qualidade d
e vida, SF-36, educador f&iacute;sico. </font></p> <hr size="1" noshade>     ^cY
#v60n1a05.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#24#20#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a05.htm##
00366000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012900078002001300207#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#25#21#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVE:</b> To assess the QO
L of physical educators.    ^cY#v60n1a05.htm##
00496000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704025900078002001300337#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#26#22#article#121#<br>  <b>METHOD:<
/b> A quantitative and cross-sectional study. A sample of 200 teachers completed
 the informed consent term, the sociodemographic questionnaire and the MOS (SF-3
6). The Nonparametric Mood's Median Test was used, with a 95% reliability.    ^c
Y#v60n1a05.htm##
00453000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704021600078002001300294#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#27#23#article#121#<br>  <b>RESULTS:
</b> The areas that were significantly associated with sex were pain, functional
 capacity and mental health. The dimensions correlated with age were the functio
nal capacity and mental health.    ^cY#v60n1a05.htm##
00360000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012300078002001300201#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#28#24#article#121#<br>  <b>CONCLUSI
ON:</b> The square presence was a positive and teaching time a negative QOL pred
ictor.</font></p>     ^cY#v60n1a05.htm##
00401000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704016400078002001300242#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#29#25#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Quality of life, 
SF-36, physical educator.</font></p> <hr size="1" noshade>     ^cY#v60n1a05.htm#
#
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#30#26#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#31#27#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00351000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011400078002001300192#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#32#28#article#121#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde;O</b></f
ont></p>     ^cY#v60n1a05.htm##
01048000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704081100078002001300889#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#33#29#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O profissional de educa&ccedil;&at
ilde;o f&iacute;sica exerce suas fun&ccedil;&otilde;es dirigidas &agrave; educa&
ccedil;&atilde;o e &agrave; sa&uacute;de, com atividades voltadas &agrave; socie
dade, em locais como escolas, clubes, academias, hospitais, cl&iacute;nicas, ent
re outros. Ele trabalha com crian&ccedil;as, adolescentes, jovens, adultos e pes
soas da melhor idade, com o intuito de proporcionar educa&ccedil;&atilde;o, laze
r e sa&uacute;de por meio da atividade f&iacute;sica, contribuindo para a qualid
ade de vida (QV) da sociedade. Acredita-se que, para esse profissional desenvolv
er suas fun&ccedil;&otilde;es da melhor forma poss&iacute;vel, seja necess&aacut
e;rio estar gozando de plena sa&uacute;de<sup>1</sup>.</font></p>     ^cY#v60n1a
05.htm##
01676000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704143900078002001301517#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#34#30#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Conforme Kimura<sup>2</sup>, QV &e
acute; um conceito multidimensional e subjetivo e, apesar das controv&eacute;rsi
as quanto ao real significado dessa express&atilde;o, h&aacute; um consenso entr
e muitos autores quanto &agrave; inclus&atilde;o de aspectos relacionados &agrav
e; capacidade funcional, &agrave;s fun&ccedil;&otilde;es fisiol&oacute;gicas, ao
 comportamento afetivo e emocional, &agrave;s intera&ccedil;&otilde;es sociais, 
ao trabalho e &agrave; situa&ccedil;&atilde;o econ&ocirc;mica, centrados na aval
ia&ccedil;&atilde;o subjetiva dos indiv&iacute;duos. Dessa forma, a QV se aprese
nta como um constructo multifatorial, muito mais amplo do que a presen&ccedil;a 
ou aus&ecirc;ncia de sa&uacute;de. Nahas<sup>3</sup> explica que os fatores que 
determinam a QV das pessoas s&atilde;o muitos; a combina&ccedil;&atilde;o deles 
resulta numa rede de fen&ocirc;menos e situa&ccedil;&otilde;es que pode abstrata
mente ser chamada de QV. Geralmente, est&atilde;o associados a ela preditores co
mo estado de sa&uacute;de, longevidade, satisfa&ccedil;&atilde;o no trabalho, sa
l&aacute;rio, lazer, rela&ccedil;&otilde;es familiares, disposi&ccedil;&atilde;o
, prazer e espiritualidade. "Num sentido mais amplo, QV pode ser uma medida da p
r&oacute;pria dignidade do homem, pois pressup&otilde;e o atendimento das necess
idades humanas fundamentais"<sup>3</sup>. </font></p>     ^cY#v60n1a05.htm##
00983000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704074600078002001300824#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#35#31#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Muitos pesquisadores tentam um equ
il&iacute;brio entre uma abordagem da QV que enfatize o indiv&iacute;duo e uma a
bordagem particular e nomot&eacute;tica que enfatize o grupo e o geral. Alguns d
eles desenvolveram medidas psicom&eacute;tricas e instrumentos individualizados 
ou gerados pelos pacientes que permitem que o respondente escolha os aspectos da
 vida a serem inclu&iacute;dos na avalia&ccedil;&atilde;o da QV. Mas, geralmente
, os m&eacute;todos de avalia&ccedil;&atilde;o s&atilde;o padronizados de forma 
que as escalas de resposta sejam uniformes durante toda a administra&ccedil;&ati
lde;o do instrumento, como &eacute; o caso do MOS-SF-36<sup>4</sup>. </font></p>
     ^cY#v60n1a05.htm##
00811000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704057400078002001300652#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#36#32#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A QV no trabalho consiste em fator
es que melhoram as condi&ccedil;&otilde;es dele, com extens&atilde;o a todas as 
fun&ccedil;&otilde;es de qualquer natureza e n&iacute;vel hier&aacute;rquico. De
vem-se levar em conta as vari&aacute;veis comportamentais e organizacionais que 
venham, juntamente com as pol&iacute;ticas de recursos humanos condizentes, huma
nizar o emprego, obtendo-se um resultado satisfat&oacute;rio tanto para os empre
gados como para a organiza&ccedil;&atilde;o<sup>5</sup>. </font></p>     ^cY#v60
n1a05.htm##
00548000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704031100078002001300389#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#37#33#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Nesse contexto objetivou-se, nesta
 pesquisa, avaliar a QV relacionada &agrave; sa&uacute;de de uma amostra de prof
issionais de educa&ccedil;&atilde;o f&iacute;sica que atuam na rede p&uacute;bli
ca estadual e municipal de ensino.</font></p>     ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#38#34#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00340000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010300078002001300181#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#39#35#article#121#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>M&Eacute;TODO</b></font></p>   
  ^cY#v60n1a05.htm##
00502000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704026500078002001300343#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#40#36#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O m&eacute;todo foi quantitativo, 
explorat&oacute;rio, descritivo, comparativo e de corte transversal. A pesquisa 
foi aprovada pelo Comit&ecirc; de &Eacute;tica em Pesquisa da UCDB. </font></p> 
    ^cY#v60n1a05.htm##
00743000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704050600078002001300584#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#41#37#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A amostragem foi casual e por conv
eni&ecirc;ncia em uma popula&ccedil;&atilde;o total de 765 professores, sendo 41
5 deles das 87 escolas p&uacute;blicas municipais existentes e 350 professores d
as 84 escolas p&uacute;blicas estaduais. A amostra consistiu de 200 participante
s, que representou um percentual de 26% da popula&ccedil;&atilde;o total de prof
essores de Educa&ccedil;&atilde;o F&iacute;sica de Campo Grande, MS. </font></p>
     ^cY#v60n1a05.htm##
01919000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704168200078002001301760#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#42#38#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foi aplicado um question&aacute;ri
o sociodemogr&aacute;fico que inclu&iacute;a as vari&aacute;veis idade, sexo, es
cola, n&iacute;vel salarial, estado civil, ter ou n&atilde;o filhos, curso de at
ualiza&ccedil;&atilde;o, carga hor&aacute;ria semanal, atua&ccedil;&atilde;o for
a da escola p&uacute;blica, atua&ccedil;&atilde;o em outra &aacute;rea, estrutur
a f&iacute;sica dos locais em que atuava e tempo de atua&ccedil;&atilde;o como p
rofessor. Aplicou-se, tamb&eacute;m, o<i> Medical Outcomes Study 36item Short Fo
rm Health Survey</i> (SF-36), que &eacute; um question&aacute;rio multidimension
al formado por 36 itens, englobados em oito escalas ou componentes: Capacidade F
uncional (dez itens), Aspectos F&iacute;sicos (quatro itens), Dor (dois itens), 
Estado Geral de Sa&uacute;de (cinco itens), Vitalidade (quatro itens), Aspectos 
Sociais (dois itens), Aspectos Emocionais (tr&ecirc;s itens) e Sa&uacute;de Ment
al (cinco itens) e mais uma quest&atilde;o de avalia&ccedil;&atilde;o comparativ
a entre as condi&ccedil;&otilde;es de sa&uacute;de atual e a de um ano atr&aacut
e;s. Avalia tanto aspectos negativos da sa&uacute;de (doen&ccedil;a ou enfermida
de) como os aspectos positivos (bem-estar), apresentando um escore final de 0 a 
100, no qual 0 corresponde a pior estado geral de sa&uacute;de e 100 a melhor es
tado de sa&uacute;de, sendo analisada cada dimens&atilde;o em separado<sup>6,7</
sup>. Foi realizado um estudo piloto com tr&ecirc;s professores de educa&ccedil;
&atilde;o f&iacute;sica para averiguar a adapta&ccedil;&atilde;o dos instrumento
s &agrave; popula&ccedil;&atilde;o estudada. </font></p>     ^cY#v60n1a05.htm##
00986000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704074900078002001300827#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#43#39#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os question&aacute;rios foram envi
ados para todos os professores de Educa&ccedil;&atilde;o F&iacute;sica das escol
as p&uacute;blicas de Campo Grande, MS, por correspond&ecirc;ncia, utilizando-se
 a mala-direta das Secretarias Municipal e Estadual de Educa&ccedil;&atilde;o. O
s question&aacute;rios foram enviados aos diretores de todas as escolas p&uacute
;blicas, acompanhados de of&iacute;cios assinados pelos representantes das secre
tarias. Os diretores ficaram respons&aacute;veis por distribuir os instrumentos 
aos professores de Educa&ccedil;&atilde;o F&iacute;sica da sua escola e, ap&oacu
te;s o seu preenchimento, devolv&ecirc;-los &agrave;s suas secretarias. </font><
/p>     ^cY#v60n1a05.htm##
00864000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704062700078002001300705#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#44#40#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foi enviado um envelope grande, la
crado e personalizado, a cada professor de Educa&ccedil;&atilde;o F&iacute;sica,
 com dois envelopes dentro, um pardo e outro branco, sem nenhuma identifica&cced
il;&atilde;o. O envelope branco continha o Termo de Consentimento e o envelope p
ardo, o question&aacute;rio sociodemogr&aacute;fico e o SF-36. Ap&oacute;s serem
 preenchidos, deveriam ser recolocados no mesmo envelope e devolvidos &agrave;s 
suas secretarias. Os question&aacute;rios foram enviados e recebidos, preenchido
s, entre maio e junho de 2008.</font></p>     ^cY#v60n1a05.htm##
00488000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704025100078002001300329#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#45#41#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Na an&aacute;lise estat&iacute;sti
ca dos dados, foi aplicado o teste n&atilde;o param&eacute;trico da mediana de <
i>Mood</i>, com n&iacute;vel de confiabilidade de 95%.</font></p>     ^cY#v60n1a
05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#46#42#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#47#43#article#121#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font></p>     ^
cY#v60n1a05.htm##
00478000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704024100078002001300319#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#48#44#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os dados demogr&aacute;ficos e pro
fissionais dos professores de educa&ccedil;&atilde;o f&iacute;sica amostrados es
t&atilde;o na <a href="#tab01">tabela 1</a>.</font></p>     ^cY#v60n1a05.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#49#45#article#121#<p><a name="tab01
"></a></p>     ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#50#46#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#51#47#article#121#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a05tab01.jpg"></p>     ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#52#48#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00500000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704026300078002001300341#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#53#49#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A <a href="#tab02">tabela 2</a> ap
resenta as vari&aacute;veis sociodemogr&aacute;ficas que exibiram diferen&ccedil
;as estatisticamente significativas e os dom&iacute;nios do SF-36.</font></p>   
  ^cY#v60n1a05.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#54#50#article#121#<p><a name="tab02
"></a></p>     ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#55#51#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#56#52#article#121#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a05tab02.jpg"></p>     ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#57#53#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00804000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704056700078002001300645#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#58#54#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">As vari&aacute;veis sociodemogr&aa
cute;ficas e profissionais que n&atilde;o apresentaram diferen&ccedil;a signific
ativa com nenhum dom&iacute;nio do SF-36 foram o tipo de escola, renda, estado c
ivil, atualiza&ccedil;&atilde;o, carga hor&aacute;ria, atua&ccedil;&atilde;o for
a da escola e atua&ccedil;&atilde;o fora da &aacute;rea. Esse resultado signific
a que nenhum desses fatores interferia na QV dos profissionais de educa&ccedil;&
atilde;o f&iacute;sica quando comparados entre si.</font></p>     ^cY#v60n1a05.h
tm##
00540000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704030300078002001300381#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#59#55#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Com rela&ccedil;&atilde;o &agrave;
 idade dos profissionais, nas dimens&otilde;es Capacidade  Funcional e Limita&cc
edil;&otilde;es de Aspectos F&iacute;sicos, quanto  menor a idade, melhor era a 
QV nesses dom&iacute;nios.</font></p>     ^cY#v60n1a05.htm##
00682000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704044500078002001300523#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#60#56#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">As mulheres apresentaram &iacute;n
dices piores de QV em rela&ccedil;&atilde;o  aos homens nas dimens&otilde;es Cap
acidade Funcional, Dor  e Sa&uacute;de Mental. J&aacute; em rela&ccedil;&atilde;
o &agrave; vari&aacute;vel se o profissional  possu&iacute;a filhos, os que n&at
ilde;o os possu&iacute;am estavam com QV melhor  no dom&iacute;nio Capacidade Fu
ncional.</font></p>     ^cY#v60n1a05.htm##
00608000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704037100078002001300449#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#61#57#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A vari&aacute;vel se a escola poss
u&iacute;a quadra foi significativa em  rela&ccedil;&atilde;o ao dom&iacute;nio 
Estado Geral de Sa&uacute;de, e os profissionais  que trabalhavam em escolas que
 n&atilde;o possu&iacute;am quadra  apresentaram piores &iacute;ndices de QV nes
se componente.</font></p>     ^cY#v60n1a05.htm##
00628000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704039100078002001300469#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#62#58#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O tempo de atua&ccedil;&atilde;o d
o profissional foi significativo nas  dimens&otilde;es Capacidade Funcional, Dor
, Aspectos Sociais e  Limita&ccedil;&otilde;es de Aspectos Emocionais; em todas 
essas dimens&otilde;es,  os profissionais com mais tempo de trabalho possu&iacut
e;am  piores &iacute;ndices de QV.</font></p>     ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#63#59#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#64#60#article#121#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p>
     ^cY#v60n1a05.htm##
01402000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704116500078002001301243#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#65#61#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Houve equil&iacute;brio entre os p
rofessores avaliados neste estudo  com rela&ccedil;&atilde;o ao sexo, contrapond
o com Rocha e Fernandes<sup>8</sup>,  que realizaram um estudo com o objetivo de
 avaliar a QV  dos professores do ensino fundamental do munic&iacute;pio de Jequ
i&eacute;,  BA, utilizando o SF-36, e constataram que a maioria dos  profissiona
is era de mulheres (95,60%). Pereira<sup>9</sup> realizou um  estudo com o objet
ivo de identificar e analisar a percep&ccedil;&atilde;o  de QV, condi&ccedil;&ot
ilde;es de trabalho e estresse relacionado ao trabalho  de professores de educa&
ccedil;&atilde;o b&aacute;sica no munic&iacute;pio de  Florian&oacute;polis, SC,
 e verificou, tamb&eacute;m, que mais de 80% da  amostra eram de mulheres. Confo
rme o mesmo autor, esse  resultado confirma que a escola &eacute; um espa&ccedil
;o de trabalho  em que ainda predominam as mulheres, diverso da maioria  das pro
fiss&otilde;es; para ele, esse aspecto faz com que o trabalho  e qualquer an&aac
ute;lise da sa&uacute;de de profissionais apresentem caracter&iacute;sticas  sin
gulares.</font></p>     ^cY#v60n1a05.htm##
00721000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704048400078002001300562#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#66#62#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Na compara&ccedil;&atilde;o da QV 
em rela&ccedil;&atilde;o ao sexo, foram encontradas  diferen&ccedil;as significa
tivas nos dom&iacute;nios Dor, Capacidas de Funcional e Sa&uacute;de Mental, e a
s mulheres obtiveram escores piores que os homens. Rocha e Fernandes<sup>8</sup>
 justificaram esse fato pela dupla jornada exercida pelas mulheres, que se ocupa
m das atividades do lar e da profiss&atilde;o. </font></p>     ^cY#v60n1a05.htm#
#
00811000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704057400078002001300652#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#67#63#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O dom&iacute;nio Aspecto Social en
volve a intera&ccedil;&atilde;o familiar, com os amigos e a comunidade. Gon&cced
il;alves e cols.<sup>10</sup> enfocaram que, al&eacute;m das condi&ccedil;&otild
e;es f&iacute;sicas, as rela&ccedil;&otilde;es entre os professores, os alunos e
 a dire&ccedil;&atilde;o da escola podem ser determinantes importantes para a sa
&uacute;de e propuseram que as an&aacute;lises com essa popula&ccedil;&atilde;o 
sejam realizadas de forma mais ampla e interdisciplinar. </font></p>     ^cY#v60
n1a05.htm##
01299000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704106200078002001301140#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#68#64#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os resultados da compara&ccedil;&a
tilde;o entre a renda dos professores e os dom&iacute;nios analisados n&atilde;o
 apontaram diferen&ccedil;as significativas. As m&eacute;dias mais elevadas fora
m na capacidade funcional, com 90,29 para quem possu&iacute;a renda de 1 a 3 sal
&aacute;rios-m&iacute;nimos (SM), 87,24 para 3 a 5 SM e 91,45 para renda acima d
e 5 SM. Esse resultado apresenta distor&ccedil;&atilde;o em compara&ccedil;&atil
de;o ao relatado por Pereira<sup>9</sup>, segundo o qual a grande desvaloriza&cc
edil;&atilde;o salarial e o pouco incentivo para a educa&ccedil;&atilde;o contin
uada s&atilde;o quest&otilde;es comuns encontradas nos estudos<sup>10-12</sup>. 
Conforme aborda Lapo e Bueno<sup>13</sup>, os professores em muitas realidades f
ormam uma das categorias com menores sal&aacute;rios e isso est&aacute; diretame
nte relacionado &agrave; insatisfa&ccedil;&atilde;o e ao abandono do trabalho do
cente, com o direcionamento para outras ocupa&ccedil;&otilde;es. </font></p>    
 ^cY#v60n1a05.htm##
00954000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704071700078002001300795#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#69#65#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Segundo Silvany Neto<i> et al.</i>
<sup>14</sup> e Esteve<sup>15</sup>, a atividade docente, a longo prazo, pode re
sultar em patologias musculoesquel&eacute;ticas e psicol&oacute;gicas, muitas ve
zes relacionadas a quadros al&eacute;rgicos intensos, podendo acarretar absente&
iacute;smos. Laranjeira<sup>16</sup> destaca, tamb&eacute;m, o problema do prese
nte&iacute;smo. Embora o trabalho docente tenha sofrido altera&ccedil;&otilde;es
 ao longo do tempo, o professor n&atilde;o teve condi&ccedil;&otilde;es de criar
 meios para se adaptar &agrave;s mudan&ccedil;as, levando ao surgimento de deseq
uil&iacute;brios na estrutura corporal. </font></p>     ^cY#v60n1a05.htm##
01238000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704100100078002001301079#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#70#66#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A correla&ccedil;&atilde;o entre a
 carga hor&aacute;ria de trabalho dos professores e os dom&iacute;nios de QV n&a
tilde;o mostrou nenhuma diferen&ccedil;a significativa. Isso contradiz os achado
s de Pereira<sup>9</sup>, nos quais os professores com maior carga hor&aacute;ri
a apresentaram &iacute;ndices piores de QV. Considerando que o profissional de E
duca&ccedil;&atilde;o F&iacute;sica apresenta conhecimentos sobre a import&acirc
;ncia da atividade f&iacute;sica para sua sa&uacute;de cardiovascular, morfol&oa
cute;gica e mental, bem como tem autonomia para prescrever sua pr&oacute;pria ro
tina de exerc&iacute;cios, ele certamente ser&aacute; um indiv&iacute;duo mais a
tivo, prevenindo o surgimento de disfun&ccedil;&otilde;es hipocin&eacute;ticas. 
Diversos estudos confirmam que cargas hor&aacute;rias maiores est&atilde;o assoc
iadas tanto com pior QV quanto com o acometimento de patologias<sup>12,17-19</su
p>. </font></p>     ^cY#v60n1a05.htm##
00939000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704070200078002001300780#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#71#67#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Da mesma forma, Codo<sup>17</sup> 
verificou forte associa&ccedil;&atilde;o entre o tempo de doc&ecirc;ncia e maior
es preval&ecirc;ncias de <i>burnout</i>, sugerindo que o tempo de aposentadoria 
dos professores seja questionado. Observa-se que o tempo de atua&ccedil;&atilde;
o dos professores, tanto dos que trabalham em sala de aula como os que atuam for
a, gera um desgaste semelhante. No entanto, acredita-se que, por causa das ativi
dades pr&aacute;ticas realizadas pelos professores de Educa&ccedil;&atilde;o F&i
acute;sica, muitas vezes junto com seus alunos, estas possam atenuar os desgaste
s f&iacute;sico e mental.</font></p>     ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#72#68#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#73#69#article#121#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUS&Atilde;O</b></font></p>
     ^cY#v60n1a05.htm##
00770000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704053300078002001300611#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#74#70#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">As mulheres apresentaram pior QV e
m rela&ccedil;&atilde;o aos homens. A infraestrutura da escola onde trabalhava, 
como a exist&ecirc;ncia de quadra, foi um fator positivo para a QV dos professor
es, com rela&ccedil;&atilde;o ao seu estado geral de sa&uacute;de. Por outro lad
o, quanto mais tempo de trabalho na doc&ecirc;ncia, pior era a QV dos professore
s, no que dizia respeito &agrave; sua capacidade funcional, dor, aspectos sociai
s e emocionais. </font></p>     ^cY#v60n1a05.htm##
00728000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704049100078002001300569#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#75#71#article#121#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A presente amostra foi pequena e n
&atilde;o representativa dos profissionais de Educa&ccedil;&atilde;o F&iacute;si
ca. Novos estudos, mais amplos e representativos, devem ser realizados, inclusiv
e com outras classes profissionais, a fim de se compararem os resultados e se pr
oporem a&ccedil;&otilde;es preventivas que visem, em &uacute;ltima an&aacute;lis
e, &agrave; melhoria da QV da popula&ccedil;&atilde;o.</font></p>     ^cY#v60n1a
05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#76#72#article#121#<p>&nbsp;</p>    
 ^cY#v60n1a05.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#77#73#article#121#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b></font></p
>     ^cY#v60n1a05.htm##
00547000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704029600080002001300376#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#78#74#article#121#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Wong WS, Chan STM
, Fung VBK, Fielding R. The differential mediating effects of pain and depressio
n on the physical and mental dimension of quality of life in Hong Kong Chinese a
dults. Health Qual Life Outcomes. 2010;8:1-6.    ^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#79#75#article#121# </font></p>     
^cY#v60n1a05.htm##
00575000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704032400080002001300404#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#80#76#article#121#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Kimura M. Tradu&c
cedil;&atilde;o para o portugu&ecirc;s e valida&ccedil;&atilde;o do "Quality of 
life index" de Ferrans e Powers &#91;tese de livre-doc&ecirc;ncia&#93;. S&atilde
;o Paulo: Escola de Enfermagem da Universidade de S&atilde;o Paulo; 1999.    ^cY
#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#81#77#article#121# </font></p>     
^cY#v60n1a05.htm##
00427000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704017600080002001300256#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#82#78#article#121#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Nahas MV. Ativida
de f&iacute;sica, sa&uacute;de e qualidade de vida. 2ª ed. Londrina: Midiograf; 
2001.    ^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#83#79#article#121# </font></p>     
^cY#v60n1a05.htm##
00459000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704020800080002001300288#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#84#80#article#121#4#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Fleck MPA, et al.
 A avalia&ccedil;&atilde;o de qualidade de vida: guia para profissionais da sa&u
acute;de. Porto Alegre: Artmed; 2008.    ^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#85#81#article#121# </font></p>     
^cY#v60n1a05.htm##
00492000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704024100080002001300321#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#86#82#article#121#5#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Queiroz IS. Fator
es que influenciam a qualidade de vida no trabalho: um estudo de caso no Institu
to M&eacute;dico Legal de Campo Grande (MS). Campo Grande: UFMS; 2005.    ^cY#v6
0n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#87#83#article#121# </font></p>     
^cY#v60n1a05.htm##
00632000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704038100080002001300461#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#88#84#article#121#6#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Ciconelli RM. Tra
du&ccedil;&atilde;o para o portugu&ecirc;s e valida&ccedil;&atilde;o do question
&aacute;rio gen&eacute;rico de avalia&ccedil;&atilde;o de qualidade de vida &#91
;tese&#93;. S&atilde;o Paulo: Universidade Federal de S&atilde;o Paulo (EPM), De
partamento de Ci&ecirc;ncias M&eacute;dicas; 1997.    ^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#89#85#article#121# </font></p>     
^cY#v60n1a05.htm##
00471000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704022000080002001300300#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#90#86#article#121#7#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Ware JE, Sherbour
ne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework
 and item selection. Med Care. 1992;30(6):473-83.    ^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#91#87#article#121# </font></p>     
^cY#v60n1a05.htm##
00518000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704026700080002001300347#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#92#88#article#121#8#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Rocha VM, Fernand
es MHJ. Qualidade de vida de professores do ensino fundamental: uma perspectiva 
para a promo&ccedil;&atilde;o da sa&uacute;de do trabalhador. J Bras Psiquiatr. 
2008;57(1):23-7.    ^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#93#89#article#121# </font></p>     
^cY#v60n1a05.htm##
00601000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704035000080002001300430#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#94#90#article#121#9#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Pereira EF. Quali
dade de vida e condi&ccedil;&otilde;es de trabalho de professores de educa&ccedi
l;&atilde;o b&aacute;sica do munic&iacute;pio de Florian&oacute;polis - SC &#91;
disserta&ccedil;&atilde;o&#93;. Florian&oacute;polis: Universidade Federal de Sa
nta Catarina; 2008.    ^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#95#91#article#121# </font></p>     
^cY#v60n1a05.htm##
00524000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704027200081002001300353#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#96#92#article#121#10#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Gon&ccedil;alve
s CGO, Penteado RZ, Silv&eacute;rio KCA. Fonoaudiologia e sa&uacute;de do trabal
hador: a quest&atilde;o da sa&uacute;de vocal do professor. Sa&uacute;de em Revi
sta. 2005;7(15):45-51.    ^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#97#93#article#121# </font></p>     
^cY#v60n1a05.htm##
00522000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704027000081002001300351#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#98#94#article#121#11#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Gasparini SM, B
arreto SM, Assun&ccedil;&atilde;o AA. O professor, as condi&ccedil;&otilde;es de
 trabalho e os efeitos sobre sua sa&uacute;de. Educa&ccedil;&atilde;o e Pesquisa
. 2005;31(2):189-99.    ^cY#v60n1a05.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#99#95#article#121# </font></p>     
^cY#v60n1a05.htm##
00495000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704024200082002001300324#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#100#96#article#121#12#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Reis EJEB, Ara
&uacute;jo TM, Carvalho FM, Barbalho L, Silva MO. Doc&ecirc;ncia e exaust&atilde
;o emocional. Educa&ccedil;&atilde;o &amp; Sociedade. 2006;27(94):229-53.    ^cY
#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002100079002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#101#97#article#121# </font></p>    
 ^cY#v60n1a05.htm##
00466000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704021300082002001300295#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#102#98#article#121#13#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Lapo FR, Bueno
 B. Os professores, desencanto com a profiss&atilde;o e abandono do magist&eacut
e;rio. Cadernos de Pesquisa. 2003;118:65-88.    ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002100079002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#103#99#article#121# </font></p>    
 ^cY#v60n1a05.htm##
00552000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704029800083002001300381#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#104#100#article#121#14#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Silvany Neto 
AM, Ara&uacute;jo TM, Dultra FRD, et al. Condi&ccedil;&otilde;es de trabalho e s
a&uacute;de de professores da rede particular de ensino de Salvador, Bahia. Rev 
Baiana Sa&uacute;de P&uacute;blica. 2002;24:42-56.    ^cY#v60n1a05.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#105#101#article#121# </font></p>   
  ^cY#v60n1a05.htm##
00429000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704017500083002001300258#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#106#102#article#121#15#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Esteve JM. O 
mal-estar docente: a sala de aula e a sa&uacute;de dos professores. Bauru: EDUSC
; 1999.    ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#107#103#article#121#</font></p>    
 ^cY#v60n1a05.htm##
00472000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704021800083002001300301#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#108#104#article#121#16#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Laranjeira CA
. El contexto organizativo y la experiencia de stress: una perspectiva integrati
va. Rev Salud Publica (Bogota). 2009;11(1):123-33.    ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#109#105#article#121#</font></p>    
 ^cY#v60n1a05.htm##
00412000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704015800083002001300241#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#110#106#article#121#17#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Codo W. Educa
&ccedil;&atilde;o: carinho e trabalho. Petr&oacute;polis: Vozes; 1999.    ^cY#v6
0n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#111#107#article#121#</font></p>    
 ^cY#v60n1a05.htm##
00483000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704022900083002001300312#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#112#108#article#121#18#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Fuess VLR, Lo
renz MC. Disfonia em professores do ensino municipal: preval&ecirc;ncia e fatore
s de risco. Rev Bras Otorrinolaringologia. 2003;69(6):807-12.    ^cY#v60n1a05.ht
m##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#113#109#article#121#</font></p>    
 ^cY#v60n1a05.htm##
00440000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704018600083002001300269#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#114#110#article#121#19#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Rocha SSL, Fe
lli VEA. Qualidade de vida no trabalho docente em enfermagem. Rev Lat-Am Enferm.
 2004;12(1):28-35.    ^cY#v60n1a05.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#115#111#article#121#</font></p>    
 ^cY#v60n1a05.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#116#112#article#121#<p>&nbsp;</p>  
   ^cY#v60n1a05.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#117#113#article#121#<p>&nbsp;</p>  
   ^cY#v60n1a05.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704023200080002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#118#114#article#121#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="
/img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <
b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a05.htm##
00277000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704003800080002001300118#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#119#115#article#121#<br>  Jos&eacut
e; Carlos Souza    ^cY#v60n1a05.htm##
00304000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006500080002001300145#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#120#116#article#121#<br>  Rua Theot
&ocirc;nio Rosa Pires, 88, Vila Rosa Pires    ^cY#v60n1a05.htm##
00280000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004100080002001300121#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#121#117#article#121#<br> 79004-340 
- Campo Grande, MS    ^cY#v60n1a05.htm##
00303000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006400080002001300144#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#122#118#article#121#<br>  Telefone:
 (67) 3325-0990 / Telefax: (67) 9981-6271    ^cY#v60n1a05.htm##
00347000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704010800080002001300188#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#123#119#article#121#<br>  E-mail: <
a href="mailto:josecarlossouza@uol.com.br">josecarlossouza@uol.com.br</a></font>
</p>     ^cY#v60n1a05.htm##
00331000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009200080002001300172#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#124#120#article#121#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 30/7/2010    ^cY#v60
n1a05.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#p#125#121#article#121#<br>  Aprovado 
em 14/1/2011</font></p>     ^cY#v60n1a05.htm##
00650000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100015000790100016000940100
01600110010001800126012014600144030002600290710000200316065000900318064000500327
031000200332014000400334865000900338002001300347#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a05.htm#S#c#126#1#article#19#1#^rND^sWong^nWS#^rND^sChan^nSTM#^
rND^sFung^nVBK#^rND^sFielding^nR#The differential mediating effects of pain and 
depression on the physical and mental dimension of quality of life in Hong Kong 
Chinese adults^len#Health Qual Life Outcomes#2#20100000#2010#8#1-6#20110000#v60n
1a05.htm##
00535000000000241000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160016000790180089000950510
01500184046001000199050004800209045000900257044000500266865000900271002001300280
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#c#127#2#article#19#2#
^rND^sKimura^nM#Tradução para o português e validação do "Quality of life index"
 de Ferrans e Powers^lpt#livre-docência#São Paulo#Universidade de São Paulo^dEsc
ola de Enfermagem#19990000#1999#20110000#v60n1a05.htm##
00442000000000241000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160016000790180048000950630
00200143066000900145062001000154065000900164064000500173865000900178002001300187
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#c#128#3#article#19#3#
^rND^sNahas^nMV#Atividade física, saúde e qualidade de vida^lpt#2#Londrina#Midio
graf#20010000#2001#20110000#v60n1a05.htm##
00471000000000241000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160017000798100006000960180
07100102066001300173062000700186065000900193064000500202865000900207002001300216
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#c#129#4#article#19#4#
^rND^sFleck^nMPA#et al#A avaliação de qualidade de vida: guia para profissionais
 da saúde^lpt#Porto Alegre#Artmed#20080000#2008#20110000#v60n1a05.htm##
00507000000000229000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160018000790180126000970660
01300223062000500236065000900241064000500250865000900255002001300264#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#c#130#5#article#19#5#^rND^sQueiro
z^nIS#Fatores que influenciam a qualidade de vida no trabalho: um estudo de caso
 no Instituto Médico Legal de Campo Grande (MS)^lpt#Campo Grande#UFMS#20050000#2
005#20110000#v60n1a05.htm##
00544000000000229000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160020000790180101000990460
01000200050006800210045000900278044000500287865000900292002001300301#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#c#131#6#article#19#6#^rND^sCicone
lli^nRM#Tradução para o português e validação do questionário genérico de avalia
ção de qualidade de vida^lpt#São Paulo#Universidade Federal de São Paulo^dDepart
amento de Ciências Médicas#19970000#1997#20110000#v60n1a05.htm##
00578000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100015000790100021000940120
09700115030000900212065000900221064000500230031000300235032000200238014000700240
865000900247002001300256035001000269801000900279#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a05.htm#S#c#132#7#article#19#7#^rND^sWare^nJE#^rND^sSherbourne^
nCD#The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework an
d item selection^len#Med Care#19920000#1992#30#6#473-83#20110000#v60n1a05.htm#00
25-7079#Med Care##
00612000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100021000950120
11600116030001700232065000900249064000500258031000300263032000200266014000500268
865000900273002001300282035001000295801001700305#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a05.htm#S#c#133#8#article#19#8#^rND^sRocha^nVM#^rND^sFernandes^
nMHJ#Qualidade de vida de professores do ensino fundamental: uma perspectiva par
a a promoção da saúde do trabalhador^lpt#J Bras Psiquiatr#20080000#2008#57#1#23-
7#20110000#v60n1a05.htm#0047-2085#J Bras Psiquiatr##
00531000000000229000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160018000790180115000970460
01400212050003900226045000900265044000500274865000900279002001300288#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#c#134#9#article#19#9#^rND^sPereir
a^nEF#Qualidade de vida e condições de trabalho de professores de educação básic
a do município de Florianópolis - SC^lpt#Florianópolis#Universidade Federal de S
anta Catarina#20080000#2008#20110000#v60n1a05.htm##
00578000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100021000810100019001020100
02000121012008100141030001700222710000200239065000900241064000500250031000200255
032000300257014000600260865000900266002001300275#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a05.htm#S#c#135#10#article#19#10#^rND^sGonçalves^nCGO#^rND^sPen
teado^nRZ#^rND^sSilvério^nKCA#Fonoaudiologia e saúde do trabalhador: a questão d
a saúde vocal do professor^lpt#Saúde em Revista#2#20050000#2005#7#15#45-51#20110
000#v60n1a05.htm##
00609000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100020000810100018001010100
01900119012007100138030002000209065000900229064000500238031000300243032000200246
014000700248865000900255002001300264035001000277801002000287#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a05.htm#S#c#136#11#article#19#11#^rND^sGasparini^nS
M#^rND^sBarreto^nSM#^rND^sAssunção^nAA#O professor, as condições de trabalho e o
s efeitos sobre sua saúde^lpt#Educação e Pesquisa#20050000#2005#31#2#189-99#2011
0000#v60n1a05.htm#1517-9702#Educação e Pesquisa##
00629000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100017000980100
01900115010001800134010001600152012003400168030002100202065000900223064000500232
03100030023703200030024001400070024386500090025000200130025903500100027280100210
0282#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#c#137#12#article#
19#12#^rND^sReis^nEJEB#^rND^sAraújo^nTM#^rND^sCarvalho^nFM#^rND^sBarbalho^nL#^rN
D^sSilva^nMO#Docência e exaustão emocional^lpt#Educação & Sociedade#20060000#200
6#27#94#229-53#20110000#v60n1a05.htm#0101-7330#Educação & Sociedade##
00559000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100015000960120
07200111030002100183065000900204064000500213031000400218014000600222865000900228
002001300237035001000250801002100260#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a05.htm#S#c#138#13#article#19#13#^rND^sLapo^nFR#^rND^sBueno^nB#Os professor
es, desencanto com a profissão e abandono do magistério^lpt#Cadernos de Pesquisa
#20030000#2003#118#65-88#20110000#v60n1a05.htm#0100-1574#Cadernos de pesquisa##
00604000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100023000810100017001040100
01800121810000600139012009700145030002500242710000200267065000900269064000500278
031000300283014000600286865000900292002001300301#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a05.htm#S#c#139#14#article#19#14#^rND^sSilvany Neto^nAM#^rND^sA
raújo^nTM#^rND^sDultra^nFRD#et al#Condições de trabalho e saúde de professores d
a rede particular de ensino de Salvador, Bahia^lpt#Rev Baiana Saúde Pública#2#20
020000#2002#24#42-56#20110000#v60n1a05.htm##
00442000000000229000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160017000810180066000980660
00600164062000600170065000900176064000500185865000900190002001300199#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#c#140#15#article#19#15#^rND^sEste
ve^nJM#O mal-estar docente: a sala de aula e a saúde dos professores^lpt#Bauru#E
DUSC#19990000#1999#20110000#v60n1a05.htm##
00530000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100021000810120085001020300
02700187710000200214065000900216064000500225031000300230032000200233014000700235
865000900242002001300251#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm
#S#c#141#16#article#19#16#^rND^sLaranjeira^nCA#El contexto organizativo y la exp
eriencia de stress: una perspectiva integrativa^les#Rev Salud Publica (Bogota)#2
#20090000#2009#11#1#123-33#20110000#v60n1a05.htm##
00411000000000229000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160014000810180033000950660
01100128062000600139065000900145064000500154865000900159002001300168#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a05.htm#S#c#142#17#article#19#17#^rND^sCodo
^nW#Educação: carinho e trabalho^lpt#Petrópolis#Vozes#19990000#1999#20110000#v60
n1a05.htm##
00553000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100017000980120
08000115030003000195710000200225065000900227064000500236031000300241032000200244
014000700246865000900253002001300262#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a05.htm#S#c#143#18#article#19#18#^rND^sFuess^nVLR#^rND^sLorenz^nMC#Disfonia
 em professores do ensino municipal: prevalência e fatores de risco^lpt#Rev Bras
 Otorrinolaringologia#2#20030000#2003#69#6#807-12#20110000#v60n1a05.htm##
00516000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100017000980120
05600115030001800171710000200189065000900191064000500200031000300205032000200208
014000600210865000900216002001300225#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a05.htm#S#c#144#19#article#19#19#^rND^sRocha^nSSL#^rND^sFelli^nVEA#Qualidad
e de vida no trabalho docente em enfermagem^lpt#Rev Lat-Am Enferm#2#20040000#200
4#12#1#28-35#20110000#v60n1a05.htm##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#o#1#1#article
#1#20110331#101357#v60n1a06.htm#184##
03956000000000637000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901201050
01690120111002740100037003850100037004220700047004590700029005060700059005350700
03700594083121800631085001001849085002801859085001901887085002001906085002301926
08312070194908500100315608500280316608500200319408500200321408500220323411700080
3256072000303264112000903267111001003276114000903286113001003295002001303305#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#h#2#1#article#1#oa#pt#br1
.1#1#4.0#ILUS#TAB#6#JBPSIQ010#nd#J. bras. psiquiatr.#60#1#20110000#^f28^l33#0047
-2085#Relação entre o craving por tabaco e o craving por crack em pacientes inte
rnados para desintoxicação^lpt#Relationship between craving for tobacco and crav
ing for crack in patients hospitalized for detoxification^len#^rND^1A01 A02^nTaí
s Cardoso de^sZeni#^rND^1A03 A04^nRenata Brasil^sAraujo#Universidade Federal do 
Rio Grande do Sul^iA01#Escola de Saúde Pública^iA02#Pontifícia Universidade Cató
lica do Rio Grande do Sul^iA03#Hospital Psiquiátrico São Pedro^iA04#^lpt^aOBJETI
VO: Verificar se há relação entre aumento do craving por crack e aumento do crav
ing por tabaco em pacientes internados para desintoxicação. MÉTODO: Ensaio clíni
co tipo quase-experimental de análise quantitativa. Amostra composta por 32 home
ns dependentes de cocaína (crack) e tabaco, em duas a três semanas de abstinênci
a. Realizou-se intervenção em grupo, no qual, inicialmente, foram aplicados: CCQ
B (Cocaine Craving Questionnaire-Brief ), QSUB (Questionnaire of Smoking Urges-B
rief ) e BAI (Inventário Beck de Ansiedade). Em seguida, foram aplicadas imagens
 relacionadas ao crack e reaplicados CCQB, QSUB e BAI. Após, foi realizada entre
vista individual em que se aplicaram FSD (Ficha com Dados Sociodemográficos) e F
TND (Fagerström Test for Nicotine Dependence). RESULTADOS: A partir da exposição
 de imagens relativas ao crack, houve aumento significativo do craving por crack
, do craving por tabaco e dos sintomas de ansiedade, estando essas medidas corre
lacionadas positivamente entre si. CONCLUSÃO: Os resultados indicam uma associaç
ão significativa entre craving por crack e craving por tabaco, sugerindo que a a
bstinência de tabaco pode ajudar na eficácia do tratamento para dependência de c
rack.#^ddecs^i1#^tm^lpt^kCocaína (crack)^i1#^tm^lpt^ktabaco^i1#^tm^lpt^kcraving^
i1#^tm^lpt^ktratamento^i1#^len^aOBJECTIVE: Verify if there is a relationship bet
ween crack craving increase and tobacco craving increase in patients hospitalize
d for detoxification. METHOD: Quasi-experimental clinical trial using a quantita
tive analysis. Sample comprised 32 crack-cocaine and tobacco-dependent males, in
 2 to 3 weeks of abstinence. A group intervention was conducted to which initial
ly Cocaine Craving Questionnaire-Brief (CCQB), QSUB (Questionnaire of Smoking Ur
ges-Brief) and BAI (Beck Anxiety Inventory) were applied. Next, crack related im
ages were applied and CCQB, QSUB and BAI were reapplied. After that, an individu
al interview was conducted in which a form containing sociodemographic informati
on and data related to the pattern of consumption of psychoactive substances (FS
D) and Fagerström Test for Nicotine Dependence (FTND) were applied. RESULTS: Fol
lowing the crack related images exposure, there was a significant increase of cr
ack craving, tobacco craving and anxiety symptoms, being them positively correla
ted. CONCLUSION: Results show a significant association between crack craving an
d tobacco craving, suggesting that tobacco abstinence can help on effectiveness 
of cocaine dependence treatment.#^ddecs^i2#^tm^len^kCocaine (crack)^i2#^tm^len^k
tobacco^i2#^tm^len^kcraving^i2#^tm^len^ktreatment^i2#vancouv#30#20101206#6/12/20
10#20110127#27/1/2011#v60n1a06.htm##
04257000000000637000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901201330
01690120132003020100037004340100037004710700047005080700029005550700059005840700
03700643083136500680085001002045085003502055085001902090085002702109085002302136
08312840215908500100344308500350345308500200348808500270350808500220353511700080
3557072000303565112000903568111001003577114000903587113001003596002001303606#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#f#3#1#article#1#oa#pt#br1
.1#1#4.0#ILUS#TAB#6#JBPSIQ010#nd#J. bras. psiquiatr.#60#1#20110000#^f28^l33#0047
-2085#<b>Relação entre o <i>craving</i> por tabaco e o <i>craving</i> por <i>cra
ck</i> em pacientes internados para desintoxicação</b>^lpt#<b>Relationship betwe
en craving for tobacco and <i>craving</i> for <i>crack</i> in patients hospitali
zed for detoxification</b>^len#^rND^1A01 A02^nTaís Cardoso de^sZeni#^rND^1A03 A0
4^nRenata Brasil^sAraujo#Universidade Federal do Rio Grande do Sul^iA01#Escola d
e Saúde Pública^iA02#Pontifícia Universidade Católica do Rio Grande do Sul^iA03#
Hospital Psiquiátrico São Pedro^iA04#^lpt^a<b>OBJETIVO:</b> Verificar se há rela
ção entre aumento do <i>craving</i> por <i>crack</i> e aumento do <i>craving </i
>por tabaco em pacientes internados para desintoxicação. <b>MÉTODO: </b>Ensaio c
línico tipo quase-experimental de análise quantitativa. Amostra composta por 32 
homens dependentes de cocaína (<i>crack</i>) e tabaco, em duas a três semanas de
 abstinência. Realizou-se intervenção em grupo, no qual, inicialmente, foram apl
icados: CCQB (<i>Cocaine Craving Questionnaire-Brief </i>), QSUB (<i>Questionnai
re of Smoking Urges-Brief </i>) e BAI (Inventário Beck de Ansiedade). Em seguida
, foram aplicadas imagens relacionadas ao <i>crack</i> e reaplicados CCQB, QSUB 
e BAI. Após, foi realizada entrevista individual em que se aplicaram FSD (Ficha 
com Dados Sociodemográficos) e FTND (<i>Fagerstr</i>ö<i>m Test for Nicotine Depe
ndence</i>). <b>RESULTADOS:</b> A partir da exposição de imagens relativas ao <i
>crack</i>, houve aumento significativo do <i>craving</i> por <i>crack</i>, do <
i>craving </i>por tabaco e dos sintomas de ansiedade, estando essas medidas corr
elacionadas positivamente entre si. <b>CONCLUSÃO: </b>Os resultados indicam uma 
associação significativa entre <i>craving </i>por <i>crack</i> e <i>craving</i> 
por tabaco, sugerindo que a abstinência de tabaco pode ajudar na eficácia do tra
tamento para dependência de <i>crack</i>.#^ddecs^i1#^tm^lpt^kCocaína (<i>crack</
i>)^i1#^tm^lpt^ktabaco^i1#^tm^lpt^k<i>craving</i>^i1#^tm^lpt^ktratamento^i1#^len
^a<b>OBJECTIVE:</b> Verify if there is a relationship between <i>crack craving</
i> increase and tobacco craving increase in patients hospitalized for detoxifica
tion. <b>METHOD:</b> Quasi-experimental clinical trial using a quantitative anal
ysis. Sample comprised 32 <i>crack</i>-cocaine and tobacco-dependent males, in 2
 to 3 weeks of abstinence. A group intervention was conducted to which initially
 <i>Cocaine Craving Questionnaire-Brief</i> (CCQB), QSUB (<i>Questionnaire of Sm
oking Urges-Brief</i>) and BAI (Beck Anxiety Inventory) were applied. Next, crac
k related images were applied and CCQB, QSUB and BAI were reapplied. After that,
 an individual interview was conducted in which a form containing sociodemograph
ic information and data related to the pattern of consumption of psychoactive su
bstances (FSD) and <i>Fagerström Test for Nicotine Dependence</i> (FTND) were ap
plied. <b>RESULTS: </b>Following the crack related images exposure, there was a 
significant increase of <i>crack craving</i>, tobacco craving and anxiety sympto
ms, being them positively correlated. <b>CONCLUSION: </b>Results show a signific
ant association between <i>crack craving</i> and tobacco craving, suggesting tha
t tobacco abstinence can help on effectiveness of cocaine dependence treatment.#
^ddecs^i2#^tm^len^kCocaine (<i>crack</i>)^i2#^tm^len^ktobacco^i2#^tm^len^k<i>cra
ving</i>^i2#^tm^len^ktreatment^i2#vancouv#30#20101206#6/12/2010#20110127#27/1/20
11#v60n1a06.htm##
04083000000000661000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000200108049001000110
15800030012003000190012303100030014203200020014506500090014701400090015603500100
01650120105001750120111002800100037003910100037004280700049004650700031005140700
06100545070003900606083121800645085001001863085002801873085001901901085002001920
08500230194008312070196308500100317008500280318008500200320808500200322808500220
32481170008032700720003032781120009032811110010032901140009033001130010033090020
01303319008008903332#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#l
#4#1#article#1#^a2011#oa#pt#br1.1#1#4.0#ilus#tab#6#JBPSIQ010#nd#J. bras. psiquia
tr#60#1#20110000#^f28^l33#0047-2085#Relação entre o craving por tabaco e o cravi
ng por crack em pacientes internados para desintoxicação^lpt#Relationship betwee
n craving for tobacco and craving for crack in patients hospitalized for detoxif
ication^len#^rND^1A01 A02^nTaís Cardoso de^sZeni#^rND^1A03 A04^nRenata Brasil^sA
raujo#^iA01^1Universidade Federal do Rio Grande do Sul#^iA02^1Escola de Saúde Pú
blica#^iA03^1Pontifícia Universidade Católica do Rio Grande do Sul#^iA04^1Hospit
al Psiquiátrico São Pedro#^lpt^aOBJETIVO: Verificar se há relação entre aumento 
do craving por crack e aumento do craving por tabaco em pacientes internados par
a desintoxicação. MÉTODO: Ensaio clínico tipo quase-experimental de análise quan
titativa. Amostra composta por 32 homens dependentes de cocaína (crack) e tabaco
, em duas a três semanas de abstinência. Realizou-se intervenção em grupo, no qu
al, inicialmente, foram aplicados: CCQB (Cocaine Craving Questionnaire-Brief ), 
QSUB (Questionnaire of Smoking Urges-Brief ) e BAI (Inventário Beck de Ansiedade
). Em seguida, foram aplicadas imagens relacionadas ao crack e reaplicados CCQB,
 QSUB e BAI. Após, foi realizada entrevista individual em que se aplicaram FSD (
Ficha com Dados Sociodemográficos) e FTND (Fagerström Test for Nicotine Dependen
ce). RESULTADOS: A partir da exposição de imagens relativas ao crack, houve aume
nto significativo do craving por crack, do craving por tabaco e dos sintomas de 
ansiedade, estando essas medidas correlacionadas positivamente entre si. CONCLUS
ÃO: Os resultados indicam uma associação significativa entre craving por crack e
 craving por tabaco, sugerindo que a abstinência de tabaco pode ajudar na eficác
ia do tratamento para dependência de crack.#^ddecs^i1#^tm^lpt^kCocaína (crack)^i
1#^tm^lpt^ktabaco^i1#^tm^lpt^kcraving^i1#^tm^lpt^ktratamento^i1#^len^aOBJECTIVE:
 Verify if there is a relationship between crack craving increase and tobacco cr
aving increase in patients hospitalized for detoxification. METHOD: Quasi-experi
mental clinical trial using a quantitative analysis. Sample comprised 32 crack-c
ocaine and tobacco-dependent males, in 2 to 3 weeks of abstinence. A group inter
vention was conducted to which initially Cocaine Craving Questionnaire-Brief (CC
QB), QSUB (Questionnaire of Smoking Urges-Brief) and BAI (Beck Anxiety Inventory
) were applied. Next, crack related images were applied and CCQB, QSUB and BAI w
ere reapplied. After that, an individual interview was conducted in which a form
 containing sociodemographic information and data related to the pattern of cons
umption of psychoactive substances (FSD) and Fagerström Test for Nicotine Depend
ence (FTND) were applied. RESULTS: Following the crack related images exposure, 
there was a significant increase of crack craving, tobacco craving and anxiety s
ymptoms, being them positively correlated. CONCLUSION: Results show a significan
t association between crack craving and tobacco craving, suggesting that tobacco
 abstinence can help on effectiveness of cocaine dependence treatment.#^ddecs^i2
#^tm^len^kCocaine (crack)^i2#^tm^len^ktobacco^i2#^tm^len^kcraving^i2#^tm^len^ktr
eatment^i2#vancouv#30#20101206#6/12/2010#20110127#27/1/2011#v60n1a06.htm#Interne
t^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0047-2085201100010000
6##
00354000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704011900076002001300195#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#5#1#article#150#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ARTIGO ORIGINAL</b>
</font></p>     ^cY#v60n1a06.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#6#2#article#150#<p>&nbsp;</p>     ^
cY#v60n1a06.htm##
00499000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704026400076002001300340#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#7#3#article#150#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Rela&cce
dil;&atilde;o entre o <i>craving</i> por tabaco e o <i>craving</i> por <i>crack<
/i> em pacientes internados para desintoxica&ccedil;&atilde;o</b></font></p>    
 ^cY#v60n1a06.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#8#4#article#150#<p>&nbsp;</p>     ^
cY#v60n1a06.htm##
00445000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704021000076002001300286#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#9#5#article#150#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Relationship between craving for 
tobacco and <i>craving</i> for <i>crack</i> in patients hospitalized for detoxif
ication</b></font></p>     ^cY#v60n1a06.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#10#6#article#150#<p>&nbsp;</p>     
^cY#v60n1a06.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#11#7#article#150#<p>&nbsp;</p>     
^cY#v60n1a06.htm##
00400000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704016400077002001300241#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#12#8#article#150#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Ta&iacute;s Cardoso de Zeni<sup>
I</sup>; Renata Brasil Araujo<sup>II</sup></b></font></p>     ^cY#v60n1a06.htm##
00416000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704018000077002001300257#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#13#9#article#150#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Universidade Federal do
 Rio Grande do Sul (UFRGS), Escola de Sa&uacute;de P&uacute;blica (ESP/RS)    ^c
Y#v60n1a06.htm##
00407000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017000078002001300248#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#14#10#article#150#<br> <sup>II</sup
>Pontif&iacute;cia Universidade Cat&oacute;lica do Rio Grande do Sul (PUCRS), Ho
spital Psiqui&aacute;trico S&atilde;o Pedro (HPSP/RS)</font></p>     ^cY#v60n1a0
6.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#15#11#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#16#12#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#17#13#article#150#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a06.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#18#14#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a06.htm##
00516000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704027900078002001300357#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#19#15#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVO:</b> Verificar se h&aa
cute; rela&ccedil;&atilde;o entre aumento do <i>craving</i> por <i>crack</i> e a
umento do <i>craving </i>por tabaco em pacientes internados para desintoxica&cce
dil;&atilde;o.    ^cY#v60n1a06.htm##
01006000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704076900078002001300847#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#20#16#article#150#<br>  <b>M&Eacute
;TODO: </b>Ensaio cl&iacute;nico tipo quase-experimental de an&aacute;lise quant
itativa. Amostra composta por 32 homens dependentes de coca&iacute;na (<i>crack<
/i>) e tabaco, em duas a tr&ecirc;s semanas de abstin&ecirc;ncia. Realizou-se in
terven&ccedil;&atilde;o em grupo, no qual, inicialmente, foram aplicados: CCQB (
<i>Cocaine Craving Questionnaire-Brief </i>), QSUB (<i>Questionnaire of Smoking 
Urges-Brief </i>) e BAI (Invent&aacute;rio Beck de Ansiedade). Em seguida, foram
 aplicadas imagens relacionadas ao <i>crack</i> e reaplicados CCQB, QSUB e BAI. 
Ap&oacute;s, foi realizada entrevista individual em que se aplicaram FSD (Ficha 
com Dados Sociodemogr&aacute;ficos) e FTND (<i>Fagerstr</i>&ouml;<i>m Test for N
icotine Dependence</i>).    ^cY#v60n1a06.htm##
00527000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704029000078002001300368#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#21#17#article#150#<br>  <b>RESULTAD
OS:</b> A partir da exposi&ccedil;&atilde;o de imagens relativas ao <i>crack</i>
, houve aumento significativo do <i>craving</i> por <i>crack</i>, do <i>craving 
</i>por tabaco e dos sintomas de ansiedade, estando essas medidas correlacionada
s positivamente entre si.    ^cY#v60n1a06.htm##
00549000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704031200078002001300390#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#22#18#article#150#<br>  <b>CONCLUS&
Atilde;O: </b>Os resultados indicam uma associa&ccedil;&atilde;o significativa e
ntre <i>craving </i>por <i>crack</i> e <i>craving</i> por tabaco, sugerindo que 
a abstin&ecirc;ncia de tabaco pode ajudar na efic&aacute;cia do tratamento para 
depend&ecirc;ncia de <i>crack</i>. </font></p>     ^cY#v60n1a06.htm##
00431000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704019400078002001300272#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#23#19#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>Coca&iacute
;na (<i>crack</i>), tabaco, <i>craving</i>, tratamento.</font></p> <hr size="1" 
noshade>     ^cY#v60n1a06.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#24#20#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a06.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704023400078002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#25#21#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVE:</b> Verify if there 
is a relationship between <i>crack craving</i> increase and tobacco craving incr
ease in patients hospitalized for detoxification.    ^cY#v60n1a06.htm##
00976000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704073900078002001300817#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#26#22#article#150#<br>  <b>METHOD:<
/b> Quasi-experimental clinical trial using a quantitative analysis. Sample comp
rised 32 <i>crack</i>-cocaine and tobacco-dependent males, in 2 to 3 weeks of ab
stinence. A group intervention was conducted to which initially <i>Cocaine Cravi
ng Questionnaire-Brief</i> (CCQB), QSUB (<i>Questionnaire of Smoking Urges-Brief
</i>) and BAI (Beck Anxiety Inventory) were applied. Next, crack related images 
were applied and CCQB, QSUB and BAI were reapplied. After that, an individual in
terview was conducted in which a form containing sociodemographic information an
d data related to the pattern of consumption of psychoactive substances (FSD) an
d <i>Fagerstr&ouml;m Test for Nicotine Dependence</i> (FTND) were applied.    ^c
Y#v60n1a06.htm##
00441000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704020400078002001300282#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#27#23#article#150#<br>  <b>RESULTS:
 </b>Following the crack related images exposure, there was a significant increa
se of <i>crack craving</i>, tobacco craving and anxiety symptoms, being them pos
itively correlated.    ^cY#v60n1a06.htm##
00465000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704022800078002001300306#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#28#24#article#150#<br>  <b>CONCLUSI
ON: </b>Results show a significant association between <i>crack craving</i> and 
tobacco craving, suggesting that tobacco abstinence can help on effectiveness of
 cocaine dependence treatment. </font></p>     ^cY#v60n1a06.htm##
00418000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704018100078002001300259#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#29#25#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Cocaine (<i>crack
</i>), tobacco, <i>craving</i>, treatment.</font></p> <hr size="1" noshade>     
^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#30#26#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#31#27#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00351000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011400078002001300192#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#32#28#article#150#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde;O</b></f
ont></p>     ^cY#v60n1a06.htm##
01697000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704146000078002001301538#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#33#29#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O <i>craving</i> (ou fissura) pode
 ser definido como um intenso desejo de utilizar uma espec&iacute;fica subst&aci
rc;ncia, o qual engloba tamb&eacute;m, para alguns autores, a inten&ccedil;&atil
de;o de realizar esse desejo, a antecipa&ccedil;&atilde;o dos efeitos refor&cced
il;adores associados ao uso e o al&iacute;vio do afeto negativo e dos sintomas r
elacionados &agrave; abstin&ecirc;ncia<sup>1,2</sup>. O <i>craving</i> deve ser 
considerado uma vari&aacute;vel importante a ser observada no tratamento da depe
nd&ecirc;ncia qu&iacute;mica, pois deixa o dependente vulner&aacute;vel ao abuso
 de drogas e pode lev&aacute;-lo &agrave; reca&iacute;da e ao abandono terap&eci
rc;utico, mesmo diante da vontade convicta de manter-se abstinente e/ou depois d
e grandes per&iacute;odos de abstin&ecirc;ncia<sup>1,2</sup>. No caso espec&iacu
te;fico da depend&ecirc;ncia de <i>crack</i>, o <i>craving</i> &eacute; descrito
 como incontrol&aacute;vel pelos usu&aacute;rios, levando-os, em sua maioria, ao
 uso compulsivo, com padr&atilde;o di&aacute;rio de consumo e por at&eacute; nov
e dias cont&iacute;nuos, sendo s&oacute; finalizado quando &eacute; atingido o e
sgotamento f&iacute;sico, ps&iacute;quico e/ou financeiro<sup>3</sup>. Diante de
ssa realidade, o manejo do <i>craving</i> adquire grande import&acirc;ncia para 
a efic&aacute;cia do tratamento de dependentes de <i>crack</i>.</font></p>     ^
cY#v60n1a06.htm##
01723000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704148600078002001301564#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#34#30#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O <i>craving</i> pode ser desencad
eado pelo que se denominam gatilhos - situa&ccedil;&otilde;es, imagens, sons, od
ores -, que s&atilde;o sugest&otilde;es cognitivas internas ou ambientais paread
as ao uso da droga<sup>4</sup>. Esse fen&ocirc;meno acontece com o uso repetido,
 quando os est&iacute;mulos relacionados &agrave; droga passam a integrar uma re
de associativa armazenada na mem&oacute;ria<sup>5</sup>. Como consequ&ecirc;ncia
, os circuitos neurais podem se tornar hipersens&iacute;veis aos est&iacute;mulo
s associados &agrave; subst&acirc;ncia<sup>6</sup> e, quando o usu&aacute;rio &e
acute; exposto a esses est&iacute;mulos, os esquemas de a&ccedil;&atilde;o s&ati
lde;o ativados, desencadeando um forte desejo, a necessidade de consumir a droga
 e o comportamento de procura por ela<sup>7</sup>. Em geral, a ativa&ccedil;&ati
lde;o do <i>craving</i> envolve multideterminantes<sup>8</sup>, podendo ser dese
ncadeada tanto por est&iacute;mulos internos - por exemplo, certas emo&ccedil;&o
tilde;es/estados de humor - quanto externos (ambientais) - por exemplo, a presen
&ccedil;a de amigos, o local de uso, o toque de uma m&uacute;sica -, que depende
m do hist&oacute;rico de uso individual. Por isso, um dos principais objetivos d
o tratamento do dependente &eacute; descobrir quais s&atilde;o esses "gatilhos" 
e como eles podem desencadear uma situa&ccedil;&atilde;o de risco para a reca&ia
cute;da. </font></p>     ^cY#v60n1a06.htm##
01274000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704103700078002001301115#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#35#31#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Aparentemente, qualquer est&iacute
;mulo que foi repetidamente associado com o consumo de coca&iacute;na pode servi
r como gatilho para seu uso<sup>9</sup>. Pesquisas t&ecirc;m evidenciado que a n
icotina possui um papel facilitador para o uso de coca&iacute;na e de outras dro
gas il&iacute;citas<sup>10</sup> e que pessoas tabagistas s&atilde;o mais propen
sas a usar coca&iacute;na e <i>crack</i><sup>11</sup>, assim como t&ecirc;m suge
rido que a exposi&ccedil;&atilde;o &agrave; nicotina pode tanto aumentar a autoa
dministra&ccedil;&atilde;o de coca&iacute;na<sup>12 </sup>quanto servir como gat
ilho para disparar o <i>craving</i> por coca&iacute;na, especialmente em usu&aac
ute;rios de <i>crack</i><sup>13</sup>. Estudos cl&iacute;nicos demonstram que do
ses agudas de coca&iacute;na podem provocar um incremento na frequ&ecirc;ncia de
 fumar<sup>14</sup><sub>, </sub>assim como um aumento de grau de prazer e de pal
adar derivado dos cigarros<sup>13</sup>.</font></p>     ^cY#v60n1a06.htm##
01067000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704083000078002001300908#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#36#32#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Por serem ambas estimulantes do SN
C, a coca&iacute;na e a nicotina t&ecirc;m efeitos neuroqu&iacute;micos interati
vos semelhantes e s&atilde;o capazes de estimular diretamente a via dopamin&eacu
te;rgica<sup>15</sup>. No caso do <i>crack</i> (coca&iacute;na) e do tabaco (nic
otina), por serem administradas pela via pulmonar, &eacute; provocada, quase ime
diatamente, uma inunda&ccedil;&atilde;o dopamin&eacute;rgica<sup>16</sup>. Al&ea
cute;m disso, a nicotina e a coca&iacute;na t&ecirc;m efeitos subjetivos similar
es<sup>17</sup>: ambas podem produzir efeitos adversos no humor e efeitos equiva
lentes no desempenho de tarefas e em medidas fisiol&oacute;gicas, tais como a fr
equ&ecirc;ncia card&iacute;aca e a press&atilde;o arterial<sup>18</sup>. </font>
</p>     ^cY#v60n1a06.htm##
00579000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704034200078002001300420#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#37#33#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Embora esses achados da literatura
 n&atilde;o necessariamente proveem uma rela&ccedil;&atilde;o causal entre fumar
 tabaco e abusar de coca&iacute;na, eles demonstram um padr&atilde;o convincente
 de associa&ccedil;&atilde;o entre ambas as drogas<sup>17</sup>. </font></p>    
 ^cY#v60n1a06.htm##
00555000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704031800078002001300396#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#38#34#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Assim, o objetivo deste estudo foi
 verificar se h&aacute; associa&ccedil;&atilde;o entre o aumento do <i>craving</
i> pelo <i>crack</i> e o aumento do <i>craving </i>pelo tabaco em pacientes inte
rnados para desintoxica&ccedil;&atilde;o.</font></p>     ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#39#35#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00340000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010300078002001300181#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#40#36#article#150#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>M&Eacute;TODO</b></font></p>   
  ^cY#v60n1a06.htm##
00636000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704039900078002001300477#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#41#37#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O projeto desta pesquisa foi prime
iramente aprovado pelo Comit&ecirc; de &Eacute;tica em Pesquisa do Hospital Psiq
ui&aacute;trico S&atilde;o Pedro (HPSP/RS), e a assinatura do Termo de Consentim
ento Livre e Esclarecido (TCLE) foi considerada como pr&eacute;-condi&ccedil;&at
ilde;o para a participa&ccedil;&atilde;o. </font></p>     ^cY#v60n1a06.htm##
01156000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704091900078002001300997#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#42#38#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Este estudo caracteriza-se como um
 ensaio cl&iacute;nico do tipo quase-experimental. A amostra foi "por conveni&ec
irc;ncia", composta por pacientes internados em uma Unidade de Desintoxica&ccedi
l;&atilde;o Masculina, que tinham diagn&oacute;stico de depend&ecirc;ncia de coc
a&iacute;na (<i>crack</i>) e de tabaco pela CID-10 (Organiza&ccedil;&atilde;o Mu
ndial de Sa&uacute;de, 1993). Eles tinham o <i>crack</i> como droga de escolha e
 tinham usado essa subst&acirc;ncia, pela &uacute;ltima vez, h&aacute;, no m&iac
ute;nimo, duas e, no m&aacute;ximo, tr&ecirc;s semanas. Inicialmente, foram pesq
uisados 46 sujeitos, sendo exclu&iacute;dos 14, por estarem desmotivados para re
sponder aos question&aacute;rios, portarem diagn&oacute;stico de retardo mental 
e/ou apresentarem sintomas psic&oacute;ticos. A amostra final foi de 32 sujeitos
. </font></p>     ^cY#v60n1a06.htm##
00414000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017700078002001300255#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#43#39#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os instrumentos utilizados foram:<
/font></p> <font size="2" face="Verdana, Arial, Helvetica, sans-serif">     ^cY#
v60n1a06.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#44#40#article#150#<blockquote>     
^cY#v60n1a06.htm##
00941000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704070400078002001300782#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#45#41#article#150#<p>&#149; Invent&
aacute;rio Beck de Ansiedade (BAI) - desenvolvido por Beck e Steer (1993), valid
ado para o Brasil por Cunha<sup>19</sup>. Consiste em um question&aacute;rio que
 tem por objetivo medir a gravidade dos sintomas de ansiedade e &eacute; compost
o por 21 itens, com quatro op&ccedil;&otilde;es de respostas (0 = absolutamente 
n&atilde;o, 1 = levemente, 2 = moderadamente e 3 = gravemente). O escore total &
eacute; obtido pelo somat&oacute;rio dos escores de cada item. Os pontos de cort
e para pacientes psiqui&aacute;tricos s&atilde;o: de 0 a 10: m&iacute;nimo; de 1
1 a 19: leve; de 20 a 30: moderado; e de 31 a 63: grave. Foi aplicado antes e de
pois da interven&ccedil;&atilde;o.</p>     ^cY#v60n1a06.htm##
00684000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704044700078002001300525#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#46#42#article#150#<p>&#149; <i>Fage
rstr</i>&ouml;<i>m Test for Nicotine Dependence </i>(FTND) - desenvolvido por Fa
gerstr&ouml;m (1978), readaptado por Healtherton <i>et al.</i> (1991) e validado
 para tabagistas no Brasil por Carmo e Pueyo<sup>20</sup>. &Eacute; um teste que
 avalia o padr&atilde;o t&iacute;pico de fumar e classifica a depend&ecirc;ncia 
de nicotina em leve, moderada ou severa. Foi aplicado somente antes da interven&
ccedil;&atilde;o.</p>     ^cY#v60n1a06.htm##
00852000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704061500078002001300693#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#47#43#article#150#<p>&#149; <i>Coca
ine Craving Questionnaire-Brief</i> (CCQB) - desenvolvido por Sussner <i>et al.<
/i> (2006) e em processo de valida&ccedil;&atilde;o no Brasil por Araujo <i>et a
l.</i><sup>21</sup> para avaliar a presen&ccedil;a do <i>craving</i> por coca&ia
cute;na. &Eacute; composto por dez quest&otilde;es em uma escala anal&oacute;gic
a visual de sete pontos. Os participantes circulam a resposta de 1 (discordo tot
almente) at&eacute; 7 (concordo totalmente). A vers&atilde;o aplicada foi adapta
da para o <i>crack</i><sup>21 </sup>e a escala foi utilizada antes e depois da i
nterven&ccedil;&atilde;o.</p>     ^cY#v60n1a06.htm##
01573000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704133600078002001301414#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#48#44#article#150#<p>&#149; <i>Ques
tionnaire of Smoking Urges-Brief</i> (QSUB) - &eacute; uma escala abreviada elab
orada por Cox <i>et al.</i> (2001) do <i>Questionnaire of Smoking Urges </i>(Tif
fany e Drobes, 1991), validada no Brasil por Araujo <i>et al.</i><sup>22</sup> e
 utilizada para avaliar a presen&ccedil;a do <i>craving</i> por tabaco. O QSUB &
eacute; composto por dez quest&otilde;es afirmativas, diante das quais o indiv&i
acute;duo se posiciona utilizando uma escala de sete pontos que vai de "discor-d
o totalmente" at&eacute; "concordo totalmente". O QSUB pode ser analisado por me
io do somat&oacute;rio total de pontos, dos pontos das categorias, dos pontos do
s fatores 1 - quest&otilde;es 1, 3, 7 e 10 -, que avaliam o <i>craving</i> assoc
iado ao refor&ccedil;o positivo do uso do tabaco (por exemplo, "antecipa&ccedil;
&atilde;o do efeito positivo"), e dos pontos dos fatores 2 - quest&otilde;es 4, 
8 e 9 -, que avaliam o <i>craving </i>associado ao refor&ccedil;o negativo do ta
baco (por exemplo, "al&iacute;vio dos sintomas de abstin&ecirc;ncia ou afeto neg
ativo"). Os pontos de corte para o total de pontos da escala s&atilde;o: de 0 a 
13 pontos, <i>craving </i>m&iacute;nimo; de 14 a 26, leve; de 27 a 42, moderado;
 e de 43 ou mais pontos, <i>craving </i>intenso. Foi aplicado antes e depois da 
interven&ccedil;&atilde;o.</p>     ^cY#v60n1a06.htm##
00654000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704041700078002001300495#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#49#45#article#150#<p>&#149; Ficha d
e Dados Sociodemogr&aacute;ficos (FSD) e referentes ao padr&atilde;o de consumo 
de subst&acirc;ncias psicoativas - question&aacute;rio constru&iacute;do para id
entificar as caracter&iacute;sticas gerais da amostra e fatores relacionados ao 
consumo de <i>crack</i> e outras subst&acirc;ncias psicoativas. Foi aplicada som
ente ap&oacute;s a interven&ccedil;&atilde;o.</p> </blockquote> </font>     ^cY#
v60n1a06.htm##
00662000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704042500078002001300503#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#50#46#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os dados foram coletados em nove i
nterven&ccedil;&otilde;es realizadas em grupo, com dura&ccedil;&atilde;o de 40 m
inutos, e em entrevistas individuais, com dura&ccedil;&atilde;o de 25 minutos. O
 grupo deveria ser constitu&iacute;do de, no m&iacute;nimo, tr&ecirc;s e, no m&a
acute;ximo, seis participantes, por ades&atilde;o volunt&aacute;ria.</font></p> 
    ^cY#v60n1a06.htm##
01775000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704153800078002001301616#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#51#47#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">No dia da interven&ccedil;&atilde;
o em grupo, todos os pacientes internados na UD que preenchiam os crit&eacute;ri
os de inclus&atilde;o e que desejassem participar do estudo foram conduzidos a u
ma sala fechada com poucas interfer&ecirc;ncias externas (luz, calor, ru&iacute;
dos), onde se sentaram em cadeiras dispostas em c&iacute;rculo em torno de uma m
esa. Ap&oacute;s, cada um dos participantes se apresentou dizendo seu nome e que
 drogas j&aacute; havia experimentado. Inicialmente, foram avaliados individualm
ente os sintomas de ansiedade, o <i>craving</i> por tabaco e o <i>craving </i>po
r coca&iacute;na dos pacientes, por meio dos instrumentos BAI, CCQB e QSUB. Em u
m segundo momento, foi utilizado o m&eacute;todo de exposi&ccedil;&atilde;o de i
magens desenvolvido por Tifanny e Drobes<sup>23</sup>, em que oito imagens fotog
r&aacute;ficas relativas ao <i>crack</i> e seu uso ("pedras", cachimbos, latas) 
foram apresentadas em folhas no tamanho A4, durante 1 minuto. Em seguida, foram 
reaplicados os instrumentos BAI, CCQB e QSUB, a fim de avaliar se houve indu&cce
dil;&atilde;o do <i>craving</i> e dos sintomas de ansiedade. No intuito de delin
ear o perfil da amostra selecionada e avaliar se os sujeitos preenchiam mais alg
um crit&eacute;rio de exclus&atilde;o, foi realizada uma entrevista individual c
om aqueles participantes que concordaram em participar da interven&ccedil;&atild
e;o at&eacute; o fim, quando, ent&atilde;o, se aplicou a FSD.</font></p>     ^cY
#v60n1a06.htm##
00804000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704056700078002001300645#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#52#48#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os dados coletados foram analisado
s no programa <i>Statistical Package for the Social Sciences</i> - SPSS - vers&a
tilde;o 12.0. Os dados foram tratados estatisticamente, sendo feita uma An&aacut
e;lise Descritiva e de Frequ&ecirc;ncia dos dados sociodemogr&aacute;ficos e ref
erentes ao padr&atilde;o de consumo de subst&acirc;ncias psicoativas. Foi utiliz
ado o teste <i>t </i>de Student para amostras pareadas para o estudo inferencial
. O n&iacute;vel de signific&acirc;ncia foi de 5%.</font></p>     ^cY#v60n1a06.h
tm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#53#49#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#54#50#article#150#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font></p>     ^
cY#v60n1a06.htm##
01192000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704095500078002001301033#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#55#51#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Quanto &agrave;s caracter&iacute;s
ticas da amostra, a m&eacute;dia de idade dos participantes foi de 24,63 anos (S
D = 4,64; 18-40) e a m&eacute;dia de anos de escolaridade foi de 8,25 anos (SD =
 1,93; 4-12). Quanto ao estado civil, 66,7% eram solteiros, 12,1%, casados e 18,
2%, separados/divorciados. Quanto &agrave; proced&ecirc;ncia, 9,1% eram de Porto
 Alegre, 72,7%, da grande Porto Alegre, 6,1%, do interior do Rio Grande do Sul (
RS) e 9,1%, do litoral do RS. Quanto &agrave; ocupa&ccedil;&atilde;o, 12,2% esta
vam desempregados, 30,3% trabalhavam com carteira assinada, 42,4% eram aut&ocirc
;nomos e 6,1% estavam em licen&ccedil;a-sa&uacute;de, recebendo benef&iacute;cio
 do INSS. A renda mensal m&eacute;dia foi de R$ 606,56 (SD = 313,04; 0-1200), ap
roximadamente 1,46 sal&aacute;rio-m&iacute;nimo (SM) utilizando-se como base de 
c&aacute;lculo o SM de junho de 2008. </font></p>     ^cY#v60n1a06.htm##
00949000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704071200078002001300790#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#56#52#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Com rela&ccedil;&atilde;o ao uso d
e subst&acirc;ncias psicoativas, 100% eram dependentes de <i>crack</i>, 100%, de
 tabaco, 57,6%, de &aacute;lcool, 93,9%, de maconha e 24,2%, de solventes. A ida
de de in&iacute;cio do uso de tabaco foi, em m&eacute;dia, 14 anos (SD = 4,095; 
9-31) e de in&iacute;cio do uso de <i>crack</i>, em m&eacute;dia, de 19,50 anos 
(SD = 4,586; 14-34). Quanto ao uso do <i>crack</i>, os pacientes consumiam uma m
&eacute;dia de 67,73 pedras por semana (SD = 62,37; 14-280). Quanto &agrave; gra
vidade do tabagismo medida pela Fagerstr&ouml;m, 14 eram leves (43,8%), 11, mode
rados (34,4%) e 7, graves (21,9%). </font></p>     ^cY#v60n1a06.htm##
00762000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704052500078002001300603#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#57#53#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os resultados deste estudo demonst
raram, segundo autorrelato dos pacientes, que o <i>craving</i> por <i>crack</i> 
pode ser desencadeado por v&aacute;rios gatilhos: usar &aacute;lcool (em 81,3% d
a amostra; n = 26), sentir emo&ccedil;&otilde;es (raiva, tristeza, alegria) (96,
9%; n = 31), ter dinheiro na m&atilde;o (90,6%; n = 29), ver usu&aacute;rios de 
<i>crack</i> (78,1%; n = 25), sentir-se sozinho (40,6%; n = 13) e outros (20,1%;
 n = 9).</font></p>     ^cY#v60n1a06.htm##
00830000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704059300078002001300671#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#58#54#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Na <a href="#tab01">tabela 1</a>, 
&eacute; apresentada a compara&ccedil;&atilde;o, por meio do teste t de Student 
para amostras pareadas, das m&eacute;dias e desvios-padr&atilde;o de <i>craving<
/i> e ansiedade antes e depois da apresenta&ccedil;&atilde;o das imagens do <i>c
rack</i> e, na <a href="#tab02">tabela 2</a>, s&atilde;o apresentadas, segundo o
 coeficiente de correla&ccedil;&atilde;o linear de Spearman, as correla&ccedil;&
otilde;es relacionadas &agrave;s pontua&ccedil;&otilde;es no <i>craving</i>.</fo
nt></p>     ^cY#v60n1a06.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#59#55#article#150#<p><a name="tab01
"></a></p>     ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#60#56#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#61#57#article#150#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a06tab01.jpg"></p>     ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#62#58#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#63#59#article#150#<p><a name="tab02
"></a></p>     ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#64#60#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#65#61#article#150#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a06tab02.jpg"></p>     ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#66#62#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#67#63#article#150#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p>
     ^cY#v60n1a06.htm##
01011000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704077400078002001300852#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#68#64#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os achados da literatura relatam q
ue os dependentes de coca&iacute;na, em geral, abusam de m&uacute;ltiplas drogas
 ou t&ecirc;m hist&oacute;rico de consumo de outras subst&acirc;ncias psicoativa
s<sup>24,25</sup>. Concordando, em nossa amostra, os dependentes de <i>crack</i>
 (100%) s&atilde;o tamb&eacute;m dependentes de tabaco (100%), de maconha (93,9%
), de &aacute;lcool (57,6%) e de solventes (24,2%). Tal uso m&uacute;ltiplo de d
rogas pode produzir efeitos cl&iacute;nicos e comportamentais adversos, cumulati
vos e sin&eacute;rgicos, via intera&ccedil;&atilde;o entre as subst&acirc;ncias,
 podendo afetar o resultado do tratamento para depend&ecirc;ncia de coca&iacute;
na<sup>17</sup>. </font></p>     ^cY#v60n1a06.htm##
00860000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704062300078002001300701#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#69#65#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Para a maioria dos indiv&iacute;du
os desta amostra, segundo autorrelato, o <i>craving</i> por <i>crack</i> pode se
r desencadeado por est&iacute;mulos externos - usar &aacute;lcool (81,3%), ter d
inheiro na m&atilde;o (90,6%), ver usu&aacute;rios de <i>crack</i> (78,1%) - e p
or est&iacute;mulos internos como sentir emo&ccedil;&otilde;es - raiva, tristeza
, alegria (96,9%). Esses resultados sugerem algumas situa&ccedil;&otilde;es de r
isco de reca&iacute;da importantes de serem avaliadas no tratamento desses indiv
&iacute;duos<sup>1</sup>. </font></p>     ^cY#v60n1a06.htm##
01511000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704127400078002001301352#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#70#66#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">As pesquisas demonstram que a expo
si&ccedil;&atilde;o do indiv&iacute;duo a "gatilhos" ambientais previamente asso
ciados com o uso de coca&iacute;na produz uma resposta fortemente condicionada, 
caracterizada pela hiperexcita&ccedil;&atilde;o auton&ocirc;mica e pelo aumento 
nas medidas subjetivas do <i>craving</i> por coca&iacute;na<sup>26,27</sup>. A p
artir da exposi&ccedil;&atilde;o de imagens relativas ao uso de <i>crack</i> nes
te estudo, houve significativa indu&ccedil;&atilde;o do <i>craving</i> pelo <i>c
rack</i>. No entanto, alguns pacientes relataram que o "gatilho" que induziu o <
i>craving</i> pelo <i>crack</i> n&atilde;o foram as imagens fotogr&aacute;ficas,
 mas sim as falas e o comportamento dos outros pacientes, que se alteraram no mo
mento da apresenta&ccedil;&atilde;o das imagens, no qual g&iacute;rias e trejeit
os peculiares e caracter&iacute;sticos do uso de <i>crack</i> foram observados p
elo pesquisador. Portanto, essa ocorr&ecirc;ncia da comunica&ccedil;&atilde;o ve
rbal e n&atilde;o verbal entre os participantes durante a interven&ccedil;&atild
e;o n&atilde;o nos permite atribuir o aumento do <i>craving</i> somente &agrave;
 exposi&ccedil;&atilde;o das imagens.</font></p>     ^cY#v60n1a06.htm##
00687000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704045000078002001300528#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#71#67#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Somente uma minoria negou a indu&c
cedil;&atilde;o do <i>craving </i>pelas imagens, fato que pode ter ocorrido pela
 dificuldade de reconhecer em si o <i>craving</i>, pelo medo de relatar o <i>cra
ving </i>e ficar mais tempo internado - mesmo com a explica&ccedil;&atilde;o do 
TCLE - ou por estarem em ambiente protegido, continente e afastado do acesso &ag
rave; droga. </font></p>     ^cY#v60n1a06.htm##
01700000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704146300078002001301541#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#72#68#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foi encontrada uma associa&ccedil;
&atilde;o significativa entre o aumento do <i>craving</i> pelo <i>crack</i> e o 
aumento do <i>craving</i> pelo tabaco em pacientes internados para desintoxica&c
cedil;&atilde;o, propondo, assim, a exist&ecirc;ncia de uma rela&ccedil;&atilde;
o estreita entre o uso de <i>crack</i> e o uso de tabaco<sup>10-14</sup>. Um dad
o interessante foi que o <i>craving</i> pelo <i>crack</i> antes da interven&cced
il;&atilde;o teve correla&ccedil;&atilde;o positiva de intensidade moderada some
nte com o total de pontos do QSUB e com o fator 2 do QSUB, respons&aacute;vel pe
lo <i>craving </i>por causa do al&iacute;vio dos sintomas de abstin&ecirc;ncia e
 do afeto negativo, enquanto, depois da interven&ccedil;&atilde;o, ao ser confro
ntado com o est&iacute;mulo, foram observadas correla&ccedil;&otilde;es positiva
s de intensidades moderadas com o total de pontos do QSUB e tanto com o fator 2 
quanto com o fator 1, o qual &eacute; respons&aacute;vel pela antecipa&ccedil;&a
tilde;o do efeito positivo do tabaco. Esse fen&ocirc;meno demonstra o que Beck <
i>et al.</i><sup>1</sup> descrevem como a a&ccedil;&atilde;o de cren&ccedil;as a
ntecipat&oacute;rias quanto ao efeito positivo da subst&acirc;ncia que se ativam
 juntamente com o <i>craving </i>quando o indiv&iacute;duo tem contato com situa
&ccedil;&otilde;es-est&iacute;mulos relacionadas ao uso da droga. </font></p>   
  ^cY#v60n1a06.htm##
00853000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704061600078002001300694#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#73#69#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Entre o <i>crack </i>(coca&iacute;
na) e o tabaco, a semelhan&ccedil;a na a&ccedil;&atilde;o neuroqu&iacute;mica - 
r&aacute;pida e intensa - e a similaridade dos efeitos subjetivos estimulantes<s
up>15-18</sup> podem explicar por que essas subst&acirc;ncias s&atilde;o usadas 
de modo concorrente com grande frequ&ecirc;ncia e por que ocorreu, em nosso estu
do, uma correla&ccedil;&atilde;o positiva consistente entre o <i>craving </i>por
 <i>crack </i>e o <i>craving </i>por tabaco, tanto antes como depois da interven
&ccedil;&atilde;o. </font></p>     ^cY#v60n1a06.htm##
01794000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704155700078002001301635#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#74#70#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Outra explica&ccedil;&atilde;o pos
s&iacute;vel para esse resultado &eacute; de car&aacute;ter comportamental. Al&e
acute;m da semelhan&ccedil;a biomec&acirc;nica<sup>13</sup> - para usar a "pedra
", conforme relato dos pacientes, &eacute; preciso colocar cinzas de cigarro na 
base do cachimbo ou lata para que haja sua combust&atilde;o. Ou seja, adicionalm
ente &agrave; similaridade do ato motor de fumar, necessita-se obrigatoriamente 
do uso do tabaco para consumir <i>crack</i>. Em nossa amostra, alguns dependente
s de <i>crack</i> mencionaram que iniciaram o consumo do tabaco a partir do uso 
do <i>crack</i>, por causa de sua forma de administra&ccedil;&atilde;o. Aqueles 
que relataram o consumo do tabaco antes do in&iacute;cio de uso do <i>crack</i> 
referiram aumento na frequ&ecirc;ncia de fumar tabaco e na quantidade de cigarro
s a partir do in&iacute;cio do uso do <i>crack</i>, principalmente nos per&iacut
e;odos de uso compulsivo deste &uacute;ltimo. Esses comportamentos modificados (
in&iacute;cio e aumento do tabagismo) tamb&eacute;m podem estar ligados &agrave;
 correla&ccedil;&atilde;o positiva entre o <i>craving</i> por <i>crack</i> e o <
i>craving</i> por tabaco encontrada nesta pesquisa, pois a mem&oacute;ria do uso
 do <i>crack</i> pode ter servido como "gatilho" para o consumo do tabaco. Embor
a j&aacute; tenha sido citada na literatura<sup>28</sup>, essa hip&oacute;tese c
omportamental deve ser investigada mais criteriosamente em estudos posteriores. 
</font></p>     ^cY#v60n1a06.htm##
01731000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704149400078002001301572#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#75#71#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os resultados do nosso estudo demo
nstraram correla&ccedil;&otilde;es positivas de intensidade moderada entre os si
ntomas de ansiedade e o <i>craving</i> por <i>crack</i> antes da interven&ccedil
;&atilde;o e o <i>craving</i> por tabaco, tanto antes como depois da interven&cc
edil;&atilde;o, assim como correla&ccedil;&atilde;o positiva de intensidade alta
 entre os sintomas de ansiedade e <i>craving</i> por <i>crack</i> depois da inte
rven&ccedil;&atilde;o. Esses achados prop&otilde;em a exist&ecirc;ncia de mecani
smos comuns subjacentes a ambos, o que nos leva a deduzir que o aumento dos sint
omas de ansiedade est&aacute; relacionado com o aumento do <i>craving</i> e vice
-versa<sup>29</sup>. No entanto, como os pacientes n&atilde;o foram avaliados ne
ste estudo quanto &agrave; exist&ecirc;ncia de comorbidades psiqui&aacute;tricas
, altamente prevalentes em dependentes de drogas, que podem produzir aumento de 
sintomas depressivos/ansiosos, n&atilde;o se sabe se o aumento dos sintomas de a
nsiedade est&aacute; relacionado somente ao aumento do <i>craving</i>. De qualqu
er forma, independentemente da exist&ecirc;ncia ou n&atilde;o de comorbidades ps
iqui&aacute;tricas, sugere-se que a aprendizagem do manejo dos sintomas de ansie
dade, por fazerem parte da sintomatologia do <i>craving</i>, deva estar inclu&ia
cute;da no tratamento para depend&ecirc;ncia de <i>crack</i> a fim de evitar uma
 reca&iacute;da. </font></p>     ^cY#v60n1a06.htm##
00656000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704041900078002001300497#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#76#72#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">&Eacute; importante destacar que a
 alta preval&ecirc;ncia de depend&ecirc;ncia de maconha em nossa amostra pode se
r considerada um fator confundidor que pode ter afetado os resultados encontrado
s neste estudo, j&aacute; que essa subst&acirc;ncia tamb&eacute;m &eacute; utili
zada pela via fumada apresentada nos est&iacute;mulos visuais.</font></p>     ^c
Y#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#77#73#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#78#74#article#150#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUS&Otilde;ES</b></font></p
>     ^cY#v60n1a06.htm##
01575000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704133800078002001301416#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#79#75#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Em virtude da ocorr&ecirc;ncia de 
uma rela&ccedil;&atilde;o estreita entre o uso de coca&iacute;na e o uso do taba
co<sup>10-14 </sup>e das evid&ecirc;ncias de que a exposi&ccedil;&atilde;o &agra
ve; nicotina pode tanto aumentar a autoadministra&ccedil;&atilde;o de coca&iacut
e;na<sup>12</sup> quanto servir como "gatilho" para disparar o <i>craving</i> po
r coca&iacute;na, especialmente em usu&aacute;rios de <i>crack</i><sup>13</sup>,
 pode-se afirmar que foi demonstrada, neste estudo, a exist&ecirc;ncia de associ
a&ccedil;&atilde;o entre o <i>craving</i> por <i>crack</i> e o <i>craving</i> po
r tabaco. Como uma estrat&eacute;gia bem-sucedida para o tratamento da depend&ec
irc;ncia de psicoestimulantes, deve-se incluir o tratamento para depend&ecirc;nc
ia de nicotina, pois, por causa do papel proeminente dos receptores nicot&iacute
;nicos nos circuitos de recompensa de drogas<sup>30</sup>, o tratamento sin&eacu
te;rgico das duas depend&ecirc;ncias (<i>crack</i> e tabaco) nesses pacientes au
mentaria as chances de evitar uma reca&iacute;da para uso do <i>crack</i>. Porta
nto, sugere-se que, para a efic&aacute;cia do tratamento para depend&ecirc;ncia 
de <i>crack</i>, o usu&aacute;rio tamb&eacute;m deve ser motivado para a abstin&
ecirc;ncia do tabaco.</font></p>     ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#80#76#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00350000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011300078002001300191#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#81#77#article#150#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONFLITOS DE INTERESSES</b></fo
nt></p>     ^cY#v60n1a06.htm##
00376000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704013900078002001300217#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#82#78#article#150#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Este estudo n&atilde;o apresenta c
onflitos de interesse.</font></p>     ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#83#79#article#150#<p>&nbsp;</p>    
 ^cY#v60n1a06.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#84#80#article#150#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b></font></p
>     ^cY#v60n1a06.htm##
00446000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704019500080002001300275#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#85#81#article#150#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Beck A, Newman C,
 Wright F. Terapia cognitiva de las drogodependencias. Barcelona: Ediciones Paid
os Ib&eacute;rica; 2000.    ^cY#v60n1a06.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#86#82#article#150#</font></p>     ^
cY#v60n1a06.htm##
00511000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704026000080002001300340#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#87#83#article#150#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Araujo RB, Olivei
ra MS, Pedroso RS, Miguel AC, Castro MGT. Craving e depend&ecirc;ncia qu&iacute;
mica: conceito, avalia&ccedil;&atilde;o e tratamento. J Bras Psiquiatr. 2008;57(
1):57-63.    ^cY#v60n1a06.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#88#84#article#150# </font></p>     
^cY#v60n1a06.htm##
00549000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704029800080002001300378#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#89#85#article#150#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Nappo SA, Galdur&
oacute;z JC, Raymundo M, Carlini EA. Changes in cocaine use as viewed by key inf
ormants: a qualitative study carried out in 1994 and 1999 in S&atilde;o Paulo, B
razil. J Psychoactive Drugs. 2001;33(3):241-53.    ^cY#v60n1a06.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#90#86#article#150# </font></p>     
^cY#v60n1a06.htm##
00446000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704019500080002001300275#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#91#87#article#150#4#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Edwards G, Dare C
. Psicoterapia e tratamento das adi&ccedil;&otilde;es. Porto Alegre: Artes M&eac
ute;dicas; 1997. p. 247.    ^cY#v60n1a06.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#92#88#article#150# </font></p>     
^cY#v60n1a06.htm##
00494000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704024300080002001300323#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#93#89#article#150#5#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Johnsen HB, Laber
g CJ, Cox MW, Vaksdal A, Hugdahl K. Alcoholic subjects' attentional bias in the 
processing of alcohol-related words. Psychol Addict Behav. 1994;8:111-5.    ^cY#
v60n1a06.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#94#90#article#150# </font></p>     
^cY#v60n1a06.htm##
00463000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704021200080002001300292#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#95#91#article#150#6#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Robinson TE, Berr
idge KC. The neural basis of drug craving: an incentive-sensitization theory of 
addiction. Brain Res Rev. 1993;18:247-91.    ^cY#v60n1a06.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#96#92#article#150# </font></p>     
^cY#v60n1a06.htm##
00453000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704020200080002001300282#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#97#93#article#150#7#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Conklin AC, Tiffa
ny ST. Applying extinction research and theory to cue-exposure addiction treatme
nts. Addiction. 2002;97:155-67.    ^cY#v60n1a06.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#98#94#article#150# </font></p>     
^cY#v60n1a06.htm##
00457000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704020600080002001300286#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#99#95#article#150#8#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Wallace BC. Psych
ological and environmental determinants of relapse in crack cocaine smokers. J S
ubst Abuse Treat. 1989;6(2):95-106.    ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002100079002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#100#96#article#150# </font></p>    
 ^cY#v60n1a06.htm##
00423000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000200079704017100081002001300252#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#101#97#article#150#9#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Siegel RK. Cocai
ne smoking disorders: diagnosis and treatment. Psychiatr Ann. 1984;14(10):728-32
.    ^cY#v60n1a06.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#102#98#article#150#</font></p>     
^cY#v60n1a06.htm##
00493000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704024000082002001300322#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#103#99#article#150#10#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Martinez-Orteg
a JM, Jurado D, Martinez-Gonzalez MA, Gurpegui M. Nicotine dependence, use of il
legal drugs and psychiatric morbidity. Addict Behav. 2006;31(9):1722-9.    ^cY#v
60n1a06.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#104#100#article#150# </font></p>   
  ^cY#v60n1a06.htm##
00473000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704021900083002001300302#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#105#101#article#150#11#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Lai S, LaiI H
, Page JB, McCoy CB. The association between cigarette smoking and drug abuse in
 the United States. J Addict Dis. 2000;19(4):11-24.    ^cY#v60n1a06.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#106#102#article#150# </font></p>   
  ^cY#v60n1a06.htm##
00949000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704069500083002001300778#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#107#103#article#150#12#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Horger BA, Gi
les MK, Schenk S. Pre-exposure to amphetamine and nicotine predisposes rats to s
elf-administer a low dose of cocaine. Psychopharmacology. 1992;107:271-6. Dispon
&iacute;vel em: <a href="http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?PrId
=3051&amp;itool=Abstr actPlus-def&amp;uid=9862770&amp;db=pubmed&amp;url=http://j
pet.aspetjournals.org/cgi/pmidlookup?view=long&amp;pmid=9862770" target="_blank"
>http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?PrId=3051&itool=Abstr actPlu
s-def&uid=9862770&db=pubmed&url=http://jpet.aspetjournals.org/cgi/pmidlookup?vie
w=long&pmid=9862770</a>. Acesso em: 4 dez 2009.    ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#108#104#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00438000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704018400083002001300267#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#109#105#article#150#13#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Sees KL, Clar
k HW. When to begin smoking cessation in substance abusers. J Subst Abuse Treat.
 1993;10:189-95.    ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#110#106#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00498000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024400083002001300327#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#111#107#article#150#14#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Roll JM, Higg
ins ST, Tidey JW. Cocaine use can increase cigarette smoking: evidence from labo
ratory and naturalistic settings. Exp Clin Psychopharmacol. 1997;5(3):263-8.    
^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#112#108#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00468000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704021400083002001300297#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#113#109#article#150#15#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Di Chiara G. 
The role of dopamine in drug abuse viewed from the perspective of its role in mo
tivation. Drug Alcohol Depend. 1995;38:95-137.    ^cY#v60n1a06.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#114#110#article#150# </font></p>   
  ^cY#v60n1a06.htm##
00569000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704031500083002001300398#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#115#111#article#150#16#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Pontiere FE, 
Tanda G, Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentia
lly increase extracellular dopamine in the "shell" as compared with "core" of th
e rat nucleus accumbens. Proc Natl Acad Sci U S A. 1996;92:12304-8.    ^cY#v60n1
a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#116#112#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00488000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023400083002001300317#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#117#113#article#150#17#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Reid MS, Mick
allan JD, Delucchi KL, Hall SM, Berger SP. An acute dose of nicotine enhances cu
e-induced cocaine craving. Drug Alcohol Depend. 1998;49(2):95-104.    ^cY#v60n1a
06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#118#114#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00499000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024500083002001300328#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#119#115#article#150#18#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Higgins ST, B
ickel WK, Hughes JR, Lynn M, Capeless MA. Effects of intranasal cocaine on human
 learning, performance and physiology. Psychopharmacology. 1990;102(4):451-8.   
 ^cY#v60n1a06.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#120#116#article#150# </font></p>   
  ^cY#v60n1a06.htm##
00456000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704020200083002001300285#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#121#117#article#150#19#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Cunha JA. Man
ual da vers&atilde;o em portugu&ecirc;s das Escalas Beck. S&atilde;o Paulo: Casa
 do Psic&oacute;logo; 2001, 171 p.    ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#122#118#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00575000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704032100083002001300404#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#123#119#article#150#20#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Carmo JT, Pue
yo A. A adapta&ccedil;&atilde;o do portugu&ecirc;s do Fagerstr&ouml;m Test for N
icotine Dependence (FTND) para avaliar a depend&ecirc;ncia e toler&acirc;ncia &a
grave; nicotina em fumantes brasileiros. Rev Bras Med. 2002;59(12):73-80.    ^cY
#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#124#120#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00511000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704025700083002001300340#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#125#121#article#150#21#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Araujo RB, Pe
droso RS, Castro MGT. A adapta&ccedil;&atilde;o transcultural para o idioma port
ugu&ecirc;s do Cocaine Craving Questionnaire Brief. Rev Psiquiatr Clin. 2010;37(
5):195-8.    ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#126#122#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00804000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704055000083002001300633#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#127#123#article#150#22#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Araujo RB, Ol
iveira MS, Moraes JFD, Pedroso RS, Port F, Castro MGT. Valida&ccedil;&atilde;o d
a vers&atilde;o brasileira do Questionnaire of Smoking Urges-Brief. Rev Psiquiat
r Clin. 2007;34(4):166-75. Dispon&iacute;vel em: <a href="http://www.scielo.br/s
cielo.php?script=sci_arttext&amp;pid=S0101608320 07000400002&amp;lng=en&amp;nrm=
iso" target="_blank">http://www.scielo.br/scielo.php?script=sci_arttext&pid=S010
1608320 07000400002&lng=en&nrm=iso</a>. Acesso em: 4 dez 2009.    ^cY#v60n1a06.h
tm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#128#124#article#150# </font></p>   
  ^cY#v60n1a06.htm##
00449000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019500083002001300278#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#129#125#article#150#23#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. Tiffany ST, D
robes DJ. Imagery and smoking urges: the manipulation of affective content. Addi
ct Behav. 1990;15(6):531-9.    ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#130#126#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00493000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023900083002001300322#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#131#127#article#150#24#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24. Ferreira Filh
o O. Perfil sociodemogr&aacute;fico e de padr&otilde;es de uso entre dependentes
 de coca&iacute;na hospitalizados. Rev Saude Publica. 2003;37(6):751-9.    ^cY#v
60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#132#128#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00468000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704021400083002001300297#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#133#129#article#150#25#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25. Duailibi LB, 
Ribeiro M, Laranjeira R. Perfil dos usu&aacute;rios de coca&iacute;na e crack no
 Brasil. Cad Saude Publica. 2008;24(4):545-57.    ^cY#v60n1a06.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#134#130#article#150# </font></p>   
  ^cY#v60n1a06.htm##
00489000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023500083002001300318#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#135#131#article#150#26#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26. Ehrman RN, Ro
bbins SJ, Childress AR, O'Brien CP. Conditioned responses to cocaine-related sti
muli in cocaine abuse patients. Psychopharmacology. 1992;107:523-9.    ^cY#v60n1
a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#136#132#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00503000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024900083002001300332#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#137#133#article#150#27#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27. O'Brien CP, C
hildress AR, McLellan T, Ehrman R. Integrating systemic cue exposure with standa
rd treatment in recovering drug dependent patients. Addict Behav. 1990;15:355-65
.    ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#138#134#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00441000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704018700083002001300270#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#139#135#article#150#28#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">28. Wiseman EJ. N
icotine dependence and withdrawal in cocaine-dependent patients. Arch Gen Psychi
atry. 2000;56:85-9.    ^cY#v60n1a06.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#140#136#article#150# </font></p>   
  ^cY#v60n1a06.htm##
00453000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019900083002001300282#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#141#137#article#150#29#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">29. Roelofs S. Hy
perventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal synd
rome. Alcohol. 1985;2(3):501-5.    ^cY#v60n1a06.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#142#138#article#150# </font></p>   
  ^cY#v60n1a06.htm##
00475000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704022100083002001300304#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#143#139#article#150#30#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">30. Bechtholt A, 
Mark G. Enhancement of cocaine-seeking behavior by repeated nicotine exposure in
 rats. Psychopharmacology (Berl). 2002;162(2):178-85.    ^cY#v60n1a06.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#144#140#article#150#</font></p>    
 ^cY#v60n1a06.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#145#141#article#150#<p>&nbsp;</p>  
   ^cY#v60n1a06.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#146#142#article#150#<p>&nbsp;</p>  
   ^cY#v60n1a06.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704023200080002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#147#143#article#150#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="
/img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <
b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a06.htm##
00282000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004300080002001300123#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#148#144#article#150#<br>    Ta&iacu
te;s Cardoso de Zeni    ^cY#v60n1a06.htm##
00308000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006900080002001300149#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#149#145#article#150#<br>    Rua Fer
reira Viana, 649/203, Bairro Petr&oacute;polis    ^cY#v60n1a06.htm##
00282000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004300080002001300123#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#150#146#article#150#<br>   90670-10
0 - Porto Alegre, RS    ^cY#v60n1a06.htm##
00279000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004000080002001300120#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#151#147#article#150#<br>    Telefon
e: (51) 8133-8527    ^cY#v60n1a06.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009800080002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#152#148#article#150#<br>    E-mail:
 <a href="mailto:taiszeni@hotmail.com">taiszeni@hotmail.com</a></font></p>     ^
cY#v60n1a06.htm##
00331000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009200080002001300172#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#153#149#article#150#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 6/12/2010    ^cY#v60
n1a06.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#p#154#150#article#150#<br>  Aprovado 
em 27/1/2011</font></p>     ^cY#v60n1a06.htm##
00497000000000253000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160014000790160016000930160
01600109018004700125066001000172062002500182065000900207064000500216865000900221
002001300230#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#155#1#a
rticle#30#1#^rND^sBeck^nA#^rND^sNewman^nC#^rND^sWright^nF#Terapia cognitiva de l
as drogodependencias^les#Barcelona#Ediciones Paidos Ibérica#20000000#2000#201100
00#v60n1a06.htm##
00653000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790100019000960100
01800115010001700133010001800150012006800168030001700236065000900253064000500262
03100030026703200020027001400060027286500090027800200130028703500100030080100170
0310#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#156#2#article#3
0#2#^rND^sAraujo^nRB#^rND^sOliveira^nMS#^rND^sPedroso^nRS#^rND^sMiguel^nAC#^rND^
sCastro^nMGT#Craving e dependência química: conceito, avaliação e tratamento^lpt
#J Bras Psiquiatr#20080000#2008#57#1#57-63#20110000#v60n1a06.htm#0047-2085#J Bra
s Psiquiatr##
00690000000000313000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100019000950100
01800114010001800132012012600150030002100276065000900297064000500306031000300311
032000200314014000700316865000900323002001300332035001000345801002100355#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#157#3#article#30#3#^rND^sNa
ppo^nSA#^rND^sGalduróz^nJC#^rND^sRaymundo^nM#^rND^sCarlini^nEA#Changes in cocain
e use as viewed by key informants: a qualitative study carried out in 1994 and 1
999 in São Paulo, Brazil^len#J Psychoactive Drugs#20010000#2001#33#3#241-53#2011
0000#v60n1a06.htm#0279-1072#J Psychoactive Drugs##
00473000000000253000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160017000790160014000960180
04200110066001300152062001400165065000900179064000500188014000400193865000900197
002001300206#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#158#4#a
rticle#30#4#^rND^sEdwards^nG#^rND^sDare^nC#Psicoterapia e tratamento das adições
^lpt#Porto Alegre#Artes Médicas#19970000#1997#247#20110000#v60n1a06.htm##
00615000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790100017000970100
01400114010001700128010001700145012008400162030002100246710000200267065000900269
064000500278031000200283014000600285865000900291002001300300#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#159#5#article#30#5#^rND^sJohnsen^nHB#^r
ND^sLaberg^nCJ#^rND^sCox^nMW#^rND^sVaksdal^nA#^rND^sHugdahl^nK#Alcoholic subject
s' attentional bias in the processing of alcohol-related words^len#Psychol Addic
t Behav#2#19940000#1994#8#111-5#20110000#v60n1a06.htm##
00530000000000265000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100019000790100019000980120
08500117030001400202710000200216065000900218064000500227031000300232014000700235
865000900242002001300251#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm
#S#c#160#6#article#30#6#^rND^sRobinson^nTE#^rND^sBerridge^nKC#The neural basis o
f drug craving: an incentive-sensitization theory of addiction^len#Brain Res Rev
#2#19930000#1993#18#247-91#20110000#v60n1a06.htm##
00550000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790100018000970120
08100115030001000196065000900206064000500215031000300220014000700223865000900230
002001300239035001000252801001000262#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a06.htm#S#c#161#7#article#30#7#^rND^sConklin^nAC#^rND^sTiffany^nST#Applying
 extinction research and theory to cue-exposure addiction treatments^len#Addicti
on#20020000#2002#97#155-67#20110000#v60n1a06.htm#0965-2140#Addiction##
00557000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790120085000970300
02000182065000900202064000500211031000200216032000200218014000700220865000900227
002001300236035001000249801002000259#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a06.htm#S#c#162#8#article#30#8#^rND^sWallace^nBC#Psychological and environm
ental determinants of relapse in crack cocaine smokers^len#J Subst Abuse Treat#1
9890000#1989#6#2#95-106#20110000#v60n1a06.htm#0740-5472#J Subst Abuse Treat##
00516000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790120055000960300
01400151065000900165064000500174031000300179032000300182014000700185865000900192
002001300201035001000214801001400224#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a06.htm#S#c#163#9#article#30#9#^rND^sSiegel^nRK#Cocaine smoking disorders: 
diagnosis and treatment^len#Psychiatr Ann#19840000#1984#14#10#728-32#20110000#v6
0n1a06.htm#0048-5713#Psychiatr Ann##
00639000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100026000810100016001070100
02800123010001800151012007200169030001300241065000900254064000500263031000300268
032000200271014000700273865000900280002001300289035001000302801001300312#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#164#10#article#30#10#^rND^s
Martinez-Ortega^nJM#^rND^sJurado^nD#^rND^sMartinez-Gonzalez^nMA#^rND^sGurpegui^n
M#Nicotine dependence, use of illegal drugs and psychiatric morbidity^len#Addict
 Behav#20060000#2006#31#9#1722-9#20110000#v60n1a06.htm#0306-4603#Addict Behav##
00618000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100013000810100014000940100
01500108010001600123012008200139030001300221065000900234064000500243031000300248
032000200251014000600253865000900259002001300268035001000281801001300291#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#165#11#article#30#11#^rND^s
Lai^nS#^rND^sLaiI^nH#^rND^sPage^nJB#^rND^sMcCoy^nCB#The association between ciga
rette smoking and drug abuse in the United States^len#J Addict Dis#20000000#2000
#19#4#11-24#20110000#v60n1a06.htm#1055-0887#J Addict Dis##
00852000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100016000980100
01600114012010300130030001900233065000900252064000500261031000400266014000600270
03701790027611000090045510900110046486500090047500200130048403500100049780100190
0507#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#166#12#article#
30#12#^rND^sHorger^nBA#^rND^sGiles^nMK#^rND^sSchenk^nS#Pre-exposure to amphetami
ne and nicotine predisposes rats to self-administer a low dose of cocaine^len#Ps
ychopharmacology#19920000#1992#107#271-6#http://www.ncbi.nlm.nih.gov/entrez/util
s/fref.fcgi?PrId=3051&itool=Abstr actPlus-def&uid=9862770&db=pubmed&url=http://j
pet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=9862770#20091204#4 dez 2009#
20110000#v60n1a06.htm#0033-3158#Psychopharmacology##
00543000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100016000960120
05700112030002000169065000900189064000500198031000300203014000700206865000900213
002001300222035001000235801002000245#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a06.htm#S#c#167#13#article#30#13#^rND^sSees^nKL#^rND^sClark^nHW#When to beg
in smoking cessation in substance abusers^len#J Subst Abuse Treat#19930000#1993#
10#189-95#20110000#v60n1a06.htm#0740-5472#J Subst Abuse Treat##
00637000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100018000960100
01600114012009900130030002500229065000900254064000500263031000200268032000200270
014000600272865000900278002001300287035001000300801002500310#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#168#14#article#30#14#^rND^sRoll^nJM#^rN
D^sHiggins^nST#^rND^sTidey^nJW#Cocaine use can increase cigarette smoking: evide
nce from laboratory and naturalistic settings^len#Exp Clin Psychopharmacol#19970
000#1997#5#3#263-8#20110000#v60n1a06.htm#1064-1297#Exp Clin Psychopharmacol##
00555000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810120093001000300
02000193065000900213064000500222031000300227014000700230865000900237002001300246
035001000259801002000269#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm
#S#c#169#15#article#30#15#^rND^sDi Chiara^nG#The role of dopamine in drug abuse 
viewed from the perspective of its role in motivation^len#Drug Alcohol Depend#19
950000#1995#38#95-137#20110000#v60n1a06.htm#0376-8716#Drug Alcohol Depend##
00697000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100015001000100
01900115012016600134030002500300065000900325064000500334031000300339014000800342
865000900350002001300359035001000372801002500382#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a06.htm#S#c#170#16#article#30#16#^rND^sPontiere^nFE#^rND^sTanda
^nG#^rND^sDi Chiara^nG#Intravenous cocaine, morphine, and amphetamine preferenti
ally increase extracellular dopamine in the "shell" as compared with "core" of t
he rat nucleus accumbens^len#Proc Natl Acad Sci U S A#19960000#1996#92#12304-8#2
0110000#v60n1a06.htm#0027-8424#Proc Natl Acad Sci U S A##
00658000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100020000960100
01900116010001500135010001700150012006700167030002000234065000900254064000500263
03100030026803200020027101400070027386500090028000200130028903500100030280100200
0312#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#171#17#article#
30#17#^rND^sReid^nMS#^rND^sMickallan^nJD#^rND^sDelucchi^nKL#^rND^sHall^nSM#^rND^
sBerger^nSP#An acute dose of nicotine enhances cue-induced cocaine craving^len#D
rug Alcohol Depend#19980000#1998#49#2#95-104#20110000#v60n1a06.htm#0376-8716#Dru
g Alcohol Depend##
00668000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100017000990100
01700116010001400133010001900147012008000166030001900246065000900265064000500274
03100040027903200020028301400060028586500090029100200130030003500100031380100190
0323#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#172#18#article#
30#18#^rND^sHiggins^nST#^rND^sBickel^nWK#^rND^sHughes^nJR#^rND^sLynn^nM#^rND^sCa
peless^nMA#Effects of intranasal cocaine on human learning, performance and phys
iology^len#Psychopharmacology#19900000#1990#102#4#451-8#20110000#v60n1a06.htm#00
33-3158#Psychopharmacology##
00442000000000229000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160016000810180051000970660
01000148062001800158065000900176064000500185865000900190002001300199#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#173#19#article#30#19#^rND^sCunh
a^nJA#Manual da versão em português das Escalas Beck^lpt#São Paulo#Casa do Psicó
logo#20010000#2001#20110000#v60n1a06.htm##
00640000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100015000970120
15400112030001300266065000900279064000500288031000300293032000300296014000600299
865000900305002001300314035001000327801001300337#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a06.htm#S#c#174#20#article#30#20#^rND^sCarmo^nJT#^rND^sPueyo^nA
#A adaptação do português do Fagerström Test for Nicotine Dependence (FTND) para
 avaliar a dependência e tolerância à nicotina em fumantes brasileiros^lpt#Rev B
ras Med#20020000#2002#59#12#73-80#20110000#v60n1a06.htm#0034-7264#Rev Bras Med##
00585000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100018000980100
01800116012009300134030001900227710000200246065000900248064000500257031000300262
032000200265014000600267865000900273002001300282#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a06.htm#S#c#175#21#article#30#21#^rND^sAraujo^nRB#^rND^sPedroso
^nRS#^rND^sCastro^nMGT#A adaptação transcultural para o idioma português do Coca
ine Craving Questionnaire Brief^lpt#Rev Psiquiatr Clin#2#20100000#2010#37#5#195-
8#20110000#v60n1a06.htm##
00805000000000361000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100019000980100
01800117010001800135010001400153010001800167012007500185030001900260710000200279
06500090028106400050029003100030029503200020029801400070030003700940030711000090
0401109001100410865000900421002001300430#v60n1#V:\SciELO\serial\jbpsiq\v60n1\mar
kup\v60n1a06.htm#S#c#176#22#article#30#22#^rND^sAraujo^nRB#^rND^sOliveira^nMS#^r
ND^sMoraes^nJFD#^rND^sPedroso^nRS#^rND^sPort^nF#^rND^sCastro^nMGT#Validação da v
ersão brasileira do Questionnaire of Smoking Urges-Brief^lpt#Rev Psiquiatr Clin#
2#20070000#2007#34#4#166-75#http://www.scielo.br/scielo.php?script=sci_arttext&p
id=S0101608320 07000400002&lng=en&nrm=iso#20091204#4 dez 2009#20110000#v60n1a06.
htm##
00558000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100017000990120
06900116030001300185065000900198064000500207031000300212032000200215014000600217
865000900223002001300232035001000245801001300255#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a06.htm#S#c#177#23#article#30#23#^rND^sTiffany^nST#^rND^sDrobes
^nDJ#Imagery and smoking urges: the manipulation of affective content^len#Addict
 Behav#19900000#1990#15#6#531-9#20110000#v60n1a06.htm#0306-4603#Addict Behav##
00568000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100024000810120092001050300
01800197065000900215064000500224031000300229032000200232014000600234865000900240
002001300249035001000262801001800272#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a06.htm#S#c#178#24#article#30#24#^rND^sFerreira Filho^nO#Perfil sociodemogr
áfico e de padrões de uso entre dependentes de cocaína hospitalizados^lpt#Rev Sa
ude Publica#20030000#2003#37#6#751-9#20110000#v60n1a06.htm#0034-8910#Rev Saude P
ublica##
00586000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100017001000100
02000117012005300137030001800190065000900208064000500217031000300222032000200225
014000700227865000900234002001300243035001000256801001800266#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#179#25#article#30#25#^rND^sDuailibi^nLB
#^rND^sRibeiro^nM#^rND^sLaranjeira^nR#Perfil dos usuários de cocaína e crack no 
Brasil^lpt#Cad Saude Publica#20080000#2008#24#4#545-57#20110000#v60n1a06.htm#010
2-311X#Cad Saude Publica##
00628000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100018000980100
02000116010001700136012007900153030001900232065000900251064000500260031000400265
014000600269865000900275002001300284035001000297801001900307#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#180#26#article#30#26#^rND^sEhrman^nRN#^
rND^sRobbins^nSJ#^rND^sChildress^nAR#^rND^sO'Brien CP#Conditioned responses to c
ocaine-related stimuli in cocaine abuse patients^len#Psychopharmacology#19920000
#1992#107#523-9#20110000#v60n1a06.htm#0033-3158#Psychopharmacology##
00636000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100020000980100
01800118010001600136012010000152030001300252065000900265064000500274031000300279
014000700282865000900289002001300298035001000311801001300321#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a06.htm#S#c#181#27#article#30#27#^rND^sO'Brien CP#^
rND^sChildress^nAR#^rND^sMcLellan^nT#^rND^sEhrman^nR#Integrating systemic cue ex
posure with standard treatment in recovering drug dependent patients^len#Addict 
Behav#19900000#1990#15#355-65#20110000#v60n1a06.htm#0306-4603#Addict Behav##
00528000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810120069000990300
02000168065000900188064000500197031000300202014000500205865000900210002001300219
035001000232801002000242#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a06.htm
#S#c#182#28#article#30#28#^rND^sWiseman^nEJ#Nicotine dependence and withdrawal i
n cocaine-dependent patients^len#Arch Gen Psychiatry#20000000#2000#56#85-9#20110
000#v60n1a06.htm#0003-990X#Arch Gen Psychiatry##
00539000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810120091000980300
00800189065000900197064000500206031000200211032000200213014000600215865000900221
002001300230035001000243801000800253#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a06.htm#S#c#183#29#article#30#29#^rND^sRoelofs^nS#Hyperventilation, anxiety
, craving for alcohol: a subacute alcohol withdrawal syndrome^len#Alcohol#198500
00#1985#2#3#501-5#20110000#v60n1a06.htm#0741-8329#Alcohol##
00597000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100014001000120
08200114030002600196065000900222064000500231031000400236032000200240014000700242
865000900249002001300258035001000271801002600281#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a06.htm#S#c#184#30#article#30#30#^rND^sBechtholt^nA#^rND^sMark^
nG#Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats
^len#Psychopharmacology (Berl)#20020000#2002#162#2#178-85#20110000#v60n1a06.htm#
0033-3158#Psychopharmacology (Berl)##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#o#1#1#article
#1#20110331#101359#v60n1a07.htm#158##
03421000000000637000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901201400
01690120132003090100052004410100048004930100033005410100034005740100046006080700
04900654083088100703085001001584085002701594085004101621085002201662083081901684
08500100250308500280251308500340254108500230257505800600259805800620265811700080
2720072000302728112000902731111001102740114000902751113001002760002001302770#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#h#2#1#article#1#oa#pt#br1
.1#1#4.0#ILUS#TAB#7#JBPSIQ010#nd#J. bras. psiquiatr.#60#1#20110000#^f34^l39#0047
-2085#Estudos de adaptação do Millon Clinical Multiaxial Inventory-III para aval
iação de aspectos psicopatológicos da personalidade no Brasil^lpt#Adaptation Stu
dies of the Millon Clinical Multiaxial Inventory-III to assess psychopatological
 aspects of personality in Brazil^len#^rND^1A01^nHannia Roberta Rodrigues Paiva 
da^sRocha#^rND^1A01^nHeloísa Karmelina Carvalho de^sSousa#^rND^1A01^nJoão Carlos
^sAlchieri#^rND^1A01^nEleni de Araújo^sSales#^rND^1A01^nJoão Carlos Nascimento d
e^sAlencar#Universidade Federal do Rio Grande do Norte^iA01#^lpt^aOBJETIVOS: Tra
duzir e adaptar para uso no Brasil o Millon Clinical Multiaxial Inventory-III (M
CMI-III), verificando as modificações envolvidas em relação à escala original. M
ÉTODO: 538 participantes responderam ao MCMI-III, ao Questionário de Saúde Geral
 de Goldberg e a um questionário sociodemográfico especificamente elaborado para
 esta pesquisa. Os sujeitos foram, então, divididos entre grupo clínico e não cl
ínico, e seus padrões de respostas foram comparados considerando-se as diferente
s variáveis sociodemográficas. RESULTADOS: Os resultados demonstram diferenças e
statisticamente significativas nos padrões de respostas para a maioria das escal
as quando comparados os grupos clínico e não clínico. CONCLUSÃO: O estudo ratifi
ca a sensibilidade de discriminação entre os diferentes grupos, apresentando ind
ícios da validade do instrumento quanto ao preceito teórico.#^ddecs^i1#^tm^lpt^k
Psicopatologia^i1#^tm^lpt^ktranstornos de personalidade^i1#^tm^lpt^kavaliação^i1
#^len^aOBJECTIVES: To translate and adapt the Millon Clinical Multiaxial Invento
ry-III (MCMI-III) for use in Brazil, testing the changes performed in the origin
al scale. METHOD: 538 participants answered the MCMI-III, the Goldberg General H
ealth Assessment and a social demographical questionnaire specifically designed 
to this research. Then, respondents were divided into clinical and non-clinical 
groups, and their answers' patterns were compared considering different social d
emographic characteristics. RESULTS: Significant statistical differences in answ
er patterns were found in most scales when clinical and non clinical groups were
 compared. CONCLUSION: This study confirms the ability of the MCMI-III to discri
minate different groups, consistent with the instrument validity based his theor
etical foundations.#^ddecs^i2#^tm^len^kPsychopathology^i2#^tm^len^kpersonality d
isorders^i2#^tm^len^kevaluation^i2#Coordenação de Aperfeiçoamento de Pessoal de 
Nível Superior#Conselho Nacional de Desenvolvimento Científico e Tecnológico#van
couv#20#20101021#21/10/2010#20101207#7/12/2010#v60n1a07.htm##
03512000000000637000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901201540
01690120146003230100052004690100048005210100033005690100034006020100046006360700
04900682083091600731085001001647085002701657085004101684085002201725083084701747
08500100259408500280260408500340263208500230266605800600268905800620274911700080
2811072000302819112000902822111001102831114000902842113001002851002001302861#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#f#3#1#article#1#oa#pt#br1
.1#1#4.0#ILUS#TAB#7#JBPSIQ010#nd#J. bras. psiquiatr.#60#1#20110000#^f34^l39#0047
-2085#<b>Estudos de adaptação do <i>Millon Clinical Multiaxial Inventory-III </i
>para avaliação de aspectos psicopatológicos da personalidade no Brasil</b>^lpt#
<b>Adaptation Studies of the <i>Millon Clinical Multiaxial Inventory-III</i> to 
assess psychopatological aspects of personality in Brazil</b>^len#^rND^1A01^nHan
nia Roberta Rodrigues Paiva da^sRocha#^rND^1A01^nHeloísa Karmelina Carvalho de^s
Sousa#^rND^1A01^nJoão Carlos^sAlchieri#^rND^1A01^nEleni de Araújo^sSales#^rND^1A
01^nJoão Carlos Nascimento de^sAlencar#Universidade Federal do Rio Grande do Nor
te^iA01#^lpt^a<b>OBJETIVOS:</b> Traduzir e adaptar para uso no Brasil o <i>Millo
n Clinical Multiaxial Inventory-III</i> (MCMI-III), verificando as modificações 
envolvidas em relação à escala original. <b>MÉTODO: </b>538 participantes respon
deram ao MCMI-III, ao Questionário de Saúde Geral de Goldberg e a um questionári
o sociodemográfico especificamente elaborado para esta pesquisa. Os sujeitos for
am, então, divididos entre grupo clínico e não clínico, e seus padrões de respos
tas foram comparados considerando-se as diferentes variáveis sociodemográficas. 
<b>RESULTADOS: </b>Os resultados demonstram diferenças estatisticamente signific
ativas nos padrões de respostas para a maioria das escalas quando comparados os 
grupos clínico e não clínico. <b>CONCLUSÃO: </b>O estudo ratifica a sensibilidad
e de discriminação entre os diferentes grupos, apresentando indícios da validade
 do instrumento quanto ao preceito teórico.#^ddecs^i1#^tm^lpt^kPsicopatologia^i1
#^tm^lpt^ktranstornos de personalidade^i1#^tm^lpt^kavaliação^i1#^len^a<b>OBJECTI
VES:</b> To translate and adapt the Millon Clinical Multiaxial Inventory-III (MC
MI-III) for use in Brazil, testing the changes performed in the original scale. 
<b>METHOD: </b>538 participants answered the MCMI-III, the Goldberg General Heal
th Assessment and a social demographical questionnaire specifically designed to 
this research. Then, respondents were divided into clinical and non-clinical gro
ups, and their answers' patterns were compared considering different social demo
graphic characteristics. <b>RESULTS: </b>Significant statistical differences in 
answer patterns were found in most scales when clinical and non clinical groups 
were compared. <b>CONCLUSION: </b>This study confirms the ability of the MCMI-II
I to discriminate different groups, consistent with the instrument validity base
d his theoretical foundations.#^ddecs^i2#^tm^len^kPsychopathology^i2#^tm^len^kpe
rsonality disorders^i2#^tm^len^kevaluation^i2#Coordenação de Aperfeiçoamento de 
Pessoal de Nível Superior#Conselho Nacional de Desenvolvimento Científico e Tecn
ológico#vancouv#20#20101021#21/10/2010#20101207#7/12/2010#v60n1a07.htm##
03542000000000661000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000200108049001000110
15800030012003000190012303100030014203200020014506500090014701400090015603500100
01650120140001750120132003150100052004470100048004990100033005470100034005800100
04600614070005100660083088100711085001001592085002701602085004101629085002201670
08308190169208500100251108500280252108500340254908500230258305800600260605800620
26661170008027280720003027361120009027391110011027481140009027591130010027680020
01302778008008902791#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#l
#4#1#article#1#^a2011#oa#pt#br1.1#1#4.0#ilus#tab#7#JBPSIQ010#nd#J. bras. psiquia
tr#60#1#20110000#^f34^l39#0047-2085#Estudos de adaptação do Millon Clinical Mult
iaxial Inventory-III para avaliação de aspectos psicopatológicos da personalidad
e no Brasil^lpt#Adaptation Studies of the Millon Clinical Multiaxial Inventory-I
II to assess psychopatological aspects of personality in Brazil^len#^rND^1A01^nH
annia Roberta Rodrigues Paiva da^sRocha#^rND^1A01^nHeloísa Karmelina Carvalho de
^sSousa#^rND^1A01^nJoão Carlos^sAlchieri#^rND^1A01^nEleni de Araújo^sSales#^rND^
1A01^nJoão Carlos Nascimento de^sAlencar#^iA01^1Universidade Federal do Rio Gran
de do Norte#^lpt^aOBJETIVOS: Traduzir e adaptar para uso no Brasil o Millon Clin
ical Multiaxial Inventory-III (MCMI-III), verificando as modificações envolvidas
 em relação à escala original. MÉTODO: 538 participantes responderam ao MCMI-III
, ao Questionário de Saúde Geral de Goldberg e a um questionário sociodemográfic
o especificamente elaborado para esta pesquisa. Os sujeitos foram, então, dividi
dos entre grupo clínico e não clínico, e seus padrões de respostas foram compara
dos considerando-se as diferentes variáveis sociodemográficas. RESULTADOS: Os re
sultados demonstram diferenças estatisticamente significativas nos padrões de re
spostas para a maioria das escalas quando comparados os grupos clínico e não clí
nico. CONCLUSÃO: O estudo ratifica a sensibilidade de discriminação entre os dif
erentes grupos, apresentando indícios da validade do instrumento quanto ao prece
ito teórico.#^ddecs^i1#^tm^lpt^kPsicopatologia^i1#^tm^lpt^ktranstornos de person
alidade^i1#^tm^lpt^kavaliação^i1#^len^aOBJECTIVES: To translate and adapt the Mi
llon Clinical Multiaxial Inventory-III (MCMI-III) for use in Brazil, testing the
 changes performed in the original scale. METHOD: 538 participants answered the 
MCMI-III, the Goldberg General Health Assessment and a social demographical ques
tionnaire specifically designed to this research. Then, respondents were divided
 into clinical and non-clinical groups, and their answers' patterns were compare
d considering different social demographic characteristics. RESULTS: Significant
 statistical differences in answer patterns were found in most scales when clini
cal and non clinical groups were compared. CONCLUSION: This study confirms the a
bility of the MCMI-III to discriminate different groups, consistent with the ins
trument validity based his theoretical foundations.#^ddecs^i2#^tm^len^kPsychopat
hology^i2#^tm^len^kpersonality disorders^i2#^tm^len^kevaluation^i2#Coordenação d
e Aperfeiçoamento de Pessoal de Nível Superior#Conselho Nacional de Desenvolvime
nto Científico e Tecnológico#vancouv#20#20101021#21/10/2010#20101207#7/12/2010#v
60n1a07.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S00
47-20852011000100007##
00354000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704011900076002001300195#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#5#1#article#134#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ARTIGO ORIGINAL</b>
</font></p>     ^cY#v60n1a07.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#6#2#article#134#<p>&nbsp;</p>     ^
cY#v60n1a07.htm##
00527000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704029200076002001300368#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#7#3#article#134#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Estudos 
de adapta&ccedil;&atilde;o do <i>Millon Clinical Multiaxial Inventory-III </i>pa
ra avalia&ccedil;&atilde;o de aspectos psicopatol&oacute;gicos da personalidade 
no Brasil</b></font></p>     ^cY#v60n1a07.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#8#4#article#134#<p>&nbsp;</p>     ^
cY#v60n1a07.htm##
00459000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704022400076002001300300#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#9#5#article#134#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Adaptation Studies of the <i>Mill
on Clinical Multiaxial Inventory-III</i> to assess psychopatological aspects of 
personality in Brazil</b></font></p>     ^cY#v60n1a07.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#10#6#article#134#<p>&nbsp;</p>     
^cY#v60n1a07.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#11#7#article#134#<p>&nbsp;</p>     
^cY#v60n1a07.htm##
00510000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704027400077002001300351#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#12#8#article#134#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Hannia Roberta Rodrigues Paiva d
a Rocha; Helo&iacute;sa Karmelina Carvalho de Sousa; Jo&atilde;o Carlos Alchieri
; Eleni de Ara&uacute;jo Sales; Jo&atilde;o Carlos Nascimento de Alencar</b></fo
nt></p>     ^cY#v60n1a07.htm##
00369000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704013300077002001300210#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#13#9#article#134#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Universidade Federal do Rio Grande 
do Norte (UFRN)</font></p>     ^cY#v60n1a07.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#14#10#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#15#11#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#16#12#article#134#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a07.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#17#13#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a07.htm##
00529000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704029200078002001300370#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#18#14#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVOS:</b> Traduzir e adapt
ar para uso no Brasil o <i>Millon Clinical Multiaxial Inventory-III</i> (MCMI-II
I), verificando as modifica&ccedil;&otilde;es envolvidas em rela&ccedil;&atilde;
o &agrave; escala original.    ^cY#v60n1a07.htm##
00694000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704045700078002001300535#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#19#15#article#134#<br>  <b>M&Eacute
;TODO: </b>538 participantes responderam ao MCMI-III, ao Question&aacute;rio de 
Sa&uacute;de Geral de Goldberg e a um question&aacute;rio sociodemogr&aacute;fic
o especificamente elaborado para esta pesquisa. Os sujeitos foram, ent&atilde;o,
 divididos entre grupo cl&iacute;nico e n&atilde;o cl&iacute;nico, e seus padr&o
tilde;es de respostas foram comparados considerando-se as diferentes vari&aacute
;veis sociodemogr&aacute;ficas.     ^cY#v60n1a07.htm##
00474000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704023700078002001300315#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#20#16#article#134#<br> <b>RESULTADO
S: </b>Os resultados demonstram diferen&ccedil;as estatisticamente significativa
s nos padr&otilde;es de respostas para a maioria das escalas quando comparados o
s grupos cl&iacute;nico e n&atilde;o cl&iacute;nico.    ^cY#v60n1a07.htm##
00472000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704023500078002001300313#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#21#17#article#134#<br>  <b>CONCLUS&
Atilde;O: </b>O estudo ratifica a sensibilidade de discrimina&ccedil;&atilde;o e
ntre os diferentes grupos, apresentando ind&iacute;cios da validade do instrumen
to quanto ao preceito te&oacute;rico. </font></p>     ^cY#v60n1a07.htm##
00436000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704019900078002001300277#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#22#18#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>Psicopatolo
gia, transtornos de personalidade, avalia&ccedil;&atilde;o. </font></p> <hr size
="1" noshade>     ^cY#v60n1a07.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#23#19#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a07.htm##
00477000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704024000078002001300318#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#24#20#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVES:</b> To translate an
d adapt the Millon Clinical Multiaxial Inventory-III (MCMI-III) for use in Brazi
l, testing the changes performed in the original scale.    ^cY#v60n1a07.htm##
00595000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704035800078002001300436#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#25#21#article#134#<br> <b> METHOD: 
</b>538 participants answered the MCMI-III, the Goldberg General Health Assessme
nt and a social demographical questionnaire specifically designed to this resear
ch. Then, respondents were divided into clinical and non-clinical groups, and th
eir answers' patterns were compared considering different social demographic cha
racteristics.    ^cY#v60n1a07.htm##
00400000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704016300078002001300241#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#26#22#article#134#<br>  <b>RESULTS:
 </b>Significant statistical differences in answer patterns were found in most s
cales when clinical and non clinical groups were compared.    ^cY#v60n1a07.htm##
00437000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704020000078002001300278#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#27#23#article#134#<br> <b>CONCLUSIO
N: </b>This study confirms the ability of the MCMI-III to discriminate different
 groups, consistent with the instrument validity based his theoretical foundatio
ns.</font></p>     ^cY#v60n1a07.htm##
00411000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017400078002001300252#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#28#24#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Psychopathology, 
personality disorders, evaluation. </font></p> <hr size="1" noshade>     ^cY#v60
n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#29#25#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#30#26#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00351000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011400078002001300192#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#31#27#article#134#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde;O</b></f
ont></p>     ^cY#v60n1a07.htm##
00913000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704067600078002001300754#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#32#28#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O <i>Millon Clinical Multiaxial In
ventory </i>(MCMI) foi um dos instrumentos desenvolvidos por Theodore Millon par
a operacionalizar sua teoria e tem como foco pessoas em tratamento cl&iacute;nic
o em psicologia ou psiquiatria<sup>1</sup>. Desde sua cria&ccedil;&atilde;o, em 
1977,  o instrumento passou por tr&ecirc;s atualiza&ccedil;&otilde;es<sup>2</sup
> para que pudes se guardar estreita rela&ccedil;&atilde;o com as mudan&ccedil;a
s sociais que se operavam em cada &eacute;poca e se refletiam no aperfei&ccedil;
oamento do <i>Diagnostic and Statistical Manual of Mental Disorders </i>(DSM). <
/font></p>     ^cY#v60n1a07.htm##
01352000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704111500078002001301193#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#33#29#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O DSM configura-se como um manual 
diagn&oacute;stico e estat&iacute;stico adotado pela APA, que se associa com a C
lassifica&ccedil;&atilde;o de Transtornos Mentais e de Comportamento (CID), da O
rganiza&ccedil;&atilde;o Mundial de Sa&uacute;de (OMS). Seu sistema classificat&
oacute;rio &eacute; multiaxial, organizado de forma a comportar 16 classes diagn
&oacute;sticas diferentes, que recebem c&oacute;digos num&eacute;ricos espec&iac
ute;ficos e s&atilde;o agrupados em cinco grandes eixos. Os aspectos avaliados p
elo MCMI-III s&atilde;o aqueles que no DSM-IV-TR se encontram nos dois primeiros
 eixos: o eixo I, que descreve os transtornos cl&iacute;nicos propriamente ditos
, e o eixo II, correspondente ao retardo mental, bem como aos transtornos de per
sonalidade<sup>3</sup>. Como todo sistema de classifica&ccedil;&atilde;o, o DSM-
IV-TR n&atilde;o &eacute; um sistema infal&iacute;vel e n&atilde;o pode fornecer
 automaticamente um diagn&oacute;stico, portanto &eacute; recomend&aacute;vel ca
utela em sua utiliza&ccedil;&atilde;o.</font></p>     ^cY#v60n1a07.htm##
01106000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704086900078002001300947#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#34#30#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Dessa forma, a primeira vers&atild
e;o do invent&aacute;rio, cujas nor-mas foram estabelecidas a partir de estudo c
om mais de 1.500 pacientes psiqui&aacute;tricos, visava avaliar personalidade e 
s&iacute;ndromes cl&iacute;nicas<sup>4</sup>. A segunda edi&ccedil;&atilde;o foi
 publicada em 1987, consoante &agrave;s mudan&ccedil;as sociais ocorridas ao log
o dos dez anos posteriores &agrave; publica&ccedil;&atilde;o da primeira vers&at
ilde;o, adequando-se ao DSM-III-R. O MCMI-III, por sua vez, foi desenvolvido em 
1994, seguindo as atualiza&ccedil;&otilde;es do DSM-IV<sup>4,5</sup>. Vale salie
ntar que a atualiza&ccedil;&atilde;o do DSM-IV para o DSM-IV-TR envolveu apenas 
revis&atilde;o textual, n&atilde;o havendo modifica&ccedil;&atilde;o nos termos 
diagn&oacute;sticos<sup>3</sup>.</font></p>     ^cY#v60n1a07.htm##
01195000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704095800078002001301036#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#35#31#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A vers&atilde;o mais atual do MCMI
 &eacute; o terceiro instrumento para avalia&ccedil;&atilde;o da personalidade m
ais utilizado no contexto internacional, ficando atr&aacute;s apenas do Rorschac
h e do <i>Minnesota Multiphasic Personality Inventory-II</i>, em termos de produ
&ccedil;&atilde;o cient&iacute;fica. Essa vers&atilde;o conta com 175 itens de r
esposta verdadeiro ou falso, que podem ser respondidos no formato papel e l&aacu
te;pis ou por meio de um aplicativo informatizado. O tempo de administra&ccedil;
&atilde;o pode variar entre 20 e 40 minutos de acordo com o n&iacute;vel de leit
ura dos indiv&iacute;duos, sendo apropriado para uso em adultos (acima dos 18 an
os de idade) que estejam em processo de avalia&ccedil;&atilde;o psicol&oacute;gi
ca ou em acompanhamento de sa&uacute;de mental. A consist&ecirc;ncia do teste es
t&aacute; entre 0,57 e 0,9<sup>5,6</sup>.</font></p>     ^cY#v60n1a07.htm##
01220000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704098300078002001301061#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#36#32#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O MCMI, em todas as suas vers&otil
de;es, distingue-se de outros invent&aacute;rios principalmente pela sua fundame
nta&ccedil;&atilde;o te&oacute;rica, estrutura multiaxial, esquema de valida&cce
dil;&atilde;o, bem como pela brevidade com que se faz a sua aplica&ccedil;&atild
e;o e a an&aacute;lise e interpreta&ccedil;&atilde;o de seus dados. Cada edi&cce
dil;&atilde;o do invent&aacute;rio procurou manter um n&uacute;mero total de ite
ns suficientemente pequenos para motivar a sua utiliza&ccedil;&atilde;o nos mais
 variados tipos de diagn&oacute;stico e de tratamento, por&eacute;m grande o bas
tante para proporcionar a an&aacute;lise de um amplo quadro de comportamentos cl
inicamente relevantes. O teste, ent&atilde;o, &eacute; consideravelmente menor d
o que outros instrumentos internacionais utilizados para avalia&ccedil;&atilde;o
 de aspectos psicopatol&oacute;gicos da personalidade<sup>5</sup>.</font></p>   
  ^cY#v60n1a07.htm##
01514000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704127700078002001301355#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#37#33#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O MCMI-III possui quatro escalas d
e verifica&ccedil;&atilde;o do instrumento: Validade, Divulga&ccedil;&atilde;o, 
Desejabilidade e Valoriza&ccedil;&atilde;o Negativa, que podem ser analisadas se
paradamente ou inter-relacionadas, mas as escalas de Validade e Divulga&ccedil;&
atilde;o podem invalidar o teste<sup>6</sup>. A escala de Validade (V) consiste 
em tr&ecirc;s declara&ccedil;&otilde;es improv&aacute;veis, e se duas delas fore
m respondidas positivamente, o teste &eacute; invalidado. Portanto, essa escala 
&eacute; a que primeiro deve ser analisada. A escala de Divulga&ccedil;&atilde;o
 (X) prop&otilde;e-se a identificar a disposi&ccedil;&atilde;o para admitir sint
omas e problemas que o sujeito possui, bem como a franqueza com que ele se exp&o
tilde;e. A escala de Desejabilidade (Y) verifica a tend&ecirc;ncia do sujeito em
 responder aos itens de forma favor&aacute;vel, ou seja, a disposi&ccedil;&atild
e;o em realizar o teste. A escala de Valoriza&ccedil;&atilde;o Negativa (Z), por
 sua vez, afere a possibilidade de que o sujeito responda ao teste acentuando ou
 exagerando problemas e sintomas que possui ou, ainda, citando problemas que de 
fato n&atilde;o apresenta<sup>5,7</sup>.</font></p>     ^cY#v60n1a07.htm##
01213000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704097600078002001301054#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#38#34#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">As demais escalas do instrumento r
eferem-se a cada tipo de desordem de personalidade identificada na teoria de Mil
lon e dividem-se em: escalas de padr&otilde;es cl&iacute;nicos de personalidade 
(Esquizoide, Evitativa, Depressiva, Dependente, Histri&ocirc;nica, Narcisista, A
ntissocial, Agressiva/S&aacute;dica, Compulsiva, Negativista e Autodestrutiva/Ma
soquista), escalas de transtornos de personalidade severa (Esquizot&iacute;pica,
 Paranoide e <i>Borderline</i>), escalas de s&iacute;ndromes cl&iacute;nicas mod
eradas (Transtorno de Ansiedade, Transtorno de Somatiza&ccedil;&atilde;o, Transt
orno Bipolar, Transtorno Dist&iacute;mico, Depend&ecirc;ncia Alco&oacute;lica, D
epend&ecirc;ncia de Drogas e Transtorno do Estresse P&oacute;s-Traum&aacute;tico
) e escalas de s&iacute;ndromes cl&iacute;nicas graves (Desordem de Pensamento, 
Depress&atilde;o Maior e Transtorno Delirante)<sup>5</sup>.</font></p>     ^cY#v
60n1a07.htm##
01032000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704079500078002001300873#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#39#35#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Beck <i>et al.</i><sup>8</sup> enf
atizam um problema envolvido no diagn&oacute;stico de transtornos da personalida
de: raramente os problemas da personalidade constituem a principal demanda de um
 paciente que busca tratamento. Tais pacientes t&ecirc;m dificuldades em lidar c
om outras pessoas independentemente de sua pr&oacute;pria conduta. Na maior part
e das vezes, esse paciente se sente vitimizado pelo mundo e pela sociedade. Algu
ns t&ecirc;m no&ccedil;&atilde;o dos elementos que envolvem seus problemas, mas 
n&atilde;o apresentam a consci&ecirc;ncia dos aspectos da personalidade na mudan
&ccedil;a de seu comportamento; da&iacute;, uma das maiores dificuldades em diag
nosticar transtornos da personalidade.</font></p>     ^cY#v60n1a07.htm##
00819000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704058200078002001300660#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#40#36#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Estudos que utilizam o MCMI-III co
mo instrumento de avalia&ccedil;&atilde;o psicol&oacute;gica sugerem que o teste
 &eacute; um dos mais adequados para avalia&ccedil;&atilde;o de certos transtorn
os. Marcus <i>et al.</i><sup>9</sup> postulam que transtornos da personalidade s
ejam abordados como se manifestando em uma dimens&atilde;o cont&iacute;nua e n&a
tilde;o como um diagn&oacute;stico categ&oacute;rico. O MCMI, portanto, se confi
guraria como um instrumento ideal para mensurar tais transtornos.</font></p>    
 ^cY#v60n1a07.htm##
01017000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704078000078002001300858#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#41#37#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Internacionalmente, o MCMI-III vem
 sendo utilizado em pesquisas associadas &agrave; psicologia forense, principalm
ente para a avalia&ccedil;&atilde;o de popula&ccedil;&atilde;o carcer&aacute;ria
<sup>10</sup>, de abusadores sexuais<sup>11</sup> e de usu&aacute;rios de &aacut
e;lcool e outras drogas<sup>12-15</sup>. No Brasil, nenhuma das vers&otilde;es d
o instrumento foi adaptada anteriormente. Carvalho<sup>16</sup> utilizou a tradu
&ccedil;&atilde;o preliminar do MCMI-III, realizada para este estudo, como par&a
circ;metro para a valida&ccedil;&atilde;o de um instrumento de avalia&ccedil;&at
ilde;o de aspectos psicopatol&oacute;gicos da personalidade baseado no modelo te
&oacute;rico de Millon.</font></p>     ^cY#v60n1a07.htm##
00566000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704032900078002001300407#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#42#38#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O presente estudo, ent&atilde;o, t
em como objetivo a adapta&ccedil;&atilde;o do <i>Millon Clinical Multiaxial Inve
ntory-III</i> para o Brasil, verificando as modifica&ccedil;&otilde;es envolvida
s em rela&ccedil;&atilde;o &agrave; escala original.</font></p>     ^cY#v60n1a07
.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#43#39#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00340000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010300078002001300181#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#44#40#article#134#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>M&Eacute;TODO</b></font></p>   
  ^cY#v60n1a07.htm##
00340000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010300078002001300181#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#45#41#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Participantes</b></font></p>   
  ^cY#v60n1a07.htm##
01922000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704168500078002001301763#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#46#42#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Participaram deste estudo 538 resp
ondentes, dos quais 294 (54,5%) do sexo feminino e 243 (45,2%) do sexo masculino
 (um participante n&atilde;o forneceu essa informa&ccedil;&atilde;o), divididos 
em dois grupos - grupo cl&iacute;nico e grupo n&atilde;o cl&iacute;nico. Para di
ferenciar os grupos, dada a inexist&ecirc;ncia no momento de um crit&eacute;rio 
de padr&atilde;o-ouro (diagn&oacute;sticos psiqui&aacute;tricos) em virtude da a
us&ecirc;ncia de diagn&oacute;sticos precisos e de fontes confi&aacute;veis, opt
ou-se pela distin&ccedil;&atilde;o baseada na autopercep&ccedil;&atilde;o e auto
descri&ccedil;&atilde;o do respondente quanto &agrave; presen&ccedil;a de indica
dores como: o hist&oacute;rico ou antecedentes de psicopatologias, atendimentos 
e tratamentos psicol&oacute;gicos e/ou psiqui&aacute;tricos com ou sem uso de ps
icofarmacoterapia, al&eacute;m da refer&ecirc;ncia a abuso de &aacute;lcool e/ou
 outras drogas, n&atilde;o se fazendo distin&ccedil;&atilde;o entre transtornos 
mentais menores, maiores ou adic&ccedil;&otilde;es, sendo a verifica&ccedil;&ati
lde;o dessa categoriza&ccedil;&atilde;o esperada na an&aacute;lise dos padr&otil
de;es de respostas dos participantes. Muito embora essa distin&ccedil;&atilde;o 
possa ser considerada t&ecirc;nue, pareceu aos autores uma forma preliminarmente
 vi&aacute;vel de verificar poss&iacute;veis distin&ccedil;&otilde;es entre os g
rupos antes de se recorrer aos crit&eacute;rios espec&iacute;ficos na sequ&ecirc
;ncia de estudos ulteriores que j&aacute; se delineiam abordando especificamente
 alguns transtornos identificados pelo MCMI-III.</font></p>     ^cY#v60n1a07.htm
##
01750000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704151300078002001301591#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#47#43#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O grupo cl&iacute;nico, portanto, 
foi composto por pessoas que referiram durante a resposta ao instrumento algum t
ipo de necessidade de cuidado ambulatorial em psicologia ou psiquiatria (198 suj
eitos, o que corresponde a 36,8% da amostra). Os sujeitos do grupo cl&iacute;nic
o foram cooptados nos Servi&ccedil;os de Sa&uacute;de Mental da cidade de Natal,
 Rio Grande do Norte, quais sejam: as cl&iacute;nicas-escolas das institui&ccedi
l;&otilde;es de ensino superior com gradua&ccedil;&atilde;o em psicologia no est
ado (Universidade Federal do Rio Grande do Norte - UFRN - e Universidade Potigua
r - UnP) e os Centros de Aten&ccedil;&atilde;o Psicossocial (CAPS), nas modalida
des de atendimento em sa&uacute;de mental geral e para usu&aacute;rios de &aacut
e;lcool e drogas; al&eacute;m dessas institui&ccedil;&otilde;es da capital do es
tado, foram coletados dados no CAPS de Currais Novos, munic&iacute;pio do interi
or do RN. Dentro das cl&iacute;nicas-escolas, foram abordadas as pessoas que agu
ardavam atendimento para triagem, psicoterapia ou avalia&ccedil;&atilde;o psicol
&oacute;gica. Nos CAPS, os sujeitos foram indicados por membros da equipe profis
sional dentre aqueles que se voluntariaram para participa&ccedil;&atilde;o na pe
squisa e puderam, durante o tempo necess&aacute;rio para a aplica&ccedil;&atilde
;o dos instrumentos, ausentar-se das atividades da casa sem nenhum preju&iacute;
zo ao sujeito ou grupo de atividade.</font></p>     ^cY#v60n1a07.htm##
00912000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704067500078002001300753#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#48#44#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O grupo n&atilde;o cl&iacute;nico,
 por sua vez, foi composto por pessoas sem refer&ecirc;ncia a alguma hist&oacute
;ria ou necessidade de cuidado psicol&oacute;gico e ou psiqui&aacute;trico (340 
sujeitos, perfazendo 63,2% da amostra), cooptadas entre os acompanhantes dos pac
ientes dos mesmos servi&ccedil;os citados no grupo cl&iacute;nico, al&eacute;m d
e indiv&iacute;duos que se submeteram &agrave; avalia&ccedil;&atilde;o para sele
&ccedil;&atilde;o pro-fissional ou vocacional, estudantes universit&aacute;rios 
e pessoas da popula&ccedil;&atilde;o geral que aceitaram participar do estudo.</
font></p>     ^cY#v60n1a07.htm##
00680000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704044300078002001300521#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#49#45#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os dois grupos foram compostos por
 adultos com idades de 18 a 85 anos, segundo indica&ccedil;&otilde;es do instrum
ento original, n&atilde;o havendo seletividade espec&iacute;fica para os n&iacut
e;veis de escolaridade, embora esse dado fosse identificado no question&aacute;r
io sociodemogr&aacute;fico para utiliza&ccedil;&atilde;o estat&iacute;stica post
erior.</font></p>     ^cY#v60n1a07.htm##
01278000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704104100078002001301119#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#50#46#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Como crit&eacute;rios de exclus&at
ilde;o, foram considerados a idade dos participantes (menos de 18 anos e mais de
 85), o n&uacute;mero de respostas omissas e/ou marcadas em duplicidade (que n&a
tilde;o deve ser superior a 11, segundo orienta&ccedil;&otilde;es do instrumento
 original) e, no caso das pessoas que compuseram o grupo cl&iacute;nico, o tempo
 em que estavam em tratamento. Considerou-se que a evolu&ccedil;&atilde;o do pac
iente que passou por mais de duas semanas de acompanhamento terap&ecirc;utico po
deria interferir nas respostas dadas &agrave;s senten&ccedil;as do MCMI-III, inf
luenciando, assim, seu resultado, optando-se, portanto, pela sua exclus&atilde;o
 dos grupos. Ap&oacute;s a tabula&ccedil;&atilde;o dos dados, verificou-se que 1
7 dos 538 sujeitos que responderam ao instrumento apresentaram n&uacute;mero de 
respostas omissas ou marcadas duplamente, sendo, ent&atilde;o, exclu&iacute;dos 
da amostra analisada para o presente estudo.</font></p>     ^cY#v60n1a07.htm##
00339000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010200078002001300180#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#51#47#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Instrumentos</b></font></p>    
 ^cY#v60n1a07.htm##
00983000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704074600078002001300824#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#52#48#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Al&eacute;m do MCMI-III, todos os 
sujeitos da amostra responderam a um question&aacute;rio sociodemogr&aacute;fico
, especificamente elaborado para os fins desta pesquisa. Os usu&aacute;rios dos 
CAPS responderam, ainda, ao Question&aacute;rio de Sa&uacute;de Geral (QSG), com
 o objetivo de verificar a possibilidade de dist&uacute;rbios menores do ponto d
e vista psiqui&aacute;trico. Al&eacute;m do QSG tamb&eacute;m foram utilizados e
m subgrupos da amostra o teste de Zulliger, o Invent&aacute;rio Millon de Estilo
s de Personalidade (MIPS), o <i>Millon Behavioral Medical Diagnostic</i> (MBMD),
 este &uacute;ltimo tamb&eacute;m em fase de adapta&ccedil;&atilde;o.</font></p>
     ^cY#v60n1a07.htm##
00340000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010300078002001300181#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#53#49#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Procedimentos</b></font></p>   
  ^cY#v60n1a07.htm##
00628000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704039100078002001300469#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#54#50#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Ap&oacute;s aprova&ccedil;&atilde;
o pelo Comit&ecirc; de &Eacute;tica do Hospital Universit&aacute;rio Onofre Lope
s (com o n&uacute;mero 324/09), foram realizados os contatos com as institui&cce
dil;&otilde;es nas quais se realizaria a coleta de dados para autoriza&ccedil;&a
tilde;o da pesquisa nesses locais.</font></p>     ^cY#v60n1a07.htm##
01289000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704105200078002001301130#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#55#51#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os participantes, em ambos os grup
os, eram abordados e recebiam uma explica&ccedil;&atilde;o sobre seus direitos c
omo participantes da pesquisa e, ap&oacute;s o esclarecimento de eventual d&uacu
te;vida e a manifesta&ccedil;&atilde;o do interesse em participar do estudo, ass
inavam o Termo de Consentimento Livre e Esclarecido e eram convidados a se dirig
ir a local mais reservado para administra&ccedil;&atilde;o do instrumento. Por c
ausa da pouca experi&ecirc;ncia em leitura da maioria dos sujeitos abordados nas
 institui&ccedil;&otilde;es de cuidado para sa&uacute;de mental, os instrumentos
 foram aplicados individualmente, com leitura e marca&ccedil;&atilde;o das respo
stas feitas pelo aplicador. A parcela do grupo n&atilde;o cl&iacute;nico constit
u&iacute;da por universit&aacute;rios recebeu as mesmas orienta&ccedil;&otilde;e
s dos sujeitos anteriores. No entanto, com esse grupo foi poss&iacute;vel realiz
ar administra&ccedil;&atilde;o coletiva do instrumento.</font></p>     ^cY#v60n1
a07.htm##
01067000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704083000078002001300908#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#56#52#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Concomitantemente &agrave; coleta 
de dados, foi desenvolvido um banco de dados e constru&iacute;do um aplicativo d
e avalia&ccedil;&atilde;o e corre&ccedil;&atilde;o informatizado (no formato de 
planilha eletr&ocirc;nica) para ser empregado nos procedimentos de an&aacute;lis
e inicial dos resultados das escalas, uma vez que estas, dadas as caracter&iacut
e;sticas do instrumento, s&atilde;o compostas de uma variedade de pontua&ccedil;
&otilde;es e valores para os itens, dificultando seu uso no formato tradicional 
em papel. Portanto, a elabora&ccedil;&atilde;o de tal aplicativo foi compat&iacu
te;vel com a necessidade do presente estudo, permitindo a utiliza&ccedil;&atilde
;o imediata dos resultados ap&oacute;s digita&ccedil;&atilde;o dos dados.</font>
</p>     ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#57#53#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#58#54#article#134#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font></p>     ^
cY#v60n1a07.htm##
00754000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704051700078002001300595#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#59#55#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Dos sujeitos que tiveram os dados 
analisados, 284 (54,5%) participantes eram do sexo feminino e 236 eram do sexo m
asculino (um foi omisso quanto a essa quest&atilde;o), com 105 dos respondentes 
com escolaridade fundamental, 212 com ensino m&eacute;dio e 196 com ensino super
ior (8 sujeitos n&atilde;o informaram sua escolaridade). Compuseram o grupo cl&i
acute;nico, ent&atilde;o, 193 sujeitos e o grupo n&atilde;o cl&iacute;nico, 328.
</font></p>     ^cY#v60n1a07.htm##
01782000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704154500078002001301623#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#60#56#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os resultados demonstram diferen&c
cedil;as significativas entre as m&eacute;dias dos fatores para o grupo cl&iacut
e;nico e n&atilde;o cl&iacute;nico nas escalas de verifica&ccedil;&atilde;o: X (
Divulga&ccedil;&atilde;o), Y (Desejabilidade Social) e Z (Valoriza&ccedil;&atild
e;o Negativa), todas com p &lt; 0,001. Quanto aos resultados das escalas de padr
&otilde;es cl&iacute;nicos de personalidade, evidenciaram-se diferen&ccedil;as n
as escalas 1 (Esquizoide), escala 2B (Depressivo), escala 3 (Dependente), escala
 6A (Antissocial) e escala 8B (Masoquista), com signific&acirc;ncia de p &lt; 0,
001 e na escala 6B (S&aacute;dico/Agressivo), com p = 0,001. Em rela&ccedil;&ati
lde;o &agrave;s escalas de transtornos de personalidade severos, apresentaram di
feren&ccedil;as significativas a escala S (Esquizot&iacute;pico) (p = 0,001) e a
 escala C (<i>Borderline</i>) (p &lt; 0,001). As escalas de s&iacute;ndromes cl&
iacute;nicas moderadas H (Somatoforme), D (Distimia), T (Depend&ecirc;ncia de Dr
ogas), B (Depend&ecirc;ncia de &Aacute;lcool) e R (Transtorno do Estresse P&oacu
te;s-Traum&aacute;tico) apresentaram signific&acirc;ncia de p &lt; 0,001, enquan
to a escala A (Ansiedade) apresentou p = 0,01. De igual forma, observaram-se dif
eren&ccedil;as entre as m&eacute;dias nas escalas de s&iacute;ndromes cl&iacute;
nicas severas - escala SS (Transtorno do Pensamento), escala CC (Depress&atilde;
o Maior) e escala PP (Transtorno Delirante), todas com p &lt; 0,001.</font></p> 
    ^cY#v60n1a07.htm##
00569000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704033200078002001300410#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#61#57#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Nesse sentido, as m&eacute;dias de
 pontua&ccedil;&otilde;es brutas para os grupos cl&iacute;nico e n&atilde;o cl&i
acute;nico nas diferentes escalas de transtornos de personalidade se distribu&ia
cute;ram de acordo com a <a href="#tab01">tabela 1</a>.</font></p>     ^cY#v60n1
a07.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#62#58#article#134#<p><a name="tab01
"></a></p>     ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#63#59#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#64#60#article#134#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a07tab01.jpg"></p>     ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#65#61#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00479000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704024200078002001300320#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#66#62#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Em rela&ccedil;&atilde;o ao conjun
to de escalas de s&iacute;ndromes cl&iacute;nicas, os resultados s&atilde;o os a
presentados na <a href="#tab02">tabela 2</a>.</font></p>     ^cY#v60n1a07.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#67#63#article#134#<p><a name="tab02
"></a></p>     ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#68#64#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#69#65#article#134#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a07tab02.jpg"></p>     ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#70#66#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#71#67#article#134#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p>
     ^cY#v60n1a07.htm##
00974000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704073700078002001300815#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#72#68#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Mesmo sendo o grupo cl&iacute;nico
 amplo e sem diferencia&ccedil;&atilde;o diagn&oacute;stica, foi poss&iacute;vel
 evidenciar distin&ccedil;&otilde;es altamente significativas para a maior parte
 das escalas, especialmente entre as de s&iacute;ndromes cl&iacute;nicas. A evid
&ecirc;ncia de diferen&ccedil;as entre os fatores e o sexo &eacute; concordante 
com a literatura, especificamente se tomados os transtornos de personalidade com
o o Antissocial (p = 0,000), Masoquista/Autodestrutivo (p = 0,001) e as S&iacute
;ndromes Cl&iacute;nicas de Ansiedade (p = 0,010), Depend&ecirc;ncia de &Aacute;
lcool (p = 0,000) e Depend&ecirc;ncia de Drogas (p = 0,000).</font></p>     ^cY#
v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#73#69#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#74#70#article#134#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a07tab03.jpg"></p>     ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#75#71#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
01125000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704088800078002001300966#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#76#72#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os estudos preliminares da adapta&
ccedil;&atilde;o brasileira do MCMI-III, ent&atilde;o, ratificam a sensibilidade
 de discrimina&ccedil;&atilde;o entre diferentes grupos subjacente &agrave; teor
ia de Millon, o que &eacute; corroborado por estudo de Brand&atilde;o e Vasco<su
p>17</sup>, realizado com o MCMI-II, segundo o qual grupos de sujeitos com difer
entes diagn&oacute;sticos (esquizofrenia, psicose e toxicodepend&ecirc;ncia) res
ponderam de forma significativamente diferente &agrave;s escalas Dependente, Ant
issocial e Compulsiva (p &lt; 0,05), Passivo-Agressivo, Negativista, Esquizot&ia
cute;pico, <i>Borderline</i>, Ansiedade, Somatoforme, Bipolar, Dist&iacute;mico,
 Depend&ecirc;ncia de &Aacute;lcool, Depend&ecirc;ncia de Drogas, Transtorno do 
Pensamento e Depress&atilde;o Maior (p &lt; 0,01). </font></p>     ^cY#v60n1a07.
htm##
00894000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704065700078002001300735#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#77#73#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Rossi <i>et al.</i><sup>18 </sup>t
amb&eacute;m enfatizaram o poder discriminativo do MCMI-III ao encontrarem difer
en&ccedil;as significativas nos padr&otilde;es de respostas de diferentes grupos
 quando comparados por sexo (p &lt; 0,001 para todas as escalas, exceto Agressiv
o, Compulsivo, Bipolar e Transtorno Dissociativo) na adapta&ccedil;&atilde;o hol
andesa do instrumento, com m&eacute;dias maiores para as mulheres nas escalas de
 Ansiedade, Somatoforme, Distimia, Transtorno do Estresse P&oacute;s-Traum&aacut
e;tico, Transtorno do Pensamento e Depress&atilde;o Maior. </font></p>      ^cY#
v60n1a07.htm##
00655000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704041800078002001300496#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#78#74#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Vanem <i>et al.</i><sup>19</sup>, 
ao compararem adictos e pessoas que n&atilde;o realizavam uso de subst&acirc;nci
a, identificaram diferen&ccedil;as entre os dois grupos nas respostas para as es
calas de Depend&ecirc;ncia de Drogas (M = 94,77, DP = 15,11), Antissocial (M = 8
2,95, DP = 12,86) e Depress&atilde;o (M = 74,33, DP = 26,66).</font></p>     ^cY
#v60n1a07.htm##
00819000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704058200078002001300660#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#79#75#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Outro estudo vem corroborar os dad
os analisados na presente discuss&atilde;o. Sinha e Watson<sup>20 </sup>sugerem,
 mediante pesquisa feita com 157 estudantes de psicologia, que o MCMI-III indica
 um padr&atilde;o distintivo de rela&ccedil;&atilde;o entre fatores psicossociai
s e transtornos de personalidade espec&iacute;ficos. As informa&ccedil;&otilde;e
s obtidas em tal estudo explicitam uma porcentagem relativamente grande de vari&
acirc;ncia em praticamente todos os transtornos de personalidade.</font></p>    
 ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#80#76#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#81#77#article#134#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUS&Atilde;O</b></font></p>
     ^cY#v60n1a07.htm##
01745000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704150800078002001301586#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#82#78#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">&Eacute; poss&iacute;vel, mesmo de
 forma preliminar e com base na autorrefer&ecirc;ncia por parte dos respondentes
, verificar que a vers&atilde;o brasileira do instrumento tem apresentado m&eacu
te;dias significativamente distintas quando considerados grupos cl&iacute;nico e
 n&atilde;o cl&iacute;nico, caracterizando um dos ind&iacute;cios de validade qu
anto ao preceito te&oacute;rico. Cabe salientar que, mesmo n&atilde;o havendo um
a diferencia&ccedil;&atilde;o nosol&oacute;gica ou mesmo sintom&aacute;tica que 
respalde a constitui&ccedil;&atilde;o do grupo cl&iacute;nico, a sensibilidade d
o instrumento foi capaz de apresentar um aspecto diferenciador e, em consequ&eci
rc;ncia, possivelmente promissor na evolu&ccedil;&atilde;o dos estudos de valida
de. Com a continuidade da coleta de dados e a amplia&ccedil;&atilde;o da amostra
, estudos seguem sendo desenvolvidos na busca de identifica&ccedil;&atilde;o e c
aracteriza&ccedil;&atilde;o de aspectos complementares nas diferen&ccedil;as ent
re sexo, idade e escolaridade dos sujeitos. Busca-se, dessa forma, elementos que
 possam amparar a verifica&ccedil;&atilde;o da estrutura fatorial do MCMI-III, e
sperando-se que esta corrobore o preconizado por Millon quanto &agrave;s caracte
r&iacute;sticas psicopatol&oacute;gicas segundo a composi&ccedil;&atilde;o de gr
upos crit&eacute;rios, al&eacute;m da verifica&ccedil;&atilde;o da validade e da
 especificidade do instrumento.</font></p>     ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#83#79#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00341000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010400078002001300182#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#84#80#article#134#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>AGRADECIMENTOS</b></font></p>  
   ^cY#v60n1a07.htm##
00520000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704028300078002001300361#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#85#81#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">&Agrave; Coordena&ccedil;&atilde;o
 de Aperfei&ccedil;oamento de Pessoal de N&iacute;vel Superior e ao Conselho Nac
ional de Desenvolvimento Cient&iacute;fico e Tecnol&oacute;gico pelo apoio finan
ceiro.</font></p>     ^cY#v60n1a07.htm##
00552000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704031500078002001300393#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#86#82#article#134#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A todos os acad&ecirc;micos de Psi
cologia participantes do Projeto de Extens&atilde;o de Avalia&ccedil;&atilde;o P
sicol&oacute;gica &agrave; Comunidade e do Projeto de Pesquisa para Adapta&ccedi
l;&atilde;o do MCMI-III para o Brasil.</font></p>     ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#87#83#article#134#<p>&nbsp;</p>    
 ^cY#v60n1a07.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#88#84#article#134#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b></font></p
>     ^cY#v60n1a07.htm##
00538000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704028700080002001300367#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#89#85#article#134#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. 	Ellis A, Abrams 
M. Personality theories: critical perspective. In: Ellis A, Abrems M. Personalit
y and psychometric tests: objective personality measures. Calif&oacute;rnia: Sag
e Publications, Inc; 2009, p. 67-70.    ^cY#v60n1a07.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#90#86#article#134# </font></p>     
^cY#v60n1a07.htm##
00439000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704018800080002001300268#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#91#87#article#134#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Millon T, Davis R
, Millon C. MCMI-III: Invent&aacute;rio Multiaxial de Millon - III - Manual. TEZ
 Ediciones; 2007.    ^cY#v60n1a07.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#92#88#article#134# </font></p>     
^cY#v60n1a07.htm##
00537000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704028600080002001300366#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#93#89#article#134#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Heim A, Westen D.
 Essentials of personality disorders. In: Oldham JM, Skodol AE, Bender DS. Perso
nality disorders: recent history and the DSM system. Arlington: American Psychia
tric Publishing Inc; 2009, p. 3-13.    ^cY#v60n1a07.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#94#90#article#134# </font></p>     
^cY#v60n1a07.htm##
00507000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704025600080002001300336#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#95#91#article#134#4#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Millon T, Millon 
CM. The Millon inventories: clinical and personality assessment. In: Millon T. H
istory, theory and validation of MCMI. New York: The Guildford Press; 1997, p. 2
3-40.    ^cY#v60n1a07.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#96#92#article#134# </font></p>     
^cY#v60n1a07.htm##
00484000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704023300080002001300313#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#97#93#article#134#5#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Craig RJ. Essenti
als of Millon inventories assessment. In: Strack S. Essentials of MCMI-III asses
sment. 3ª ed. Nova York: John Wiley &amp; Sons; 2008, p. 1-55.    ^cY#v60n1a07.h
tm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#98#94#article#134# </font></p>     
^cY#v60n1a07.htm##
00459000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704020800080002001300288#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#99#95#article#134#6#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Millon T, Davis R
, Millon C, Grossman S. The Millon Clinical Multiaxial Inventory - III. 3ª ed. M
inneapolis: Pearson Assessment; 2006.    ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002100079002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#100#96#article#134# </font></p>    
 ^cY#v60n1a07.htm##
00630000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000200079704037800081002001300459#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#101#97#article#134#7#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Millon T, Rogers
 D, Millon C, Grossman S. The Millon Clinical Multiaxial Inventory-III. 3ª ed. &
#91;with new norms and updated scoring&#93;. Dispon&iacute;vel em:<a href="http:
//www.millon.net/instruments/MCMI_III.htm" target="_blank">//www.millon.net/inst
ruments/MCMI_III.htm</a>. Acesso em: 4 out 2010.    ^cY#v60n1a07.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#102#98#article#134#</font></p>     
^cY#v60n1a07.htm##
00449000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000200079704019700081002001300278#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#103#99#article#134#8#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Beck AT, Freeman
 A, Davis DD, et al. Terapia cognitiva dos transtornos de personalidade. 2ª ed. 
Porto Alegre: Artmed; 2007.    ^cY#v60n1a07.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#104#100#article#134# </font></p>   
  ^cY#v60n1a07.htm##
00545000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000200080704029200082002001300374#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#105#101#article#134#9#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Marcus DK, Rusc
io J, Lilienfeld SO, Hughes KT. Converging evidence for the latent structure of 
antisocial personality disorder: consistency of taxometric and latent class anal
yses. Crim Justic Behav. 2008;35(3):284-93.    ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#106#102#article#134#</font></p>    
 ^cY#v60n1a07.htm##
00520000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704026600083002001300349#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#107#103#article#134#10#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Duque AF, Nev
es PG. Automutila&ccedil;&atilde;o em meio prisional: avalia&ccedil;&atilde;o da
s perturba&ccedil;&otilde;es da personalidade. Psic Sa&uacute;de Doen&ccedil;as.
 2004;5(2):215-27.    ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#108#104#article#134#</font></p>    
 ^cY#v60n1a07.htm##
00507000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704025300083002001300336#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#109#105#article#134#11#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Pechorro PS, 
Poiares C, Vieira RX. Caracteriza&ccedil;&atilde;o psicol&oacute;gica de uma amo
stra forense de abusadores sexuais. An&aacute; Psicol&oacute;gica. 2008;21(4):61
5-23.    ^cY#v60n1a07.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#110#106#article#134# </font></p>   
  ^cY#v60n1a07.htm##
00501000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024700083002001300330#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#111#107#article#134#12#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Herrero J. Al
teraciones de la personalidad asociadas a las conductas adictivas: influencia de
 la duraci&oacute;n del consumo y sus implicaciones. Psykhe. 2004;(13)1:91-100. 
   ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#112#108#article#134#</font></p>    
 ^cY#v60n1a07.htm##
00597000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704034300083002001300426#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#113#109#article#134#13#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Gonz&aacute;l
ez MCT, Riveros MMP, Uribe JI, Luna SM. Validaci&oacute;n de la prueba Young Adu
lt Alcohol Problems Screening Teste, YAAPST, en un grupo de estudiantes universi
tarios de la Pontificia Universidad Javeriana de Bogot&aacute;. Univ Psychol. 20
06;1(5):175-90.    ^cY#v60n1a07.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#114#110#article#134# </font></p>   
  ^cY#v60n1a07.htm##
00517000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704026300083002001300346#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#115#111#article#134#14#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. H&eacute;rran
 OF, Ardila MF, Barba DM. Consumo problem&aacute;tico de alcohol en Bucaramanga,
 Colombia: dise&ntilde;o y validaci&oacute;n de una prueba. Biom&eacute;dica. 20
07;(28)1:25-37.    ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#116#112#article#134#</font></p>    
 ^cY#v60n1a07.htm##
00487000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023300083002001300316#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#117#113#article#134#15#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. P&eacute;rez 
CL, Lara CV. Asertividad, resistencia a la pr&eacute;sion de grupo y consumo de 
alcohol en universitarios. Acta Colomb Psicol. 2008;(11)1:155-62.    ^cY#v60n1a0
7.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#118#114#article#134#</font></p>    
 ^cY#v60n1a07.htm##
00545000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704029100083002001300374#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#119#115#article#134#16#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Carvalho LF. 
Constru&ccedil;&atilde;o e valida&ccedil;&atilde;o do Invent&aacute;rio Dimensio
nal de Transtornos da Personalidade &#91;disserta&ccedil;&atilde;o&#93;. Itatiba
: Universidade S&atilde;o Franscisco; 2008.    ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#120#116#article#134#</font></p>    
 ^cY#v60n1a07.htm##
00551000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704029700083002001300380#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#121#117#article#134#17#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Brand&atilde;
o A, Vasco AB. Discrep&acirc;ncias do eu: diferen&ccedil;as estruturais entre as
 popula&ccedil;&otilde;es cl&iacute;nica e n&atilde;o cl&iacute;nica avaliadas c
om o MCMI-II. Psic&oacute;logos. 2008;3(1):22-52.    ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#122#118#article#134#</font></p>    
 ^cY#v60n1a07.htm##
00464000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704021000083002001300293#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#123#119#article#134#18#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Rossi G, Van 
der Ark LA, Sloore H. Factor analysis of the Dutch-language version of the MCMI-
III. J Personal Assess. 2007;88(2):144-57.    ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#124#120#article#134#</font></p>    
 ^cY#v60n1a07.htm##
00460000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704020600083002001300289#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#125#121#article#134#19#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Vanem PC, Kro
g D, Hartmann E. Assessment of substance abusers on the MCMI-III and the Rorscha
ch. Scand J Psychol. 2008;49(1):83-91.    ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#126#122#article#134#</font></p>    
 ^cY#v60n1a07.htm##
00467000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704021300083002001300296#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#127#123#article#134#20#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Sinha BK, Wat
son DC. Psychosocial predictors of personality disorder traits in a non-clinical
 sample. Pers Individ Dif. 1997;22(4):527-37.    ^cY#v60n1a07.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#128#124#article#134#</font></p>    
 ^cY#v60n1a07.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#129#125#article#134#<p>&nbsp;</p>  
   ^cY#v60n1a07.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#130#126#article#134#<p>&nbsp;</p>  
   ^cY#v60n1a07.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704023200080002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#131#127#article#134#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="
/img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <
b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a07.htm##
00292000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704005300080002001300133#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#132#128#article#134#<br>  Hannia Ro
berta Rodrigues Paiva da Rocha    ^cY#v60n1a07.htm##
00297000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704005800080002001300138#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#133#129#article#134#<br>  Rua Beatr
iz Ramalho, 3570, Candel&aacute;ria    ^cY#v60n1a07.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704003400080002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#134#130#article#134#<br> 59064-660 
- Natal, RN    ^cY#v60n1a07.htm##
00304000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006500080002001300145#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#135#131#article#134#<br>  Telefones
: (84) 3215-3590, ramal 230/(84) 9144-0593    ^cY#v60n1a07.htm##
00347000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704010800080002001300188#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#136#132#article#134#<br>  E-mail: <
a href="mailto:hanniaroberta@yahoo.com.br">hanniaroberta@yahoo.com.br</a></font>
</p>     ^cY#v60n1a07.htm##
00332000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009300080002001300173#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#137#133#article#134#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 21/10/2010    ^cY#v6
0n1a07.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#p#138#134#article#134#<br>  Aprovado 
em 7/12/2010</font></p>     ^cY#v60n1a07.htm##
00625000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100015000790100016000940120
04700110016001500157016001600172018007100188066001100259062002300270014000600293
065000900299064000500308865000900313002001300322#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a07.htm#S#c#139#1#article#20#1#^rND^sEllis^nA#^rND^sAbrams^nM#P
ersonality theories: critical perspective^len#^rND^sEllis^nA#^rND^sAbrems^nM#Per
sonality and psychometric tests: objective personality measures^len#Califórnia#S
age Publications, Inc#67-70#20090000#2009#20110000#v60n1a07.htm##
00479000000000241000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160016000790160015000950160
01600110018006100126062001400187065000900201064000500210865000900215002001300224
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#c#140#2#article#20#2#
^rND^sMillon^nT#^rND^sDavis^nR#^rND^sMillon^nC#MCMI-III: Inventário Multiaxial d
e Millon - III - Manual^lpt#TEZ Ediciones#20070000#2007#20110000#v60n1a07.htm##
00650000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100014000790100016000930120
04000109016001700149016001700166016001700183018006100200066001000261062003600271
014000500307065000900312064000500321865000900326002001300335#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a07.htm#S#c#141#3#article#20#3#^rND^sHeim^nA#^rND^s
Westen^nD#Essentials of personality disorders^len#^rND^sOldham^nJM#^rND^sSkodol^
nAE#^rND^sBender^nDS#Personality disorders: recent history and the DSM system^le
n#Arlington#American Psychiatric Publishing Inc#3-13#20090000#2009#20110000#v60n
1a07.htm##
00584000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100017000950120
06400112016001600176018004300192066000900235062002000244014000600264065000900270
064000500279865000900284002001300293#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a07.htm#S#c#142#4#article#20#4#^rND^sMillon^nT#^rND^sMillon^nCM#The Millon 
inventories: clinical and personality assessment^len#^rND^sMillon^nT#History, th
eory and validation of MCMI^len#New York#The Guildford Press#23-40#19970000#1997
#20110000#v60n1a07.htm##
00546000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790120048000950160
01600143018003800159063000200197066001000199062001800209065000900227064000500236
014000500241865000900246002001300255#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a07.htm#S#c#143#5#article#20#5#^rND^sCraig^nRJ#Essentials of Millon invento
ries assessment^len#^rND^sStrack^nS#Essentials of MCMI-III assessment^len#3#Nova
 York#John Wiley & Sons#20080000#2008#1-55#20110000#v60n1a07.htm##
00542000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160016000790160015000950160
01600110016001800126018005100144063000200195066001200197062001900209065000900228
064000500237865000900242002001300251#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a07.htm#S#c#144#6#article#20#6#^rND^sMillon^nT#^rND^sDavis^nR#^rND^sMillon^
nC#^rND^sGrossman^nS#The Millon Clinical Multiaxial Inventory - III^len#3#Minnea
polis#Pearson Assessment#20060000#2006#20110000#v60n1a07.htm##
00546000000000265000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160016000790160016000950160
01600111016001800127018004900145063000200194037004200196110000900238109001100247
865000900258002001300267#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm
#S#c#145#7#article#20#7#^rND^sMillon^nT#^rND^sRogers^nD#^rND^sMillon^nC#^rND^sGr
ossman^nS#The Millon Clinical Multiaxial Inventory-III^len#3#//www.millon.net/in
struments/MCMI_III.htm#20101004#4 out 2010#20110000#v60n1a07.htm##
00524000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160015000790160017000940160
01600111810000600127018005500133063000200188066001300190062000700203065000900210
064000500219865000900224002001300233#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a07.htm#S#c#146#8#article#20#8#^rND^sBeck^nAT#^rND^sFreeman^nA#^rND^sDavis^
nDD#et al#Terapia cognitiva dos transtornos de personalidade^lpt#2#Porto Alegre#
Artmed#20070000#2007#20110000#v60n1a07.htm##
00657000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790100016000960100
02100112010001700133012013700150030001800287710000200305065000900307064000500316
031000300321032000200324014000700326865000900333002001300342#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a07.htm#S#c#147#9#article#20#9#^rND^sMarcus^nDK#^rN
D^sRuscio^nJ#^rND^sLilienfeld^nSO#^rND^sHughes^nKT#Converging evidence for the l
atent structure of antisocial personality disorder: consistency of taxometric an
d latent class analyses^len#Crim Justic Behav#2#20080000#2008#35#3#284-93#201100
00#v60n1a07.htm##
00540000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100016000970120
08100113030001900194710000200213065000900215064000500224031000200229032000200231
014000700233865000900240002001300249#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a07.htm#S#c#148#10#article#20#10#^rND^sDuque^nAF#^rND^sNeves^nPG#Automutila
ção em meio prisional: avaliação das perturbações da personalidade^lpt#Psic Saúd
e Doenças#2#20040000#2004#5#2#215-27#20110000#v60n1a07.htm##
00566000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100017001000100
01700117012007600134030001600210710000200226065000900228064000500237031000300242
032000200245014000700247865000900254002001300263#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a07.htm#S#c#149#11#article#20#11#^rND^sPechorro^nPS#^rND^sPoiar
es^nC#^rND^sVieira^nRX#Caracterização psicológica de uma amostra forense de abus
adores sexuais^lpt#Aná Psicológica#2#20080000#2008#21#4#615-23#20110000#v60n1a07
.htm##
00552000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810120131000980300
00700229710000200236065000900238064000500247032000300252031000200255014000700257
865000900264002001300273#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm
#S#c#150#12#article#20#12#^rND^sHerrero^nJ#Alteraciones de la personalidad asoci
adas a las conductas adictivas: influencia de la duración del consumo y sus impl
icaciones^les#Psykhe#2#20040000#2004#13#1#91-100#20110000#v60n1a07.htm##
00688000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100020000810100019001010100
01600120010001500136012017300151030001300324710000200337065000900339064000500348
031000200353032000200355014000700357865000900364002001300373#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a07.htm#S#c#151#13#article#20#13#^rND^sGonzález^nMC
T#^rND^sRiveros^nMMP#^rND^sUribe^nJI#^rND^sLuna^nSM#Validación de la prueba Youn
g Adult Alcohol Problems Screening Teste, YAAPST, en un grupo de estudiantes uni
versitarios de la Pontificia Universidad Javeriana de Bogotá^les#Univ Psychol#2#
20060000#2006#1#5#175-90#20110000#v60n1a07.htm##
00606000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100017000980100
01600115012009600131030001000227065000900237064000500246032000300251031000200254
014000600256865000900262002001300271035001000284801001000294#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a07.htm#S#c#152#14#article#20#14#^rND^sHérran^nOF#^
rND^sArdila^nMF#^rND^sBarba^nDM#Consumo problemático de alcohol en Bucaramanga, 
Colombia: diseño y validación de una prueba^les#Biomédica#20070000#2007#28#1#25-
37#20110000#v60n1a07.htm#0120-4157#Biomédica##
00549000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100015000970120
09000112030001900202710000200221065000900223064000500232032000300237031000200240
014000700242865000900249002001300258#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a07.htm#S#c#153#15#article#20#15#^rND^sPérez^nCL#^rND^sLara^nCV#Asertividad
, resistencia a la présion de grupo y consumo de alcohol en universitarios^les#A
cta Colomb Psicol#2#20080000#2008#11#1#155-62#20110000#v60n1a07.htm##
00487000000000229000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160019000810180085001000460
00800185050002800193045000900221044000500230865000900235002001300244#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a07.htm#S#c#154#16#article#20#16#^rND^sCarv
alho^nLF#Construção e validação do Inventário Dimensional de Transtornos da Pers
onalidade^lpt#Itatiba#Universidade São Franscisco#20080000#2008#20110000#v60n1a0
7.htm##
00565000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100016000980120
11400114030001100228710000200239065000900241064000500250031000200255032000200257
014000600259865000900265002001300274#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a07.htm#S#c#155#17#article#20#17#^rND^sBrandão^nA#^rND^sVasco^nAB#Discrepân
cias do eu: diferenças estruturais entre as populações clínica e não clínica ava
liadas com o MCMI-II^lpt#Psicólogos#2#20080000#2008#3#1#22-52#20110000#v60n1a07.
htm##
00558000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100022000960100
01600118012006600134030001800200710000200218065000900220064000500229031000300234
032000200237014000700239865000900246002001300255#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a07.htm#S#c#156#18#article#20#18#^rND^sRossi^nG#^rND^sVan der A
rk^nLA#^rND^sSloore^nH#Factor analysis of the Dutch-language version of the MCMI
-III^len#J Personal Assess#2#20070000#2007#88#2#144-57#20110000#v60n1a07.htm##
00590000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100014000970100
01800111012007000129030001600199065000900215064000500224031000300229032000200232
014000600234865000900240002001300249035001000262801001600272#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a07.htm#S#c#157#19#article#20#19#^rND^sVanem^nPC#^r
ND^sKrog^nD#^rND^sHartmann^nE#Assessment of substance abusers on the MCMI-III an
d the Rorschach^len#Scand J Psychol#20080000#2008#49#1#83-91#20110000#v60n1a07.h
tm#0036-5564#Scand J Psychol##
00580000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100017000970120
08400114030001700198065000900215064000500224031000300229032000200232014000700234
865000900241002001300250035001000263801001700273#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a07.htm#S#c#158#20#article#20#20#^rND^sSinha^nBK#^rND^sWatson^n
DC#Psychosocial predictors of personality disorder traits in a non-clinical samp
le^len#Pers Individ Dif#19970000#1997#22#4#527-37#20110000#v60n1a07.htm#0191-886
9#Pers Individ Dif##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#o#1#1#article
#1#20110331#101402#v60n1a08.htm#188##
04430000000000601000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901200950
01690120089002640100041003530100028003940700039004220831678004610850010021390850
02202149085002102171085002502192085004002217083140302257085001003660085002003670
08500220369008500240371208500300373611700080376607200030377411200090377711100100
3786114000903796113001003805002001303815#v60n1#V:\SciELO\serial\jbpsiq\v60n1\mar
kup\v60n1a08.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#ILUS#TAB#8#JBPSIQ010#nd#J. 
bras. psiquiatr.#60#1#20110000#^f40^l45#0047-2085#Sintomas de internalização e e
xternalização em crianças e adolescentes com excesso de peso^lpt#Internalizing a
nd externalizing symptoms in children and adolescents with overweight^len#^rND^1
A01^nMarcos Rogério Capello^sSousa#^rND^1A01^nCésar de^sMoraes#Universidade Esta
dual de Campinas^iA01#^lpt^aOBJETIVO: Comparar sintomas de internalização e exte
rnalização em crianças e adolescentes com e sem excesso de peso. MÉTODO: 88 indi
víduos (53 com excesso de peso e 35 eutróficos), entre 6 e 18 anos, foram avalia
dos por meio do Inventário de Comportamentos da Infância e Adolescência (CBCL-6/
18) e de medidas antropométricas. Foram considerados com excesso de peso os indi
víduos com índice de massa corporal (IMC) > 1 desvio-padrão. Os indivíduos com T
-score > 70 no CBCL-6/18 foram considerados como tendo sintomas emocionais. O te
ste de Mann-Whitney foi utilizado para verificar se houve diferença entre as méd
ias do IMC, as médias de idade e os T-scores médios obtidos nas subescalas de in
ternalização e externalização, de acordo com os grupos pesquisados. Foi utilizad
o o índice de correlação de Spearman para verificar correlação entre o IMC e os 
T-scores médios obtidos nas subescalas de internalização e externalização. RESUL
TADOS: Sintomas de internalização ocorreram em 14 indivíduos com excesso de peso
 e em 4 eutróficos (médias de T-score: 59,09 e 49,40, respectivamente, p-valor =
 0,003). Sintomas de externalização ocorreram em 9 indivíduos com excesso de pes
o e em 2 eutróficos (médias de T-score: 53,71 e 47,91, respectivamente, p-valor 
= 0,019). Foi encontrada uma correlação positiva entre o IMC dos indivíduos pesq
uisados e a presença de sintomas de internalização e externalização. O mesmo oco
rreu, quando se correlacionou os T-scores médios dos sintomas de internalização 
e externalização. CONCLUSÃO: Sintomas psiquiátricos prevaleceram nos indivíduos 
com excesso de peso. Quanto maior é o IMC, maior o risco do desenvolvimento de s
intomas emocionais.#^ddecs^i1#^tm^lpt^kObesidade^i1#^tm^lpt^kinfância^i1#^tm^lpt
^kadolescência^i1#^tm^lpt^ktranstorno de comportamento^i1#^len^aOBJECTIVE: The a
im of this study was to compare the internalizing and externalizing symptoms in 
children and adolescents with and without weight excess. METHOD: Child Behavior 
Checklist (CBCL-6/18) and Body Mass Index (BMI) have been used to assess 88 indi
viduals from 6 to 18 years of age. The individuals with BMI > 1 sd were consider
ed overweight (53 overweight and 35 eutrophic) and those individuals with CBCL-6
/18 T-score > 70 were considered having emotional symptoms. The Mann-Whitney tes
t was used to measure any possible difference in the average BMI, between age av
erages and mean t-scores obtained in internalizing and externalizing subscales a
ccording to the researched groups. Spearman Correlation Index was used to verify
 the correlation between BMI and T-score averages. RESULTS: Internalizing sympto
ms have been observed in 14 overweight individuals and in 4 eutrophic individual
s. (T-score average: 59.09 and 49.40, respectively, p value = 0.003). Externaliz
ing symptoms have been found in 9 overweight individuals and in 2 eutrophic indi
viduals. (T-score average: 53.71 and 47.91, respectively, p-value = 0.019). Ther
e was a positive correlation between BMI and internalizing and externalizing sym
ptoms. CONCLUSION: Psychiatric symptoms have been observed frequently in overwei
ght individuals and the higher is the BMI, the higher is the risk for developing
 emotional symptoms.#^ddecs^i2#^tm^len^kObesity^i2#^tm^len^kchildhood^i2#^tm^len
^kadolescence^i2#^tm^len^kbehavior disorder^i2#vancouv#29#20091108#8/11/2009#201
10124#24/1/2011#v60n1a08.htm##
04582000000000601000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901201020
01690120096002710100041003670100028004080700039004360831754004750850010022290850
02202239085002102261085002502282085004002307083146502347085001003812085002003822
08500220384208500240386408500300388811700080391807200030392611200090392911100100
3938114000903948113001003957002001303967#v60n1#V:\SciELO\serial\jbpsiq\v60n1\mar
kup\v60n1a08.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#ILUS#TAB#8#JBPSIQ010#nd#J. 
bras. psiquiatr.#60#1#20110000#^f40^l45#0047-2085#<b>Sintomas de internalização 
e externalização em crianças e adolescentes com excesso de peso</b>^lpt#<b>Inter
nalizing and externalizing symptoms in children and adolescents with overweight<
/b>^len#^rND^1A01^nMarcos Rogério Capello^sSousa#^rND^1A01^nCésar de^sMoraes#Uni
versidade Estadual de Campinas^iA01#^lpt^a<b>OBJETIVO:</b> Comparar sintomas de 
internalização e externalização em crianças e adolescentes com e sem excesso de 
peso. <b>MÉTODO:</b> 88 indivíduos (53 com excesso de peso e 35 eutróficos), ent
re 6 e 18 anos, foram avaliados por meio do Inventário de Comportamentos da Infâ
ncia e Adolescência (CBCL-6/18) e de medidas antropométricas. Foram considerados
 com excesso de peso os indivíduos com índice de massa corporal (IMC) &gt; 1 des
vio-padrão. Os indivíduos com T-<i>score </i>&gt; 70 no CBCL-6/18 foram consider
ados como tendo sintomas emocionais. O teste de Mann-Whitney foi utilizado para 
verificar se houve diferença entre as médias do IMC, as médias de idade e os T-<
i>scores</i> médios obtidos nas subescalas de internalização e externalização, d
e acordo com os grupos pesquisados. Foi utilizado o índice de correlação de Spea
rman para verificar correlação entre o IMC e os T-<i>scores</i> médios obtidos n
as subescalas de internalização e externalização. <b>RESULTADOS: </b>Sintomas de
 internalização ocorreram em 14 indivíduos com excesso de peso e em 4 eutróficos
 (médias de T-<i>score</i>: 59,09 e 49,40, respectivamente, p-valor = 0,003). Si
ntomas de externalização ocorreram em 9 indivíduos com excesso de peso e em 2 eu
tróficos (médias de T-<i>score</i>: 53,71 e 47,91, respectivamente, p-valor = 0,
019). Foi encontrada uma correlação positiva entre o IMC dos indivíduos pesquisa
dos e a presença de sintomas de internalização e externalização. O mesmo ocorreu
, quando se correlacionou os T-<i>scores</i> médios dos sintomas de internalizaç
ão e externalização. <b>CONCLUSÃO: </b>Sintomas psiquiátricos prevaleceram nos i
ndivíduos com excesso de peso. Quanto maior é o IMC, maior o risco do desenvolvi
mento de sintomas emocionais.#^ddecs^i1#^tm^lpt^kObesidade^i1#^tm^lpt^kinfância^
i1#^tm^lpt^kadolescência^i1#^tm^lpt^ktranstorno de comportamento^i1#^len^a<b>OBJ
ECTIVE:</b> The aim of this study was to compare the internalizing and externali
zing symptoms in children and adolescents with and without weight excess. <b>MET
HOD:</b> Child Behavior Checklist (CBCL-6/18) and Body Mass Index (BMI) have bee
n used to assess 88 individuals from 6 to 18 years of age. The individuals with 
BMI &gt; 1 sd were considered overweight (53 overweight and 35 eutrophic) and th
ose individuals with CBCL-6/18 T-<i>score</i> &gt; 70 were considered having emo
tional symptoms. The Mann-Whitney test was used to measure any possible differen
ce in the average BMI, between age averages and mean t-scores obtained in intern
alizing and externalizing subscales according to the researched groups. Spearman
 Correlation Index was used to verify the correlation between BMI and T-<i>score
</i> averages. <b>RESULTS: </b>Internalizing symptoms have been observed in 14 o
verweight individuals and in 4 eutrophic individuals. (T-<i>score</i> average: 5
9.09 and 49.40, respectively, p value = 0.003). Externalizing symptoms have been
 found in 9 overweight individuals and in 2 eutrophic individuals. (T-<i>score</
i> average: 53.71 and 47.91, respectively, p-value = 0.019). There was a positiv
e correlation between BMI and internalizing and externalizing symptoms. <b>CONCL
USION:</b> Psychiatric symptoms have been observed frequently in overweight indi
viduals and the higher is the BMI, the higher is the risk for developing emotion
al symptoms.#^ddecs^i2#^tm^len^kObesity^i2#^tm^len^kchildhood^i2#^tm^len^kadoles
cence^i2#^tm^len^kbehavior disorder^i2#vancouv#29#20091108#8/11/2009#20110124#24
/1/2011#v60n1a08.htm##
04551000000000625000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000200108049001000110
15800030012003000190012303100030014203200020014506500090014701400090015603500100
01650120095001750120089002700100041003590100028004000700041004280831678004690850
01002147085002202157085002102179085002502200085004002225083140302265085001003668
08500200367808500220369808500240372008500300374411700080377407200030378211200090
3785111001003794114000903804113001003813002001303823008008903836#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#l#4#1#article#1#^a2011#oa#pt#br1.1#1#
4.0#ilus#tab#8#JBPSIQ010#nd#J. bras. psiquiatr#60#1#20110000#^f40^l45#0047-2085#
Sintomas de internalização e externalização em crianças e adolescentes com exces
so de peso^lpt#Internalizing and externalizing symptoms in children and adolesce
nts with overweight^len#^rND^1A01^nMarcos Rogério Capello^sSousa#^rND^1A01^nCésa
r de^sMoraes#^iA01^1Universidade Estadual de Campinas#^lpt^aOBJETIVO: Comparar s
intomas de internalização e externalização em crianças e adolescentes com e sem 
excesso de peso. MÉTODO: 88 indivíduos (53 com excesso de peso e 35 eutróficos),
 entre 6 e 18 anos, foram avaliados por meio do Inventário de Comportamentos da 
Infância e Adolescência (CBCL-6/18) e de medidas antropométricas. Foram consider
ados com excesso de peso os indivíduos com índice de massa corporal (IMC) > 1 de
svio-padrão. Os indivíduos com T-score > 70 no CBCL-6/18 foram considerados como
 tendo sintomas emocionais. O teste de Mann-Whitney foi utilizado para verificar
 se houve diferença entre as médias do IMC, as médias de idade e os T-scores méd
ios obtidos nas subescalas de internalização e externalização, de acordo com os 
grupos pesquisados. Foi utilizado o índice de correlação de Spearman para verifi
car correlação entre o IMC e os T-scores médios obtidos nas subescalas de intern
alização e externalização. RESULTADOS: Sintomas de internalização ocorreram em 1
4 indivíduos com excesso de peso e em 4 eutróficos (médias de T-score: 59,09 e 4
9,40, respectivamente, p-valor = 0,003). Sintomas de externalização ocorreram em
 9 indivíduos com excesso de peso e em 2 eutróficos (médias de T-score: 53,71 e 
47,91, respectivamente, p-valor = 0,019). Foi encontrada uma correlação positiva
 entre o IMC dos indivíduos pesquisados e a presença de sintomas de internalizaç
ão e externalização. O mesmo ocorreu, quando se correlacionou os T-scores médios
 dos sintomas de internalização e externalização. CONCLUSÃO: Sintomas psiquiátri
cos prevaleceram nos indivíduos com excesso de peso. Quanto maior é o IMC, maior
 o risco do desenvolvimento de sintomas emocionais.#^ddecs^i1#^tm^lpt^kObesidade
^i1#^tm^lpt^kinfância^i1#^tm^lpt^kadolescência^i1#^tm^lpt^ktranstorno de comport
amento^i1#^len^aOBJECTIVE: The aim of this study was to compare the internalizin
g and externalizing symptoms in children and adolescents with and without weight
 excess. METHOD: Child Behavior Checklist (CBCL-6/18) and Body Mass Index (BMI) 
have been used to assess 88 individuals from 6 to 18 years of age. The individua
ls with BMI > 1 sd were considered overweight (53 overweight and 35 eutrophic) a
nd those individuals with CBCL-6/18 T-score > 70 were considered having emotiona
l symptoms. The Mann-Whitney test was used to measure any possible difference in
 the average BMI, between age averages and mean t-scores obtained in internalizi
ng and externalizing subscales according to the researched groups. Spearman Corr
elation Index was used to verify the correlation between BMI and T-score average
s. RESULTS: Internalizing symptoms have been observed in 14 overweight individua
ls and in 4 eutrophic individuals. (T-score average: 59.09 and 49.40, respective
ly, p value = 0.003). Externalizing symptoms have been found in 9 overweight ind
ividuals and in 2 eutrophic individuals. (T-score average: 53.71 and 47.91, resp
ectively, p-value = 0.019). There was a positive correlation between BMI and int
ernalizing and externalizing symptoms. CONCLUSION: Psychiatric symptoms have bee
n observed frequently in overweight individuals and the higher is the BMI, the h
igher is the risk for developing emotional symptoms.#^ddecs^i2#^tm^len^kObesity^
i2#^tm^len^kchildhood^i2#^tm^len^kadolescence^i2#^tm^len^kbehavior disorder^i2#v
ancouv#29#20091108#8/11/2009#20110124#24/1/2011#v60n1a08.htm#Internet^ihttp://ww
w.scielo.br/scielo.php?script=sci_arttext&pid=S0047-20852011000100008##
00354000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704011900076002001300195#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#5#1#article#155#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>ARTIGO ORIGINAL</b>
</font></p>     ^cY#v60n1a08.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#6#2#article#155#<p>&nbsp;</p>     ^
cY#v60n1a08.htm##
00475000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704024000076002001300316#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#7#3#article#155#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Sintomas
 de internaliza&ccedil;&atilde;o e externaliza&ccedil;&atilde;o em crian&ccedil;
as e adolescentes com excesso de peso</b></font></p>     ^cY#v60n1a08.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#8#4#article#155#<p>&nbsp;</p>     ^
cY#v60n1a08.htm##
00409000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704017400076002001300250#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#9#5#article#155#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Internalizing and externalizing s
ymptoms in children and adolescents with overweight</b></font></p>     ^cY#v60n1
a08.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#10#6#article#155#<p>&nbsp;</p>     
^cY#v60n1a08.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#11#7#article#155#<p>&nbsp;</p>     
^cY#v60n1a08.htm##
00385000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704014900077002001300226#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#12#8#article#155#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Marcos Rog&eacute;rio Capello So
usa; C&eacute;sar de Moraes</b></font></p>     ^cY#v60n1a08.htm##
00362000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704012600077002001300203#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#13#9#article#155#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Universidade Estadual de Campinas (
Unicamp)</font></p>     ^cY#v60n1a08.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#14#10#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#15#11#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a08.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#16#12#article#155#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a08.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#17#13#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a08.htm##
00466000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704022900078002001300307#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#18#14#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVO:</b> Comparar sintomas
 de internaliza&ccedil;&atilde;o e externaliza&ccedil;&atilde;o em crian&ccedil;
as e adolescentes com e sem excesso de peso.    ^cY#v60n1a08.htm##
01295000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704105800078002001301136#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#19#15#article#155#<br>  <b>M&Eacute
;TODO:</b> 88 indiv&iacute;duos (53 com excesso de peso e 35 eutr&oacute;ficos),
 entre 6 e 18 anos, foram avaliados por meio do Invent&aacute;rio de Comportamen
tos da Inf&acirc;ncia e Adolesc&ecirc;ncia (CBCL-6/18) e de medidas antropom&eac
ute;tricas. Foram considerados com excesso de peso os indiv&iacute;duos com &iac
ute;ndice de massa corporal (IMC) &gt; 1 desvio-padr&atilde;o. Os indiv&iacute;d
uos com T-<i>score </i>&gt; 70 no CBCL-6/18 foram considerados como tendo sintom
as emocionais. O teste de Mann-Whitney foi utilizado para verificar se houve dif
eren&ccedil;a entre as m&eacute;dias do IMC, as m&eacute;dias de idade e os T-<i
>scores</i> m&eacute;dios obtidos nas subescalas de internaliza&ccedil;&atilde;o
 e externaliza&ccedil;&atilde;o, de acordo com os grupos pesquisados. Foi utiliz
ado o &iacute;ndice de correla&ccedil;&atilde;o de Spearman para verificar corre
la&ccedil;&atilde;o entre o IMC e os T-<i>scores</i> m&eacute;dios obtidos nas s
ubescalas de internaliza&ccedil;&atilde;o e externaliza&ccedil;&atilde;o.    ^cY
#v60n1a08.htm##
01023000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704078600078002001300864#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#20#16#article#155#<br>  <b>RESULTAD
OS: </b>Sintomas de internaliza&ccedil;&atilde;o ocorreram em 14 indiv&iacute;du
os com excesso de peso e em 4 eutr&oacute;ficos (m&eacute;dias de T-<i>score</i>
: 59,09 e 49,40, respectivamente, p-valor = 0,003). Sintomas de externaliza&cced
il;&atilde;o ocorreram em 9 indiv&iacute;duos com excesso de peso e em 2 eutr&oa
cute;ficos (m&eacute;dias de T-<i>score</i>: 53,71 e 47,91, respectivamente, p-v
alor = 0,019). Foi encontrada uma correla&ccedil;&atilde;o positiva entre o IMC 
dos indiv&iacute;duos pesquisados e a presen&ccedil;a de sintomas de internaliza
&ccedil;&atilde;o e externaliza&ccedil;&atilde;o. O mesmo ocorreu, quando se cor
relacionou os T-<i>scores</i> m&eacute;dios dos sintomas de internaliza&ccedil;&
atilde;o e externaliza&ccedil;&atilde;o.     ^cY#v60n1a08.htm##
00458000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704022100078002001300299#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#21#17#article#155#<br> <b>CONCLUS&A
tilde;O: </b>Sintomas psiqui&aacute;tricos prevaleceram nos indiv&iacute;duos co
m excesso de peso. Quanto maior &eacute; o IMC, maior o risco do desenvolvimento
 de sintomas emocionais.</font></p>     ^cY#v60n1a08.htm##
00441000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704020400078002001300282#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#22#18#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>Obesidade, 
inf&acirc;ncia, adolesc&ecirc;ncia, transtorno de comportamento. </font></p> <hr
 size="1" noshade>     ^cY#v60n1a08.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#23#19#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a08.htm##
00468000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704023100078002001300309#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#24#20#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVE:</b> The aim of this 
study was to compare the internalizing and externalizing symptoms in children an
d adolescents with and without weight excess.     ^cY#v60n1a08.htm##
00910000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704067300078002001300751#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#25#21#article#155#<br> <b>METHOD:</
b> Child Behavior Checklist (CBCL-6/18) and Body Mass Index (BMI) have been used
 to assess 88 individuals from 6 to 18 years of age. The individuals with BMI &g
t; 1 sd were considered overweight (53 overweight and 35 eutrophic) and those in
dividuals with CBCL-6/18 T-<i>score</i> &gt; 70 were considered having emotional
 symptoms. The Mann-Whitney test was used to measure any possible difference in 
the average BMI, between age averages and mean t-scores obtained in internalizin
g and externalizing subscales according to the researched groups. Spearman Corre
lation Index was used to verify the correlation between BMI and T-<i>score</i> a
verages.    ^cY#v60n1a08.htm##
00707000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704047000078002001300548#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#26#22#article#155#<br>  <b>RESULTS:
 </b>Internalizing symptoms have been observed in 14 overweight individuals and 
in 4 eutrophic individuals. (T-<i>score</i> average: 59.09 and 49.40, respective
ly, p value = 0.003). Externalizing symptoms have been found in 9 overweight ind
ividuals and in 2 eutrophic individuals. (T-<i>score</i> average: 53.71 and 47.9
1, respectively, p-value = 0.019). There was a positive correlation between BMI 
and internalizing and externalizing symptoms.    ^cY#v60n1a08.htm##
00443000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704020600078002001300284#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#27#23#article#155#<br> <b>CONCLUSIO
N:</b> Psychiatric symptoms have been observed frequently in overweight individu
als and the higher is the BMI, the higher is the risk for developing emotional s
ymptoms. </font></p>     ^cY#v60n1a08.htm##
00410000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017300078002001300251#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#28#24#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords:</b> Obesity, childhoo
d, adolescence, behavior disorder.</font></p> <hr size="1" noshade>     ^cY#v60n
1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#29#25#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#30#26#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a08.htm##
00351000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011400078002001300192#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#31#27#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde;O</b></f
ont></p>     ^cY#v60n1a08.htm##
02220000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704198300078002001302061#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#32#28#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O excesso de peso na inf&acirc;nci
a e adolesc&ecirc;ncia &eacute; um problema mundial, acometendo pa&iacute;ses de
senvolvidos e em desenvolvimento<sup>1,2</sup>. A Organiza&ccedil;&atilde;o Mund
ial de Sa&uacute;de (OMS) estima que 10% dos indiv&iacute;duos entre 5-17 anos e
st&atilde;o com sobrepeso e 2%-3% est&atilde;o com obesidade<sup>3</sup>. At&eac
ute; 2005 havia 20 milh&otilde;es de crian&ccedil;as menores de 5 anos com exces
so de peso<sup>4</sup>. Monteiro <i>et al.</i><sup>5 </sup>encontraram preval&ec
irc;ncia de 20,5% para sobrepeso e 7,7% para obesidade entre adolescentes (14-16
 anos). Seu surgimento precoce aumenta a possibilidade da obesidade no adulto (f
en&ocirc;meno da trilha ou <i>tracking</i>)<a href="#link01"><sup>*</sup></a><su
p>6</sup>,<a name="link001"></a> antecipando doen&ccedil;as cujas taxas de morbi
mortalidade j&aacute; contabilizam 59% das 57 milh&otilde;es de mortes anuais e 
46% de todas as doen&ccedil;as. O Minist&eacute;rio da Sa&uacute;de<sup>7</sup> 
registrou 43,4% de adultos com excesso de peso e 27% de mortes por doen&ccedil;a
 cardiovascular<sup>8,9</sup>, independentemente da idade. Condi&ccedil;&otilde;
es patol&oacute;gicas frequentes ligadas &agrave; obesidade como diabetes tipo I
I, transtornos emocionais - <i>bullying</i>, ansiedade, depress&atilde;o<sup>10 
</sup>- e osteoartropatias<sup>11 </sup>podem surgir subitamente com o agravamen
to de doen&ccedil;a sem controle ou sem diagn&oacute;stico, suscitando tratament
o emergencial especializado e, posteriormente, reabilita&ccedil;&atilde;o para r
eintegra&ccedil;&atilde;o social. Esse cen&aacute;rio de interven&ccedil;&otilde
;es curativas e de reabilita&ccedil;&atilde;o com reintegra&ccedil;&atilde;o soc
ial p&otilde;e em risco os sistemas de sa&uacute;de e previdenci&aacute;rios de 
pa&iacute;ses desenvolvidos, mas principalmente aqueles de pa&iacute;ses em dese
nvolvimento<sup>12</sup>. </font></p>     ^cY#v60n1a08.htm##
02333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704209600078002001302174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#33#29#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A g&ecirc;nese da obesidade infant
o-juvenil parece mais ligada &agrave;s mudan&ccedil;as ambientais relacionadas &
agrave; organiza&ccedil;&atilde;o da economia capitalista mundial nos &uacute;lt
imos 40 anos<sup>13-15</sup>. Estas t&ecirc;m impacto nas mudan&ccedil;as de com
portamento e na cultura das comunidades, escolas, lares e locais de trabalho, ma
s ainda h&aacute; pouca investiga&ccedil;&atilde;o<sup>16</sup> de media&ccedil;
&otilde;es como aquela que se d&aacute; entre a realidade e a subjetividade dos 
indiv&iacute;duos, principalmente as crian&ccedil;as, e que &eacute; feita pela 
m&iacute;dia por meio de propagandas abusivas incentivando o consumo e o lazer s
edent&aacute;rio<sup>17</sup>. Nessa perspectiva, para dimensionar o impacto da 
obesidade na sa&uacute;de coletiva e propor interven&ccedil;&otilde;es, a avalia
&ccedil;&atilde;o do comportamento infanto-juvenil torna-se imperativa ao lado d
as avalia&ccedil;&otilde;es diet&eacute;ticas e da pr&aacute;tica de exerc&iacut
e;cio f&iacute;sico. Para isso, s&atilde;o necess&aacute;rios instrumentos valid
ados que identifiquem se os dist&uacute;rbios ps&iacute;quicos comportam-se como
 causa, consequ&ecirc;ncia ou um fator associado &agrave; obesidade. Sabe-se que
 indiv&iacute;duos com depress&atilde;o frequentemente apresentam estilo de vida
 prec&aacute;rio por causa consumo excessivo de fumo, &aacute;lcool, dietas n&at
ilde;o saud&aacute;veis e sedentarismo e apresentam baixa ades&atilde;o aos trat
amentos m&eacute;dicos. Mas, mesmo na aus&ecirc;ncia desses fatores, existem alt
era&ccedil;&otilde;es fisiol&oacute;gicas nos quadros depressivos que poderiam r
esponder pelas elevadas taxas de doen&ccedil;as cardiovasculares nesses indiv&ia
cute;duos como os mecanismos auton&ocirc;micos de regula&ccedil;&atilde;o da fre
qu&ecirc;ncia card&iacute;aca, a desregula&ccedil;&atilde;o do eixo hipot&aacute
;lamo-pituit&aacute;ria-adrenal e a perda da modula&ccedil;&atilde;o dos process
os inflamat&oacute;rios e hemost&aacute;ticos<sup>18</sup>.</font></p>     ^cY#v
60n1a08.htm##
01474000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704123700078002001301315#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#34#30#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Estudos populacionais correlaciona
ndo disfun&ccedil;&otilde;es ps&iacute;quicas e obesidade em crian&ccedil;as e a
dolescentes ainda s&atilde;o escassos, mas, mesmo n&atilde;o permitindo generali
za&ccedil;&otilde;es nem explicando mecanismos mediadores entre obesog&ecirc;nes
e e psicopatias na popula&ccedil;&atilde;o infanto-juvenil, eles t&ecirc;m demon
strado aumento na preval&ecirc;ncia de dist&uacute;rbios ps&iacute;quicos nessas
 faixas et&aacute;rias. Isso, por si s&oacute;, evidencia a import&acirc;ncia da
 inclus&atilde;o de avalia&ccedil;&otilde;es psiqui&aacute;tricas validadas em a
tendimentos especializados<sup>19</sup>. Qualquer que seja a rela&ccedil;&atilde
;o entre obesidade e transtorno mental, o objetivo de verificar problemas emocio
nais em crian&ccedil;as e adolescentes obesos por meio desses inqu&eacute;ritos 
&eacute;, al&eacute;m de construir conhecimento cient&iacute;fico que subsidie a
s a&ccedil;&otilde;es assistenciais, identificar precocemente os indiv&iacute;du
os cujos comportamentos de risco interfiram nas interven&ccedil;&otilde;es e pre
ven&ccedil;&atilde;o do fen&ocirc;meno da trilha (<i>tracking</i>)<sup>6</sup>. 
</font></p>     ^cY#v60n1a08.htm##
00560000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704032300078002001300401#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#35#31#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Segundo Achenbach<sup>20</sup>, ma
nifesta&ccedil;&otilde;es emocionais em crian&ccedil;as e adolescentes podem ser
 divididas em dois grandes grupos: os sintomas de internaliza&ccedil;&atilde;o e
 os sintomas de externaliza&ccedil;&atilde;o. </font></p>     ^cY#v60n1a08.htm##
00708000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704047100078002001300549#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#36#32#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Sintomas de internaliza&ccedil;&at
ilde;o s&atilde;o aqueles percebidos pela crian&ccedil;a e adolescente de forma 
subjetiva ou f&iacute;sica, sem uma manifesta&ccedil;&atilde;o comportamental, n
ecessariamente, associada a ele. Sintomas de ansiedade, depress&atilde;o, retrai
mento, al&eacute;m das manifesta&ccedil;&otilde;es som&aacute;ticas, s&atilde;o 
exemplos de sintomas desse grupo. </font></p>     ^cY#v60n1a08.htm##
00564000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704032700078002001300405#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#37#33#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Por outro lado, os sintomas de ext
ernaliza&ccedil;&atilde;o s&atilde;o aqueles manifestados de forma claramente co
mportamental por meio de atos motores. A agressividade e o comportamento delinqu
ente s&atilde;o exemplos de sintomas desse grupo. </font></p>     ^cY#v60n1a08.h
tm##
00552000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704031500078002001300393#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#38#34#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">De forma geral, sintomas de extern
aliza&ccedil;&atilde;o geram maior impacto negativo sobre o ambiente. J&aacute; 
os sintomas de internaliza&ccedil;&atilde;o geram maior sofrimento emocional e s
ubjetivo para a pr&oacute;pria pessoa.</font></p>     ^cY#v60n1a08.htm##
00626000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704038900078002001300467#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#39#35#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O objetivo deste estudo &eacute; c
omparar a frequ&ecirc;ncia de sintomas psiqui&aacute;tricos de internaliza&ccedi
l;&atilde;o e externaliza&ccedil;&atilde;o em indiv&iacute;duos com e sem excess
o de peso, numa popula&ccedil;&atilde;o infanto-juvenil usu&aacute;ria de unidad
e b&aacute;sica de sa&uacute;de.</font></p>     ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#40#36#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a08.htm##
00341000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010400078002001300182#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#41#37#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>M&Eacute;TODOS</b></font></p>  
   ^cY#v60n1a08.htm##
00397000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704016000078002001300238#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#42#38#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foi utilizado um m&eacute;todo qua
ntitativo, transversal, com grupo controle.</font></p>     ^cY#v60n1a08.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#43#39#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Sujeitos</b></font></p>     ^cY
#v60n1a08.htm##
00509000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704027200078002001300350#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#44#40#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foram avaliados 88 crian&ccedil;as
 e adolescentes, com idade entre 6 e 17 anos, divididas em dois grupos: 53 indiv
&iacute;duos com excesso de peso e 35 indiv&iacute;duos eutr&oacute;ficos. </fon
t></p>     ^cY#v60n1a08.htm##
00636000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704039900078002001300477#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#45#41#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os indiv&iacute;duos foram selecio
nados nas Unidades B&aacute;sicas de Sa&uacute;de (UBS), conveniadas com a PUC-C
ampinas, ou no ambulat&oacute;rio de pediatria geral do Hospital Universit&aacut
e;rio da referida universidade. Esses servi&ccedil;os atendem a uma regi&atilde;
o de periferia da cidade de Campinas, SP. </font></p>     ^cY#v60n1a08.htm##
00645000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704040800078002001300486#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#46#42#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Baseados nos crit&eacute;rios da O
MS<sup>21-23</sup>, foram inclu&iacute;dos no grupo de excesso de peso os indiv&
iacute;duos com &iacute;ndice de massa corporal (IMC) maior que 1 e 2 desvios-pa
dr&atilde;o (dp). Foram inclu&iacute;dos no grupo de eutr&oacute;ficos indiv&iac
ute;duos com IMC menor que 1 dp e maior que -2 dp. </font></p>     ^cY#v60n1a08.
htm##
00790000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704055300078002001300631#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#47#43#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foram exclu&iacute;dos crian&ccedi
l;as e adolescentes com obesidade de causa end&oacute;gena, em uso de medica&cce
dil;&otilde;es que promovem ganho de peso, gestantes ou qualquer outra situa&cce
dil;&atilde;o cl&iacute;nica pedi&aacute;trica que interferisse na aferi&ccedil;
&atilde;o precisa do peso e estatura para c&aacute;lculo do IMC. Foram realizada
s avalia&ccedil;&otilde;es pedi&aacute;tricas para descartar outras patologias q
ue favore&ccedil;am o ganho de peso.</font></p>     ^cY#v60n1a08.htm##
00350000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011300078002001300191#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#48#44#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Instrumentos utilizados</b></fo
nt></p>     ^cY#v60n1a08.htm##
00520000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704028300078002001300361#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#49#45#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A aferi&ccedil;&atilde;o dos dados
 antropom&eacute;tricos foi realizada com roupas leves; a estatura foi medida em
 estadi&ocirc;metro de parede (Sanny) e o peso, em balan&ccedil;a digital (Filiz
ola). </font></p>     ^cY#v60n1a08.htm##
00731000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704049400078002001300572#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#50#46#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A avalia&ccedil;&atilde;o dos sint
omas comportamentais foi realizada por meio do <i>Childhood Behavior Checklist</
i> 6-18 (CBCL-6/18). O instrumento &eacute; um question&aacute;rio que avalia &a
acute;reas de compet&ecirc;ncia e sintomas de internaliza&ccedil;&atilde;o e ext
ernaliza&ccedil;&atilde;o em crian&ccedil;as e adolescentes de 6 a 18 anos, a pa
rtir de informa&ccedil;&otilde;es fornecidas pelos pais. </font></p>     ^cY#v60
n1a08.htm##
00832000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704059500078002001300673#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#51#47#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Desenvolvido por Achenbach<sup>20<
/sup>, destaca-se dentre os question&aacute;rios de comportamentos mais citados 
na literatura americana, n&atilde;o somente pelo rigor metodol&oacute;gico com q
ue foi elaborado, como tamb&eacute;m por sua utilidade na pr&aacute;tica cl&iacu
te;nica e aplica&ccedil;&atilde;o em trabalhos cient&iacute;ficos. Pode ser util
izado em escolas e em servi&ccedil;os de sa&uacute;de mental, por seu poder de d
iscriminar indiv&iacute;duos com psicopatologia de indiv&iacute;duos normais. </
font></p>     ^cY#v60n1a08.htm##
00616000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704037900078002001300457#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#52#48#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Traduzido em mais de 30 idiomas, t
em sido empregado internacionalmente em pesquisas envolvendo epidemiologia, diag
n&oacute;stico, taxonomia, etiologia, tratamento e compara&ccedil;&otilde;es ent
re culturas. Foi validado para a realidade brasileira por Bordin <i>et al.</i>, 
em 1995<sup>24</sup>. </font></p>     ^cY#v60n1a08.htm##
00597000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704036000078002001300438#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#53#49#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Para efeito de an&aacute;lise, for
am utilizadas as subescalas de Internaliza&ccedil;&atilde;o e Externaliza&ccedil
;&atilde;o do CBCL-6/18, sendo considerados indiv&iacute;duos sintom&aacute;tico
s aqueles que obtiveram um resultado de T-<i>score</i> maior ou igual a 70 ponto
s. </font></p>     ^cY#v60n1a08.htm##
00488000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704025100078002001300329#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#54#50#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foi aplicada uma anamnese pedi&aac
ute;trica estruturada para coleta de antecedentes, problemas cl&iacute;nicos ass
ociados e outros crit&eacute;rios de exclus&atilde;o. </font></p>     ^cY#v60n1a
08.htm##
00361000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012400078002001300202#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#55#51#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Procedimentos experimentais ger
ais</b></font></p>     ^cY#v60n1a08.htm##
01054000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704081700078002001300895#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#56#52#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Ap&oacute;s assinatura do Termo de
 Consentimento Livre e Esclarecido (aprovado pelo Comit&ecirc; de &Eacute;tica e
m Pesquisa da PUC-Campinas) pelos pais ou respons&aacute;veis dos indiv&iacute;d
uos pesquisados (e tamb&eacute;m por aqueles adolescentes que tinham clara compr
eens&atilde;o dos prop&oacute;sitos e encaminhamentos da pesquisa), foram seleci
onados os sujeitos, segundo os crit&eacute;rios de inclus&atilde;o e exclus&atil
de;o, e divididos os grupos, de acordo com os resultados dos dados antropom&eacu
te;tricos. Depois da sele&ccedil;&atilde;o dos sujeitos, os seus pais foram conv
idados para uma entrevista. Nesse momento, foram respondidos os instrumentos de 
avalia&ccedil;&atilde;o (CBCL-6/18 e anamnese estruturada). </font></p>     ^cY#
v60n1a08.htm##
00360000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012300078002001300201#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#57#53#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>An&aacute;lise estat&iacute;sti
ca</b></font></p>     ^cY#v60n1a08.htm##
00660000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704042300078002001300501#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#58#54#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Al&eacute;m da estat&iacute;stica 
descritiva, foi realizado o teste exato de Fischer para avaliar as vari&aacute;v
eis categoriais, como a propor&ccedil;&atilde;o de homens e mulheres e a presen&
ccedil;a de sintomas de internaliza&ccedil;&atilde;o e externaliza&ccedil;&atild
e;o entre os indiv&iacute;duos dos diferentes grupos pesquisados. </font></p>   
  ^cY#v60n1a08.htm##
00649000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704041200078002001300490#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#59#55#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O teste de Mann-Whitney foi utiliz
ado para verificar se houve diferen&ccedil;a entre as m&eacute;dias do &iacute;n
dice de massa corporal (IMC), as m&eacute;dias de idade e os T-<i>scores</i> m&e
acute;dios obtidos nas subescalas de internaliza&ccedil;&atilde;o e externaliza&
ccedil;&atilde;o, de acordo com os grupos pesquisados. </font></p>     ^cY#v60n1
a08.htm##
00573000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704033600078002001300414#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#60#56#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foi utilizado o &iacute;ndice de c
orrela&ccedil;&atilde;o de Spearman para verificar se houve correla&ccedil;&atil
de;o entre o IMC e os T-<i>scores</i> m&eacute;dios obtidos nas subescalas de in
ternaliza&ccedil;&atilde;o e externaliza&ccedil;&atilde;o. </font></p>     ^cY#v
60n1a08.htm##
00430000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704019300078002001300271#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#61#57#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Para todos os testes utilizados, f
oi considerado um n&iacute;vel de signific&acirc;ncia com p-valor &lt; 0.05.</fo
nt></p>     ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#62#58#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a08.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#63#59#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font></p>     ^
cY#v60n1a08.htm##
00891000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704065400078002001300732#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#64#60#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Entre os 53 indiv&iacute;duos do g
rupo de obeso/sobrepeso, havia 31 do sexo masculino e 22 do sexo feminino, com i
dade m&eacute;dia de 10,02 ± 2,53 anos e IMC m&eacute;dio de 25,65 ± 5,46. Indiv
&iacute;duos controles eutr&oacute;ficos foram 35, sendo 14 do sexo masculino e 
21 do sexo feminino, com idade m&eacute;dia de 11,03 ± 3,04 anos e IMC m&eacute;
dio de 17,37 ± 2,31. N&atilde;o houve diferen&ccedil;a estatisticamente signific
ativa em rela&ccedil;&atilde;o &agrave;s m&eacute;dias de idade e a propor&ccedi
l;&atilde;o de homens e mulheres nos grupos pesquisados. </font></p>     ^cY#v60
n1a08.htm##
00810000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704057300078002001300651#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#65#61#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Do total dos indiv&iacute;duos est
udados, 18 (20,6%) apresentaram sintomas de internaliza&ccedil;&atilde;o e 11 (1
2,64%), de externaliza&ccedil;&atilde;o. O T<i>-score </i>m&eacute;dio para sint
omas de internaliza&ccedil;&atilde;o foram significativamente maiores entre os i
ndiv&iacute;duos obesos/ sobrepeso do que entre os indiv&iacute;duos eutr&oacute
;ficos. O mesmo ocorreu com o T-<i>score</i> m&eacute;dio para sintomas de exter
naliza&ccedil;&atilde;o (<a href="#tab01">Tabela 1</a>).</font></p>     ^cY#v60n
1a08.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#66#62#article#155#<p><a name="tab01
"></a></p>     ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#67#63#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a08.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#68#64#article#155#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a08tab01.jpg"></p>     ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#69#65#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a08.htm##
01047000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704081000078002001300888#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#70#66#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Quando se considera um T-<i>score<
/i> m&eacute;dio &gt; 70 para descrever indiv&iacute;duos sintom&aacute;ticos, n
ota-se que, dentre indiv&iacute;duos com excesso de peso, 17 (32,07%) apresentar
am sintomas psiqui&aacute;tricos de internaliza&ccedil;&atilde;o e/ou externaliz
a&ccedil;&atilde;o. O mesmo ocorreu em 5 indiv&iacute;duos (14,7%) do grupo dos 
eutr&oacute;ficos (p-valor = 0,49). Dentre os indiv&iacute;duos com sintomas de 
internaliza&ccedil;&atilde;o, 14 (77,7%) estavam acima do peso e apenas 4 (24,3%
) eram eutr&oacute;ficos (p-valor = 0,73). Dentre os indiv&iacute;duos com sinto
mas de externaliza&ccedil;&atilde;o, 9 (81,8%) apresentavam excesso de peso e 2 
(18,2%) estavam eutr&oacute;ficos (p-valor = 0,106). </font></p>     ^cY#v60n1a0
8.htm##
00886000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704064900078002001300727#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#71#67#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foi utilizada uma an&aacute;lise d
e correla&ccedil;&atilde;o para avaliar a rela&ccedil;&atilde;o entre a gravidad
e do excesso de peso e os sintomas de internaliza&ccedil;&atilde;o e externaliza
&ccedil;&atilde;o. O IMC se correlacionou positivamente com os sintomas de inter
naliza&ccedil;&atilde;o (r = 0,374, p &lt; 0,001) e de externaliza&ccedil;&atild
e;o (r = 0,217; p = 0,042). Al&eacute;m disso, os sintomas de internaliza&ccedil
;&atilde;o tamb&eacute;m se correlacionaram positivamente com os sintomas de ext
ernaliza&ccedil;&atilde;o (r = 0,767, p &lt; 0,001).</font></p>     ^cY#v60n1a08
.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#72#68#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a08.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#73#69#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p>
     ^cY#v60n1a08.htm##
00500000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704026300078002001300341#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#74#70#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O estudo identificou, por meio do 
CBCL, maior frequ&ecirc;ncia de sintomas de internaliza&ccedil;&atilde;o e exter
naliza&ccedil;&atilde;o em indiv&iacute;duos com excesso de peso. </font></p>   
  ^cY#v60n1a08.htm##
00583000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704034600078002001300424#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#75#71#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">H&aacute; v&aacute;rios estudos na
 literatura utilizando o CBCL para verificar o comportamento de crian&ccedil;as 
e adolescentes tanto em grupos com doen&ccedil;as definidas quanto em grupos com
 perfil de risco para surgimento de doen&ccedil;as ps&iacute;quicas. </font></p>
     ^cY#v60n1a08.htm##
01299000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704106200078002001301140#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#76#72#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Vila <i>et al</i>.<sup>19</sup> ut
ilizaram o CBCL como um de seus instrumentos de pesquisa para verifica&ccedil;&a
tilde;o de sintomas emocionais em crian&ccedil;as e adolescentes franceses obeso
s comparados com um grupo de diab&eacute;ticos. Os autores encontraram taxas de 
sintomas de internaliza&ccedil;&atilde;o e externaliza&ccedil;&atilde;o bem maio
res que as encontradas em nosso estudo: 43% dos indiv&iacute;duos obesos estudad
os apresentaram sintomas de internaliza&ccedil;&atilde;o e 25%, de externaliza&c
cedil;&atilde;o. Neste trabalho, 26% dos indiv&iacute;duos obesos apresentaram s
intomas de internaliza&ccedil;&atilde;o e 17% apresentaram sintomas de externali
za&ccedil;&atilde;o. Ou seja, as taxas de sintomas de internaliza&ccedil;&atilde
;o e externaliza&ccedil;&atilde;o foram duas (internaliza&ccedil;&atilde;o) a tr
&ecirc;s vezes (externaliza&ccedil;&atilde;o) maiores no grupo com excesso de pe
so se comparado ao grupo de indiv&iacute;duos eutr&oacute;ficos. </font></p>    
 ^cY#v60n1a08.htm##
01000000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704076300078002001300841#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#77#73#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Outros estudos utilizaram instrume
ntos diagn&oacute;sticos, em vez de instrumentos de verifica&ccedil;&atilde;o de
 sintomas (como CBCL), para a detec&ccedil;&atilde;o de transtornos psiqui&aacut
e;tricos em indiv&iacute;duos obesos. Estudando indiv&iacute;duos canadenses com
 15 anos ou mais, Mather <i>et al.</i><sup>25 </sup>relataram que a obesidade se
 relaciona positivamente com uma s&eacute;rie de patologias psiqui&aacute;tricas
, a saber, depress&atilde;o, mania, ataques de p&acirc;nico, fobia social e idea
&ccedil;&atilde;o suicida. Alguns estudos t&ecirc;m verificado a presen&ccedil;a
 de patologias psiqui&aacute;tricas em indiv&iacute;duos obesos adultos<sup>26</
sup>. </font></p>     ^cY#v60n1a08.htm##
01014000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704077700078002001300855#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#78#74#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Petry <i>et al.</i><sup>27</sup> e
ncontraram taxas maiores de transtornos de ansiedade e abuso de subst&acirc;ncia
s psicoativas entre indiv&iacute;duos obesos, mas n&atilde;o encontraram taxas m
aiores de depress&atilde;o. Apesar de a maioria desses estudos ter sido realizad
a com adultos, eles apresentaram resultados similares aos nossos, isto &eacute;,
 demonstraram que os transtornos depressivos e de ansiedade s&atilde;o mais prev
alentes na popula&ccedil;&atilde;o de indiv&iacute;duos obesos. Em nosso estudo,
 as altas taxas de sintomas de internaliza&ccedil;&atilde;o observadas por meio 
do CBCL se referem fundamentalmente a sintomas de ansiedade, depress&atilde;o e 
retraimento social. </font></p>     ^cY#v60n1a08.htm##
01068000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704083100078002001300909#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#79#75#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Por outro lado, apesar de n&atilde
;o haver relatos da presen&ccedil;a de sintomas de externaliza&ccedil;&atilde;o 
nos estudos revisados (comportamento agressivo e comportamento delinquente), ele
s aparecem, em nosso estudo, em indiv&iacute;duos que tamb&eacute;m apresentavam
 sintomas de internaliza&ccedil;&atilde;o. Em sua grande parte, essa associa&cce
dil;&atilde;o de sintomas ocorreu em meninas, apesar de os sintomas de externali
za&ccedil;&atilde;o serem quase duas vezes mais frequentes em meninos do que em 
meninas<sup>28</sup>. Esse fato pode indicar maior gravidade dos transtornos emo
cionais e comportamentais em meninas. Os sintomas de externaliza&ccedil;&atilde;
o e internaliza&ccedil;&atilde;o puros ocorreram apenas entre os meninos. </font
></p>     ^cY#v60n1a08.htm##
01079000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704084200078002001300920#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#80#76#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Percebeu-se uma clara correla&cced
il;&atilde;o entre a presen&ccedil;a de sintomas de depress&atilde;o, de ansieda
de e de comportamentos disruptivos com um maior IMC dos indiv&iacute;duos pesqui
sados. Isso demonstra que a presen&ccedil;a desses sintomas pode ser um fator de
 risco para a presen&ccedil;a de obesidade, por cursar com aumento de apetite, r
edu&ccedil;&atilde;o da atividade f&iacute;sica e maior ingesta de alimentos cal
&oacute;ricos (como chocolates e doces). Por outro lado, uma autoimagem negativa
 (e, consequentemente, uma baixa autoestima), decorrente da presen&ccedil;a da o
besidade, pode gerar sintomas emocionais como dificuldades de relacionamento soc
ial, maior isolamento, altera&ccedil;&otilde;es de conduta e comportamento oposi
tor. </font></p>     ^cY#v60n1a08.htm##
01138000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704090100078002001300979#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#81#77#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Al&eacute;m disso, o estudo demons
tra que a presen&ccedil;a de um grupo de sintomas pesquisados (internaliza&ccedi
l;&atilde;o ou externaliza&ccedil;&atilde;o) favorece a presen&ccedil;a do outro
 grupo de sintomas pesquisados. Por exemplo, o indiv&iacute;duo obeso que aprese
ntar um grupo de sintomas depressivos e ansiosos (sintomas de internaliza&ccedil
;&atilde;o) tem uma chance aumentada de apresentar tamb&eacute;m sintomas disrup
tivos (sintomas de externaliza&ccedil;&atilde;o: furtar, mentir, agredir). O est
udo de Bruffaerts <i>et al.</i><sup>26</sup>, com a popula&ccedil;&atilde;o gera
l de seis pa&iacute;ses europeus, refor&ccedil;a esse fato. Eles encontraram que
 os indiv&iacute;duos obesos costumam apresentar mais de uma patologia psiqui&aa
cute;trica e que a depress&atilde;o &eacute; a principal delas. </font></p>     
^cY#v60n1a08.htm##
01278000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704104100078002001301119#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#82#78#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Uma das principais limita&ccedil;&
otilde;es dessa pesquisa foi a utiliza&ccedil;&atilde;o de um instrumento pautad
o na resposta dos pais, sem que as crian&ccedil;as e adolescentes tivessem passa
do por uma avalia&ccedil;&atilde;o posterior para confirma&ccedil;&atilde;o dos 
sintomas e pesquisa de poss&iacute;veis diagn&oacute;sticos. Segundo Bordin e Pa
ula<sup>29</sup>, as taxas de problemas de sa&uacute;de mental entre crian&ccedi
l;as e adolescentes brasileiros, quando s&atilde;o considerados os pais como &ua
cute;nicos informantes, s&atilde;o de 13,5% a 35,2%, enquanto nos estudos que ut
ilizam os adolescentes como &uacute;nicos informantes essas taxas diminuem para 
12,6% a 13,1%. Novos estudos que utilizem m&eacute;todos de seguimento ao longo 
do desenvolvimento infanto-juvenil, e n&atilde;o apenas estudos transversais, e 
que pesquisem os sintomas emocionais e comportamentais de acordo com a gravidade
 da obesidade s&atilde;o necess&aacute;rios.</font></p>     ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#83#79#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a08.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#84#80#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUS&Otilde;ES</b></font></p
>     ^cY#v60n1a08.htm##
01057000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704082000078002001300898#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#85#81#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Sintomas psiqui&aacute;tricos de i
nternaliza&ccedil;&atilde;o e externaliza&ccedil;&atilde;o s&atilde;o mais comun
s entre crian&ccedil;as e adolescentes com excesso de peso do que entre indiv&ia
cute;duos eutr&oacute;ficos. A proposta de utilizar o CBCL para triagem de crian
&ccedil;as e adolescentes com excesso de peso e sintomas ps&iacute;quicos torna-
se relevante, pois se trata de um instrumento validado e que pode facilitar o tr
abalho do m&eacute;dico pediatra ao abordar a crian&ccedil;a e o adolescente com
 excesso de peso e propor um programa de reeduca&ccedil;&atilde;o alimentar e de
 atividade f&iacute;sica, tendo em conta que transtornos do comportamento podem 
comprometer interven&ccedil;&otilde;es preventivas e curativas.</font></p>     ^
cY#v60n1a08.htm##
00617000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704038000078002001300458#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#86#82#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os resultados obtidos a partir do 
trabalho integrado de duas &aacute;reas m&eacute;dicas - pediatria e psiquiatria
 infantil - mostram a necessidade de readequarmos nossas abordagens diagn&oacute
;sticas para tentar interromper a g&ecirc;nese da obesidade na popula&ccedil;&at
ilde;o infanto-juvenil.</font></p>     ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#87#83#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a08.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#88#84#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b></font></p
>     ^cY#v60n1a08.htm##
00597000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704034600080002001300426#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#89#85#article#155#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. WHO: Regional Off
ice for Europe. The challenge of obesity in the WHO European Region and the stra
tegies for response. Dispon&iacute;vel em: &lt;<a href="http://www.euro.who.int/
pubrequest" target="_blank">http://www.euro.who.int/pubrequest</a>&gt;. Acesso e
m: 17 dez 2007.    ^cY#v60n1a08.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#90#86#article#155#</font></p>     ^
cY#v60n1a08.htm##
00535000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704028400080002001300364#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#91#87#article#155#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Silveira D, Tadde
i JA, Escriv&atilde;o MA, Oliveira FL, Ancona-Lopez F. Risk factors for overweig
ht among Brazilian adolescents of low-income families: a case-control study. Pub
lic Health Nutr. 2006;9(4):421-8.    ^cY#v60n1a08.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#92#88#article#155# </font></p>     
^cY#v60n1a08.htm##
00579000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704032800080002001300408#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#93#89#article#155#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. WHO. Facts relate
d chronic diseases. Dispon&iacute;vel em: <a href="http://www.who.int/dietphysic
alactivity/publications/facts/chronic/en/" target="_blank">http://www.who.int/di
etphysicalactivity/publications/facts/chronic/en/</a>. Acesso em: 9 jun 2004.   
 ^cY#v60n1a08.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#94#90#article#155#</font></p>     ^
cY#v60n1a08.htm##
00580000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704032900080002001300409#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#95#91#article#155#4#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. WHO. Obesity: pre
venting and managing the global epidemic. Report of a WHO Consultation on Obesit
y. Geneva; 1998. Dispon&iacute;vel em: &lt;<a href="http://www.who.int/childgrow
th/" target="_blank">www.who.int/childgrowth/</a>&gt;. Acesso em: 17 dez 2007.  
  ^cY#v60n1a08.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#96#92#article#155#</font></p>     ^
cY#v60n1a08.htm##
00499000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704024800080002001300328#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#97#93#article#155#5#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Monteiro POA, Vic
tora CG, Barros FC, Monteiro LMA. Birth size, early childhood growth, and adoles
cent obesity in a Brazilian birth cohort. Int J Obesity. 2003;27(10):1274-82.   
 ^cY#v60n1a08.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#98#94#article#155#</font></p>     ^
cY#v60n1a08.htm##
00505000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704025400080002001300334#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#99#95#article#155#6#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Tan F, Okamoto M,
 Suyama A, Miyamoto T. Tracking of cardiovascular risk factors and cohort study 
on hyperlipidemia in rural schoolchildren in Japan. J Epidemiol. 2000;10(4):255-
61.    ^cY#v60n1a08.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#100#96#article#155#</font></p>     
^cY#v60n1a08.htm##
00541000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000200079704028900081002001300370#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#101#97#article#155#7#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Minist&eacute;ri
o da Sa&uacute;de. Portal da Sa&uacute;de. Mapa da Sa&uacute;de. Dispon&iacute;v
el em: &lt;<a href="http://www.saude.gov.br/" target="_blank">http://www.saude.g
ov.br/</a>&gt;. Acesso em: 7 abr. 2008.    ^cY#v60n1a08.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#102#98#article#155#</font></p>     
^cY#v60n1a08.htm##
00605000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000200079704035300081002001300434#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#103#99#article#155#8#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Minist&eacute;ri
o da Sa&uacute;de. DATASUS. Informa&ccedil;&otilde;es sobre mortalidade, informa
&ccedil;&otilde;es demogr&aacute;ficas. Dispon&iacute;vel em: &lt;<a href="http:
//tabnet.datasus.gov.br" target="_blank">http://tabnet.datasus.gov.br</a>&gt;. A
cesso em: 10 abr. 2008.    ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#104#100#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00625000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000200080704037200082002001300454#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#105#101#article#155#9#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Godoy MF, Lucen
a JM, Miquelin AR, Paiva FF, Oliveira DLQ, Augustin Jr JL. Mortalidade por doen&
ccedil;as cardiovasculares e n&iacute;veis socioecon&ocirc;micos na popula&ccedi
l;&atilde;o de S&atilde;o Jos&eacute; do Rio Preto, Estado de S&atilde;o Paulo, 
Brasil. Arq Bras Cardiol. 2007;88(2):200-6.    ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#106#102#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00399000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704014500083002001300228#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#107#103#article#155#10#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Ross CE. Over
weight and depression. J Health Soc Behav. 1994;35:63-79.    ^cY#v60n1a08.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#108#104#article#155# </font></p>   
  ^cY#v60n1a08.htm##
00451000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019700083002001300280#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#109#105#article#155#11#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Fisberg M. At
ualiza&ccedil;&atilde;o em obesidade na inf&acirc;ncia e adolesc&ecirc;ncia. S&a
tilde;o Paulo: Atheneu; 2005.    ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#110#106#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00456000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704020200083002001300285#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#111#107#article#155#12#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Kottke TE, Wu
 LA, Hoffman RS. Economic and psychological implications of the obesity epidemic
. Mayo Clin Proc. 2003;78(1):92-4.    ^cY#v60n1a08.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#112#108#article#155# </font></p>   
  ^cY#v60n1a08.htm##
00767000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704051300083002001300596#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#113#109#article#155#13#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Bordo AA. Os 
eixos de desenvolvimento e a estrutura&ccedil;&atilde;o urbano-industrial do est
ado de S&atilde;o Paulo, Brasil. Scripta Nova. Revista Electr&ocirc;nica de Geog
raf&iacute;a y Ciencias Sociales. Barcelona. Universidade de Barcelona, agosto, 
2005 vol IX, 194(79). Dispon&iacute;vel em: &lt;<a href="http://www.ub.es/geocri
t/sn-194-79.htm" target="_blank">http://www.ub.es/geocrit/sn-194-79.htm</a>&gt;.
 Acesso em: 12 set. 2006.    ^cY#v60n1a08.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#114#110#article#155# </font></p>   
  ^cY#v60n1a08.htm##
00827000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704057300083002001300656#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#115#111#article#155#14#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Anais XII Sim
p&oacute;sio Brasileiro de Sensoriamento Remoto. Jakob AAE, Cunha JMP. Delimita&
ccedil;&atilde;o de &aacute;reas de segrega&ccedil;&atilde;o espacial da popula&
ccedil;&atilde;o na mancha urbana da regi&atilde;o metropolitana de Campinas a p
artir de imagens de sat&eacute;lite e t&eacute;cnicas de estat&iacute;stica espa
cial. Dispon&iacute;vel em: &lt;<a href="http://www.ub.es/geocrit/sn-194-79.htm"
 target="_blank">http://www.ub.es/geocrit/sn-194-79.htm</a>. Acesso em: 12 set. 
2006.    ^cY#v60n1a08.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#116#112#article#155# </font></p>   
  ^cY#v60n1a08.htm##
00592000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704033800083002001300421#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#117#113#article#155#15#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Kumanyika S, 
Jeffery RW, Morabia A, Ritenbaugh C, Antipatis VJ; Public Health Approaches to t
he Prevention of Obesity (PHAPO). Working Group of the International Obesity Tas
k Force (IOTF). Obesity prevention: the case for action. Int J Obesity. 2002;26(
3):425-36.    ^cY#v60n1a08.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#118#114#article#155# </font></p>   
  ^cY#v60n1a08.htm##
00456000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704020200083002001300285#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#119#115#article#155#16#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Dressler WW, 
Santos JE. Social and cultural dimensions of hypertension in Brazil: review. Cad
 Saude Publica. 2000;16(2):303-15.    ^cY#v60n1a08.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#120#116#article#155# </font></p>   
  ^cY#v60n1a08.htm##
00490000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023600083002001300319#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#121#117#article#155#17#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Miotto AC, Ol
iveira AF. A influ&ecirc;ncia da m&iacute;dia nos h&aacute;bitos alimentares de 
crian&ccedil;as de baixa renda. Rev Paul Pediatr. 2006;24(2):115-20.    ^cY#v60n
1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#122#118#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00551000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704029700083002001300380#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#123#119#article#155#18#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Kinder LS, Ca
rnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic s
yndrome in young adults: findings from the Third National Health and Nutrition E
xamination Survey. Psychosom Med. 2004;66:316-22.    ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#124#120#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00479000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704022500083002001300308#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#125#121#article#155#19#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Vila G, Zippe
r E, Dabbas M, Bertrand C, Robert JJ, Ricour C, et al. Mental disorders in obese
 children and adolescents. Psychosom Med. 2004;66:387-94.    ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#126#122#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00476000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704022200083002001300305#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#127#123#article#155#20#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Achenbach TA.
 Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Burlington, VT: 
University of Vermont, Department of Psychiatry; 1991.    ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#128#124#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00513000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704025900083002001300342#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#129#125#article#155#21#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Onis M, Onyan
go AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth ref
erence for school-aged children and adolescents. Bull World Health Organ. 2007;8
5(9):660-7.    ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#130#126#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00564000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704031000083002001300393#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#131#127#article#155#22#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. World Health 
Organization (WHO). WHO Child Growth Standards Training Course on Child Growth. 
Dispon&iacute;vel em: &lt;<a href="http://www.who.int/childgrowth/" target="_bla
nk">www.who.int/childgrowth/</a>&gt;. Acesso em: 18 set. 2007.    ^cY#v60n1a08.h
tm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#132#128#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00518000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704026400083002001300347#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#133#129#article#155#23#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. World Health 
Organization (WHO). Dispon&iacute;vel em: &lt;<a href="http://www.who.int/ageing
/en/" target="_blank">http://www.who.int/ageing/en/</a>&gt;. Acesso em: 1º abr. 
2008</font></p>     ^cY#v60n1a08.htm##
00566000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704031200083002001300395#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#134#130#article#155#24#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24. 	Bordin IAS, 
Mari JJ, Caieiro MF. Validade da vers&atilde;o brasileira do "Child Behavior Che
cklist" (CBCL) (Invent&aacute;rio de Comportamentos da Inf&acirc;ncia e Adolesc&
ecirc;ncia): dados preliminares. Rev ABP-APAL. 1995;17(2):55-66.    ^cY#v60n1a08
.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#135#131#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00508000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704025400083002001300337#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#136#132#article#155#25#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25. 	Mather AA, C
ox BJ, Enns MW, Sareen J. Associations of obesity with psychiatry disorder and s
uicidal behavior in a nationally representative sample. J Psychom Res. 2009;66:2
77-85.    ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#137#133#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00562000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704030800083002001300391#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#138#134#article#155#26#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26. Bruffaerts R,
 Demyttenaere K, Vilagut G, Martinez M, Bonnewyn A, De Graeff R, et al. The rela
tion between body mass index, mental health, functional disability: a European p
opulation perspective. Can J Psychiatry. 2008;50(10):679-88.    ^cY#v60n1a08.htm
##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#139#135#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00549000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704029500083002001300378#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#140#136#article#155#27#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27. 	Petry N, Bar
ry D, Pietrzak RH, Wagner J. Overweight and obesity are associated with psychiat
ric disorders: results from the National Epidemiologic Survey on Alcohol and rel
ated conditions. Psychosom Med. 2008;70:288-97.    ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#141#137#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00448000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019400083002001300277#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#142#138#article#155#28#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">28. 	Nock MK, Kaz
din AE, Hiripin E, Kessler, RC. National Comorbidity Survey Replication. Psychol
 Med. 2006;36 (5):699-710.    ^cY#v60n1a08.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#143#139#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00562000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704030800083002001300391#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#144#140#article#155#29#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">29. Bordin IAS, P
aula CS. Estudos populacionais sobre sa&uacute;de mental de crian&ccedil;as e ad
olescentes. In: Mello MF, Mello AAF, Kohn R, organizadores. Epidemiologia da Sa&
uacute;de Mental no  Brasil. S&atilde;o Paulo: Artmed; 2007.    ^cY#v60n1a08.htm
##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#145#141#article#155#</font></p>    
 ^cY#v60n1a08.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#146#142#article#155#<p>&nbsp;</p>  
   ^cY#v60n1a08.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#147#143#article#155#<p>&nbsp;</p>  
   ^cY#v60n1a08.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704023200080002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#148#144#article#155#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="
/img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <
b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a08.htm##
00277000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704003800080002001300118#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#149#145#article#155#<br>    C&eacut
e;sar de Moraes    ^cY#v60n1a08.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#150#146#article#155#<br>    Rua Alv
aro Bosco, 157, ap. 31-B    ^cY#v60n1a08.htm##
00278000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704003900080002001300119#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#151#147#article#155#<br>    3087-72
3 - Campinas, SP    ^cY#v60n1a08.htm##
00301000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006200080002001300142#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#152#148#article#155#<br>    Telefon
e: (19) 9219-8987 - Fax: (19) 3236-2487    ^cY#v60n1a08.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009600080002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#153#149#article#155#<br>    E-mail:
 <a href="mailto:cemoraes@uol.com.br">cemoraes@uol.com.br</a></font></p>     ^cY
#v60n1a08.htm##
00331000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009200080002001300172#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#154#150#article#155#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 8/11/2009    ^cY#v60
n1a08.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#155#151#article#155#<br>  Aprovado 
em 24/1/2011</font></p>     ^cY#v60n1a08.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#156#152#article#155#<p>&nbsp;</p>  
   ^cY#v60n1a08.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#157#153#article#155#<p>&nbsp;</p>  
   ^cY#v60n1a08.htm##
00510000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704027100080002001300351#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#158#154#article#155#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Trabalho desenvolvido nas UBS do
 Jd. Florence e Jd. Rossin, Campinas, SP, por meio de parceria entre a Pontif&ia
cute;cia Universidade Cat&oacute;lica de  Campinas e a prefeitura municipal de C
ampinas.    ^cY#v60n1a08.htm##
00556000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704031700080002001300397#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#p#159#155#article#155#<br> <a name="l
ink01"></a><a href="#link001">*</a> Condi&ccedil;&otilde;es de risco associadas 
&agrave; obesidade como hipertens&atilde;o arterial, dislipidemia e resist&ecirc
;ncia insul&iacute;nica, que, iniciadas durante a inf&acirc;ncia-adolesc&ecirc;n
cia, tendem a se expressar na vida adulta.</font></p>     ^cY#v60n1a08.htm##
00495000000000217000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770170032000790180088001110370
03500199110000900234109001200243865000900255002001300264#v60n1#V:\SciELO\serial\
jbpsiq\v60n1\markup\v60n1a08.htm#S#c#160#1#article#29#1#WHO^dRegional Office for
 Europe#The challenge of obesity in the WHO European Region and the strategies f
or response^len#http://www.euro.who.int/pubrequest#20071217#17 dez 2007#20110000
#v60n1a08.htm##
00660000000000313000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790100017000970100
01900114010001900133010002200152012010500174030001900279710000200298065000900300
064000500309031000200314032000200316014000600318865000900324002001300333#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#161#2#article#29#2#^rND^sSi
lveira^nD#^rND^sTaddei^nJA#^rND^sEscrivão^nMA#^rND^sOliveira^nFL#^rND^sAncona-Lo
pez^nF#Risk factors for overweight among Brazilian adolescents of low-income fam
ilies: a case-control study^len#Public Health Nutr#2#20060000#2006#9#4#421-8#201
10000#v60n1a08.htm##
00449000000000217000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770170004000790180035000830370
07100118110000900189109001100198865000900209002001300218#v60n1#V:\SciELO\serial\
jbpsiq\v60n1\markup\v60n1a08.htm#S#c#162#3#article#29#3#WHO#Facts related chroni
c diseases^len#http://www.who.int/dietphysicalactivity/publications/facts/chroni
c/en/#20040609#9 jun 2004#20110000#v60n1a08.htm##
00524000000000253000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770170004000790180098000830660
00700181065000900188064000500197037002500202110000900227109001200236865000900248
002001300257#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#163#4#a
rticle#29#4#WHO#Obesity: preventing and managing the global epidemic. Report of 
a WHO Consultation on Obesity^len#Geneva#19980000#1998#www.who.int/childgrowth/#
20071217#17 dez 2007#20110000#v60n1a08.htm##
00613000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100020000790100018000990100
01700117010002000134012009100154030001400245710000200259065000900261064000500270
031000300275032000300278014000800281865000900289002001300298#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#164#5#article#29#5#^rND^sMonteiro^nPOA#
^rND^sVictora^nCG#^rND^sBarros^nFC#^rND^sMonteiro^nLMA#Birth size, early childho
od growth, and adolescent obesity in a Brazilian birth cohort^len#Int J Obesity#
2#20030000#2003#27#10#1274-82#20110000#v60n1a08.htm##
00651000000000313000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100013000790100017000920100
01600109010001800125012011200143030001200255065000900267064000500276031000300281
032000200284014000700286865000900293002001300302035001000315801001200325#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#165#6#article#29#6#^rND^sTa
n^nF#^rND^sOkamoto^nM#^rND^sSuyama^nA#^rND^sMiyamoto^nT#Tracking of cardiovascul
ar risk factors and cohort study on hyperlipidemia in rural schoolchildren in Ja
pan^len#J Epidemiol#20000000#2000#10#4#255-61#20110000#v60n1a08.htm#0917-5040#J 
Epidemiol##
00420000000000217000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770170037000790180018001160370
02500134110000900159109001200168865000900180002001300189#v60n1#V:\SciELO\serial\
jbpsiq\v60n1\markup\v60n1a08.htm#S#c#166#7#article#29#7#Ministério da Saúde^dPor
tal da Saúde#Mapa da Saúde^lpt#http://www.saude.gov.br/#20080407#7 abr. 2008#201
10000#v60n1a08.htm##
00459000000000217000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770170029000790180060001080370
02900168110000900197109001300206865000900219002001300228#v60n1#V:\SciELO\serial\
jbpsiq\v60n1\markup\v60n1a08.htm#S#c#167#8#article#29#8#Ministério da Saúde^dDAT
ASUS#Informações sobre mortalidade, informações demográficas^lpt#http://tabnet.d
atasus.gov.br#20080410#10 abr. 2008#20110000#v60n1a08.htm##
00755000000000337000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100017000950100
01900112010001600131010002000147010002200167012013700189030001700326065000900343
06400050035203100030035703200020036001400060036286500090036800200130037703500100
0390801001700400#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#168
#9#article#29#9#^rND^sGodoy^nMF#^rND^sLucena^nJM#^rND^sMiquelin^nAR#^rND^sPaiva^
nFF#^rND^sOliveira^nDLQ#^rND^sAugustin Jr^nJL#Mortalidade por doenças cardiovasc
ulares e níveis socioeconômicos na população de São José do Rio Preto, Estado de
 São Paulo, Brasil^lpt#Arq Bras Cardiol#20070000#2007#88#2#200-6#20110000#v60n1a
08.htm#0066-782X#Arq Bras Cardiol##
00485000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810120030000960300
01900126065000900145064000500154031000300159014000600162865000900168002001300177
035001000190801001900200#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm
#S#c#169#10#article#29#10#^rND^sRoss^nCE#Overweight and depression^len#J Health 
Soc Behav#19940000#1994#35#63-79#20110000#v60n1a08.htm#0022-1465#J Health Soc Be
hav##
00438000000000229000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160017000810180056000980660
01000154062000800164065000900172064000500181865000900186002001300195#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#170#11#article#29#11#^rND^sFisb
erg^nM#Atualização em obesidade na infância e adolescência^lpt#São Paulo#Atheneu
#20050000#2005#20110000#v60n1a08.htm##
00585000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100013000980100
01800111012006800129030001500197065000900212064000500221031000300226032000200229
014000500231865000900236002001300245035001000258801001500268#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#171#12#article#29#12#^rND^sKottke^nTE#^
rND^sWu^nLA#^rND^sHoffman^nRS#Economic and psychological implications of the obe
sity epidemic^len#Mayo Clin Proc#20030000#2003#78#1#92-4#20110000#v60n1a08.htm#0
025-6196#Mayo Clin Proc##
00635000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810120098000970300
06700195710000200262031000300264031000400267032000300271037003900274110000900313
109001300322865000900335002001300344#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a08.htm#S#c#172#13#article#29#13#^rND^sBordo^nAA#Os eixos de desenvolviment
o e a estruturação urbano-industrial do estado de São Paulo, Brasil^lpt#Scripta 
Nova. Revista Electrônica de Geografía y Ciencias Sociales#2#IX#194#79#http://ww
w.ub.es/geocrit/sn-194-79.htm#20060912#12 set. 2006#20110000#v60n1a08.htm##
00665000000000241000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780170044000810160017001250160
01700142018018100159037003900340110000900379109001300388865000900401002001300410
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#173#14#article#29#1
4#Simpósio Brasileiro de Sensoriamento Remoto#^rND^sJakob^nAAE#^rND^sCunha^nJMP#
Delimitação de áreas de segregação espacial da população na mancha urbana da reg
ião metropolitana de Campinas a partir de imagens de satélite e técnicas de esta
tística espacial^lpt#http://www.ub.es/geocrit/sn-194-79.htm#20060912#12 set. 200
6#20110000#v60n1a08.htm##
00729000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100018001000100
01700118010002000135010002000155011005400175011005400229012004400283030001400327
71000020034106500090034306400050035203100030035703200020036001400070036286500090
0369002001300378#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#174
#15#article#29#15#^rND^sKumanyika^nS#^rND^sJeffery^nRW#^rND^sMorabia^nA#^rND^sRi
tenbaugh^nC#^rND^sAntipatis^nVJ#Public Health Approaches to the Prevention of Ob
esity#Working Group of the International Obesity Task Force#Obesity prevention: 
the case for action^len#Int J Obesity#2#20020000#2002#26#3#425-36#20110000#v60n1
a08.htm##
00570000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100017001000120
06900117030001800186065000900204064000500213031000300218032000200221014000700223
865000900230002001300239035001000252801001800262#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a08.htm#S#c#175#16#article#29#16#^rND^sDressler^nWW#^rND^sSanto
s^nJE#Social and cultural dimensions of hypertension in Brazil: review^len#Cad S
aude Publica#20000000#2000#16#2#303-15#20110000#v60n1a08.htm#0102-311X#Cad Saude
 Publica##
00539000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100019000980120
07700117030001700194710000200211065000900213064000500222031000300227032000200230
014000700232865000900239002001300248#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a08.htm#S#c#176#17#article#29#17#^rND^sMiotto^nAC#^rND^sOliveira^nAF#A infl
uência da mídia nos hábitos alimentares de crianças de baixa renda^lpt#Rev Paul 
Pediatr#2#20060000#2006#24#2#115-20#20110000#v60n1a08.htm##
00704000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100020000980100
02200118010001500140010001900155012013200174030001400306065000900320064000500329
031000300334014000700337865000900344002001300353035001000366801001400376#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#177#18#article#29#18#^rND^s
Kinder^nLS#^rND^sCarnethon^nMR#^rND^sPalaniappan^nLP#^rND^sKing^nAC#^rND^sFortma
nn^nSP#Depression and the metabolic syndrome in young adults: findings from the 
Third National Health and Nutrition Examination Survey^len#Psychosom Med#2004000
0#2004#66#316-22#20110000#v60n1a08.htm#0033-3174#Psychosom Med##
00661000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100014000810100016000950100
01600111010001800127010001700145010001600162810000600178012005500184030001400239
06500090025306400050026203100030026701400070027086500090027700200130028603500100
0299801001400309#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#178
#19#article#29#19#^rND^sVila^nG#^rND^sZipper^nE#^rND^sDabbas^nM#^rND^sBertrand^n
C#^rND^sRobert^nJJ#^rND^sRicour^nC#et al#Mental disorders in obese children and 
adolescents^len#Psychosom Med#20040000#2004#66#387-94#20110000#v60n1a08.htm#0033
-3174#Psychosom Med##
00496000000000229000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160020000810180066001010660
01500167062004800182065000900230064000500239865000900244002001300253#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#179#20#article#29#20#^rND^sAche
nbach^nTA#Manual for the Child Behavior Checklist/4-18 and 1991 Profile^len#Burl
ington^eVT#University of Vermont, Department of Psychiatry#19910000#1991#2011000
0#v60n1a08.htm##
00705000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100014000810100018000950100
01600113010001500129010001700144010001800161012008300179030002400262065000900286
06400050029503100030030003200020030301400060030586500090031100200130032003500100
0333801002400343#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#180
#21#article#29#21#^rND^sOnis^nM#^rND^sOnyango^nAW#^rND^sBorghi^nE#^rND^sSiyam^nA
#^rND^sNishida^nC#^rND^sSiekmann^nJ#Development of a WHO growth reference for sc
hool-aged children and adolescents^len#Bull World Health Organ#20070000#2007#85#
9#660-7#20110000#v60n1a08.htm#0042-9686#Bull World Health Organ##
00457000000000217000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780170026000810180063001070370
02500170110000900195109001300204865000900217002001300226#v60n1#V:\SciELO\serial\
jbpsiq\v60n1\markup\v60n1a08.htm#S#c#181#22#article#29#22#World Health Organizat
ion#WHO Child Growth Standards Training Course on Child Growth^len#www.who.int/c
hildgrowth/#20070918#18 set. 2007#20110000#v60n1a08.htm##
00387000000000205000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780170026000810370030001071100
00900137109001300146865000900159002001300168#v60n1#V:\SciELO\serial\jbpsiq\v60n1
\markup\v60n1a08.htm#S#c#182#23#article#29#23#World Health Organization#http://w
ww.who.int/ageing/en/#20080401#1º abr. 2008#20110000#v60n1a08.htm##
00633000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100015000990100
01800114012014900132030001300281710000200294065000900296064000500305031000300310
032000200313014000600315865000900321002001300330#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a08.htm#S#c#183#24#article#29#24#^rND^sBordin^nIAS#^rND^sMari^n
JJ#^rND^sCaieiro^nMF#Validade da versão brasileira do "Child Behavior Checklist"
 (CBCL) (Inventário de Comportamentos da Infância e Adolescência): dados prelimi
nares^lpt#Rev ABP-APAL#2#19950000#1995#17#2#55-66#20110000#v60n1a08.htm##
00608000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100014000980100
01500112010001600127012011300143030001400256710000200270065000900272064000500281
031000300286014000700289865000900296002001300305#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a08.htm#S#c#184#25#article#29#25#^rND^sMather^nAA#^rND^sCox^nBJ
#^rND^sEnns^nMW#^rND^sSareen^nJ#Associations of obesity with psychiatry disorder
 and suicidal behavior in a nationally representative sample^len#J Psychom Res#2
#20090000#2009#66#277-85#20110000#v60n1a08.htm##
00758000000000349000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100020000810100022001010100
01700123010001800140010001800158010001900176810000600195012011400201030001700315
06500090033206400050034103100030034603200030034901400070035286500090035900200130
0368035001000381801001700391#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08
.htm#S#c#185#26#article#29#26#^rND^sBruffaerts^nR#^rND^sDemyttenaere^nK#^rND^sVi
lagut^nG#^rND^sMartinez^nM#^rND^sBonnewyn^nA#^rND^sDe Graeff^nR#et al#The relati
on between body mass index, mental health, functional disability: a European pop
ulation perspective^len#Can J Psychiatry#20080000#2008#50#10#679-88#20110000#v60
n1a08.htm#0706-7437#Can J Psychiatry##
00683000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100015000960100
01900111010001600130012015100146030001400297065000900311064000500320031000300325
014000700328865000900335002001300344035001000357801001400367#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#186#27#article#29#27#^rND^sPetry^nN#^rN
D^sBarry^nD#^rND^sPietrzak^nRH#^rND^sWagner^nJ#Overweight and obesity are associ
ated with psychiatric disorders: results from the National Epidemiologic Survey 
on Alcohol and related conditions^len#Psychosom Med#20080000#2008#70#288-97#2011
0000#v60n1a08.htm#0033-3174#Psychosom Med##
00606000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100017000960100
01700113010001400130010000900144012004400153030001200197065000900209064000500218
03100030022303200020022601400080022886500090023600200130024503500100025880100120
0268#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a08.htm#S#c#187#28#article#
29#28#^rND^sNock^nMK#^rND^sKazdin^nAE#^rND^sHiripin^nE#^rND^sKessler#^rND^sRC#Na
tional Comorbidity Survey Replication^len#Psychol Med#20060000#2006#36#5#699-710
#20110000#v60n1a08.htm#0033-2917#Psychol Med##
00624000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100016000990120
07200115016001700187016001800204016001500222018004400237066001000281062000700291
065000900298064000500307865000900312002001300321#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a08.htm#S#c#188#29#article#29#29#^rND^sBordin^nIAS#^rND^sPaula^
nCS#Estudos populacionais sobre saúde mental de crianças e adolescentes^lpt#^rOR
G^sMello^nMF#^rORG^sMello^nAAF#^rORG^sKohn^nR#Epidemiologia da Saúde Mental no B
rasil^lpt#São Paulo#Artmed#20070000#2007#20110000#v60n1a08.htm##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#o#1#1#article
#1#20110331#101405#v60n1a09.htm#125##
04353000000000649000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901201210
01690120122002900100039004120100049004510100041005000100045005410100033005860700
03600619070003500655083138600690085001002076085001902086085001902105085001802124
08500170214208313950215908500100355408500200356408500220358408500180360608500170
36241170008036410720003036491120009036521110010036611140009036711130010036800020
01303690#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#h#2#1#article
#1#oa#pt#br1.1#1#4.0#ILUS#TAB#9#JBPSIQ250#nd#J. bras. psiquiatr.#60#1#20110000#^
f46^l49#0047-2085#Estudo do autorrelato de adesão e uso problemático de álcool e
m uma população de indivíduos com AIDS em uso de HAART^lpt#Study of self-report 
of adherence and problematic use of alcohol in a population of individuals with 
AIDS using HAART^len#^rND^1A01^nSamuel Robson Moreira^sRego#^rND^1A01^nCarlos Fr
ancisco Almeida de^sOliveira#^rND^1A01^nDaianny Macedo de Sousa^sRego#^rND^1A02^
nRaimundo Félix dos^sSantos Júnior#^rND^1A02^nVitor Brito da^sSilva#Universidade
 Estadual do Piauí^iA01#Universidade Federal do Piauí^iA02#^lpt^aOBJETIVO: O obj
etivo deste estudo foi analisar a força de associação entre as variáveis autorre
lato de adesão à medicação e uso problemático de álcool em uma população de indi
víduos com AIDS que fazem uso de HAART. MÉTODO: Foram entrevistados 103 paciente
s com AIDS, em uso de HAART há pelo menos seis meses, que frequentavam o ambulat
ório do Instituto de Doenças Tropicais Natan Portela (IDTNP), localizado na cida
de de Teresina, PI. A variável independente estudada foi o uso problemático de á
lcool, além de variáveis sociodemográficas. O questionário utilizado para avalia
r o uso problemático de álcool foi o AUDIT (Alcohol Use Disorders Identification
 Test). A variável dependente avaliada neste estudo foi o autorrelato de adesão 
ao tratamento para o HIV. Para sua mensuração, optou-se por utilizar o QSAM (Que
stionário Simplificado de Adesão à Medicação), por tratar-se de um questionário 
bastante simples e de fácil aplicação. RESULTADOS: A frequência de AUDIT > 08 fo
i de 33%; já o autorrelato de adesão, avaliado pelo QSAM, foi positivo em 45% da
 amostra. Testada a associação entre a frequência de QSAM positivo e o AUDIT pos
itivo, encontrou-se forte associação entre essas variáveis (p = 0,004). CONCLUSÃ
O: Conclui-se deste estudo que o autorrelato de falha na adesão ao HAART aferido
 por meio do QSAM é um fator de risco para a presença de uso problemático de álc
ool.#^ddecs^i1#^tm^lpt^kÁlcool^i1#^tm^lpt^kadesão^i1#^tm^lpt^kHAART^i1#^tm^lpt^k
AIDS^i1#^len^aOBJECTIVE: The aim of this study was to analyze the strength of as
sociation between the variables self-report of adherence to medication and probl
ematic use of alcohol in a population of individuals with AIDS making use of HAA
RT. METHOD: 103 patients with AIDS, using HAART for at least six months and whic
h visited the infirmary of the Natan Portela Institute for Tropical Diseases (DN
PITD), located in the city of Teresina-PI, were interviewed. The independent var
iable studied was problematic use of alcohol, and sociodemographical variables. 
The questionnaire used to evaluate the problematic use of alcohol was the AUDIT 
(Alcohol Use Disorders Identification Test). The dependent variable evaluated in
 this study was the self-report of adherence to HIV treatment. For its measureme
nt we chose to use the SQAM (Simplified Questionnaire of Adherence to Medication
), for its simplicity and ease of application. RESULTS: The frequency of AUDIT >
 08 was of 33%. The self-report of adherence, evaluated by the SQAM, was positiv
e in 45% of the sample. Once tested the association between the frequency of pos
itive SQAM and the positive AUDIT, a strong association was found between those 
variables (p = 0,004). CONCLUSION: We conclude from this study that the self-rep
ort of failure of adherence to HAART, gathered by the SQAM is a risk factor to t
he presence of problematic use of alcohol.#^ddecs^i2#^tm^len^kAlcohol^i2#^tm^len
^kadherence^i2#^tm^len^kHAART^i2#^tm^len^kAIDS^i2#vancouv#15#20100920#20/9/2010#
20110118#18/1/2011#v60n1a09.htm##
04450000000000649000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000200101049001000103158000300113
03000200011603100030013603200020013906500090014101400090015003500100015901201280
01690120129002970100039004260100049004650100041005140100045005550100033006000700
03600633070003500669083143100704085001002135085001902145085001902164085001802183
08500170220108314330221808500100365108500200366108500220368108500180370308500170
37211170008037380720003037461120009037491110010037581140009037681130010037770020
01303787#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#f#3#1#article
#1#oa#pt#br1.1#1#4.0#ILUS#TAB#9#JBPSIQ250#nd#J. bras. psiquiatr.#60#1#20110000#^
f46^l49#0047-2085#<b>Estudo do autorrelato de adesão e uso problemático de álcoo
l em uma população de indivíduos com AIDS em uso de HAART</b>^lpt#<b>Study of se
lf-report of adherence and problematic use of alcohol in a population of individ
uals with AIDS using HAART</b>^len#^rND^1A01^nSamuel Robson Moreira^sRego#^rND^1
A01^nCarlos Francisco Almeida de^sOliveira#^rND^1A01^nDaianny Macedo de Sousa^sR
ego#^rND^1A02^nRaimundo Félix dos^sSantos Júnior#^rND^1A02^nVitor Brito da^sSilv
a#Universidade Estadual do Piauí^iA01#Universidade Federal do Piauí^iA02#^lpt^a<
b>OBJETIVO:</b> O objetivo deste estudo foi analisar a força de associação entre
 as variáveis autorrelato de adesão à medicação e uso problemático de álcool em 
uma população de indivíduos com AIDS que fazem uso de HAART. <b>MÉTODO:</b> Fora
m entrevistados 103 pacientes com AIDS, em uso de HAART há pelo menos seis meses
, que frequentavam o ambulatório do Instituto de Doenças Tropicais Natan Portela
 (IDTNP), localizado na cidade de Teresina, PI. A variável independente estudada
 foi o uso problemático de álcool, além de variáveis sociodemográficas. O questi
onário utilizado para avaliar o uso problemático de álcool foi o AUDIT (<i>Alcoh
ol Use Disorders Identification Test</i>). A variável dependente avaliada neste 
estudo foi o autorrelato de adesão ao tratamento para o HIV. Para sua mensuração
, optou-se por utilizar o QSAM (Questionário Simplificado de Adesão à Medicação)
, por tratar-se de um questionário bastante simples e de fácil aplicação. <b>RES
ULTADOS:</b> A frequência de AUDIT <u>&gt;</u> 08 foi de 33%; já o autorrelato d
e adesão, avaliado pelo QSAM, foi positivo em 45% da amostra. Testada a associaç
ão entre a frequência de QSAM positivo e o AUDIT positivo, encontrou-se forte as
sociação entre essas variáveis (p = 0,004). <b>CONCLUSÃO: </b>Conclui-se deste e
studo que o autorrelato de falha na adesão ao HAART aferido por meio do QSAM é u
m fator de risco para a presença de uso problemático de álcool.#^ddecs^i1#^tm^lp
t^kÁlcool^i1#^tm^lpt^kadesão^i1#^tm^lpt^kHAART^i1#^tm^lpt^kAIDS^i1#^len^a<b>OBJE
CTIVE:</b> The aim of this study was to analyze the strength of association betw
een the variables self-report of adherence to medication and problematic use of 
alcohol in a population of individuals with AIDS making use of HAART. <b>METHOD:
</b> 103 patients with AIDS, using HAART for at least six months and which visit
ed the infirmary of the Natan Portela Institute for Tropical Diseases (DNPITD), 
located in the city of Teresina-PI, were interviewed. The independent variable s
tudied was problematic use of alcohol, and sociodemographical variables. The que
stionnaire used to evaluate the problematic use of alcohol was the AUDIT (Alcoho
l Use Disorders Identification Test). The dependent variable evaluated in this s
tudy was the self-report of adherence to HIV treatment. For its measurement we c
hose to use the SQAM (Simplified Questionnaire of Adherence to Medication), for 
its simplicity and ease of application. <b>RESULTS:</b> The frequency of AUDIT <
u>&gt;</u> 08 was of 33%. The self-report of adherence, evaluated by the SQAM, w
as positive in 45% of the sample. Once tested the association between the freque
ncy of positive SQAM and the positive AUDIT, a strong association was found betw
een those variables (p = 0,004). <b>CONCLUSION:</b> We conclude from this study 
that the self-report of failure of adherence to HAART, gathered by the SQAM is a
 risk factor to the presence of problematic use of alcohol.#^ddecs^i2#^tm^len^kA
lcohol^i2#^tm^len^kadherence^i2#^tm^len^kHAART^i2#^tm^len^kAIDS^i2#vancouv#15#20
100920#20/9/2010#20110118#18/1/2011#v60n1a09.htm##
04508000000000673000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000200108049001000110
15800030012003000190012303100030014203200020014506500090014701400090015603500100
01650120121001750120122002960100039004180100049004570100041005060100045005470100
03300592070003800625070003700663083140400700085001002104085001902114085001902133
08500180215208500170217008314090218708500100359608500200360608500220362608500180
36480850017036661170008036830720003036911120009036941110010037031140009037131130
01003722002001303732008008903745#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n
1a09.htm#S#l#4#1#article#1#^a2011#oa#pt#br1.1#1#4.0#ilus#tab#9#JBPSIQ250#nd#J. b
ras. psiquiatr#60#1#20110000#^f46^l49#0047-2085#Estudo do autorrelato de adesão 
e uso problemático de álcool em uma população de indivíduos com AIDS em uso de H
AART^lpt#Study of self-report of adherence and problematic use of alcohol in a p
opulation of individuals with AIDS using HAART^len#^rND^1A01^nSamuel Robson More
ira^sRego#^rND^1A01^nCarlos Francisco Almeida de^sOliveira#^rND^1A01^nDaianny Ma
cedo de Sousa^sRego#^rND^1A02^nRaimundo Félix dos^sSantos Júnior#^rND^1A02^nVito
r Brito da^sSilva#^iA01^1Universidade Estadual do Piauí#^iA02^1Universidade Fede
ral do Piauí#^lpt^aOBJETIVO: O objetivo deste estudo foi analisar a força de ass
ociação entre as variáveis autorrelato de adesão à medicação e uso problemático 
de álcool em uma população de indivíduos com AIDS que fazem uso de HAART. MÉTODO
: Foram entrevistados 103 pacientes com AIDS, em uso de HAART há pelo menos seis
 meses, que frequentavam o ambulatório do Instituto de Doenças Tropicais Natan P
ortela (IDTNP), localizado na cidade de Teresina, PI. A variável independente es
tudada foi o uso problemático de álcool, além de variáveis sociodemográficas. O 
questionário utilizado para avaliar o uso problemático de álcool foi o AUDIT (Al
cohol Use Disorders Identification Test). A variável dependente avaliada neste e
studo foi o autorrelato de adesão ao tratamento para o HIV. Para sua mensuração,
 optou-se por utilizar o QSAM (Questionário Simplificado de Adesão à Medicação),
 por tratar-se de um questionário bastante simples e de fácil aplicação. RESULTA
DOS: A frequência de AUDIT > 08 foi de 33 por cento; já o autorrelato de adesão,
 avaliado pelo QSAM, foi positivo em 45 por cento da amostra. Testada a associaç
ão entre a frequência de QSAM positivo e o AUDIT positivo, encontrou-se forte as
sociação entre essas variáveis (p = 0,004). CONCLUSÃO: Conclui-se deste estudo q
ue o autorrelato de falha na adesão ao HAART aferido por meio do QSAM é um fator
 de risco para a presença de uso problemático de álcool.#^ddecs^i1#^tm^lpt^kÁlco
ol^i1#^tm^lpt^kadesão^i1#^tm^lpt^kHAART^i1#^tm^lpt^kAIDS^i1#^len^aOBJECTIVE: The
 aim of this study was to analyze the strength of association between the variab
les self-report of adherence to medication and problematic use of alcohol in a p
opulation of individuals with AIDS making use of HAART. METHOD: 103 patients wit
h AIDS, using HAART for at least six months and which visited the infirmary of t
he Natan Portela Institute for Tropical Diseases (DNPITD), located in the city o
f Teresina-PI, were interviewed. The independent variable studied was problemati
c use of alcohol, and sociodemographical variables. The questionnaire used to ev
aluate the problematic use of alcohol was the AUDIT (Alcohol Use Disorders Ident
ification Test). The dependent variable evaluated in this study was the self-rep
ort of adherence to HIV treatment. For its measurement we chose to use the SQAM 
(Simplified Questionnaire of Adherence to Medication), for its simplicity and ea
se of application. RESULTS: The frequency of AUDIT > 08 was of 33 percent. The s
elf-report of adherence, evaluated by the SQAM, was positive in 45 percent of th
e sample. Once tested the association between the frequency of positive SQAM and
 the positive AUDIT, a strong association was found between those variables (p =
 0,004). CONCLUSION: We conclude from this study that the self-report of failure
 of adherence to HAART, gathered by the SQAM is a risk factor to the presence of
 problematic use of alcohol.#^ddecs^i2#^tm^len^kAlcohol^i2#^tm^len^kadherence^i2
#^tm^len^kHAART^i2#^tm^len^kAIDS^i2#vancouv#15#20100920#20/9/2010#20110118#18/1/
2011#v60n1a09.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&p
id=S0047-20852011000100009##
00370000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704013500076002001300211#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#5#1#article#106#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>COMUNICA&Ccedil;&At
ilde;O BREVE</b></font></p>     ^cY#v60n1a09.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#6#2#article#106#<p>&nbsp;</p>     ^
cY#v60n1a09.htm##
00508000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704027300076002001300349#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#7#3#article#106#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Estudo d
o autorrelato de ades&atilde;o e uso problem&aacute;tico de &aacute;lcool em uma
 popula&ccedil;&atilde;o de indiv&iacute;duos com AIDS em uso de HAART</b></font
></p>     ^cY#v60n1a09.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#8#4#article#106#<p>&nbsp;</p>     ^
cY#v60n1a09.htm##
00442000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704020700076002001300283#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#9#5#article#106#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Study of self-report of adherence
 and problematic use of alcohol in a population of individuals with AIDS using H
AART</b></font></p>     ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#10#6#article#106#<p>&nbsp;</p>     
^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#11#7#article#106#<p>&nbsp;</p>     
^cY#v60n1a09.htm##
00552000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704031600077002001300393#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#12#8#article#106#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Samuel Robson Moreira Rego<sup>I
</sup>; Carlos Francisco Almeida de Oliveira<sup>I</sup>; Daianny Macedo de Sous
a Rego<sup>I</sup>; Raimundo F&eacute;lix dos Santos J&uacute;nior<sup>II</sup>;
 Vitor Brito da Silva<sup>II</sup></b></font></p>     ^cY#v60n1a09.htm##
00364000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704012800077002001300205#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#13#9#article#106#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Universidade Estadual d
o Piau&iacute; (UESPI)    ^cY#v60n1a09.htm##
00318000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008100078002001300159#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#14#10#article#106#<br> <sup>II</sup
>Universidade Federal do Piau&iacute; (UFPI)</font></p>     ^cY#v60n1a09.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#15#11#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#16#12#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#17#13#article#106#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a09.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#18#14#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a09.htm##
00620000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704038300078002001300461#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#19#15#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVO:</b> O objetivo deste 
estudo foi analisar a for&ccedil;a de associa&ccedil;&atilde;o entre as vari&aac
ute;veis autorrelato de ades&atilde;o &agrave; medica&ccedil;&atilde;o e uso pro
blem&aacute;tico de &aacute;lcool em uma popula&ccedil;&atilde;o de indiv&iacute
;duos com AIDS que fazem uso de HAART.    ^cY#v60n1a09.htm##
01165000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704092800078002001301006#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#20#16#article#106#<br>  <b>M&Eacute
;TODO:</b> Foram entrevistados 103 pacientes com AIDS, em uso de HAART h&aacute;
 pelo menos seis meses, que frequentavam o ambulat&oacute;rio do Instituto de Do
en&ccedil;as Tropicais Natan Portela (IDTNP), localizado na cidade de Teresina, 
PI. A vari&aacute;vel independente estudada foi o uso problem&aacute;tico de &aa
cute;lcool, al&eacute;m de vari&aacute;veis sociodemogr&aacute;ficas. O question
&aacute;rio utilizado para avaliar o uso problem&aacute;tico de &aacute;lcool fo
i o AUDIT (<i>Alcohol Use Disorders Identification Test</i>). A vari&aacute;vel 
dependente avaliada neste estudo foi o autorrelato de ades&atilde;o ao tratament
o para o HIV. Para sua mensura&ccedil;&atilde;o, optou-se por utilizar o QSAM (Q
uestion&aacute;rio Simplificado de Ades&atilde;o &agrave; Medica&ccedil;&atilde;
o), por tratar-se de um question&aacute;rio bastante simples e de f&aacute;cil a
plica&ccedil;&atilde;o.    ^cY#v60n1a09.htm##
00601000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704036400078002001300442#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#21#17#article#106#<br>  <b>RESULTAD
OS:</b> A frequ&ecirc;ncia de AUDIT <u>&gt;</u> 08 foi de 33%; j&aacute; o autor
relato de ades&atilde;o, avaliado pelo QSAM, foi positivo em 45% da amostra. Tes
tada a associa&ccedil;&atilde;o entre a frequ&ecirc;ncia de QSAM positivo e o AU
DIT positivo, encontrou-se forte associa&ccedil;&atilde;o entre essas vari&aacut
e;veis (p = 0,004).    ^cY#v60n1a09.htm##
00484000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704024700078002001300325#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#22#18#article#106#<br>  <b>CONCLUS&
Atilde;O: </b>Conclui-se deste estudo que o autorrelato de falha na ades&atilde;
o ao HAART aferido por meio do QSAM &eacute; um fator de risco para a presen&cce
dil;a de uso problem&aacute;tico de &aacute;lcool.</font></p>     ^cY#v60n1a09.h
tm##
00407000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017000078002001300248#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#23#19#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>&Aacute;lco
ol, ades&atilde;o, HAART, AIDS.</font></p> <hr size="1" noshade>     ^cY#v60n1a0
9.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#24#20#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a09.htm##
00544000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704030700078002001300385#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#25#21#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVE:</b> The aim of this 
study was to analyze the strength of association between the variables self-repo
rt of adherence to medication and problematic use of alcohol in a population of 
individuals with AIDS making use of HAART.    ^cY#v60n1a09.htm##
00941000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704070400078002001300782#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#26#22#article#106#<br> <b> METHOD:<
/b> 103 patients with AIDS, using HAART for at least six months and which visite
d the infirmary of the Natan Portela Institute for Tropical Diseases (DNPITD), l
ocated in the city of Teresina-PI, were interviewed. The independent variable st
udied was problematic use of alcohol, and sociodemographical variables. The ques
tionnaire used to evaluate the problematic use of alcohol was the AUDIT (Alcohol
 Use Disorders Identification Test). The dependent variable evaluated in this st
udy was the self-report of adherence to HIV treatment. For its measurement we ch
ose to use the SQAM (Simplified Questionnaire of Adherence to Medication),  for 
its simplicity and ease of application.    ^cY#v60n1a09.htm##
00566000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704032900078002001300407#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#27#23#article#106#<br>  <b>RESULTS:
</b> The frequency of AUDIT <u>&gt;</u> 08 was of 33%. The  self-report of adher
ence, evaluated by the SQAM, was positive in 45% of the sample. Once tested the 
 association between the frequency of positive SQAM and the positive AUDIT, a st
rong association  was found between those variables (p = 0,004).    ^cY#v60n1a09
.htm##
00451000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704021400078002001300292#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#28#24#article#106#<br>  <b>CONCLUSI
ON:</b> We conclude from this study that the  self-report of failure of adherenc
e to HAART, gathered by the SQAM is a risk factor to the presence of  problemati
c use of alcohol.</font></p>     ^cY#v60n1a09.htm##
00391000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015400078002001300232#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#29#25#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords:</b> Alcohol, adherenc
e, HAART, AIDS.</font></p> <hr size="1" noshade>     ^cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#30#26#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#31#27#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00351000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011400078002001300192#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#32#28#article#106#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde;O</b></f
ont></p>     ^cY#v60n1a09.htm##
01065000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704082800078002001300906#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#33#29#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A s&iacute;ndrome da imunodefici&e
circ;ncia adquirida (AIDS) teve seus primeiros relatos no in&iacute;cio da d&eac
ute;cada de 1980. Contudo, no Brasil, apenas na d&eacute;cada de 1990 foi tra&cc
edil;ado o perfil epidemiol&oacute;gico que orienta as pol&iacute;ticas de enfre
ntamento da doen&ccedil;a. Essas an&aacute;lises demonstraram as tend&ecirc;ncia
s da epidemia de <i>interioriza&ccedil;&atilde;o, heterossexualiza&ccedil;&atild
e;o, feminiza&ccedil;&atilde;o </i>e <i>pauperiza&ccedil;&atilde;o</i>. Todavia,
 a taxa de incid&ecirc;ncia parece ter se estabilizado, sendo, entretanto, eleva
da e em torno de 19 casos para cada 100 mil habitantes, de forma que entre 2002 
e 2006 foram registrados 186.283 casos de AIDS no Brasil<sup>1,2</sup>.</font></
p>     ^cY#v60n1a09.htm##
01586000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704134900078002001301427#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#34#30#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Um aspecto importante em rela&cced
il;&atilde;o ao combate dessa epidemia tem sido o desafio do tratamento aos paci
entes com AIDS. Embora j&aacute; existam drogas que sejam eficazes em inibir a p
rolifera&ccedil;&atilde;o viral e o avan&ccedil;o da doen&ccedil;a, o tratamento
, em geral, esbarra em um ponto de extrema import&acirc;ncia no caso de doen&cce
dil;as cr&ocirc;nicas: a ades&atilde;o. Em rela&ccedil;&atilde;o ao tratamento d
a AIDS, uma ades&atilde;o superior a 90% &eacute; requerida para que o tratament
o seja eficaz. Apenas aproximadamente metade dos pacientes com AIDS que apresent
am &iacute;ndices de ades&atilde;o em torno de 80%-90% atinge carga viral indete
ct&aacute;vel<sup>3</sup>, diferentemente de outras doen&ccedil;as cr&ocirc;nica
s, como a hipertens&atilde;o, na qual &iacute;ndices de ades&atilde;o de 80% j&a
acute; s&atilde;o considerados satisfat&oacute;rios<sup>4</sup>. &Eacute; import
ante lembrar que a n&atilde;o ades&atilde;o aos novos medicamentos antirretrovir
ais pode ser considerada uma amea&ccedil;a tanto &agrave; efetividade do tratame
nto como para a dissemina&ccedil;&atilde;o de v&iacute;rus-resist&ecirc;ncia. Se
ndo assim, a ades&atilde;o passa a ser importante n&atilde;o apenas individualme
nte, mas para toda a comunidade.</font></p>     ^cY#v60n1a09.htm##
00895000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704065800078002001300736#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#35#31#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">No Brasil, alguns estudos encontra
ram taxas de ades&atilde;o ao HAART (<i>Highly Active Antiretroviral Therapy</i>
) entre 50% e 75%. Um estudo encontrou frequ&ecirc;ncia de ades&atilde;o de 57% 
em Pelotas e outro, no Distrito Federal, encontrou um percentual de 72%<sup>3,5<
/sup>. Um estudo multic&ecirc;ntrico envolvendo 1.972 pacientes de 60 servi&cced
il;os de sa&uacute;de em sete estados brasileiros (S&atilde;o Paulo, Rio de Jane
iro, Rio Grande do Sul, Mato Grosso do Sul, Cear&aacute;, Maranh&atilde;o e Par&
aacute;) encontrou taxa de ades&atilde;o de 75%<sup>6</sup>. </font></p>     ^cY
#v60n1a09.htm##
01015000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704077800078002001300856#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#36#32#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O consumo de &aacute;lcool est&aac
ute; associado &agrave; redu&ccedil;&atilde;o nos &iacute;ndices de ades&atilde;
o ao HAART, al&eacute;m de um pior progn&oacute;stico em pacientes com AIDS<sup>
7</sup>. O seu uso problem&aacute;tico tamb&eacute;m pode propiciar comportament
os de risco, como uso de outras drogas e aumentar a frequ&ecirc;ncia de depress&
atilde;o<sup>8</sup>. Segundo estudos, a frequ&ecirc;ncia de uso abusivo de &aac
ute;lcool em pessoas convivendo com HIV &eacute; bastante elevada e variou de 8%
 a 41%<sup>7-9</sup>. Apesar desses n&uacute;meros, estima-se que a maioria dos 
m&eacute;dicos n&atilde;o investiga problemas decorrentes do uso de &aacute;lcoo
l em seus pacientes. </font></p>     ^cY#v60n1a09.htm##
00615000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704037800078002001300456#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#37#33#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O objetivo deste estudo foi analis
ar a for&ccedil;a de associa&ccedil;&atilde;o entre as vari&aacute;veis autorrel
ato de ades&atilde;o &agrave; medica&ccedil;&atilde;o e uso problem&aacute;tico 
de &aacute;lcool em uma popula&ccedil;&atilde;o de indiv&iacute;duos com AIDS qu
e fazem uso de HAART.</font></p>     ^cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#38#34#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00341000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010400078002001300182#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#39#35#article#106#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>M&Eacute;TODOS</b></font></p>  
   ^cY#v60n1a09.htm##
02282000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704204500078002001302123#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#40#36#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foi realizado um estudo do tipo ca
so-controle no qual a popula&ccedil;&atilde;o fonte foram os pacientes com AIDS 
em uso de HAART h&aacute; pelo menos seis meses que, na &eacute;poca da entrevis
ta, tinham mais de 18 anos e frequentavam o ambulat&oacute;rio do Instituto de D
oen&ccedil;as Tropicais Natan Portela (IDTNP). Esse &eacute; um hospital-escola 
considerado um centro de refer&ecirc;ncia para tratamento de pacientes com AIDS 
n&atilde;o apenas do Piau&iacute;, mas tamb&eacute;m de regi&otilde;es circunviz
inhas do Cear&aacute;, Maranh&atilde;o, Par&aacute; e Tocantins. Foi selecionada
 uma amostra representativa desses pacientes, com n em tor-no de 100 indiv&iacut
e;duos. Para isso, foi levado em conta que o IDTNP tinha cadastrado no seu siste
ma de dispensa&ccedil;&atilde;o de medicamentos, na &eacute;poca do estudo, 2.13
7 indiv&iacute;duos. Essa amostra foi calculada aceitando um erro amostral de 10
% e n&iacute;vel de confian&ccedil;a de 95% e estimando uma frequ&ecirc;ncia m&a
acute;xima de AUDIT positivo de 40%. A vari&aacute;vel independente deste estudo
 foi o uso problem&aacute;tico de &aacute;lcool, al&eacute;m de vari&aacute;veis
 sociodemogr&aacute;ficas. O question&aacute;rio utilizado para avaliar o modo d
e consumo alco&oacute;lico foi o AUDIT (<i>Alcohol Use Disorders Identification 
Test</i>), que &eacute; um <i>screening</i> criado pela Organiza&ccedil;&atilde;
o Mundial de Sa&uacute;de (OMS) com o objetivo de identificar bebedores de risco
. Ele &eacute; composto de 10 itens que investigam o padr&atilde;o de consumo no
s &uacute;ltimos 12 meses, sendo tr&ecirc;s abordando uso de &aacute;lcool, quat
ro sobre depend&ecirc;ncia e tr&ecirc;s sobre problemas decorrentes do consumo. 
Sua pontua&ccedil;&atilde;o varia de 0 a 40 e o ponto de corte considerado neste
 estudo foi 08. Nesse <i>cut-off</i>, o AUDIT apresenta sensibilidade de 92% e e
specificidade de 93% para consumo problem&aacute;tico de &aacute;lcool<sup>10,11
</sup>. </font></p>     ^cY#v60n1a09.htm##
01409000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704117200078002001301250#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#41#37#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A vari&aacute;vel dependente avali
ada neste estudo foi o autorrelato de ades&atilde;o ao tratamento para o HIV. Es
sa tem sido uma das formas mais utilizadas na investiga&ccedil;&atilde;o de ades
&atilde;o &agrave; medica&ccedil;&atilde;o, por se tratar de uma maneira f&aacut
e;cil, r&aacute;pida e barata de avaliar o indiv&iacute;duo. Embora n&atilde;o s
eja uma medida fidedigna, alguns autores t&ecirc;m encontrado uma boa correla&cc
edil;&atilde;o entre autorrelato e medidas mais objetivas como a mensura&ccedil;
&atilde;o da carga viral ou a contagem eletr&ocirc;nica de p&iacute;lulas. Contu
do, os trabalhos apresentam uma grande diversidade na forma de captar o autorrel
ato e t&ecirc;m sido utilizados tanto question&aacute;rios estruturados como o Q
SAM (Question&aacute;rio Simplificado de Ades&atilde;o &agrave; Medica&ccedil;&a
tilde;o) e o PMAQ (<i>Patient Medication Adherence Questionnaire</i>) como tamb&
eacute;m avaliada diretamente a forma como o indiv&iacute;duo utilizou a medica&
ccedil;&atilde;o nos tr&ecirc;s dias ou na semana anterior &agrave; entrevista<s
up>6,12</sup>. </font></p>     ^cY#v60n1a09.htm##
01260000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704102300078002001301101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#42#38#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">No presente estudo, optou-se por u
tilizar o QSAM, por tratar-se de um question&aacute;rio bastante simples e de f&
aacute;cil aplica&ccedil;&atilde;o. Ele foi validado por Knobel em 2002 em uma p
opula&ccedil;&atilde;o de Madrid e &eacute; constitu&iacute;do por seis quest&ot
ilde;es, sendo quatro de "sim" ou "n&atilde;o" e duas qualitativas nas quais se 
investiga o n&atilde;o uso da medica&ccedil;&atilde;o na &uacute;ltima semana e 
nos &uacute;ltimos tr&ecirc;s meses, respectivamente. Considera-se o autorrelato
 como n&atilde;o aderente ou QSAM positivo caso uma das perguntas qualitativas s
eja respondida positivamente. Embora ele n&atilde;o tenha sido validado no Brasi
l, n&atilde;o se encontrou impedimento em utiliz&aacute;-lo j&aacute; que nosso 
objetivo n&atilde;o &eacute; encontrar a preval&ecirc;ncia de ades&atilde;o e no
 momento desta pesquisa n&atilde;o havia nenhum outro question&aacute;rio valida
do no Brasil<sup>13</sup>.</font></p>     ^cY#v60n1a09.htm##
00702000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704046500078002001300543#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#43#39#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A an&aacute;lise dos dados foi rea
lizada por um estat&iacute;stico por meio de um programa, o Epi Info vers&atilde
;o 6. Foi realizada uma an&aacute;lise bivariada para verificar associa&ccedil;&
atilde;o entre propor&ccedil;&otilde;es dicot&ocirc;micas utilizando o teste do 
qui-quadrado. O n&iacute;vel de signific&acirc;ncia adotado para essa an&aacute;
lise foi de 1% (p &lt; 0,01)</font></p>     ^cY#v60n1a09.htm##
00577000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704034000078002001300418#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#44#40#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O estudo foi aprovado pelo comit&e
circ; de &eacute;tica em pesquisa da Universidade Federal do Piau&iacute; (Proto
colo SISNEP - 0058.0.045.000-09) e uma carta para obten&ccedil;&atilde;o de cons
entimento livre e esclarecido foi entregue a cada participante.</font></p>     ^
cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#45#41#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#46#42#article#106#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font></p>     ^
cY#v60n1a09.htm##
00635000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704039800078002001300476#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#47#43#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foram aplicados 103 question&aacut
e;rios ao longo dos meses de agosto a novembro de 2009. A idade dos participante
s variou de 21 a 62 anos, com m&eacute;dia de 38,9 (DP = 9,3). Prevaleceram indi
v&iacute;duos do g&ecirc;nero masculino, pessoas com baixa escolaridade e de bai
xa renda (<a href="#tab01">Tabela 1</a>).</font></p>     ^cY#v60n1a09.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#48#44#article#106#<p><a name="tab01
"></a></p>     ^cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#49#45#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#50#46#article#106#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a09tab01.jpg"></p>     ^cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#51#47#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
01294000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704105700078002001301135#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#52#48#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A frequ&ecirc;ncia de uso abusivo 
de &aacute;lcool em pacientes com AIDS, avaliados neste estudo utilizando como f
erramenta de <i>screening</i> o AUDIT <u>&gt;</u> 08, foi de 33%. Ela foi bastan
te elevada, assim como a encontrada em estudo anterior, de 41%, embora nesse ten
ha sido utilizado outro instrumento de <i>screening</i>, o MAST (<i>Michigan Alc
ohol Screening Test</i>)<sup>9</sup>. J&aacute; o autorrelato de ades&atilde;o, 
avaliado pelo QSAM, foi positivo em 45% da amostra (<a href="#tab02">Tabela 2</a
>). Observou-se uma tend&ecirc;ncia de maior frequ&ecirc;ncia de autorrelatos de
 ades&atilde;o negativos &agrave; medida que h&aacute; um aumento na gravidade d
o AUDIT (<a href="#tab01">Tabela 1</a>). Fen&ocirc;meno semelhante foi descrito 
em um estudo realizado por Parsons, no qual se observou que a quantidade de <i>d
rinks</i> consumida pelo indiv&iacute;duo &eacute; capaz de predizer se haver&aa
cute;, ou n&atilde;o, falhas na ades&atilde;o<sup>14</sup>. </font></p>     ^cY#
v60n1a09.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#53#49#article#106#<p><a name="tab02
"></a></p>     ^cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#54#50#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#55#51#article#106#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a09tab02.jpg"></p>     ^cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#56#52#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00569000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704033200078002001300410#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#57#53#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Quando testada a associa&ccedil;&a
tilde;o entre a frequ&ecirc;ncia de QSAM positivo e o AUDIT positivo, encontrou-
se forte associa&ccedil;&atilde;o entre essas vari&aacute;veis, como pode ser ob
servado na <a href="#tab02">tabela 2</a>, p &lt; 0,01. </font></p>     ^cY#v60n1
a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#58#54#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#59#55#article#106#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p>
     ^cY#v60n1a09.htm##
00612000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704037500078002001300453#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#60#56#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A ades&atilde;o &eacute; um ponto 
crucial no tratamento de doen&ccedil;as cr&ocirc;nicas. No caso dos antirretrovi
rais passa a ter relev&acirc;ncia maior ainda j&aacute; que &iacute;ndices de ad
es&atilde;o em torno de 95% s&atilde;o requeridos para que haja um bom controle 
da doen&ccedil;a. </font></p>     ^cY#v60n1a09.htm##
01320000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704108300078002001301161#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#61#57#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">V&aacute;rios pesquisadores t&ecir
c;m se empenhado em estudar os fatores que podem limitar a ades&atilde;o, al&eac
ute;m de interven&ccedil;&otilde;es apropriadas que otimizem a ader&ecirc;ncia. 
Esses fatores podem estar relacionados ao indiv&iacute;duo, &agrave; doen&ccedil
;a e ao tratamento. Algumas das situa&ccedil;&otilde;es que s&atilde;o tidas com
o de risco para uma baixa ades&atilde;o s&atilde;o: tempo de tratamento prolonga
do, grande quantidade de comprimidos ingeridos por dia, terapia com v&aacute;rio
s medicamentos e em v&aacute;rias tomadas durante o dia tornando o esquema de to
madas muito complexo, presen&ccedil;a de efeitos colaterais intensos, baixo supo
rte social e familiar, fraca rela&ccedil;&atilde;o m&eacute;dico-paciente, hist&
oacute;ria psiqui&aacute;trica, epis&oacute;dio depressivo, etilismo e uso de dr
ogas il&iacute;citas. Desses, o uso de &aacute;lcool tem se mostrado consistente
mente associado a d&eacute;ficits na ades&atilde;o aos antirretrovirais<sup>15</
sup>. </font></p>     ^cY#v60n1a09.htm##
00916000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704067900078002001300757#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#62#58#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A frequ&ecirc;ncia de uso problem&
aacute;tico de &aacute;lcool em popula&ccedil;&otilde;es de indiv&iacute;duos em
 tratamento com o HAART &eacute; bastante vari&aacute;vel e vai de 8% at&eacute;
 41%<sup>7-9</sup>. Independentemente da preval&ecirc;ncia, a associa&ccedil;&at
ilde;o entre essa vari&aacute;vel e d&eacute;ficit na ades&atilde;o vem sendo re
plicada na maioria dos estudos, conforme se observa em uma revis&atilde;o realiz
ada por R&ecirc;go e R&ecirc;go<sup>15</sup>. Nesta, de 21 artigos selecionados,
 apenas tr&ecirc;s n&atilde;o encontraram associa&ccedil;&atilde;o significativa
. </font></p>     ^cY#v60n1a09.htm##
01286000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704104900078002001301127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#63#59#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Em rela&ccedil;&atilde;o &agrave; 
investiga&ccedil;&atilde;o de ades&atilde;o, v&aacute;rios m&eacute;todos t&ecir
c;m sido empregados com essa finalidade. Eles podem ser diretos (determina&ccedi
l;&atilde;o das concentra&ccedil;&otilde;es plasm&aacute;ticas de f&aacute;rmaco
s e marcadores biol&oacute;gicos) e indiretos (contagem de comprimidos, registro
s da dispensa de medicamentos na farm&aacute;cia, ju&iacute;zo cl&iacute;nico, c
omunica&ccedil;&atilde;o da ades&atilde;o pelo doente, por meio de question&aacu
te;rios e entrevistas e sistemas de controle eletr&ocirc;nico). Em uma revis&ati
lde;o realizada por Ventura, dos 32 artigos selecionados, 10 utilizaram exclusiv
amente a entrevista ou question&aacute;rios estruturados para avaliar o relato d
e ades&atilde;o. Nessa mesma revis&atilde;o, os estudos que empregaram question&
aacute;rios e outro m&eacute;todo simultaneamente encontraram uma boa correla&cc
edil;&atilde;o entre os m&eacute;todos<sup>4</sup>. </font></p>     ^cY#v60n1a09
.htm##
01086000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704084900078002001300927#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#64#60#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O presente estudo encontrou forte 
associa&ccedil;&atilde;o entre falha na ades&atilde;o ao HAART aferida por meio 
do autorrelato e consumo problem&aacute;tico de &aacute;lcool aferido pelo AUDIT
. Contudo, por n&atilde;o ser um estudo prospectivo, n&atilde;o se pode afirmar 
tratar-se de uma associa&ccedil;&atilde;o causal. Todavia, fica evidente que na 
presen&ccedil;a de um autorrelato de n&atilde;o ades&atilde;o, a probabilidade d
e se estar diante de um indiv&iacute;duo com uso nocivo de &aacute;lcool &eacute
; bastante grande. Dessa forma, o m&eacute;dico-assistente poderia, ao investiga
r rotineiramente a ades&atilde;o ao tratamento, identificar os pacientes com aut
orrelato negativo e referenci&aacute;-los para avalia&ccedil;&atilde;o psiqui&aa
cute;trica. </font></p>     ^cY#v60n1a09.htm##
00630000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704039300078002001300471#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#65#61#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Estudos que avaliem o impacto da i
nterven&ccedil;&atilde;o terap&ecirc;utica nos pacientes que fazem uso abusivo d
e &aacute;lcool e est&atilde;o, concomitantemente, em tratamento com HAART devem
 ser realizados para que se possa estimular a interconsulta psiqui&aacute;trica 
nos servi&ccedil;os de infectologia.</font></p>     ^cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#66#62#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#67#63#article#106#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUS&Atilde;O</b></font></p>
     ^cY#v60n1a09.htm##
00923000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704068600078002001300764#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#68#64#article#106#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Conclui-se deste estudo que o auto
rrelato de falha na ades&atilde;o ao HAART aferido por meio do QSAM &eacute; um 
fator de risco para a presen&ccedil;a de uso problem&aacute;tico de &aacute;lcoo
l. Por ser um question&aacute;rio simples e de f&aacute;cil aplica&ccedil;&atild
e;o, pode ser utilizado pelo cl&iacute;nico que presta assist&ecirc;ncia aos pac
ientes com AIDS no intuito n&atilde;o apenas de avaliar a ades&atilde;o, mas tam
b&eacute;m de ajudar a identificar pacientes com problemas relacionados ao consu
mo de &aacute;lcool e que n&atilde;o relatam espontaneamente essa condi&ccedil;&
atilde;o.</font></p>     ^cY#v60n1a09.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#69#65#article#106#<p>&nbsp;</p>    
 ^cY#v60n1a09.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#70#66#article#106#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b></font></p
>     ^cY#v60n1a09.htm##
00496000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704024500080002001300325#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#71#67#article#106#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Grangeiro A, Escu
der MML, Castilho EA. Magnitude e tend&ecirc;ncia de epidemia de AIDS em munic&i
acute;pios brasileiros de 2002-2006. Rev Saude Publica. 2010;44(3):430-41.    ^c
Y#v60n1a09.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#72#68#article#106#</font></p>     ^
cY#v60n1a09.htm##
00565000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704031400080002001300394#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#73#69#article#106#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Sousa MCP, Esp&ia
cute;rito Santo ACG, Motta SKA. G&ecirc;nero, vulnerabilidade das mulheres ao HI
V/ AIDS e a&ccedil;&otilde;es de preven&ccedil;&atilde;o em bairro da periferia 
de Teresina, Piau&iacute;, Brasil. Saude Soc. 2008;17(2):58-68.    ^cY#v60n1a09.
htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#74#70#article#106# </font></p>     
^cY#v60n1a09.htm##
00527000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704027600080002001300356#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#75#71#article#106#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Seidl EMF, Melch&
iacute;ades A, Farias V, Brito A. Pessoas vivendo com HIV/AIDS: Vari&aacute;veis
 associadas &agrave; ades&atilde;o ao tratamento antirretroviral. Cad Saude Publ
ica. 2007;23(10):2305-16.    ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#76#72#article#106# </font></p>     
^cY#v60n1a09.htm##
00497000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704024600080002001300326#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#77#73#article#106#4#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Ventura A. Ades&a
tilde;o a terap&ecirc;utica antirretrov&iacute;rica na infec&ccedil;&atilde;o VI
H/SIDA: revis&atilde;o de arquivos publicados. Arq Med. 2006;20(1-2):37-49.    ^
cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#78#74#article#106# </font></p>     
^cY#v60n1a09.htm##
00551000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704030000080002001300380#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#79#75#article#106#5#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Pinheiro CAT, Car
valho-Leite JC, Drachler ML, Silveira VL. Factors associated with adherence to a
ntiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern 
Brazil. Braz J Med Biol Res. 2002;35(10):1173-81.    ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#80#76#article#106# </font></p>     
^cY#v60n1a09.htm##
00434000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704018300080002001300263#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#81#77#article#106#6#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Nemes MIB, Carval
ho HB, Souza MFM. Antiretroviral therapy adherence in Brazil. AIDS. 2004;18(Supp
l 3):515-20.    ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#82#78#article#106# </font></p>     
^cY#v60n1a09.htm##
00498000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704024700080002001300327#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#83#79#article#106#7#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Parsons JT, Rosof
 E, Mustanski B. Patient-related factors predicting HIV medication adherence amo
ng men and women with alcohol problems. J Health Psychol. 2007;12(2):357-70.    
^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#84#80#article#106# </font></p>     
^cY#v60n1a09.htm##
00525000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704027400080002001300354#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#85#81#article#106#8#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Kim TW, Palepu A,
 Cheng DM, Libman H, Saitz R, Samet JH. Factor associated with descontinuation o
f antiretroviral therapy in HIV-infected patients with alcohol problems. AIDS Ca
re. 2007;19(8):1039-47.    ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#86#82#article#106# </font></p>     
^cY#v60n1a09.htm##
00445000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704019400080002001300274#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#87#83#article#106#9#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Lefevre F, O'Lear
y B, Moran M, et al. Alcohol consumption among HIV-infected patients. J Gen Inte
rn Med. 1995;10:458-60.    ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#88#84#article#106# </font></p>     
^cY#v60n1a09.htm##
00528000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704027600081002001300357#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#89#85#article#106#10#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Figlie NB, Pill
on SC, Laranjeira RR, Dunn J. AUDIT identifica a necessidade de interconsulta es
pec&iacute;fica para dependentes de &aacute;lcool no hospital geral? J Bras Psiq
uiatr. 1997;46(11):589-93.    ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#90#86#article#106# </font></p>     
^cY#v60n1a09.htm##
00511000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704025900081002001300340#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#91#87#article#106#11#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Lima CT, Freire
 ACC, Silva APB, Teixeira RM, Farrell M, Prince M. Concurrent and construct vali
dity of the AUDIT in an urban Brazilian sample. Alcohol and Alcoholism. 2005;40(
6):584-9.    ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#92#88#article#106# </font></p>     
^cY#v60n1a09.htm##
00578000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704032600081002001300407#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#93#89#article#106#12#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> 12. Garcia R, Bada
r&oacute; R, Netto EM, Silva M, Amorin FS, Ramos A, et al. Cross-sectional study
 to evaluate factors associated with adherence to antiretroviral therapy by Braz
ilian HIV-infected patients. AIDS Res Hum Retroviruses. 2006;22(12):1248-52.    
^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#94#90#article#106# </font></p>     
^cY#v60n1a09.htm##
00557000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704030500081002001300386#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#95#91#article#106#13#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Knobel H, Alons
o J, Casado JL, Collazos J, Gonz&aacute;lez J, Ruiz I, et al. Validation of a si
mplified medication adherence questionnaire in a large cohort of HIV infected pa
tients: the GEEMA study group. AIDS. 2002;16(4):605-13.    ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#96#92#article#106# </font></p>     
^cY#v60n1a09.htm##
00551000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704029900081002001300380#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#97#93#article#106#14#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Parsons JT, Ros
of E, Mustanski B. Medication adherence mediates the relationship between adhere
nce self-efficacy and biological assessments of HIV health among those with alco
hol use disorders. AIDS Behav. 2008;12(1):95-103.    ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#98#94#article#106# </font></p>     
^cY#v60n1a09.htm##
00544000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704029200081002001300373#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#99#95#article#106#15#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Rego SRM, Rego 
DMS. Associa&ccedil;&atilde;o entre uso de &aacute;lcool em indiv&iacute;duos co
m AIDS e ades&atilde;o ao tratamento antirretroviral: uma revis&atilde;o da lite
ratura. J Bras Psiquiatr. 2010;59(1):70-3.    ^cY#v60n1a09.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#100#96#article#106#</font></p>     
^cY#v60n1a09.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002200079002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#101#97#article#106#<p>&nbsp;</p>   
  ^cY#v60n1a09.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002200079002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#102#98#article#106#<p>&nbsp;</p>   
  ^cY#v60n1a09.htm##
00470000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704023200079002001300311#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#103#99#article#106#<p><font size="2
" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="/
img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <b
>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a09.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004200080002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#104#100#article#106#<br>    Samuel 
Robson Moreira Rego    ^cY#v60n1a09.htm##
00301000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006200080002001300142#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#105#101#article#106#<br>    Av. Vil
mary, 2505, S&atilde;o Cristov&atilde;o    ^cY#v60n1a09.htm##
00278000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704003900080002001300119#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#106#102#article#106#<br>   64051-12
0 - Teresina, PI    ^cY#v60n1a09.htm##
00283000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004400080002001300124#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#107#103#article#106#<br>    Telefon
e: (86) 3232-9406        ^cY#v60n1a09.htm##
00358000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704011900080002001300199#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#108#104#article#106#<br>   E-mail: 
<a href="mailto:samuelregoteresina@yahoo.com.br">samuelregoteresina@yahoo.com.br
</a></font></p>     ^cY#v60n1a09.htm##
00331000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009200080002001300172#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#109#105#article#106#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 20/9/2010    ^cY#v60
n1a09.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#p#110#106#article#106#<br>  Aprovado 
em 18/1/2011</font></p>     ^cY#v60n1a09.htm##
00617000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100019000790100019000980100
01900117012008500136030001800221065000900239064000500248031000300253032000200256
014000700258865000900265002001300274035001000287801001800297#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a09.htm#S#c#111#1#article#15#1#^rND^sGrangeiro^nA#^
rND^sEscuder^nMML#^rND^sCastilho^nEA#Magnitude e tendência de epidemia de AIDS e
m municípios brasileiros de 2002-2006^lpt#Rev Saude Publica#20100000#2010#44#3#4
30-41#20110000#v60n1a09.htm#0034-8910#Rev Saude Publica##
00613000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790100026000960100
01700122012012500139030001000264710000200274065000900276064000500285031000300290
032000200293014000600295865000900301002001300310#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a09.htm#S#c#112#2#article#15#2#^rND^sSousa^nMCP#^rND^sEspírito 
Santo^nACG#^rND^sMotta^nSKA#Gênero, vulnerabilidade das mulheres ao HIV/ AIDS e 
ações de prevenção em bairro da periferia de Teresina, Piauí, Brasil^lpt#Saude S
oc#2#20080000#2008#17#2#58-68#20110000#v60n1a09.htm##
00651000000000313000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790100020000960100
01600116010001500132012009400147030001800241065000900259064000500268031000300273
032000300276014000800279865000900287002001300296035001000309801001800319#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#c#113#3#article#15#3#^rND^sSe
idl^nEMF#^rND^sMelchíades^nA#^rND^sFarias^nV#^rND^sBrito^nA#Pessoas vivendo com 
HIV/AIDS: Variáveis associadas à adesão ao tratamento antirretroviral^lpt#Cad Sa
ude Publica#20070000#2007#23#10#2305-16#20110000#v60n1a09.htm#0102-311X#Cad Saud
e Publica##
00516000000000265000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790120095000960300
00800191710000200199065000900201064000500210031000300215032000400218014000600222
865000900228002001300237#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm
#S#c#114#4#article#15#4#^rND^sVentura^nA#Adesão a terapêutica antirretrovírica n
a infecção VIH/SIDA: revisão de arquivos publicados^lpt#Arq Med#2#20060000#2006#
20#1-2#37-49#20110000#v60n1a09.htm##
00705000000000313000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100020000790100025000990100
01900124010001900143012012900162030002000291065000900311064000500320031000300325
032000300328014000800331865000900339002001300348035001000361801002000371#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#c#115#5#article#15#5#^rND^sPi
nheiro^nCAT#^rND^sCarvalho-Leite^nJC#^rND^sDrachler^nML#^rND^sSilveira^nVL#Facto
rs associated with adherence to antiretroviral therapy in HIV/AIDS patients: a c
ross-sectional study in Southern Brazil^len#Braz J Med Biol Res#20020000#2002#35
#10#1173-81#20110000#v60n1a09.htm#0100-879X#Braz J Med Biol Res##
00551000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790100019000960100
01700115012004700132030000500179065000900184064000500193031000300198032000400201
014000700205865000900212002001300221035001000234801000500244#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a09.htm#S#c#116#6#article#15#6#^rND^sNemes^nMIB#^rN
D^sCarvalho^nHB#^rND^sSouza^nMFM#Antiretroviral therapy adherence in Brazil^len#
AIDS#20040000#2004#18#^s3#515-20#20110000#v60n1a09.htm#0269-9370#AIDS##
00594000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790100015000970100
01900112012010600131030001700237710000200254065000900256064000500265031000300270
032000200273014000700275865000900282002001300291#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a09.htm#S#c#117#7#article#15#7#^rND^sParsons^nJT#^rND^sRosof^nE
#^rND^sMustanski^nB#Patient-related factors predicting HIV medication adherence 
among men and women with alcohol problems^len#J Health Psychol#2#20070000#2007#1
2#2#357-70#20110000#v60n1a09.htm##
00705000000000337000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100014000790100016000930100
01600109010001600125010001500141010001600156012011600172030001000288065000900298
06400050030703100030031203200020031501400080031786500090032500200130033403500100
0347801001000357#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#c#118
#8#article#15#8#^rND^sKim^nTW#^rND^sPalepu^nA#^rND^sCheng^nDM#^rND^sLibman^nH#^r
ND^sSaitz^nR#^rND^sSamet^nJH#Factor associated with descontinuation of antiretro
viral therapy in HIV-infected patients with alcohol problems^len#AIDS Care#20070
000#2007#19#8#1039-47#20110000#v60n1a09.htm#0954-0121#AIDS care##
00578000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790100017000960100
01500113810000600128012005200134030001700186065000900203064000500212031000300217
014000700220865000900227002001300236035001000249801001700259#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a09.htm#S#c#119#9#article#15#9#^rND^sLefevre^nF#^rN
D^sO'Leary^nB#^rND^sMoran^nM#et al#Alcohol consumption among HIV-infected patien
ts^len#J Gen Intern Med#19950000#1995#10#458-60#20110000#v60n1a09.htm#0884-8734#
J Gen Intern Med##
00665000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100017000980100
02100115010001400136012010800150030001700258065000900275064000500284031000300289
032000300292014000700295865000900302002001300311035001000324801001700334#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#c#120#10#article#15#10#^rND^s
Figlie^nNB#^rND^sPillon^nSC#^rND^sLaranjeira^nRR#^rND^sDunn^nJ#AUDIT identifica 
a necessidade de interconsulta específica para dependentes de álcool no hospital
 geral^lpt#J Bras Psiquiatr#19970000#1997#46#11#589-93#20110000#v60n1a09.htm#004
7-2085#J Bras Psiquiatr##
00704000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100018000960100
01700114010001900131010001700150010001600167012008000183030002300263065000900286
06400050029503100030030003200020030301400060030586500090031100200130032003500100
0333801002300343#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09.htm#S#c#121
#11#article#15#11#^rND^sLima^nCT#^rND^sFreire^nACC#^rND^sSilva^nAPB#^rND^sTeixei
ra^nRM#^rND^sFarrell^nM#^rND^sPrince^nM#Concurrent and construct validity of the
 AUDIT in an urban Brazilian sample^len#Alcohol and Alcoholism#20050000#2005#40#
6#584-9#20110000#v60n1a09.htm#0735-0414#Alcohol and Alcoholism##
00777000000000349000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100016000970100
01600113010001500129010001700144010001500161810000600176012013300182030002600315
06500090034106400050035003100030035503200030035801400080036186500090036900200130
0378035001000391801002600401#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09
.htm#S#c#122#12#article#15#12#^rND^sGarcia^nR#^rND^sBadaró^nR#^rND^sNetto^nEM#^r
ND^sSilva^nM#^rND^sAmorin^nFS#^rND^sRamos^nA#et al#Cross-sectional study to eval
uate factors associated with adherence to antiretroviral therapy by Brazilian HI
V-infected patients^len#AIDS Res Hum Retroviruses#20060000#2006#22#12#1248-52#20
110000#v60n1a09.htm#0889-2229#AIDS Res Hum Retroviruses##
00736000000000349000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100016000970100
01700113010001800130010001800148010001400166810000600180012013200186030000500318
06500090032306400050033203100030033703200020034001400070034286500090034900200130
0358035001000371801000500381#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a09
.htm#S#c#123#13#article#15#13#^rND^sKnobel^nH#^rND^sAlonso^nJ#^rND^sCasado^nJL#^
rND^sCollazos^nJ#^rND^sGonzález^nJ#^rND^sRuiz^nI#et al#Validation of a simplifie
d medication adherence questionnaire in a large cohort of HIV infected patients:
 the GEEMA study group^len#AIDS#20020000#2002#16#4#605-13#20110000#v60n1a09.htm#
0269-9370#AIDS##
00678000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100015000990100
01900114012016300133030001100296065000900307064000500316031000300321032000200324
014000700326865000900333002001300342035001000355801001100365#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a09.htm#S#c#124#14#article#15#14#^rND^sParsons^nJT#
^rND^sRosof^nE#^rND^sMustanski^nB#Medication adherence mediates the relationship
 between adherence self-efficacy and biological assessments of HIV health among 
those with alcohol use disorders^len#AIDS Behav#20080000#2008#12#1#95-103#201100
00#v60n1a09.htm#1090-7165#AIDS Behav##
00617000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100016000970120
12400113030001700237065000900254064000500263031000300268032000200271014000500273
865000900278002001300287035001000300801001700310#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a09.htm#S#c#125#15#article#15#15#^rND^sRego^nSRM#^rND^sRego^nDM
S#Associação entre uso de álcool em indivíduos com AIDS e adesão ao tratamento a
ntirretroviral: uma revisão da literatura^lpt#J Bras Psiquiatr#20100000#2010#59#
1#70-3#20110000#v60n1a09.htm#0047-2085#J Bras Psiquiatr##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#o#1#1#article
#1#20110331#101412#v60n1a11.htm#210##
04098000000000589000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000300101049001000104158000300114
03000200011703100030013703200020014006500090014201400090015103500100016001200380
01700120044002080100036002520100036002880700151003240700068004750831412005430850
01001955085002701965085002901992085002002021083131502041085001003356085003103366
08500290339708500190342611700080344507200030345311200090345611100110346511400090
3476113001003485002001303495#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11
.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#ILUS#TAB#11#JBPSIQ220#nd#J. bras. psiqu
iatr.#60#1#20110000#^f57^l63#0047-2085#Anorexia nervosa e retardo mental^lpt#Ano
rexia nervosa and mental retardation^len#^rND^1A01^nAdriana Trejger^sKachani#^rN
D^1A02^nTáki Athanássios^sCordás#Universidade de São Paulo^iA01^1Faculdade de Me
dicina^2Hospital das Clínicas^3Instituto de Psiquiatria Programa de Atenção à Mu
lher Dependente Química#USP^iA02^1FM^2HC^3IPq Programa de Transtornos Alimentare
s (Ambulim)#^lpt^aOBJETIVO: Revisar a literatura pertinente, observando a preval
ência, etiopatogenia, aspectos nutricionais, diagnóstico e tratamento da anorexi
a nervosa (AN) em pacientes com retardo mental (RM). MÉTODO: Revisão bibliográfi
ca realizada nos sistemas Medline, SciELO e PubMed usando os descritores "transt
ornos alimentares", "anorexia nervosa" e "retardo mental". RESULTADOS: A AN pode
 se manifestar de formas atípicas em indivíduos com RM, exigindo critérios diagn
ósticos específicos. O mais utilizado atualmente é o Diagnostic Criteria for Psy
chiatric Disorders for Use with Adults with Learning Disabilities/Mental Retarda
tion, conhecido por DC-LC. A prevalência é incerta e o tratamento ainda não está
 estabelecido, apesar de exigir treinamento específico da equipe. A alimentação 
costuma ser "pobre" e alimentos que engordam normalmente são evitados. Na maiori
a das vezes, é difícil acessar a complexa psicopatologia da AN nesses pacientes,
 em virtude das dificuldades de obter o relato de insatisfação e/ou distorção da
 imagem corporal, baixa autoestima e crenças alimentares. CONCLUSÃO: Muitos fato
res indicam a necessidade de maiores estudos de AN no RM, entre eles a falta de 
critérios diagnósticos próprios validados e diretrizes para tratamento. Paralela
mente, o debate da forma de acesso à conceitualização e ao tratamento dos distúr
bios da imagem corporal nessa população deve ser intensificado.#^ddecs^i1#^tm^lp
t^kRetardo mental^i1#^tm^lpt^kanorexia nervosa^i1#^tm^lpt^kadultos^i1#^len^aOBJE
CTIVE: To review prevalence, ethiopathogenesis, nutritional aspects, diagnostic 
and treatment in patients with MR and anorexia nervosa (AN). METHOD: A literatur
e review was carried out in Medline, SciELO and PubMed using the key words "eati
ng disorders", "anorexia nervosa" and "mental retardation". RESULTS: Anorexia ne
rvosa may have an atypical presentation in patients with MR, and therefore requi
res specific diagnostic criteria. It is currently used the Diagnostic Criteria f
or Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental R
etardation (DC-LC). There are no recommendations on treatment either but the car
e team requires specific training. Eating is usually "poor" and fattening foods 
are often avoided. It is most often difficult to access the complex psychopathol
ogy of AN in these patients due to difficulty obtaining an account of dissatisfa
ction and/or distorted body image, low self-esteem, and food beliefs. CONCLUSION
: There is a need for further studies investigating AN in patients with RM, espe
cially because there are no validated diagnostic criteria and guidelines for tre
atment. In addition, the discussion on how to approach these patients as well as
 on the conceptualization and treatment of body image disorders in this populati
on should be stimulated.#^ddecs^i2#^tm^len^kMental retardation^i2#^tm^len^kanore
xia nervosa^i2#^tm^len^kadults^i2#vancouv#34#20101020#20/10/2010#20110118#18/1/2
011#v60n1a11.htm##
04175000000000589000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000300101049001000104158000300114
03000200011703100030013703200020014006500090014201400090015103500100016001200450
01700120051002150100036002660100036003020700151003380700068004890831447005570850
01002004085002702014085002902041085002002070083134302090085001003433085003103443
08500290347408500190350311700080352207200030353011200090353311100110354211400090
3553113001003562002001303572#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11
.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#ILUS#TAB#11#JBPSIQ220#nd#J. bras. psiqu
iatr.#60#1#20110000#^f57^l63#0047-2085#<b>Anorexia nervosa e retardo mental</b>^
lpt#<b>Anorexia nervosa and mental retardation</b>^len#^rND^1A01^nAdriana Trejge
r^sKachani#^rND^1A02^nTáki Athanássios^sCordás#Universidade de São Paulo^iA01^1F
aculdade de Medicina^2Hospital das Clínicas^3Instituto de Psiquiatria Programa d
e Atenção à Mulher Dependente Química#USP^iA02^1FM^2HC^3IPq Programa de Transtor
nos Alimentares (Ambulim)#^lpt^a<b>OBJETIVO:</b> Revisar a literatura pertinente
, observando a prevalência, etiopatogenia, aspectos nutricionais, diagnóstico e 
tratamento da anorexia nervosa (AN) em pacientes com retardo mental (RM). <b>MÉT
ODO: </b>Revisão bibliográfica realizada nos sistemas Medline, SciELO e PubMed u
sando os descritores "transtornos alimentares", "anorexia nervosa" e "retardo me
ntal". <b>RESULTADOS: </b>A AN pode se manifestar de formas atípicas em indivídu
os com RM, exigindo critérios diagnósticos específicos. O mais utilizado atualme
nte é o <i>Diagnostic Criteria for Psychiatric Disorders for Use with Adults wit
h Learning Disabilities/Mental Retardation</i>, conhecido por DC-LC. A prevalênc
ia é incerta e o tratamento ainda não está estabelecido, apesar de exigir treina
mento específico da equipe. A alimentação costuma ser "pobre" e alimentos que en
gordam normalmente são evitados. Na maioria das vezes, é difícil acessar a compl
exa psicopatologia da AN nesses pacientes, em virtude das dificuldades de obter 
o relato de insatisfação e/ou distorção da imagem corporal, baixa autoestima e c
renças alimentares. <b>CONCLUSÃO:</b> Muitos fatores indicam a necessidade de ma
iores estudos de AN no RM, entre eles a falta de critérios diagnósticos próprios
 validados e diretrizes para tratamento. Paralelamente, o debate da forma de ace
sso à conceitualização e ao tratamento dos distúrbios da imagem corporal nessa p
opulação deve ser intensificado.#^ddecs^i1#^tm^lpt^kRetardo mental^i1#^tm^lpt^ka
norexia nervosa^i1#^tm^lpt^kadultos^i1#^len^a<b>OBJECTIVE:</b> To review prevale
nce, ethiopathogenesis, nutritional aspects, diagnostic and treatment in patient
s with MR and anorexia nervosa (AN). <b>METHOD: </b>A literature review was carr
ied out in Medline, SciELO and PubMed using the key words "eating disorders", "a
norexia nervosa" and "mental retardation". <b>RESULTS: </b>Anorexia nervosa may 
have an atypical presentation in patients with MR, and therefore requires specif
ic diagnostic criteria. It is currently used the Diagnostic Criteria for Psychia
tric Disorders for Use with Adults with Learning Disabilities/Mental Retardation
 (DC-LC). There are no recommendations on treatment either but the care team req
uires specific training. Eating is usually "poor" and fattening foods are often 
avoided. It is most often difficult to access the complex psychopathology of AN 
in these patients due to difficulty obtaining an account of dissatisfaction and/
or distorted body image, low self-esteem, and food beliefs. <b>CONCLUSION: </b>T
here is a need for further studies investigating AN in patients with RM, especia
lly because there are no validated diagnostic criteria and guidelines for treatm
ent. In addition, the discussion on how to approach these patients as well as on
 the conceptualization and treatment of body image disorders in this population 
should be stimulated.#^ddecs^i2#^tm^len^kMental retardation^i2#^tm^len^kanorexia
 nervosa^i2#^tm^len^kadults^i2#vancouv#34#20101020#20/10/2010#20110118#18/1/2011
#v60n1a11.htm##
04221000000000613000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000300108049001000111
15800030012103000190012403100030014303200020014606500090014801400090015703500100
01660120038001760120044002140100036002580100036002940700153003300700070004830831
41200553085001001965085002701975085002902002085002002031083131502051085001003366
08500310337608500290340708500190343611700080345507200030346311200090346611100110
3475114000903486113001003495002001303505008008903518#v60n1#V:\SciELO\serial\jbps
iq\v60n1\markup\v60n1a11.htm#S#l#4#1#article#1#^a2011#oa#pt#br1.1#1#4.0#ilus#tab
#11#JBPSIQ220#nd#J. bras. psiquiatr#60#1#20110000#^f57^l63#0047-2085#Anorexia ne
rvosa e retardo mental^lpt#Anorexia nervosa and mental retardation^len#^rND^1A01
^nAdriana Trejger^sKachani#^rND^1A02^nTáki Athanássios^sCordás#^iA01^1Universida
de de São Paulo^2Faculdade de Medicina^3Hospital das Clínicas. Instituto de Psiq
uiatria Programa de Atenção à Mulher Dependente Química#^iA02^1USP^2FM^3HC. IPq 
Programa de Transtornos Alimentares (Ambulim)#^lpt^aOBJETIVO: Revisar a literatu
ra pertinente, observando a prevalência, etiopatogenia, aspectos nutricionais, d
iagnóstico e tratamento da anorexia nervosa (AN) em pacientes com retardo mental
 (RM). MÉTODO: Revisão bibliográfica realizada nos sistemas Medline, SciELO e Pu
bMed usando os descritores "transtornos alimentares", "anorexia nervosa" e "reta
rdo mental". RESULTADOS: A AN pode se manifestar de formas atípicas em indivíduo
s com RM, exigindo critérios diagnósticos específicos. O mais utilizado atualmen
te é o Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Le
arning Disabilities/Mental Retardation, conhecido por DC-LC. A prevalência é inc
erta e o tratamento ainda não está estabelecido, apesar de exigir treinamento es
pecífico da equipe. A alimentação costuma ser "pobre" e alimentos que engordam n
ormalmente são evitados. Na maioria das vezes, é difícil acessar a complexa psic
opatologia da AN nesses pacientes, em virtude das dificuldades de obter o relato
 de insatisfação e/ou distorção da imagem corporal, baixa autoestima e crenças a
limentares. CONCLUSÃO: Muitos fatores indicam a necessidade de maiores estudos d
e AN no RM, entre eles a falta de critérios diagnósticos próprios validados e di
retrizes para tratamento. Paralelamente, o debate da forma de acesso à conceitua
lização e ao tratamento dos distúrbios da imagem corporal nessa população deve s
er intensificado.#^ddecs^i1#^tm^lpt^kRetardo mental^i1#^tm^lpt^kanorexia nervosa
^i1#^tm^lpt^kadultos^i1#^len^aOBJECTIVE: To review prevalence, ethiopathogenesis
, nutritional aspects, diagnostic and treatment in patients with MR and anorexia
 nervosa (AN). METHOD: A literature review was carried out in Medline, SciELO an
d PubMed using the key words "eating disorders", "anorexia nervosa" and "mental 
retardation". RESULTS: Anorexia nervosa may have an atypical presentation in pat
ients with MR, and therefore requires specific diagnostic criteria. It is curren
tly used the Diagnostic Criteria for Psychiatric Disorders for Use with Adults w
ith Learning Disabilities/Mental Retardation (DC-LC). There are no recommendatio
ns on treatment either but the care team requires specific training. Eating is u
sually "poor" and fattening foods are often avoided. It is most often difficult 
to access the complex psychopathology of AN in these patients due to difficulty 
obtaining an account of dissatisfaction and/or distorted body image, low self-es
teem, and food beliefs. CONCLUSION: There is a need for further studies investig
ating AN in patients with RM, especially because there are no validated diagnost
ic criteria and guidelines for treatment. In addition, the discussion on how to 
approach these patients as well as on the conceptualization and treatment of bod
y image disorders in this population should be stimulated.#^ddecs^i2#^tm^len^kMe
ntal retardation^i2#^tm^len^kanorexia nervosa^i2#^tm^len^kadults^i2#vancouv#34#2
0101020#20/10/2010#20110118#18/1/2011#v60n1a11.htm#Internet^ihttp://www.scielo.b
r/scielo.php?script=sci_arttext&pid=S0047-20852011000100011##
00367000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704013200076002001300208#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#5#1#article#172#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>REVIS&Atilde;O DA L
ITERATURA</b></font></p>     ^cY#v60n1a11.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#6#2#article#172#<p>&nbsp;</p>     ^
cY#v60n1a11.htm##
00383000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704014800076002001300224#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#7#3#article#172#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Anorexia
 nervosa e retardo mental</b></font></p>     ^cY#v60n1a11.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#8#4#article#172#<p>&nbsp;</p>     ^
cY#v60n1a11.htm##
00364000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704012900076002001300205#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#9#5#article#172#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Anorexia nervosa and mental retar
dation</b></font></p>     ^cY#v60n1a11.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#10#6#article#172#<p>&nbsp;</p>     
^cY#v60n1a11.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#11#7#article#172#<p>&nbsp;</p>     
^cY#v60n1a11.htm##
00420000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704018400077002001300261#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#12#8#article#172#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Adriana Trejger Kachani<sup>I</s
up>; T&aacute;ki Athan&aacute;ssios Cord&aacute;s<sup>II</sup></b></font></p>   
  ^cY#v60n1a11.htm##
00529000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704029300077002001300370#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#13#9#article#172#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Universidade de S&atild
e;o Paulo, Faculdade de Medicina, Hospital das Cl&iacute;nicas, Instituto de Psi
quiatria, Programa de Aten&ccedil;&atilde;o &agrave; Mulher Dependente Qu&iacute
;mica (PROMUD-IPq-HC/FMUSP)    ^cY#v60n1a11.htm##
00334000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009700078002001300175#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#14#10#article#172#<br> <sup>II</sup
>IPq-HC/FMUSP, Programa de Transtornos Alimentares (Ambulim)</font></p>     ^cY#
v60n1a11.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#15#11#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#16#12#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#17#13#article#172#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a11.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#18#14#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a11.htm##
00522000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704028500078002001300363#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#19#15#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVO:</b> Revisar a literat
ura pertinente, observando a preval&ecirc;ncia, etiopatogenia, aspectos nutricio
nais, diagn&oacute;stico e tratamento da anorexia nervosa (AN) em pacientes com 
retardo mental (RM).    ^cY#v60n1a11.htm##
00444000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704020700078002001300285#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#20#16#article#172#<br>  <b>M&Eacute
;TODO: </b>Revis&atilde;o bibliogr&aacute;fica realizada nos sistemas Medline, S
ciELO e PubMed usando os descritores "transtornos alimentares", "anorexia nervos
a" e "retardo mental".    ^cY#v60n1a11.htm##
01129000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704089200078002001300970#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#21#17#article#172#<br>  <b>RESULTAD
OS: </b>A AN pode se manifestar de formas at&iacute;picas em indiv&iacute;duos c
om RM, exigindo crit&eacute;rios diagn&oacute;sticos espec&iacute;ficos. O mais 
utilizado atualmente &eacute; o <i>Diagnostic Criteria for Psychiatric Disorders
 for Use with Adults with Learning Disabilities/Mental Retardation</i>, conhecid
o por DC-LC. A preval&ecirc;ncia &eacute; incerta e o tratamento ainda n&atilde;
o est&aacute; estabelecido, apesar de exigir treinamento espec&iacute;fico da eq
uipe. A alimenta&ccedil;&atilde;o costuma ser "pobre" e alimentos que engordam n
ormalmente s&atilde;o evitados. Na maioria das vezes, &eacute; dif&iacute;cil ac
essar a complexa psicopatologia da AN nesses pacientes, em virtude das dificulda
des de obter o relato de insatisfa&ccedil;&atilde;o e/ou distor&ccedil;&atilde;o
 da imagem corporal, baixa autoestima e cren&ccedil;as alimentares.    ^cY#v60n1
a11.htm##
00665000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704042800078002001300506#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#22#18#article#172#<br>  <b>CONCLUS&
Atilde;O:</b> Muitos fatores indicam a necessidade de maiores estudos de AN no R
M, entre eles a falta de crit&eacute;rios diagn&oacute;sticos pr&oacute;prios va
lidados e diretrizes para tratamento. Paralelamente, o debate da forma de acesso
 &agrave; conceitualiza&ccedil;&atilde;o e ao tratamento dos dist&uacute;rbios d
a imagem corporal nessa popula&ccedil;&atilde;o deve ser intensificado.</font></
p>     ^cY#v60n1a11.htm##
00407000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017000078002001300248#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#23#19#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>Retardo men
tal, anorexia nervosa, adultos.</font></p> <hr size="1" noshade>     ^cY#v60n1a1
1.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#24#20#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a11.htm##
00459000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704022200078002001300300#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#25#21#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVE:</b> To review preval
ence, ethiopathogenesis, nutritional aspects, diagnostic and treatment in patien
ts with MR and anorexia nervosa (AN).    ^cY#v60n1a11.htm##
00416000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017900078002001300257#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#26#22#article#172#<br>  <b>METHOD: 
</b>A literature review was carried out in Medline, SciELO and PubMed using the 
key words "eating disorders", "anorexia nervosa" and "mental retardation".    ^c
Y#v60n1a11.htm##
00907000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704067000078002001300748#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#27#23#article#172#<br>  <b>RESULTS:
 </b>Anorexia nervosa may have an atypical presentation in patients with MR, and
 therefore requires specific diagnostic criteria. It is currently used the Diagn
ostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disab
ilities/Mental Retardation (DC-LC). There are no recommendations on treatment ei
ther but the care team requires specific training. Eating is usually "poor" and 
fattening foods are often avoided. It is most often difficult to access the comp
lex psychopathology of AN in these patients due to difficulty obtaining an accou
nt of dissatisfaction and/or distorted body image, low self-esteem, and food bel
iefs.    ^cY#v60n1a11.htm##
00624000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704038700078002001300465#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#28#24#article#172#<br>  <b>CONCLUSI
ON: </b>There is a need for further studies investigating AN in patients with RM
, especially because there are no validated diagnostic criteria and guidelines f
or treatment. In addition, the discussion on how to approach these patients as w
ell as on the conceptualization and treatment of body image disorders in this po
pulation should be stimulated.</font></p>     ^cY#v60n1a11.htm##
00404000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704016700078002001300245#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#29#25#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Mental retardatio
n, anorexia nervosa, adults.</font></p> <hr size="1" noshade>     ^cY#v60n1a11.h
tm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#30#26#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#31#27#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00351000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011400078002001300192#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#32#28#article#172#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde;O</b></f
ont></p>     ^cY#v60n1a11.htm##
01308000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704107100078002001301149#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#33#29#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A caracter&iacute;stica essencial 
do retardo mental (RM) consiste em um funcionamento intelectual significativamen
te inferior &agrave; m&eacute;dia, acompanhado de limita&ccedil;&otilde;es no fu
ncionamento adaptativo em pelo menos duas das seguintes &aacute;reas de habilida
des: comunica&ccedil;&atilde;o, autocuidado, vida dom&eacute;stica, habilidades 
sociais/interpessoais, uso de recursos comunit&aacute;rios, autossufici&ecirc;nc
ia, habilidades acad&ecirc;micas, trabalho, lazer, sa&uacute;de e seguran&ccedil
;a. O RM divide-se em quatro n&iacute;veis de gravidade, variando entre o RM lev
e e o RM profundo. A adapta&ccedil;&atilde;o &agrave; sociedade e a possibilidad
e de adquirir habilidades sociais e profissionais adequadas para um custeio m&ia
cute;nimo das pr&oacute;prias despesas dependem do n&iacute;vel de gravidade do 
indiv&iacute;duo, embora graus variados de supervis&atilde;o, orienta&ccedil;&at
ilde;o e assist&ecirc;ncia sejam em geral necess&aacute;rios<sup>1</sup>. </font
></p>     ^cY#v60n1a11.htm##
01092000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704085500078002001300933#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#34#30#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A preval&ecirc;ncia do retardo men
tal tem sido estimada em 1% da popula&ccedil;&atilde;o geral e &eacute; 1,5 vez 
mais comum entre homens do que entre mulheres<sup>2-4</sup>. Dessa forma, estima
-se que 650 milh&otilde;es de indiv&iacute;duos tenham RM, a maioria deles resid
indo em pa&iacute;ses desenvolvidos, com idade pedi&aacute;trica<sup>3</sup>. De
 acordo com um censo realizado pela Organiza&ccedil;&atilde;o das Na&ccedil;&oti
lde;es Unidas (ONU), cerca de 5% da popula&ccedil;&atilde;o brasileira apresenta
m algum tipo de RM<sup>5</sup>, uma alta taxa de preval&ecirc;ncia se comparada 
com a de outros pa&iacute;ses em desenvolvimento como o M&eacute;xico, cuja prev
al&ecirc;ncia encontrada recentemente foi de 4,2/10.000 rec&eacute;m-nascidos co
m RM<sup>4</sup>. </font></p>     ^cY#v60n1a11.htm##
00993000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704075600078002001300834#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#35#31#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Apesar dos autores cl&aacute;ssico
s n&atilde;o acreditarem na possibilidade de indiv&iacute;duos com RM apresentar
em transtornos do humor, sabe-se hoje que o RM &eacute; fator de risco para tran
stornos psiqui&aacute;tricos, em especial a depress&atilde;o<sup>6,7</sup>. Em a
dolescentes, a preval&ecirc;ncia de transtornos do humor &eacute; significativam
ente alta, mormente em mulheres<sup>8</sup>. No entanto, poucos trabalhos t&ecir
c;m aprofundado o estudo da associa&ccedil;&atilde;o de defici&ecirc;ncia mental
 e transtornos alimentares (TA), sejam cl&iacute;nicos ou epidemiol&oacute;gicos
, dificultando o reconhecimento e a assist&ecirc;ncia a esse tipo de paciente. <
/font></p>     ^cY#v60n1a11.htm##
01428000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704119100078002001301269#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#36#32#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os TA s&atilde;o s&iacute;ndromes 
comportamentais cujos crit&eacute;rios diagn&oacute;sticos t&ecirc;m sido amplam
ente estudados nos &uacute;ltimos 30 anos. Os principais transtornos alimentares
 - anorexia nervosa, bulimia nervosa e transtorno alimentar n&atilde;o especific
ado - compartilham aspectos psicopatol&oacute;gicos comuns, entre eles a preocup
a&ccedil;&atilde;o com o peso e a forma do corpo, bem como o medo de engordar<su
p>9</sup>. Essa ideia leva os pacientes a se engajarem em dietas restritivas e a
 utilizarem m&eacute;todos inapropriados para alcan&ccedil;arem um corpo idealiz
ado. Consequentemente, os pacientes t&ecirc;m um controle considerado patol&oacu
te;gico do peso corporal, associado a dist&uacute;rbios da percep&ccedil;&atilde
;o do formato de seus corpos, levando a um comportamento alimentar gravemente pe
rturbado<sup>9</sup>. A dificuldade em expressar com clareza os complexos sinais
 e sintomas pr&oacute;prios dos TA ocasiona apresenta&ccedil;&otilde;es cl&iacut
e;nicas quase sempre at&iacute;picas, complicando a confirma&ccedil;&atilde;o do
 diagn&oacute;stico<sup>10</sup>. </font></p>     ^cY#v60n1a11.htm##
00678000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704044100078002001300519#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#37#33#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Considerando que os TA s&atilde;o 
doen&ccedil;as graves que podem piorar a qualidade de vida e aumentar a mortalid
ade nessa popula&ccedil;&atilde;o<sup>11</sup>, o objetivo deste trabalho &eacut
e; revisar a literatura pertinente, observando a preval&ecirc;ncia, etiopatogeni
a, diagn&oacute;stico, aspectos nutricionais e tratamento da AN em pacientes com
 RM.</font></p>     ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#38#34#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00338000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010100078002001300179#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#39#35#article#172#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>METODOLOGIA</b></font></p>     
^cY#v60n1a11.htm##
00957000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704072000078002001300798#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#40#36#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A revis&atilde;o bibliogr&aacute;f
ica foi realizada nos sistemas Medline (<i>Index Medicus</i>), SciELO e PubMed u
tilizando os descritores "retardo mental", "transtornos da alimenta&ccedil;&atil
de;o" e "anorexia nervosa", em l&iacute;ngua portuguesa e inglesa. Em virtude do
 escasso n&uacute;mero de trabalhos, n&atilde;o foi estabelecida nenhuma restri&
ccedil;&atilde;o quanto ao per&iacute;odo de publica&ccedil;&atilde;o do artigo 
para ser inclu&iacute;do nesta revis&atilde;o. Foi realizada tamb&eacute;m pesqu
isa manual em revistas especializadas e livros de refer&ecirc;ncia na &aacute;re
a de psiquiatria e transtornos alimentares.</font></p>     ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#41#37#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#42#38#article#172#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font></p>     ^
cY#v60n1a11.htm##
00698000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704046100078002001300539#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#43#39#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foram encontrados 34 trabalhos que
 tratam de RM e AN, todos em l&iacute;ngua inglesa. Apenas 12 desses artigos est
avam dispon&iacute;veis para leitura nos bancos de dados brasileiros; dentre ele
s, oito eram estudos de caso. Nenhum livro de refer&ecirc;ncia abordou diretamen
te o assunto, eles foram utilizados neste artigo somente para esclarecer conceit
os pertinentes ao tema. </font></p>     ^cY#v60n1a11.htm##
01672000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704143500078002001301513#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#44#40#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O primeiro relato de caso de AN em
 um paciente com RM data de 1979: adolescente de 15 anos, com RM, vivia no sub&u
acute;rbio de Boston (Estados Unidos), onde frequentava a escola p&uacute;blica 
regular. A menarca aos 10 anos foi uma experi&ecirc;ncia traum&aacute;tica. O at
raso no desenvolvimento fez com que perdesse os amigos aos poucos. Nessa &eacute
;poca iniciou tratamento psicoter&aacute;pico, que n&atilde;o prosseguiu. Aos 12
 anos ficou amenorreica. Aos 13 anos teve sua primeira interna&ccedil;&atilde;o,
 seguida de outra aos 15 anos, quando foi transferida para uma institui&ccedil;&
atilde;o para indiv&iacute;duos especiais. Nesse momento, come&ccedil;ou a recus
ar comida e a perder peso, sempre alegando que estava muito gorda. Muito deprimi
da e ansiosa, foi internada na enfermaria da institui&ccedil;&atilde;o, com a in
ten&ccedil;&atilde;o de recuperar o peso. Ap&oacute;s 50 dias de tratamento medi
camentoso e programa de modifica&ccedil;&atilde;o de h&aacute;bitos alimentares,
 recuperou 5 kg e teve alta da enfermaria. Seis meses depois j&aacute; ha-via re
cuperado 10 kg, e a menstrua&ccedil;&atilde;o bem como o humor foram normalizado
s. O caso discute tamb&eacute;m a rela&ccedil;&atilde;o entre uma intelig&ecirc;
ncia abaixo da m&eacute;dia populacional e a apresenta&ccedil;&atilde;o de sinto
mas de anorexia nervosa<sup>12</sup>. </font></p>     ^cY#v60n1a11.htm##
00760000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704052300078002001300601#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#45#41#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Outros casos de AN em pacientes co
m RM t&ecirc;m sido relatados desde ent&atilde;o, incluindo indiv&iacute;duos co
m s&iacute;ndrome de Down<sup>13-17</sup> e fenilceton&uacute;ria<sup>18</sup>. 
A maioria dos casos &eacute; com&oacute;rbida com depress&atilde;o; um deles &ea
cute; associado ao transtorno obsessivo-compulsivo<sup>17</sup> e outro ao trans
torno de personalidade <i>borderline</i><sup>10</sup> (<a href="#fig01">Figura 1
</a>).</font></p>     ^cY#v60n1a11.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704003600078002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#46#42#article#172#<p><a name="fig01
"></a></p>     ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#47#43#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#48#44#article#172#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a11fig01.jpg"></p>     ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#49#45#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#50#46#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Preval&ecirc;ncia</b></font></p
>     ^cY#v60n1a11.htm##
01398000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704116100078002001301239#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#51#47#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Trabalhos epidemiol&oacute;gicos a
 respeito da associa&ccedil;&atilde;o entre transtornos alimentares e retardo me
ntal t&ecirc;m sido realizados desde 1978, e na maioria das vezes conduzidos em 
popula&ccedil;&otilde;es institucionalizadas e pacientes com idades variadas. Al
&eacute;m da sele&ccedil;&atilde;o da amostra, outro problema frequente s&atilde
;o os crit&eacute;rios diagn&oacute;sticos utilizados, que muitas vezes incluem 
sintomas como pica e comportamentos decorrentes da pr&oacute;pria s&iacute;ndrom
e como a de Prader-Willi entre os TA<sup>19</sup>. Em metan&aacute;lise realizad
a no ano de 2000, foi encontrada uma preval&ecirc;ncia flex&iacute;vel como 3% a
 42% em adultos institucionalizados e de 1% a 19% em pacientes que viviam na com
unidade<sup>11</sup>. Talvez a elasticidade na preval&ecirc;ncia seja decorrente
 da diferen&ccedil;a  nas popula&ccedil;&otilde;es estudadas e dos m&uacute;ltip
los crit&eacute;rios  adotados para o diagn&oacute;stico de TA em pacientes com 
RM  - crit&eacute;rios esses que ser&atilde;o detalhados ainda nesta revis&atild
e;o.</font></p>     ^cY#v60n1a11.htm##
01707000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704147000078002001301548#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#52#48#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Somente dois trabalhos avaliaram e
specificamente a preval&ecirc;ncia de AN. No primeiro, foram encontrados problem
as alimentares cr&ocirc;nicos em 42% da popula&ccedil;&atilde;o com RM (p. ex.: 
pica, hiperfagia, rumina&ccedil;&atilde;o e outros); entre eles, 7% com AN<sup>2
0</sup>. Mais recentemente, com crit&eacute;rios diagn&oacute;sticos mais r&iacu
te;gidos e preconizados pelo <i>Diagnostic Criteria for Psychiatric Disorders fo
r Use with Adults with Learning Disabilities/Mental Retardation </i>(LC-DC)<sup>
21</sup>, numa pesquisa que envolveu uma popula&ccedil;&atilde;o de 412 indiv&ia
cute;duos com RM que viviam na costa oeste da Noruega, foi encontrada uma preval
&ecirc;ncia de 27% de TAs. A preval&ecirc;ncia de AN nessa amostra foi de 1,6%, 
o que se relacionou diretamente com a gravidade do RM: indiv&iacute;duos com ret
ardo mental mais grave estavam mais propensos a desenvolver AN, principalmente e
ntre a popula&ccedil;&atilde;o mais jovem, entre 18 e 39 anos. Nesse trabalho, d
iferen&ccedil;as de g&ecirc;nero na preval&ecirc;ncia de AN n&atilde;o foram enc
ontradas. O autor apontou ainda preval&ecirc;ncia de 19% de transtorno de compul
s&atilde;o alimentar peri&oacute;dica, 1,3% de bulimia nervosa e recusa alimenta
r (conceito esse de dif&iacute;cil interpreta&ccedil;&atilde;o, n&atilde;o escla
recido no artigo) e 0,3% de v&ocirc;mito psicog&ecirc;nico<sup>19</sup>. </font>
</p>     ^cY#v60n1a11.htm##
00345000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010800078002001300186#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#53#49#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Diagn&oacute;stico</b></font></
p>     ^cY#v60n1a11.htm##
01343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704110600078002001301184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#54#50#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Em 1982, foi proposta uma classifi
ca&ccedil;&atilde;o bidimensional para diagnosticar indiv&iacute;duos com RM e T
A<sup>22</sup>. Essa classifica&ccedil;&atilde;o se baseava na suposta etiologia
 do problema alimentar, classificando-a em comportamental, oral, neuromotora, bi
ol&oacute;gica e da pr&oacute;pria doen&ccedil;a - que atualmente se acredita se
rem categorias de dif&iacute;cil individualiza&ccedil;&atilde;o - e nos tipos de
 comportamentos inadequados relacionados &agrave; alimenta&ccedil;&atilde;o, por
 exemplo, roubo de comida, alimenta&ccedil;&atilde;o desordenada, pica, rumina&c
cedil;&atilde;o e regurgita&ccedil;&atilde;o<sup>11</sup>. Anos mais tarde, foi 
sugerida uma classifica&ccedil;&atilde;o tridimensional, em que se observavam no
vamente as hipot&eacute;ticas causas dos problemas alimentares (ambiental, compo
rtamental, desordens neuromotoras), as &aacute;reas alimentares afetadas (autoal
imenta&ccedil;&atilde;o, degluti&ccedil;&atilde;o) e os comportamentos alimentar
es inadequados<sup>23</sup>. </font></p>     ^cY#v60n1a11.htm##
01639000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704140200078002001301480#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#55#51#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A CID-10<sup>24</sup> apresenta cr
it&eacute;rios diagn&oacute;sticos para AN t&iacute;pica (F 50.0) e at&iacute;pi
ca (F 50.1) e bulimia nervosa (F 50.2). O manual menciona ainda, sem apresentar 
crit&eacute;rios diagn&oacute;sticos definidos, superalimenta&ccedil;&atilde;o p
sicog&ecirc;nica (F 50.4) e v&ocirc;mito psicog&ecirc;nico (F 50.5). Em sua vers
&atilde;o para o retardo mental, a CID-10 MR<sup>25 </sup>apresenta crit&eacute;
rios diagn&oacute;sticos semelhantes para a AN (<a href="#fig01">Figura 1</a>) e
 ainda permite que se usem as classifica&ccedil;&otilde;es dos transtornos da al
imenta&ccedil;&atilde;o da primeira inf&acirc;ncia como rumina&ccedil;&atilde;o 
(F 98.2), recusa alimentar (F 98.2) e pica (F 98.3) da CID10 em indiv&iacute;duo
s com RM. Nesse caso, s&atilde;o classificados como transtornos alimentares n&at
ilde;o especificados (F 50.8). Por&eacute;m, diagnosticar TA em pacientes com RM
 usando a CID-10 MR tem sido muito questionado, uma vez que muitos pacientes t&e
circ;m comunica&ccedil;&atilde;o limitada e dificuldade em abstrair certos conce
itos importantes, como j&aacute; referido. A classifica&ccedil;&atilde;o tamb&ea
cute;m n&atilde;o utiliza a metodologia de classifica&ccedil;&atilde;o hier&aacu
te;rquica, t&atilde;o importante quando se trata desse tipo de paciente<sup>11</
sup>.</font></p>     ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#56#52#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00397000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704016000078002001300238#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#57#53#article#172#<p align="center"
><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="/img/revis
tas/jbpsiq/v60n1/a11tab01.jpg">Tabela 1</a></font></p>     ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#58#54#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
01268000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704103100078002001301109#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#59#55#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Assim, o profissional de sa&uacute
;de mental tem um grande desafio cl&iacute;nico &agrave; sua frente: quando um c
omportamento alimentar inadequado &eacute; considerado um transtorno geralmente 
diagnosticado pela primeira vez na inf&acirc;ncia ou adolesc&ecirc;ncia relacion
ado ao quadro de RM e quando ele pode ser considerado um TA. O conceito de TA im
plica que a sintomatologia alimentar afeta adversamente a sa&uacute;de f&iacute;
sica (incluindo o peso), mental ou funcionamento social do indiv&iacute;duo<sup>
1</sup>. Se for considerado o risco m&uacute;ltiplo de problemas desse tipo que 
acometem o indiv&iacute;duo com RM, existe o risco de sobreposi&ccedil;&atilde;o
 dos dois diagn&oacute;sticos, principalmente porque altera&ccedil;&otilde;es co
gnitivas no &acirc;mbito alimentar e cuidados pessoais, ou seja, a express&atild
e;o da defici&ecirc;ncia mental no dom&iacute;nio alimentar, poderiam simular um
 TA prim&aacute;rio<sup>26</sup>. </font></p>     ^cY#v60n1a11.htm##
00897000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704066000078002001300738#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#60#56#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Elaborado em 2001 pelo <i>Royal Co
llege of Psychiatrists</i>, o DC-LC<sup>21</sup> pretende ser mais expl&iacute;c
ito no diagn&oacute;stico diferencial hier&aacute;rquico entre TAs e transtornos
 da alimenta&ccedil;&atilde;o nessa popula&ccedil;&atilde;o, pois exige o relato
 de informantes antes que seja realizado o diagn&oacute;stico, al&eacute;m de es
se ser realizado transversalmente<sup>26</sup>. Segundo o <i>Royal College of Ps
ychiatrists</i><sup>21</sup>, os crit&eacute;rios diagn&oacute;sticos s&atilde;o
: </font></p> <font size="2" face="Verdana, Arial, Helvetica, sans-serif">     ^
cY#v60n1a11.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#61#57#article#172#<blockquote>     
^cY#v60n1a11.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#62#58#article#172#<p>1. &Iacute;ndi
ce de massa corp&oacute;rea (IMC): menor do que 17 kg/m<sup>2</sup>.</p>     ^cY
#v60n1a11.htm##
00323000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008600078002001300164#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#63#59#article#172#<p>2. Peso: em de
cl&iacute;nio ou manuten&ccedil;&atilde;o do baixo peso.</p>     ^cY#v60n1a11.ht
m##
00338000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010100078002001300179#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#64#60#article#172#<p>3. Ingest&atil
de;o alimentar: pobre e evita&ccedil;&atilde;o de alimentos gordurosos.</p>     
^cY#v60n1a11.htm##
00321000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008400078002001300162#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#65#61#article#172#<p>4. Compuls&oti
lde;es alimentares: menos do que duas ocasi&otilde;es.</p>     ^cY#v60n1a11.htm#
#
00301000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704006400078002001300142#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#66#62#article#172#<p>5. V&ocirc;mit
os: podem ou n&atilde;o acontecer.</p>     ^cY#v60n1a11.htm##
00460000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704022300078002001300301#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#67#63#article#172#<p>6. Outros: jej
uns, exerc&iacute;cios f&iacute;sicos compulsivos, purga&ccedil;&otilde;es, dist
or&ccedil;&atilde;o de imagem corporal, disfun&ccedil;&atilde;o de horm&ocirc;ni
os sexuais.</p> </blockquote> </font>     ^cY#v60n1a11.htm##
00574000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704033700078002001300415#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#68#64#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Em rela&ccedil;&atilde;o ao diagn&
oacute;stico diferencial, o DC-LC<sup>21</sup> sugere como diagn&oacute;stico di
ferencial para AN os seguintes quadros cl&iacute;nicos e psiqui&aacute;tricos: <
/font></p> <font size="2" face="Verdana, Arial, Helvetica, sans-serif">     ^cY#
v60n1a11.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#69#65#article#172#<blockquote>     
^cY#v60n1a11.htm##
00625000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704038800078002001300466#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#70#66#article#172#<p>1. <u>Doen&cce
dil;as cl&iacute;nicas:</u> perda de peso cr&ocirc;nica relacionada a dietas esp
ec&iacute;ficas, c&acirc;ncer, doen&ccedil;a de Crohn, doen&ccedil;as mal-absort
ivas, s&iacute;ndromes metab&oacute;licas e s&iacute;ndrome da art&eacute;ria su
perior mesent&eacute;rica (que ocasiona v&ocirc;mitos p&oacute;s-prandiais e obs
tru&ccedil;&atilde;o g&aacute;strica).</p>     ^cY#v60n1a11.htm##
00450000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704021300078002001300291#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#71#67#article#172#<p>2. <u>Doen&cce
dil;as psiqui&aacute;tricas:</u> autismo, personalidade psic&oacute;tica, transt
ornos afetivos, do humor, somatoformes, obsessivo-compulsivos e de personalidade
.</p> </blockquote> </font>     ^cY#v60n1a11.htm##
00348000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011100078002001300189#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#72#68#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Fatores precipitantes</b></font
></p>     ^cY#v60n1a11.htm##
01515000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704127800078002001301356#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#73#69#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A AN em adultos com RM parece esta
r relacionada com experi&ecirc;ncias anteriores referentes a alimenta&ccedil;&at
ilde;o, din&acirc;mica familiar, forma de lidar com luto e temas sexuais, regres
s&atilde;o psiqui&aacute;trica e f&iacute;sica<sup>11</sup>. Apesar da AN em pac
ientes com RM n&atilde;o ter sua etiologia muito bem elucidada, estudos de caso 
t&ecirc;m demonstrado que em pacientes portadores de s&iacute;ndrome de Down os 
sintomas da doen&ccedil;a podem aparecer na &eacute;poca da menarca ou tardiamen
te, quando o indiv&iacute;duo consegue se deparar com os questionamentos t&iacut
e;picos dessa fase da vida<sup>13</sup> - ao contr&aacute;rio de indiv&iacute;du
os sem RM, nesses pacientes deve-se considerar a idade de desenvolvimento, e n&a
tilde;o a idade cronol&oacute;gica como &eacute; de costume. &Eacute; o que se o
bserva no primeiro caso do g&ecirc;nero relatado<sup>12</sup>, cuja menarca ocor
reu precocemente aos 10 anos, exigindo um desenvolvimento psicossocial diferente
 dos amigos, separando-os. Num outro relato de caso, novos incentivos sexuais co
ncomitantes &agrave; perda de parentes pr&oacute;ximos foram fatores decisivos p
ara o desenvolvimento de TA<sup>13</sup>.</font></p>     ^cY#v60n1a11.htm##
00795000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704055800078002001300636#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#74#70#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">At&eacute; onde &eacute; do nosso 
conhecimento, o &uacute;nico caso at&eacute; hoje relatado em uma paciente com f
enilceton&uacute;ria, seus sintomas de anorexia nervosa come&ccedil;aram a apare
cer 12 meses ap&oacute;s a menarca, no momento em que seu pai, que n&atilde;o el
a via h&aacute; tr&ecirc;s anos, reapareceu com uma namorada apenas 10 anos mais
 velha do que a paciente, o que pode t&ecirc;-la levado a questionar sobre seu c
orpo e forma f&iacute;sica<sup>18</sup>. </font></p>     ^cY#v60n1a11.htm##
00787000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704055000078002001300628#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#75#71#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">&Agrave; semelhan&ccedil;a de paci
entes com TA sem RM, alguns pacientes desenvolvem a doen&ccedil;a ap&oacute;s se
rem ridicularizados pelos amigos por causa de seu peso e forma f&iacute;sica<sup
>10,14</sup>. O sentimento de contrariedade e perda de controle da vida, fato in
evit&aacute;vel quando o indiv&iacute;duo possui RM de qualquer n&iacute;vel, ta
mb&eacute;m &eacute; relatado na literatura como desencadeador de TA nessa popul
a&ccedil;&atilde;o<sup>17</sup>. </font></p>     ^cY#v60n1a11.htm##
00347000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011000078002001300188#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#76#72#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Aspectos alimentares</b></font>
</p>     ^cY#v60n1a11.htm##
01362000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704112500078002001301203#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#77#73#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Muitas vezes, os recursos usados p
elo paciente com RM na busca da perda de peso intencional carecem de sofistica&c
cedil;&atilde;o na sua dissimula&ccedil;&atilde;o, comportamento frequente entre
 pacientes com TA, levando o cl&iacute;nico atento ao reconhecimento r&aacute;pi
do e evidente de sua motiva&ccedil;&atilde;o<sup>10</sup>. Paralelamente, poucos
 pacientes conseguem estabelecer linearidade entre purga&ccedil;&otilde;es e/ou 
atividade f&iacute;sica com a perda de peso<sup>12</sup>. Num dos casos encontra
dos, a paciente cuspia na bandeja ou jogava a comida no ch&atilde;o. Quando ques
tionada sobre o que havia feito, recusava-se a responder<sup>12</sup>. Outra pac
iente afirmava que n&atilde;o podia engolir. No momento em que foi comprovado qu
e n&atilde;o havia nenhum problema org&acirc;nico que a impedisse de engolir, a 
paciente come&ccedil;ou a ficar seletiva<sup>13</sup>. Num outro relato de caso,
 a paciente dizia que ia vomitar, pois sua boneca (imagin&aacute;ria) "Chuckie" 
achava que ela estava muito gorda<sup>10</sup>.s</font></p>     ^cY#v60n1a11.htm
##
01001000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704076400078002001300842#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#78#74#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A inadequa&ccedil;&atilde;o social
 que algumas vezes atinge o paciente com RM, aliada a pensamentos obsessivos rel
acionados &agrave; comida, pode levar o paciente com AN a problemas legais, como
 acontecia com uma paciente que, em momentos de compuls&atilde;o alimentar, entr
ava em restaurantes com servi&ccedil;o de <i>buffet </i>&agrave; beira da estrad
a de ferro e se satisfazia sem pagar. Numa ocasi&atilde;o, foi presa ao roubar u
m peda&ccedil;o de bolo. Nesse caso espec&iacute;fico, a paciente, portadora de 
fenilceton&uacute;ria, tinha as compuls&otilde;es alimentares exacerbadas pelo d
escontrole das concentra&ccedil;&otilde;es s&eacute;ricas de fenilalanina<sup>18
</sup>.</font></p>     ^cY#v60n1a11.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#79#75#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Tratamento</b></font></p>     ^
cY#v60n1a11.htm##
00660000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704042300078002001300501#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#80#76#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A escassez de estudos tamb&eacute;
m se reflete na aus&ecirc;ncia de protocolos de tratamento para pacientes com AN
 e RM. Na maioria dos casos, os profissionais obtiveram bons resultados fazendo 
uso de abordagem comportamental, medica&ccedil;&atilde;o psicoativa e realimenta
&ccedil;&atilde;o em casos isolados ou em n&uacute;mero restrito. </font></p>   
  ^cY#v60n1a11.htm##
00994000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704075700078002001300835#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#81#77#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A exemplo do que ocorre com pacien
tes com RM e dist&uacute;rbios do comportamento<sup>27</sup>, na maioria dos cas
os apresentados foram utilizados antipsic&oacute;ticos como tioridozina, haloper
idol e risperidona<sup>10,12</sup>. Antidepressivos inibidores seletivos da reca
pta&ccedil;&atilde;o serotonin&eacute;rgica (ISRS) como paroxetina e citalopram<
sup>10,17 </sup>e antidepressivos tric&iacute;clicos como amitriptilina e nortri
ptilina tamb&eacute;m j&aacute; foram utilizados<sup>14,16</sup>. Por&eacute;m, 
a indica&ccedil;&atilde;o psicopatol&oacute;gica do uso de antipsic&oacute;ticos
 e antidepressivos nesses pacientes n&atilde;o &eacute; descrita adequadamente. 
</font></p>     ^cY#v60n1a11.htm##
01713000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704147600078002001301554#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#82#78#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Em rela&ccedil;&atilde;o ao tratam
ento nutricional, os objetivos s&atilde;o os mesmos que no tratamento convencion
al para a AN: avaliar o consumo alimentar e as poss&iacute;veis defici&ecirc;nci
as nutricionais; elaborar um plano alimentar visando ao restabelecimento do peso
 corporal adequado; corrigir sequelas fisiol&oacute;gicas da desnutri&ccedil;&at
ilde;o; normalizar o padr&atilde;o alimentar; normalizar a percep&ccedil;&atilde
;o de fome e saciedade; melhorar a rela&ccedil;&atilde;o do paciente com o alime
nto e o corpo; promover h&aacute;bitos alimentares saud&aacute;veis<sup>28-30</s
up>. Por&eacute;m, a forma de tratar e o modo de lidar com o problema devem ser 
diferentes, tendo em mente desenvolver ao m&aacute;ximo o potencial do paciente,
 sem se esquecer de considerar especificidades de cada s&iacute;ndrome. Dessa fo
rma, enfoques comportamentais s&atilde;o importantes e a participa&ccedil;&atild
e;o familiar &eacute; fundamental. Os respons&aacute;veis devem acompanhar a ali
menta&ccedil;&atilde;o do paciente e n&atilde;o ter vergonha de dar ordens de a&
ccedil;&atilde;o, tais como: "coma mais", "n&atilde;o corte o alimento em peda&c
cedil;os t&atilde;o pequenos", entre outras. Em casos de pacientes com maior aut
onomia, deve-se sugerir novas formas de preparo dos alimentos, com apresenta&cce
dil;&otilde;es diferenciadas e melhor aproveitamento de nutrientes<sup>5</sup>.<
/font></p>     ^cY#v60n1a11.htm##
01448000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704121100078002001301289#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#83#79#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Uma vez que a AN pode ser uma defe
sa contra conflitos relacionados &agrave; sexualidade e aos novos desafios da ad
olesc&ecirc;ncia, a psicoterapia &eacute; indicada como alternativa da forma de 
express&atilde;o dessas viv&ecirc;ncias<sup>31,32</sup>. Considerando que pacien
tes com RM possuem a express&atilde;o verbal prejudicada, esses pacientes t&ecir
c;m dificuldade em revelar sentimentos tais como ang&uacute;stia e culpa, entre 
outros<sup>33</sup>. Por outro lado, os pacientes com RM t&ecirc;m uma estrutura
 cognitiva l&oacute;gica que depende de refer&ecirc;ncias concretas, o que suger
e que a terapia cognitivo-comportamental (TCC) - em que n&atilde;o existe a preo
cupa&ccedil;&atilde;o em entender por que certos fatos acontecem, mas sim focar 
o aprendizado de novos comportamentos relacionados &agrave; raiva, adapta&ccedil
;&atilde;o social e sexualidade - seja a mais indicada<sup>33,34</sup>. Paralela
mente, deve-se considerar que os tratamentos para TA mais modernos adotam a TCC<
sup>33,34</sup>, o que refor&ccedil;a essa orienta&ccedil;&atilde;o psicoter&aac
ute;pica como primeira escolha para casos de RM e AN. </font></p>     ^cY#v60n1a
11.htm##
01129000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704089200078002001300970#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#84#80#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Um dos casos relatados na literatu
ra &eacute; especialmente interessante, na medida em que exclui o tratamento med
icamentoso e incluiu somente programa de realimenta&ccedil;&atilde;o, mudan&cced
il;as no comportamento alimentar, terapia individual e parental - apesar de o ar
tigo n&atilde;o esclarecer que linha psicoter&aacute;pica foi seguida. As sess&o
tilde;es de psicoterapia individual focaram o despertar da sexualidade, novas mu
dan&ccedil;as na din&acirc;mica familiar e a quest&atilde;o da morte, muito pres
ente na vida da paciente em quest&atilde;o. J&aacute; as sess&otilde;es com os p
ais trataram da aceita&ccedil;&atilde;o do crescimento e desenvolvimento da sexu
alidade da filha, da culpa por terem gerado uma filha especial e das expectativa
s futuras em rela&ccedil;&atilde;o a ela<sup>13</sup>. </font></p>     ^cY#v60n1
a11.htm##
00616000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704037900078002001300457#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#85#81#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">De qualquer forma, sabe-se que o m
elhor resultado est&aacute; na combina&ccedil;&atilde;o do trabalho em equipe in
terdisciplinar com profissionais da &aacute;rea de psiquiatria, nutri&ccedil;&at
ilde;o, psicologia, acompanhante terap&ecirc;utico, terapeuta ocupacional, entre
 outros<sup>34</sup>. </font></p>     ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#86#82#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#87#83#article#172#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p>
     ^cY#v60n1a11.htm##
00859000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704062200078002001300700#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#88#84#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Todos os estudos de caso encontrad
os focaram as dificuldades diagn&oacute;sticas derivadas da dif&iacute;cil comun
ica&ccedil;&atilde;o, conceitualiza&ccedil;&atilde;o, acesso &agrave; imagem cor
poral e possibilidade de diagn&oacute;stico diferencial encontrados nos paciente
s com RM. A discuss&atilde;o &eacute; pertinente, visto o impacto do diagn&oacut
e;stico dos TA no peso, sa&uacute;de f&iacute;sica e mental e o impacto funciona
l de pacientes, visto que seus crit&eacute;rios ainda n&atilde;o est&atilde;o es
tabelecidos<sup>11</sup>.</font></p>     ^cY#v60n1a11.htm##
00986000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704074900078002001300827#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#89#85#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Uma diferen&ccedil;a entre os crit
&eacute;rios diagn&oacute;sticos do LC-DC<sup>21</sup>, CID-10<sup>25</sup> e DS
M-IV<sup>1</sup> &eacute; o fato de que o primeiro insere todos os tipos de TA d
entro da mesma categoria, enquanto os dois &uacute;ltimos separam-nos em TA e tr
anstornos geralmente diagnosticados pela primeira vez na inf&acirc;ncia ou adole
sc&ecirc;ncia. Mas talvez a maior diferen&ccedil;a seja que problemas relacionad
os &agrave; imagem corporal n&atilde;o s&atilde;o crit&eacute;rios diagn&oacute;
sticos para AN no LC-DC, e excluir esse crit&eacute;rio talvez seja respons&aacu
te;vel por falsos-positivos nessa popula&ccedil;&atilde;o<sup>19</sup>. </font><
/p>     ^cY#v60n1a11.htm##
00720000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704048300078002001300561#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#90#86#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Dessa forma, &eacute; necess&aacut
e;ria aten&ccedil;&atilde;o ao realizar o diagn&oacute;stico. O conceito de TA i
mplica uma psicopatologia que afeta a funcionalidade do indiv&iacute;duo. Visto 
que pacientes com RM muitas vezes n&atilde;o s&atilde;o funcionais, ser ou n&ati
lde;o "funcional" n&atilde;o &eacute; crit&eacute;rio diagn&oacute;stico de AN n
essa popula&ccedil;&atilde;o<sup>19,26</sup>. </font></p>     ^cY#v60n1a11.htm##
01188000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704095100078002001301029#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#91#87#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O fato de muitos psiquiatras cl&ia
cute;nicos possu&iacute;rem pouca experi&ecirc;ncia com RM faz com que acreditem
 que esses indiv&iacute;duos n&atilde;o tenham sentimentos particulares, uma vez
 que t&ecirc;m dificuldade em exprimir-se e comunicar-se. Especialmente nos caso
s leves e moderados, os transtornos psiqui&aacute;tricos e a AN em particular de
monstram que os sentimentos existem e que muitas vezes os problemas s&atilde;o s
ubdiagnosticados e n&atilde;o tratados, por esses indiv&iacute;duos n&atilde;o c
onseguirem se expressar e demonstrar que algo est&aacute; errado em suas vidas<s
up>12</sup>. Em alguns casos em que a linguagem &eacute; menos prejudicada, o pa
ciente consegue expressar sentimentos de culpa, tristeza, insatisfa&ccedil;&atil
de;o, entre outros, por meio de queixas som&aacute;ticas e sensa&ccedil;&atilde;
o de "estar doente"<sup>14</sup>. </font></p>     ^cY#v60n1a11.htm##
00668000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704043100078002001300509#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#92#88#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">As mudan&ccedil;as hormonais, comp
ortamentais e psicol&oacute;gicas causadas pela adolesc&ecirc;ncia devem ser obs
ervadas nesse tipo de paciente. Nessa fase, a opini&atilde;o dos pares e a neces
sidade de busca da pr&oacute;pria identidade podem assumir propor&ccedil;&otilde
;es n&atilde;o realistas tamb&eacute;m para pacientes com RM<sup>18</sup>.</font
></p>     ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#93#89#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#94#90#article#172#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUS&Atilde;O</b></font></p>
     ^cY#v60n1a11.htm##
01010000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704077300078002001300851#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#95#91#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A AN em pacientes com RN pode esta
r associada a consider&aacute;veis preju&iacute;zos cl&iacute;nicos, psiqui&aacu
te;tricos, psicol&oacute;gicos, comportamentais e sociais. Sua etiologia multifa
cetada e desconhecida, assim como a falta de um protocolo de tratamento, prejudi
ca a evolu&ccedil;&atilde;o desses pacientes. Tendo em vista a cronicidade e a g
ravidade do problema, profissionais devem ser formados e bem treinados a fim de 
oferecer assist&ecirc;ncia adequada. Considerando que o tratamento de TA, bem co
mo o de RM, requer uma equipe multidisciplinar, acredita-se que essa seja a melh
or forma&ccedil;&atilde;o tamb&eacute;m para o caso espec&iacute;fico de pacient
es com RM e AN. </font></p>     ^cY#v60n1a11.htm##
00585000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704034800078002001300426#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#96#92#article#172#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Apesar da necessidade de programas
 de preven&ccedil;&atilde;o e tratamento, mais pesquisas sobre o assunto devem s
er incentivadas, a fim que se conhe&ccedil;a melhor a preval&ecirc;ncia, causas,
 tratamento e evolu&ccedil;&atilde;o da AN em indiv&iacute;duos com RM.</font></
p>     ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#97#93#article#172#<p>&nbsp;</p>    
 ^cY#v60n1a11.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#98#94#article#172#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b></font></p
>     ^cY#v60n1a11.htm##
00481000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704023000080002001300310#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#99#95#article#172#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. American Psychiat
ryc Association (APA). Diagnostic and statistical manual of mental disorders. 4ª
 ed. Washington DC: American Psychiatric Association; 1994.    ^cY#v60n1a11.htm#
#
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#100#96#article#172#</font></p>     
^cY#v60n1a11.htm##
00414000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000200079704016200081002001300243#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#101#97#article#172#2#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Sadock BJ, Sadoc
k VA. Comp&ecirc;ndio de psiquiatria. 9ª ed. Porto Alegre: Artmed; 2007.    ^cY#
v60n1a11.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#102#98#article#172#</font></p>     
^cY#v60n1a11.htm##
00436000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000200079704018400081002001300265#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#103#99#article#172#3#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. World Health Org
anization (WHO). The WHO newsletter of disability and rehabilitation. Geneva: WH
O; 2009, n. 8.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#104#100#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00498000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000200080704024500082002001300327#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#105#101#article#172#4#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Poblano A, Arte
aga C, Garcia-Sanch&eacute;z G. Prevalence of early neurodevelopmental disabilit
ies  in Mexico: a sistematic review. Arq Neuro-Psiquiatr. 2009;67(3):736-40.    
^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#106#102#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00484000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000200080704023100082002001300313#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#107#103#article#172#5#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Cur&aacute;tolo
 E, Rocha DF. Retardo mental. In: Cord&aacute;s TA, Kachani AT. Nutri&ccedil;&at
ilde;o em psiquiatria. Porto Alegre: Artmed; 2009, p. 291-304.    ^cY#v60n1a11.h
tm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#108#104#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00491000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000200080704023800082002001300320#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#109#105#article#172#6#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Helman T. Depre
ssive mood in students with mild intellectual disability: students' reports and 
teacher's evaluations. J Intellect Disabil Res. 2001;45(Pt 6):526-34.    ^cY#v60
n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#110#106#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00538000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000200080704028500082002001300367#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#111#107#article#172#7#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Ross E, Oliver 
C. The relantioship between levels of mood, interest and pleasure and challengin
g behaviour in adults with severe and profund intellectual disability. J Intelle
ct Disabil Res. 2002;46(Pt 3):191-7.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#112#108#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00448000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000200080704019500082002001300277#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#113#109#article#172#8#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Jackowska E, De
ga-Rudewicz K. Depressive disorders in adolescents with mild retardation. Psychi
atr Pol. 2004;38(1):37-49.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#114#110#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00502000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000200080704024900082002001300331#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#115#111#article#172#9#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Claudino AM, Bo
rges MBF. Crit&eacute;rios diagn&oacute;sticos para os transtornos alimentares: 
conceitos em evolu&ccedil;&atilde;o. Rev Bras Psiquiatr. 2002;24(Supl III):7-12.
    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#116#112#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00478000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704022400083002001300307#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#117#113#article#172#10#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Dymek M, Le G
range D. Anorexia nervosa with comorbid psychosis and borderline mental retardat
ion: a case report. Int J Eat Disord. 2002;31(4):478-82.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#118#114#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00443000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704018900083002001300272#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#119#115#article#172#11#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Gravestock S.
 Eating disorders in adults with intellectual disability. J Intellect Disabil Re
s. 2000;44(6):625-37.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#120#116#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00439000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704018500083002001300268#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#121#117#article#172#12#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Hurley AD, So
vner R. Anorexia nervosa and mental retardation: a case report. J Clin Psychiatr
y. 1979;40:480-2.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#122#118#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00445000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019100083002001300274#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#123#119#article#172#13#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Cottrell R, C
risp AH. Anorexia nervosa in a Down's syndrome patient: a case report. Br J Psyc
hiatry. 1984;145:195-6.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#124#120#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00454000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704020000083002001300283#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#125#121#article#172#14#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Szimanski LS,
 Biederman J. Depression and anorexia nervosa of persons with Down syndrome. Am 
J Ment Defic. 1984;89(3):246-51.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#126#122#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00442000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704018800083002001300271#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#127#123#article#172#15#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Holt M, Boura
s N, Watson JP. Down's syndrome and eating disorders: a case study. Br J Psychia
try. 1988;152:847-8.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#128#124#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00424000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704017000083002001300253#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#129#125#article#172#16#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Morgan JR. A 
case of Down's syndrome, insulinoma and anorexia. J Ment Defic Res. 1989;33:185-
7.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#130#126#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00496000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024200083002001300325#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#131#127#article#172#17#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Raitasuo S, V
irtanen H, Raitasuo J. Anorexia nervosa, major depression and obsessive-compulsi
ve disorder in a Down's syndrome patient. Int J Eat Disord. 1998;23:107-9.    ^c
Y#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#132#128#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00419000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704016500083002001300248#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#133#129#article#172#18#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Clarke DJ, Ya
pa P. Phenylketonuria and anorexia nervosa. J Ment Defic Res. 1991;35:165-70.   
 ^cY#v60n1a11.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#134#130#article#172# </font></p>   
  ^cY#v60n1a11.htm##
00463000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704020900083002001300292#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#135#131#article#172#19#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Hove O. Preva
lence of eating disorders in adults with mental retardation living in the commun
ity. Am J Ment Retard. 2004;109(6):501-6.    ^cY#v60n1a11.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#136#132#article#172# </font></p>   
  ^cY#v60n1a11.htm##
00453000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019900083002001300282#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#137#133#article#172#20#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Danford DE, H
uber AM. Eating dysfunctions in an institutionalized mentally retarded populatio
n. J Intake Res. 1981;2:281-92.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#138#134#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00502000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024800083002001300331#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#139#135#article#172#21#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Royal College
 of Psychiatrists. DC-LC: diagnostic criteria for psychiatric disorders for use 
with adults with learning disabilities/mental retardation. London: Author; 2001.
    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#140#136#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00588000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704033400083002001300417#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#141#137#article#172#22#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Jones TW. Tre
atment of behavior-related eating problems in retarded students: a review of the
 literature. In: Hollis JH; Meyers CE. Life threatening behavior: analysis and i
ntervention. Washington, DC: American Association on Mental Deficiency; 1982, p.
 3-26.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#142#138#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00439000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704018500083002001300268#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#143#139#article#172#23#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. O'Brien S, Re
pp AC, Williams GE, Christophersen ER. Pediatric feeding disorders. Behav Modif.
 1991;15:394-418.    ^cY#v60n1a11.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#144#140#article#172# </font></p>   
  ^cY#v60n1a11.htm##
00484000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023000083002001300313#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#145#141#article#172#24#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24. World Health 
Organization (WHO). Classifica&ccedil;&atilde;o de transtornos mentais e de comp
ortamento da CID-10. Porto Alegre: Artes M&eacute;dicas; 1993.    ^cY#v60n1a11.h
tm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#146#142#article#172# </font></p>   
  ^cY#v60n1a11.htm##
00421000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704016700083002001300250#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#147#143#article#172#25#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25. World Health 
Organization (WHO). The ICD-10 guide for mental retardation. Geneva: WHO; 1996. 
   ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#148#144#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00611000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704035700083002001300440#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#149#145#article#172#26#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26. Gravestock S.
 Diagnosis and classification of eating disorders in adults with intellectual di
sability: the Diagnostic Criteria for psychiatric disorders for Use with Adults 
with Learning Disabilities/Mental Retardatio (DC-LC) approach. J Intellect Disab
il Res. 2003;47(Suppl):72-83.    ^cY#v60n1a11.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#150#146#article#172# </font></p>   
  ^cY#v60n1a11.htm##
00456000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704020200083002001300285#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#151#147#article#172#27#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27. Bhaumik S, Br
anford D. The frith prescribing guidelines in adults with learning disability. L
ondon: Taylor &amp; Francis; 2005.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#152#148#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00556000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704030200083002001300385#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#153#149#article#172#28#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">28. American Diet
etic Association (ADA). Position of the American Dietetic Association: nutrition
 intervention in the treatment of anorexia nervosa, bulimia nervosa and other ea
ting disorders. J Am Diet Assoc. 2006;106(12):2073-82.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#154#150#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00499000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024500083002001300328#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#155#151#article#172#29#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">29. American Psyc
hiatric Association (APA). Practice Guidelines for the treatment of patients wit
h eating disorders. 3ª ed. Washington: American Psychiatry Association; 2005.   
 ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#156#152#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00496000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024200083002001300325#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#157#153#article#172#30#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">30. Aratangy EW, 
Kaio DJI, Fassarella ES. Anorexia nervosa. In: Cord&aacute;s TA, Kachani AT. Nut
ri&ccedil;&atilde;o em Psiquiatria. Porto Alegre: Artmed; 2009, p. 135-52.    ^c
Y#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#158#154#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00503000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024900083002001300332#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#159#155#article#172#31#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">31. Vitousek KB. 
Cognitive-behavioral therapy for anorexia nervosa. In: Fairburn CG, Brownell KD.
 Eating disorders and obesity. 2ª ed. New York, London: The Guilford Press; 2002
.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#160#156#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00460000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704020600083002001300289#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#161#157#article#172#32#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">32. Duchesne M, A
lmeida PEM. Terapia cognitivo-comportamental dos transtornos alimentares. Rev Br
as Psiquiatr. 2002;24(Supl III):49-53.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#162#158#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00445000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019100083002001300274#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#163#159#article#172#33#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">33. Romana MS. Co
gnitive-behavioral therapy: treating individuals with dual diagnoses. J Psychos 
Nurs. 2003;41(12):31-5.    ^cY#v60n1a11.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#164#160#article#172#</font></p>    
 ^cY#v60n1a11.htm##
00494000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024000083002001300323#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#165#161#article#172#34#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">34. Katz G, Ponce
 E. Intellectual disability: definition, etiological factors, classification, di
agnosis, treatment and prognosis. Salud Publica Mex. 2008;50(2):S132-41.    ^cY#
v60n1a11.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#166#162#article#172# </font></p>   
  ^cY#v60n1a11.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#167#163#article#172#<p>&nbsp;</p>  
   ^cY#v60n1a11.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#168#164#article#172#<p>&nbsp;</p>  
   ^cY#v60n1a11.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704023200080002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#169#165#article#172#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="
/img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <
b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a11.htm##
00278000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704003900080002001300119#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#170#166#article#172#<br>    Adriana
 Trejger Kachani    ^cY#v60n1a11.htm##
00277000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704003800080002001300118#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#171#167#article#172#<br>    Rua Bah
ia, 945, ap. 71    ^cY#v60n1a11.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#172#168#article#172#<br>   01244-00
1 - S&atilde;o Paulo, SP    ^cY#v60n1a11.htm##
00302000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006300080002001300143#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#173#169#article#172#<br>    Telefax
: (11) 3511-3888/Celular: (11) 8276-9299    ^cY#v60n1a11.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009800080002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#174#170#article#172#<br>  E-mail: <
a href="mailto:drikachani@uol.com.br">drikachani@uol.com.br</a></font></p>     ^
cY#v60n1a11.htm##
00332000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009300080002001300173#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#175#171#article#172#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 20/10/2010    ^cY#v6
0n1a11.htm##
00285000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004600080002001300126#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#p#176#172#article#172#<br> Aprovado e
m 18/1/2011</font></p>     ^cY#v60n1a11.htm##
00498000000000241000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770170033000790180058001120630
00200170066001500172062003300187065000900220064000500229865000900234002001300243
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#c#177#1#article#34#1#
American Psychiatryc Association#Diagnostic and statistical manual of mental dis
orders^len#4#Washington^eDC#American Psychiatric Association#19940000#1994#20110
000#v60n1a11.htm##
00454000000000253000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770160017000790160017000960180
02900113063000200142066001300144062000700157065000900164064000500173865000900178
002001300187#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#c#178#2#a
rticle#34#2#^rND^sSadock^nBJ#^rND^sSadock^nVA#Compêndio de psiquiatria^lpt#9#Por
to Alegre#Artmed#20070000#2007#20110000#v60n1a11.htm##
00438000000000229000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770170026000790180056001050660
00700161062000400168065000900172064000500181865000900186002001300195#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#c#179#3#article#34#3#World Health
 Organization#The WHO newsletter of disability and rehabilitation^len#Geneva#WHO
#20090000#2009#20110000#v60n1a11.htm##
00584000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100017000790100017000960100
02400113012008700137030002000224710000200244065000900246064000500255031000300260
032000200263014000700265865000900272002001300281#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a11.htm#S#c#180#4#article#34#4#^rND^sPoblano^nA#^rND^sArteaga^n
C#^rND^sGarcia-Sanchéz^nG#Prevalence of early neurodevelopmental disabilities in
 Mexico: a sistematic review^len#Arq Neuro-Psiquiatr#2#20090000#2009#67#3#736-40
#20110000#v60n1a11.htm##
00549000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790100016000970120
01900113016001700132016001800149018002800167066001300195062000700208014000800215
065000900223064000500232865000900237002001300246#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a11.htm#S#c#181#5#article#34#5#^rND^sCurátolo^nE#^rND^sRocha^nD
F#Retardo mental^lpt#^rND^sCordás^nTA#^rND^sKachani^nAT#Nutrição em psiquiatria^
lpt#Porto Alegre#Artmed#291-304#20090000#2009#20110000#v60n1a11.htm##
00590000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790120111000950300
02400206065000900230064000500239031000300244034000200247014000700249865000900256
002001300265035001000278801002400288#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#182#6#article#34#6#^rND^sHelman^nT#Depressive mood in students 
with mild intellectual disability: students' reports and teacher's evaluations^l
en#J Intellect Disabil Res#20010000#2001#45#6#526-34#20110000#v60n1a11.htm#0964-
2633#J Intellect Disabil Res##
00655000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100014000790100016000930120
15100109030002400260065000900284064000500293031000300298034000200301014000600303
865000900309002001300318035001000331801002400341#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a11.htm#S#c#183#7#article#34#7#^rND^sRoss^nE#^rND^sOliver^nC#Th
e relantioship between levels of mood, interest and pleasure and challenging beh
aviour in adults with severe and profund intellectual disability^len#J Intellect
 Disabil Res#20020000#2002#46#3#191-7#20110000#v60n1a11.htm#0964-2633#J Intellec
t Disabil Res##
00558000000000289000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100019000790100023000980120
06200121030001400183065000900197064000500206031000300211032000200214014000600216
865000900222002001300231035001000244801001400254#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a11.htm#S#c#184#8#article#34#8#^rND^sJackowska^nE#^rND^sDega-Ru
dewicz^nK#Depressive disorders in adolescents with mild retardation^len#Psychiat
r Pol#20040000#2004#38#1#37-49#20110000#v60n1a11.htm#0033-2674#Psychiatr Pol##
00547000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100019000790100018000980120
08200116030001900198710000200217065000900219064000500228031000300233032000600236
014000500242865000900247002001300256#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#185#9#article#34#9#^rND^sClaudino^nAM#^rND^sBorges^nMBF#Critéri
os diagnósticos para os transtornos alimentares: conceitos em evolução^lpt#Rev B
ras Psiquiatr#2#20020000#2002#24#^sIII#7-12#20110000#v60n1a11.htm##
00591000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100019000960120
09400115030001700209065000900226064000500235031000300240032000200243014000700245
865000900252002001300261035001000274801001700284#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a11.htm#S#c#186#10#article#34#10#^rND^sDymek^nM#^rND^sLe Grange
^nD#Anorexia nervosa with comorbid psychosis and borderline mental retardation: 
a case report^len#Int J Eat Disord#20020000#2002#31#4#478-82#20110000#v60n1a11.h
tm#0276-3478#Int J Eat Disord##
00545000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100020000810120060001010300
02400161065000900185064000500194031000300199032000200202014000700204865000900211
002001300220035001000233801002400243#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#187#11#article#34#11#^rND^sGravestock^nS#Eating disorders in ad
ults with intellectual disability^len#J Intellect Disabil Res#20000000#2000#44#6
#625-37#20110000#v60n1a11.htm#0964-2633#J Intellect Disabil Res##
00542000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100016000980120
05900114030001800173065000900191064000500200031000300205014000600208865000900214
002001300223035001000236801001800246#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#188#12#article#34#12#^rND^sHurley^nAD#^rND^sSovner^nR#Anorexia 
nervosa and mental retardation: a case report^len#J Clin Psychiatry#19790000#197
9#40#480-2#20110000#v60n1a11.htm#0160-6689#J Clin Psychiatry##
00546000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100016000990120
06500115030001600180065000900196064000500205031000400210014000600214865000900220
002001300229035001000242801001600252#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#189#13#article#34#13#^rND^sCottrell^nR#^rND^sCrisp^nAH#Anorexia
 nervosa in a Down's syndrome patient: a case report^len#Br J Psychiatry#1984000
0#1984#145#195-6#20110000#v60n1a11.htm#0007-1250#Br J Psychiatry##
00566000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100020000810100019001010120
06600120030001600186065000900202064000500211031000300216032000200219014000700221
865000900228002001300237035001000250801001600260#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a11.htm#S#c#190#14#article#34#14#^rND^sSzimanski^nLS#^rND^sBied
erman^nJ#Depression and anorexia nervosa of persons with Down syndrome^len#Am J 
Ment Defic#19840000#1984#89#3#246-51#20110000#v60n1a11.htm#0002-9351#Am J Ment D
efic##
00561000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100014000810100016000950100
01700111012005500128030001600183065000900199064000500208031000400213014000600217
865000900223002001300232035001000245801001600255#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a11.htm#S#c#191#15#article#34#15#^rND^sHolt^nM#^rND^sBouras^nN#
^rND^sWatson^nJP#Down's syndrome and eating disorders: a case study^len#Br J Psy
chiatry#19880000#1988#152#847-8#20110000#v60n1a11.htm#0007-1250#Br J Psychiatry#
#
00508000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810120055000980300
01700153065000900170064000500179031000300184014000600187865000900193002001300202
035001000215801001700225#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm
#S#c#192#16#article#34#16#^rND^sMorgan^nJR#A case of Down's syndrome, insulinoma
 and anorexia^len#J Ment Defic Res#19890000#1989#33#185-7#20110000#v60n1a11.htm#
0022-264X#J Ment Defic Res##
00616000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100018000990100
01800117012010200135030001700237065000900254064000500263031000300268014000600271
865000900277002001300286035001000299801001700309#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a11.htm#S#c#193#17#article#34#17#^rND^sRaitasuo^nS#^rND^sVirtan
en^nH#^rND^sRaitasuo^nJ#Anorexia nervosa, major depression and obsessive-compuls
ive disorder in a Down's syndrome patient^len#Int J Eat Disord#19980000#1998#23#
107-9#20110000#v60n1a11.htm#0276-3478#Int J Eat Disord##
00521000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100014000980120
04100112030001700153065000900170064000500179031000300184014000700187865000900194
002001300203035001000216801001700226#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#194#18#article#34#18#^rND^sClarke^nDJ#^rND^sYapa^nP#Phenylketon
uria and anorexia nervosa^len#J Ment Defic Res#19910000#1991#35#165-70#20110000#
v60n1a11.htm#0022-264X#J Ment Defic Res##
00558000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100014000810120093000950300
01700188065000900205064000500214031000400219032000200223014000600225865000900231
002001300240035001000253801001700263#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#195#19#article#34#19#^rND^sHove^nO#Prevalence of eating disorde
rs in adults with mental retardation living in the community^len#Am J Ment Retar
d#20040000#2004#109#6#501-6#20110000#v60n1a11.htm#0895-8017#Am J Ment Retard##
00518000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100016000990120
07700115030001300192710000200205065000900207064000500216031000200221014000700223
865000900230002001300239#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm
#S#c#196#20#article#34#20#^rND^sDanford^nDE#^rND^sHuber^nAM#Eating dysfunctions 
in an institutionalized mentally retarded population^len#J Intake Res#2#19810000
#1981#2#281-92#20110000#v60n1a11.htm##
00515000000000229000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780170031000810180123001120660
00700235062000700242065000900249064000500258865000900263002001300272#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#c#197#21#article#34#21#Royal Coll
ege of Psychiatrists#DC-LC: diagnostic criteria for psychiatric disorders for us
e with adults with learning disabilities/mental retardation^len#London#Author#20
010000#2001#20110000#v60n1a11.htm##
00663000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810120099000970160
01700196016001700213018005700230066001500287062004200302014000500344065000900349
064000500358865000900363002001300372#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#198#22#article#34#22#^rND^sJones^nTW#Treatment of behavior-rela
ted eating problems in retarded students: a review of the literature^len#^rND^sH
ollis^nJH#^rND^sMeyers^nCE#Life threatening behavior: analysis and intervention^
len#Washington^eDC#American Association on Mental Deficiency#3-26#19820000#1982#
20110000#v60n1a11.htm##
00572000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100015000980100
01900113010002500132012003200157030001200189065000900201064000500210031000300215
014000800218865000900226002001300235035001000248801001200258#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a11.htm#S#c#199#23#article#34#23#^rND^sO'Brien^nS#^
rND^sRepp^nAC#^rND^sWilliams^nGE#^rND^sChristophersen^nER#Pediatric feeding diso
rders^len#Behav Modif#19910000#1991#15#394-418#20110000#v60n1a11.htm#0145-4455#B
ehav Modif##
00470000000000229000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780170026000810180070001070660
01300177062001400190065000900204064000500213865000900218002001300227#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#c#200#24#article#34#24#World Heal
th Organization#Classificação de transtornos mentais e de comportamento da CID-1
0^lpt#Porto Alegre#Artes Médicas#19930000#1993#20110000#v60n1a11.htm##
00428000000000229000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780170026000810180044001070660
00700151062000400158065000900162064000500171865000900176002001300185#v60n1#V:\Sc
iELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#c#201#25#article#34#25#World Heal
th Organization#The ICD-10 guide for mental retardation^len#Geneva#WHO#19960000#
1996#20110000#v60n1a11.htm##
00715000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100020000810120225001010300
02400326065000900350064000500359031000300364032000800367014000600375865000900381
002001300390035001000403801002400413#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#202#26#article#34#26#^rND^sGravestock^nS#Diagnosis and classifi
cation of eating disorders in adults with intellectual disability: the Diagnosti
c Criteria for psychiatric disorders for Use with Adults with Learning Disabilit
ies/Mental Retardatio (DC-LC) approach^len#J Intellect Disabil Res#20030000#2003
#47#^sSuppl#72-83#20110000#v60n1a11.htm#0964-2633#J Intellect Disabil Res##
00490000000000241000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160017000810160018000980180
07200116066000700188062001700195065000900212064000500221865000900226002001300235
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#c#203#27#article#34#2
7#^rND^sBhaumik^nS#^rND^sBranford^nD#The frith prescribing guidelines in adults 
with learning disability^len#London#Taylor & Francis#20050000#2005#20110000#v60n
1a11.htm##
00637000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780110030000810120155001110300
01600266065000900282064000500291031000400296032000300300014000800303865000900311
002001300320035001000333801001600343#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#204#28#article#34#28#American Dietetic Association#Position of 
the American Dietetic Association: nutrition intervention in the treatment of an
orexia nervosa, bulimia nervosa and other eating disorders^len#J Am Diet Assoc#2
0060000#2006#106#12#2073-82#20110000#v60n1a11.htm#0002-8223#J Am Diet Assoc##
00513000000000241000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780170033000810180076001140630
00200190066001100192062003200203065000900235064000500244865000900249002001300258
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm#S#c#205#29#article#34#2
9#American Psychiatric Association#Practice Guidelines for the treatment of pati
ents with eating disorders^len#3#Washington#American Psychiatry Association#2005
0000#2005#20110000#v60n1a11.htm##
00586000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100016001000100
02100116012002100137016001700158016001800175018002800193066001300221062000700234
014000700241065000900248064000500257865000900262002001300271#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a11.htm#S#c#206#30#article#34#30#^rND^sAratangy^nEW
#^rND^sKaio^nDJI#^rND^sFassarella^nES#Anorexia nervosa^lpt#^rND^sCordás^nTA#^rND
^sKachani^nAT#Nutrição em Psiquiatria^lpt#Porto Alegre#Artmed#135-52#20090000#20
09#20110000#v60n1a11.htm##
00588000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810120054001000160
01900154016001900173018003300192063000200225066000900227066000700236062001900243
065000900262064000500271865000900276002001300285#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a11.htm#S#c#207#31#article#34#31#^rND^sVitousek^nKB#Cognitive-b
ehavioral therapy for anorexia nervosa^len#^rND^sFairburn^nCG#^rND^sBrownell^nKD
#Eating disorders and obesity^len#2#New York#London#The Guilford Press#20020000#
2002#20110000#v60n1a11.htm##
00533000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100019000990120
06500118030001900183710000200202065000900204064000500213031000300218032000600221
014000600227865000900233002001300242#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a11.htm#S#c#208#32#article#34#32#^rND^sDuchesne^nM#^rND^sAlmeida^nPEM#Terap
ia cognitivo-comportamental dos transtornos alimentares^lpt#Rev Bras Psiquiatr#2
#20020000#2002#24#^sIII#49-53#20110000#v60n1a11.htm##
00503000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810120075000980300
01500173710000200188065000900190064000500199031000300204032000300207014000500210
865000900215002001300224#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a11.htm
#S#c#209#33#article#34#33#^rND^sRomana^nMS#Cognitive-behavioral therapy: treatin
g individuals with dual diagnoses^len#J Psychos Nurs#2#20030000#2003#41#12#31-5#
20110000#v60n1a11.htm##
00608000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100014000810100015000950120
11300110030001800223065000900241064000500250031000300255032000200258014000800260
865000900268002001300277035001000290801001800300#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a11.htm#S#c#210#34#article#34#34#^rND^sKatz^nG#^rND^sPonce^nE#I
ntellectual disability: definition, etiological factors, classification, diagnos
is, treatment and prognosis^len#Salud Publica Mex#20080000#2008#50#2#S132-41#201
10000#v60n1a11.htm#0036-3634#Salud Publica Mex##
00276000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00300103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#o#1#1#article
#1#20110407#123102#v60n1a12.htm#71##
02955000000000589000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092121000300097049001000100158000300110030002000113
03100030013303200020013606500090013801400090014703500100015601201130016601200900
02790100027003690100025003960100038004210700128004590700125005870830699007120850
01001411085005001421085002701471085003001498083066601528085001002194085004302204
08500280224708500290227511700080230407200020231211200090231411100100232311400090
2333113001002342002001302352#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a12
.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#ILUS#12#JBPSIQ240#nd#J. bras. psiquiatr
.#60#1#20110000#^f64^l66#0047-2085#Transtorno de estresse pós-traumático de iníc
io tardio? Reflexões diagnósticas baseadas em um relato de caso^lpt#Delayed-onse
t post-traumatic stress disorder? Diagnostic reflections on a case report^len#^r
ND^1A01^nMárcia^sFreitas#^rND^1A01^nZanon^sPassos#^rND^1A01 A02^nLeonardo F^sFon
tenelle#Universidade Federal Fluminense^iA01^1Instituto de Saúde da Comunidade^2
Departamento de Psiquiatria e Saúde Mental^cNiterói^sRJ#Universidade Federal do 
Rio de Janeiro^iA02^1Instituto de Psiquiatria^2Programa de Ansiedade e Depressão
^cRio de Janeiro^sRJ#^lpt^aOBJETIVO: Neste estudo, o objetivo foi relatar o caso
 de uma paciente com transtorno de estresse pós-traumático (TEPT) de início apar
entemente tardio e os diferentes dilemas surgidos durante seu diagnóstico. MÉTOD
O: Relato de caso. RESULTADOS: Paciente feminina, de 34 anos, casada e do lar, a
presentou TEPT 25 anos após o desabamento de sua residência durante uma enchente
. O quadro surgiu após relatos na imprensa de eventos semelhantes associados ao 
soterramento de dezenas de vítimas em um município vizinho. CONCLUSÃO: Este caso
 sugere que pacientes podem desenvolver quadros semelhantes ao TEPT de início ta
rdio após a reexposição a eventos previamente desprovidos de impacto emocional.#
^ddecs^i1#^tm^lpt^kTranstorno de estresse pós-traumático^i1#^tm^lpt^kpsicopatolo
gia^i1#^tm^lpt^kaspectos clínicos^i1#^len^aOBJECTIVE: In this study, our objecti
ve was to report a patient with an apparent diagnosis of delayed-onset posttraum
atic stress disorder (PTSD) and the different dilemmas faced during the diagnost
ic process. METHOD: Case report. RESULTS: A female patient, aged 34, married, ho
usewife, presented PTSD 25 years after the collapse of her home during a floodin
g. The condition emerged after press reports of similar events associated with t
he death of dozens of victims in a nearby town. CONCLUSION: Our case suggests th
at patients may develop conditions that bear resemblance to late-onset PTSD afte
r re-exposure to events previously devoid of emotional impact.#^ddecs^i2#^tm^len
^kPost-traumatic stress disorder^i2#^tm^len^kpsychopathology^i2#^tm^len^kclinica
l aspects^i2#vancouv#4#20110118#18/1/2011#20110118#18/1/2011#v60n1a12.htm##
03046000000000589000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092121000300097049001000100158000300110030002000113
03100030013303200020013606500090013801400090014703500100015601201270016601201110
02930100027004040100025004310100038004560700128004940700125006220830727007470850
01001474085005001484085002701534085003001561083069401591085001002285085004302295
08500280233808500290236611700080239507200020240311200090240511100100241411400090
2424113001002433002001302443#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a12
.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#ILUS#12#JBPSIQ240#nd#J. bras. psiquiatr
.#60#1#20110000#^f64^l66#0047-2085#<b>Transtorno de estresse pós-traumático de i
nício tardio?</b> <b>Reflexões diagnósticas baseadas em um relato de caso</b>^lp
t#<b>Delayed-onset post-traumatic stress disorder?</b> <b>D</b><b>iagnostic refl
ections on a case report</b>^len#^rND^1A01^nMárcia^sFreitas#^rND^1A01^nZanon^sPa
ssos#^rND^1A01 A02^nLeonardo F^sFontenelle#Universidade Federal Fluminense^iA01^
1Instituto de Saúde da Comunidade^2Departamento de Psiquiatria e Saúde Mental^cN
iterói^sRJ#Universidade Federal do Rio de Janeiro^iA02^1Instituto de Psiquiatria
^2Programa de Ansiedade e Depressão^cRio de Janeiro^sRJ#^lpt^a<b>OBJETIVO:</b> N
este estudo, o objetivo foi relatar o caso de uma paciente com transtorno de est
resse pós-traumático (TEPT) de início aparentemente tardio e os diferentes dilem
as surgidos durante seu diagnóstico. <b>MÉTODO:</b> Relato de caso. <b>RESULTADO
S:</b> Paciente feminina, de 34 anos, casada e do lar, apresentou TEPT 25 anos a
pós o desabamento de sua residência durante uma enchente. O quadro surgiu após r
elatos na imprensa de eventos semelhantes associados ao soterramento de dezenas 
de vítimas em um município vizinho. <b>CONCLUSÃO: </b>Este caso sugere que pacie
ntes podem desenvolver quadros semelhantes ao TEPT de início tardio após a reexp
osição a eventos previamente desprovidos de impacto emocional.#^ddecs^i1#^tm^lpt
^kTranstorno de estresse pós-traumático^i1#^tm^lpt^kpsicopatologia^i1#^tm^lpt^ka
spectos clínicos^i1#^len^a<b>OBJECTIVE:</b> In this study, our objective was to 
report a patient with an apparent diagnosis of delayed-onset posttraumatic stres
s disorder (PTSD) and the different dilemmas faced during the diagnostic process
. <b>METHOD: </b>Case report. <b>RESULTS:</b> A female patient, aged 34, married
, housewife, presented PTSD 25 years after the collapse of her home during a flo
oding. The condition emerged after press reports of similar events associated wi
th the death of dozens of victims in a nearby town. <b>CONCLUSION:</b> Our case 
suggests that patients may develop conditions that bear resemblance to late-onse
t PTSD after re-exposure to events previously devoid of emotional impact.#^ddecs
^i2#^tm^len^kPost-traumatic stress disorder^i2#^tm^len^kpsychopathology^i2#^tm^l
en^kclinical aspects^i2#vancouv#4#20110118#18/1/2011#20110118#18/1/2011#v60n1a12
.htm##
03078000000000613000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099121000300104049001000107158000300117
03000190012003100030013903200020014206500090014401400090015303500100016201201130
01720120090002850100027003750100025004020100038004270700130004650700127005950830
69900722085001001421085005001431085002701481085003001508083066601538085001002204
08500430221408500280225708500290228511700080231407200020232211200090232411100100
2333114000902343113001002352002001302362008008902375#v60n1#V:\SciELO\serial\jbps
iq\v60n1\markup\v60n1a12.htm#S#l#4#1#article#1#^a2011#oa#pt#br1.1#1#4.0#ilus#12#
JBPSIQ240#nd#J. bras. psiquiatr#60#1#20110000#^f64^l66#0047-2085#Transtorno de e
stresse pós-traumático de início tardio? Reflexões diagnósticas baseadas em um r
elato de caso^lpt#Delayed-onset post-traumatic stress disorder? Diagnostic refle
ctions on a case report^len#^rND^1A01^nMárcia^sFreitas#^rND^1A01^nZanon^sPassos#
^rND^1A01 A02^nLeonardo F^sFontenelle#^iA01^1Universidade Federal Fluminense^2In
stituto de Saúde da Comunidade^3Departamento de Psiquiatria e Saúde Mental^cNite
rói^sRJ#^iA02^1Universidade Federal do Rio de Janeiro^2Instituto de Psiquiatria^
3Programa de Ansiedade e Depressão^cRio de Janeiro^sRJ#^lpt^aOBJETIVO: Neste est
udo, o objetivo foi relatar o caso de uma paciente com transtorno de estresse pó
s-traumático (TEPT) de início aparentemente tardio e os diferentes dilemas surgi
dos durante seu diagnóstico. MÉTODO: Relato de caso. RESULTADOS: Paciente femini
na, de 34 anos, casada e do lar, apresentou TEPT 25 anos após o desabamento de s
ua residência durante uma enchente. O quadro surgiu após relatos na imprensa de 
eventos semelhantes associados ao soterramento de dezenas de vítimas em um munic
ípio vizinho. CONCLUSÃO: Este caso sugere que pacientes podem desenvolver quadro
s semelhantes ao TEPT de início tardio após a reexposição a eventos previamente 
desprovidos de impacto emocional.#^ddecs^i1#^tm^lpt^kTranstorno de estresse pós-
traumático^i1#^tm^lpt^kpsicopatologia^i1#^tm^lpt^kaspectos clínicos^i1#^len^aOBJ
ECTIVE: In this study, our objective was to report a patient with an apparent di
agnosis of delayed-onset posttraumatic stress disorder (PTSD) and the different 
dilemmas faced during the diagnostic process. METHOD: Case report. RESULTS: A fe
male patient, aged 34, married, housewife, presented PTSD 25 years after the col
lapse of her home during a flooding. The condition emerged after press reports o
f similar events associated with the death of dozens of victims in a nearby town
. CONCLUSION: Our case suggests that patients may develop conditions that bear r
esemblance to late-onset PTSD after re-exposure to events previously devoid of e
motional impact.#^ddecs^i2#^tm^len^kPost-traumatic stress disorder^i2#^tm^len^kp
sychopathology^i2#^tm^len^kclinical aspects^i2#vancouv#4#20110118#18/1/2011#2011
0118#18/1/2011#v60n1a12.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci
_arttext&pid=S0047-20852011000100012##
00352000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000300072704011800075002001300193#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#5#1#article#63#<p align="right"><fo
nt size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RELATO DE CASO</b></
font></p>     ^cY#v60n1a12.htm##
00256000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000300072704002200075002001300097#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#6#2#article#63#<p>&nbsp;</p>     ^c
Y#v60n1a12.htm##
00492000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000300072704025800075002001300333#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#7#3#article#63#<p><font size="4" fa
ce="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Transtorn
o de estresse p&oacute;s-traum&aacute;tico de in&iacute;cio tardio? Reflex&otild
e;es diagn&oacute;sticas baseadas em um relato de caso</b></font></p>     ^cY#v6
0n1a12.htm##
00256000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000300072704002200075002001300097#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#8#4#article#63#<p>&nbsp;</p>     ^c
Y#v60n1a12.htm##
00410000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000300072704017600075002001300251#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#9#5#article#63#<p><font size="3" fa
ce="Verdana, Arial, Helvetica, sans-serif"><b>Delayed-onset post-traumatic stres
s disorder? Diagnostic reflections on a case report </b></font></p>     ^cY#v60n
1a12.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000300073704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#10#6#article#63#<p>&nbsp;</p>     ^
cY#v60n1a12.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000300073704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#11#7#article#63#<p>&nbsp;</p>     ^
cY#v60n1a12.htm##
00426000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000300073704019100076002001300267#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#12#8#article#63#<p><font size="2" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>M&aacute;rcia    Freitas<sup>I</s
up>; Zanon Passos<sup>I</sup>; Leonardo F. Fontenelle<sup>I,II</sup></b></font><
/p>     ^cY#v60n1a12.htm##
00467000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000300073704023200076002001300308#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#13#9#article#63#<p><font size="2" f
ace="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Universidade Federal Flu
minense (UFF), Instituto de Sa&uacute;de da Comunidade, Departamento de Psiquiat
ria e Sa&uacute;de Mental, Niter&oacute;i, RJ    ^cY#v60n1a12.htm##
00408000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704017200077002001300249#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#14#10#article#63#<br> <sup>II</sup>
Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Psiquiatria, Program
a de Ansiedade e Depress&atilde;o, Rio de Janeiro, RJ </font></p>     ^cY#v60n1a
12.htm##
00388000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704015200077002001300229#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#15#11#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&ccedi
l;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a12.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#16#12#article#63#<p>&nbsp;</p>     
^cY#v60n1a12.htm##
00280000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704004400077002001300121#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#17#13#article#63#<p>&nbsp;</p> <hr 
size="1" noshade>     ^cY#v60n1a12.htm##
00332000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704009600077002001300173#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#18#14#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v6
0n1a12.htm##
00549000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704031300077002001300390#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#19#15#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVO:</b> Neste estudo, o ob
jetivo foi relatar o caso de uma paciente com transtorno de estresse p&oacute;s-
traum&aacute;tico (TEPT) de in&iacute;cio aparentemente tardio e os diferentes d
ilemas surgidos durante seu diagn&oacute;stico.    ^cY#v60n1a12.htm##
00287000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704005100077002001300128#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#20#16#article#63#<br>  <b>M&Eacute;
TODO:</b> Relato de caso.    ^cY#v60n1a12.htm##
00571000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704033500077002001300412#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#21#17#article#63#<br>  <b>RESULTADO
S:</b> Paciente feminina, de 34 anos, casada e do lar, apresentou TEPT 25 anos a
p&oacute;s o desabamento de sua resid&ecirc;ncia durante uma enchente. O quadro 
surgiu ap&oacute;s relatos na imprensa de eventos semelhantes associados ao sote
rramento de dezenas de v&iacute;timas em um munic&iacute;pio vizinho.    ^cY#v60
n1a12.htm##
00484000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704024800077002001300325#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#22#18#article#63#<br>  <b>CONCLUS&A
tilde;O: </b>Este caso sugere que pacientes podem desenvolver quadros semelhante
s ao TEPT de in&iacute;cio tardio ap&oacute;s a reexposi&ccedil;&atilde;o a even
tos previamente desprovidos de impacto emocional. </font></p>     ^cY#v60n1a12.h
tm##
00459000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704022300077002001300300#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#23#19#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>Transtorno d
e estresse p&oacute;s-traum&aacute;tico, psicopatologia, aspectos cl&iacute;nico
s. </font></p> <hr size="1" noshade>     ^cY#v60n1a12.htm##
00334000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704009800077002001300175#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#24#20#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY#
v60n1a12.htm##
00522000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704028600077002001300363#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#25#21#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVE:</b> In this study, ou
r objective was to report a patient with an apparent diagnosis of delayed-onset 
posttraumatic stress disorder (PTSD) and the different dilemmas faced during the
 diagnostic process.    ^cY#v60n1a12.htm##
00277000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704004100077002001300118#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#26#22#article#63#<br>  <b>METHOD: <
/b>Case report.    ^cY#v60n1a12.htm##
00511000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704027500077002001300352#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#27#23#article#63#<br>  <b>RESULTS:<
/b> A female patient, aged 34, married, housewife, presented PTSD 25 years after
 the collapse of her home during a flooding. The condition emerged after press r
eports of similar events associated with the death of dozens of victims in a nea
rby town.    ^cY#v60n1a12.htm##
00444000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704020800077002001300285#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#28#24#article#63#<br>  <b>CONCLUSIO
N:</b> Our case suggests that patients may develop conditions that bear resembla
nce to late-onset PTSD after re-exposure to events previously devoid of emotiona
l impact. </font></p>     ^cY#v60n1a12.htm##
00425000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704018900077002001300266#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#29#25#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords: </b>Post-traumatic str
ess disorder, psychopathology, clinical aspects. </font></p> <hr size="1" noshad
e>     ^cY#v60n1a12.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#30#26#article#63#<p>&nbsp;</p>     
^cY#v60n1a12.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#31#27#article#63#<p>&nbsp;</p>     
^cY#v60n1a12.htm##
00350000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704011400077002001300191#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#32#28#article#63#<p><font size="3" 
face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde;O</b></fo
nt></p>     ^cY#v60n1a12.htm##
01577000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704134100077002001301418#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#33#29#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">O subtipo de transtorno do estresse
 p&oacute;s-traum&aacute;tico (TEPT) de in&iacute;cio tardio, cujos sintomas se 
instalam pelo menos seis meses ap&oacute;s o evento traum&aacute;tico, foi descr
ito formalmente em 1980<sup>1,2</sup>. Uma revis&atilde;o sistem&aacute;tica apo
ntou para uma preval&ecirc;ncia extremamente vari&aacute;vel dessa condi&ccedil;
&atilde;o, que acometeria de 0% at&eacute; 68% dos pacientes com TEPT em geral<s
up>1</sup>. Essa grande varia&ccedil;&atilde;o foi atribu&iacute;da a diferen&cc
edil;as no tipo de trauma, nas defini&ccedil;&otilde;es de TEPT de in&iacute;cio
 tardio, nos desenhos dos estudos, nos m&eacute;todos de avalia&ccedil;&atilde;o
 e nas dura&ccedil;&otilde;es dos per&iacute;odos de <i>follow-up</i>. Casos de 
TEPT de in&iacute;cio tardio que ocorrem em popula&ccedil;&otilde;es civis, n&at
ilde;o precedidos por quaisquer sintomas de TEPT ou que se instalam mais de 12 m
eses ap&oacute;s o evento traum&aacute;tico, foram descritos como muito raros<su
p>1</sup>. Neste estudo, nosso objetivo foi relatar o caso de uma paciente com d
iagn&oacute;stico de TEPT de in&iacute;cio aparentemente tardio (ou pseudotardio
) e os diferentes dilemas surgidos durante o processo diagn&oacute;stico dessa c
ondi&ccedil;&atilde;o. </font></p>     ^cY#v60n1a12.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#34#30#article#63#<p>&nbsp;</p>     
^cY#v60n1a12.htm##
00340000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704010400077002001300181#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#35#31#article#63#<p><font size="3" 
face="Verdana, Arial, Helvetica, sans-serif"><b>RELATO DE CASO</b></font></p>   
  ^cY#v60n1a12.htm##
00936000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704070000077002001300777#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#36#32#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Sra. A., dona de casa de 34 anos, c
asada, residente do munic&iacute;pio de S&atilde;o Gon&ccedil;alo, RJ, com ensin
o fundamental incompleto, iniciou o acompanhamento ambulatorial em virtude de si
ntomas depressivos que se iniciaram dois anos antes. Descrevia tristeza e perda 
do prazer nas atividades di&aacute;rias na maior parte do tempo e em quase todos
 os dias, dificuldade de concentra&ccedil;&atilde;o, sentimento de menos-valia e
 de culpa, inquieta&ccedil;&atilde;o, redu&ccedil;&atilde;o do apetite com perda
 de peso e ins&ocirc;nia inicial. N&atilde;o havia relato de epis&oacute;dios se
melhantes no passado. </font></p>     ^cY#v60n1a12.htm##
00862000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704062600077002001300703#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#37#33#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Durante o exame do estado mental, a
 Sra. A relatou tamb&eacute;m um intenso "medo de chuva", que a fazia "perder o 
controle". Esses sintomas teriam aparecido h&aacute; um ano, ap&oacute;s uma tem
pestade acompanhada do desabamento de diversas casas e morte de dezenas de pesso
as no munic&iacute;pio vizinho de Niter&oacute;i, no estado do Rio de Janeiro. E
mbora sua casa n&atilde;o tenha apresentado quaisquer avarias, a Sra. A alega te
r acompanhado o evento pela imprensa, o que a teria deixado atordoada, com extre
ma ang&uacute;stia e pavor. </font></p>     ^cY#v60n1a12.htm##
00956000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704072000077002001300797#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#38#34#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Desde ent&atilde;o, a Sra. A. passo
u a ter pesadelos recorrentes, cujos conte&uacute;dos envolviam desabamentos, ma
s que n&atilde;o inclu&iacute;am lembran&ccedil;as espec&iacute;ficas de um even
to traum&aacute;tico realmente ocorrido. Ao presenciar tempo chuvoso ou nebuloso
, a Sra. A passou a evitar ao m&aacute;ximo sair de casa, jogando-se debaixo da 
cama, sentindo suas m&atilde;os geladas e apresentando tremores em membros super
iores. Os filhos, ao notarem essa atitude, ficavam aterrorizados. Depois do even
to, afastou-se das pessoas, passou a acreditar que n&atilde;o tinha futuro e com
e&ccedil;ou a sentir-se melhor s&oacute;. </font></p>     ^cY#v60n1a12.htm##
00727000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704049100077002001300568#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#39#35#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">A Sra. A descreve que, aos 8 anos d
e idade, a casa onde morava desabou ap&oacute;s uma forte tempestade. Na ocasi&a
tilde;o, n&atilde;o houve v&iacute;timas, mas sua casa ficou totalmente destru&i
acute;da. Embora tenha se assustado com o ocorrido, esqueceu-se do evento com o 
tempo. Quando chovia, sentia um leve desconforto, mas n&atilde;o evitava sair de
 casa ou deixava de executar suas tarefas habituais. </font></p>     ^cY#v60n1a1
2.htm##
00957000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704072100077002001300798#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#40#36#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">A Sra. A nasceu de parto normal a t
ermo em ambiente hospitalar. Seu desenvolvimento psicomotor n&atilde;o se caract
erizou por maiores altera&ccedil;&otilde;es. Frequentou a escola sem apresentar 
dificuldades no aprendizado. No entanto, interrompeu os estudos ainda no ensino 
fundamental, pois o pai acreditava que mulheres n&atilde;o precisavam estudar. C
aracteriza a fam&iacute;lia como "problem&aacute;tica e machista". Segundo a Sra
. A, sua m&atilde;e sempre foi "seca" e pouco atenciosa. H&aacute; tr&ecirc;s an
os passou a ser cuidadora de sua ex-cunhada, que &eacute; portadora de mielite t
ransversa, atividade que segue realizando. </font></p>     ^cY#v60n1a12.htm##
00899000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704066300077002001300740#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#41#37#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Seu pai e sua m&atilde;e s&atilde;o
 etilistas. Tem 11 irm&atilde;os, um dos quais tamb&eacute;m &eacute; etilista e
 os outros 10 s&atilde;o saud&aacute;veis. A Sra. A tem dois filhos, frutos de d
iferentes relacionamentos: um menino de 14 anos, com paralisia cerebral, e uma m
enina de 10 anos, saud&aacute;vel. Reside em casa de alvenaria com seis c&ocirc;
modos, onde moram cinco pessoas, incluindo companheiro, filhos e cunhada. Fazia 
uso espor&aacute;dico, mas em grande quantidade, de derivados et&iacute;licos e 
cigarro desde os 9 anos, mas interrompeu o uso h&aacute; 14 anos.</font></p>    
 ^cY#v60n1a12.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#42#38#article#63#<p>&nbsp;</p>     
^cY#v60n1a12.htm##
00342000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704010600077002001300183#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#43#39#article#63#<p><font size="3" 
face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p> 
    ^cY#v60n1a12.htm##
01199000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704096300077002001301040#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#44#40#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Neste relato, descrevemos uma pacie
nte que apresentou TEPT de in&iacute;cio "pseudotardio", com intervalo de 25 ano
s entre a exposi&ccedil;&atilde;o do evento supostamente traum&aacute;tico e a i
nstala&ccedil;&atilde;o completa da s&iacute;ndrome. O interesse na descri&ccedi
l;&atilde;o deste caso &eacute; ilustrado pela controv&eacute;rsia em torno da v
alidade desse subtipo de TEPT, que tem sido encarado com ceticismo por diferente
s pesquisadores. Alguns autores sugerem, por exemplo, que o TEPT de in&iacute;ci
o tardio resulta de um exame do estado mental superficial, o que explicaria a pr
eval&ecirc;ncia elevada em estudos epidemiol&oacute;gicos e sua virtual aus&ecir
c;ncia na pr&aacute;tica cl&iacute;nica<sup>1</sup>. De fato, uma s&eacute;rie d
e observa&ccedil;&otilde;es levanta d&uacute;vidas quanto ao enquadramento de no
ssa paciente no referido diagn&oacute;stico. </font></p>     ^cY#v60n1a12.htm##
01304000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704106800077002001301145#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#45#41#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Em primeiro lugar, os sintomas intr
usivos, fundamentais para o diagn&oacute;stico de TEPT, n&atilde;o inclu&iacute;
ram mem&oacute;rias espec&iacute;ficas do desabamento ocorrido na inf&acirc;ncia
, mas apenas desabamentos em geral. De fato, a DSM-IV-TR n&atilde;o faz qualquer
 men&ccedil;&atilde;o &agrave; possibilidade de que o conte&uacute;do dos sintom
as intrusivos seja referente ao conceito global do evento traum&aacute;tico (<i>
e.g.</i>, desabamento), e n&atilde;o ao evento traum&aacute;tico em si (<i>e.g.<
/i>, desabamento da resid&ecirc;ncia ocorrido durante a inf&acirc;ncia)<sup>2</s
up>. Na aus&ecirc;ncia do sintoma intrusivo, o diagn&oacute;stico de TEPT n&atil
de;o poderia ser realizado, cabendo, por exemplo, o diagn&oacute;stico de fobia 
espec&iacute;fica do tipo ambiente natural. No entanto, como pesadelos n&atilde;
o fazem parte dos crit&eacute;rios diagn&oacute;sticos de fobia espec&iacute;fic
a, acreditamos que o diagn&oacute;stico de TEPT seja mais apropriado. </font></p
>     ^cY#v60n1a12.htm##
01154000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704091800077002001300995#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#46#42#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Em segundo lugar, embora teoricamen
te traumatizante, o primeiro desabamento n&atilde;o foi descrito pela Sra. A com
o um evento propriamente aterrorizador. De fato, seu relato sobre o evento ocorr
ido em sua inf&acirc;ncia foi relativamente burocr&aacute;tico e, aparentemente,
 sem maior impacto emocional. No entanto, devemos lembrar que a DSM-IV-TR sugere
 que crian&ccedil;as expostas a eventos traum&aacute;ticos podem n&atilde;o desc
rever os fen&ocirc;menos que acompanham eventos traum&aacute;ticos tipicamente o
bservados em adultos, como medo, desamparo ou horror<sup>2</sup>. Al&eacute;m di
sso, evid&ecirc;ncias crescentes sugerem que experi&ecirc;ncias subjetivas negat
ivas associadas aos eventos potencialmente traum&aacute;ticos n&atilde;o s&atild
e;o estritamente necess&aacute;rias para o desenvolvimento de TEPT<sup>3</sup>. 
</font></p>     ^cY#v60n1a12.htm##
01256000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704102000077002001301097#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#47#43#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Finalmente, embora a paciente tenha
 acompanhado desabamentos recentes apenas pela imprensa, e n&atilde;o pessoalmen
te, acreditamos que o segundo evento traum&aacute;tico foi o principal determina
nte do quadro de TEPT. No entanto, chama a aten&ccedil;&atilde;o o fato de a pac
iente ter sido exposta previamente a um evento traum&aacute;tico de conte&uacute
;do id&ecirc;ntico (i.e., desabamento) e com graves implica&ccedil;&otilde;es ma
teriais e pessoais. Em um estudo de seguimento, Horesh <i>et al.</i><sup>4</sup>
 observaram que eventos estressantes mais recentes contribu&iacute;ram de forma 
mais significativa para a vari&acirc;ncia na idade de in&iacute;cio do TEPT, sug
erindo que um TEPT "latente" pode ser precipitado por gatilhos ambientais. Dessa
 forma, o primeiro evento traum&aacute;tico pode ter sensibilizado nossa pacient
e aos efeitos de futuros traumas, especialmente aqueles envolvendo desabamentos 
ou desastres naturais.</font></p>     ^cY#v60n1a12.htm##
01083000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704084700077002001300924#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#48#44#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Em resumo, nosso caso sugere que pa
cientes podem desenvolver quadros semelhantes ao TEPT de in&iacute;cio tardio ap
&oacute;s a reexposi&ccedil;&atilde;o a eventos previamente desprovidos de impac
to emocional. Acreditamos que o segundo desabamento, ainda que visto pela televi
s&atilde;o, tenha sido o principal determinante do TEPT, o que torna o quadro t&
iacute;pico, e n&atilde;o de in&iacute;cio tardio. A elevada frequ&ecirc;ncia co
m que eventos traum&aacute;ticos ocorrem ao longo da vida podem resultar em arte
fatos relacionados &agrave; idade de in&iacute;cio do TEPT. In&uacute;meras ques
t&otilde;es, incluindo a defini&ccedil;&atilde;o de trauma e de outros sintomas 
de TEPT na DSM-V, devem orientar as pesquisas futuras sobre TEPT de in&iacute;ci
o tardio.</font></p>     ^cY#v60n1a12.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#49#45#article#63#<p>&nbsp;</p>     
^cY#v60n1a12.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704010700077002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#50#46#article#63#<p><font size="3" 
face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b></font></p>
     ^cY#v60n1a12.htm##
00488000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074888000200077704023800079002001300317#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#51#47#article#63#1#<p><
font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Andrews B, Brewin 
CR, Philpott R, Stewart L. Delayed-onset posttraumatic stress disorder: a system
atic review of the evidence. Am J Psychiatry. 2007;164(9):1319-26.    ^cY#v60n1a
12.htm##
00256000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002000077002001300097#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#52#48#article#63#</font></p>     ^c
Y#v60n1a12.htm##
00499000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074888000200077704024900079002001300328#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#53#49#article#63#2#<p><
font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. American Psychiatr
ic Association. Diagnostic and Statistical Manual of Mental Disorders. 4ª editio
n, text revision ed. Washington, D.C.: American Psychiatric Publishing; 2000.   
 ^cY#v60n1a12.htm##
00256000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002000077002001300097#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#54#50#article#63#</font></p>     ^c
Y#v60n1a12.htm##
00502000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074888000200077704025200079002001300331#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#55#51#article#63#3#<p><
font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. O'Donnell ML, Crea
mer M, McFarlane AC, Silove D, Bryant RA. Should A2 be a diagnostic requirement 
for posttraumatic stress disorder in DSM-V? Psychiatry Res. 2010;176(23):257-60.
    ^cY#v60n1a12.htm##
00256000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002000077002001300097#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#56#52#article#63#</font></p>     ^c
Y#v60n1a12.htm##
00497000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074888000200077704024700079002001300326#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#57#53#article#63#4#<p><
font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Horesh D, Solomon 
Z, Zerach G, Ein-Dor T. Delayed-onset PTSD among war veterans: the role of life 
events throughout the life cycle. Soc Psychiatry Psychiatr Epidemiol. 2010.    ^
cY#v60n1a12.htm##
00256000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002000077002001300097#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#58#54#article#63#</font></p>     ^c
Y#v60n1a12.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#59#55#article#63#<p>&nbsp;</p>     
^cY#v60n1a12.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#60#56#article#63#<p>&nbsp;</p>     
^cY#v60n1a12.htm##
00468000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704023200077002001300309#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#61#57#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="/im
g/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <b>E
ndere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a12.htm##
00272000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704003600077002001300113#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#62#58#article#63#<br>  Leonardo F. 
Fontenelle    ^cY#v60n1a12.htm##
00287000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704005100077002001300128#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#63#59#article#63#<br>  Av. Vencesla
u Br&aacute;s, 71, Fundos    ^cY#v60n1a12.htm##
00287000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704005100077002001300128#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#64#60#article#63#<br> 22290-140 - R
io de Janeiro, RJ, Brasil    ^cY#v60n1a12.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704009900077002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#65#61#article#63#<br>  E-mail: <a h
ref="mailto:lfontenelle@gmail.com">lfontenelle@gmail.com</a> </font></p>     ^cY
#v60n1a12.htm##
00328000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704009200077002001300169#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#66#62#article#63#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Recebido em 18/1/2011    ^cY#v60n1a
12.htm##
00284000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000300074704004800077002001300125#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#p#67#63#article#63#<br>  Aprovado em 
18/1/2011 </font></p>     ^cY#v60n1a12.htm##
00637000000000313000450000400060000070200500000670500020005670600020005870000030
00607010002000637090008000657080002000731180002000750100017000770100017000940100
01800111010001700129012008500146030001600231065000900247064000500256031000400261
032000200265014000800267865000900275002001300284035001000297801001600307#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#c#68#1#article#4#1#^rND^sAndr
ews^nB#^rND^sBrewin^nCR#^rND^sPhilpott^nR#^rND^sStewart^nL#Delayed-onset posttra
umatic stress disorder: a systematic review of the evidence^len#Am J Psychiatry#
20070000#2007#164#9#1319-26#20110000#v60n1a12.htm#0002-953X#Am J Psychiatry##
00496000000000241000450000400060000070200500000670500020005670600020005870000030
00607010002000637090008000657080002000731180002000750170033000770180058001100630
00200168066001600170062003200186065000900218064000500227865000900232002001300241
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#c#69#2#article#4#2#Am
erican Psychiatric Association#Diagnostic and Statistical Manual of Mental Disor
ders^len#4#Washington^eD.C#American Psychiatric Publishing#20000000#2000#2011000
0#v60n1a12.htm##
00667000000000325000450000400060000070200500000670500020005670600020005870000030
00607010002000637090008000657080002000731180002000750100019000770100017000960100
02000113010001600133010001700149012008500166030001500251065000900266064000500275
03100040028003200030028401400070028786500090029400200130030303500100031680100150
0326#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a12.htm#S#c#70#3#article#4#
3#^rND^sO'Donnell ML#^rND^sCreamer^nM#^rND^sMcFarlane^nAC#^rND^sSilove^nD#^rND^s
Bryant^nRA#Should A2 be a diagnostic requirement for posttraumatic stress disord
er in DSM-V^len#Psychiatry Res#20100000#2010#176#23#257-60#20110000#v60n1a12.htm
#0165-1781#Psychiatry res##
00630000000000277000450000400060000070200500000670500020005670600020005870000030
00607010002000637090008000657080002000731180002000750100016000770100017000930100
01600110010001700126012009300143030003500236065000900271064000500280865000900285
002001300294035001000307801003500317#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a12.htm#S#c#71#4#article#4#4#^rND^sHoresh^nD#^rND^sSolomon^nZ#^rND^sZerach^
nG#^rND^sEin-Dor^nT#Delayed-onset PTSD among war veterans: the role of life even
ts throughout the life cycle^len#Soc Psychiatry Psychiatr Epidemiol#20100000#201
0#20110000#v60n1a12.htm#0933-7954#Soc Psychiatry Psychiatr Epidemiol##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#o#1#1#article
#1#20110331#101414#v60n1a13.htm#111##
01879000000000481000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092121000300097049001000100158000300110030002000113
03100030013303200020013606500090013801400090014703500100015601200940016601200960
02600100035003560100027003910700081004180700070004990830377005690830389009461170
00801335072000201343112000901345111001101354114000901365113001001374002001301384
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#h#2#1#article#1#oa#pt
#br1.1#1#4.0#ILUS#13#JBPSIQ240#nd#J. bras. psiquiatr.#60#1#20110000#^f67^l70#004
7-2085#Simulação de transtorno de estresse pós-traumático secundário a combate e
m exame pericial^lpt#Feigned combat-related post-traumatic stress disorder in a 
forensic psychiatric examination^len#^rND^1A01 A02^nMauro V^sMendlowicz#^rND^1A0
2^nWilliam^sBerger#Universidade Federal Fluminense^iA01^1Departamento de Psiquia
tria e Saúde Mental#Universidade Federal do Rio de Janeiro^iA02^1Instituto de Ps
iquiatria#^lpt^aNeste artigo, apresentamos relato de uma perícia de um caso de s
imulação de transtorno de estresse pós-traumático. Nosso objetivo era apresentar
 o leitor às dificuldades que o perito pode encontrar diante desses casos e demo
nstrar como um exame atento, combinado com conhecimento das peculiaridades dessa
 doença, pode contribuir poderosamente para o diagnóstico correto.#^len^aIn this
 article, we present the report of the forensic examination of a case of malinge
red post-traumatic stress disorder. Our goal was to introduce the reader to the 
hurdles forensic psychiatric have to face while dealing with similar cases and t
o demonstrate that a careful examination combined with a good knowledge about th
is disorder is critical to reach the correct diagnosis.#vancouv#3#20101218#18/12
/2010#20110127#27/1/2011#v60n1a13.htm##
01893000000000481000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092121000300097049001000100158000300110030002000113
03100030013303200020013606500090013801400090014703500100015601201010016601201030
02670100035003700100027004050700081004320700070005130830377005830830389009601170
00801349072000201357112000901359111001101368114000901379113001001388002001301398
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#f#3#1#article#1#oa#pt
#br1.1#1#4.0#ILUS#13#JBPSIQ240#nd#J. bras. psiquiatr.#60#1#20110000#^f67^l70#004
7-2085#<b>Simulação de transtorno de estresse pós-traumático secundário a combat
e em exame pericial</b>^lpt#<b>Feigned combat-related post-traumatic stress diso
rder in a forensic psychiatric examination</b>^len#^rND^1A01 A02^nMauro V^sMendl
owicz#^rND^1A02^nWilliam^sBerger#Universidade Federal Fluminense^iA01^1Departame
nto de Psiquiatria e Saúde Mental#Universidade Federal do Rio de Janeiro^iA02^1I
nstituto de Psiquiatria#^lpt^aNeste artigo, apresentamos relato de uma perícia d
e um caso de simulação de transtorno de estresse pós-traumático. Nosso objetivo 
era apresentar o leitor às dificuldades que o perito pode encontrar diante desse
s casos e demonstrar como um exame atento, combinado com conhecimento das peculi
aridades dessa doença, pode contribuir poderosamente para o diagnóstico correto.
#^len^aIn this article, we present the report of the forensic examination of a c
ase of malingered post-traumatic stress disorder. Our goal was to introduce the 
reader to the hurdles forensic psychiatric have to face while dealing with simil
ar cases and to demonstrate that a careful examination combined with a good know
ledge about this disorder is critical to reach the correct diagnosis.#vancouv#3#
20101218#18/12/2010#20110127#27/1/2011#v60n1a13.htm##
02002000000000505000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099121000300104049001000107158000300117
03000190012003100030013903200020014206500090014401400090015303500100016201200940
01720120096002660100035003620100027003970700083004240700072005070830377005790830
38900956117000801345072000201353112000901355111001101364114000901375113001001384
002001301394008008901407#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a13.htm
#S#l#4#1#article#1#^a2011#oa#pt#br1.1#1#4.0#ilus#13#JBPSIQ240#nd#J. bras. psiqui
atr#60#1#20110000#^f67^l70#0047-2085#Simulação de transtorno de estresse pós-tra
umático secundário a combate em exame pericial^lpt#Feigned combat-related post-t
raumatic stress disorder in a forensic psychiatric examination^len#^rND^1A01 A02
^nMauro V^sMendlowicz#^rND^1A02^nWilliam^sBerger#^iA01^1Universidade Federal Flu
minense^2Departamento de Psiquiatria e Saúde Mental#^iA02^1Universidade Federal 
do Rio de Janeiro^2Instituto de Psiquiatria#^lpt^aNeste artigo, apresentamos rel
ato de uma perícia de um caso de simulação de transtorno de estresse pós-traumát
ico. Nosso objetivo era apresentar o leitor às dificuldades que o perito pode en
contrar diante desses casos e demonstrar como um exame atento, combinado com con
hecimento das peculiaridades dessa doença, pode contribuir poderosamente para o 
diagnóstico correto.#^len^aIn this article, we present the report of the forensi
c examination of a case of malingered post-traumatic stress disorder. Our goal w
as to introduce the reader to the hurdles forensic psychiatric have to face whil
e dealing with similar cases and to demonstrate that a careful examination combi
ned with a good knowledge about this disorder is critical to reach the correct d
iagnosis.#vancouv#3#20101218#18/12/2010#20110127#27/1/2011#v60n1a13.htm#Internet
^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0047-20852011000100013
##
00353000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704011800076002001300194#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#5#1#article#104#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>RELATO DE CASO</b><
/font></p>     ^cY#v60n1a13.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#6#2#article#104#<p>&nbsp;</p>     ^
cY#v60n1a13.htm##
00474000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704023900076002001300315#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#7#3#article#104#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Simula&c
cedil;&atilde;o de transtorno de estresse p&oacute;s-traum&aacute;tico secund&aa
cute;rio a combate em exame pericial</b></font></p>     ^cY#v60n1a13.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#8#4#article#104#<p>&nbsp;</p>     ^
cY#v60n1a13.htm##
00416000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704018100076002001300257#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#9#5#article#104#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Feigned combat-related post-traum
atic stress disorder in a forensic psychiatric examination</b></font></p>     ^c
Y#v60n1a13.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#10#6#article#104#<p>&nbsp;</p>     
^cY#v60n1a13.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#11#7#article#104#<p>&nbsp;</p>     
^cY#v60n1a13.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704015300077002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#12#8#article#104#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Mauro V. Mendlowicz<sup>I,II</su
p>; William Berger<sup>II</sup></b></font></p>     ^cY#v60n1a13.htm##
00407000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704017100077002001300248#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#13#9#article#104#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Universidade Federal Fl
uminense (UFF), Departamento de Psiquiatria e Sa&uacute;de Mental    ^cY#v60n1a1
3.htm##
00350000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011300078002001300191#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#14#10#article#104#<br>     <sup>II<
/sup>Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Psiquiatria</fo
nt></p>     ^cY#v60n1a13.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#15#11#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a13.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#16#12#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#17#13#article#104#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a13.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#18#14#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a13.htm##
00768000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704053100078002001300609#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#19#15#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Neste artigo, apresentamos relato 
de uma per&iacute;cia de um caso de simula&ccedil;&atilde;o de transtorno de est
resse p&oacute;s-traum&aacute;tico. Nosso objetivo era apresentar o leitor &agra
ve;s dificuldades que o perito pode encontrar diante desses casos e demonstrar c
omo um exame atento, combinado com conhecimento das peculiaridades dessa doen&cc
edil;a, pode contribuir poderosamente para o diagn&oacute;stico correto.</font><
/p> <hr size="1" noshade>     ^cY#v60n1a13.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#20#16#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a13.htm##
00724000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704048700078002001300565#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#21#17#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">In this article, we present the re
port of the forensic examination of a case of malingered post-traumatic stress d
isorder. Our goal was to introduce the reader to the hurdles forensic psychiatri
c have to face while dealing with similar cases and to demonstrate that a carefu
l examination combined with a good knowledge about this disorder is critical to 
reach the correct diagnosis.</font></p> <hr size="1" noshade>     ^cY#v60n1a13.h
tm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#22#18#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#23#19#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00351000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011400078002001300192#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#24#20#article#104#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde;O</b></f
ont></p>     ^cY#v60n1a13.htm##
00920000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704068300078002001300761#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#25#21#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O transtorno de estresse p&oacute;
s-traum&aacute;tico (TEPT) &eacute; um transtorno relativamente comum - com uma 
preval&ecirc;ncia para a vida toda estimada em 7,5% (Kessler, 1995<sup>1</sup>) 
- e de grande impacto cl&iacute;nico. Mas sua import&acirc;ncia nos contextos fo
renses &eacute; desproporcional, maior que sua ineg&aacute;vel estatura epidemio
l&oacute;gica e cl&iacute;nica. Diagn&oacute;sticos de TEPT - reais ou supostos 
- s&atilde;o uma causa comum para a realiza&ccedil;&atilde;o de per&iacute;cias 
visando &agrave; obten&ccedil;&atilde;o de indeniza&ccedil;&otilde;es por vias l
egais.</font></p>     ^cY#v60n1a13.htm##
00712000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704047500078002001300553#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#26#22#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O relato de uma per&iacute;cia de 
um caso de simula&ccedil;&atilde;o de TEPT que se segue busca exemplificar as di
ficuldades que o perito (e, &agrave;s vezes, o cl&iacute;nico tamb&eacute;m) enc
ontra perante esses casos e demonstrar como um exame atento combinado com conhec
imento das peculiaridades dessa doen&ccedil;a pode contribuir poderosamente para
 chegar ao diagn&oacute;stico correto.</font></p>     ^cY#v60n1a13.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#27#23#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00368000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704013100078002001300209#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#28#24#article#104#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DESCRI&Ccedil;&Atilde;O DO EXAM
E PERICIAL</b></font></p>     ^cY#v60n1a13.htm##
00354000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011700078002001300195#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#29#25#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Identifica&ccedil;&atilde;o</b>
</font></p>     ^cY#v60n1a13.htm##
00474000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704023700078002001300315#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#30#26#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Sr. A., brasileiro, 54 anos, sexo 
masculino, cor parda, casado, biscateiro, quarta s&eacute;rie do ensino fundamen
tal, natural de Macei&oacute;, Alagoas. </font></p>     ^cY#v60n1a13.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#31#27#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00355000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011800078002001300196#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#32#28#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Elementos colhidos nos autos</b
></font></p>     ^cY#v60n1a13.htm##
00504000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704026700078002001300345#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#33#29#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">"Que o pedido de reforma do Autor 
gira em torno da ALIENA&Ccedil;&Atilde;O MENTAL..., pois &eacute; o Autor pessoa
 inv&aacute;lida e incapaz de exercer qualquer atividade laborativa." </font></p
>     ^cY#v60n1a13.htm##
00467000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704023000078002001300308#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#34#30#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">"...O servi&ccedil;o militar que p
restou na Rep&uacute;blica Dominicana agiu como fator desencadeante deste mal qu
e, atualmente, aflige o Autor..."</font></p>     ^cY#v60n1a13.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#35#31#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Queixa principal</b></font></p>
     ^cY#v60n1a13.htm##
00364000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012700078002001300205#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#36#32#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">" Tenho uma metralhadora na cabe&c
cedil;a." </font></p>     ^cY#v60n1a13.htm##
00365000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012800078002001300206#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#37#33#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Hist&oacute;ria da doen&ccedil;
a atual</b></font></p>     ^cY#v60n1a13.htm##
01021000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704078400078002001300862#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#38#34#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Todos os dados anamn&eacute;sicos 
foram colhidos, por causa da falta de colabora&ccedil;&atilde;o do periciado, co
m sua esposa, a Sra. B. Os dois se conheceram em 1966 e se casaram em 1971. Segu
ndo lhe relatou a genitora do examinando, este era "nervoso" desde antes da "gue
rra" (na verdade, a participa&ccedil;&atilde;o no Destacamento Brasileiro da For
&ccedil;a Armada Interamericana - FAIBR&Aacute;S - na Rep&uacute;blica Dominican
a em 1956-1966). Ao retornar ao Brasil no final de sua experi&ecirc;ncia militar
, estava ainda "mais nervoso". O examinando n&atilde;o fez qualquer tratamento e
nquanto estava a servi&ccedil;o do ex&eacute;rcito e recebeu baixa logo ap&oacut
e;s seu retorno ao Brasil. </font></p>     ^cY#v60n1a13.htm##
01193000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704095600078002001301034#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#39#35#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Ao longo dos anos, o periciado tra
balhou muitas vezes como biscateiro, mas "ficava nervoso e largava (logo) o empr
ego". O "nervosismo" agravou-se progressivamente a partir de 1987, logo atingind
o a configura&ccedil;&atilde;o e a intensidade atuais. O periciado foi ao psiqui
atra duas vezes (uma em 1988 e a outra em 1992), mas rasgou as receitas de Rohyp
nol&reg; e Rivotril&reg; que lhe foram entregues na segunda ocasi&atilde;o. Desd
e ent&atilde;o, a despeito do seu estado, o examinando n&atilde;o se consultou c
om qualquer especialista em sa&uacute;de mental nem tampouco empreendeu qualquer
 tratamento, fato que a Sra. B. justificou pela dificuldade de acesso aos servi&
ccedil;os de sa&uacute;de. A Sra. B. afirmou categoricamente que o quadro aprese
ntado pelo periciado durante a entrevista (<i>vide</i> exame ps&iacute;quico aba
ixo) corresponde a seu estado habitual.</font></p>     ^cY#v60n1a13.htm##
00774000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704053700078002001300615#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#40#36#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Segundo a Sra. B., o periciado n&a
tilde;o desenvolve qualquer atividade produtiva. N&atilde;o se mostra agressivo,
 seja verbal ou fisicamente. Alimenta-se irregularmente, sendo necess&aacute;ria
, &agrave;s vezes, a ajuda de sua mulher para que fa&ccedil;a suas refei&ccedil;
&otilde;es. Da mesma forma, a Sra. B. alega ser ami&uacute;de necess&aacute;rio 
estimul&aacute;-lo para que fa&ccedil;a sua higiene. O casal n&atilde;o tem vida
 sexual desde 1987. </font></p>     ^cY#v60n1a13.htm##
00361000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012400078002001300202#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#41#37#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Antecedentes pessoais e familia
res</b></font></p>     ^cY#v60n1a13.htm##
00582000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704034500078002001300423#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#42#38#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O periciado e sua esposa se conhec
eram em 1966, casaram-se em 1971 e tiveram tr&ecirc;s filhos. Durante alguns ano
s, contaram com a ajuda do pai da Sra. B. para sobreviver, mas este faleceu em 1
981. Desde ent&atilde;o, a fam&iacute;lia tem passado necessidades. </font></p> 
    ^cY#v60n1a13.htm##
00358000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012100078002001300199#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#43#39#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Antecedentes patol&oacute;gicos
</b></font></p>     ^cY#v60n1a13.htm##
00462000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704022500078002001300303#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#44#40#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A esposa do periciado nega que ele
 pade&ccedil;a de etilismo, de tabagismo, de doen&ccedil;as f&iacute;sicas ou qu
e fa&ccedil;a uso de drogas.</font></p>     ^cY#v60n1a13.htm##
00348000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011100078002001300189#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#45#41#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Exame ps&iacute;quico</b></font
></p>     ^cY#v60n1a13.htm##
00761000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704052400078002001300602#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#46#42#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O periciado chegou ao local acompa
nhado de sua esposa. &Eacute; um homem de estatura mediana e idade aparente comp
at&iacute;vel com a cronol&oacute;gica. Seu rosto &eacute; um pouco infiltrado. 
Mostrava-se cabisbaixo, com cenho continuamente franzido e mancava discretamente
. Trajava vestes pr&oacute;prias, muito modestas, mas em bom estado higi&ecirc;n
ico. Apresentava um cavanhaque e barba por fazer. N&atilde;o cumprimentou o exam
inador.</font></p>     ^cY#v60n1a13.htm##
00506000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704026900078002001300347#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#47#43#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"> O casal sentou-se no local indica
do. Quase incontinenti, o periciado afundou o rosto em suas m&atilde;os e se p&o
circ;s a murmurar como que para si mesmo: "Quero ir para o quartel...". </font><
/p>     ^cY#v60n1a13.htm##
00592000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704035500078002001300433#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#48#44#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Sua esposa explicou ent&atilde;o q
ue o periciado s&oacute; sa&iacute;a de casa para ir ocasionalmente a um determi
nado quartel, mas n&atilde;o soube explicar como &eacute; que um militar reforma
do de baixa patente tinha livre acesso a instala&ccedil;&otilde;es militares. </
font></p>     ^cY#v60n1a13.htm##
00398000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704016100078002001300239#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#49#45#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Entrementes, o examinando come&cce
dil;ou a falar sozinho em tom mais elevado: </font></p>     ^cY#v60n1a13.htm##
00491000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704025400078002001300332#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#50#46#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">"...EU AVISEI QUE ESTAVA MINADO, E
U AVISEI, MAS NINGU&Eacute;M ME OUVIU!!!!!!... Tem uma metralhadora tocando na m
inha cabe&ccedil;a... Eu quero ficar junto com eles...". </font></p>     ^cY#v60
n1a13.htm##
00573000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704033600078002001300414#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#51#47#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Seguiu-se um per&iacute;odo de sil
&ecirc;ncio no qual o examinando permaneceu cabisbaixo, mexendo apenas com os p&
eacute;s. Em seguida, ele rompeu espontaneamente o sil&ecirc;ncio, dizendo em to
m de s&uacute;plica para sua mulher: "...vamos embora...". </font></p>     ^cY#v
60n1a13.htm##
00687000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704045000078002001300528#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#52#48#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Convidado diversas vezes a falar s
obre sua vida e seus problemas, o periciado permaneceu sempre em sil&ecirc;ncio.
 Ocasionalmente, punha as m&atilde;os na cabe&ccedil;a, baixava-a e bufava. Volt
a e meia repetia "vamos embora" com um tom desalentado. Em uma ocasi&atilde;o, b
eijou uma medalhinha que trazia no pesco&ccedil;o sem dar qualquer explica&ccedi
l;&atilde;o. </font></p>     ^cY#v60n1a13.htm##
00581000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704034400078002001300422#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#53#49#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A despeito de sua aparente insist&
ecirc;ncia em ir embora, o examinando em nenhum momento tomou a iniciativa de se
 levantar. Apenas quando o entrevistador deu a entrevista por conclu&iacute;da, 
o periciado se levantou e se dirigiu para a porta sem se despedir. </font></p>  
   ^cY#v60n1a13.htm##
00363000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012600078002001300204#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#54#50#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>S&uacute;mula psicopatol&oacute
;gica</b></font></p>     ^cY#v60n1a13.htm##
01167000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704093000078002001301008#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#55#51#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Apar&ecirc;ncia relativamente cuid
ada. Atitude predominantemente negativista que, intercalada com epis&oacute;dios
 de conduta teatral, comprometeu a extens&atilde;o e a profundidade da investiga
&ccedil;&atilde;o psicopatol&oacute;gica. Consci&ecirc;ncia e orienta&ccedil;&at
ilde;o n&atilde;o aferidas. Manifesta&ccedil;&otilde;es emocionais objetivas res
tritas ao polo ansioso/depressivo. Presen&ccedil;a de solil&oacute;quios. Caract
er&iacute;sticas formais do pensamento n&atilde;o avaliadas. N&atilde;o constate
i a presen&ccedil;a de atividade delirante ou de dist&uacute;rbios da sensoperce
p&ccedil;&atilde;o. Intelig&ecirc;ncia e fun&ccedil;&otilde;es mn&ecirc;micas n&
atilde;o aferidas. Atividade psicomotora reduzida. Presen&ccedil;a aparente de c
onsci&ecirc;ncia de morbidade. Capacidade de planejamento e pragmatismo n&atilde
;o avaliados.</font></p>     ^cY#v60n1a13.htm##
00346000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010900078002001300187#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#56#52#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Exame f&iacute;sico</b></font><
/p>     ^cY#v60n1a13.htm##
00418000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704018100078002001300259#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#57#53#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Nada a registrar de import&acirc;n
cia m&eacute;dico-legal, do ponto de vista psiqui&aacute;trico. </font></p>     
^cY#v60n1a13.htm##
00348000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011100078002001300189#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#58#54#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Exames complementares</b></font
></p>     ^cY#v60n1a13.htm##
00382000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704014500078002001300223#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#59#55#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">N&atilde;o s&atilde;o necess&aacut
e;rios para o caso em tela. </font></p>     ^cY#v60n1a13.htm##
00345000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010800078002001300186#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#60#56#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Diagn&oacute;stico</b></font></
p>     ^cY#v60n1a13.htm##
00489000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704025200078002001300330#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#61#57#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">De acordo com os dados colhidos du
rante a entrevista, n&atilde;o &eacute; poss&iacute;vel concluir que o examinand
o seja portador no momento de algum transtorno mental. </font></p>     ^cY#v60n1
a13.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#62#58#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#63#59#article#104#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p>
     ^cY#v60n1a13.htm##
00676000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704043900078002001300517#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#64#60#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A simula&ccedil;&atilde;o &eacute;
 a produ&ccedil;&atilde;o ou inven&ccedil;&atilde;o intencional de sintomas ou i
ncapacidades f&iacute;sicas ou psicol&oacute;gicas motivada pela busca de vantag
ens pessoais (<i>e.g.</i>, indeniza&ccedil;&otilde;es) ou pela tentativa de evad
ir-se a responsabilidades (<i>e.g.</i>, obter dispensa do servi&ccedil;o militar
).</font></p>     ^cY#v60n1a13.htm##
00582000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704034500078002001300423#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#65#61#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Durante o exame pericial, o perici
ado procurou simular um quadro de transtorno de estresse p&oacute;s-traum&aacute
;tico (TEPT). Esse transtorno &eacute; descrito na 10ª revis&atilde;o da Classif
ica&ccedil;&atilde;o Internacional das Doen&ccedil;as (CID-10) como:</font></p> 
    ^cY#v60n1a13.htm##
00677000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704044000078002001300518#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#66#62#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">"... uma resposta tardia e/ou prot
ra&iacute;da a um evento ou situa&ccedil;&atilde;o estressante de uma natureza e
xcepcionalmente amea&ccedil;adora ou catastr&oacute;fica, a qual provavelmente c
ausa ang&uacute;stia invasiva em quase toda as pessoas (p. ex., desastre natural
 ou feito pelo homem, combate, ..., testemunhar a morte violenta de outros,....)
". </font></p>     ^cY#v60n1a13.htm##
00446000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704020900078002001300287#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#67#63#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os sintomas de TEPT podem ser agru
pados em tr&ecirc;s categorias:</font></p> <font size="2" face="Verdana, Arial, 
Helvetica, sans-serif">     ^cY#v60n1a13.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#68#64#article#104#<blockquote>     
^cY#v60n1a13.htm##
00413000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017600078002001300254#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#69#65#article#104#<p>1) Experi&ecir
c;ncias involunt&aacute;rias de revivesc&ecirc;ncia do epide recorda&ccedil;&oti
lde;es e sonhos recorrentes e aflitivos ou como <i>flashbacks</i>.</p>     ^cY#v
60n1a13.htm##
00455000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704021800078002001300296#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#70#66#article#104#<p>2) Esquiva per
sistente dos est&iacute;mulos associados com o trauma, manifesta como esfor&cced
il;os para evitar pensamentos, atividades, locais ou pessoas que ativem recorda&
ccedil;&otilde;es do trauma.</p>     ^cY#v60n1a13.htm##
00480000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704024300078002001300321#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#71#67#article#104#<p>3) Sintomas pe
rsistentes de excitabilidade aumentada, como dificuldade em conciliar e manter o
 sono, irritabilidade, dificuldade em concentrar-se, hipervigil&acirc;ncia e res
posta de sobressalto exagerada.</p> </blockquote> </font>     ^cY#v60n1a13.htm##
00589000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704035200078002001300430#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#72#68#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Nas diretrizes diagn&oacute;sticas
 para TEPT providas pela CID-10, consta que "este transtorno n&atilde;o deve ser
 diagnosticado a menos que haja evid&ecirc;ncia de que ele surgiu dentro de seis
 meses ap&oacute;s um evento traum&aacute;tico de excepcional gravida-de". </fon
t></p>     ^cY#v60n1a13.htm##
00633000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704039600078002001300474#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#73#69#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Na vers&atilde;o atual da classifi
ca&ccedil;&atilde;o da Associa&ccedil;&atilde;o Americana de Psiquiatria, a DSM-
IV-TR, o TEPT &eacute; classificado entre os transtornos de ansiedade. Na CID-10
, o TEPT &eacute; classificado sob a rubrica "Transtornos neur&oacute;ticos, rel
acionados ao estresse e somatoformes". </font></p>     ^cY#v60n1a13.htm##
00558000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704032100078002001300399#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#74#70#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">No decorrer da entrevista e do exa
me, observamos diversas inconsist&ecirc;ncias e contradi&ccedil;&otilde;es que d
eixaram claro que o quadro cl&iacute;nico apresentado pelo periciado n&atilde;o 
correspondia ao diagn&oacute;stico de TEPT. </font></p>     ^cY#v60n1a13.htm##
00351000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011400078002001300192#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#75#71#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Evento traum&aacute;tico</b></f
ont></p>     ^cY#v60n1a13.htm##
00870000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704063300078002001300711#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#76#72#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A ocorr&ecirc;ncia de exposi&ccedi
l;&atilde;o a um evento traum&aacute;tico, elemento-chave do diagn&oacute;stico 
de TEPT, n&atilde;o ficou comprovada. O simples fato de que o periciado integrou
 uma for&ccedil;a de paz n&atilde;o garante que ele tenha sido exposto a eventos
 traum&aacute;ticos. A atua&ccedil;&atilde;o do Destacamento Brasileiro da For&c
cedil;a Armada Interamericana (FAIBR&Aacute;S) na Rep&uacute;blica Dominicana em
 1956-1966 foi pac&iacute;fica, n&atilde;o estando registrado o envolvimento em 
situa&ccedil;&otilde;es de combate. </font></p>     ^cY#v60n1a13.htm##
00354000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011700078002001300195#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#77#73#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Elemento cronol&oacute;gico</b>
</font></p>     ^cY#v60n1a13.htm##
01262000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704102500078002001301103#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#78#74#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Geralmente, os sintomas de TEPT se
 manifestam nos tr&ecirc;s primeiros meses ap&oacute;s o trauma. A CID-10, como 
visto acima, exige que os sintomas apare&ccedil;am no m&aacute;ximo seis meses a
p&oacute;s o evento traum&aacute;tico. Um estudo recente revelou que o TEPT de i
n&iacute;cio tardio verdadeiro &eacute; um fen&ocirc;meno raro, sendo muito mais
 comum a reativa&ccedil;&atilde;o ou a exacerba&ccedil;&atilde;o de sintomas pre
existentes (Andrews <i>et al.</i><sup>2</sup>, 2007). A erup&ccedil;&atilde;o ap
arentemente imotivada de um pretenso quadro de TEPT duas d&eacute;cadas depois d
os eventos supostamente traum&aacute;ticos &eacute;, portanto, a exce&ccedil;&at
ilde;o &agrave; regra. Por outro lado, deve-se considerar que os sintomas vieram
 a se manifestar num contexto que envolve importantes ganhos secund&aacute;rios 
(a&ccedil;&atilde;o judicial visando responsabilizar a Uni&atilde;o pela suposta
 incapacidade do periciado).</font></p>     ^cY#v60n1a13.htm##
00348000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011100078002001300189#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#79#75#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Quadro cl&iacute;nico</b></font
></p>     ^cY#v60n1a13.htm##
01492000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704125500078002001301333#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#80#76#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O TEPT &eacute; considerado um tra
nstorno de ansiedade (segundo a DSM-IV) ou um transtorno relacionado aos quadros
 neur&oacute;ticos (segundo a CID-10). O quadro cl&iacute;nico apresentado pelo 
examinando durante a entrevista n&atilde;o &eacute; compat&iacute;vel com um tra
nstorno neur&oacute;tico ou de ansiedade. O quadro que descrevemos combina dois 
componentes: a) uma atitude negativista que &eacute; observada apenas em quadros
 psic&oacute;ticos, dissociativos ou de simula&ccedil;&atilde;o; e b) uma repres
enta&ccedil;&atilde;o teatralizada do que seria a revivesc&ecirc;ncia de um even
to traum&aacute;tico. Essa combina&ccedil;&atilde;o &eacute; tosca, mas potencia
lmente efetiva, uma vez que ao mesmo tempo em que dificulta que o periciado seja
 examinado com profundidade, serve para veicular a mensagem que &eacute; de seu 
interesse. Em que pese a ocorr&ecirc;ncia mais ou menos frequente de sintomas di
ssociativos e psic&oacute;ticos no TEPT (Braakman <i>et al.</i><sup>3</sup>, 200
9), o quadro apresentado pelo periciado &eacute; mais evocativo das representa&c
cedil;&otilde;es cinematogr&aacute;ficas desse transtorno do que de sua realidad
e cl&iacute;nica. </font></p>     ^cY#v60n1a13.htm##
00346000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010900078002001300187#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#81#77#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Sintomas de esquiva</b></font><
/p>     ^cY#v60n1a13.htm##
00941000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704070400078002001300782#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#82#78#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Tamb&eacute;m deve ser registrado 
o fato de que a Sra. B. afirmou e insistiu que o examinando tem por h&aacute;bit
o visitar um determinado quartel do ex&eacute;rcito perto de sua resid&ecirc;nci
a. Ora, por defini&ccedil;&atilde;o, o padecente de TEPT necessariamente evita p
ensamentos, pessoas, situa&ccedil;&otilde;es e locais que o fa&ccedil;am se lemb
rar do evento traum&aacute;tico. Nesse contexto, seria inexplic&aacute;vel a ins
ist&ecirc;ncia paradoxal do periciado em frequentar instala&ccedil;&otilde;es mi
litares. E sem sintomas de esquiva n&atilde;o &eacute; poss&iacute;vel selar o d
iagn&oacute;stico de TEPT. </font></p>     ^cY#v60n1a13.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#83#79#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#84#80#article#104#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p>
     ^cY#v60n1a13.htm##
01663000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704142600078002001301504#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#85#81#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O caso apresentado ilustra as difi
culdades encontradas para fazer um diagn&oacute;stico de TEPT em situa&ccedil;&o
tilde;es periciais. O exame pericial normalmente &eacute; feito sob condi&ccedil
;&otilde;es adversas. O periciado em geral tem grande interesse em ver selado o 
diagn&oacute;stico de TEPT, uma vez que esse diagn&oacute;stico representa ami&u
acute;de um atalho para obter indeniza&ccedil;&otilde;es do poder p&uacute;blico
. Frequentemente, h&aacute; escassez (ou mesmo sonega&ccedil;&atilde;o ativa) de
 informa&ccedil;&otilde;es necess&aacute;rias para fechar ou excluir tal diagn&o
acute;stico e a decis&atilde;o tem de ser baseada em elementos pontuais. &Eacute
; vital, portanto, procurar obter o m&aacute;ximo poss&iacute;vel de informa&cce
dil;&otilde;es sobre o caso em todas as fontes dispon&iacute;veis (internet, aut
os judiciais, prontu&aacute;rio m&eacute;dico, parentes, informantes e o pr&oacu
te;prio paciente). &Eacute; preciso tamb&eacute;m conhecer profundamente as cara
cter&iacute;sticas do quadro de TEPT para estar apto a detectar poss&iacute;veis
 inconsist&ecirc;ncias do relato do periciado, principalmente levando-se em cont
a que hoje em dia as informa&ccedil;&otilde;es b&aacute;sicas sobre essa doen&cc
edil;a s&atilde;o facilmente acess&iacute;veis pela internet e pela m&iacute;dia
 escrita e eletr&ocirc;nica. </font></p>     ^cY#v60n1a13.htm##
01290000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704105300078002001301131#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#86#82#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Nesse contexto, as informa&ccedil;
&otilde;es fragment&aacute;rias obtidas pelo perito t&ecirc;m que ser avaliadas 
e ponderadas para que se chegue ao diagn&oacute;stico correto. No caso em tela, 
a aus&ecirc;ncia de evento traum&aacute;tico identific&aacute;vel, a suposta eru
p&ccedil;&atilde;o ultratardia do quadro e a apresenta&ccedil;&atilde;o cl&iacut
e;nica duvidosa seriam o bastante para excluir o diagn&oacute;stico de TEPT. Mas
 na &acirc;nsia de fortalecer o seu caso, o periciando e sua parceira incidiram 
em um erro comum nas simula&ccedil;&otilde;es de TEPT de origem militar: tentara
m fazer ressaltar a vincula&ccedil;&atilde;o do periciado &agrave; vida militar.
 A partir desse momento, tornou-se poss&iacute;vel fazer um diagn&oacute;stico p
ositivo da simula&ccedil;&atilde;o, uma vez que n&atilde;o &eacute; poss&iacute;
vel diagnosticar o TEPT na aus&ecirc;ncia da esquiva aos fatos e situa&ccedil;&o
tilde;es que evoquem o suposto evento traum&aacute;tico.</font></p>     ^cY#v60n
1a13.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#87#83#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#88#84#article#104#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUS&Atilde;O</b></font></p>
     ^cY#v60n1a13.htm##
00935000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704069800078002001300776#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#89#85#article#104#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Embora essas observa&ccedil;&otild
e;es pare&ccedil;am ser aplic&aacute;veis exclusivamente aos exames periciais, n
&atilde;o se deve descartar sua relev&acirc;ncia para as situa&ccedil;&otilde;es
 cl&iacute;nicas. Muitas vezes, o primeiro passo para dar in&iacute;cio a a&cced
il;&otilde;es de indeniza&ccedil;&atilde;o consiste em obter uma declara&ccedil;
&atilde;o do cl&iacute;nico com determinados diagn&oacute;sticos. &Eacute; preci
so, portanto, que todos os especialistas em sa&uacute;de mental estejam familiar
izados com as peculiaridades do TEPT e preparados para identificar as tentativas
 de simul&aacute;-lo.</font></p>     ^cY#v60n1a13.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#90#86#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#91#87#article#104#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b></font></p
>     ^cY#v60n1a13.htm##
00486000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704023500080002001300315#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#92#88#article#104#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Kessler RC, Sonne
ga A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the Nation
al Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048-60.    ^cY#v60n1a13
.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002000078002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#93#89#article#104#</font></p>     ^
cY#v60n1a13.htm##
00489000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704023800080002001300318#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#94#90#article#104#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Andrews B, Brewin
 CR, Philpott R, Stewart L. Delayed-onset posttraumatic stress disorder: a syste
matic review of the evidence. Am J Psychiatry. 2007;164(9):1319-26.    ^cY#v60n1
a13.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#95#91#article#104# </font></p>     
^cY#v60n1a13.htm##
00514000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704026300080002001300343#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#96#92#article#104#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Braakman MH, Kort
mann FA, Van den Brink W. Validity of "post-traumatic stress disorder with secon
dary psychotic features": a review of the evidence. Acta Psychiatr Scand. 2009;1
19(1):15-24.    ^cY#v60n1a13.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#97#93#article#104# </font></p>     
^cY#v60n1a13.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#98#94#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#99#95#article#104#<p>&nbsp;</p>    
 ^cY#v60n1a13.htm##
00470000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704023200079002001300311#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#100#96#article#104#<p><font size="2
" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="/
img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <b
>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a13.htm##
00273000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704003500079002001300114#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#101#97#article#104#<br>    Mauro V.
 Mendlowicz    ^cY#v60n1a13.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704010500079002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#102#98#article#104#<br>   Departame
nto de Psiquiatria e Sa&uacute;de Mental da Universidade Federal Fluminense (UFF
)    ^cY#v60n1a13.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704009500079002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#103#99#article#104#<br>   Rua Marqu
es de Paran&aacute;, 303, Fundos, terceiro andar do Pr&eacute;dio Anexo    ^cY#v
60n1a13.htm##
00302000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006300080002001300143#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#104#100#article#104#<br> 24033-900 
- Niter&oacute;i, Rio de Janeiro, Brasil    ^cY#v60n1a13.htm##
00283000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004400080002001300124#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#105#101#article#104#<br>   Telefone
: (+ 55 21) 2629-9351    ^cY#v60n1a13.htm##
00320000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704008100080002001300161#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#106#102#article#104#<br> E-mail: <a
 href="mailto:msm@vm.uff.br">msm@vm.uff.br</a></font></p>     ^cY#v60n1a13.htm##
00332000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009300080002001300173#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#107#103#article#104#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 18/12/2010    ^cY#v6
0n1a13.htm##
00285000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004600080002001300126#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#p#108#104#article#104#<br> Aprovado e
m 27/1/2011</font></p>     ^cY#v60n1a13.htm##
00657000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080002000741180002000760100018000780100017000960100
01600113010001600129010001700145012006900162030002000231065000900251064000500260
03100030026503200030026801400080027186500090027900200130028803500100030180100200
0311#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#c#109#1#article#3
#1#^rND^sKessler^nRC#^rND^sSonnega^nA#^rND^sBromet^nE#^rND^sHughes^nM#^rND^sNels
on^nCB#Posttraumatic stress disorder in the National Comorbidity Survey^len#Arch
 Gen Psychiatry#19950000#1995#52#12#1048-60#20110000#v60n1a13.htm#0003-990X#Arch
 Gen Psychiatry##
00638000000000313000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080002000741180002000760100017000780100017000950100
01800112010001700130012008500147030001600232065000900248064000500257031000400262
032000200266014000800268865000900276002001300285035001000298801001600308#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a13.htm#S#c#110#2#article#3#2#^rND^sAnd
rews^nB#^rND^sBrewin^nCR#^rND^sPhilpott^nR#^rND^sStewart^nL#Delayed-onset posttr
aumatic stress disorder: a systematic review of the evidence^len#Am J Psychiatry
#20070000#2007#164#9#1319-26#20110000#v60n1a13.htm#0002-953X#Am J Psychiatry##
00650000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080002000741180002000760100019000780100019000970100
02300116012010900139030002100248065000900269064000500278031000400283032000200287
014000600289865000900295002001300304035001000317801002100327#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a13.htm#S#c#111#3#article#3#3#^rND^sBraakman^nMH#^r
ND^sKortmann^nFA#^rND^sVan den Brink^nW#Validity of "post-traumatic stress disor
der with secondary psychotic features": a review of the evidence^len#Acta Psychi
atr Scand#20090000#2009#119#1#15-24#20110000#v60n1a13.htm#0001-690X#Acta Psychia
tr Scand##
00273000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090005000647080002000690910009000710920007000800020013000877030
00300100#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#o#1#1#text#1#
20110331#101415#v60n1a14.htm#48##
01015000000000421000450000400060000070200500000670500020005670600020005870000020
00607010002000627090005000647080002000690710003000710400003000740010006000770420
00200083120000400085038000500089121000300094049001000097158000300107030002000110
03100030013003200020013306500090013501400090014403500100015312300020016301200540
01650100030002190100035002490700107002840700108003910700071004991170008005700720
00200578002001300580#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#h
#2#1#text#1#oa#en#br1.1#1#4.0#ILUS#14#JBPSIQ270#nd#J. bras. psiquiatr.#60#1#2011
0000#^f71^l72#0047-2085#1#Fregoli syndrome associated with violent behavior^len#
^rND^1A01^nHéloïse^sDelavenne#^rND^1A02 A03^nFrederico D^sGarcia#University of R
ouen^iA01^1Rouen University Hospital-Charles Nicolle^2Addictology Department^cRo
uen^pFrance#Rouen University^iA02^1Rouen University Hospital^2Federative Institu
te for Peptide Research ADEN Laboratory#Rouen Institute of Medical Research and 
Innovation^iA03^cRouen^pFrance#vancouv#6#v60n1a14.htm##
01022000000000421000450000400060000070200500000670500020005670600020005870000020
00607010002000627090005000647080002000690710003000710400003000740010006000770420
00200083120000400085038000500089121000300094049001000097158000300107030002000110
03100030013003200020013306500090013501400090014403500100015312300020016301200610
01650100030002260100035002560700107002910700108003980700071005061170008005770720
00200585002001300587#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#f
#3#1#text#1#oa#en#br1.1#1#4.0#ILUS#14#JBPSIQ270#nd#J. bras. psiquiatr.#60#1#2011
0000#^f71^l72#0047-2085#1#<b>Fregoli syndrome associated with violent behavior</
b>^len#^rND^1A01^nHéloïse^sDelavenne#^rND^1A02 A03^nFrederico D^sGarcia#Universi
ty of Rouen^iA01^1Rouen University Hospital-Charles Nicolle^2Addictology Departm
ent^cRouen^pFrance#Rouen University^iA02^1Rouen University Hospital^2Federative 
Institute for Peptide Research ADEN Laboratory#Rouen Institute of Medical Resear
ch and Innovation^iA03^cRouen^pFrance#vancouv#6#v60n1a14.htm##
01140000000000445000450000400060000070200500000670500020005670600020005870000020
00607010002000627090005000647080002000690640007000710710003000780400003000810010
00600084042000200090120000400092038000500096121000300101049001000104158000300114
03000190011703100030013603200020013906500090014101400090015003500100015912300020
01690120054001710100030002250100035002550700109002900700110003990700073005091170
00800582072000200590002001300592008008900605#v60n1#V:\SciELO\serial\jbpsiq\v60n1
\markup\v60n1a14.htm#S#l#4#1#text#1#^a2011#oa#en#br1.1#1#4.0#ilus#14#JBPSIQ270#n
d#J. bras. psiquiatr#60#1#20110000#^f71^l72#0047-2085#1#Fregoli syndrome associa
ted with violent behavior^len#^rND^1A01^nHéloïse^sDelavenne#^rND^1A02 A03^nFrede
rico D^sGarcia#^iA01^1University of Rouen^2Rouen University Hospital-Charles Nic
olle^3Addictology Department^cRouen^pFrance#^iA02^1Rouen University^2Rouen Unive
rsity Hospital^3Federative Institute for Peptide Research ADEN Laboratory#^iA03^
1Rouen Institute of Medical Research and Innovation^cRouen^pFrance#vancouv#6#v60
n1a14.htm#Internet^ihttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0047
-20852011000100014##
00355000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000500064708000300069704012400072002001300196#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#5#1#text#38#<p align="right"><font 
size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>LETTER TO THE EDITOR</b
></font></p>     ^cY#v60n1a14.htm##
00253000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000500064708000300069704002200072002001300094#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#6#2#text#38#<p>&nbsp;</p>     ^cY#v
60n1a14.htm##
00395000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000500064708000300069704016400072002001300236#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#7#3#text#38#<p><font size="4" face=
"Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Fregoli synd
rome associated with violent behavior</b></font></p>     ^cY#v60n1a14.htm##
00253000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000500064708000300069704002200072002001300094#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#8#4#text#38#<p>&nbsp;</p>     ^cY#v
60n1a14.htm##
00253000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000500064708000300069704002200072002001300094#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#9#5#text#38#<p>&nbsp;</p>     ^cY#v
60n1a14.htm##
00397000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000500065708000300070704016500073002001300238#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#10#6#text#38#<p><font size="2" face
="Verdana, Arial, Helvetica, sans-serif"><b>H&eacute;lo&iuml;se Delavenne<sup>I<
/sup>; Frederico D. Garcia<sup>II</sup></b></font></p>     ^cY#v60n1a14.htm##
00415000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000500065708000300070704018300073002001300256#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#11#7#text#38#<p><font size="2" face
="Verdana, Arial, Helvetica, sans-serif"><sup>I</sup>Rouen University Hospital-C
harles Nicolle, Addictology Department; University of Rouen, Rouen France    ^cY
#v60n1a14.htm##
00470000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000500065708000300070704023800073002001300311#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#12#8#text#38#<br> <sup>II</sup>Roue
n University &amp; Rouen University Hospital, Federative Institute for Peptide R
esearch (IFRMP 23), ADEN Laboratory (EA 4311) and Rouen Institute of Medical Res
earch and Innovation, Rouen, France </font></p>     ^cY#v60n1a14.htm##
00368000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000500065708000300070704013600073002001300209#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#13#9#text#38#<p><font size="2" face
="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Address for corr
espondence</a></font></p>     ^cY#v60n1a14.htm##
00255000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002200074002001300096#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#14#10#text#38#<p>&nbsp;</p>     ^cY
#v60n1a14.htm##
00255000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002200074002001300096#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#15#11#text#38#<p>&nbsp;</p>     ^cY
#v60n1a14.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704010200074002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#16#12#text#38#<p><font size="3" fac
e="Verdana, Arial, Helvetica, sans-serif"><b>Dear editor,</b></font></p>     ^cY
#v60n1a14.htm##
00756000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704052300074002001300597#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#17#13#text#38#<p><font size="2" fac
e="Verdana, Arial, Helvetica, sans-serif">Fregoli syndrome is one of the misiden
tification delusional syndromes which occur in the setting of schizophrenic, aff
ective or organic disorders<sup>1</sup>. In Fregoli syndrome the patient believe
s that one or more familiar persons, considered as persecutors, repeatedly chang
e their appearance, becoming a double or a look-alike<sup>2</sup>. Diagnosing th
is phenotypic syndrome may be important for personalizing treatment and research
. </font></p>     ^cY#v60n1a14.htm##
01743000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704151000074002001301584#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#18#14#text#38#<p><font size="2" fac
e="Verdana, Arial, Helvetica, sans-serif">The aim of this letter was to describe
 a case of Fregoli syndrome and violent behavior in woman presenting paranoid sc
hizophrenia. A 30 year old unemployed single woman was admitted to the Psychiatr
ic Emergency Department by official request because she presented with incoheren
t speech during a police investigation. The patient reported that during psychia
tric anamnesis she was convinced that one of her boy friends often changed his a
ppearance into other people (a look-alike) in order to follow her. According to 
her, she was investigated because she had broken her General Practitioner's Offi
ce Windows 3 months before and because she had the conviction that he was a look
-alike. After that episode she then took a plane to go abroad on vacation in ord
er to escape from him. In her medical history a previous diagnosis of paranoid s
chizophrenia was found 2 years earlier and the patient reported interruption of 
psychiatric medication 6 months prior to consultation. During the physical exami
nation she appeared anxious and presented a normal speech pattern with delusiona
l persecutory content. Hallucinatory perceptions referred to the existence of lo
ok-alikes. She also presented marked affective flattening and avolition. Facial 
recognition tests<sup>3</sup> and CT brain scan did not show any abnormalities. 
Her delusional symptoms resumed with antipsychotic medication (aripiprazol&reg;)
 after 10 days of treatment. </font></p>     ^cY#v60n1a14.htm##
01043000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704081000074002001300884#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#19#15#text#38#<p><font size="2" fac
e="Verdana, Arial, Helvetica, sans-serif">To our knowledge reports of Fregoli sy
ndrome are rare and little is known about the physiopathology and treatment of t
his misidentification delusional syndrome<sup>2</sup>. They occur in the setting
 of psychiatric disorders and neurologic diseases, such as dementia, partial epi
lepsy and cerebral vascular accidents<sup>1,4</sup>. The right cerebral lobe is 
involved in most cases. At a cognitive level, dysfunctions of identity attributi
on have been reported rather than dysfunction of facial recognition<sup>5</sup>.
 As this syndrome is seldom associated with violent behavior<sup>6</sup> a bette
r understanding of its psychopathology may increase its screening in emergency p
ractice and subsequently avoid violent behavior. </font></p>     ^cY#v60n1a14.ht
m##
00496000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704026300074002001300337#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#20#16#text#38#<p><font size="2" fac
e="Verdana, Arial, Helvetica, sans-serif">The authors are most grateful to Richa
rd Medeiros, Rouen University Hospital Medical Editor, for editing the manuscrip
t. We declare no competing interests, financial or otherwise. </font></p>     ^c
Y#v60n1a14.htm##
00255000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002200074002001300096#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#21#17#text#38#<p>&nbsp;</p>     ^cY
#v60n1a14.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704010000074002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#22#18#text#38#<p><font size="3" fac
e="Verdana, Arial, Helvetica, sans-serif"><b>REFERENCES</b></font></p>     ^cY#v
60n1a14.htm##
00504000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071888000200074704025700076002001300333#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#23#19#text#38#1#<p><fon
t size="2" face="Verdana, Arial, Helvetica, sans-serif">1. 	Forstl H, Almeida OP
, Owen AM, Burns A, Howard R. Psychiatric, neurological and medical aspects of m
isidentification syndromes: a review of 260 cases. Psychol Med. 1991;21(4):905-1
0.    ^cY#v60n1a14.htm##
00253000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002000074002001300094#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#24#20#text#38#</font></p>     ^cY#v
60n1a14.htm##
00507000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071888000200074704026000076002001300336#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#25#21#text#38#2#<p><fon
t size="2" face="Verdana, Arial, Helvetica, sans-serif">2. 	Christodoulou GN, Ma
rgariti M, Kontaxakis VP, Christodoulou NG. The delusional misidentification syn
dromes: strange, fascinating, and instructive. Curr Psychiatry Rep. 2009;11(3):1
85-9.    ^cY#v60n1a14.htm##
00253000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002000074002001300094#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#26#22#text#38#</font></p>     ^cY#v
60n1a14.htm##
00423000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071888000200074704017600076002001300252#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#27#23#text#38#3#<p><fon
t size="2" face="Verdana, Arial, Helvetica, sans-serif">3. 	Bruyer R, Schweich M
. A clinical test battery of face processing. Int J Neurosci. 1991;61(1-2):19-30
.    ^cY#v60n1a14.htm##
00254000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002100074002001300095#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#28#24#text#38# </font></p>     ^cY#
v60n1a14.htm##
00437000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071888000200074704019000076002001300266#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#29#25#text#38#4#<p><fon
t size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Duggal HS. Interictal
 psychosis presenting with Fregoli syndrome. J Neuropsychiatry Clin Neurosci. 20
04;16(4):543-4.    ^cY#v60n1a14.htm##
00253000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002000074002001300094#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#30#26#text#38#</font></p>     ^cY#v
60n1a14.htm##
00525000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071888000200074704027800076002001300354#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#31#27#text#38#5#<p><fon
t size="2" face="Verdana, Arial, Helvetica, sans-serif">5. 	De Bonis M, De Boeck
 P, Lida-Pulik H, Bazin N, Masure MC, Feline A. Person identification and self-c
oncept in the delusional misidentification syndrome: a case study. Psychopatholo
gy. 1994;27(1-2):48-57.    ^cY#v60n1a14.htm##
00253000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002000074002001300094#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#32#28#text#38#</font></p>     ^cY#v
60n1a14.htm##
00445000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071888000200074704019800076002001300274#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#33#29#text#38#6#<p><fon
t size="2" face="Verdana, Arial, Helvetica, sans-serif">6. 	De Pauw KW, Szulecka
 TK. Dangerous delusions: violence and the misidentification syndromes. Br J Psy
chiatry. 1988;152:91-6.    ^cY#v60n1a14.htm##
00253000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002000074002001300094#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#34#30#text#38#</font></p>     ^cY#v
60n1a14.htm##
00255000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002200074002001300096#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#35#31#text#38#<p>&nbsp;</p>     ^cY
#v60n1a14.htm##
00255000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002200074002001300096#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#36#32#text#38#<p>&nbsp;</p>     ^cY
#v60n1a14.htm##
00449000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704021600074002001300290#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#37#33#text#38#<p><font size="2" fac
e="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="/img/r
evistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <b>Addr
ess for correspondence:</b>    ^cY#v60n1a14.htm##
00276000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704004300074002001300117#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#38#34#text#38#<br>  H&eacute;lo&ium
l;se Delavenne    ^cY#v60n1a14.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704010000074002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#39#35#text#38#<br>  Addictology Dep
artment - Rouen University Hospital - Charles Nicolle 1, rue de Germont    ^cY#v
60n1a14.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704002600074002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#40#36#text#38#<br>  76031 Rouen    
 ^cY#v60n1a14.htm##
00293000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704006000074002001300134#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#41#37#text#38#<br> Tel.: +33 2 32 8
8 90 22 Fax: +33 2 32 88 83 37     ^cY#v60n1a14.htm##
00348000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000500066708000300071704011500074002001300189#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#p#42#38#text#38#<br> E-mail: <a href=
"mailto:heloise.delavenne@chu-voila.fr">heloise.delavenne@chu-voila.fr</a></font
></p>     ^cY#v60n1a14.htm##
00666000000000325000450000400060000070200500000670500020005670600020005870000030
00607010002000637090005000657080002000701180002000720100016000740100018000900100
01500108010001500123010001600138012010400154030001200258065000900270064000500279
03100030028403200020028701400070028986500090029600200130030503500100031880100120
0328#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#c#43#1#text#6#1#^
rND^sForstl^nH#^rND^sAlmeida^nOP#^rND^sOwen^nAM#^rND^sBurns^nA#^rND^sHoward^nR#P
sychiatric, neurological and medical aspects of misidentification syndromes: a r
eview of 260 cases^len#Psychol Med#19910000#1991#21#4#905-10#20110000#v60n1a14.h
tm#0033-2917#Psychol Med##
00619000000000301000450000400060000070200500000670500020005670600020005870000030
00607010002000637090005000657080002000701180002000720100024000740100019000980100
02100117010002400138012008600162030002000248710000200268065000900270064000500279
031000300284032000200287014000600289865000900295002001300304#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a14.htm#S#c#44#2#text#6#2#^rND^sChristodoulou^nGN#^
rND^sMargariti^nM#^rND^sKontaxakis^nVP#^rND^sChristodoulou^nNG#The delusional mi
sidentification syndromes: strange, fascinating, and instructive^len#Curr Psychi
atry Rep#2#20090000#2009#11#3#185-9#20110000#v60n1a14.htm##
00534000000000289000450000400060000070200500000670500020005670600020005870000030
00607010002000637090005000657080002000701180002000720100016000740100018000900120
04700108030001500155065000900170064000500179031000300184032000400187014000600191
865000900197002001300206035001000219801001500229#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a14.htm#S#c#45#3#text#6#3#^rND^sBruyer^nR#^rND^sSchweich^nM#A c
linical test battery of face processing^len#Int J Neurosci#19910000#1991#61#1-2#
19-30#20110000#v60n1a14.htm#0020-7454#Int J Neurosci##
00548000000000277000450000400060000070200500000670500020005670600020005870000030
00607010002000637090005000657080002000701180002000720100017000740120058000910300
03200149065000900181064000500190031000300195032000200198014000600200865000900206
002001300215035001000228801003200238#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a14.htm#S#c#46#4#text#6#4#^rND^sDuggal^nHS#Interictal psychosis presenting 
with Fregoli syndrome^len#J Neuropsychiatry Clin Neurosci#20040000#2004#16#4#543
-4#20110000#v60n1a14.htm#0895-0172#J Neuropsychiatry Clin Neurosci##
00709000000000337000450000400060000070200500000670500020005670600020005870000030
00607010002000637090005000657080002000701180002000720100018000740100018000920100
02000110010001500130010001700145010001600162012010200178030001600280065000900296
06400050030503100030031003200040031301400060031786500090032300200130033203500100
0345801001600355#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a14.htm#S#c#47#
5#text#6#5#^rND^sDe Bonis^nM#^rND^sDe Boeck^nP#^rND^sLida-Pulik^nH#^rND^sBazin^n
N#^rND^sMasure^nMC#^rND^sFeline^nA#Person identification and self-concept in the
 delusional misidentification syndrome: a case study^len#Psychopathology#1994000
0#1994#27#1-2#48-57#20110000#v60n1a14.htm#0254-4962#Psychopathology##
00546000000000277000450000400060000070200500000670500020005670600020005870000030
00607010002000637090005000657080002000701180002000720100018000740100019000920120
07000111030001600181065000900197064000500206031000400211014000500215865000900220
002001300229035001000242801001600252#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a14.htm#S#c#48#6#text#6#6#^rND^sDe Pauw^nKW#^rND^sSzulecka^nTK#Dangerous de
lusions: violence and the misidentification syndromes^len#Br J Psychiatry#198800
00#1988#152#91-6#20110000#v60n1a14.htm#0007-1250#Br J Psychiatry##
00277000000000169000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720910009000740920007000830020013000907030
00400103#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#o#1#1#article
#1#20110331#101549#v60n1a10.htm#194##
04267000000000625000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000300101049001000104158000300114
03000200011703100030013703200020014006500090014201400090015103500100016001201060
01700120104002760100044003800100032004240100026004560100027004820700178005090831
38400687085001002071085002102081085002402102085003502126085003202161083126702193
08500100346008500210347008500240349108500330351508500310354811700080357907200030
3587112000903590111001003599114000903609113001003618002001303628#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#h#2#1#article#1#oa#pt#br1.1#1#4.0#ILU
S#TAB#10#JBPSIQ220#nd#J. bras. psiquiatr.#60#1#20110000#^f50^l56#0047-2085#Consc
iência da doença na demência do tipo Alzheimer: uma revisão sistemática de estud
os longitudinais^lpt#Awareness of disease in dementia of the Alzheimer type: a s
ystematic review of longitudinal studies^len#^rND^1A01^nMaria Fernanda Barroso d
e^sSousa#^rND^1A01^nRaquel Luiza^sSantos#^rND^1A01^nDenise^sBrasil#^rND^1A01^nMa
rcia^sDourado#Universidade Federal do Rio de Janeiro^iA01^1IPUB^2Centro de Doenç
a de Alzheimer e outros Transtornos Mentais na Velhice^3Programa de Pós-graduaçã
o em Psiquiatria e Saúde Mental#^lpt^aOBJETIVOS: Avaliar as definições, métodos 
de avaliação e hipóteses etiológicas utilizadas em estudos longitudinais sobre c
onsciência da doença na demência do tipo Alzheimer. MÉTODO: Pesquisa, nas bases 
de dados Medline, ISI, Lilacs e SciELO, de estudos longitudinais sobre consciênc
ia da doença na demência do tipo Alzheimer entre 1999 e 2009. As palavras-chave 
utilizadas foram: "Alzheimer", "dementia", "anosognosia", "awareness of deficit"
, "awareness of disease", "insight" e "longitudinal study". Os artigos examinado
s foram classificados conforme as hipóteses etiológicas encontradas. RESULTADOS:
 Os nove artigos selecionados foram divididos em duas áreas: hipóteses etiológic
as biológicas e hipóteses etiológicas psicossociais. Os termos "falta de consciê
ncia dos déficits", "consciência do déficit", "insight" e "negação do déficit de
 memória" são utilizados nos estudos como sinônimos do termo "anosognosia", mesm
o sendo, conceitualmente, diferentes. O método de avaliação mais utilizado foi o
 uso de questionários de discrepância entre os relatos dos pacientes e cuidadore
s. CONCLUSÕES: Os estudos longitudinais apresentam hipóteses etiológicas heterog
êneas, além da inexistência de um padrão conceitual e metodológico de avaliação.
 Essas dificuldades impossibilitam a obtenção de resultados homogêneos, o que ge
ra a necessidade de aprofundamento dos estudos na área.#^ddecs^i1#^tm^lpt^kDemên
cia^i1#^tm^lpt^kanosognosia^i1#^tm^lpt^kconsciência do déficit^i1#^tm^lpt^kestud
o longitudinal^i1#^len^aOBJECTIVES: To evaluate the definitions, assessment meth
ods and etiological hypotheses used in longitudinal studies on awareness of dise
ase in dementia of the Alzheimer type. METHOD: Search in Medline, ISI, Lilacs an
d SciELO database, looking for longitudinal studies about awareness of disease i
n dementia of the Alzheimer type between 1999 and 2009. The keywords used were "
Alzheimer", "dementia", "anosognosia", "awareness of deficit", "awareness of dis
ease", "insight" e "longitudinal study". The articles reviewed were classified a
ccording to the etiological hypotheses. RESULTS: Nine articles were selected and
 they were divided into two areas: biological etiological hypotheses and psychos
ocial etiological hypotheses. The terms "lack of awareness of deficits", "awaren
ess of deficit", "insight" and "denial of memory" deficit were used as synonyms 
of "anosognosia", although conceptually different. The questionnaires discrepanc
y between patients and caregivers was the most used evaluation method. CONCLUSIO
NS: Longitudinal studies show heterogeneous etiological hypotheses, a lack of a 
standard conceptual and methodological assessment. These difficulties make impos
sible to obtain homogeneous results. There is a need of further studies in the a
rea.#^ddecs^i2#^tm^len^kDementia^i2#^tm^len^kanosognosia^i2#^tm^len^kawareness o
f deficit^i2#^tm^len^klongitudinal study^i2#vancouv#35#20100818#18/8/2010#201101
10#10/1/2011#v60n1a10.htm##
04463000000000625000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720710003000740400003000770010006000800420
00200086120000400088038000500092038000400097121000300101049001000104158000300114
03000200011703100030013703200020014006500090014201400090015103500100016001201200
01700120118002900100044004080100032004520100026004840100027005100700178005370831
46800715085001002183085002102193085002402214085003502238085003202273083135102305
08500100365608500210366608500240368708500330371108500310374411700080377507200030
3783112000903786111001003795114000903805113001003814002001303824#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#f#3#1#article#1#oa#pt#br1.1#1#4.0#ILU
S#TAB#10#JBPSIQ220#nd#J. bras. psiquiatr.#60#1#20110000#^f50^l56#0047-2085#<b>Co
nsciência da doença na demência do tipo Alzheimer</b>: <b>uma revisão sistemátic
a de estudos longitudinais</b>^lpt#<b>Awareness of disease in dementia of the Al
zheimer type</b>: <b>a systematic review of longitudinal studies</b>^len#^rND^1A
01^nMaria Fernanda Barroso de^sSousa#^rND^1A01^nRaquel Luiza^sSantos#^rND^1A01^n
Denise^sBrasil#^rND^1A01^nMarcia^sDourado#Universidade Federal do Rio de Janeiro
^iA01^1IPUB^2Centro de Doença de Alzheimer e outros Transtornos Mentais na Velhi
ce^3Programa de Pós-graduação em Psiquiatria e Saúde Mental#^lpt^a<b>OBJETIVOS:<
/b> Avaliar as definições, métodos de avaliação e hipóteses etiológicas utilizad
as em estudos longitudinais sobre consciência da doença na demência do tipo Alzh
eimer. <b>MÉTODO:</b> Pesquisa, nas bases de dados Medline, ISI, Lilacs e SciELO
, de estudos longitudinais sobre consciência da doença na demência do tipo Alzhe
imer entre 1999 e 2009. As palavras-chave utilizadas foram: "<i>Alzheimer</i>", 
"<i>dementia</i>", "<i>anosognosia</i>", "<i>awareness of deficit</i>", "<i>awar
eness of disease</i>", "<i>insight"</i> e <i>"longitudinal study</i>". Os artigo
s examinados foram classificados conforme as hipóteses etiológicas encontradas. 
<b>RESULTADOS:</b> Os nove artigos selecionados foram divididos em duas áreas: h
ipóteses etiológicas biológicas e hipóteses etiológicas psicossociais. Os termos
 "falta de consciência dos déficits", "consciência do déficit", "<i>insight</i>"
 e "negação do déficit de memória" são utilizados nos estudos como sinônimos do 
termo "anosognosia", mesmo sendo, conceitualmente, diferentes. O método de avali
ação mais utilizado foi o uso de questionários de discrepância entre os relatos 
dos pacientes e cuidadores. <b>CONCLUSÕES: </b>Os estudos longitudinais apresent
am hipóteses etiológicas heterogêneas, além da inexistência de um padrão conceit
ual e metodológico de avaliação. Essas dificuldades impossibilitam a obtenção de
 resultados homogêneos, o que gera a necessidade de aprofundamento dos estudos n
a área.#^ddecs^i1#^tm^lpt^kDemência^i1#^tm^lpt^kanosognosia^i1#^tm^lpt^kconsciên
cia do déficit^i1#^tm^lpt^kestudo longitudinal^i1#^len^a<b>OBJECTIVES:</b> To ev
aluate the definitions, assessment methods and etiological hypotheses used in lo
ngitudinal studies on awareness of disease in dementia of the Alzheimer type. <b
>METHOD:</b> Search in Medline, ISI, Lilacs and SciELO database, looking for lon
gitudinal studies about awareness of disease in dementia of the Alzheimer type b
etween 1999 and 2009. The keywords used were "<i>Alzheimer</i>", "<i>dementia</i
>", "<i>anosognosia</i>", "<i>awareness of deficit</i>", "<i>awareness of diseas
e</i>", "<i>insight</i>" e "<i>longitudinal study</i>". The articles reviewed we
re classified according to the etiological hypotheses. <b>RESULTS: </b>Nine arti
cles were selected and they were divided into two areas: biological etiological 
hypotheses and psychosocial etiological hypotheses. The terms "lack of awareness
 of deficits", "awareness of deficit", "<i>insight</i>" and "denial of memory" d
eficit were used as synonyms of "anosognosia", although conceptually different. 
The questionnaires discrepancy between patients and caregivers was the most used
 evaluation method. <b>CONCLUSIONS:</b> Longitudinal studies show heterogeneous 
etiological hypotheses, a lack of a standard conceptual and methodological asses
sment. These difficulties make impossible to obtain homogeneous results. There i
s a need of further studies in the area.#^ddecs^i2#^tm^len^kDementia^i2#^tm^len^
kanosognosia^i2#^tm^len^kawareness of deficit^i2#^tm^len^klongitudinal study^i2#
vancouv#35#20100818#18/8/2010#20110110#10/1/2011#v60n1a10.htm##
04388000000000649000450000400060000070200500000670500020005670600020005870000020
00607010002000627090008000647080002000720640007000740710003000810400003000840010
00600087042000200093120000400095038000500099038000400104121000300108049001000111
15800030012103000190012403100030014303200020014606500090014801400090015703500100
01660120106001760120104002820100044003860100032004300100026004620100027004880700
18000515083138400695085001002079085002102089085002402110085003502134085003202169
08312670220108500100346808500210347808500240349908500330352308500310355611700080
35870720003035951120009035981110010036071140009036171130010036260020013036360080
08903649#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#l#4#1#article
#1#^a2011#oa#pt#br1.1#1#4.0#ilus#tab#10#JBPSIQ220#nd#J. bras. psiquiatr#60#1#201
10000#^f50^l56#0047-2085#Consciência da doença na demência do tipo Alzheimer: um
a revisão sistemática de estudos longitudinais^lpt#Awareness of disease in demen
tia of the Alzheimer type: a systematic review of longitudinal studies^len#^rND^
1A01^nMaria Fernanda Barroso de^sSousa#^rND^1A01^nRaquel Luiza^sSantos#^rND^1A01
^nDenise^sBrasil#^rND^1A01^nMarcia^sDourado#^iA01^1Universidade Federal do Rio d
e Janeiro^2IPUB^3Centro de Doença de Alzheimer e outros Transtornos Mentais na V
elhice. Programa de Pós-graduação em Psiquiatria e Saúde Mental#^lpt^aOBJETIVOS:
 Avaliar as definições, métodos de avaliação e hipóteses etiológicas utilizadas 
em estudos longitudinais sobre consciência da doença na demência do tipo Alzheim
er. MÉTODO: Pesquisa, nas bases de dados Medline, ISI, Lilacs e SciELO, de estud
os longitudinais sobre consciência da doença na demência do tipo Alzheimer entre
 1999 e 2009. As palavras-chave utilizadas foram: "Alzheimer", "dementia", "anos
ognosia", "awareness of deficit", "awareness of disease", "insight" e "longitudi
nal study". Os artigos examinados foram classificados conforme as hipóteses etio
lógicas encontradas. RESULTADOS: Os nove artigos selecionados foram divididos em
 duas áreas: hipóteses etiológicas biológicas e hipóteses etiológicas psicossoci
ais. Os termos "falta de consciência dos déficits", "consciência do déficit", "i
nsight" e "negação do déficit de memória" são utilizados nos estudos como sinôni
mos do termo "anosognosia", mesmo sendo, conceitualmente, diferentes. O método d
e avaliação mais utilizado foi o uso de questionários de discrepância entre os r
elatos dos pacientes e cuidadores. CONCLUSÕES: Os estudos longitudinais apresent
am hipóteses etiológicas heterogêneas, além da inexistência de um padrão conceit
ual e metodológico de avaliação. Essas dificuldades impossibilitam a obtenção de
 resultados homogêneos, o que gera a necessidade de aprofundamento dos estudos n
a área.#^ddecs^i1#^tm^lpt^kDemência^i1#^tm^lpt^kanosognosia^i1#^tm^lpt^kconsciên
cia do déficit^i1#^tm^lpt^kestudo longitudinal^i1#^len^aOBJECTIVES: To evaluate 
the definitions, assessment methods and etiological hypotheses used in longitudi
nal studies on awareness of disease in dementia of the Alzheimer type. METHOD: S
earch in Medline, ISI, Lilacs and SciELO database, looking for longitudinal stud
ies about awareness of disease in dementia of the Alzheimer type between 1999 an
d 2009. The keywords used were "Alzheimer", "dementia", "anosognosia", "awarenes
s of deficit", "awareness of disease", "insight" e "longitudinal study". The art
icles reviewed were classified according to the etiological hypotheses. RESULTS:
 Nine articles were selected and they were divided into two areas: biological et
iological hypotheses and psychosocial etiological hypotheses. The terms "lack of
 awareness of deficits", "awareness of deficit", "insight" and "denial of memory
" deficit were used as synonyms of "anosognosia", although conceptually differen
t. The questionnaires discrepancy between patients and caregivers was the most u
sed evaluation method. CONCLUSIONS: Longitudinal studies show heterogeneous etio
logical hypotheses, a lack of a standard conceptual and methodological assessmen
t. These difficulties make impossible to obtain homogeneous results. There is a 
need of further studies in the area.#^ddecs^i2#^tm^len^kDementia^i2#^tm^len^kano
sognosia^i2#^tm^len^kawareness of deficit^i2#^tm^len^klongitudinal study^i2#vanc
ouv#35#20100818#18/8/2010#20110110#10/1/2011#v60n1a10.htm#Internet^ihttp://www.s
cielo.br/scielo.php?script=sci_arttext&pid=S0047-20852011000100010##
00367000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704013200076002001300208#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#5#1#article#155#<p align="right"><f
ont size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>REVIS&Atilde;O DA L
ITERATURA</b></font></p>     ^cY#v60n1a10.htm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#6#2#article#155#<p>&nbsp;</p>     ^
cY#v60n1a10.htm##
00484000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704024900076002001300325#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#7#3#article#155#<p><font size="4" f
ace="Verdana, Arial, Helvetica, sans-serif"><a name="linkinicio"></a><b>Consci&e
circ;ncia da doen&ccedil;a na dem&ecirc;ncia do tipo Alzheimer: uma revis&atilde
;o sistem&aacute;tica de estudos longitudinais</b></font></p>     ^cY#v60n1a10.h
tm##
00257000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704002200076002001300098#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#8#4#article#155#<p>&nbsp;</p>     ^
cY#v60n1a10.htm##
00424000000000145000450000400060000070200500000670500020005670600020005870000020
0060701000200062709000800064708000400072704018900076002001300265#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#9#5#article#155#<p><font size="3" f
ace="Verdana, Arial, Helvetica, sans-serif"><b>Awareness of disease in dementia 
of the Alzheimer type: a systematic review of longitudinal studies</b></font></p
>     ^cY#v60n1a10.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#10#6#article#155#<p>&nbsp;</p>     
^cY#v60n1a10.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704002200077002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#11#7#article#155#<p>&nbsp;</p>     
^cY#v60n1a10.htm##
00409000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704017300077002001300250#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#12#8#article#155#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif"><b>Maria Fernanda Barroso de Sousa;
 Raquel Luiza Santos; Denise Brasil; Marcia Dourado</b></font></p>     ^cY#v60n1
a10.htm##
00532000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000200063709000800065708000400073704029600077002001300373#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#13#9#article#155#<p><font size="2" 
face="Verdana, Arial, Helvetica, sans-serif">Universidade Federal do Rio de Jane
iro (IPUB/UFRJ), Centro de Doen&ccedil;a de Alzheimer e outros Transtornos Menta
is na Velhice, Programa de P&oacute;s-gradua&ccedil;&atilde;o em Psiquiatria e S
a&uacute;de Mental</font></p>     ^cY#v60n1a10.htm##
00389000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704015200078002001300230#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#14#10#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkcorresp">Endere&cced
il;o para correspond&ecirc;ncia</a></font></p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#15#11#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00281000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704004400078002001300122#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#16#12#article#155#<p>&nbsp;</p> <hr
 size="1" noshade>     ^cY#v60n1a10.htm##
00333000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009600078002001300174#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#17#13#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESUMO</b></font></p>     ^cY#v
60n1a10.htm##
00556000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704031900078002001300397#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#18#14#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJETIVOS:</b> Avaliar as defin
i&ccedil;&otilde;es, m&eacute;todos de avalia&ccedil;&atilde;o e hip&oacute;tese
s etiol&oacute;gicas utilizadas em estudos longitudinais sobre consci&ecirc;ncia
 da doen&ccedil;a na dem&ecirc;ncia do tipo Alzheimer.    ^cY#v60n1a10.htm##
00763000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704052600078002001300604#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#19#15#article#155#<br>  <b>M&Eacute
;TODO:</b> Pesquisa, nas bases de dados Medline, ISI, Lilacs e SciELO, de estudo
s longitudinais sobre consci&ecirc;ncia da doen&ccedil;a na dem&ecirc;ncia do ti
po Alzheimer entre 1999 e 2009. As palavras-chave utilizadas foram: "<i>Alzheime
r</i>", "<i>dementia</i>", "<i>anosognosia</i>", "<i>awareness of deficit</i>", 
"<i>awareness of disease</i>", "<i>insight"</i> e <i>"longitudinal study</i>". O
s artigos examinados foram classificados conforme as hip&oacute;teses etiol&oacu
te;gicas encontradas.    ^cY#v60n1a10.htm##
00901000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704066400078002001300742#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#20#16#article#155#<br>  <b>RESULTAD
OS:</b> Os nove artigos selecionados foram divididos em duas &aacute;reas: hip&o
acute;teses etiol&oacute;gicas biol&oacute;gicas e hip&oacute;teses etiol&oacute
;gicas psicossociais. Os termos "falta de consci&ecirc;ncia dos d&eacute;ficits"
, "consci&ecirc;ncia do d&eacute;ficit", "<i>insight</i>" e "nega&ccedil;&atilde
;o do d&eacute;ficit de mem&oacute;ria" s&atilde;o utilizados nos estudos como s
in&ocirc;nimos do termo "anosognosia", mesmo sendo, conceitualmente, diferentes.
 O m&eacute;todo de avalia&ccedil;&atilde;o mais utilizado foi o uso de question
&aacute;rios de discrep&acirc;ncia entre os relatos dos pacientes e cuidadores. 
   ^cY#v60n1a10.htm##
00657000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704042000078002001300498#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#21#17#article#155#<br>  <b>CONCLUS&
Otilde;ES: </b>Os estudos longitudinais apresentam hip&oacute;teses etiol&oacute
;gicas heterog&ecirc;neas, al&eacute;m da inexist&ecirc;ncia de um padr&atilde;o
 conceitual e metodol&oacute;gico de avalia&ccedil;&atilde;o. Essas dificuldades
 impossibilitam a obten&ccedil;&atilde;o de resultados homog&ecirc;neos, o que g
era a necessidade de aprofundamento dos estudos na &aacute;rea.</font></p>     ^
cY#v60n1a10.htm##
00451000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704021400078002001300292#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#22#18#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Palavras-chave: </b>Dem&ecirc;n
cia, anosognosia, consci&ecirc;ncia do d&eacute;ficit, estudo longitudinal.</fon
t></p> <hr size="1" noshade>     ^cY#v60n1a10.htm##
00335000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704009800078002001300176#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#23#19#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>ABSTRACT</b></font></p>     ^cY
#v60n1a10.htm##
00489000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704025200078002001300330#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#24#20#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>OBJECTIVES:</b> To evaluate the
 definitions, assessment methods and etiological hypotheses used in longitudinal
 studies on awareness of disease in dementia of the Alzheimer type.    ^cY#v60n1
a10.htm##
00707000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704047000078002001300548#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#25#21#article#155#<br>  <b>METHOD:<
/b> Search in Medline, ISI, Lilacs and SciELO database, looking for longitudinal
 studies about awareness of disease in dementia of the Alzheimer type between 19
99 and 2009. The keywords used were "<i>Alzheimer</i>", "<i>dementia</i>", "<i>a
nosognosia</i>", "<i>awareness of deficit</i>", "<i>awareness of disease</i>", "
<i>insight</i>" e "<i>longitudinal study</i>". The articles reviewed were classi
fied according to the etiological hypotheses.    ^cY#v60n1a10.htm##
00696000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704045900078002001300537#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#26#22#article#155#<br>  <b>RESULTS:
 </b>Nine articles were selected and they were divided into two areas: biologica
l etiological hypotheses and psychosocial etiological hypotheses. The terms "lac
k of awareness of deficits", "awareness of deficit", "<i>insight</i>" and "denia
l of memory" deficit were used as synonyms of "anosognosia", although conceptual
ly different. The questionnaires discrepancy between patients and caregivers was
 the most  used evaluation method.    ^cY#v60n1a10.htm##
00525000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704028800078002001300366#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#27#23#article#155#<br>  <b>CONCLUSI
ONS:</b> Longitudinal studies show heterogeneous etiological hypotheses,  a lack
 of a standard conceptual and methodological assessment. These difficulties make
  impossible to obtain homogeneous results. There is a need of further studies i
n the area.</font></p>     ^cY#v60n1a10.htm##
00422000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704018500078002001300263#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#28#24#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Keywords:</b> Dementia, anosogn
osia,awareness of deficit, longitudinal study.</font></p> <hr size="1" noshade> 
    ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#29#25#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#30#26#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00351000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704011400078002001300192#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#31#27#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>INTRODU&Ccedil;&Atilde;O</b></f
ont></p>     ^cY#v60n1a10.htm##
01139000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704090200078002001300980#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#32#28#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A consci&ecirc;ncia da doen&ccedil
;a na dem&ecirc;ncia tem sido definida tanto como a discrep&acirc;ncia entre as 
queixas subjetivas e o desempenho nos testes neuropsicol&oacute;gicos e em outra
s escalas de avalia&ccedil;&atilde;o<sup>1</sup> como tamb&eacute;m o reconhecim
ento de que o paciente tem de seu comprometimento generalizado<sup>2</sup>. Al&e
acute;m de n&atilde;o existir uma defini&ccedil;&atilde;o precisa do conceito<su
p>3-5</sup>, h&aacute; dificuldades relacionadas &agrave; sua operacionaliza&cce
dil;&atilde;o, pois a presen&ccedil;a dos d&eacute;ficits cognitivos torna o fen
&ocirc;meno da consci&ecirc;ncia da doen&ccedil;a um objeto de estudo bastante c
omplexo, j&aacute; que envolve fatores neuroanat&ocirc;micos, mecanismos psicol&
oacute;gicos e a influ&ecirc;ncia do contexto social<sup>6</sup>.</font></p>    
 ^cY#v60n1a10.htm##
01547000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704131000078002001301388#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#33#29#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A maioria das pesquisas sobre a co
nsci&ecirc;ncia da doen&ccedil;a se baliza em desenhos de corte transversal<sup>
7</sup>. Os achados na &aacute;rea indicam que h&aacute; rela&ccedil;&atilde;o p
ositiva entre consci&ecirc;ncia da doen&ccedil;a e disfun&ccedil;&atilde;o no lo
bo frontal, depress&atilde;o e gravidade cl&iacute;nica da dem&ecirc;ncia. Entre
tanto, esses estudos em grande parte fornecem um cunho dicot&ocirc;mico para ess
as avalia&ccedil;&otilde;es, pois analisam apenas a presen&ccedil;a ou aus&ecirc
;ncia de consci&ecirc;ncia<sup>8</sup>. Essa dicotomia &eacute; problem&aacute;t
ica, pois a consci&ecirc;ncia da doen&ccedil;a &eacute; um fen&ocirc;meno flutua
nte, uma vez que os pacientes podem reconhecer altera&ccedil;&otilde;es causadas
 pela doen&ccedil;a em um determinado dom&iacute;nio e n&atilde;o perceber o com
prometimento em outras &aacute;reas<sup>9</sup>. Dessa forma, estudos longitudin
ais podem oferecer informa&ccedil;&otilde;es mais acuradas sobre o processo da c
onsci&ecirc;ncia da doen&ccedil;a e sobre a sua rela&ccedil;&atilde;o com outras
 vari&aacute;veis como mudan&ccedil;as na pontua&ccedil;&atilde;o do Miniexame d
o Estado Mental (MEEM) ou aspectos sociodemogr&aacute;ficos<sup>7</sup>. </font>
</p>     ^cY#v60n1a10.htm##
00558000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704032100078002001300399#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#34#30#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Esta revis&atilde;o sistem&aacute;
tica tem o objetivo de avaliar nos estudos longitudinais as defini&ccedil;&otild
e;es de consci&ecirc;ncia da doen&ccedil;a, m&eacute;todos de avalia&ccedil;&ati
lde;o e hip&oacute;teses etiol&oacute;gicas.</font></p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#35#31#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00340000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010300078002001300181#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#36#32#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>M&Eacute;TODO</b></font></p>   
  ^cY#v60n1a10.htm##
01367000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704113000078002001301208#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#37#33#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Realizou-se busca de artigos, em t
odas as l&iacute;nguas, nas bases ISI, PubMed, SciELO e Lilacs, entre 1999 e 200
9, utilizando as palavras-chave "<i>Alzheimer</i>", "<i>dementia</i>", "<i>anoso
gnosia</i>", "<i>awareness of deficit</i>", "<i>awareness of disease</i>", "<i>i
nsight</i>" e "<i>longitudinal study</i>". Os crit&eacute;rios de inclus&atilde;
o dos artigos foram: estudos longitudinais, randomizados ou n&atilde;o randomiza
dos, com ou sem grupo controle, com pacientes com dem&ecirc;ncia do tipo Alzheim
er (DA) pr&eacute;-senil e senil e DA comparada a outros tipos de dem&ecirc;ncia
 neurodegenerativas, em todos os est&aacute;gios cl&iacute;nicos da doen&ccedil;
a. Foram exclu&iacute;dos artigos de revis&atilde;o, estudos sobre consci&ecirc;
ncia da doen&ccedil;a com desenho de corte transversal, estudos que avaliaram so
mente interven&ccedil;&atilde;o ou que associaram consci&ecirc;ncia da doen&cced
il;a a traumatismo cranioencef&aacute;lico, condi&ccedil;&otilde;es metab&oacute
;licas e qualquer outra etiologia de dem&ecirc;ncia. </font></p>     ^cY#v60n1a1
0.htm##
00769000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704053200078002001300610#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#38#34#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Inicialmente, todos os resumos sel
ecionados foram lidos por dois avaliadores. Os avaliadores agruparam de forma in
dependente a defini&ccedil;&atilde;o usada para o conceito, n da amostra, desenh
o metodol&oacute;gico e instrumentos utilizados, hip&oacute;tese etiol&oacute;gi
ca e resultados obtidos. Aqueles aprovados pelos dois eram inclu&iacute;dos na r
evis&atilde;o. Os que apresentassem discord&acirc;ncia eram submetidos a um terc
eiro avaliador.</font></p>     ^cY#v60n1a10.htm##
00515000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704027800078002001300356#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#39#35#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">As hip&oacute;teses etiol&oacute;g
icas para consci&ecirc;ncia da doen&ccedil;a foram classificadas nos artigos sel
ecionados em hip&oacute;teses biol&oacute;gicas e hip&oacute;teses psicossociais
.</font></p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#40#36#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00337000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010000078002001300178#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#41#37#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>RESULTADOS</b></font></p>     ^
cY#v60n1a10.htm##
00931000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704069400078002001300772#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#42#38#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Foram encontrados 148 artigos na b
ase ISI, 146 na PubMed, zero no SciELO e zero no Lilacs. Retiradas as refer&ecir
c;ncias constantes em mais de uma base, foram selecionados sete artigos e adicio
nados, manualmente, dois artigos, divididos em duas &aacute;reas, de acordo com 
a hip&oacute;tese etiol&oacute;gica. Os artigos exclu&iacute;dos desta revis&ati
lde;o (n = 86) foram classificados em dom&iacute;nios como desenho do estudo<sup
>5,7</sup>, interven&ccedil;&atilde;o<sup>7,8</sup>, participantes<sup>3,5,7,8</
sup>, fatores de risco para dem&ecirc;ncia<sup>3,8</sup> e avalia&ccedil;&otilde
;es<sup>3</sup>. </font></p>     ^cY#v60n1a10.htm##
01653000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704141600078002001301494#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#43#39#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Na primeira &aacute;rea de classif
ica&ccedil;&atilde;o das hip&oacute;teses etiol&oacute;gicas, sete artigos relac
ionaram o comprometimento da consci&ecirc;ncia da doen&ccedil;a na dem&ecirc;nci
a a fatores biol&oacute;gicos como gravidade cl&iacute;nica da doen&ccedil;a (n 
= 3), disfun&ccedil;&atilde;o no lobo frontal (n = 2) e depress&atilde;o (n = 2)
. Esses estudos utilizaram termos como anosognosia (n = 3), consci&ecirc;ncia do
 d&eacute;ficit (n = 1), falta de consci&ecirc;ncia dos d&eacute;ficits (n = 1),
 <i>insight </i>(n = 1) e nega&ccedil;&atilde;o do d&eacute;ficit de mem&oacute;
ria (n = 1). Os m&eacute;todos de avalia&ccedil;&atilde;o utilizados foram quest
ion&aacute;rio de avalia&ccedil;&atilde;o da discrep&acirc;ncia entre os relatos
 de pacientes e cuidadores (n = 5); escalas de avalia&ccedil;&atilde;o da consci
&ecirc;ncia (n = 2); question&aacute;rio de avalia&ccedil;&atilde;o da discrep&a
circ;ncia entre o relato do paciente e seu desempenho em testes objetivos (n = 1
); testes de mem&oacute;ria (n = 1); entrevista cl&iacute;nica (n = 3) e classif
ica&ccedil;&otilde;es pela observa&ccedil;&atilde;o cl&iacute;nica (n = 2). A av
alia&ccedil;&atilde;o longitudinal da consci&ecirc;ncia da doen&ccedil;a variou 
bastante quanto ao tempo de dura&ccedil;&atilde;o dos estudos - entre mente dito
 em testes (n = 1).</font></p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#44#40#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00319000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704008200078002001300160#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#45#41#article#155#<p align="center"
><img src="/img/revistas/jbpsiq/v60n1/a10tab01.jpg"></p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#46#42#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
01248000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704101100078002001301089#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#47#43#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os artigos (n = 2) que apresentara
m como hip&oacute;tese etiol&oacute;gica  fatores psicossociais abordaram aspect
os org&acirc;nicos e  psicossociais do adoecimento como contexto sociocultural, 
 caracter&iacute;sticas de personalidade e mecanismos psicol&oacute;gicos  de de
fesa. Nesses estudos, foram encontrados os termos  consci&ecirc;ncia (n = 1) e c
onsci&ecirc;ncia do d&eacute;ficit da mem&oacute;ria (n = 1). Os m&eacute;todos 
de avalia&ccedil;&atilde;o utilizados foram question&aacute;rio de  avalia&ccedi
l;&atilde;o da discrep&acirc;ncia entre os relatos de pacientes e cuidadores  (n
 = 1) e question&aacute;rio de avalia&ccedil;&atilde;o da discrep&acirc;ncia  en
tre a predi&ccedil;&atilde;o de desempenho e o desempenho propriamente dito em t
estes (n = 1). Os pacientes foram avaliados  longitudinalmente em dois momentos 
e em tr&ecirc;s momentos  e o tempo de dura&ccedil;&atilde;o dos dois estudos fo
i de 12 meses.</font></p>     ^cY#v60n1a10.htm##
00553000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704031600078002001300394#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#48#44#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A avalia&ccedil;&atilde;o do desen
ho metodol&oacute;gico observou que os estudos  n&atilde;o eram randomizados, ut
ilizando tanto m&eacute;todo quantitativo  de avalia&ccedil;&atilde;o (n = 8) qu
anto m&eacute;todo qualitativo (n = 1).</font></p>     ^cY#v60n1a10.htm##
00507000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704027000078002001300348#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#49#45#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Todos os estudos longitudinais enc
ontrados buscaram  associa&ccedil;&atilde;o entre a hip&oacute;tese etiol&oacute
;gica e o comprometimento  do grau da consci&ecirc;ncia da doen&ccedil;a.</font>
</p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#50#46#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#51#47#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>DISCUSS&Atilde;O</b></font></p>
     ^cY#v60n1a10.htm##
00408000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704017100078002001300249#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#52#48#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Operacionaliza&ccedil;&atilde;o
 do conceito de consci&ecirc;ncia da doen&ccedil;a</b></font></p>     ^cY#v60n1a
10.htm##
01278000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704104100078002001301119#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#53#49#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Por ser um fen&ocirc;meno flutuant
e e multidimensional, a operacionaliza&ccedil;&atilde;o do conceito tem sido pos
ta em segundo plano, al&eacute;m de n&atilde;o existir um padr&atilde;o uniforme
 para grada&ccedil;&atilde;o da consci&ecirc;ncia da doen&ccedil;a. Assim, a con
sci&ecirc;ncia da doen&ccedil;a pode ser considerada presente ou ausente ou grad
uada como preservada, comprometida ou parcial e ausente<sup>8</sup>. A maioria d
os estudos longitudinais avaliados utiliza o pr&oacute;prio m&eacute;todo de ava
lia&ccedil;&atilde;o como a operacionaliza&ccedil;&atilde;o da consci&ecirc;ncia
 da doen&ccedil;a<sup>7,10-15</sup>. No entanto, dois estudos indicaram a operac
ionaliza&ccedil;&atilde;o adotada, consci&ecirc;ncia intacta, consci&ecirc;ncia 
levemente comprometida, consci&ecirc;ncia moderadamente comprometida e consci&ec
irc;ncia ausente<sup>5</sup> e consci&ecirc;ncia total, consci&ecirc;ncia parcia
l e consci&ecirc;ncia ausente<sup>16</sup>. </font></p>     ^cY#v60n1a10.htm##
01219000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704098200078002001301060#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#54#50#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Grande parte desses estudos n&atil
de;o define consci&ecirc;ncia da doen&ccedil;a<sup>7,10-16</sup>. Termos como "f
alta de consci&ecirc;ncia dos d&eacute;ficits"<sup>10</sup>, "anosognosia"<sup>1
1,12,16</sup>, "consci&ecirc;ncia do d&eacute;ficit da mem&oacute;ria"<sup>5</su
p>, "consci&ecirc;ncia"<sup>7</sup>, "consci&ecirc;ncia do d&eacute;ficit"<sup>1
4</sup>, "<i>insight</i>"<sup>13</sup> e "nega&ccedil;&atilde;o do d&eacute;fici
t de mem&oacute;ria"<sup>15</sup> s&atilde;o usados como sin&ocirc;nimos. Essa m
esma problem&aacute;tica &eacute; encontrada nos estudos transversais<sup>17-22<
/sup>. A falta de defini&ccedil;&atilde;o por parte dos estudos e a aus&ecirc;nc
ia de um consenso sobre o que seria consci&ecirc;ncia da doen&ccedil;a interfere
 na metodologia utilizada e na interpreta&ccedil;&atilde;o dos resultados, o que
 impossibilita a replica&ccedil;&atilde;o dos estudos propostos. </font></p>    
 ^cY#v60n1a10.htm##
01031000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704079400078002001300872#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#55#51#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A consci&ecirc;ncia da doen&ccedil
;a &eacute; definida somente em um dos estudos longitudinais como a consci&ecirc
;ncia do comprometimento da mem&oacute;ria e seus impactos na vida da pessoa com
 dem&ecirc;ncia<sup>5</sup>. De maneira geral, o termo "consci&ecirc;ncia"<sup>7
</sup> tem sido considerado como sin&ocirc;nimo de "consci&ecirc;ncia do d&eacut
e;ficit da mem&oacute;ria"<sup>5</sup>. Ao avaliar apenas a mem&oacute;ria, outr
os aspectos da consci&ecirc;ncia da doen&ccedil;a s&atilde;o desconsiderados, j&
aacute; que &aacute;reas como as rela&ccedil;&otilde;es sociais, familiares, afe
tivas e as atividades de vida di&aacute;ria tamb&eacute;m s&atilde;o comprometid
as pela dem&ecirc;ncia<sup>23</sup>. </font></p>     ^cY#v60n1a10.htm##
01158000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704092100078002001300999#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#56#52#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">"Anosognosia" &eacute; o termo mai
s utilizado nos estudos longitudinais<sup>11,12,16</sup> e pode ser definida com
o um fen&ocirc;meno cognitivo de n&atilde;o percep&ccedil;&atilde;o expl&iacute;
cita de um d&eacute;ficit, normalmente relacionado a les&otilde;es do hemisf&eac
ute;rio direito, sendo a redu&ccedil;&atilde;o do metabolismo um correlato, part
icularmente, nas regi&otilde;es do lobo frontal<sup>24</sup>. Anosognosia tem si
do relacionada &agrave; gravidade cl&iacute;nica da doen&ccedil;a<sup>11,16</sup
>. Apesar de sua defini&ccedil;&atilde;o ser mais precisa, esse termo tem sido a
dotado tanto na percep&ccedil;&atilde;o do comprometimento cognitivo<sup>11,16</
sup> como no preju&iacute;zo neurol&oacute;gico<sup>12</sup>, o que pode ocasion
ar inadequa&ccedil;&atilde;o na escolha do m&eacute;todo de avalia&ccedil;&atild
e;o.</font></p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#57#53#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00397000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704016000078002001300238#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#58#54#article#155#<p align="center"
><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="/img/revis
tas/jbpsiq/v60n1/a10tab02.jpg">Tabela 2</a></font></p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#59#55#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#60#56#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00397000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704016000078002001300238#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#61#57#article#155#<p align="center"
><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><a href="/img/revis
tas/jbpsiq/v60n1/a10tab03.jpg">Tabela 3</a></font></p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#62#58#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
01775000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704153800078002001301616#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#63#59#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Os termos "falta de consci&ecirc;n
cia dos d&eacute;ficits"<sup>10</sup>, "consci&ecirc;ncia do d&eacute;ficit"<sup
>14</sup>, "<i>insight</i>"<sup>13</sup> e "nega&ccedil;&atilde;o do d&eacute;fi
cit de mem&oacute;ria"<sup>15</sup> s&atilde;o utilizados nos estudos como sin&o
circ;nimos de "anosognosia". A falta de consci&ecirc;ncia dos d&eacute;ficits<su
p>10</sup> e a nega&ccedil;&atilde;o do d&eacute;ficit de mem&oacute;ria<sup>15<
/sup> se referem &agrave; percep&ccedil;&atilde;o do comprometimento cognitivo, 
do mesmo modo que em consci&ecirc;ncia do d&eacute;ficit<sup>14</sup> e <i>insig
ht</i><sup>13</sup>. No entanto, a defini&ccedil;&atilde;o de consci&ecirc;ncia 
do d&eacute;ficit &eacute; mais global, pois abrange a consci&ecirc;ncia dos d&e
acute;ficits cognitivos, emocionais e das rela&ccedil;&otilde;es sociais<sup>25<
/sup>. Apesar disso, a consci&ecirc;ncia do d&eacute;ficit n&atilde;o necessaria
mente est&aacute; relacionada ao adoecimento, pois o d&eacute;ficit pode ser atr
ibu&iacute;do a outros fatores como idade, evento ocorrido ou preocupa&ccedil;&a
tilde;o<sup>26</sup>. Em contrapartida, o termo "<i>insight</i>" pode ser consid
erado como o mais impreciso, porque abarca o reconhecimento de uma s&eacute;rie 
de eventos como a identifica&ccedil;&atilde;o de certos sintomas como patol&oacu
te;gicos, percep&ccedil;&atilde;o de que &eacute; portador de uma doen&ccedil;a 
e o n&iacute;vel de ades&atilde;o ao tratamento<sup>26</sup>.</font></p>     ^cY
#v60n1a10.htm##
00892000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704065500078002001300733#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#64#60#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Uma defini&ccedil;&atilde;o mais a
dequada, apesar de apresentada em um estudo transversal, seria conceituar a cons
ci&ecirc;ncia da doen&ccedil;a como a capacidade de perceber em si e/ou nas ativ
idades da vida di&aacute;ria altera&ccedil;&otilde;es ocasionadas por d&eacute;f
icits associados ao processo de adoecimento<sup>27</sup>. Essa defini&ccedil;&at
ilde;o abarca aspectos do comprometimento cognitivo, funcional e relacional do a
doecimento na dem&ecirc;ncia, enquanto outras conceitua&ccedil;&otilde;es se rep
ortam, geralmente, a apenas um aspecto do comprometimento.</font></p>     ^cY#v6
0n1a10.htm##
00362000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704012500078002001300203#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#65#61#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"><b>Hip&oacute;teses etiol&oacute;g
icas</b></font></p>     ^cY#v60n1a10.htm##
01848000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704161100078002001301689#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#66#62#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A associa&ccedil;&atilde;o entre f
atores biol&oacute;gicos (gravidade cl&iacute;nica da doen&ccedil;a, disfun&cced
il;&atilde;o no lobo frontal e depress&atilde;o) e consci&ecirc;ncia da doen&cce
dil;a pode ser considerada inconclusiva. Foi encontrada associa&ccedil;&atilde;o
 entre a hip&oacute;tese etiol&oacute;gica biol&oacute;gica e o comprometimento 
da consci&ecirc;ncia da doen&ccedil;a em alguns estudos longitudinais<sup>10,12,
14,16</sup>, mas em outros n&atilde;o foi evidenciada essa rela&ccedil;&atilde;o
<sup>11,13,15</sup>. A inconsist&ecirc;ncia dos resultados obtidos nesses estudo
s pode ser atribu&iacute;da &agrave; falta de padroniza&ccedil;&atilde;o metodol
&oacute;gica decorrente da aus&ecirc;ncia de um instrumento padr&atilde;o-ouro p
ara avalia&ccedil;&atilde;o na &aacute;rea. V&aacute;rios estudos n&atilde;o uti
lizaram instrumentos espec&iacute;ficos para avalia&ccedil;&atilde;o da consci&e
circ;ncia da doen&ccedil;a, mas sim para avalia&ccedil;&atilde;o de d&eacute;fic
its de mem&oacute;ria<sup>10,14-16 </sup>e sintomas psicol&oacute;gicos e compor
tamentais<sup>14,16</sup>. Apenas o estudo de Monta&ntilde;&eacute;s e Quintero 
(2007)<sup>11</sup> utilizou uma escala para avalia&ccedil;&atilde;o de anosogno
sia, entretanto essa escala n&atilde;o pode ser considerada como instrumento de 
avalia&ccedil;&atilde;o de consci&ecirc;ncia da doen&ccedil;a, pois se limita &a
grave; aferi&ccedil;&atilde;o do reconhecimento dos d&eacute;ficits cognitivos s
em que isso seja atribu&iacute;do a uma doen&ccedil;a.</font></p>     ^cY#v60n1a
10.htm##
01020000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704078300078002001300861#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#67#63#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif"> A gravidade cl&iacute;nica da doe
n&ccedil;a se refere ao grau de comprometimento cognitivo, comportamental e func
ional ao longo do tempo<sup>10,11,15</sup>. Estudos avaliam gravidade cl&iacute;
nica da doen&ccedil;a em rela&ccedil;&atilde;o a dois aspectos: tempo de dura&cc
edil;&atilde;o da doen&ccedil;a e idade de in&iacute;cio. Esses aspectos s&atild
e;o, muitas vezes, complicadores na avalia&ccedil;&atilde;o da consci&ecirc;ncia
 da doen&ccedil;a, pois n&atilde;o h&aacute; acur&aacute;cia por parte dos cuida
dores em localizar os sintomas iniciais da doen&ccedil;a, geralmente atribu&iacu
te;dos ao envelhecimento normal, &agrave;s situa&ccedil;&otilde;es pontuais de p
erdas e depress&atilde;o. </font></p>     ^cY#v60n1a10.htm##
00838000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704060100078002001300679#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#68#64#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A depress&atilde;o tamb&eacute;m t
em sido observada como um fa-tor etiol&oacute;gico para o comprometimento da con
sci&ecirc;ncia da doen&ccedil;a<sup>11,16</sup>. Entretanto, deve ser considerad
a n&atilde;o como um fator etiol&oacute;gico, mas sim como um fator de confundim
ento, pois contribui para o agravamento dos d&eacute;ficits cognitivos, o que in
terfere na avalia&ccedil;&atilde;o da consci&ecirc;ncia da doen&ccedil;a e impli
ca a necessidade de tratamento estat&iacute;stico espec&iacute;fico<sup>5,28</su
p>. </font></p>     ^cY#v60n1a10.htm##
01347000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704111000078002001301188#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#69#65#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Alguns estudos relacionaram o comp
rometimento da consci&ecirc;ncia da doen&ccedil;a &agrave; disfun&ccedil;&atilde
;o no lobo frontal<sup>12,14</sup>. Foram encontrados comprometimento da perfus&
atilde;o sangu&iacute;nea no lobo frontal<sup>14</sup> e grande quantidade de pl
acas senis na regi&atilde;o direita do <i>prosubiculum</i> do hipocampo<sup>12</
sup>. Nesses estudos, os pacientes se encontravam no est&aacute;gio leve<sup>14<
/sup> e est&aacute;gio grave da dem&ecirc;ncia<sup>12</sup>. Estudos que avaliar
am o comprometimento da perfus&atilde;o sangu&iacute;nea sugerem que esses resul
tados n&atilde;o s&atilde;o homog&ecirc;neos em pacientes com DA leve, em fun&cc
edil;&atilde;o da heterogeneidade da topografia cerebral<sup>29-31</sup>. Portan
to, a rela&ccedil;&atilde;o entre comprometimento da consci&ecirc;ncia da doen&c
cedil;a e a disfun&ccedil;&atilde;o no lobo frontal &eacute; dependente de unifo
rmidade da amostra cl&iacute;nica, que deve estar no mesmo grau de estadiamento 
cl&iacute;nico da doen&ccedil;a. </font></p>     ^cY#v60n1a10.htm##
01353000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704111600078002001301194#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#70#66#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O m&eacute;todo de avalia&ccedil;&
atilde;o mais utilizado foi o uso de question&aacute;rios de discrep&acirc;ncia 
entre os relatos dos pacientes e cuidadores<sup>10,11,14,15</sup>. Nesse m&eacut
e;todo, paciente e cuidador respondem &agrave;s mesmas perguntas sobre o reconhe
cimento do d&eacute;ficit cognitivo, principalmente a mem&oacute;ria. Geralmente
, pacientes subestimam suas altera&ccedil;&otilde;es de mem&oacute;ria quando co
mparados ao relato do cuidador<sup>32</sup>. A sobrecarga do cuidador, assim com
o o tipo de rela&ccedil;&atilde;o pr&eacute;-m&oacute;rbida entre paciente e cui
dador, caracter&iacute;sticas de personalidade, condi&ccedil;&otilde;es f&iacute
;sicas, sintomas ansiosos e depressivos do pr&oacute;prio cuidador interferem na
 avalia&ccedil;&atilde;o dele sobre o desempenho do paciente<sup>33</sup>. No en
tanto, nenhum dos estudos longitudinais controlou esses aspectos, o que coloca e
m quest&atilde;o a acur&aacute;cia dos relatos dos cuidadores, uma grande limita
&ccedil;&atilde;o metodol&oacute;gica. </font></p>     ^cY#v60n1a10.htm##
01529000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704129200078002001301370#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#71#67#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Outros m&eacute;todos como escalas
 de mensura&ccedil;&atilde;o da consci&ecirc;ncia<sup>11,13</sup>, question&aacu
te;rio de discrep&acirc;ncia entre o relato do paciente e seu desempenho em test
es objetivos<sup>11</sup>, entrevista cl&iacute;nica<sup>14,16</sup>, testes de 
mem&oacute;ria<sup>14</sup> e observa&ccedil;&otilde;es cl&iacute;nicas<sup>14,1
5</sup>, al&eacute;m do question&aacute;rio de discrep&acirc;ncia entre os relat
os dos pacientes e cuidadores foram adotados. Um dos estudos utilizou somente a 
entrevista cl&iacute;nica como m&eacute;todo de avalia&ccedil;&atilde;o<sup>12</
sup>. Essa variedade de m&eacute;todos de avalia&ccedil;&atilde;o &eacute; conse
qu&ecirc;ncia da aus&ecirc;ncia de uma defini&ccedil;&atilde;o-padr&atilde;o par
a a consci&ecirc;ncia da doen&ccedil;a, impossibilitando a replica&ccedil;&atild
e;o dos estudos e dos resultados e a ado&ccedil;&atilde;o de um instrumento cons
iderado padr&atilde;o-ouro na &aacute;rea. Os instrumentos existentes como a dis
crep&acirc;ncia entre o relato do paciente e seu desempenho em testes objetivos 
limita-se a avaliar pontos espec&iacute;ficos, o que restringe a avalia&ccedil;&
atilde;o de um conceito que &eacute; multidimensional. </font></p>     ^cY#v60n1
a10.htm##
00908000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704067100078002001300749#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#72#68#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">Estudos longitudinais apresentaram
 limita&ccedil;&otilde;es no tempo de avalia&ccedil;&atilde;o, pois n&atilde;o h
&aacute; intervalos padronizados entre as reaplica&ccedil;&otilde;es e a dura&cc
edil;&atilde;o do tempo dos estudos tamb&eacute;m n&atilde;o &eacute; uniforme<s
up>10-16</sup>. Essa diversidade nos intervalos utilizados nas avalia&ccedil;&ot
ilde;es impossibilita a ado&ccedil;&atilde;o de um denominador comum para os res
ultados desses estudos, at&eacute; mesmo em estudos participantes de uma mesma h
ip&oacute;tese etiol&oacute;gica para consci&ecirc;ncia da doen&ccedil;a. </font
></p>     ^cY#v60n1a10.htm##
01442000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704120500078002001301283#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#73#69#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A hip&oacute;tese etiol&oacute;gic
a biol&oacute;gica &eacute; criticada por adotar uma vis&atilde;o reducionista d
a consci&ecirc;ncia da doen&ccedil;a<sup>2</sup>. Essa concep&ccedil;&atilde;o, 
al&eacute;m de considerar unicamente o d&eacute;ficit cognitivo na avalia&ccedil
;&atilde;o, reduz o comprometimento da consci&ecirc;ncia da doen&ccedil;a a um s
intoma da dem&ecirc;ncia<sup>2,6,34</sup>. A presen&ccedil;a de fatores como mec
anismos de enfrentamento da doen&ccedil;a, respostas emocionais ao adoecimento e
 sintomas depressivos &eacute; a base da hip&oacute;tese psicossocial<sup>5,7</s
up>. Essa hip&oacute;tese foi aventada com a finalidade de criticar o modelo org
&acirc;nico vigente, que desconsideraria aspectos emocionais e comportamentais<s
up>2,8</sup>. Entretanto, os estudos que adotaram a hip&oacute;tese etiol&oacute
;gica psicossocial realizaram somente a avalia&ccedil;&atilde;o de d&eacute;fici
ts de mem&oacute;ria e sintomas psicol&oacute;gicos e comportamentais e n&atilde
;o utilizaram instrumentos espec&iacute;ficos para avalia&ccedil;&atilde;o da co
nsci&ecirc;ncia da doen&ccedil;a<sup>5,7</sup>.</font></p>      ^cY#v60n1a10.htm
##
01556000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704131900078002001301397#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#74#70#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A hip&oacute;tese psicossocial tem
 recebido cr&iacute;ticas relacionadas &agrave; ado&ccedil;&atilde;o do termo bi
opsicossocial que engloba aspectos diversos como a gravidade da doen&ccedil;a, a
 utiliza&ccedil;&atilde;o de mecanismos de defesa e problemas relacionados ao co
ntexto da entrevista, o que poderia transformar o comprometimento da consci&ecir
c;ncia da doen&ccedil;a em um fen&ocirc;meno excessivamente generalista e superf
icial. O m&eacute;todo de avalia&ccedil;&atilde;o desses estudos, geralmente qua
litativo, &eacute; tamb&eacute;m alvo de cr&iacute;ticas. O m&eacute;todo qualit
ativo ocasiona limita&ccedil;&otilde;es para replica&ccedil;&atilde;o, pois muit
as vezes as avalia&ccedil;&otilde;es se pautam em entrevistas semiestruturadas o
u abertas que contemplam m&uacute;ltiplos dom&iacute;nios. Essas entrevistas req
uerem que os pacientes tenham express&atilde;o verbal preservada e a interpreta&
ccedil;&atilde;o &eacute; baseada na observa&ccedil;&atilde;o do entrevistador, 
o que pode afetar os resultados do estudo<sup>2,35</sup>. Outra cr&iacute;tica f
eita a essa hip&oacute;tese &eacute; o n&uacute;mero reduzido de sujeitos, que i
nviabiliza a amplia&ccedil;&atilde;o dos resultados para a comunidade<sup>7</sup
>.</font></p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#75#71#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00343000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010600078002001300184#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#76#72#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>CONCLUS&Atilde;O</b></font></p>
     ^cY#v60n1a10.htm##
00860000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704062300078002001300701#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#77#73#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">A consci&ecirc;ncia da doen&ccedil
;a &eacute; um fen&ocirc;meno flutuante, uma vez que os fatores biol&oacute;gico
s, psicol&oacute;gicos e sociais influenciam na varia&ccedil;&atilde;o da percep
&ccedil;&atilde;o do paciente sobre os seus d&eacute;ficits. Os estudos longitud
inais podem contribuir com dados relevantes para o estudo do fen&ocirc;meno da c
onsci&ecirc;ncia da doen&ccedil;a ao acompanharem o processo da consci&ecirc;nci
a da doen&ccedil;a e estabelecerem rela&ccedil;&otilde;es com outras vari&aacute
;veis ao longo do estudo. </font></p>     ^cY#v60n1a10.htm##
01801000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704156400078002001301642#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#78#74#article#155#<p><font size="2"
 face="Verdana, Arial, Helvetica, sans-serif">O desenho longitudinal para avalia
&ccedil;&atilde;o da consci&ecirc;ncia da doen&ccedil;a apresenta dificuldades r
elacionadas ao acompanhamento de um grande n&uacute;mero de pacientes, m&eacute;
todos de avalia&ccedil;&atilde;o variados, avalia&ccedil;&atilde;o de v&aacute;r
ios tipos de dem&ecirc;ncia em um mesmo estudo e participantes que apresentam di
feren&ccedil;a estat&iacute;stica pouco significativa entre as aplica&ccedil;&ot
ilde;es. Al&eacute;m disso, as hip&oacute;teses etiol&oacute;gicas s&atilde;o va
riadas, a operacionaliza&ccedil;&atilde;o da consci&ecirc;ncia da doen&ccedil;a 
n&atilde;o &eacute; padronizada, n&atilde;o existe uma defini&ccedil;&atilde;o p
recisa do conceito nem um instrumento padr&atilde;o-ouro para a &aacute;rea. Ess
as dificuldades impossibilitam a obten&ccedil;&atilde;o de resultados homog&ecir
c;neos, o que gera a necessidade de aprofundamento dos estudos na &aacute;rea co
m o objetivo de valida&ccedil;&atilde;o de instrumentos que possam fornecer dado
s mais consistentes de um fen&ocirc;meno que pode interferir na qualidade de vid
a de pacientes e cuidadores. Assim tamb&eacute;m a &aacute;rea necessita do dese
nvolvimento de um instrumento adequado para avalia&ccedil;&atilde;o da consci&ec
irc;ncia da doen&ccedil;a, levando em considera&ccedil;&atilde;o que a consci&ec
irc;ncia da doen&ccedil;a deve ser definida como o reconhecimento de altera&cced
il;&otilde;es n&atilde;o apenas cognitivas, mas tamb&eacute;m funcionais e relac
ionais.</font></p>     ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002200078002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#79#75#article#155#<p>&nbsp;</p>    
 ^cY#v60n1a10.htm##
00344000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704010700078002001300185#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#80#76#article#155#<p><font size="3"
 face="Verdana, Arial, Helvetica, sans-serif"><b>REFER&Ecirc;NCIAS</b></font></p
>     ^cY#v60n1a10.htm##
00484000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704023300080002001300313#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#81#77#article#155#1#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Wagner M, Spangen
berg K, Bachman D. Unawareness of cognitive deficit in Alzheimer disease and rel
ated dementias. Alzheimer Dis Assoc Disord. 1997;11(3):125-31.    ^cY#v60n1a10.h
tm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#82#78#article#155# </font></p>     
^cY#v60n1a10.htm##
00438000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704018700080002001300267#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#83#79#article#155#2#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Clare L. Managing
 threats to self: awareness in early stage Alzheimer's disease. Social Sci Med. 
2003;57:1017-29.    ^cY#v60n1a10.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#84#80#article#155# </font></p>     
^cY#v60n1a10.htm##
00455000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704020400080002001300284#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#85#81#article#155#3#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Markov&aacute; IS
, Clare L, Wang M, Romero B, Kenny G. Awareness in dementia: conceptual issues. 
Aging Ment Health. 2005;9:386-93.    ^cY#v60n1a10.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#86#82#article#155# </font></p>     
^cY#v60n1a10.htm##
00563000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704031200080002001300392#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#87#83#article#155#4#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Dourado MCN, Laks
 J, Rocha M, Soares C, Leibing A, Engelhardt E. Consci&ecirc;ncia da doen&ccedil
;a na dem&ecirc;ncia: resultados preliminares em pacientes com doen&ccedil;a de 
Alzheimer leve e moderada. Arq Neuropsiquiatr. 2005;63:114-8.    ^cY#v60n1a10.ht
m##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#88#84#article#155# </font></p>     
^cY#v60n1a10.htm##
00506000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704025500080002001300335#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#89#85#article#155#5#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Aalten P, Van Val
en E, De Vugt ME, Lousberg R, Jolles J, Verhey FRJ. Awareness and behavioral pro
blems in dementia patients: a prospective study. Int Psychogeriatr. 2006;18(1):3
-17.    ^cY#v60n1a10.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#90#86#article#155# </font></p>     
^cY#v60n1a10.htm##
00457000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704020600080002001300286#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#91#87#article#155#6#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Clare L. Developi
ng awareness about awareness in early-stage dementia. The role of psychosocial f
actor. Dementia. 2002;1(2):295-312.    ^cY#v60n1a10.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#92#88#article#155# </font></p>     
^cY#v60n1a10.htm##
00563000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704031200080002001300392#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#93#89#article#155#7#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Clare L, Wilson B
A. Longitudinal assessment of awareness in early-stage Alzheimer's disease using
 comparable questionnaire-based and performance-based measures: a prospective on
e-year follow-up study. Aging Ment Health. 2006;10(2):156-65.    ^cY#v60n1a10.ht
m##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#94#90#article#155# </font></p>     
^cY#v60n1a10.htm##
00470000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704021900080002001300299#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#95#91#article#155#8#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Dourado MCN, Laks
 J, Leibing A, Engelhardt E. Consci&ecirc;ncia da doen&ccedil;a na dem&ecirc;nci
a. Rev Psiquiatr Cl&iacute;n. 2006;33(6):313-21.    ^cY#v60n1a10.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#96#92#article#155# </font></p>     
^cY#v60n1a10.htm##
00462000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000200078704021100080002001300291#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#97#93#article#155#9#<p>
<font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Lamar M, Lasarev 
MR, Libon DJ. Determining Levels of Unawareness in Dementia Research. J Neuropsy
chiatry Clin Neurosci. 2002;14(4):430-7.    ^cY#v60n1a10.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074704002100078002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#98#94#article#155# </font></p>     
^cY#v60n1a10.htm##
00501000000000157000450000400060000070200500000670500020005670600020005870000030
0060701000300063709000800066708000400074888000300078704024900081002001300330#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#99#95#article#155#10#<p
><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Akai T, Haruo H
, Hirofumi S, Tomohiko S, Toshihiko I. Longitudinal patterns of unawareness of m
emory deficits in mild Alzheimer's disease. Geriatr Gerontol Int. 2009;9:16-20. 
   ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002100079002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#100#96#article#155# </font></p>    
 ^cY#v60n1a10.htm##
00523000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704027000082002001300352#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#101#97#article#155#11#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">11. Monta&ntilde;&
eacute;s P, Quintero E. La anosognosia en la enfermedad de Alzheimer: una aproxi
maci&oacute;n cl&iacute;nica para el estudio de la conciencia. Rev Latinoam Psic
ol. 2007;39(1):63-73.    ^cY#v60n1a10.htm##
00258000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075704002000079002001300099#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#102#98#article#155#</font></p>     
^cY#v60n1a10.htm##
00537000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000300064709000800067708000400075888000300079704028400082002001300366#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#103#99#article#155#12#<
p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">12. Marshall GA, K
aufer DI, Lopez OL, Rao GR, Hamilton RL, Dekosky ST. Right prosubiculum amyloid 
plaque density correlates with anosognosia in Alzheimer's disease. J Neurol Neur
osurg Psychiatry. 2004;75:1396-400.    ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#104#100#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00495000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024100083002001300324#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#105#101#article#155#13#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">13. Arkin S, Mahe
ndra N. Insight in Alzheimer's patients: results of a longitudinal study using t
hree assessment methods. Am J Alzheimers Dis Other Demen. 2001;16:211-24.    ^cY
#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#106#102#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00557000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704030300083002001300386#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#107#103#article#155#14#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">14. Derouesn&eacu
te; C, Thibault S, Lagha-Pierucci S, Baudouin-Madec V, Ancri D, Lacomblez L. Dec
reased awareness of cognitive deficits in patients with mild dementia of the Alz
heimer type. Int J Geriatr Psychiatry. 1999;14:1019-30.    ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#108#104#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00489000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023500083002001300318#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#109#105#article#155#15#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">15. Sevush S. Rel
ationship between denial of memory deficit and dementia severity in Alzheimer di
sease. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12(2):88-94.    ^cY#v60n1
a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#110#106#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00531000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704027700083002001300360#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#111#107#article#155#16#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">16. Vogel A, Hass
elbalch SG, Andersen BB, Mortensen EL, Waldemar G. Patient versus informant repo
rted quality of life in the earliest phases of Alzheimer's disease. Int J Geriat
r Psychiatry. 2006;21:1132-8.    ^cY#v60n1a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#112#108#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00507000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704025300083002001300336#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#113#109#article#155#17#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">17. Shibata, K, N
arumoto J, Kitabayashi Y, Ushijima Y, Fukui K. Correlation between anosognosia a
nd regional cerebral blood flow in Alzheimer's disease. Neurosci Lett. 2008;435:
7-10.    ^cY#v60n1a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#114#110#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00566000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704031200083002001300395#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#115#111#article#155#18#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">18. Clare L, Rowl
ands J, Bruce E, Surr C, Downs M. 'I don't do like I used to do': a grounded the
ory approach to conceptualizing awareness in people with moderate to severe deme
ntia living in long-term care. Soc Sci Med. 2008;66(11):2366-77.    ^cY#v60n1a10
.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#116#112#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00541000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704028700083002001300370#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#117#113#article#155#19#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">19. Oyebode JR, T
elling AL, Hardy RM, Austin J. Awareness of memory functioning in early Alzheime
r's disease: lessons from a comparison with healthy older people and young adult
s. Aging Ment Health. 2007;11(6):761-7.    ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#118#114#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00485000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023100083002001300314#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#119#115#article#155#20#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">20. Cosentino S, 
Metcalfe J, Butterfield B, Stern Y. Objective metamemory testing captures awaren
ess of deficit in Alzheimer's disease. Cortex. 2007;43:1004-19.    ^cY#v60n1a10.
htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#120#116#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00542000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704028800083002001300371#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#121#117#article#155#21#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">21. Kazui H, Hiro
no N, Hashimoto M, Nakano Y, Matsumoto K, Takatsuki Y, et al. Symptoms underlyin
g unawareness of memory impairment in patients with mild Alzheimer's disease. J 
Geriatr Psychiatry Neurol. 2006;19:3-12.    ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#122#118#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00618000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704036400083002001300447#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#123#119#article#155#22#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">22. Onor ML, Trev
isiol M, Negro C, Aguglia E. Different perception of cognitive impairment, behav
ioral disturbances, and functional disabilities between persons with mild cognit
ive impairment and mild Alzheimer's disease and their caregivers. Am J Alzheimer
s Dis Other Demen. 2006;21(5):333-8.    ^cY#v60n1a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#124#120#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00477000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704022300083002001300306#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#125#121#article#155#23#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">23. Duke LM, Selt
zer B, Seltzer JE, Vasterling JJ. Cognitive components of deficit awareness in A
lzheimer's disease. Neuropsychology. 2002;16(3):359-69.    ^cY#v60n1a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#126#122#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00498000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024400083002001300327#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#127#123#article#155#24#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">24. Michon A, Dew
eer B, Pillon B, Agid Y, Dubois B. Relation of anosognosia to frontal lobe dysfu
nction in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1994;57:805-9.    
^cY#v60n1a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#128#124#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00580000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704032600083002001300409#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#129#125#article#155#25#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">25. Seltzer B, Va
sterling JJ, Mathias CW, Brennan A. Clinical and neuropsychological correlates o
f impaired awareness of deficits in Alzheimer disease and Parkinson disease: a c
omparative study. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14(2):122-9.  
  ^cY#v60n1a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#130#126#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00570000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704031600083002001300399#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#131#127#article#155#26#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">26. Zanetti O, Va
llotti B, Frisoni GB, Geroldi C, Bianchetti A, Pasqualetti P, et al. Insight in 
dementia: when does it occur? Evidence for a nonlinear relationship between insi
ght and cognitive status. J Gerontol Psychol Sci. 1999;54B(2):100-6.    ^cY#v60n
1a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#132#128#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00501000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704024700083002001300330#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#133#129#article#155#27#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">27. Dourado MCN, 
Marinho V, Soares C, Engelhardt E, Laks J. Awareness of disease in dementia: dev
elopment of a multidimensional rating scale. Dement Neuropsychol. 2007;1:74-80. 
   ^cY#v60n1a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#134#130#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00467000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704021300083002001300296#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#135#131#article#155#28#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">28. Antoine C, An
toine P, Guermonprez P, Frigard B. Awareness of deficits and anosognosia in Alzh
eimer's disease. Encephale. 2004;30(6):570-7.    ^cY#v60n1a10.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#136#132#article#155# </font></p>   
   ^cY#v60n1a10.htm##
00561000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704030700083002001300390#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#137#133#article#155#29#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">29. Haxby JV, Gra
dy CL, Koss E, Horwitz B, Heston L, Shapiro M, et al. Longitudinal study of cere
bral metabolic asymmetries and associated neuropsychological patterns in early d
ementia of the Alzheimer type. Arch Neurol. 1990;47:753-60.    ^cY#v60n1a10.htm#
#
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#138#134#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00417000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704016300083002001300246#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#139#135#article#155#30#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">30. Pakrasi S, O'
Brien JT. Emission tomography in dementia. Nucl Med Commun. 2005;26:189-96.    ^
cY#v60n1a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#140#136#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00509000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704025500083002001300338#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#141#137#article#155#31#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">31. Waldemar G, H
ogh P, Paulson OB. Functional brain imaging with single proton emission computed
 tomography in the diagnosis of Alzheimer's disease. Int Psychogeriat. 1997;9(1)
:223-7.    ^cY#v60n1a10.htm##
00260000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002100080002001300101#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#142#138#article#155# </font></p>   
  ^cY#v60n1a10.htm##
00557000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704030300083002001300386#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#143#139#article#155#32#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">32. Vogel A, Hass
elbalch SG, Ziebell M, Gade A, Stokholm J, Waldemar G. Awareness of deficits in 
mild cognitive impairment and Alzheimer's disease: do MCI patients have impaired
 insight? Dement Geriatr Cogn Disord. 2004;17(3):181-7.    ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#144#140#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00484000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704023000083002001300313#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#145#141#article#155#33#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">33. Correa DD, Gr
aves RE, Costa L. Awareness of memory deficit in Alzheimer's patient and memory-
impaired older adults. Aging Neuropsychol Cogn. 1996;3:215-28.    ^cY#v60n1a10.h
tm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#146#142#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00452000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704019800083002001300281#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#147#143#article#155#34#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">34. Clare L. Awar
eness in early-stage Alzheimer's disease: a review of methods and evidence. Br J
 Clin Psychol. 2004;43:177-96.    ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#148#144#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00476000000000157000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076888000300080704022200083002001300305#v60
n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#149#145#article#155#35#
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">35. Markov&aacute
; IS, Berrios GE. Insight into memory deficits. Memory disorders in psychiatric 
practice. Cambridge: Cambridge University Press; 2000.    ^cY#v60n1a10.htm##
00259000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002000080002001300100#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#150#146#article#155#</font></p>    
 ^cY#v60n1a10.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#151#147#article#155#<p>&nbsp;</p>  
   ^cY#v60n1a10.htm##
00261000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704002200080002001300102#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#152#148#article#155#<p>&nbsp;</p>  
   ^cY#v60n1a10.htm##
00471000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704023200080002001300312#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#153#149#article#155#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif"><a href="#linkinicio"><img src="
/img/revistas/jbpsiq/v60n1/seta.jpg" border="0"></a><a name="linkcorresp"></a> <
b>Endere&ccedil;o para correspond&ecirc;ncia:</b>    ^cY#v60n1a10.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#154#150#article#155#<br>    Maria F
ernanda Barroso de Sousa    ^cY#v60n1a10.htm##
00302000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704006300080002001300143#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#155#151#article#155#<br>    Rua Dou
tor Catrambi, 161/102, Alto da Boa Vista    ^cY#v60n1a10.htm##
00292000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704005300080002001300133#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#156#152#article#155#<br>   20531-00
5 - Rio de Janeiro, RJ, Brasil    ^cY#v60n1a10.htm##
00353000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704011400080002001300194#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#157#153#article#155#<br>  E-mail: <
a href="mailto:maria_fernandabs@yahoo.com.br">maria_fernandabs@yahoo.com.br</a><
/font></p>     ^cY#v60n1a10.htm##
00331000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704009200080002001300172#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#158#154#article#155#<p><font size="
2" face="Verdana, Arial, Helvetica, sans-serif">Recebido em 18/8/2010    ^cY#v60
n1a10.htm##
00286000000000145000450000400060000070200500000670500020005670600020005870000040
0060701000400064709000800068708000400076704004700080002001300127#v60n1#V:\SciELO
\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#p#159#155#article#155#<br>  Aprovado 
em 10/1/2011</font></p>     ^cY#v60n1a10.htm##
00627000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100021000950100
01700116012008000133030002700213065000900240064000500249031000300254032000200257
014000700259865000900266002001300275035001000288801002700298#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#160#1#article#35#1#^rND^sWagner^nM#^rND
^sSpangenberg^nK#^rND^sBachman^nD#Unawareness of cognitive deficit in Alzheimer 
disease and related dementias^len#Alzheimer Dis Assoc Disord#19970000#1997#11#3#
125-31#20110000#v60n1a10.htm#0893-0341#Alzheimer Dis Assoc Disord##
00487000000000253000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100015000790120075000940300
01500169710000200184065000900186064000500195031000300200014000800203865000900211
002001300220#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#161#2#a
rticle#35#2#^rND^sClare^nL#Managing threats to self: awareness in early stage Al
zheimer's disease^len#Social Sci Med#2#20030000#2003#57#1017-29#20110000#v60n1a1
0.htm##
00569000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100018000790100015000970100
01400112010001600126010001500142012004500157030001800202710000200220065000900222
064000500231031000200236014000700238865000900245002001300254#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#162#3#article#35#3#^rND^sMarková^nIS#^r
ND^sClare^nL#^rND^sWang^nM#^rND^sRomero^nB#^rND^sKenny^nG#Awareness in dementia:
 conceptual issues^len#Aging Ment Health#2#20050000#2005#9#386-93#20110000#v60n1
a10.htm##
00715000000000325000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100019000790100014000980100
01500112010001600127010001700143010002000160012011600180030001900296065000900315
06400050032403100030032901400060033286500090033800200130034703500100036080100190
0370#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#163#4#article#3
5#4#^rND^sDourado^nMCN#^rND^sLaks^nJ#^rND^sRocha^nM#^rND^sSoares^nC#^rND^sLeibin
g^nA#^rND^sEngelhardt^nE#Consciência da doença na demência: resultados prelimina
res em pacientes com doença de Alzheimer leve e moderada^lpt#Arq Neuropsiquiatr#
20050000#2005#63#114-8#20110000#v60n1a10.htm#0004-282X#Arq Neuropsiquiatr##
00694000000000337000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100016000790100019000950100
01800114010001800132010001600150010001800166012008000184030001800264065000900282
06400050029103100030029603200020029901400050030186500090030600200130031503500100
0328801001800338#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#164
#5#article#35#5#^rND^sAalten^nP#^rND^sVan Valen^nE#^rND^sDe Vugt^nME#^rND^sLousb
erg^nR#^rND^sJolles^nJ#^rND^sVerhey^nFRJ#Awareness and behavioral problems in de
mentia patients: a prospective study^len#Int Psychogeriatr#20060000#2006#18#1#3-
17#20110000#v60n1a10.htm#1041-6102#Int Psychogeriatr##
00546000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100015000790120098000940300
00900192065000900201064000500210031000200215032000200217014000800219865000900227
002001300236035001000249801000900259#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a10.htm#S#c#165#6#article#35#6#^rND^sClare^nL#Developing awareness about aw
areness in early-stage dementia: The role of psychosocial factor^len#Dementia#20
020000#2002#1#2#295-312#20110000#v60n1a10.htm#0913-6835#DEMENTIA##
00641000000000277000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100015000790100017000940120
18400111030001800295710000200313065000900315064000500324031000300329032000200332
014000700334865000900341002001300350#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a10.htm#S#c#166#7#article#35#7#^rND^sClare^nL#^rND^sWilson^nBA#Longitudinal
 assessment of awareness in early-stage Alzheimer's disease using comparable que
stionnaire-based and performance-based measures: a prospective one-year follow-u
p study^len#Aging Ment Health#2#20060000#2006#10#2#156-65#20110000#v60n1a10.htm#
#
00558000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100019000790100014000980100
01700112010002000129012003800149030001900187710000200206065000900208064000500217
031000300222032000200225014000700227865000900234002001300243#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#167#8#article#35#8#^rND^sDourado^nMCN#^
rND^sLaks^nJ#^rND^sLeibing^nA#^rND^sEngelhardt^nE#Consciência da doença na demên
cia^lpt#Rev Psiquiatr Clín#2#20060000#2006#33#6#313-21#20110000#v60n1a10.htm##
00610000000000301000450000400060000070200500000670500020005670600020005870000040
00607010002000647090008000667080003000741180002000770100015000790100018000940100
01600112012005900128030003200187065000900219064000500228031000300233032000200236
014000600238865000900244002001300253035001000266801003200276#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#168#9#article#35#9#^rND^sLamar^nM#^rND^
sLasarev^nMR#^rND^sLibon^nDJ#Determining Levels of Unawareness in Dementia Resea
rch^len#J Neuropsychiatry Clin Neurosci#20020000#2002#14#4#430-7#20110000#v60n1a
10.htm#0895-0172#J Neuropsychiatry Clin Neurosci##
00622000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100014000810100015000950100
01800110010001800128010001900146012008800165030002100253710000200274065000900276
064000500285031000200290014000600292865000900298002001300307#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#169#10#article#35#10#^rND^sAkai^nT#^rND
^sHaruo^nH#^rND^sHirofumi^nS#^rND^sTomohiko^nS#^rND^sToshihiko^nI#Longitudinal p
atterns of unawareness of memory deficits in mild Alzheimer's disease^len#Geriat
r Gerontol Int#2#20090000#2009#9#16-20#20110000#v60n1a10.htm##
00612000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100018000990120
10800117030002000225065000900245064000500254031000300259032000200262014000600264
865000900270002001300279035001000292801002000302#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a10.htm#S#c#170#11#article#35#11#^rND^sMontañés^nP#^rND^sQuinte
ro^nE#La anosognosia en la enfermedad de Alzheimer: una aproximación clínica par
a el estudio de la conciencia^les#Rev Latinoam Psicol#20070000#2007#39#1#63-73#2
0110000#v60n1a10.htm#0120-0534#Rev Latinoam Psicol##
00725000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100017001000100
01600117010001400133010001900147010001800166012009700184030003000281065000900311
06400050032003100030032501400090032886500090033700200130034603500100035980100300
0369#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#171#12#article#
35#12#^rND^sMarshall^nGA#^rND^sKaufer^nDI#^rND^sLopez^nOL#^rND^sRao^nGR#^rND^sHa
milton^nRL#^rND^sDekosky^nST#Right prosubiculum amyloid plaque density correlate
s with anosognosia in Alzheimer's disease^len#J Neurol Neurosurg Psychiatry#2004
0000#2004#75#1396-400#20110000#v60n1a10.htm#0022-3050#J Neurol Neurosurg Psychia
try##
00560000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100018000960120
10000114030003200214710000200246065000900248064000500257031000300262014000700265
865000900272002001300281#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm
#S#c#172#13#article#35#13#^rND^sArkin^nS#^rND^sMahendra^nN#Insight in Alzheimer'
s patients: results of a longitudinal study using three assessment methods^len#A
m J Alzheimers Dis Other Demen#2#20010000#2001#16#211-24#20110000#v60n1a10.htm##
00732000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100018001000100
02400118010002400142010001500166010001900181012009900200030002500299065000900324
06400050033303100030033801400080034186500090034900200130035803500100037180100250
0381#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#173#14#article#
35#14#^rND^sDerouesné^nC#^rND^sThibault^nS#^rND^sLagha-Pierucci^nS#^rND^sBaudoui
n-Madec^nV#^rND^sAncri^nD#^rND^sLacomblez^nL#Decreased awareness of cognitive de
ficits in patients with mild dementia of the Alzheimer type^len#Int J Geriatr Ps
ychiatry#19990000#1999#14#1019-30#20110000#v60n1a10.htm#0885-6230#Int J Geriatr 
Psychiatry##
00609000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810120093000970300
04200190065000900232064000500241031000300246032000200249014000600251865000900257
002001300266035001000279801004200289#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a10.htm#S#c#174#15#article#35#15#^rND^sSevush^nS#Relationship between denia
l of memory deficit and dementia severity in Alzheimer disease^len#Neuropsychiat
ry Neuropsychol Behav Neurol#19990000#1999#12#2#88-94#20110000#v60n1a10.htm#0894
-878X#Neuropsychiatry Neuropsychol Behav Neurol##
00695000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100022000960100
01900118010002000137010001800157012010000175030002500275065000900300064000500309
031000300314014000700317865000900324002001300333035001000346801002500356#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#175#16#article#35#16#^rND^s
Vogel^nA#^rND^sHasselbalch^nSG#^rND^sAndersen^nBB#^rND^sMortensen^nEL#^rND^sWald
emar^nG#Patient versus informant reported quality of life in the earliest phases
 of Alzheimer's disease^len#Int J Geriatr Psychiatry#20060000#2006#21#1132-8#201
10000#v60n1a10.htm#0885-6230#Int J Geriatr Psychiatry##
00659000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100018000980100
02100116010001800137010001500155012009200170030001400262065000900276064000500285
031000400290014000500294865000900299002001300308035001000321801001400331#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#176#17#article#35#17#^rND^s
Shibata^nK#^rND^sNarumoto^nJ#^rND^sKitabayashi^nY#^rND^sUshijima^nY#^rND^sFukui^
nK#Correlation between anosognosia and regional cerebral blood flow in Alzheimer
's disease^len#Neurosci Lett#20080000#2008#435#7-10#20110000#v60n1a10.htm#0304-3
940#Neurosci Lett##
00728000000000325000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100018000960100
01500114010001400129010001500143012016000158030001200318065000900330064000500339
03100030034403200030034701400080035086500090035800200130036703500100038080100120
0390#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#177#18#article#
35#18#^rND^sClare^nL#^rND^sRowlands^nJ#^rND^sBruce^nE#^rND^sSurr^nC#^rND^sDowns^
nM#'I don't do like I used to do': a grounded theory approach to conceptualizing
 awareness in people with moderate to severe dementia living in long-term care^l
en#Soc Sci Med#20080000#2008#66#11#2366-77#20110000#v60n1a10.htm#0037-7856#Soc S
ci Med##
00653000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100018000990100
01600117010001600133012013500149030001800284710000200302065000900304064000500313
031000300318032000200321014000600323865000900329002001300338#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#178#19#article#35#19#^rND^sOyebode^nJR#
^rND^sTelling^nAL#^rND^sHardy^nRM#^rND^sAustin^nJ#Awareness of memory functionin
g in early Alzheimer's disease: lessons from a comparison with healthy older peo
ple and young adults^len#Aging Ment Health#2#20070000#2007#11#6#761-7#20110000#v
60n1a10.htm##
00613000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100018001000100
02100118010001500139012008600154030000700240065000900247064000500256031000300261
014000800264865000900272002001300281035001000294801000700304#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#179#20#article#35#20#^rND^sCosentino^nS
#^rND^sMetcalfe^nJ#^rND^sButterfield^nB#^rND^sStern^nY#Objective metamemory test
ing captures awareness of deficit in Alzheimer's disease^len#Cortex#20070000#200
7#43#1004-19#20110000#v60n1a10.htm#0010-9452#Cortex##
00738000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100016000960100
01900112010001600131010001900147010001900166810000600185012009900191030002800290
06500090031806400050032703100030033201400050033586500090034000200130034903500100
0362801002800372#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#180
#21#article#35#21#^rND^sKazui^nH#^rND^sHirono^nN#^rND^sHashimoto^nM#^rND^sNakano
^nY#^rND^sMatsumoto^nK#^rND^sTakatsuki^nY#et al#Symptoms underlying unawareness 
of memory impairment in patients with mild Alzheimer's disease^len#J Geriatr Psy
chiatry Neurol#20060000#2006#19#3-12#20110000#v60n1a10.htm#0891-9887#J Geriatr P
sychiatry Neurol##
00730000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100019000960100
01500115010001700130012020000147030003200347710000200379065000900381064000500390
031000300395032000200398014000600400865000900406002001300415#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#181#22#article#35#22#^rND^sOnor^nML#^rN
D^sTrevisiol^nM#^rND^sNegro^nC#^rND^sAguglia^nE#Different perception of cognitiv
e impairment, behavioral disturbances, and functional disabilities between perso
ns with mild cognitive impairment and mild Alzheimer's disease and their caregiv
ers^len#Am J Alzheimers Dis Other Demen#2#20060000#2006#21#5#333-8#20110000#v60n
1a10.htm##
00625000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100017000960100
01800113010002100131012006900152030001600221065000900237064000500246031000300251
032000200254014000700256865000900263002001300272035001000285801001600295#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#182#23#article#35#23#^rND^s
Duke^nLM#^rND^sSeltzer^nB#^rND^sSeltzer^nJE#^rND^sVasterling^nJJ#Cognitive compo
nents of deficit awareness in Alzheimer's disease^len#Neuropsychology#20020000#2
002#16#3#359-69#20110000#v60n1a10.htm#0894-4105#NEUROPSYCHOLOGY##
00667000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100016000970100
01600113010001400129010001600143012007900159030003000238065000900268064000500277
031000300282014000600285865000900291002001300300035001000313801003000323#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#183#24#article#35#24#^rND^s
Michon^nA#^rND^sDeweer^nB#^rND^sPillon^nB#^rND^sAgid^nY#^rND^sDubois^nB#Relation
 of anosognosia to frontal lobe dysfunction in Alzheimer's disease^len#J Neurol 
Neurosurg Psychiatry#19940000#1994#57#805-9#20110000#v60n1a10.htm#0022-3050#J Ne
urol Neurosurg Psychiatry##
00754000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100021000980100
01800119010001700137012014500154030004200299065000900341064000500350031000300355
032000200358014000600360865000900366002001300375035001000388801004200398#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#184#25#article#35#25#^rND^s
Seltzer^nB#^rND^sVasterling^nJJ#^rND^sMathias^nCW#^rND^sBrennan^nA#Clinical and 
neuropsychological correlates of impaired awareness of deficits in Alzheimer dis
ease and Parkinson disease: a comparative study^len#Neuropsychiatry Neuropsychol
 Behav Neurol#20010000#2001#14#2#122-9#20110000#v60n1a10.htm#0894-878X#Neuropsyc
hiatry Neuropsychol Behav Neurol##
00729000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100018000980100
01800116010001700134010002000151010002100171810000600192012012000198030002300318
71000020034106500090034306400050035203100040035703200020036101400060036386500090
0369002001300378#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#185
#26#article#35#26#^rND^sZanetti^nO#^rND^sVallotti^nB#^rND^sFrisoni^nGB#^rND^sGer
oldi^nC#^rND^sBianchetti^nA#^rND^sPasqualetti^nP#et al#Insight in dementia: when
 does it occur? Evidence for a nonlinear relationship between insight and cognit
ive status^len#J Gerontol Psychol Sci#2#19990000#1999#54B#2#100-6#20110000#v60n1
a10.htm##
00620000000000301000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100019000810100017001000100
01600117010002000133010001400153012008500167030002000252710000200272065000900274
064000500283031000200288014000600290865000900296002001300305#v60n1#V:\SciELO\ser
ial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#186#27#article#35#27#^rND^sDourado^nMCN
#^rND^sMarinho^nV#^rND^sSoares^nC#^rND^sEngelhardt^nE#^rND^sLaks^nJ#Awareness of
 disease in dementia: development of a multidimensional rating scale^len#Dement 
Neuropsychol#2#20070000#2007#1#74-80#20110000#v60n1a10.htm##
00609000000000313000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100017000980100
02100115010001700136012006500153030001000218065000900228064000500237031000300242
032000200245014000600247865000900253002001300262035001000275801001000285#v60n1#V
:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#187#28#article#35#28#^rND^s
Antoine^nC#^rND^sAntoine^nP#^rND^sGuermonprez^nP#^rND^sFrigard^nB#Awareness of d
eficits and anosognosia in Alzheimer's disease^len#Encephale#20040000#2004#30#6#
570-7#20110000#v60n1a10.htm#0013-7006#Encephale##
00741000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100016000810100016000970100
01400113010001700127010001600144010001700160810000600177012014000183030001200323
06500090033506400050034403100030034901400070035286500090035900200130036803500100
0381801001200391#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#188
#29#article#35#29#^rND^sHaxby^nJV#^rND^sGrady^nCL#^rND^sKoss^nE#^rND^sHorwitz^nB
#^rND^sHeston^nL#^rND^sShapiro^nM#et al#Longitudinal study of cerebral metabolic
 asymmetries and associated neuropsychological patterns in early dementia of the
 Alzheimer type^len#Arch Neurol#19900000#1990#47#753-60#20110000#v60n1a10.htm#00
03-9942#Arch Neurol##
00517000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100017000980120
03600115030001600151065000900167064000500176031000300181014000700184865000900191
002001300200035001000213801001600223#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a10.htm#S#c#189#30#article#35#30#^rND^sPakrasi^nS#^rND^sO'Brien JT#Emission
 tomography in dementia^len#Nucl Med Commun#20050000#2005#26#189-96#20110000#v60
n1a10.htm#0143-3636#Nucl Med Commun##
00603000000000289000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100018000810100014000990100
01800113012011700131030001700248710000200265065000900267064000500276031000200281
032000200283014000600285865000900291002001300300#v60n1#V:\SciELO\serial\jbpsiq\v
60n1\markup\v60n1a10.htm#S#c#190#31#article#35#31#^rND^sWaldemar^nG#^rND^sHogh^n
P#^rND^sPaulson^nOB#Functional brain imaging with single proton emission compute
d tomography in the diagnosis of Alzheimer's disease^len#Int Psychogeriat#2#1997
0000#1997#9#1#223-7#20110000#v60n1a10.htm##
00753000000000337000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810100022000960100
01700118010001400135010001800149010001800167012011900185030002700304065000900331
06400050034003100030034503200020034801400060035086500090035600200130036503500100
0378801002700388#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#191
#32#article#35#32#^rND^sVogel^nA#^rND^sHasselbalch^nSG#^rND^sZiebell^nM#^rND^sGa
de^nA#^rND^sStokholm^nJ#^rND^sWaldemar^nG#Awareness of deficits in mild cognitiv
e impairment and Alzheimer's disease: do MCI patients have impaired insight?^len
#Dement Geriatr Cogn Disord#20040000#2004#17#3#181-7#20110000#v60n1a10.htm#1420-
8008#Dement Geriatr Cogn Disord##
00567000000000277000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100017000810100017000980100
01500115012008800130030002400218710000200242065000900244064000500253031000200258
014000700260865000900267002001300276#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\
v60n1a10.htm#S#c#192#33#article#35#33#^rND^sCorrea^nDD#^rND^sGraves^nRE#^rND^sCo
sta^nL#Awareness of memory deficit in Alzheimer's patient and memory-impaired ol
der adults^len#Aging Neuropsychol Cogn#2#19960000#1996#3#215-28#20110000#v60n1a1
0.htm##
00537000000000265000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780100015000810120083000960300
01800179065000900197064000500206031000300211014000700214865000900221002001300230
035001000243801001800253#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm
#S#c#193#34#article#35#34#^rND^sClare^nL#Awareness in early-stage Alzheimer's di
sease: a review of methods and evidence^len#Br J Clin Psychol#20040000#2004#43#1
77-96#20110000#v60n1a10.htm#0144-6657#Br J Clin Psychol##
00507000000000241000450000400060000070200500000670500020005670600020005870000040
00607010003000647090008000677080003000751180003000780160018000810160018000990180
07500117066001000192062002700202065000900229064000500238865000900243002001300252
#v60n1#V:\SciELO\serial\jbpsiq\v60n1\markup\v60n1a10.htm#S#c#194#35#article#35#3
5#^rND^sMarková^nIS#^rND^sBerrios^nGE#Insight into memory deficits: Memory disor
ders in psychiatric practice^len#Cambridge#Cambridge University Press#20000000#2
000#20110000#v60n1a10.htm##
